# Analysis Type:	PANTHER Overrepresentation Test (Released 20210224)
# Annotation Version and Release Date:	GO Ontology database DOI:  10.5281/zenodo.4437524 Released 2021-01-01
# Analyzed List:	HG_high_agg.txt (Mus musculus)
# Reference List:	ORF_backgound.txt (Mus musculus)
# Test Type:	FISHER
# Correction:	FDR
# GO biological process complete	ORF_backgound.txt - REFLIST (9445)	HG_high_agg.txt (259)	HG_high_agg.txt (expected)	HG_high_agg.txt (over/under)	HG_high_agg.txt (fold Enrichment)	HG_high_agg.txt (raw P-value)	HG_high_agg.txt (FDR)
dolichol biosynthetic process (GO:0019408)	1	1	.03	+	36.47	5.27E-02	1.00E00
positive regulation of cellular defense response (GO:0010186)	1	1	.03	+	36.47	5.27E-02	1.00E00
regulation of cellular defense response (GO:0010185)	1	1	.03	+	36.47	5.27E-02	1.00E00
negative regulation of erythrocyte aggregation (GO:0034119)	1	1	.03	+	36.47	5.27E-02	1.00E00
regulation of erythrocyte aggregation (GO:0034118)	1	1	.03	+	36.47	5.27E-02	1.00E00
negative regulation of erythrocyte clearance (GO:0034107)	1	1	.03	+	36.47	5.27E-02	1.00E00
regulation of erythrocyte clearance (GO:0034106)	1	1	.03	+	36.47	5.27E-02	1.00E00
fatty alcohol metabolic process (GO:1903173)	1	1	.03	+	36.47	5.27E-02	1.00E00
dolichol metabolic process (GO:0019348)	1	1	.03	+	36.47	5.27E-02	1.00E00
chemokine receptor transport within lipid bilayer (GO:0033606)	1	1	.03	+	36.47	5.27E-02	1.00E00
dCTP metabolic process (GO:0046065)	1	1	.03	+	36.47	5.27E-02	1.00E00
ITP metabolic process (GO:0046041)	1	1	.03	+	36.47	5.27E-02	1.00E00
negative regulation of T cell homeostatic proliferation (GO:0046014)	1	1	.03	+	36.47	5.27E-02	1.00E00
regulation of T cell homeostatic proliferation (GO:0046013)	1	1	.03	+	36.47	5.27E-02	1.00E00
artery vasodilation involved in baroreceptor response to increased systemic arterial blood pressure (GO:0001984)	1	1	.03	+	36.47	5.27E-02	1.00E00
baroreceptor response to increased systemic arterial blood pressure (GO:0001983)	1	1	.03	+	36.47	5.27E-02	1.00E00
regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback (GO:0001978)	1	1	.03	+	36.47	5.27E-02	1.00E00
metanephric connecting tubule development (GO:0072286)	1	1	.03	+	36.47	5.27E-02	1.00E00
metanephric glomerular endothelium development (GO:0072264)	1	1	.03	+	36.47	5.27E-02	1.00E00
metanephric glomerular mesangial cell proliferation involved in metanephros development (GO:0072262)	1	1	.03	+	36.47	5.27E-02	1.00E00
metanephric glomerular mesangial cell development (GO:0072255)	1	1	.03	+	36.47	5.27E-02	1.00E00
metanephric glomerular mesangial cell differentiation (GO:0072254)	1	1	.03	+	36.47	5.27E-02	1.00E00
metanephric glomerular mesangium development (GO:0072223)	1	1	.03	+	36.47	5.27E-02	1.00E00
metanephric mesangial cell differentiation (GO:0072209)	1	1	.03	+	36.47	5.27E-02	1.00E00
hepatic immune response (GO:0002384)	1	1	.03	+	36.47	5.27E-02	1.00E00
endomitotic cell cycle (GO:0007113)	1	1	.03	+	36.47	5.27E-02	1.00E00
generation of ovulation cycle rhythm (GO:0060112)	1	1	.03	+	36.47	5.27E-02	1.00E00
negative regulation of transforming growth factor beta3 production (GO:0032913)	1	1	.03	+	36.47	5.27E-02	1.00E00
phosphatidylserine catabolic process (GO:0006660)	1	1	.03	+	36.47	5.27E-02	1.00E00
neutrophil apoptotic process (GO:0001781)	1	1	.03	+	36.47	5.27E-02	1.00E00
phytol metabolic process (GO:0033306)	1	1	.03	+	36.47	5.27E-02	1.00E00
connecting tubule development (GO:0072027)	1	1	.03	+	36.47	5.27E-02	1.00E00
interleukin-33-mediated signaling pathway (GO:0038172)	1	1	.03	+	36.47	5.27E-02	1.00E00
glomerular endothelium development (GO:0072011)	1	1	.03	+	36.47	5.27E-02	1.00E00
tRNA wobble base cytosine methylation (GO:0002127)	1	1	.03	+	36.47	5.27E-02	1.00E00
positive regulation of eosinophil chemotaxis (GO:2000424)	1	1	.03	+	36.47	5.27E-02	1.00E00
regulation of eosinophil chemotaxis (GO:2000422)	1	1	.03	+	36.47	5.27E-02	1.00E00
positive regulation of eosinophil migration (GO:2000418)	1	1	.03	+	36.47	5.27E-02	1.00E00
regulation of eosinophil migration (GO:2000416)	1	1	.03	+	36.47	5.27E-02	1.00E00
ovarian cumulus expansion (GO:0001550)	1	1	.03	+	36.47	5.27E-02	1.00E00
chemokine receptor transport out of membrane raft (GO:0032600)	1	1	.03	+	36.47	5.27E-02	1.00E00
DNA double-strand break attachment to nuclear envelope (GO:1990683)	1	1	.03	+	36.47	5.27E-02	1.00E00
peptidyl-serine ADP-deribosylation (GO:0140290)	1	1	.03	+	36.47	5.27E-02	1.00E00
protein transport out of membrane raft (GO:0032599)	1	1	.03	+	36.47	5.27E-02	1.00E00
positive regulation of male germ cell proliferation (GO:2000256)	1	1	.03	+	36.47	5.27E-02	1.00E00
positive regulation of hypoxia-inducible factor-1alpha signaling pathway (GO:1902073)	1	1	.03	+	36.47	5.27E-02	1.00E00
dCTP catabolic process (GO:0006253)	1	1	.03	+	36.47	5.27E-02	1.00E00
positive regulation of germ cell proliferation (GO:1905938)	1	1	.03	+	36.47	5.27E-02	1.00E00
ITP catabolic process (GO:0006193)	1	1	.03	+	36.47	5.27E-02	1.00E00
CMP-N-acetylneuraminate biosynthetic process (GO:0006055)	1	1	.03	+	36.47	5.27E-02	1.00E00
N-terminal peptidyl-glutamic acid acetylation (GO:0018002)	1	1	.03	+	36.47	5.27E-02	1.00E00
radial pattern formation (GO:0009956)	1	1	.03	+	36.47	5.27E-02	1.00E00
regulation of mitochondrial ATP synthesis coupled proton transport (GO:1905706)	1	1	.03	+	36.47	5.27E-02	1.00E00
protein maturation by [2Fe-2S] cluster transfer (GO:0106034)	1	1	.03	+	36.47	5.27E-02	1.00E00
negative regulation of white fat cell proliferation (GO:0070351)	1	1	.03	+	36.47	5.27E-02	1.00E00
glycine import into mitochondrion (GO:1904983)	1	1	.03	+	36.47	5.27E-02	1.00E00
negative regulation of macrophage proliferation (GO:0120042)	1	1	.03	+	36.47	5.27E-02	1.00E00
N-terminal peptidyl-aspartic acid acetylation (GO:0017190)	1	1	.03	+	36.47	5.27E-02	1.00E00
positive regulation of hepatic stellate cell proliferation (GO:1904899)	1	1	.03	+	36.47	5.27E-02	1.00E00
regulation of hepatic stellate cell proliferation (GO:1904897)	1	1	.03	+	36.47	5.27E-02	1.00E00
epinephrine secretion (GO:0048242)	1	1	.03	+	36.47	5.27E-02	1.00E00
epinephrine transport (GO:0048241)	1	1	.03	+	36.47	5.27E-02	1.00E00
glucagon secretion (GO:0070091)	1	1	.03	+	36.47	5.27E-02	1.00E00
fused antrum stage (GO:0048165)	1	1	.03	+	36.47	5.27E-02	1.00E00
regulation of granulosa cell apoptotic process (GO:1904708)	1	1	.03	+	36.47	5.27E-02	1.00E00
positive regulation of vascular associated smooth muscle cell dedifferentiation (GO:1905176)	1	1	.03	+	36.47	5.27E-02	1.00E00
B cell costimulation (GO:0031296)	1	1	.03	+	36.47	5.27E-02	1.00E00
pseudopodium retraction (GO:0031270)	1	1	.03	+	36.47	5.27E-02	1.00E00
metanephric part of ureteric bud development (GO:0035502)	1	1	.03	+	36.47	5.27E-02	1.00E00
purine ribonucleoside triphosphate catabolic process (GO:0009207)	1	1	.03	+	36.47	5.27E-02	1.00E00
ribonucleoside triphosphate catabolic process (GO:0009203)	1	1	.03	+	36.47	5.27E-02	1.00E00
glycine transport (GO:0015816)	1	1	.03	+	36.47	5.27E-02	1.00E00
positive regulation of CD80 production (GO:0150145)	1	1	.03	+	36.47	5.27E-02	1.00E00
regulation of CD80 production (GO:0150143)	1	1	.03	+	36.47	5.27E-02	1.00E00
positive regulation of CD86 production (GO:0150142)	1	1	.03	+	36.47	5.27E-02	1.00E00
regulation of CD86 production (GO:0150140)	1	1	.03	+	36.47	5.27E-02	1.00E00
positive regulation of skeletal muscle acetylcholine-gated channel clustering (GO:1904395)	1	1	.03	+	36.47	5.27E-02	1.00E00
fatty acid elongation (GO:0030497)	1	1	.03	+	36.47	5.27E-02	1.00E00
positive regulation of PERK-mediated unfolded protein response (GO:1903899)	1	1	.03	+	36.47	5.27E-02	1.00E00
positive regulation of calcium-dependent ATPase activity (GO:1903612)	1	1	.03	+	36.47	5.27E-02	1.00E00
regulation of growth plate cartilage chondrocyte proliferation (GO:0003420)	1	1	.03	+	36.47	5.27E-02	1.00E00
positive regulation of T cell homeostatic proliferation (GO:0042103)	1	1	.03	+	36.47	5.27E-02	1.00E00
tRNA threonylcarbamoyladenosine modification (GO:0002949)	1	1	.03	+	36.47	5.27E-02	1.00E00
regulation of growth hormone activity (GO:1903547)	1	1	.03	+	36.47	5.27E-02	1.00E00
negative regulation of hair follicle placode formation (GO:0061170)	1	1	.03	+	36.47	5.27E-02	1.00E00
regulation of hair follicle placode formation (GO:0061168)	1	1	.03	+	36.47	5.27E-02	1.00E00
regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling (GO:0060665)	1	1	.03	+	36.47	5.27E-02	1.00E00
positive regulation of natural killer cell cytokine production (GO:0002729)	1	1	.03	+	36.47	5.27E-02	1.00E00
regulation of natural killer cell cytokine production (GO:0002727)	1	1	.03	+	36.47	5.27E-02	1.00E00
negative regulation of polyamine transmembrane transport (GO:1902268)	3	2	.08	+	24.31	6.73E-03	1.00E00
response to interleukin-18 (GO:0070673)	3	2	.08	+	24.31	6.73E-03	1.00E00
activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO:0008635)	3	2	.08	+	24.31	6.73E-03	1.00E00
epithelial cell proliferation involved in salivary gland morphogenesis (GO:0060664)	3	2	.08	+	24.31	6.73E-03	1.00E00
response to glucagon (GO:0033762)	2	1	.05	+	18.23	7.80E-02	1.00E00
L-cysteine catabolic process to taurine (GO:0019452)	2	1	.05	+	18.23	7.80E-02	1.00E00
regulation of systemic arterial blood pressure by baroreceptor feedback (GO:0003025)	2	1	.05	+	18.23	7.80E-02	1.00E00
regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034127)	2	1	.05	+	18.23	7.80E-02	1.00E00
regulation of MyD88-dependent toll-like receptor signaling pathway (GO:0034124)	2	1	.05	+	18.23	7.80E-02	1.00E00
inflammatory cell apoptotic process (GO:0006925)	2	1	.05	+	18.23	7.80E-02	1.00E00
positive regulation of luteinizing hormone secretion (GO:0033686)	2	1	.05	+	18.23	7.80E-02	1.00E00
regulation of luteinizing hormone secretion (GO:0033684)	2	1	.05	+	18.23	7.80E-02	1.00E00
negative regulation of exo-alpha-sialidase activity (GO:1903016)	2	1	.05	+	18.23	7.80E-02	1.00E00
regulation of exo-alpha-sialidase activity (GO:1903015)	2	1	.05	+	18.23	7.80E-02	1.00E00
metanephric glomerular epithelium development (GO:0072244)	2	1	.05	+	18.23	7.80E-02	1.00E00
monoacylglycerol catabolic process (GO:0052651)	2	1	.05	+	18.23	7.80E-02	1.00E00
plasma cell differentiation (GO:0002317)	2	1	.05	+	18.23	7.80E-02	1.00E00
glomerular mesangial cell development (GO:0072144)	2	1	.05	+	18.23	7.80E-02	1.00E00
positive regulation of adenosine receptor signaling pathway (GO:0060168)	2	1	.05	+	18.23	7.80E-02	1.00E00
glomerular mesangial cell proliferation (GO:0072110)	2	1	.05	+	18.23	7.80E-02	1.00E00
L-alpha-amino acid transmembrane transport (GO:1902475)	4	2	.11	+	18.23	9.92E-03	1.00E00
deactivation of mitotic spindle assembly checkpoint (GO:1902426)	2	1	.05	+	18.23	7.80E-02	1.00E00
T-helper 1 cell lineage commitment (GO:0002296)	2	1	.05	+	18.23	7.80E-02	1.00E00
microglial cell activation involved in immune response (GO:0002282)	2	1	.05	+	18.23	7.80E-02	1.00E00
follicular dendritic cell differentiation (GO:0002268)	2	1	.05	+	18.23	7.80E-02	1.00E00
follicular dendritic cell activation (GO:0002266)	2	1	.05	+	18.23	7.80E-02	1.00E00
xenobiotic detoxification by transmembrane export across the plasma membrane (GO:1990961)	2	1	.05	+	18.23	7.80E-02	1.00E00
positive regulation of metanephric mesenchymal cell migration (GO:2000591)	2	1	.05	+	18.23	7.80E-02	1.00E00
negative regulation by host of viral glycoprotein metabolic process (GO:0044871)	2	1	.05	+	18.23	7.80E-02	1.00E00
modulation by host of viral glycoprotein metabolic process (GO:0044870)	2	1	.05	+	18.23	7.80E-02	1.00E00
negative regulation by host of viral exo-alpha-sialidase activity (GO:0044869)	2	1	.05	+	18.23	7.80E-02	1.00E00
modulation by host of viral catalytic activity (GO:0044867)	2	1	.05	+	18.23	7.80E-02	1.00E00
modulation by host of viral exo-alpha-sialidase activity (GO:0044866)	2	1	.05	+	18.23	7.80E-02	1.00E00
protein localization to plasma membrane raft (GO:0044860)	2	1	.05	+	18.23	7.80E-02	1.00E00
glomerular mesangial cell differentiation (GO:0072008)	2	1	.05	+	18.23	7.80E-02	1.00E00
modulation by host of symbiont catalytic activity (GO:0052422)	2	1	.05	+	18.23	7.80E-02	1.00E00
negative regulation by host of symbiont catalytic activity (GO:0052403)	2	1	.05	+	18.23	7.80E-02	1.00E00
cellular response to mycophenolic acid (GO:0071506)	2	1	.05	+	18.23	7.80E-02	1.00E00
response to mycophenolic acid (GO:0071505)	2	1	.05	+	18.23	7.80E-02	1.00E00
tRNA wobble cytosine modification (GO:0002101)	2	1	.05	+	18.23	7.80E-02	1.00E00
negative regulation of hepatic stellate cell activation (GO:2000490)	2	1	.05	+	18.23	7.80E-02	1.00E00
regulation of glycogen (starch) synthase activity (GO:2000465)	2	1	.05	+	18.23	7.80E-02	1.00E00
cell cycle DNA replication maintenance of fidelity (GO:1902298)	2	1	.05	+	18.23	7.80E-02	1.00E00
positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway (GO:0038033)	2	1	.05	+	18.23	7.80E-02	1.00E00
dolichyl diphosphate biosynthetic process (GO:0006489)	2	1	.05	+	18.23	7.80E-02	1.00E00
paracrine signaling (GO:0038001)	2	1	.05	+	18.23	7.80E-02	1.00E00
asparaginyl-tRNA aminoacylation (GO:0006421)	2	1	.05	+	18.23	7.80E-02	1.00E00
regulation of cell growth by extracellular stimulus (GO:0001560)	2	1	.05	+	18.23	7.80E-02	1.00E00
modulation of catalytic activity in other organism involved in symbiotic interaction (GO:0052203)	2	1	.05	+	18.23	7.80E-02	1.00E00
interleukin-21 production (GO:0032625)	2	1	.05	+	18.23	7.80E-02	1.00E00
interferon-beta production (GO:0032608)	2	1	.05	+	18.23	7.80E-02	1.00E00
cellular response to interleukin-18 (GO:0071351)	2	1	.05	+	18.23	7.80E-02	1.00E00
T-helper 2 cell differentiation (GO:0045064)	4	2	.11	+	18.23	9.92E-03	1.00E00
negative regulation of catalytic activity in other organism involved in symbiotic interaction (GO:0052199)	2	1	.05	+	18.23	7.80E-02	1.00E00
peripheral nervous system neuron axonogenesis (GO:0048936)	2	1	.05	+	18.23	7.80E-02	1.00E00
regulation of hypoxia-inducible factor-1alpha signaling pathway (GO:1902071)	2	1	.05	+	18.23	7.80E-02	1.00E00
mitotic DNA replication maintenance of fidelity (GO:1990505)	2	1	.05	+	18.23	7.80E-02	1.00E00
peptidyl-aspartic acid modification (GO:0018197)	2	1	.05	+	18.23	7.80E-02	1.00E00
protein urmylation (GO:0032447)	2	1	.05	+	18.23	7.80E-02	1.00E00
mitotic recombination-dependent replication fork processing (GO:1990426)	2	1	.05	+	18.23	7.80E-02	1.00E00
negative regulation of phospholipid biosynthetic process (GO:0071072)	2	1	.05	+	18.23	7.80E-02	1.00E00
chitin catabolic process (GO:0006032)	2	1	.05	+	18.23	7.80E-02	1.00E00
chitin metabolic process (GO:0006030)	2	1	.05	+	18.23	7.80E-02	1.00E00
regulation of chorionic trophoblast cell proliferation (GO:1901382)	2	1	.05	+	18.23	7.80E-02	1.00E00
positive regulation of gonadotropin secretion (GO:0032278)	2	1	.05	+	18.23	7.80E-02	1.00E00
positive regulation of inflammatory response to wounding (GO:0106016)	2	1	.05	+	18.23	7.80E-02	1.00E00
negative regulation of inflammatory response to wounding (GO:0106015)	2	1	.05	+	18.23	7.80E-02	1.00E00
rRNA (guanine-N7)-methylation (GO:0070476)	2	1	.05	+	18.23	7.80E-02	1.00E00
nucleotide-binding oligomerization domain containing 1 signaling pathway (GO:0070427)	2	1	.05	+	18.23	7.80E-02	1.00E00
circadian sleep/wake cycle, sleep (GO:0050802)	2	1	.05	+	18.23	7.80E-02	1.00E00
cellular amide catabolic process (GO:0043605)	2	1	.05	+	18.23	7.80E-02	1.00E00
insulin catabolic process (GO:1901143)	2	1	.05	+	18.23	7.80E-02	1.00E00
regulation of white fat cell proliferation (GO:0070350)	2	1	.05	+	18.23	7.80E-02	1.00E00
lymphatic endothelial cell migration (GO:1904977)	2	1	.05	+	18.23	7.80E-02	1.00E00
positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway (GO:0035793)	2	1	.05	+	18.23	7.80E-02	1.00E00
T-helper 2 cell cytokine production (GO:0035745)	2	1	.05	+	18.23	7.80E-02	1.00E00
CD4-positive, alpha-beta T cell cytokine production (GO:0035743)	2	1	.05	+	18.23	7.80E-02	1.00E00
vacuolar proton-transporting V-type ATPase complex assembly (GO:0070072)	2	1	.05	+	18.23	7.80E-02	1.00E00
proton-transporting V-type ATPase complex assembly (GO:0070070)	2	1	.05	+	18.23	7.80E-02	1.00E00
catecholamine secretion (GO:0050432)	2	1	.05	+	18.23	7.80E-02	1.00E00
regulation of vascular associated smooth muscle cell dedifferentiation (GO:1905174)	2	1	.05	+	18.23	7.80E-02	1.00E00
interleukin-18-mediated signaling pathway (GO:0035655)	2	1	.05	+	18.23	7.80E-02	1.00E00
lymphocyte costimulation (GO:0031294)	6	3	.16	+	18.23	1.40E-03	1.00E00
folic acid-containing compound catabolic process (GO:0009397)	2	1	.05	+	18.23	7.80E-02	1.00E00
positive regulation of metalloendopeptidase activity (GO:1904685)	2	1	.05	+	18.23	7.80E-02	1.00E00
circadian sleep/wake cycle, non-REM sleep (GO:0042748)	2	1	.05	+	18.23	7.80E-02	1.00E00
regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway (GO:1900238)	2	1	.05	+	18.23	7.80E-02	1.00E00
positive regulation of metallopeptidase activity (GO:1905050)	2	1	.05	+	18.23	7.80E-02	1.00E00
10-formyltetrahydrofolate catabolic process (GO:0009258)	2	1	.05	+	18.23	7.80E-02	1.00E00
pyrimidine deoxyribonucleoside triphosphate catabolic process (GO:0009213)	2	1	.05	+	18.23	7.80E-02	1.00E00
positive regulation of hyaluronan biosynthetic process (GO:1900127)	2	1	.05	+	18.23	7.80E-02	1.00E00
L-glutamate transmembrane transport (GO:0015813)	2	1	.05	+	18.23	7.80E-02	1.00E00
pyrimidine nucleoside triphosphate catabolic process (GO:0009149)	2	1	.05	+	18.23	7.80E-02	1.00E00
histone H3-R17 methylation (GO:0034971)	2	1	.05	+	18.23	7.80E-02	1.00E00
histone H3-R2 methylation (GO:0034970)	2	1	.05	+	18.23	7.80E-02	1.00E00
pteridine-containing compound catabolic process (GO:0042560)	2	1	.05	+	18.23	7.80E-02	1.00E00
positive regulation of establishment of T cell polarity (GO:1903905)	2	1	.05	+	18.23	7.80E-02	1.00E00
regulation of PERK-mediated unfolded protein response (GO:1903897)	2	1	.05	+	18.23	7.80E-02	1.00E00
negative regulation of cellular response to transforming growth factor beta stimulus (GO:1903845)	2	1	.05	+	18.23	7.80E-02	1.00E00
neuroinflammatory response (GO:0150076)	2	1	.05	+	18.23	7.80E-02	1.00E00
'de novo' GDP-L-fucose biosynthetic process (GO:0042351)	2	1	.05	+	18.23	7.80E-02	1.00E00
fructosamine metabolic process (GO:0030389)	2	1	.05	+	18.23	7.80E-02	1.00E00
polyprenol biosynthetic process (GO:0016094)	2	1	.05	+	18.23	7.80E-02	1.00E00
polyprenol metabolic process (GO:0016093)	2	1	.05	+	18.23	7.80E-02	1.00E00
negative regulation of phospholipid metabolic process (GO:1903726)	2	1	.05	+	18.23	7.80E-02	1.00E00
negative regulation of adipose tissue development (GO:1904178)	2	1	.05	+	18.23	7.80E-02	1.00E00
DNA protection (GO:0042262)	2	1	.05	+	18.23	7.80E-02	1.00E00
negative regulation of complement-dependent cytotoxicity (GO:1903660)	2	1	.05	+	18.23	7.80E-02	1.00E00
regulation of calcium-dependent ATPase activity (GO:1903610)	2	1	.05	+	18.23	7.80E-02	1.00E00
lymphatic endothelial cell fate commitment (GO:0060838)	2	1	.05	+	18.23	7.80E-02	1.00E00
tRNA C5-cytosine methylation (GO:0002946)	2	1	.05	+	18.23	7.80E-02	1.00E00
negative regulation of phosphatidylinositol biosynthetic process (GO:0010512)	2	1	.05	+	18.23	7.80E-02	1.00E00
regulation of phosphatidylinositol biosynthetic process (GO:0010511)	2	1	.05	+	18.23	7.80E-02	1.00E00
dolichyl diphosphate metabolic process (GO:0046465)	2	1	.05	+	18.23	7.80E-02	1.00E00
actin modification (GO:0030047)	2	1	.05	+	18.23	7.80E-02	1.00E00
positive regulation of T cell mediated immune response to tumor cell (GO:0002842)	2	1	.05	+	18.23	7.80E-02	1.00E00
circadian sleep/wake cycle process (GO:0022410)	2	1	.05	+	18.23	7.80E-02	1.00E00
positive regulation of mitotic cell cycle, embryonic (GO:0045977)	2	1	.05	+	18.23	7.80E-02	1.00E00
negative regulation of T-helper 1 type immune response (GO:0002826)	2	1	.05	+	18.23	7.80E-02	1.00E00
CMP-N-acetylneuraminate metabolic process (GO:0046381)	2	1	.05	+	18.23	7.80E-02	1.00E00
mesenchymal-epithelial cell signaling (GO:0060638)	2	1	.05	+	18.23	7.80E-02	1.00E00
sclerotome development (GO:0061056)	2	1	.05	+	18.23	7.80E-02	1.00E00
secretion by lung epithelial cell involved in lung growth (GO:0061033)	2	1	.05	+	18.23	7.80E-02	1.00E00
positive regulation of glomerular filtration (GO:0003104)	2	1	.05	+	18.23	7.80E-02	1.00E00
germinal center B cell differentiation (GO:0002314)	5	2	.14	+	14.59	1.36E-02	1.00E00
regulation of hepatic stellate cell activation (GO:2000489)	5	2	.14	+	14.59	1.36E-02	1.00E00
regulation of polyamine transmembrane transport (GO:1902267)	5	2	.14	+	14.59	1.36E-02	1.00E00
T cell costimulation (GO:0031295)	5	2	.14	+	14.59	1.36E-02	1.00E00
habituation (GO:0046959)	5	2	.14	+	14.59	1.36E-02	1.00E00
T follicular helper cell differentiation (GO:0061470)	5	2	.14	+	14.59	1.36E-02	1.00E00
chromosome attachment to the nuclear envelope (GO:0097240)	5	2	.14	+	14.59	1.36E-02	1.00E00
positive regulation of immune response to tumor cell (GO:0002839)	5	2	.14	+	14.59	1.36E-02	1.00E00
positive regulation of response to tumor cell (GO:0002836)	5	2	.14	+	14.59	1.36E-02	1.00E00
branching involved in salivary gland morphogenesis (GO:0060445)	8	3	.22	+	13.68	2.65E-03	1.00E00
lipid translocation (GO:0034204)	3	1	.08	+	12.16	1.03E-01	1.00E00
L-cysteine catabolic process (GO:0019448)	3	1	.08	+	12.16	1.03E-01	1.00E00
regulation of glomerular filtration (GO:0003093)	3	1	.08	+	12.16	1.03E-01	1.00E00
negative regulation of megakaryocyte differentiation (GO:0045653)	3	1	.08	+	12.16	1.03E-01	1.00E00
metanephric glomerulus vasculature development (GO:0072239)	3	1	.08	+	12.16	1.03E-01	1.00E00
thiamine metabolic process (GO:0006772)	3	1	.08	+	12.16	1.03E-01	1.00E00
positive regulation of apoptotic DNA fragmentation (GO:1902512)	3	1	.08	+	12.16	1.03E-01	1.00E00
T cell cytokine production (GO:0002369)	3	1	.08	+	12.16	1.03E-01	1.00E00
mesangial cell development (GO:0072143)	3	1	.08	+	12.16	1.03E-01	1.00E00
negative regulation of interleukin-1-mediated signaling pathway (GO:2000660)	3	1	.08	+	12.16	1.03E-01	1.00E00
regulation of adenosine receptor signaling pathway (GO:0060167)	3	1	.08	+	12.16	1.03E-01	1.00E00
glomerular mesangium development (GO:0072109)	3	1	.08	+	12.16	1.03E-01	1.00E00
regulation of transforming growth factor beta3 production (GO:0032910)	3	1	.08	+	12.16	1.03E-01	1.00E00
SRP-dependent cotranslational protein targeting to membrane (GO:0006614)	6	2	.16	+	12.16	1.79E-02	1.00E00
cotranslational protein targeting to membrane (GO:0006613)	6	2	.16	+	12.16	1.79E-02	1.00E00
positive regulation of MHC class II biosynthetic process (GO:0045348)	6	2	.16	+	12.16	1.79E-02	1.00E00
phospholipid translocation (GO:0045332)	3	1	.08	+	12.16	1.03E-01	1.00E00
regulation of metanephric mesenchymal cell migration (GO:2000589)	3	1	.08	+	12.16	1.03E-01	1.00E00
modulation by host of viral molecular function (GO:0044868)	3	1	.08	+	12.16	1.03E-01	1.00E00
granzyme-mediated programmed cell death signaling pathway (GO:0140507)	3	1	.08	+	12.16	1.03E-01	1.00E00
thrombopoietin-mediated signaling pathway (GO:0038163)	3	1	.08	+	12.16	1.03E-01	1.00E00
mesangial cell differentiation (GO:0072007)	3	1	.08	+	12.16	1.03E-01	1.00E00
tRNA wobble position uridine thiolation (GO:0002143)	3	1	.08	+	12.16	1.03E-01	1.00E00
positive regulation of hepatic stellate cell activation (GO:2000491)	3	1	.08	+	12.16	1.03E-01	1.00E00
oligosaccharide-lipid intermediate biosynthetic process (GO:0006490)	3	1	.08	+	12.16	1.03E-01	1.00E00
dolichol-linked oligosaccharide biosynthetic process (GO:0006488)	3	1	.08	+	12.16	1.03E-01	1.00E00
regulation of circadian sleep/wake cycle, non-REM sleep (GO:0045188)	6	2	.16	+	12.16	1.79E-02	1.00E00
antral ovarian follicle growth (GO:0001547)	3	1	.08	+	12.16	1.03E-01	1.00E00
protein palmitoylation (GO:0018345)	3	1	.08	+	12.16	1.03E-01	1.00E00
negative regulation of hair follicle development (GO:0051799)	3	1	.08	+	12.16	1.03E-01	1.00E00
medium-chain fatty acid biosynthetic process (GO:0051792)	3	1	.08	+	12.16	1.03E-01	1.00E00
myeloid cell apoptotic process (GO:0033028)	3	1	.08	+	12.16	1.03E-01	1.00E00
protein transport within lipid bilayer (GO:0032594)	6	2	.16	+	12.16	1.79E-02	1.00E00
peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231)	3	1	.08	+	12.16	1.03E-01	1.00E00
peptidyl-L-cysteine S-palmitoylation (GO:0018230)	3	1	.08	+	12.16	1.03E-01	1.00E00
fatty acid transmembrane transport (GO:1902001)	3	1	.08	+	12.16	1.03E-01	1.00E00
export across plasma membrane (GO:0140115)	3	1	.08	+	12.16	1.03E-01	1.00E00
negative regulation of glucocorticoid biosynthetic process (GO:0031947)	3	1	.08	+	12.16	1.03E-01	1.00E00
negative regulation of glucocorticoid metabolic process (GO:0031944)	3	1	.08	+	12.16	1.03E-01	1.00E00
negative regulation of spindle checkpoint (GO:0090233)	3	1	.08	+	12.16	1.03E-01	1.00E00
negative regulation of cortisol biosynthetic process (GO:2000065)	3	1	.08	+	12.16	1.03E-01	1.00E00
negative regulation of aldosterone biosynthetic process (GO:0032348)	3	1	.08	+	12.16	1.03E-01	1.00E00
negative regulation of aldosterone metabolic process (GO:0032345)	3	1	.08	+	12.16	1.03E-01	1.00E00
foam cell differentiation (GO:0090077)	3	1	.08	+	12.16	1.03E-01	1.00E00
xenophagy (GO:0098792)	3	1	.08	+	12.16	1.03E-01	1.00E00
plasma membrane phospholipid scrambling (GO:0017121)	3	1	.08	+	12.16	1.03E-01	1.00E00
establishment or maintenance of microtubule cytoskeleton polarity (GO:0030951)	3	1	.08	+	12.16	1.03E-01	1.00E00
xenobiotic transport (GO:0042908)	3	1	.08	+	12.16	1.03E-01	1.00E00
thiamine-containing compound metabolic process (GO:0042723)	3	1	.08	+	12.16	1.03E-01	1.00E00
L-amino acid transport (GO:0015807)	3	1	.08	+	12.16	1.03E-01	1.00E00
nonassociative learning (GO:0046958)	6	2	.16	+	12.16	1.79E-02	1.00E00
cysteine catabolic process (GO:0009093)	3	1	.08	+	12.16	1.03E-01	1.00E00
positive regulation of mitotic sister chromatid segregation (GO:0062033)	3	1	.08	+	12.16	1.03E-01	1.00E00
sleep (GO:0030431)	3	1	.08	+	12.16	1.03E-01	1.00E00
microglial cell proliferation (GO:0061518)	3	1	.08	+	12.16	1.03E-01	1.00E00
macrophage proliferation (GO:0061517)	3	1	.08	+	12.16	1.03E-01	1.00E00
GDP-L-fucose biosynthetic process (GO:0042350)	3	1	.08	+	12.16	1.03E-01	1.00E00
pericyte cell differentiation (GO:1904238)	3	1	.08	+	12.16	1.03E-01	1.00E00
positive regulation of mitotic centrosome separation (GO:0046604)	3	1	.08	+	12.16	1.03E-01	1.00E00
growth hormone secretion (GO:0030252)	3	1	.08	+	12.16	1.03E-01	1.00E00
mammalian oogenesis stage (GO:0022605)	3	1	.08	+	12.16	1.03E-01	1.00E00
regulation of complement-dependent cytotoxicity (GO:1903659)	3	1	.08	+	12.16	1.03E-01	1.00E00
L-ascorbic acid biosynthetic process (GO:0019853)	3	1	.08	+	12.16	1.03E-01	1.00E00
endothelial cell fate commitment (GO:0060839)	3	1	.08	+	12.16	1.03E-01	1.00E00
lymphatic endothelial cell differentiation (GO:0060836)	3	1	.08	+	12.16	1.03E-01	1.00E00
positive regulation of B cell apoptotic process (GO:0002904)	3	1	.08	+	12.16	1.03E-01	1.00E00
amino acid transmembrane transport (GO:0003333)	6	2	.16	+	12.16	1.79E-02	1.00E00
monoacylglycerol metabolic process (GO:0046462)	3	1	.08	+	12.16	1.03E-01	1.00E00
L-cysteine metabolic process (GO:0046439)	3	1	.08	+	12.16	1.03E-01	1.00E00
protein repair (GO:0030091)	3	1	.08	+	12.16	1.03E-01	1.00E00
regulation of T cell mediated immune response to tumor cell (GO:0002840)	3	1	.08	+	12.16	1.03E-01	1.00E00
regulation of immune response to tumor cell (GO:0002837)	6	2	.16	+	12.16	1.79E-02	1.00E00
regulation of response to tumor cell (GO:0002834)	6	2	.16	+	12.16	1.79E-02	1.00E00
protein transport from ciliary membrane to plasma membrane (GO:1903445)	3	1	.08	+	12.16	1.03E-01	1.00E00
GDP-L-fucose metabolic process (GO:0046368)	3	1	.08	+	12.16	1.03E-01	1.00E00
protein localization to basolateral plasma membrane (GO:1903361)	3	1	.08	+	12.16	1.03E-01	1.00E00
positive regulation of epithelial cell proliferation involved in lung morphogenesis (GO:0060501)	3	1	.08	+	12.16	1.03E-01	1.00E00
mature B cell differentiation involved in immune response (GO:0002313)	14	4	.38	+	10.42	1.13E-03	1.00E00
heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157)	7	2	.19	+	10.42	2.26E-02	1.00E00
positive regulation of growth hormone secretion (GO:0060124)	7	2	.19	+	10.42	2.26E-02	1.00E00
T-helper cell lineage commitment (GO:0002295)	7	2	.19	+	10.42	2.26E-02	1.00E00
positive regulation of interleukin-13 production (GO:0032736)	7	2	.19	+	10.42	2.26E-02	1.00E00
glial cell proliferation (GO:0014009)	7	2	.19	+	10.42	2.26E-02	1.00E00
type 2 immune response (GO:0042092)	7	2	.19	+	10.42	2.26E-02	1.00E00
negative regulation of chronic inflammatory response (GO:0002677)	4	1	.11	+	9.12	1.27E-01	1.00E00
lung growth (GO:0060437)	4	1	.11	+	9.12	1.27E-01	1.00E00
toll-like receptor 2 signaling pathway (GO:0034134)	4	1	.11	+	9.12	1.27E-01	1.00E00
positive regulation of T-helper 2 cell differentiation (GO:0045630)	4	1	.11	+	9.12	1.27E-01	1.00E00
positive regulation of cell-cell adhesion mediated by integrin (GO:0033634)	4	1	.11	+	9.12	1.27E-01	1.00E00
negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394)	4	1	.11	+	9.12	1.27E-01	1.00E00
positive regulation of circadian sleep/wake cycle, non-REM sleep (GO:0046010)	4	1	.11	+	9.12	1.27E-01	1.00E00
fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540)	4	1	.11	+	9.12	1.27E-01	1.00E00
renal system process involved in regulation of blood volume (GO:0001977)	4	1	.11	+	9.12	1.27E-01	1.00E00
metanephric distal tubule development (GO:0072235)	4	1	.11	+	9.12	1.27E-01	1.00E00
metanephric glomerulus development (GO:0072224)	4	1	.11	+	9.12	1.27E-01	1.00E00
metanephric distal convoluted tubule development (GO:0072221)	4	1	.11	+	9.12	1.27E-01	1.00E00
cell proliferation involved in metanephros development (GO:0072203)	4	1	.11	+	9.12	1.27E-01	1.00E00
alpha-beta T cell lineage commitment (GO:0002363)	8	2	.22	+	9.12	2.77E-02	1.00E00
estrogen biosynthetic process (GO:0006703)	4	1	.11	+	9.12	1.27E-01	1.00E00
response to yeast (GO:0001878)	4	1	.11	+	9.12	1.27E-01	1.00E00
regulation of interleukin-1-mediated signaling pathway (GO:2000659)	4	1	.11	+	9.12	1.27E-01	1.00E00
positive regulation of glomerular mesangial cell proliferation (GO:0072126)	4	1	.11	+	9.12	1.27E-01	1.00E00
negative regulation of primary miRNA processing (GO:2000635)	4	1	.11	+	9.12	1.27E-01	1.00E00
regulation of primary miRNA processing (GO:2000634)	4	1	.11	+	9.12	1.27E-01	1.00E00
maternal process involved in parturition (GO:0060137)	4	1	.11	+	9.12	1.27E-01	1.00E00
phosphatidylserine metabolic process (GO:0006658)	4	1	.11	+	9.12	1.27E-01	1.00E00
regulation of MHC class II biosynthetic process (GO:0045346)	8	2	.22	+	9.12	2.77E-02	1.00E00
post-chaperonin tubulin folding pathway (GO:0007023)	4	1	.11	+	9.12	1.27E-01	1.00E00
distal convoluted tubule development (GO:0072025)	4	1	.11	+	9.12	1.27E-01	1.00E00
meiotic telomere tethering at nuclear periphery (GO:0044821)	4	1	.11	+	9.12	1.27E-01	1.00E00
catecholamine transport (GO:0051937)	4	1	.11	+	9.12	1.27E-01	1.00E00
positive regulation of cellular respiration (GO:1901857)	4	1	.11	+	9.12	1.27E-01	1.00E00
negative regulation of mitochondrial depolarization (GO:0051902)	4	1	.11	+	9.12	1.27E-01	1.00E00
positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902237)	4	1	.11	+	9.12	1.27E-01	1.00E00
regulation of circadian sleep/wake cycle, sleep (GO:0045187)	8	2	.22	+	9.12	2.77E-02	1.00E00
interferon-alpha production (GO:0032607)	4	1	.11	+	9.12	1.27E-01	1.00E00
regulation of male germ cell proliferation (GO:2000254)	4	1	.11	+	9.12	1.27E-01	1.00E00
regulation of mitochondrial mRNA stability (GO:0044528)	4	1	.11	+	9.12	1.27E-01	1.00E00
cellular response to muramyl dipeptide (GO:0071225)	8	2	.22	+	9.12	2.77E-02	1.00E00
cellular response to peptidoglycan (GO:0071224)	4	1	.11	+	9.12	1.27E-01	1.00E00
cellular response to lipoteichoic acid (GO:0071223)	4	1	.11	+	9.12	1.27E-01	1.00E00
regulation of germ cell proliferation (GO:1905936)	4	1	.11	+	9.12	1.27E-01	1.00E00
peptidyl-arginine ADP-ribosylation (GO:0018120)	4	1	.11	+	9.12	1.27E-01	1.00E00
response to interleukin-12 (GO:0070671)	4	1	.11	+	9.12	1.27E-01	1.00E00
regulation of intracellular cholesterol transport (GO:0032383)	4	1	.11	+	9.12	1.27E-01	1.00E00
regulation of intracellular sterol transport (GO:0032380)	4	1	.11	+	9.12	1.27E-01	1.00E00
regulation of intracellular lipid transport (GO:0032377)	4	1	.11	+	9.12	1.27E-01	1.00E00
negative regulation of skeletal muscle tissue development (GO:0048642)	4	1	.11	+	9.12	1.27E-01	1.00E00
protein maturation by [4Fe-4S] cluster transfer (GO:0106035)	4	1	.11	+	9.12	1.27E-01	1.00E00
regulation of inflammatory response to wounding (GO:0106014)	4	1	.11	+	9.12	1.27E-01	1.00E00
negative regulation of steroid hormone biosynthetic process (GO:0090032)	4	1	.11	+	9.12	1.27E-01	1.00E00
positive regulation by symbiont of entry into host (GO:0075294)	4	1	.11	+	9.12	1.27E-01	1.00E00
regulation of mitotic cell cycle, embryonic (GO:0009794)	4	1	.11	+	9.12	1.27E-01	1.00E00
response to lipoteichoic acid (GO:0070391)	4	1	.11	+	9.12	1.27E-01	1.00E00
positive regulation of DNA ligation (GO:0051106)	4	1	.11	+	9.12	1.27E-01	1.00E00
regulation of DNA ligation (GO:0051105)	4	1	.11	+	9.12	1.27E-01	1.00E00
negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901029)	4	1	.11	+	9.12	1.27E-01	1.00E00
positive regulation of thymocyte apoptotic process (GO:0070245)	4	1	.11	+	9.12	1.27E-01	1.00E00
hydrogen peroxide biosynthetic process (GO:0050665)	4	1	.11	+	9.12	1.27E-01	1.00E00
negative regulation of activation-induced cell death of T cells (GO:0070236)	4	1	.11	+	9.12	1.27E-01	1.00E00
protein homotrimerization (GO:0070207)	4	1	.11	+	9.12	1.27E-01	1.00E00
regulation of macrophage proliferation (GO:0120040)	4	1	.11	+	9.12	1.27E-01	1.00E00
mRNA 5'-splice site recognition (GO:0000395)	4	1	.11	+	9.12	1.27E-01	1.00E00
N-terminal peptidyl-methionine acetylation (GO:0017196)	4	1	.11	+	9.12	1.27E-01	1.00E00
meiotic attachment of telomere to nuclear envelope (GO:0070197)	4	1	.11	+	9.12	1.27E-01	1.00E00
positive regulation of isotype switching to IgE isotypes (GO:0048295)	4	1	.11	+	9.12	1.27E-01	1.00E00
activation of Janus kinase activity (GO:0042976)	4	1	.11	+	9.12	1.27E-01	1.00E00
RNA (guanine-N7)-methylation (GO:0036265)	4	1	.11	+	9.12	1.27E-01	1.00E00
CD4-positive, alpha-beta T cell lineage commitment (GO:0043373)	8	2	.22	+	9.12	2.77E-02	1.00E00
negative regulation of protein localization to centrosome (GO:1904780)	4	1	.11	+	9.12	1.27E-01	1.00E00
pseudopodium organization (GO:0031268)	4	1	.11	+	9.12	1.27E-01	1.00E00
regulation of metalloendopeptidase activity (GO:1904683)	4	1	.11	+	9.12	1.27E-01	1.00E00
regulation of circadian sleep/wake cycle (GO:0042749)	8	2	.22	+	9.12	2.77E-02	1.00E00
circadian sleep/wake cycle (GO:0042745)	4	1	.11	+	9.12	1.27E-01	1.00E00
positive regulation of amyloid-beta clearance (GO:1900223)	4	1	.11	+	9.12	1.27E-01	1.00E00
positive regulation of histone H3-K9 trimethylation (GO:1900114)	4	1	.11	+	9.12	1.27E-01	1.00E00
positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103)	4	1	.11	+	9.12	1.27E-01	1.00E00
amino acid import (GO:0043090)	4	1	.11	+	9.12	1.27E-01	1.00E00
nucleoside triphosphate catabolic process (GO:0009143)	8	2	.22	+	9.12	2.77E-02	1.00E00
neutral amino acid transport (GO:0015804)	4	1	.11	+	9.12	1.27E-01	1.00E00
regulation of establishment of T cell polarity (GO:1903903)	4	1	.11	+	9.12	1.27E-01	1.00E00
regulation of skeletal muscle acetylcholine-gated channel clustering (GO:1904393)	4	1	.11	+	9.12	1.27E-01	1.00E00
mannosylation (GO:0097502)	4	1	.11	+	9.12	1.27E-01	1.00E00
positive regulation of keratinocyte proliferation (GO:0010838)	4	1	.11	+	9.12	1.27E-01	1.00E00
protein mannosylation (GO:0035268)	4	1	.11	+	9.12	1.27E-01	1.00E00
oxygen transport (GO:0015671)	4	1	.11	+	9.12	1.27E-01	1.00E00
negative regulation of membrane depolarization (GO:1904180)	4	1	.11	+	9.12	1.27E-01	1.00E00
positive regulation of cytoplasmic mRNA processing body assembly (GO:0010606)	4	1	.11	+	9.12	1.27E-01	1.00E00
L-ascorbic acid metabolic process (GO:0019852)	4	1	.11	+	9.12	1.27E-01	1.00E00
positive regulation of DNA catabolic process (GO:1903626)	4	1	.11	+	9.12	1.27E-01	1.00E00
positive regulation of viral entry into host cell (GO:0046598)	4	1	.11	+	9.12	1.27E-01	1.00E00
strand invasion (GO:0042148)	4	1	.11	+	9.12	1.27E-01	1.00E00
vascular endothelial growth factor production (GO:0010573)	4	1	.11	+	9.12	1.27E-01	1.00E00
opsonization (GO:0008228)	4	1	.11	+	9.12	1.27E-01	1.00E00
cellular response to camptothecin (GO:0072757)	4	1	.11	+	9.12	1.27E-01	1.00E00
S-adenosylhomocysteine metabolic process (GO:0046498)	4	1	.11	+	9.12	1.27E-01	1.00E00
T-helper 1 type immune response (GO:0042088)	8	2	.22	+	9.12	2.77E-02	1.00E00
positive regulation of inflammatory response to antigenic stimulus (GO:0002863)	4	1	.11	+	9.12	1.27E-01	1.00E00
alkanesulfonate metabolic process (GO:0019694)	4	1	.11	+	9.12	1.27E-01	1.00E00
regulation of branching involved in salivary gland morphogenesis (GO:0060693)	4	1	.11	+	9.12	1.27E-01	1.00E00
telomere tethering at nuclear periphery (GO:0034398)	4	1	.11	+	9.12	1.27E-01	1.00E00
COP9 signalosome assembly (GO:0010387)	4	1	.11	+	9.12	1.27E-01	1.00E00
taurine metabolic process (GO:0019530)	4	1	.11	+	9.12	1.27E-01	1.00E00
epithelial cell proliferation involved in liver morphogenesis (GO:0072575)	4	1	.11	+	9.12	1.27E-01	1.00E00
hepatocyte proliferation (GO:0072574)	4	1	.11	+	9.12	1.27E-01	1.00E00
tRNA thio-modification (GO:0034227)	4	1	.11	+	9.12	1.27E-01	1.00E00
mature B cell differentiation (GO:0002335)	17	4	.47	+	8.58	2.07E-03	1.00E00
salivary gland morphogenesis (GO:0007435)	13	3	.36	+	8.42	8.13E-03	1.00E00
CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294)	18	4	.49	+	8.10	2.48E-03	1.00E00
microglial cell activation (GO:0001774)	9	2	.25	+	8.10	3.33E-02	1.00E00
polyamine biosynthetic process (GO:0006596)	9	2	.25	+	8.10	3.33E-02	1.00E00
positive regulation of interleukin-10 production (GO:0032733)	18	4	.49	+	8.10	2.48E-03	1.00E00
regulation of interleukin-13 production (GO:0032656)	9	2	.25	+	8.10	3.33E-02	1.00E00
positive regulation of alpha-beta T cell proliferation (GO:0046641)	9	2	.25	+	8.10	3.33E-02	1.00E00
T-helper cell differentiation (GO:0042093)	18	4	.49	+	8.10	2.48E-03	1.00E00
salivary gland development (GO:0007431)	14	3	.38	+	7.81	9.69E-03	1.00E00
mitochondrial cytochrome c oxidase assembly (GO:0033617)	14	3	.38	+	7.81	9.69E-03	1.00E00
response to protozoan (GO:0001562)	14	3	.38	+	7.81	9.69E-03	1.00E00
defense response to protozoan (GO:0042832)	14	3	.38	+	7.81	9.69E-03	1.00E00
respiratory chain complex IV assembly (GO:0008535)	14	3	.38	+	7.81	9.69E-03	1.00E00
alpha-beta T cell differentiation involved in immune response (GO:0002293)	19	4	.52	+	7.68	2.94E-03	1.00E00
alpha-beta T cell activation involved in immune response (GO:0002287)	19	4	.52	+	7.68	2.94E-03	1.00E00
regulation of chronic inflammatory response (GO:0002676)	5	1	.14	+	7.29	1.50E-01	1.00E00
positive regulation of fibroblast growth factor receptor signaling pathway (GO:0045743)	5	1	.14	+	7.29	1.50E-01	1.00E00
negative regulation of cardiac muscle hypertrophy in response to stress (GO:1903243)	5	1	.14	+	7.29	1.50E-01	1.00E00
melanosome assembly (GO:1903232)	5	1	.14	+	7.29	1.50E-01	1.00E00
leukocyte migration involved in inflammatory response (GO:0002523)	5	1	.14	+	7.29	1.50E-01	1.00E00
positive regulation of T-helper 1 cell differentiation (GO:0045627)	5	1	.14	+	7.29	1.50E-01	1.00E00
type I interferon signaling pathway (GO:0060337)	5	1	.14	+	7.29	1.50E-01	1.00E00
purine ribonucleoside bisphosphate metabolic process (GO:0034035)	5	1	.14	+	7.29	1.50E-01	1.00E00
positive regulation of B cell differentiation (GO:0045579)	5	1	.14	+	7.29	1.50E-01	1.00E00
potassium ion transmembrane transport (GO:0071805)	5	1	.14	+	7.29	1.50E-01	1.00E00
protein localization to membrane raft (GO:1903044)	5	1	.14	+	7.29	1.50E-01	1.00E00
regulation of epithelial cell proliferation involved in lung morphogenesis (GO:2000794)	5	1	.14	+	7.29	1.50E-01	1.00E00
lymph vessel development (GO:0001945)	10	2	.27	+	7.29	3.93E-02	1.00E00
metanephric nephron epithelium development (GO:0072243)	10	2	.27	+	7.29	3.93E-02	1.00E00
metanephric collecting duct development (GO:0072205)	5	1	.14	+	7.29	1.50E-01	1.00E00
negative regulation of mesenchymal cell proliferation (GO:0072201)	5	1	.14	+	7.29	1.50E-01	1.00E00
polyphosphate catabolic process (GO:0006798)	5	1	.14	+	7.29	1.50E-01	1.00E00
polyphosphate metabolic process (GO:0006797)	5	1	.14	+	7.29	1.50E-01	1.00E00
Mo-molybdopterin cofactor biosynthetic process (GO:0006777)	5	1	.14	+	7.29	1.50E-01	1.00E00
NADH regeneration (GO:0006735)	5	1	.14	+	7.29	1.50E-01	1.00E00
pre-B cell differentiation (GO:0002329)	5	1	.14	+	7.29	1.50E-01	1.00E00
marginal zone B cell differentiation (GO:0002315)	5	1	.14	+	7.29	1.50E-01	1.00E00
activation of adenylate cyclase activity (GO:0007190)	5	1	.14	+	7.29	1.50E-01	1.00E00
T cell differentiation involved in immune response (GO:0002292)	20	4	.55	+	7.29	3.46E-03	1.00E00
negative regulation of monocyte chemotactic protein-1 production (GO:0071638)	5	1	.14	+	7.29	1.50E-01	1.00E00
negative regulation of transforming growth factor beta production (GO:0071635)	5	1	.14	+	7.29	1.50E-01	1.00E00
positive regulation of MHC class I biosynthetic process (GO:0045345)	5	1	.14	+	7.29	1.50E-01	1.00E00
DNA repair complex assembly (GO:0090735)	5	1	.14	+	7.29	1.50E-01	1.00E00
membrane raft assembly (GO:0001765)	5	1	.14	+	7.29	1.50E-01	1.00E00
lysosomal lumen acidification (GO:0007042)	5	1	.14	+	7.29	1.50E-01	1.00E00
tubulin complex assembly (GO:0007021)	5	1	.14	+	7.29	1.50E-01	1.00E00
negative regulation of CD4-positive, alpha-beta T cell proliferation (GO:2000562)	5	1	.14	+	7.29	1.50E-01	1.00E00
regulation of CD4-positive, alpha-beta T cell proliferation (GO:2000561)	5	1	.14	+	7.29	1.50E-01	1.00E00
positive regulation of T-helper 2 cell cytokine production (GO:2000553)	5	1	.14	+	7.29	1.50E-01	1.00E00
parathyroid gland development (GO:0060017)	5	1	.14	+	7.29	1.50E-01	1.00E00
negative regulation by host of symbiont molecular function (GO:0052405)	5	1	.14	+	7.29	1.50E-01	1.00E00
positive regulation of transmission of nerve impulse (GO:0051971)	5	1	.14	+	7.29	1.50E-01	1.00E00
C-terminal protein lipidation (GO:0006501)	5	1	.14	+	7.29	1.50E-01	1.00E00
positive regulation of cell migration by vascular endothelial growth factor signaling pathway (GO:0038089)	5	1	.14	+	7.29	1.50E-01	1.00E00
vascular endothelial growth factor signaling pathway (GO:0038084)	10	2	.27	+	7.29	3.93E-02	1.00E00
positive regulation of interleukin-5 production (GO:0032754)	5	1	.14	+	7.29	1.50E-01	1.00E00
positive regulation of interleukin-17 production (GO:0032740)	10	2	.27	+	7.29	3.93E-02	1.00E00
N-terminal protein amino acid acetylation (GO:0006474)	10	2	.27	+	7.29	3.93E-02	1.00E00
negative regulation of molecular function in other organism involved in symbiotic interaction (GO:0052204)	5	1	.14	+	7.29	1.50E-01	1.00E00
cellular response to type I interferon (GO:0071357)	5	1	.14	+	7.29	1.50E-01	1.00E00
T-helper 1 cell differentiation (GO:0045063)	5	1	.14	+	7.29	1.50E-01	1.00E00
positive regulation of immature T cell proliferation (GO:0033091)	5	1	.14	+	7.29	1.50E-01	1.00E00
protein de-ADP-ribosylation (GO:0051725)	5	1	.14	+	7.29	1.50E-01	1.00E00
negative regulation of T cell differentiation in thymus (GO:0033085)	5	1	.14	+	7.29	1.50E-01	1.00E00
positive regulation of calcineurin-NFAT signaling cascade (GO:0070886)	5	1	.14	+	7.29	1.50E-01	1.00E00
response to camptothecin (GO:1901563)	5	1	.14	+	7.29	1.50E-01	1.00E00
negative regulation of dendrite development (GO:2000171)	5	1	.14	+	7.29	1.50E-01	1.00E00
regulation of presynaptic cytosolic calcium ion concentration (GO:0099509)	5	1	.14	+	7.29	1.50E-01	1.00E00
mRNA pseudouridine synthesis (GO:1990481)	5	1	.14	+	7.29	1.50E-01	1.00E00
positive regulation of cAMP-mediated signaling (GO:0043950)	5	1	.14	+	7.29	1.50E-01	1.00E00
negative regulation of molecular function in other organism (GO:0044362)	5	1	.14	+	7.29	1.50E-01	1.00E00
regulation of cortisol biosynthetic process (GO:2000064)	5	1	.14	+	7.29	1.50E-01	1.00E00
regulation of aldosterone biosynthetic process (GO:0032347)	5	1	.14	+	7.29	1.50E-01	1.00E00
regulation of aldosterone metabolic process (GO:0032344)	5	1	.14	+	7.29	1.50E-01	1.00E00
DNA recombinase assembly (GO:0000730)	5	1	.14	+	7.29	1.50E-01	1.00E00
positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482)	5	1	.14	+	7.29	1.50E-01	1.00E00
positive chemotaxis (GO:0050918)	5	1	.14	+	7.29	1.50E-01	1.00E00
regulation of gonadotropin secretion (GO:0032276)	5	1	.14	+	7.29	1.50E-01	1.00E00
positive regulation of calcineurin-mediated signaling (GO:0106058)	5	1	.14	+	7.29	1.50E-01	1.00E00
kinetochore assembly (GO:0051382)	10	2	.27	+	7.29	3.93E-02	1.00E00
negative regulation of fat cell proliferation (GO:0070345)	5	1	.14	+	7.29	1.50E-01	1.00E00
prosthetic group metabolic process (GO:0051189)	5	1	.14	+	7.29	1.50E-01	1.00E00
molybdopterin cofactor metabolic process (GO:0043545)	5	1	.14	+	7.29	1.50E-01	1.00E00
glucosamine-containing compound catabolic process (GO:1901072)	5	1	.14	+	7.29	1.50E-01	1.00E00
positive regulation of lymphocyte apoptotic process (GO:0070230)	10	2	.27	+	7.29	3.93E-02	1.00E00
protein trimerization (GO:0070206)	5	1	.14	+	7.29	1.50E-01	1.00E00
nuclear envelope reassembly (GO:0031468)	5	1	.14	+	7.29	1.50E-01	1.00E00
regulation of amyloid precursor protein biosynthetic process (GO:0042984)	5	1	.14	+	7.29	1.50E-01	1.00E00
cellular response to increased oxygen levels (GO:0036295)	5	1	.14	+	7.29	1.50E-01	1.00E00
regulation of long-term synaptic depression (GO:1900452)	5	1	.14	+	7.29	1.50E-01	1.00E00
platelet-derived growth factor receptor-beta signaling pathway (GO:0035791)	5	1	.14	+	7.29	1.50E-01	1.00E00
CD8-positive, alpha-beta T cell differentiation (GO:0043374)	5	1	.14	+	7.29	1.50E-01	1.00E00
CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369)	10	2	.27	+	7.29	3.93E-02	1.00E00
proton-transporting two-sector ATPase complex assembly (GO:0070071)	5	1	.14	+	7.29	1.50E-01	1.00E00
3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427)	5	1	.14	+	7.29	1.50E-01	1.00E00
peroxisome fission (GO:0016559)	5	1	.14	+	7.29	1.50E-01	1.00E00
surfactant homeostasis (GO:0043129)	10	2	.27	+	7.29	3.93E-02	1.00E00
10-formyltetrahydrofolate metabolic process (GO:0009256)	5	1	.14	+	7.29	1.50E-01	1.00E00
pyrimidine deoxyribonucleoside triphosphate metabolic process (GO:0009211)	5	1	.14	+	7.29	1.50E-01	1.00E00
regulation of hyaluronan biosynthetic process (GO:1900125)	5	1	.14	+	7.29	1.50E-01	1.00E00
glucose catabolic process to pyruvate (GO:0061718)	5	1	.14	+	7.29	1.50E-01	1.00E00
purine nucleoside triphosphate catabolic process (GO:0009146)	5	1	.14	+	7.29	1.50E-01	1.00E00
regulation of protein complex stability (GO:0061635)	5	1	.14	+	7.29	1.50E-01	1.00E00
canonical glycolysis (GO:0061621)	5	1	.14	+	7.29	1.50E-01	1.00E00
retina layer formation (GO:0010842)	10	2	.27	+	7.29	3.93E-02	1.00E00
protein maturation by iron-sulfur cluster transfer (GO:0097428)	10	2	.27	+	7.29	3.93E-02	1.00E00
cardiac vascular smooth muscle cell differentiation (GO:0060947)	5	1	.14	+	7.29	1.50E-01	1.00E00
self proteolysis (GO:0097264)	5	1	.14	+	7.29	1.50E-01	1.00E00
activation of cysteine-type endopeptidase activity (GO:0097202)	5	1	.14	+	7.29	1.50E-01	1.00E00
Mo-molybdopterin cofactor metabolic process (GO:0019720)	5	1	.14	+	7.29	1.50E-01	1.00E00
chorionic trophoblast cell differentiation (GO:0060718)	5	1	.14	+	7.29	1.50E-01	1.00E00
negative regulation of inflammatory response to antigenic stimulus (GO:0002862)	5	1	.14	+	7.29	1.50E-01	1.00E00
regulation of inflammatory response to antigenic stimulus (GO:0002861)	10	2	.27	+	7.29	3.93E-02	1.00E00
positive regulation of type 2 immune response (GO:0002830)	10	2	.27	+	7.29	3.93E-02	1.00E00
positive regulation of circadian sleep/wake cycle, sleep (GO:0045938)	5	1	.14	+	7.29	1.50E-01	1.00E00
adenohypophysis development (GO:0021984)	5	1	.14	+	7.29	1.50E-01	1.00E00
T-helper 17 cell lineage commitment (GO:0072540)	5	1	.14	+	7.29	1.50E-01	1.00E00
adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189)	16	3	.44	+	6.84	1.33E-02	1.00E00
CD4-positive, alpha-beta T cell differentiation (GO:0043367)	27	5	.74	+	6.75	1.45E-03	1.00E00
metanephric epithelium development (GO:0072207)	11	2	.30	+	6.63	4.56E-02	1.00E00
negative regulation of collagen biosynthetic process (GO:0032966)	11	2	.30	+	6.63	4.56E-02	1.00E00
regulation of growth hormone secretion (GO:0060123)	11	2	.30	+	6.63	4.56E-02	1.00E00
organ or tissue specific immune response (GO:0002251)	11	2	.30	+	6.63	4.56E-02	1.00E00
regulation of interleukin-10 production (GO:0032653)	22	4	.60	+	6.63	4.67E-03	1.00E00
protein targeting to ER (GO:0045047)	11	2	.30	+	6.63	4.56E-02	1.00E00
negative regulation of collagen metabolic process (GO:0010713)	11	2	.30	+	6.63	4.56E-02	1.00E00
cellular modified amino acid catabolic process (GO:0042219)	11	2	.30	+	6.63	4.56E-02	1.00E00
positive regulation of activated T cell proliferation (GO:0042104)	11	2	.30	+	6.63	4.56E-02	1.00E00
positive regulation of chemokine production (GO:0032722)	28	5	.77	+	6.51	1.68E-03	1.00E00
CD4-positive, alpha-beta T cell activation (GO:0035710)	29	5	.80	+	6.29	1.92E-03	1.00E00
negative regulation of acute inflammatory response (GO:0002674)	6	1	.16	+	6.08	1.73E-01	1.00E00
negative regulation of immunoglobulin production (GO:0002638)	6	1	.16	+	6.08	1.73E-01	1.00E00
respiratory burst (GO:0045730)	6	1	.16	+	6.08	1.73E-01	1.00E00
multi-ciliated epithelial cell differentiation (GO:1903251)	6	1	.16	+	6.08	1.73E-01	1.00E00
negative regulation of neuroblast proliferation (GO:0007406)	6	1	.16	+	6.08	1.73E-01	1.00E00
regulation of T-helper 1 cell differentiation (GO:0045625)	6	1	.16	+	6.08	1.73E-01	1.00E00
positive regulation of cell adhesion mediated by integrin (GO:0033630)	12	2	.33	+	6.08	5.23E-02	1.00E00
positive regulation of integrin activation (GO:0033625)	6	1	.16	+	6.08	1.73E-01	1.00E00
positive regulation of cell proliferation in bone marrow (GO:0071864)	6	1	.16	+	6.08	1.73E-01	1.00E00
germinal center formation (GO:0002467)	6	1	.16	+	6.08	1.73E-01	1.00E00
negative regulation of glycoprotein metabolic process (GO:1903019)	6	1	.16	+	6.08	1.73E-01	1.00E00
regulation of glomerular mesangial cell proliferation (GO:0072124)	6	1	.16	+	6.08	1.73E-01	1.00E00
cell proliferation involved in kidney development (GO:0072111)	6	1	.16	+	6.08	1.73E-01	1.00E00
innate immune response in mucosa (GO:0002227)	6	1	.16	+	6.08	1.73E-01	1.00E00
regulation of MHC class I biosynthetic process (GO:0045343)	6	1	.16	+	6.08	1.73E-01	1.00E00
protein catabolic process in the vacuole (GO:0007039)	6	1	.16	+	6.08	1.73E-01	1.00E00
distal tubule development (GO:0072017)	6	1	.16	+	6.08	1.73E-01	1.00E00
glomerular epithelium development (GO:0072010)	6	1	.16	+	6.08	1.73E-01	1.00E00
modulation by host of symbiont molecular function (GO:0052428)	6	1	.16	+	6.08	1.73E-01	1.00E00
positive regulation of natural killer cell differentiation (GO:0032825)	6	1	.16	+	6.08	1.73E-01	1.00E00
maintenance of epithelial cell apical/basal polarity (GO:0045199)	6	1	.16	+	6.08	1.73E-01	1.00E00
positive regulation of cell proliferation involved in kidney development (GO:1901724)	6	1	.16	+	6.08	1.73E-01	1.00E00
glomerular visceral epithelial cell migration (GO:0090521)	6	1	.16	+	6.08	1.73E-01	1.00E00
negative regulation of chemokine production (GO:0032682)	12	2	.33	+	6.08	5.23E-02	1.00E00
positive regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000343)	6	1	.16	+	6.08	1.73E-01	1.00E00
modulation of molecular function in other organism involved in symbiotic interaction (GO:0052205)	6	1	.16	+	6.08	1.73E-01	1.00E00
medium-chain fatty acid metabolic process (GO:0051791)	6	1	.16	+	6.08	1.73E-01	1.00E00
DNA deamination (GO:0045006)	6	1	.16	+	6.08	1.73E-01	1.00E00
peripheral nervous system neuron development (GO:0048935)	6	1	.16	+	6.08	1.73E-01	1.00E00
peripheral nervous system neuron differentiation (GO:0048934)	6	1	.16	+	6.08	1.73E-01	1.00E00
positive regulation of cell aging (GO:0090343)	6	1	.16	+	6.08	1.73E-01	1.00E00
chemical homeostasis within a tissue (GO:0048875)	12	2	.33	+	6.08	5.23E-02	1.00E00
regulation of glucocorticoid biosynthetic process (GO:0031946)	6	1	.16	+	6.08	1.73E-01	1.00E00
modulation of molecular function in other organism (GO:0044359)	6	1	.16	+	6.08	1.73E-01	1.00E00
polyadenylation-dependent snoRNA 3'-end processing (GO:0071051)	6	1	.16	+	6.08	1.73E-01	1.00E00
glucose catabolic process (GO:0006007)	6	1	.16	+	6.08	1.73E-01	1.00E00
positive regulation of collateral sprouting (GO:0048672)	6	1	.16	+	6.08	1.73E-01	1.00E00
tRNA threonylcarbamoyladenosine metabolic process (GO:0070525)	6	1	.16	+	6.08	1.73E-01	1.00E00
positive regulation of extracellular matrix disassembly (GO:0090091)	6	1	.16	+	6.08	1.73E-01	1.00E00
nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070431)	6	1	.16	+	6.08	1.73E-01	1.00E00
nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423)	6	1	.16	+	6.08	1.73E-01	1.00E00
regulation of activation-induced cell death of T cells (GO:0070235)	6	1	.16	+	6.08	1.73E-01	1.00E00
intermembrane lipid transfer (GO:0120009)	6	1	.16	+	6.08	1.73E-01	1.00E00
regulation of isotype switching to IgE isotypes (GO:0048293)	6	1	.16	+	6.08	1.73E-01	1.00E00
sequestering of actin monomers (GO:0042989)	6	1	.16	+	6.08	1.73E-01	1.00E00
response to increased oxygen levels (GO:0036296)	6	1	.16	+	6.08	1.73E-01	1.00E00
negative regulation of cell killing (GO:0031342)	6	1	.16	+	6.08	1.73E-01	1.00E00
lysosomal protein catabolic process (GO:1905146)	6	1	.16	+	6.08	1.73E-01	1.00E00
ceramide transport (GO:0035627)	6	1	.16	+	6.08	1.73E-01	1.00E00
oligosaccharide catabolic process (GO:0009313)	6	1	.16	+	6.08	1.73E-01	1.00E00
CD8-positive, alpha-beta T cell activation (GO:0036037)	6	1	.16	+	6.08	1.73E-01	1.00E00
sulfur amino acid catabolic process (GO:0000098)	6	1	.16	+	6.08	1.73E-01	1.00E00
regulation of metallopeptidase activity (GO:1905048)	6	1	.16	+	6.08	1.73E-01	1.00E00
nucleotide-sugar biosynthetic process (GO:0009226)	12	2	.33	+	6.08	5.23E-02	1.00E00
deoxyribonucleoside triphosphate catabolic process (GO:0009204)	6	1	.16	+	6.08	1.73E-01	1.00E00
negative regulation of macrophage activation (GO:0043031)	6	1	.16	+	6.08	1.73E-01	1.00E00
monoamine transport (GO:0015844)	6	1	.16	+	6.08	1.73E-01	1.00E00
retinoic acid metabolic process (GO:0042573)	6	1	.16	+	6.08	1.73E-01	1.00E00
positive regulation of receptor clustering (GO:1903911)	6	1	.16	+	6.08	1.73E-01	1.00E00
gas transport (GO:0015669)	6	1	.16	+	6.08	1.73E-01	1.00E00
protein localization to non-motile cilium (GO:0097499)	6	1	.16	+	6.08	1.73E-01	1.00E00
water-soluble vitamin biosynthetic process (GO:0042364)	6	1	.16	+	6.08	1.73E-01	1.00E00
liver regeneration (GO:0097421)	6	1	.16	+	6.08	1.73E-01	1.00E00
negative regulation of fibroblast migration (GO:0010764)	6	1	.16	+	6.08	1.73E-01	1.00E00
regulation of alpha-beta T cell proliferation (GO:0046640)	18	3	.49	+	6.08	1.75E-02	1.00E00
regulation of adipose tissue development (GO:1904177)	6	1	.16	+	6.08	1.73E-01	1.00E00
negative regulation of cardiac muscle adaptation (GO:0010616)	6	1	.16	+	6.08	1.73E-01	1.00E00
regulation of cytoplasmic mRNA processing body assembly (GO:0010603)	6	1	.16	+	6.08	1.73E-01	1.00E00
centromere complex assembly (GO:0034508)	18	3	.49	+	6.08	1.75E-02	1.00E00
U4 snRNA 3'-end processing (GO:0034475)	6	1	.16	+	6.08	1.73E-01	1.00E00
muscle atrophy (GO:0014889)	6	1	.16	+	6.08	1.73E-01	1.00E00
positive regulation of natural killer cell mediated cytotoxicity (GO:0045954)	6	1	.16	+	6.08	1.73E-01	1.00E00
GDP-mannose metabolic process (GO:0019673)	6	1	.16	+	6.08	1.73E-01	1.00E00
regulation of membrane lipid distribution (GO:0097035)	6	1	.16	+	6.08	1.73E-01	1.00E00
positive regulation of natural killer cell mediated immunity (GO:0002717)	6	1	.16	+	6.08	1.73E-01	1.00E00
parturition (GO:0007567)	6	1	.16	+	6.08	1.73E-01	1.00E00
liver morphogenesis (GO:0072576)	6	1	.16	+	6.08	1.73E-01	1.00E00
cellular component disassembly involved in execution phase of apoptosis (GO:0006921)	13	2	.36	+	5.61	5.93E-02	1.00E00
regulation of ATP biosynthetic process (GO:2001169)	13	2	.36	+	5.61	5.93E-02	1.00E00
regulation of sensory perception of pain (GO:0051930)	13	2	.36	+	5.61	5.93E-02	1.00E00
regulation of chemokine production (GO:0032642)	39	6	1.07	+	5.61	1.16E-03	1.00E00
positive regulation of calcium-mediated signaling (GO:0050850)	13	2	.36	+	5.61	5.93E-02	1.00E00
positive regulation of mitochondrial translation (GO:0070131)	13	2	.36	+	5.61	5.93E-02	1.00E00
regulation of viral entry into host cell (GO:0046596)	26	4	.71	+	5.61	7.87E-03	1.00E00
regulation of T-helper 1 type immune response (GO:0002825)	13	2	.36	+	5.61	5.93E-02	1.00E00
establishment of protein localization to endoplasmic reticulum (GO:0072599)	13	2	.36	+	5.61	5.93E-02	1.00E00
exocrine system development (GO:0035272)	20	3	.55	+	5.47	2.24E-02	1.00E00
regulation of cardiac muscle hypertrophy in response to stress (GO:1903242)	7	1	.19	+	5.21	1.95E-01	1.00E00
positive regulation of systemic arterial blood pressure (GO:0003084)	7	1	.19	+	5.21	1.95E-01	1.00E00
renal system process involved in regulation of systemic arterial blood pressure (GO:0003071)	7	1	.19	+	5.21	1.95E-01	1.00E00
negative regulation of tissue remodeling (GO:0034104)	14	2	.38	+	5.21	6.66E-02	1.00E00
positive regulation of T-helper cell differentiation (GO:0045624)	14	2	.38	+	5.21	6.66E-02	1.00E00
adenosine metabolic process (GO:0046085)	7	1	.19	+	5.21	1.95E-01	1.00E00
regulation of cell proliferation in bone marrow (GO:0071863)	7	1	.19	+	5.21	1.95E-01	1.00E00
regulation of B cell differentiation (GO:0045577)	14	2	.38	+	5.21	6.66E-02	1.00E00
spinal cord association neuron differentiation (GO:0021527)	7	1	.19	+	5.21	1.95E-01	1.00E00
T cell lineage commitment (GO:0002360)	14	2	.38	+	5.21	6.66E-02	1.00E00
maternal placenta development (GO:0001893)	21	3	.58	+	5.21	2.51E-02	1.00E00
complement activation, lectin pathway (GO:0001867)	7	1	.19	+	5.21	1.95E-01	1.00E00
regulation of mRNA binding (GO:1902415)	7	1	.19	+	5.21	1.95E-01	1.00E00
T cell activation involved in immune response (GO:0002286)	28	4	.77	+	5.21	9.91E-03	1.00E00
positive regulation of endothelial cell chemotaxis (GO:2001028)	7	1	.19	+	5.21	1.95E-01	1.00E00
B cell apoptotic process (GO:0001783)	7	1	.19	+	5.21	1.95E-01	1.00E00
neutrophil homeostasis (GO:0001780)	7	1	.19	+	5.21	1.95E-01	1.00E00
regulation of T-helper 2 cell cytokine production (GO:2000551)	7	1	.19	+	5.21	1.95E-01	1.00E00
polyamine metabolic process (GO:0006595)	14	2	.38	+	5.21	6.66E-02	1.00E00
regulation of sensory perception (GO:0051931)	14	2	.38	+	5.21	6.66E-02	1.00E00
modulation by symbiont of entry into host (GO:0052372)	28	4	.77	+	5.21	9.91E-03	1.00E00
signal transduction in absence of ligand (GO:0038034)	14	2	.38	+	5.21	6.66E-02	1.00E00
negative regulation of T-helper 17 cell differentiation (GO:2000320)	7	1	.19	+	5.21	1.95E-01	1.00E00
regulation of immature T cell proliferation (GO:0033083)	7	1	.19	+	5.21	1.95E-01	1.00E00
negative regulation of nitric oxide biosynthetic process (GO:0045019)	7	1	.19	+	5.21	1.95E-01	1.00E00
double-strand break repair via synthesis-dependent strand annealing (GO:0045003)	7	1	.19	+	5.21	1.95E-01	1.00E00
positive regulation of keratinocyte migration (GO:0051549)	7	1	.19	+	5.21	1.95E-01	1.00E00
regulation of glucocorticoid metabolic process (GO:0031943)	7	1	.19	+	5.21	1.95E-01	1.00E00
negative regulation of hormone biosynthetic process (GO:0032353)	7	1	.19	+	5.21	1.95E-01	1.00E00
negative regulation of hormone metabolic process (GO:0032351)	7	1	.19	+	5.21	1.95E-01	1.00E00
anterograde dendritic transport (GO:0098937)	7	1	.19	+	5.21	1.95E-01	1.00E00
collateral sprouting (GO:0048668)	7	1	.19	+	5.21	1.95E-01	1.00E00
negative regulation of muscle organ development (GO:0048635)	14	2	.38	+	5.21	6.66E-02	1.00E00
rRNA base methylation (GO:0070475)	7	1	.19	+	5.21	1.95E-01	1.00E00
dicarboxylic acid catabolic process (GO:0043649)	7	1	.19	+	5.21	1.95E-01	1.00E00
regulation of fat cell proliferation (GO:0070344)	7	1	.19	+	5.21	1.95E-01	1.00E00
steroid hormone biosynthetic process (GO:0120178)	7	1	.19	+	5.21	1.95E-01	1.00E00
positive regulation of T cell apoptotic process (GO:0070234)	7	1	.19	+	5.21	1.95E-01	1.00E00
positive regulation of isotype switching to IgG isotypes (GO:0048304)	7	1	.19	+	5.21	1.95E-01	1.00E00
nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)	7	1	.19	+	5.21	1.95E-01	1.00E00
establishment or maintenance of cytoskeleton polarity (GO:0030952)	7	1	.19	+	5.21	1.95E-01	1.00E00
positive T cell selection (GO:0043368)	14	2	.38	+	5.21	6.66E-02	1.00E00
cytochrome complex assembly (GO:0017004)	21	3	.58	+	5.21	2.51E-02	1.00E00
snRNA transcription by RNA polymerase III (GO:0042796)	7	1	.19	+	5.21	1.95E-01	1.00E00
regulation of amyloid-beta clearance (GO:1900221)	7	1	.19	+	5.21	1.95E-01	1.00E00
very long-chain fatty acid metabolic process (GO:0000038)	7	1	.19	+	5.21	1.95E-01	1.00E00
positive regulation of execution phase of apoptosis (GO:1900119)	7	1	.19	+	5.21	1.95E-01	1.00E00
neuron remodeling (GO:0016322)	7	1	.19	+	5.21	1.95E-01	1.00E00
positive regulation of xenophagy (GO:1904417)	7	1	.19	+	5.21	1.95E-01	1.00E00
regulation of xenophagy (GO:1904415)	7	1	.19	+	5.21	1.95E-01	1.00E00
negative regulation of nitric oxide metabolic process (GO:1904406)	7	1	.19	+	5.21	1.95E-01	1.00E00
negative regulation of alpha-beta T cell proliferation (GO:0046642)	7	1	.19	+	5.21	1.95E-01	1.00E00
maintenance of apical/basal cell polarity (GO:0035090)	7	1	.19	+	5.21	1.95E-01	1.00E00
glyoxylate metabolic process (GO:0046487)	7	1	.19	+	5.21	1.95E-01	1.00E00
cellular response to hydroxyurea (GO:0072711)	7	1	.19	+	5.21	1.95E-01	1.00E00
extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192)	14	2	.38	+	5.21	6.66E-02	1.00E00
chorion development (GO:0060717)	7	1	.19	+	5.21	1.95E-01	1.00E00
positive regulation of T-helper 1 type immune response (GO:0002827)	7	1	.19	+	5.21	1.95E-01	1.00E00
short-term memory (GO:0007614)	7	1	.19	+	5.21	1.95E-01	1.00E00
T-helper 17 cell differentiation (GO:0072539)	7	1	.19	+	5.21	1.95E-01	1.00E00
regulation of glycoprotein metabolic process (GO:1903018)	22	3	.60	+	4.97	2.80E-02	1.00E00
regulation of mitochondrial translation (GO:0070129)	22	3	.60	+	4.97	2.80E-02	1.00E00
kinetochore organization (GO:0051383)	15	2	.41	+	4.86	7.42E-02	1.00E00
cellular response to virus (GO:0098586)	30	4	.82	+	4.86	1.23E-02	1.00E00
N-terminal protein amino acid modification (GO:0031365)	15	2	.41	+	4.86	7.42E-02	1.00E00
positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427)	15	2	.41	+	4.86	7.42E-02	1.00E00
regulation of T-helper cell differentiation (GO:0045622)	23	3	.63	+	4.76	3.11E-02	1.00E00
diterpenoid metabolic process (GO:0016101)	23	3	.63	+	4.76	3.11E-02	1.00E00
positive regulation of acute inflammatory response (GO:0002675)	8	1	.22	+	4.56	2.16E-01	1.00E00
negative regulation of bone resorption (GO:0045779)	8	1	.22	+	4.56	2.16E-01	1.00E00
negative regulation of heterotypic cell-cell adhesion (GO:0034115)	8	1	.22	+	4.56	2.16E-01	1.00E00
regulation of proton transport (GO:0010155)	16	2	.44	+	4.56	8.20E-02	1.00E00
regulation of cell-cell adhesion mediated by integrin (GO:0033632)	8	1	.22	+	4.56	2.16E-01	1.00E00
regulation of integrin activation (GO:0033623)	8	1	.22	+	4.56	2.16E-01	1.00E00
leukocyte apoptotic process (GO:0071887)	16	2	.44	+	4.56	8.20E-02	1.00E00
regulation of activated T cell proliferation (GO:0046006)	16	2	.44	+	4.56	8.20E-02	1.00E00
tyrosine phosphorylation of STAT protein (GO:0007260)	8	1	.22	+	4.56	2.16E-01	1.00E00
ventral spinal cord interneuron differentiation (GO:0021514)	8	1	.22	+	4.56	2.16E-01	1.00E00
metanephric nephron tubule development (GO:0072234)	8	1	.22	+	4.56	2.16E-01	1.00E00
mucosal immune response (GO:0002385)	8	1	.22	+	4.56	2.16E-01	1.00E00
positive regulation of ATP biosynthetic process (GO:2001171)	8	1	.22	+	4.56	2.16E-01	1.00E00
immature B cell differentiation (GO:0002327)	8	1	.22	+	4.56	2.16E-01	1.00E00
B cell activation involved in immune response (GO:0002312)	32	4	.88	+	4.56	1.49E-02	1.00E00
phosphatidylcholine biosynthetic process (GO:0006656)	8	1	.22	+	4.56	2.16E-01	1.00E00
macrophage activation involved in immune response (GO:0002281)	8	1	.22	+	4.56	2.16E-01	1.00E00
negative regulation of cell cycle checkpoint (GO:1901977)	8	1	.22	+	4.56	2.16E-01	1.00E00
glomerulus vasculature development (GO:0072012)	8	1	.22	+	4.56	2.16E-01	1.00E00
killing by host of symbiont cells (GO:0051873)	8	1	.22	+	4.56	2.16E-01	1.00E00
glycogen biosynthetic process (GO:0005978)	16	2	.44	+	4.56	8.20E-02	1.00E00
regulation of interleukin-5 production (GO:0032674)	8	1	.22	+	4.56	2.16E-01	1.00E00
regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341)	8	1	.22	+	4.56	2.16E-01	1.00E00
negative regulation of T-helper 17 type immune response (GO:2000317)	8	1	.22	+	4.56	2.16E-01	1.00E00
peptidyl-methionine modification (GO:0018206)	8	1	.22	+	4.56	2.16E-01	1.00E00
positive regulation of DNA methylation-dependent heterochromatin assembly (GO:0090309)	8	1	.22	+	4.56	2.16E-01	1.00E00
regulation of keratinocyte migration (GO:0051547)	8	1	.22	+	4.56	2.16E-01	1.00E00
replication-born double-strand break repair via sister chromatid exchange (GO:1990414)	8	1	.22	+	4.56	2.16E-01	1.00E00
positive regulation of calcium ion import (GO:0090280)	8	1	.22	+	4.56	2.16E-01	1.00E00
regulation of cell-cell adhesion involved in gastrulation (GO:0070587)	8	1	.22	+	4.56	2.16E-01	1.00E00
detection of temperature stimulus involved in sensory perception of pain (GO:0050965)	8	1	.22	+	4.56	2.16E-01	1.00E00
detection of temperature stimulus involved in sensory perception (GO:0050961)	8	1	.22	+	4.56	2.16E-01	1.00E00
regulation of renal system process (GO:0098801)	8	1	.22	+	4.56	2.16E-01	1.00E00
negative regulation of nervous system process (GO:0031645)	8	1	.22	+	4.56	2.16E-01	1.00E00
insulin metabolic process (GO:1901142)	8	1	.22	+	4.56	2.16E-01	1.00E00
response to food (GO:0032094)	8	1	.22	+	4.56	2.16E-01	1.00E00
tongue morphogenesis (GO:0043587)	8	1	.22	+	4.56	2.16E-01	1.00E00
positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030)	8	1	.22	+	4.56	2.16E-01	1.00E00
positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996)	8	1	.22	+	4.56	2.16E-01	1.00E00
regulation of mucus secretion (GO:0070255)	8	1	.22	+	4.56	2.16E-01	1.00E00
lymph vessel morphogenesis (GO:0036303)	8	1	.22	+	4.56	2.16E-01	1.00E00
positive regulation of receptor signaling pathway via STAT (GO:1904894)	16	2	.44	+	4.56	8.20E-02	1.00E00
negative regulation of receptor signaling pathway via STAT (GO:1904893)	16	2	.44	+	4.56	8.20E-02	1.00E00
regulation of lysosomal lumen pH (GO:0035751)	8	1	.22	+	4.56	2.16E-01	1.00E00
regulation of glucagon secretion (GO:0070092)	8	1	.22	+	4.56	2.16E-01	1.00E00
negative regulation of vascular associated smooth muscle cell differentiation (GO:1905064)	8	1	.22	+	4.56	2.16E-01	1.00E00
rRNA methylation (GO:0031167)	16	2	.44	+	4.56	8.20E-02	1.00E00
glucan biosynthetic process (GO:0009250)	16	2	.44	+	4.56	8.20E-02	1.00E00
acidic amino acid transport (GO:0015800)	8	1	.22	+	4.56	2.16E-01	1.00E00
histone arginine methylation (GO:0034969)	8	1	.22	+	4.56	2.16E-01	1.00E00
glycolytic process through glucose-6-phosphate (GO:0061620)	8	1	.22	+	4.56	2.16E-01	1.00E00
negative regulation of viral life cycle (GO:1903901)	16	2	.44	+	4.56	8.20E-02	1.00E00
detection of temperature stimulus (GO:0016048)	8	1	.22	+	4.56	2.16E-01	1.00E00
regulation of extracellular matrix disassembly (GO:0010715)	8	1	.22	+	4.56	2.16E-01	1.00E00
kidney vasculature development (GO:0061440)	8	1	.22	+	4.56	2.16E-01	1.00E00
renal system vasculature development (GO:0061437)	8	1	.22	+	4.56	2.16E-01	1.00E00
alpha-beta T cell differentiation (GO:0046632)	40	5	1.10	+	4.56	6.66E-03	1.00E00
regulation of mitotic centrosome separation (GO:0046602)	8	1	.22	+	4.56	2.16E-01	1.00E00
regulation of cardiac muscle adaptation (GO:0010612)	8	1	.22	+	4.56	2.16E-01	1.00E00
negative regulation of viral entry into host cell (GO:0046597)	16	2	.44	+	4.56	8.20E-02	1.00E00
positive regulation of T cell proliferation (GO:0042102)	40	5	1.10	+	4.56	6.66E-03	1.00E00
response to hydroxyurea (GO:0072710)	8	1	.22	+	4.56	2.16E-01	1.00E00
negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426)	16	2	.44	+	4.56	8.20E-02	1.00E00
amino sugar catabolic process (GO:0046348)	8	1	.22	+	4.56	2.16E-01	1.00E00
excretion (GO:0007588)	8	1	.22	+	4.56	2.16E-01	1.00E00
T-helper 17 type immune response (GO:0072538)	8	1	.22	+	4.56	2.16E-01	1.00E00
fibroblast growth factor receptor signaling pathway (GO:0008543)	25	3	.69	+	4.38	3.77E-02	1.00E00
acute-phase response (GO:0006953)	17	2	.47	+	4.29	9.01E-02	1.00E00
protein lipidation (GO:0006497)	17	2	.47	+	4.29	9.01E-02	1.00E00
response to muramyl dipeptide (GO:0032495)	17	2	.47	+	4.29	9.01E-02	1.00E00
negative regulation of defense response to virus (GO:0050687)	17	2	.47	+	4.29	9.01E-02	1.00E00
positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372)	17	2	.47	+	4.29	9.01E-02	1.00E00
positive regulation of B cell proliferation (GO:0030890)	17	2	.47	+	4.29	9.01E-02	1.00E00
maternal process involved in female pregnancy (GO:0060135)	26	3	.71	+	4.21	4.12E-02	1.00E00
positive regulation of reactive oxygen species biosynthetic process (GO:1903428)	26	3	.71	+	4.21	4.12E-02	1.00E00
regulation of receptor signaling pathway via JAK-STAT (GO:0046425)	35	4	.96	+	4.17	1.96E-02	1.00E00
regulation of acute inflammatory response (GO:0002673)	18	2	.49	+	4.05	9.84E-02	1.00E00
negative regulation of systemic arterial blood pressure (GO:0003085)	9	1	.25	+	4.05	2.37E-01	1.00E00
nuclear envelope organization (GO:0006998)	18	2	.49	+	4.05	9.84E-02	1.00E00
regulation of T-helper 2 cell differentiation (GO:0045628)	9	1	.25	+	4.05	2.37E-01	1.00E00
positive regulation of type I interferon-mediated signaling pathway (GO:0060340)	9	1	.25	+	4.05	2.37E-01	1.00E00
amino acid transport (GO:0006865)	18	2	.49	+	4.05	9.84E-02	1.00E00
potassium ion transport (GO:0006813)	9	1	.25	+	4.05	2.37E-01	1.00E00
nervous system process involved in regulation of systemic arterial blood pressure (GO:0001976)	9	1	.25	+	4.05	2.37E-01	1.00E00
regulation of apoptotic DNA fragmentation (GO:1902510)	9	1	.25	+	4.05	2.37E-01	1.00E00
terpenoid metabolic process (GO:0006721)	27	3	.74	+	4.05	4.49E-02	1.00E00
regulation of nitric oxide biosynthetic process (GO:0045428)	27	3	.74	+	4.05	4.49E-02	1.00E00
metanephric tubule development (GO:0072170)	9	1	.25	+	4.05	2.37E-01	1.00E00
regulation of collagen biosynthetic process (GO:0032965)	27	3	.74	+	4.05	4.49E-02	1.00E00
collecting duct development (GO:0072044)	9	1	.25	+	4.05	2.37E-01	1.00E00
sulfation (GO:0051923)	9	1	.25	+	4.05	2.37E-01	1.00E00
leptin-mediated signaling pathway (GO:0033210)	9	1	.25	+	4.05	2.37E-01	1.00E00
negative regulation by host of viral process (GO:0044793)	9	1	.25	+	4.05	2.37E-01	1.00E00
positive regulation of interferon-gamma production (GO:0032729)	27	3	.74	+	4.05	4.49E-02	1.00E00
killing of cells in other organism involved in symbiotic interaction (GO:0051883)	9	1	.25	+	4.05	2.37E-01	1.00E00
type I interferon production (GO:0032606)	9	1	.25	+	4.05	2.37E-01	1.00E00
response to peptidoglycan (GO:0032494)	9	1	.25	+	4.05	2.37E-01	1.00E00
regulation of establishment of cell polarity (GO:2000114)	18	2	.49	+	4.05	9.84E-02	1.00E00
positive regulation of leukocyte apoptotic process (GO:2000108)	18	2	.49	+	4.05	9.84E-02	1.00E00
positive regulation of histone H3-K9 methylation (GO:0051574)	9	1	.25	+	4.05	2.37E-01	1.00E00
modification of postsynaptic actin cytoskeleton (GO:0098885)	9	1	.25	+	4.05	2.37E-01	1.00E00
protein heterotetramerization (GO:0051290)	9	1	.25	+	4.05	2.37E-01	1.00E00
positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552)	18	2	.49	+	4.05	9.84E-02	1.00E00
membrane raft organization (GO:0031579)	9	1	.25	+	4.05	2.37E-01	1.00E00
negative regulation of actin nucleation (GO:0051126)	9	1	.25	+	4.05	2.37E-01	1.00E00
regulation of retinoic acid receptor signaling pathway (GO:0048385)	9	1	.25	+	4.05	2.37E-01	1.00E00
regulation of isotype switching to IgG isotypes (GO:0048302)	9	1	.25	+	4.05	2.37E-01	1.00E00
protein deneddylation (GO:0000338)	9	1	.25	+	4.05	2.37E-01	1.00E00
regulation of receptor signaling pathway via STAT (GO:1904892)	36	4	.99	+	4.05	2.13E-02	1.00E00
mitochondrial fission (GO:0000266)	9	1	.25	+	4.05	2.37E-01	1.00E00
regulation of RNA binding (GO:1905214)	9	1	.25	+	4.05	2.37E-01	1.00E00
negative regulation of B cell proliferation (GO:0030889)	9	1	.25	+	4.05	2.37E-01	1.00E00
maintenance of blood-brain barrier (GO:0035633)	9	1	.25	+	4.05	2.37E-01	1.00E00
snRNA transcription by RNA polymerase II (GO:0042795)	9	1	.25	+	4.05	2.37E-01	1.00E00
carboxylic acid transmembrane transport (GO:1905039)	18	2	.49	+	4.05	9.84E-02	1.00E00
regulation of cell fate specification (GO:0042659)	9	1	.25	+	4.05	2.37E-01	1.00E00
ventricular cardiac muscle cell development (GO:0055015)	9	1	.25	+	4.05	2.37E-01	1.00E00
vitamin biosynthetic process (GO:0009110)	9	1	.25	+	4.05	2.37E-01	1.00E00
regulation of mitochondrial gene expression (GO:0062125)	27	3	.74	+	4.05	4.49E-02	1.00E00
positive regulation of cytokine production involved in inflammatory response (GO:1900017)	9	1	.25	+	4.05	2.37E-01	1.00E00
norepinephrine metabolic process (GO:0042415)	9	1	.25	+	4.05	2.37E-01	1.00E00
extraembryonic membrane development (GO:1903867)	9	1	.25	+	4.05	2.37E-01	1.00E00
organic acid transmembrane transport (GO:1903825)	18	2	.49	+	4.05	9.84E-02	1.00E00
regulation of glycoprotein biosynthetic process (GO:0010559)	18	2	.49	+	4.05	9.84E-02	1.00E00
retina vasculature development in camera-type eye (GO:0061298)	9	1	.25	+	4.05	2.37E-01	1.00E00
nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' (GO:0034427)	9	1	.25	+	4.05	2.37E-01	1.00E00
negative regulation of smooth muscle contraction (GO:0045986)	9	1	.25	+	4.05	2.37E-01	1.00E00
positive regulation of transcription by RNA polymerase III (GO:0045945)	9	1	.25	+	4.05	2.37E-01	1.00E00
protein localization to ciliary membrane (GO:1903441)	9	1	.25	+	4.05	2.37E-01	1.00E00
negative regulation of amyloid precursor protein catabolic process (GO:1902992)	9	1	.25	+	4.05	2.37E-01	1.00E00
protein localization to cell surface (GO:0034394)	18	2	.49	+	4.05	9.84E-02	1.00E00
response to type I interferon (GO:0034340)	9	1	.25	+	4.05	2.37E-01	1.00E00
negative regulation of muscle adaptation (GO:0014745)	9	1	.25	+	4.05	2.37E-01	1.00E00
regulation of nitric oxide metabolic process (GO:0080164)	27	3	.74	+	4.05	4.49E-02	1.00E00
positive regulation of non-motile cilium assembly (GO:1902857)	9	1	.25	+	4.05	2.37E-01	1.00E00
regulation of interferon-gamma production (GO:0032649)	46	5	1.26	+	3.96	1.13E-02	1.00E00
positive regulation of macroautophagy (GO:0016239)	46	5	1.26	+	3.96	1.13E-02	1.00E00
alpha-beta T cell activation (GO:0046631)	46	5	1.26	+	3.96	1.13E-02	1.00E00
isoprenoid metabolic process (GO:0006720)	37	4	1.01	+	3.94	2.32E-02	1.00E00
regulation of CD4-positive, alpha-beta T cell activation (GO:2000514)	37	4	1.01	+	3.94	2.32E-02	1.00E00
positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531)	28	3	.77	+	3.91	4.88E-02	1.00E00
regulation of collagen metabolic process (GO:0010712)	28	3	.77	+	3.91	4.88E-02	1.00E00
cellular polysaccharide biosynthetic process (GO:0033692)	19	2	.52	+	3.84	1.07E-01	1.00E00
neuropeptide signaling pathway (GO:0007218)	19	2	.52	+	3.84	1.07E-01	1.00E00
positive regulation of nitric oxide biosynthetic process (GO:0045429)	19	2	.52	+	3.84	1.07E-01	1.00E00
positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)	19	2	.52	+	3.84	1.07E-01	1.00E00
tRNA wobble base modification (GO:0002097)	19	2	.52	+	3.84	1.07E-01	1.00E00
negative regulation of interferon-gamma production (GO:0032689)	19	2	.52	+	3.84	1.07E-01	1.00E00
regulation of interleukin-17 production (GO:0032660)	19	2	.52	+	3.84	1.07E-01	1.00E00
amino sugar metabolic process (GO:0006040)	19	2	.52	+	3.84	1.07E-01	1.00E00
polysaccharide biosynthetic process (GO:0000271)	19	2	.52	+	3.84	1.07E-01	1.00E00
nucleotide-sugar metabolic process (GO:0009225)	19	2	.52	+	3.84	1.07E-01	1.00E00
positive regulation of nitric oxide metabolic process (GO:1904407)	19	2	.52	+	3.84	1.07E-01	1.00E00
regulation of B cell proliferation (GO:0030888)	29	3	.80	+	3.77	5.28E-02	1.00E00
regulation of tyrosine phosphorylation of STAT protein (GO:0042509)	39	4	1.07	+	3.74	2.71E-02	1.00E00
cAMP-mediated signaling (GO:0019933)	30	3	.82	+	3.65	5.70E-02	1.00E00
response to UV-C (GO:0010225)	10	1	.27	+	3.65	2.58E-01	1.00E00
negative regulation of gluconeogenesis (GO:0045721)	10	1	.27	+	3.65	2.58E-01	1.00E00
Golgi to vacuole transport (GO:0006896)	10	1	.27	+	3.65	2.58E-01	1.00E00
retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)	20	2	.55	+	3.65	1.16E-01	1.00E00
cell differentiation involved in metanephros development (GO:0072202)	10	1	.27	+	3.65	2.58E-01	1.00E00
cytokine production involved in immune response (GO:0002367)	10	1	.27	+	3.65	2.58E-01	1.00E00
epithelial cell fate commitment (GO:0072148)	10	1	.27	+	3.65	2.58E-01	1.00E00
autophagy of nucleus (GO:0044804)	10	1	.27	+	3.65	2.58E-01	1.00E00
acetylcholine receptor signaling pathway (GO:0095500)	10	1	.27	+	3.65	2.58E-01	1.00E00
cysteine metabolic process (GO:0006534)	10	1	.27	+	3.65	2.58E-01	1.00E00
regulation of transmission of nerve impulse (GO:0051969)	10	1	.27	+	3.65	2.58E-01	1.00E00
tRNA 5'-leader removal (GO:0001682)	10	1	.27	+	3.65	2.58E-01	1.00E00
regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235)	10	1	.27	+	3.65	2.58E-01	1.00E00
regulation of dopamine secretion (GO:0014059)	10	1	.27	+	3.65	2.58E-01	1.00E00
C-terminal protein amino acid modification (GO:0018410)	10	1	.27	+	3.65	2.58E-01	1.00E00
cellular response to superoxide (GO:0071451)	10	1	.27	+	3.65	2.58E-01	1.00E00
cellular response to oxygen radical (GO:0071450)	10	1	.27	+	3.65	2.58E-01	1.00E00
meiotic telomere clustering (GO:0045141)	10	1	.27	+	3.65	2.58E-01	1.00E00
positive regulation of myoblast fusion (GO:1901741)	10	1	.27	+	3.65	2.58E-01	1.00E00
regulation of cell proliferation involved in kidney development (GO:1901722)	10	1	.27	+	3.65	2.58E-01	1.00E00
protein localization to endoplasmic reticulum (GO:0070972)	20	2	.55	+	3.65	1.16E-01	1.00E00
positive regulation of reactive oxygen species metabolic process (GO:2000379)	50	5	1.37	+	3.65	1.53E-02	1.00E00
T cell selection (GO:0045058)	20	2	.55	+	3.65	1.16E-01	1.00E00
positive regulation of rRNA processing (GO:2000234)	10	1	.27	+	3.65	2.58E-01	1.00E00
peptidyl-arginine methylation (GO:0018216)	10	1	.27	+	3.65	2.58E-01	1.00E00
peptidyl-cysteine modification (GO:0018198)	10	1	.27	+	3.65	2.58E-01	1.00E00
negative regulation of multicellular organism growth (GO:0040015)	10	1	.27	+	3.65	2.58E-01	1.00E00
regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266)	10	1	.27	+	3.65	2.58E-01	1.00E00
positive regulation of lipid kinase activity (GO:0090218)	20	2	.55	+	3.65	1.16E-01	1.00E00
negative regulation of release of cytochrome c from mitochondria (GO:0090201)	10	1	.27	+	3.65	2.58E-01	1.00E00
histone mRNA catabolic process (GO:0071044)	10	1	.27	+	3.65	2.58E-01	1.00E00
nuclear mRNA surveillance (GO:0071028)	10	1	.27	+	3.65	2.58E-01	1.00E00
nuclear RNA surveillance (GO:0071027)	10	1	.27	+	3.65	2.58E-01	1.00E00
COPII-coated vesicle cargo loading (GO:0090110)	10	1	.27	+	3.65	2.58E-01	1.00E00
sensory perception of temperature stimulus (GO:0050951)	10	1	.27	+	3.65	2.58E-01	1.00E00
protein kinase C signaling (GO:0070528)	10	1	.27	+	3.65	2.58E-01	1.00E00
attachment of mitotic spindle microtubules to kinetochore (GO:0051315)	10	1	.27	+	3.65	2.58E-01	1.00E00
positive regulation of heterochromatin organization (GO:0120263)	10	1	.27	+	3.65	2.58E-01	1.00E00
activation of protein kinase B activity (GO:0032148)	10	1	.27	+	3.65	2.58E-01	1.00E00
regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994)	10	1	.27	+	3.65	2.58E-01	1.00E00
pyroptosis (GO:0070269)	10	1	.27	+	3.65	2.58E-01	1.00E00
positive regulation of heterochromatin assembly (GO:0031453)	10	1	.27	+	3.65	2.58E-01	1.00E00
sperm capacitation (GO:0048240)	10	1	.27	+	3.65	2.58E-01	1.00E00
interleukin-6-mediated signaling pathway (GO:0070102)	10	1	.27	+	3.65	2.58E-01	1.00E00
positive regulation of circadian rhythm (GO:0042753)	10	1	.27	+	3.65	2.58E-01	1.00E00
sno(s)RNA processing (GO:0043144)	10	1	.27	+	3.65	2.58E-01	1.00E00
phospholipid transport (GO:0015914)	20	2	.55	+	3.65	1.16E-01	1.00E00
sno(s)RNA 3'-end processing (GO:0031126)	10	1	.27	+	3.65	2.58E-01	1.00E00
regulation of receptor binding (GO:1900120)	10	1	.27	+	3.65	2.58E-01	1.00E00
regulation of endoplasmic reticulum unfolded protein response (GO:1900101)	10	1	.27	+	3.65	2.58E-01	1.00E00
detection of stimulus involved in sensory perception of pain (GO:0062149)	10	1	.27	+	3.65	2.58E-01	1.00E00
glycolytic process through fructose-6-phosphate (GO:0061615)	10	1	.27	+	3.65	2.58E-01	1.00E00
serine family amino acid catabolic process (GO:0009071)	10	1	.27	+	3.65	2.58E-01	1.00E00
negative regulation of bone remodeling (GO:0046851)	10	1	.27	+	3.65	2.58E-01	1.00E00
hormone biosynthetic process (GO:0042446)	10	1	.27	+	3.65	2.58E-01	1.00E00
positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800)	10	1	.27	+	3.65	2.58E-01	1.00E00
sno(s)RNA metabolic process (GO:0016074)	10	1	.27	+	3.65	2.58E-01	1.00E00
negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799)	10	1	.27	+	3.65	2.58E-01	1.00E00
positive regulation of glycoprotein biosynthetic process (GO:0010560)	10	1	.27	+	3.65	2.58E-01	1.00E00
estrogen metabolic process (GO:0008210)	10	1	.27	+	3.65	2.58E-01	1.00E00
androgen metabolic process (GO:0008209)	10	1	.27	+	3.65	2.58E-01	1.00E00
regulation of mitotic spindle checkpoint (GO:1903504)	10	1	.27	+	3.65	2.58E-01	1.00E00
microtubule anchoring at centrosome (GO:0034454)	10	1	.27	+	3.65	2.58E-01	1.00E00
mesenchymal cell proliferation (GO:0010463)	10	1	.27	+	3.65	2.58E-01	1.00E00
negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002823)	20	2	.55	+	3.65	1.16E-01	1.00E00
negative regulation of alcohol biosynthetic process (GO:1902931)	10	1	.27	+	3.65	2.58E-01	1.00E00
positive regulation of T cell mediated immunity (GO:0002711)	20	2	.55	+	3.65	1.16E-01	1.00E00
negative regulation of membrane potential (GO:0045837)	10	1	.27	+	3.65	2.58E-01	1.00E00
negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894)	10	1	.27	+	3.65	2.58E-01	1.00E00
mitochondrial respiratory chain complex assembly (GO:0033108)	51	5	1.40	+	3.58	1.64E-02	1.00E00
negative regulation of tumor necrosis factor production (GO:0032720)	31	3	.85	+	3.53	6.13E-02	1.00E00
presynaptic endocytosis (GO:0140238)	31	3	.85	+	3.53	6.13E-02	1.00E00
synaptic vesicle endocytosis (GO:0048488)	31	3	.85	+	3.53	6.13E-02	1.00E00
regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)	31	3	.85	+	3.53	6.13E-02	1.00E00
negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556)	31	3	.85	+	3.53	6.13E-02	1.00E00
negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)	21	2	.58	+	3.47	1.25E-01	1.00E00
positive regulation of interleukin-1 beta production (GO:0032731)	21	2	.58	+	3.47	1.25E-01	1.00E00
protein ADP-ribosylation (GO:0006471)	21	2	.58	+	3.47	1.25E-01	1.00E00
peptidyl-arginine modification (GO:0018195)	21	2	.58	+	3.47	1.25E-01	1.00E00
macrophage activation (GO:0042116)	21	2	.58	+	3.47	1.25E-01	1.00E00
microtubule anchoring (GO:0034453)	21	2	.58	+	3.47	1.25E-01	1.00E00
actin filament polymerization (GO:0030041)	21	2	.58	+	3.47	1.25E-01	1.00E00
response to activity (GO:0014823)	21	2	.58	+	3.47	1.25E-01	1.00E00
regulation of type 2 immune response (GO:0002828)	21	2	.58	+	3.47	1.25E-01	1.00E00
regulation of alpha-beta T cell activation (GO:0046634)	53	5	1.45	+	3.44	1.89E-02	1.00E00
positive regulation of immunoglobulin production (GO:0002639)	32	3	.88	+	3.42	6.58E-02	1.00E00
adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188)	32	3	.88	+	3.42	6.58E-02	1.00E00
positive regulation of chromatin assembly or disassembly (GO:0045799)	11	1	.30	+	3.32	2.77E-01	1.00E00
negative regulation of homotypic cell-cell adhesion (GO:0034111)	11	1	.30	+	3.32	2.77E-01	1.00E00
regulation of homotypic cell-cell adhesion (GO:0034110)	22	2	.60	+	3.32	1.34E-01	1.00E00
monocyte chemotaxis (GO:0002548)	11	1	.30	+	3.32	2.77E-01	1.00E00
humoral immune response mediated by circulating immunoglobulin (GO:0002455)	22	2	.60	+	3.32	1.34E-01	1.00E00
activation of NF-kappaB-inducing kinase activity (GO:0007250)	11	1	.30	+	3.32	2.77E-01	1.00E00
I-kappaB kinase/NF-kappaB signaling (GO:0007249)	33	3	.90	+	3.32	7.04E-02	1.00E00
release of cytochrome c from mitochondria (GO:0001836)	11	1	.30	+	3.32	2.77E-01	1.00E00
positive regulation of mononuclear cell proliferation (GO:0032946)	55	5	1.51	+	3.32	2.16E-02	1.00E00
regulation of monocyte chemotactic protein-1 production (GO:0071637)	11	1	.30	+	3.32	2.77E-01	1.00E00
regulation of endothelial cell chemotaxis (GO:2001026)	11	1	.30	+	3.32	2.77E-01	1.00E00
regulation of exit from mitosis (GO:0007096)	11	1	.30	+	3.32	2.77E-01	1.00E00
mitotic chromosome condensation (GO:0007076)	11	1	.30	+	3.32	2.77E-01	1.00E00
vacuolar acidification (GO:0007035)	11	1	.30	+	3.32	2.77E-01	1.00E00
regulation of establishment or maintenance of cell polarity (GO:0032878)	22	2	.60	+	3.32	1.34E-01	1.00E00
catecholamine metabolic process (GO:0006584)	22	2	.60	+	3.32	1.34E-01	1.00E00
positive regulation of natural killer cell activation (GO:0032816)	11	1	.30	+	3.32	2.77E-01	1.00E00
receptor catabolic process (GO:0032801)	11	1	.30	+	3.32	2.77E-01	1.00E00
positive regulation of interleukin-4 production (GO:0032753)	11	1	.30	+	3.32	2.77E-01	1.00E00
positive regulation of interferon-alpha production (GO:0032727)	11	1	.30	+	3.32	2.77E-01	1.00E00
negative regulation of interleukin-8 production (GO:0032717)	11	1	.30	+	3.32	2.77E-01	1.00E00
regulation of myoblast fusion (GO:1901739)	11	1	.30	+	3.32	2.77E-01	1.00E00
retinoid metabolic process (GO:0001523)	22	2	.60	+	3.32	1.34E-01	1.00E00
positive regulation of mast cell activation involved in immune response (GO:0033008)	11	1	.30	+	3.32	2.77E-01	1.00E00
melanosome organization (GO:0032438)	11	1	.30	+	3.32	2.77E-01	1.00E00
chromosome localization to nuclear envelope involved in homologous chromosome segregation (GO:0090220)	11	1	.30	+	3.32	2.77E-01	1.00E00
pigment granule organization (GO:0048753)	11	1	.30	+	3.32	2.77E-01	1.00E00
regulation of phospholipid biosynthetic process (GO:0071071)	11	1	.30	+	3.32	2.77E-01	1.00E00
regulation of collateral sprouting (GO:0048670)	11	1	.30	+	3.32	2.77E-01	1.00E00
protein heterooligomerization (GO:0051291)	11	1	.30	+	3.32	2.77E-01	1.00E00
catechol-containing compound metabolic process (GO:0009712)	22	2	.60	+	3.32	1.34E-01	1.00E00
glucosamine-containing compound metabolic process (GO:1901071)	11	1	.30	+	3.32	2.77E-01	1.00E00
regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028)	11	1	.30	+	3.32	2.77E-01	1.00E00
positive regulation of lymphocyte proliferation (GO:0050671)	55	5	1.51	+	3.32	2.16E-02	1.00E00
regulation of thymocyte apoptotic process (GO:0070243)	11	1	.30	+	3.32	2.77E-01	1.00E00
platelet morphogenesis (GO:0036344)	11	1	.30	+	3.32	2.77E-01	1.00E00
positive regulation of nitric-oxide synthase activity (GO:0051000)	11	1	.30	+	3.32	2.77E-01	1.00E00
nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289)	11	1	.30	+	3.32	2.77E-01	1.00E00
cellular response to hepatocyte growth factor stimulus (GO:0035729)	11	1	.30	+	3.32	2.77E-01	1.00E00
positive regulation of mast cell degranulation (GO:0043306)	11	1	.30	+	3.32	2.77E-01	1.00E00
regulation of protein localization to centrosome (GO:1904779)	11	1	.30	+	3.32	2.77E-01	1.00E00
regulation of purine nucleotide biosynthetic process (GO:1900371)	22	2	.60	+	3.32	1.34E-01	1.00E00
regulation of nucleotide biosynthetic process (GO:0030808)	22	2	.60	+	3.32	1.34E-01	1.00E00
cellular response to acetylcholine (GO:1905145)	11	1	.30	+	3.32	2.77E-01	1.00E00
response to acetylcholine (GO:1905144)	11	1	.30	+	3.32	2.77E-01	1.00E00
amine biosynthetic process (GO:0009309)	22	2	.60	+	3.32	1.34E-01	1.00E00
snRNA transcription (GO:0009301)	11	1	.30	+	3.32	2.77E-01	1.00E00
myeloid dendritic cell differentiation (GO:0043011)	11	1	.30	+	3.32	2.77E-01	1.00E00
pore complex assembly (GO:0046931)	11	1	.30	+	3.32	2.77E-01	1.00E00
intracellular estrogen receptor signaling pathway (GO:0030520)	11	1	.30	+	3.32	2.77E-01	1.00E00
regulation of receptor clustering (GO:1903909)	11	1	.30	+	3.32	2.77E-01	1.00E00
negative regulation of programmed necrotic cell death (GO:0062099)	11	1	.30	+	3.32	2.77E-01	1.00E00
cellular biogenic amine biosynthetic process (GO:0042401)	22	2	.60	+	3.32	1.34E-01	1.00E00
adrenal gland development (GO:0030325)	11	1	.30	+	3.32	2.77E-01	1.00E00
establishment of skin barrier (GO:0061436)	11	1	.30	+	3.32	2.77E-01	1.00E00
regulation of natural killer cell mediated cytotoxicity (GO:0042269)	11	1	.30	+	3.32	2.77E-01	1.00E00
platelet formation (GO:0030220)	11	1	.30	+	3.32	2.77E-01	1.00E00
regulation of DNA catabolic process (GO:1903624)	11	1	.30	+	3.32	2.77E-01	1.00E00
lipoprotein biosynthetic process (GO:0042158)	22	2	.60	+	3.32	1.34E-01	1.00E00
B cell differentiation (GO:0030183)	55	5	1.51	+	3.32	2.16E-02	1.00E00
negative regulation of platelet activation (GO:0010544)	11	1	.30	+	3.32	2.77E-01	1.00E00
negative regulation of adaptive immune response (GO:0002820)	22	2	.60	+	3.32	1.34E-01	1.00E00
telomere localization (GO:0034397)	11	1	.30	+	3.32	2.77E-01	1.00E00
positive regulation of cytokine production involved in immune response (GO:0002720)	22	2	.60	+	3.32	1.34E-01	1.00E00
regulation of natural killer cell mediated immunity (GO:0002715)	11	1	.30	+	3.32	2.77E-01	1.00E00
negative regulation of necroptotic process (GO:0060546)	11	1	.30	+	3.32	2.77E-01	1.00E00
positive regulation of interleukin-6 production (GO:0032755)	45	4	1.23	+	3.24	4.11E-02	1.00E00
G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)	34	3	.93	+	3.22	7.52E-02	1.00E00
positive regulation of alpha-beta T cell activation (GO:0046635)	34	3	.93	+	3.22	7.52E-02	1.00E00
water-soluble vitamin metabolic process (GO:0006767)	23	2	.63	+	3.17	1.43E-01	1.00E00
cellular response to nerve growth factor stimulus (GO:1990090)	23	2	.63	+	3.17	1.43E-01	1.00E00
response to nerve growth factor (GO:1990089)	23	2	.63	+	3.17	1.43E-01	1.00E00
response to fungus (GO:0009620)	23	2	.63	+	3.17	1.43E-01	1.00E00
regulation of T cell apoptotic process (GO:0070232)	23	2	.63	+	3.17	1.43E-01	1.00E00
execution phase of apoptosis (GO:0097194)	23	2	.63	+	3.17	1.43E-01	1.00E00
lymphocyte activation involved in immune response (GO:0002285)	58	5	1.59	+	3.14	2.61E-02	1.00E00
protein targeting to membrane (GO:0006612)	35	3	.96	+	3.13	8.01E-02	1.00E00
synaptic vesicle recycling (GO:0036465)	35	3	.96	+	3.13	8.01E-02	1.00E00
regulation of lymphocyte apoptotic process (GO:0070228)	35	3	.96	+	3.13	8.01E-02	1.00E00
response to virus (GO:0009615)	119	10	3.26	+	3.06	2.34E-03	1.00E00
regulation of systemic arterial blood pressure (GO:0003073)	36	3	.99	+	3.04	8.51E-02	1.00E00
microtubule anchoring at microtubule organizing center (GO:0072393)	12	1	.33	+	3.04	2.97E-01	1.00E00
regulation of water loss via skin (GO:0033561)	12	1	.33	+	3.04	2.97E-01	1.00E00
positive regulation of glycoprotein metabolic process (GO:1903020)	12	1	.33	+	3.04	2.97E-01	1.00E00
dorsal spinal cord development (GO:0021516)	12	1	.33	+	3.04	2.97E-01	1.00E00
positive regulation of mitotic sister chromatid separation (GO:1901970)	12	1	.33	+	3.04	2.97E-01	1.00E00
regulation of natural killer cell differentiation (GO:0032823)	12	1	.33	+	3.04	2.97E-01	1.00E00
positive regulation of protein sumoylation (GO:0033235)	12	1	.33	+	3.04	2.97E-01	1.00E00
regulation of T-helper 17 cell differentiation (GO:2000319)	12	1	.33	+	3.04	2.97E-01	1.00E00
positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770)	12	1	.33	+	3.04	2.97E-01	1.00E00
cellular response to alkaloid (GO:0071312)	12	1	.33	+	3.04	2.97E-01	1.00E00
positive regulation of mast cell activation (GO:0033005)	12	1	.33	+	3.04	2.97E-01	1.00E00
pyrimidine nucleotide catabolic process (GO:0006244)	12	1	.33	+	3.04	2.97E-01	1.00E00
regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308)	12	1	.33	+	3.04	2.97E-01	1.00E00
regulation of spindle checkpoint (GO:0090231)	12	1	.33	+	3.04	2.97E-01	1.00E00
regulation of cytosolic calcium ion concentration (GO:0051480)	72	6	1.97	+	3.04	1.77E-02	1.00E00
telomere maintenance via recombination (GO:0000722)	12	1	.33	+	3.04	2.97E-01	1.00E00
resolution of meiotic recombination intermediates (GO:0000712)	12	1	.33	+	3.04	2.97E-01	1.00E00
RNA surveillance (GO:0071025)	12	1	.33	+	3.04	2.97E-01	1.00E00
dendritic transport (GO:0098935)	12	1	.33	+	3.04	2.97E-01	1.00E00
regulation of steroid hormone biosynthetic process (GO:0090030)	12	1	.33	+	3.04	2.97E-01	1.00E00
tRNA 5'-end processing (GO:0099116)	12	1	.33	+	3.04	2.97E-01	1.00E00
cellular response to vascular endothelial growth factor stimulus (GO:0035924)	24	2	.66	+	3.04	1.52E-01	1.00E00
nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)	12	1	.33	+	3.04	2.97E-01	1.00E00
response to hepatocyte growth factor (GO:0035728)	12	1	.33	+	3.04	2.97E-01	1.00E00
positive regulation of leukocyte degranulation (GO:0043302)	12	1	.33	+	3.04	2.97E-01	1.00E00
neuron cellular homeostasis (GO:0070050)	12	1	.33	+	3.04	2.97E-01	1.00E00
positive regulation of purine nucleotide biosynthetic process (GO:1900373)	12	1	.33	+	3.04	2.97E-01	1.00E00
positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707)	24	2	.66	+	3.04	1.52E-01	1.00E00
positive regulation of nucleotide biosynthetic process (GO:0030810)	12	1	.33	+	3.04	2.97E-01	1.00E00
rRNA modification (GO:0000154)	24	2	.66	+	3.04	1.52E-01	1.00E00
proteasome assembly (GO:0043248)	12	1	.33	+	3.04	2.97E-01	1.00E00
oligosaccharide metabolic process (GO:0009311)	12	1	.33	+	3.04	2.97E-01	1.00E00
vascular endothelial growth factor receptor signaling pathway (GO:0048010)	12	1	.33	+	3.04	2.97E-01	1.00E00
regulation of vascular associated smooth muscle cell differentiation (GO:1905063)	12	1	.33	+	3.04	2.97E-01	1.00E00
pyrimidine deoxyribonucleotide catabolic process (GO:0009223)	12	1	.33	+	3.04	2.97E-01	1.00E00
regulation of histone H3-K9 trimethylation (GO:1900112)	12	1	.33	+	3.04	2.97E-01	1.00E00
vesicle cargo loading (GO:0035459)	12	1	.33	+	3.04	2.97E-01	1.00E00
pyrimidine nucleoside triphosphate metabolic process (GO:0009147)	12	1	.33	+	3.04	2.97E-01	1.00E00
organophosphate ester transport (GO:0015748)	24	2	.66	+	3.04	1.52E-01	1.00E00
carbohydrate phosphorylation (GO:0046835)	12	1	.33	+	3.04	2.97E-01	1.00E00
apoptotic nuclear changes (GO:0030262)	12	1	.33	+	3.04	2.97E-01	1.00E00
ovulation cycle process (GO:0022602)	24	2	.66	+	3.04	1.52E-01	1.00E00
protein localization to kinetochore (GO:0034501)	12	1	.33	+	3.04	2.97E-01	1.00E00
regulation of platelet activation (GO:0010543)	24	2	.66	+	3.04	1.52E-01	1.00E00
trophoblast giant cell differentiation (GO:0060707)	12	1	.33	+	3.04	2.97E-01	1.00E00
maintenance of cell polarity (GO:0030011)	12	1	.33	+	3.04	2.97E-01	1.00E00
mitotic DNA replication (GO:1902969)	12	1	.33	+	3.04	2.97E-01	1.00E00
positive regulation of T cell cytokine production (GO:0002726)	12	1	.33	+	3.04	2.97E-01	1.00E00
negative regulation of striated muscle tissue development (GO:0045843)	12	1	.33	+	3.04	2.97E-01	1.00E00
positive regulation of mitotic metaphase/anaphase transition (GO:0045842)	12	1	.33	+	3.04	2.97E-01	1.00E00
positive regulation of mitotic nuclear division (GO:0045840)	24	2	.66	+	3.04	1.52E-01	1.00E00
positive regulation of membrane potential (GO:0045838)	12	1	.33	+	3.04	2.97E-01	1.00E00
lactation (GO:0007595)	12	1	.33	+	3.04	2.97E-01	1.00E00
positive regulation of leukocyte proliferation (GO:0070665)	61	5	1.67	+	2.99	3.11E-02	1.00E00
positive regulation of T cell activation (GO:0050870)	86	7	2.36	+	2.97	1.20E-02	1.00E00
ovarian follicle development (GO:0001541)	37	3	1.01	+	2.96	9.03E-02	1.00E00
cellular response to fibroblast growth factor stimulus (GO:0044344)	37	3	1.01	+	2.96	9.03E-02	1.00E00
positive regulation of interleukin-1 production (GO:0032732)	25	2	.69	+	2.92	1.61E-01	1.00E00
neuron apoptotic process (GO:0051402)	25	2	.69	+	2.92	1.61E-01	1.00E00
regulation of fibroblast migration (GO:0010762)	25	2	.69	+	2.92	1.61E-01	1.00E00
negative regulation of alpha-beta T cell activation (GO:0046636)	25	2	.69	+	2.92	1.61E-01	1.00E00
negative regulation of cardiac muscle cell apoptotic process (GO:0010667)	25	2	.69	+	2.92	1.61E-01	1.00E00
positive regulation of lymphocyte mediated immunity (GO:0002708)	50	4	1.37	+	2.92	5.55E-02	1.00E00
positive regulation of NF-kappaB transcription factor activity (GO:0051092)	76	6	2.08	+	2.88	2.21E-02	1.00E00
cyclic-nucleotide-mediated signaling (GO:0019935)	38	3	1.04	+	2.88	9.56E-02	1.00E00
regulation of T cell proliferation (GO:0042129)	76	6	2.08	+	2.88	2.21E-02	1.00E00
cellular biogenic amine metabolic process (GO:0006576)	51	4	1.40	+	2.86	5.86E-02	1.00E00
cellular amine metabolic process (GO:0044106)	51	4	1.40	+	2.86	5.86E-02	1.00E00
amine metabolic process (GO:0009308)	51	4	1.40	+	2.86	5.86E-02	1.00E00
cholesterol homeostasis (GO:0042632)	51	4	1.40	+	2.86	5.86E-02	1.00E00
sterol homeostasis (GO:0055092)	51	4	1.40	+	2.86	5.86E-02	1.00E00
positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824)	51	4	1.40	+	2.86	5.86E-02	1.00E00
positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731)	91	7	2.50	+	2.81	1.57E-02	1.00E00
fatty acid oxidation (GO:0019395)	52	4	1.43	+	2.81	6.19E-02	1.00E00
negative regulation of T-helper cell differentiation (GO:0045623)	13	1	.36	+	2.81	3.15E-01	1.00E00
T cell mediated immunity (GO:0002456)	13	1	.36	+	2.81	3.15E-01	1.00E00
positive regulation of leukocyte mediated cytotoxicity (GO:0001912)	13	1	.36	+	2.81	3.15E-01	1.00E00
protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205)	13	1	.36	+	2.81	3.15E-01	1.00E00
phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200)	13	1	.36	+	2.81	3.15E-01	1.00E00
positive regulation of glial cell proliferation (GO:0060252)	13	1	.36	+	2.81	3.15E-01	1.00E00
response to fibroblast growth factor (GO:0071774)	39	3	1.07	+	2.81	1.01E-01	1.00E00
membrane assembly (GO:0071709)	13	1	.36	+	2.81	3.15E-01	1.00E00
positive regulation of syncytium formation by plasma membrane fusion (GO:0060143)	13	1	.36	+	2.81	3.15E-01	1.00E00
positive regulation of granulocyte chemotaxis (GO:0071624)	13	1	.36	+	2.81	3.15E-01	1.00E00
myeloid dendritic cell activation (GO:0001773)	13	1	.36	+	2.81	3.15E-01	1.00E00
positive regulation of chromosome segregation (GO:0051984)	13	1	.36	+	2.81	3.15E-01	1.00E00
mRNA cis splicing, via spliceosome (GO:0045292)	13	1	.36	+	2.81	3.15E-01	1.00E00
regulation of intracellular estrogen receptor signaling pathway (GO:0033146)	26	2	.71	+	2.81	1.71E-01	1.00E00
regulation of interleukin-4 production (GO:0032673)	13	1	.36	+	2.81	3.15E-01	1.00E00
regulation of interferon-alpha production (GO:0032647)	13	1	.36	+	2.81	3.15E-01	1.00E00
regulation of transcription by RNA polymerase III (GO:0006359)	13	1	.36	+	2.81	3.15E-01	1.00E00
positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101)	13	1	.36	+	2.81	3.15E-01	1.00E00
positive regulation of response to endoplasmic reticulum stress (GO:1905898)	13	1	.36	+	2.81	3.15E-01	1.00E00
response to cAMP (GO:0051591)	26	2	.71	+	2.81	1.71E-01	1.00E00
negative regulation of leukocyte proliferation (GO:0070664)	39	3	1.07	+	2.81	1.01E-01	1.00E00
positive regulation of oligodendrocyte differentiation (GO:0048714)	13	1	.36	+	2.81	3.15E-01	1.00E00
cellular response to leptin stimulus (GO:0044320)	13	1	.36	+	2.81	3.15E-01	1.00E00
regulation of phosphatidylinositol 3-kinase activity (GO:0043551)	26	2	.71	+	2.81	1.71E-01	1.00E00
negative regulation of smooth muscle cell differentiation (GO:0051151)	13	1	.36	+	2.81	3.15E-01	1.00E00
positive regulation of blood vessel endothelial cell migration (GO:0043536)	39	3	1.07	+	2.81	1.01E-01	1.00E00
regulation of defense response to virus (GO:0050688)	39	3	1.07	+	2.81	1.01E-01	1.00E00
modification of postsynaptic structure (GO:0099010)	13	1	.36	+	2.81	3.15E-01	1.00E00
vascular associated smooth muscle cell differentiation (GO:0035886)	13	1	.36	+	2.81	3.15E-01	1.00E00
response to oxygen radical (GO:0000305)	13	1	.36	+	2.81	3.15E-01	1.00E00
response to superoxide (GO:0000303)	13	1	.36	+	2.81	3.15E-01	1.00E00
regulation of execution phase of apoptosis (GO:1900117)	13	1	.36	+	2.81	3.15E-01	1.00E00
phosphorylated carbohydrate dephosphorylation (GO:0046838)	13	1	.36	+	2.81	3.15E-01	1.00E00
muscle cell cellular homeostasis (GO:0046716)	13	1	.36	+	2.81	3.15E-01	1.00E00
decidualization (GO:0046697)	13	1	.36	+	2.81	3.15E-01	1.00E00
negative regulation of striated muscle cell apoptotic process (GO:0010664)	26	2	.71	+	2.81	1.71E-01	1.00E00
positive regulation of striated muscle cell apoptotic process (GO:0010663)	13	1	.36	+	2.81	3.15E-01	1.00E00
regulation of striated muscle cell apoptotic process (GO:0010662)	39	3	1.07	+	2.81	1.01E-01	1.00E00
S-adenosylmethionine metabolic process (GO:0046500)	13	1	.36	+	2.81	3.15E-01	1.00E00
regulation of ketone biosynthetic process (GO:0010566)	13	1	.36	+	2.81	3.15E-01	1.00E00
regulation of B cell apoptotic process (GO:0002902)	13	1	.36	+	2.81	3.15E-01	1.00E00
reactive oxygen species biosynthetic process (GO:1903409)	13	1	.36	+	2.81	3.15E-01	1.00E00
diacylglycerol metabolic process (GO:0046339)	13	1	.36	+	2.81	3.15E-01	1.00E00
cytoplasmic pattern recognition receptor signaling pathway (GO:0002753)	13	1	.36	+	2.81	3.15E-01	1.00E00
regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898)	13	1	.36	+	2.81	3.15E-01	1.00E00
regulation of non-motile cilium assembly (GO:1902855)	13	1	.36	+	2.81	3.15E-01	1.00E00
positive regulation of autophagy (GO:0010508)	92	7	2.52	+	2.77	1.65E-02	1.00E00
positive regulation of production of molecular mediator of immune response (GO:0002702)	53	4	1.45	+	2.75	6.52E-02	1.00E00
activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919)	40	3	1.10	+	2.74	1.07E-01	1.00E00
fatty acid beta-oxidation (GO:0006635)	40	3	1.10	+	2.74	1.07E-01	1.00E00
regulation of tumor necrosis factor production (GO:0032680)	80	6	2.19	+	2.74	2.72E-02	1.00E00
autophagosome assembly (GO:0000045)	40	3	1.10	+	2.74	1.07E-01	1.00E00
regulation of alpha-beta T cell differentiation (GO:0046637)	40	3	1.10	+	2.74	1.07E-01	1.00E00
regulation of tumor necrosis factor superfamily cytokine production (GO:1903555)	80	6	2.19	+	2.74	2.72E-02	1.00E00
regulation of macroautophagy (GO:0016241)	67	5	1.84	+	2.72	4.29E-02	1.00E00
positive regulation of leukocyte cell-cell adhesion (GO:1903039)	94	7	2.58	+	2.72	1.82E-02	1.00E00
NADH dehydrogenase complex assembly (GO:0010257)	27	2	.74	+	2.70	1.81E-01	1.00E00
positive regulation of DNA replication (GO:0045740)	27	2	.74	+	2.70	1.81E-01	1.00E00
acute inflammatory response (GO:0002526)	27	2	.74	+	2.70	1.81E-01	1.00E00
negative regulation of T cell differentiation (GO:0045581)	27	2	.74	+	2.70	1.81E-01	1.00E00
positive regulation of cytokine-mediated signaling pathway (GO:0001961)	27	2	.74	+	2.70	1.81E-01	1.00E00
mitochondrial respiratory chain complex I assembly (GO:0032981)	27	2	.74	+	2.70	1.81E-01	1.00E00
ovulation cycle (GO:0042698)	27	2	.74	+	2.70	1.81E-01	1.00E00
negative regulation of anion transmembrane transport (GO:1903960)	27	2	.74	+	2.70	1.81E-01	1.00E00
negative regulation of mitochondrion organization (GO:0010823)	27	2	.74	+	2.70	1.81E-01	1.00E00
regulation of T cell mediated immunity (GO:0002709)	27	2	.74	+	2.70	1.81E-01	1.00E00
leukocyte activation involved in immune response (GO:0002366)	82	6	2.25	+	2.67	3.00E-02	1.00E00
lipid oxidation (GO:0034440)	55	4	1.51	+	2.65	7.22E-02	1.00E00
positive regulation of adaptive immune response (GO:0002821)	55	4	1.51	+	2.65	7.22E-02	1.00E00
positive regulation of leukocyte mediated immunity (GO:0002705)	55	4	1.51	+	2.65	7.22E-02	1.00E00
B cell activation (GO:0042113)	83	6	2.28	+	2.64	3.15E-02	1.00E00
positive regulation of G protein-coupled receptor signaling pathway (GO:0045745)	14	1	.38	+	2.60	3.34E-01	1.00E00
toll-like receptor 4 signaling pathway (GO:0034142)	14	1	.38	+	2.60	3.34E-01	1.00E00
negative regulation of osteoclast differentiation (GO:0045671)	14	1	.38	+	2.60	3.34E-01	1.00E00
regulation of cell adhesion mediated by integrin (GO:0033628)	28	2	.77	+	2.60	1.90E-01	1.00E00
neuromuscular synaptic transmission (GO:0007274)	14	1	.38	+	2.60	3.34E-01	1.00E00
cell activation involved in immune response (GO:0002263)	84	6	2.30	+	2.60	3.30E-02	1.00E00
microtubule depolymerization (GO:0007019)	14	1	.38	+	2.60	3.34E-01	1.00E00
excitatory postsynaptic potential (GO:0060079)	14	1	.38	+	2.60	3.34E-01	1.00E00
negative regulation of muscle tissue development (GO:1901862)	14	1	.38	+	2.60	3.34E-01	1.00E00
protein N-linked glycosylation (GO:0006487)	14	1	.38	+	2.60	3.34E-01	1.00E00
auditory receptor cell morphogenesis (GO:0002093)	14	1	.38	+	2.60	3.34E-01	1.00E00
pseudouridine synthesis (GO:0001522)	14	1	.38	+	2.60	3.34E-01	1.00E00
regulation of interleukin-6 production (GO:0032675)	70	5	1.92	+	2.60	4.97E-02	1.00E00
regulation of hair follicle development (GO:0051797)	14	1	.38	+	2.60	3.34E-01	1.00E00
regulation of nitric-oxide synthase biosynthetic process (GO:0051769)	14	1	.38	+	2.60	3.34E-01	1.00E00
regulation of mitotic spindle assembly (GO:1901673)	14	1	.38	+	2.60	3.34E-01	1.00E00
regulation of rRNA processing (GO:2000232)	14	1	.38	+	2.60	3.34E-01	1.00E00
negative regulation of neural precursor cell proliferation (GO:2000178)	14	1	.38	+	2.60	3.34E-01	1.00E00
purine nucleobase metabolic process (GO:0006144)	14	1	.38	+	2.60	3.34E-01	1.00E00
positive regulation of chromosome separation (GO:1905820)	14	1	.38	+	2.60	3.34E-01	1.00E00
response to leptin (GO:0044321)	14	1	.38	+	2.60	3.34E-01	1.00E00
sulfur compound catabolic process (GO:0044273)	14	1	.38	+	2.60	3.34E-01	1.00E00
positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050)	14	1	.38	+	2.60	3.34E-01	1.00E00
defense response to fungus (GO:0050832)	14	1	.38	+	2.60	3.34E-01	1.00E00
lymphocyte apoptotic process (GO:0070227)	14	1	.38	+	2.60	3.34E-01	1.00E00
epithelial cell differentiation involved in kidney development (GO:0035850)	14	1	.38	+	2.60	3.34E-01	1.00E00
interstrand cross-link repair (GO:0036297)	28	2	.77	+	2.60	1.90E-01	1.00E00
positive regulation of vascular associated smooth muscle cell migration (GO:1904754)	14	1	.38	+	2.60	3.34E-01	1.00E00
protein autoprocessing (GO:0016540)	14	1	.38	+	2.60	3.34E-01	1.00E00
midbody abscission (GO:0061952)	14	1	.38	+	2.60	3.34E-01	1.00E00
deoxyribonucleoside triphosphate metabolic process (GO:0009200)	14	1	.38	+	2.60	3.34E-01	1.00E00
ventricular cardiac muscle cell differentiation (GO:0055012)	14	1	.38	+	2.60	3.34E-01	1.00E00
positive regulation of macrophage activation (GO:0043032)	14	1	.38	+	2.60	3.34E-01	1.00E00
dopamine metabolic process (GO:0042417)	14	1	.38	+	2.60	3.34E-01	1.00E00
negative regulation of gene silencing by miRNA (GO:0060965)	14	1	.38	+	2.60	3.34E-01	1.00E00
positive regulation of alpha-beta T cell differentiation (GO:0046638)	28	2	.77	+	2.60	1.90E-01	1.00E00
cellular carbohydrate biosynthetic process (GO:0034637)	28	2	.77	+	2.60	1.90E-01	1.00E00
histone mRNA metabolic process (GO:0008334)	14	1	.38	+	2.60	3.34E-01	1.00E00
metanephros morphogenesis (GO:0003338)	14	1	.38	+	2.60	3.34E-01	1.00E00
regulation of adaptive immune response (GO:0002819)	84	6	2.30	+	2.60	3.30E-02	1.00E00
negative regulation of necrotic cell death (GO:0060547)	14	1	.38	+	2.60	3.34E-01	1.00E00
positive regulation of ERK1 and ERK2 cascade (GO:0070374)	85	6	2.33	+	2.57	3.46E-02	1.00E00
positive regulation of endopeptidase activity (GO:0010950)	85	6	2.33	+	2.57	3.46E-02	1.00E00
positive regulation of lymphocyte differentiation (GO:0045621)	57	4	1.56	+	2.56	7.95E-02	1.00E00
autophagosome organization (GO:1905037)	43	3	1.18	+	2.54	1.24E-01	1.00E00
replication fork processing (GO:0031297)	29	2	.80	+	2.51	2.00E-01	1.00E00
positive regulation of cysteine-type endopeptidase activity (GO:2001056)	73	5	2.00	+	2.50	5.71E-02	1.00E00
regulation of immunoglobulin production (GO:0002637)	44	3	1.21	+	2.49	1.30E-01	1.00E00
positive regulation of B cell activation (GO:0050871)	44	3	1.21	+	2.49	1.30E-01	1.00E00
macroautophagy (GO:0016236)	74	5	2.03	+	2.46	5.96E-02	1.00E00
substrate-dependent cell migration (GO:0006929)	15	1	.41	+	2.43	3.52E-01	1.00E00
hexose catabolic process (GO:0019320)	15	1	.41	+	2.43	3.52E-01	1.00E00
positive regulation of endothelial cell proliferation (GO:0001938)	45	3	1.23	+	2.43	1.36E-01	1.00E00
regulation of syncytium formation by plasma membrane fusion (GO:0060142)	15	1	.41	+	2.43	3.52E-01	1.00E00
auditory receptor cell development (GO:0060117)	15	1	.41	+	2.43	3.52E-01	1.00E00
mitotic cytokinetic process (GO:1902410)	15	1	.41	+	2.43	3.52E-01	1.00E00
phosphatidic acid biosynthetic process (GO:0006654)	15	1	.41	+	2.43	3.52E-01	1.00E00
regulation of T-helper 17 type immune response (GO:2000316)	15	1	.41	+	2.43	3.52E-01	1.00E00
regulation of T cell differentiation in thymus (GO:0033081)	15	1	.41	+	2.43	3.52E-01	1.00E00
DNA unwinding involved in DNA replication (GO:0006268)	15	1	.41	+	2.43	3.52E-01	1.00E00
chemical synaptic transmission, postsynaptic (GO:0099565)	15	1	.41	+	2.43	3.52E-01	1.00E00
positive regulation of protein autophosphorylation (GO:0031954)	15	1	.41	+	2.43	3.52E-01	1.00E00
intracellular pH reduction (GO:0051452)	15	1	.41	+	2.43	3.52E-01	1.00E00
multicellular organismal water homeostasis (GO:0050891)	15	1	.41	+	2.43	3.52E-01	1.00E00
negative regulation of T cell activation (GO:0050868)	60	4	1.65	+	2.43	9.11E-02	1.00E00
regulation of heterochromatin organization (GO:0120261)	15	1	.41	+	2.43	3.52E-01	1.00E00
post-translational protein modification (GO:0043687)	15	1	.41	+	2.43	3.52E-01	1.00E00
negative regulation of T cell apoptotic process (GO:0070233)	15	1	.41	+	2.43	3.52E-01	1.00E00
negative regulation of lipid biosynthetic process (GO:0051055)	30	2	.82	+	2.43	2.10E-01	1.00E00
regulation of heterochromatin assembly (GO:0031445)	15	1	.41	+	2.43	3.52E-01	1.00E00
response to pain (GO:0048265)	15	1	.41	+	2.43	3.52E-01	1.00E00
regulation of cell killing (GO:0031341)	30	2	.82	+	2.43	2.10E-01	1.00E00
chemokine-mediated signaling pathway (GO:0070098)	15	1	.41	+	2.43	3.52E-01	1.00E00
regulation of ubiquitin protein ligase activity (GO:1904666)	15	1	.41	+	2.43	3.52E-01	1.00E00
animal organ regeneration (GO:0031100)	15	1	.41	+	2.43	3.52E-01	1.00E00
regulation of macrophage activation (GO:0043030)	30	2	.82	+	2.43	2.10E-01	1.00E00
positive regulation of peptidase activity (GO:0010952)	90	6	2.47	+	2.43	4.31E-02	1.00E00
intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631)	15	1	.41	+	2.43	3.52E-01	1.00E00
negative regulation of steroid biosynthetic process (GO:0010894)	15	1	.41	+	2.43	3.52E-01	1.00E00
rRNA catabolic process (GO:0016075)	15	1	.41	+	2.43	3.52E-01	1.00E00
autophagosome maturation (GO:0097352)	15	1	.41	+	2.43	3.52E-01	1.00E00
negative regulation of T cell proliferation (GO:0042130)	30	2	.82	+	2.43	2.10E-01	1.00E00
positive regulation of vascular endothelial growth factor production (GO:0010575)	15	1	.41	+	2.43	3.52E-01	1.00E00
glycerophospholipid catabolic process (GO:0046475)	15	1	.41	+	2.43	3.52E-01	1.00E00
ncRNA 5'-end processing (GO:0034471)	15	1	.41	+	2.43	3.52E-01	1.00E00
regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002822)	75	5	2.06	+	2.43	6.23E-02	1.00E00
negative regulation of steroid metabolic process (GO:0045939)	15	1	.41	+	2.43	3.52E-01	1.00E00
NAD metabolic process (GO:0019674)	15	1	.41	+	2.43	3.52E-01	1.00E00
positive regulation of vasoconstriction (GO:0045907)	15	1	.41	+	2.43	3.52E-01	1.00E00
regulation of T cell cytokine production (GO:0002724)	15	1	.41	+	2.43	3.52E-01	1.00E00
regulation of necroptotic process (GO:0060544)	15	1	.41	+	2.43	3.52E-01	1.00E00
endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888)	46	3	1.26	+	2.38	1.42E-01	1.00E00
defense response to bacterium (GO:0042742)	92	6	2.52	+	2.38	4.69E-02	1.00E00
immunoglobulin mediated immune response (GO:0016064)	46	3	1.26	+	2.38	1.42E-01	1.00E00
B cell mediated immunity (GO:0019724)	46	3	1.26	+	2.38	1.42E-01	1.00E00
regulation of leukocyte proliferation (GO:0070663)	108	7	2.96	+	2.36	3.41E-02	1.00E00
positive regulation of phagocytosis (GO:0050766)	31	2	.85	+	2.35	2.20E-01	1.00E00
chromosome localization (GO:0050000)	62	4	1.70	+	2.35	9.93E-02	1.00E00
positive regulation of response to cytokine stimulus (GO:0060760)	31	2	.85	+	2.35	2.20E-01	1.00E00
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460)	78	5	2.14	+	2.34	7.07E-02	1.00E00
protein-DNA complex assembly (GO:0065004)	78	5	2.14	+	2.34	7.07E-02	1.00E00
regulation of cold-induced thermogenesis (GO:0120161)	78	5	2.14	+	2.34	7.07E-02	1.00E00
production of molecular mediator of immune response (GO:0002440)	47	3	1.29	+	2.33	1.48E-01	1.00E00
regulation of leukocyte cell-cell adhesion (GO:1903037)	141	9	3.87	+	2.33	1.90E-02	1.00E00
positive regulation of tumor necrosis factor production (GO:0032760)	47	3	1.29	+	2.33	1.48E-01	1.00E00
regulation of leukocyte apoptotic process (GO:2000106)	47	3	1.29	+	2.33	1.48E-01	1.00E00
positive regulation of cold-induced thermogenesis (GO:0120162)	47	3	1.29	+	2.33	1.48E-01	1.00E00
positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557)	47	3	1.29	+	2.33	1.48E-01	1.00E00
extrinsic apoptotic signaling pathway (GO:0097191)	47	3	1.29	+	2.33	1.48E-01	1.00E00
lymphocyte mediated immunity (GO:0002449)	63	4	1.73	+	2.32	1.04E-01	1.00E00
positive regulation of blood pressure (GO:0045777)	16	1	.44	+	2.28	3.69E-01	1.00E00
dicarboxylic acid transport (GO:0006835)	16	1	.44	+	2.28	3.69E-01	1.00E00
regulation of endothelial cell proliferation (GO:0001936)	64	4	1.76	+	2.28	1.08E-01	1.00E00
regulation of transcription initiation from RNA polymerase II promoter (GO:0060260)	32	2	.88	+	2.28	2.30E-01	1.00E00
metanephric nephron development (GO:0072210)	16	1	.44	+	2.28	3.69E-01	1.00E00
blastocyst hatching (GO:0001835)	16	1	.44	+	2.28	3.69E-01	1.00E00
positive regulation of collagen biosynthetic process (GO:0032967)	16	1	.44	+	2.28	3.69E-01	1.00E00
negative regulation of posttranscriptional gene silencing (GO:0060149)	16	1	.44	+	2.28	3.69E-01	1.00E00
organism emergence from protective structure (GO:0071684)	16	1	.44	+	2.28	3.69E-01	1.00E00
regulation of mitochondrial depolarization (GO:0051900)	16	1	.44	+	2.28	3.69E-01	1.00E00
modulation by host of viral process (GO:0044788)	16	1	.44	+	2.28	3.69E-01	1.00E00
positive regulation of monooxygenase activity (GO:0032770)	16	1	.44	+	2.28	3.69E-01	1.00E00
NIK/NF-kappaB signaling (GO:0038061)	16	1	.44	+	2.28	3.69E-01	1.00E00
tRNA wobble uridine modification (GO:0002098)	16	1	.44	+	2.28	3.69E-01	1.00E00
glycogen metabolic process (GO:0005977)	32	2	.88	+	2.28	2.30E-01	1.00E00
neuron death (GO:0070997)	32	2	.88	+	2.28	2.30E-01	1.00E00
mitotic recombination (GO:0006312)	16	1	.44	+	2.28	3.69E-01	1.00E00
RNA 5'-end processing (GO:0000966)	16	1	.44	+	2.28	3.69E-01	1.00E00
regulation of platelet aggregation (GO:0090330)	16	1	.44	+	2.28	3.69E-01	1.00E00
regulation of calcium ion import (GO:0090279)	16	1	.44	+	2.28	3.69E-01	1.00E00
cellular glucan metabolic process (GO:0006073)	32	2	.88	+	2.28	2.30E-01	1.00E00
COPII-coated vesicle budding (GO:0090114)	16	1	.44	+	2.28	3.69E-01	1.00E00
cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742)	32	2	.88	+	2.28	2.30E-01	1.00E00
negative regulation of cold-induced thermogenesis (GO:0120163)	32	2	.88	+	2.28	2.30E-01	1.00E00
glucan metabolic process (GO:0044042)	32	2	.88	+	2.28	2.30E-01	1.00E00
tongue development (GO:0043586)	16	1	.44	+	2.28	3.69E-01	1.00E00
regulation of cellular respiration (GO:0043457)	16	1	.44	+	2.28	3.69E-01	1.00E00
negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371)	16	1	.44	+	2.28	3.69E-01	1.00E00
hydrogen peroxide metabolic process (GO:0042743)	16	1	.44	+	2.28	3.69E-01	1.00E00
entrainment of circadian clock by photoperiod (GO:0043153)	16	1	.44	+	2.28	3.69E-01	1.00E00
positive regulation of viral life cycle (GO:1903902)	16	1	.44	+	2.28	3.69E-01	1.00E00
regulation of keratinocyte proliferation (GO:0010837)	16	1	.44	+	2.28	3.69E-01	1.00E00
telomere maintenance via telomere lengthening (GO:0010833)	16	1	.44	+	2.28	3.69E-01	1.00E00
cellular hormone metabolic process (GO:0034754)	32	2	.88	+	2.28	2.30E-01	1.00E00
vasodilation (GO:0042311)	16	1	.44	+	2.28	3.69E-01	1.00E00
carbohydrate biosynthetic process (GO:0016051)	48	3	1.32	+	2.28	1.55E-01	1.00E00
positive regulation of collagen metabolic process (GO:0010714)	16	1	.44	+	2.28	3.69E-01	1.00E00
hatching (GO:0035188)	16	1	.44	+	2.28	3.69E-01	1.00E00
dendritic spine morphogenesis (GO:0060997)	16	1	.44	+	2.28	3.69E-01	1.00E00
negative regulation of gene silencing by RNA (GO:0060967)	16	1	.44	+	2.28	3.69E-01	1.00E00
isoprenoid biosynthetic process (GO:0008299)	16	1	.44	+	2.28	3.69E-01	1.00E00
negative regulation of muscle contraction (GO:0045932)	16	1	.44	+	2.28	3.69E-01	1.00E00
peptide secretion (GO:0002790)	64	4	1.76	+	2.28	1.08E-01	1.00E00
positive regulation of protein tyrosine kinase activity (GO:0061098)	16	1	.44	+	2.28	3.69E-01	1.00E00
pH reduction (GO:0045851)	16	1	.44	+	2.28	3.69E-01	1.00E00
positive regulation of epithelial cell proliferation (GO:0050679)	97	6	2.66	+	2.26	5.72E-02	1.00E00
tRNA modification (GO:0006400)	65	4	1.78	+	2.24	1.12E-01	1.00E00
positive regulation of cell-cell adhesion (GO:0022409)	114	7	3.13	+	2.24	4.31E-02	1.00E00
regulation of reactive oxygen species biosynthetic process (GO:1903426)	49	3	1.34	+	2.23	1.61E-01	1.00E00
regulation of lymphocyte proliferation (GO:0050670)	99	6	2.71	+	2.21	6.17E-02	1.00E00
purine ribonucleoside metabolic process (GO:0046128)	33	2	.90	+	2.21	2.40E-01	1.00E00
negative regulation of leukocyte cell-cell adhesion (GO:1903038)	66	4	1.81	+	2.21	1.17E-01	1.00E00
vitamin metabolic process (GO:0006766)	33	2	.90	+	2.21	2.40E-01	1.00E00
localization within membrane (GO:0051668)	33	2	.90	+	2.21	2.40E-01	1.00E00
regulation of cholesterol transport (GO:0032374)	33	2	.90	+	2.21	2.40E-01	1.00E00
regulation of sterol transport (GO:0032371)	33	2	.90	+	2.21	2.40E-01	1.00E00
regulation of peptidyl-tyrosine phosphorylation (GO:0050730)	132	8	3.62	+	2.21	3.38E-02	1.00E00
positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280)	66	4	1.81	+	2.21	1.17E-01	1.00E00
purine ribonucleoside triphosphate metabolic process (GO:0009205)	33	2	.90	+	2.21	2.40E-01	1.00E00
negative regulation of immune effector process (GO:0002698)	66	4	1.81	+	2.21	1.17E-01	1.00E00
vacuole organization (GO:0007033)	83	5	2.28	+	2.20	8.59E-02	1.00E00
regulation of T cell activation (GO:0050863)	150	9	4.11	+	2.19	3.96E-02	1.00E00
regulation of mononuclear cell proliferation (GO:0032944)	100	6	2.74	+	2.19	6.40E-02	1.00E00
cytokine-mediated signaling pathway (GO:0019221)	101	6	2.77	+	2.17	6.64E-02	1.00E00
regulation of autophagy (GO:0010506)	169	10	4.63	+	2.16	2.92E-02	1.00E00
positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737)	17	1	.47	+	2.15	3.86E-01	1.00E00
skeletal muscle contraction (GO:0003009)	17	1	.47	+	2.15	3.86E-01	1.00E00
phenol-containing compound metabolic process (GO:0018958)	34	2	.93	+	2.15	2.50E-01	1.00E00
regulation of heterotypic cell-cell adhesion (GO:0034114)	17	1	.47	+	2.15	3.86E-01	1.00E00
homotypic cell-cell adhesion (GO:0034109)	17	1	.47	+	2.15	3.86E-01	1.00E00
regulation of megakaryocyte differentiation (GO:0045652)	17	1	.47	+	2.15	3.86E-01	1.00E00
negative regulation of lymphocyte differentiation (GO:0045620)	34	2	.93	+	2.15	2.50E-01	1.00E00
regulation of lymphocyte differentiation (GO:0045619)	102	6	2.80	+	2.15	6.88E-02	1.00E00
xenobiotic metabolic process (GO:0006805)	17	1	.47	+	2.15	3.86E-01	1.00E00
positive regulation of T cell differentiation (GO:0045582)	51	3	1.40	+	2.15	1.74E-01	1.00E00
positive regulation of extracellular matrix organization (GO:1903055)	17	1	.47	+	2.15	3.86E-01	1.00E00
leukocyte cell-cell adhesion (GO:0007159)	17	1	.47	+	2.15	3.86E-01	1.00E00
positive regulation of defense response to virus by host (GO:0002230)	17	1	.47	+	2.15	3.86E-01	1.00E00
regulation of oxidative phosphorylation (GO:0002082)	17	1	.47	+	2.15	3.86E-01	1.00E00
protein localization to chromosome, centromeric region (GO:0071459)	17	1	.47	+	2.15	3.86E-01	1.00E00
protein K48-linked ubiquitination (GO:0070936)	34	2	.93	+	2.15	2.50E-01	1.00E00
modification of synaptic structure (GO:0099563)	17	1	.47	+	2.15	3.86E-01	1.00E00
regulation of fibroblast growth factor receptor signaling pathway (GO:0040036)	17	1	.47	+	2.15	3.86E-01	1.00E00
energy reserve metabolic process (GO:0006112)	34	2	.93	+	2.15	2.50E-01	1.00E00
aminoglycan catabolic process (GO:0006026)	17	1	.47	+	2.15	3.86E-01	1.00E00
regulation of muscle organ development (GO:0048634)	34	2	.93	+	2.15	2.50E-01	1.00E00
meiotic chromosome separation (GO:0051307)	17	1	.47	+	2.15	3.86E-01	1.00E00
positive regulation of behavior (GO:0048520)	17	1	.47	+	2.15	3.86E-01	1.00E00
cell death in response to oxidative stress (GO:0036473)	17	1	.47	+	2.15	3.86E-01	1.00E00
photoperiodism (GO:0009648)	17	1	.47	+	2.15	3.86E-01	1.00E00
positive regulation of small GTPase mediated signal transduction (GO:0051057)	34	2	.93	+	2.15	2.50E-01	1.00E00
response to exogenous dsRNA (GO:0043330)	17	1	.47	+	2.15	3.86E-01	1.00E00
regulation of catecholamine secretion (GO:0050433)	17	1	.47	+	2.15	3.86E-01	1.00E00
regulation of programmed necrotic cell death (GO:0062098)	17	1	.47	+	2.15	3.86E-01	1.00E00
regulation of chromatin assembly (GO:0010847)	17	1	.47	+	2.15	3.86E-01	1.00E00
positive regulation of peptidyl-threonine phosphorylation (GO:0010800)	17	1	.47	+	2.15	3.86E-01	1.00E00
lipid storage (GO:0019915)	17	1	.47	+	2.15	3.86E-01	1.00E00
tetrahydrofolate metabolic process (GO:0046653)	17	1	.47	+	2.15	3.86E-01	1.00E00
regulation of amyloid precursor protein catabolic process (GO:1902991)	17	1	.47	+	2.15	3.86E-01	1.00E00
monosaccharide catabolic process (GO:0046365)	17	1	.47	+	2.15	3.86E-01	1.00E00
dendritic cell differentiation (GO:0097028)	17	1	.47	+	2.15	3.86E-01	1.00E00
regulation of lymphocyte mediated immunity (GO:0002706)	68	4	1.86	+	2.15	1.26E-01	1.00E00
negative regulation of production of molecular mediator of immune response (GO:0002701)	17	1	.47	+	2.15	3.86E-01	1.00E00
pyrimidine-containing compound catabolic process (GO:0072529)	17	1	.47	+	2.15	3.86E-01	1.00E00
negative regulation of cell activation (GO:0050866)	103	6	2.82	+	2.12	7.12E-02	1.00E00
female pregnancy (GO:0007565)	52	3	1.43	+	2.10	1.81E-01	1.00E00
positive regulation of cell activation (GO:0050867)	157	9	4.31	+	2.09	4.45E-02	1.00E00
intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332)	35	2	.96	+	2.08	2.60E-01	1.00E00
regulation of interleukin-8 production (GO:0032677)	35	2	.96	+	2.08	2.60E-01	1.00E00
DNA-dependent DNA replication maintenance of fidelity (GO:0045005)	35	2	.96	+	2.08	2.60E-01	1.00E00
cellular polysaccharide metabolic process (GO:0044264)	35	2	.96	+	2.08	2.60E-01	1.00E00
regulation of calcium-mediated signaling (GO:0050848)	35	2	.96	+	2.08	2.60E-01	1.00E00
positive regulation of DNA-binding transcription factor activity (GO:0051091)	140	8	3.84	+	2.08	6.22E-02	1.00E00
peptide hormone secretion (GO:0030072)	35	2	.96	+	2.08	2.60E-01	1.00E00
regulation of cytokine production involved in immune response (GO:0002718)	35	2	.96	+	2.08	2.60E-01	1.00E00
defense response to symbiont (GO:0140546)	88	5	2.41	+	2.07	1.03E-01	1.00E00
defense response to virus (GO:0051607)	88	5	2.41	+	2.07	1.03E-01	1.00E00
fatty acid biosynthetic process (GO:0006633)	53	3	1.45	+	2.06	1.88E-01	1.00E00
regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143)	53	3	1.45	+	2.06	1.88E-01	1.00E00
positive regulation of inflammatory response (GO:0050729)	53	3	1.45	+	2.06	1.88E-01	1.00E00
fatty acid catabolic process (GO:0009062)	53	3	1.45	+	2.06	1.88E-01	1.00E00
positive regulation of immune effector process (GO:0002699)	106	6	2.91	+	2.06	1.26E-01	1.00E00
regulation of cytokine-mediated signaling pathway (GO:0001959)	71	4	1.95	+	2.05	1.40E-01	1.00E00
regulation of B cell activation (GO:0050864)	71	4	1.95	+	2.05	1.40E-01	1.00E00
regulation of endopeptidase activity (GO:0052548)	178	10	4.88	+	2.05	3.50E-02	1.00E00
regulation of type I interferon-mediated signaling pathway (GO:0060338)	18	1	.49	+	2.03	4.02E-01	1.00E00
ATP biosynthetic process (GO:0006754)	18	1	.49	+	2.03	4.02E-01	1.00E00
immunoglobulin production (GO:0002377)	36	2	.99	+	2.03	2.70E-01	1.00E00
prostaglandin metabolic process (GO:0006693)	18	1	.49	+	2.03	4.02E-01	1.00E00
prostanoid metabolic process (GO:0006692)	18	1	.49	+	2.03	4.02E-01	1.00E00
late endosome to vacuole transport (GO:0045324)	18	1	.49	+	2.03	4.02E-01	1.00E00
polysaccharide metabolic process (GO:0005976)	36	2	.99	+	2.03	2.70E-01	1.00E00
positive regulation of nuclear division (GO:0051785)	36	2	.99	+	2.03	2.70E-01	1.00E00
cellular response to interleukin-6 (GO:0071354)	18	1	.49	+	2.03	4.02E-01	1.00E00
regulation of calcineurin-NFAT signaling cascade (GO:0070884)	18	1	.49	+	2.03	4.02E-01	1.00E00
peptidyl-glutamic acid modification (GO:0018200)	18	1	.49	+	2.03	4.02E-01	1.00E00
cellular response to misfolded protein (GO:0071218)	18	1	.49	+	2.03	4.02E-01	1.00E00
peptidyl-tyrosine phosphorylation (GO:0018108)	54	3	1.48	+	2.03	1.94E-01	1.00E00
regulation of nitric-oxide synthase activity (GO:0050999)	18	1	.49	+	2.03	4.02E-01	1.00E00
regulation of skeletal muscle tissue development (GO:0048641)	18	1	.49	+	2.03	4.02E-01	1.00E00
regulation of calcineurin-mediated signaling (GO:0106056)	18	1	.49	+	2.03	4.02E-01	1.00E00
circadian behavior (GO:0048512)	18	1	.49	+	2.03	4.02E-01	1.00E00
zymogen activation (GO:0031638)	18	1	.49	+	2.03	4.02E-01	1.00E00
regulation of behavior (GO:0050795)	36	2	.99	+	2.03	2.70E-01	1.00E00
membrane biogenesis (GO:0044091)	18	1	.49	+	2.03	4.02E-01	1.00E00
regulation of lipid kinase activity (GO:0043550)	36	2	.99	+	2.03	2.70E-01	1.00E00
entrainment of circadian clock (GO:0009649)	18	1	.49	+	2.03	4.02E-01	1.00E00
negative regulation of lymphocyte proliferation (GO:0050672)	36	2	.99	+	2.03	2.70E-01	1.00E00
alternative mRNA splicing, via spliceosome (GO:0000380)	18	1	.49	+	2.03	4.02E-01	1.00E00
chaperone cofactor-dependent protein refolding (GO:0051085)	18	1	.49	+	2.03	4.02E-01	1.00E00
positive regulation of cell killing (GO:0031343)	18	1	.49	+	2.03	4.02E-01	1.00E00
regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079)	54	3	1.48	+	2.03	1.94E-01	1.00E00
ribonucleoside triphosphate metabolic process (GO:0009199)	36	2	.99	+	2.03	2.70E-01	1.00E00
hair follicle morphogenesis (GO:0031069)	18	1	.49	+	2.03	4.02E-01	1.00E00
purine ribonucleotide catabolic process (GO:0009154)	18	1	.49	+	2.03	4.02E-01	1.00E00
apoptotic mitochondrial changes (GO:0008637)	36	2	.99	+	2.03	2.70E-01	1.00E00
negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512)	36	2	.99	+	2.03	2.70E-01	1.00E00
regulation of ruffle assembly (GO:1900027)	18	1	.49	+	2.03	4.02E-01	1.00E00
regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798)	18	1	.49	+	2.03	4.02E-01	1.00E00
response to organophosphorus (GO:0046683)	36	2	.99	+	2.03	2.70E-01	1.00E00
negative regulation of alpha-beta T cell differentiation (GO:0046639)	18	1	.49	+	2.03	4.02E-01	1.00E00
purine nucleoside metabolic process (GO:0042278)	36	2	.99	+	2.03	2.70E-01	1.00E00
negative regulation of ossification (GO:0030279)	18	1	.49	+	2.03	4.02E-01	1.00E00
regulation of vascular endothelial growth factor production (GO:0010574)	18	1	.49	+	2.03	4.02E-01	1.00E00
water homeostasis (GO:0030104)	18	1	.49	+	2.03	4.02E-01	1.00E00
antimicrobial humoral response (GO:0019730)	36	2	.99	+	2.03	2.70E-01	1.00E00
phosphatidic acid metabolic process (GO:0046473)	18	1	.49	+	2.03	4.02E-01	1.00E00
acylglycerol catabolic process (GO:0046464)	18	1	.49	+	2.03	4.02E-01	1.00E00
neutral lipid catabolic process (GO:0046461)	18	1	.49	+	2.03	4.02E-01	1.00E00
snRNA 3'-end processing (GO:0034472)	18	1	.49	+	2.03	4.02E-01	1.00E00
cell differentiation involved in embryonic placenta development (GO:0060706)	18	1	.49	+	2.03	4.02E-01	1.00E00
negative regulation of reactive oxygen species biosynthetic process (GO:1903427)	18	1	.49	+	2.03	4.02E-01	1.00E00
regulation of production of molecular mediator of immune response (GO:0002700)	72	4	1.97	+	2.03	1.45E-01	1.00E00
T cell differentiation (GO:0030217)	91	5	2.50	+	2.00	1.14E-01	1.00E00
positive regulation of response to biotic stimulus (GO:0002833)	73	4	2.00	+	2.00	1.50E-01	1.00E00
positive regulation of lymphocyte activation (GO:0051251)	128	7	3.51	+	1.99	9.47E-02	1.00E00
positive regulation of defense response (GO:0031349)	110	6	3.02	+	1.99	1.32E-01	1.00E00
nucleoside triphosphate metabolic process (GO:0009141)	55	3	1.51	+	1.99	2.01E-01	1.00E00
negative regulation of mononuclear cell proliferation (GO:0032945)	37	2	1.01	+	1.97	2.79E-01	1.00E00
retina morphogenesis in camera-type eye (GO:0060042)	37	2	1.01	+	1.97	2.79E-01	1.00E00
regulation of interleukin-1 beta production (GO:0032651)	37	2	1.01	+	1.97	2.79E-01	1.00E00
regulation of interferon-beta production (GO:0032648)	37	2	1.01	+	1.97	2.79E-01	1.00E00
thymus development (GO:0048538)	37	2	1.01	+	1.97	2.79E-01	1.00E00
regulation of nervous system process (GO:0031644)	74	4	2.03	+	1.97	1.55E-01	1.00E00
regulation of cardiac muscle cell apoptotic process (GO:0010665)	37	2	1.01	+	1.97	2.79E-01	1.00E00
actin polymerization or depolymerization (GO:0008154)	37	2	1.01	+	1.97	2.79E-01	1.00E00
protein maturation (GO:0051604)	112	6	3.07	+	1.95	1.36E-01	1.00E00
regulation of cyclin-dependent protein kinase activity (GO:1904029)	56	3	1.54	+	1.95	2.08E-01	1.00E00
regulation of peptidase activity (GO:0052547)	206	11	5.65	+	1.95	4.97E-02	1.00E00
regulation of cell-cell adhesion (GO:0022407)	206	11	5.65	+	1.95	4.97E-02	1.00E00
positive regulation of leukocyte activation (GO:0002696)	150	8	4.11	+	1.94	7.44E-02	1.00E00
cellular calcium ion homeostasis (GO:0006874)	114	6	3.13	+	1.92	1.40E-01	1.00E00
peptidyl-tyrosine modification (GO:0018212)	57	3	1.56	+	1.92	2.15E-01	1.00E00
negative regulation of NF-kappaB transcription factor activity (GO:0032088)	57	3	1.56	+	1.92	2.15E-01	1.00E00
regulation of toll-like receptor signaling pathway (GO:0034121)	38	2	1.04	+	1.92	2.89E-01	1.00E00
regulation of tissue remodeling (GO:0034103)	38	2	1.04	+	1.92	2.89E-01	1.00E00
intra-Golgi vesicle-mediated transport (GO:0006891)	19	1	.52	+	1.92	4.18E-01	1.00E00
reciprocal meiotic recombination (GO:0007131)	38	2	1.04	+	1.92	2.89E-01	1.00E00
reciprocal homologous recombination (GO:0140527)	38	2	1.04	+	1.92	2.89E-01	1.00E00
regulation of postsynaptic membrane potential (GO:0060078)	19	1	.52	+	1.92	4.18E-01	1.00E00
regulation of protein sumoylation (GO:0033233)	19	1	.52	+	1.92	4.18E-01	1.00E00
'de novo' protein folding (GO:0006458)	19	1	.52	+	1.92	4.18E-01	1.00E00
negative regulation of peptidyl-serine phosphorylation (GO:0033137)	19	1	.52	+	1.92	4.18E-01	1.00E00
regulation of production of small RNA involved in gene silencing by RNA (GO:0070920)	19	1	.52	+	1.92	4.18E-01	1.00E00
transcription by RNA polymerase III (GO:0006383)	19	1	.52	+	1.92	4.18E-01	1.00E00
response to misfolded protein (GO:0051788)	19	1	.52	+	1.92	4.18E-01	1.00E00
regulation of mast cell activation involved in immune response (GO:0033006)	19	1	.52	+	1.92	4.18E-01	1.00E00
positive regulation of protein targeting to membrane (GO:0090314)	19	1	.52	+	1.92	4.18E-01	1.00E00
negative regulation of G1/S transition of mitotic cell cycle (GO:2000134)	38	2	1.04	+	1.92	2.89E-01	1.00E00
protein localization to chromatin (GO:0071168)	19	1	.52	+	1.92	4.18E-01	1.00E00
regulation of spindle assembly (GO:0090169)	19	1	.52	+	1.92	4.18E-01	1.00E00
muscle adaptation (GO:0043500)	19	1	.52	+	1.92	4.18E-01	1.00E00
'de novo' posttranslational protein folding (GO:0051084)	19	1	.52	+	1.92	4.18E-01	1.00E00
regulation of mast cell degranulation (GO:0043304)	19	1	.52	+	1.92	4.18E-01	1.00E00
pyrimidine deoxyribonucleotide metabolic process (GO:0009219)	19	1	.52	+	1.92	4.18E-01	1.00E00
ribonucleoside metabolic process (GO:0009119)	38	2	1.04	+	1.92	2.89E-01	1.00E00
neuron maturation (GO:0042551)	19	1	.52	+	1.92	4.18E-01	1.00E00
embryonic forelimb morphogenesis (GO:0035115)	19	1	.52	+	1.92	4.18E-01	1.00E00
chromosome condensation (GO:0030261)	19	1	.52	+	1.92	4.18E-01	1.00E00
neural retina development (GO:0003407)	38	2	1.04	+	1.92	2.89E-01	1.00E00
lipoprotein metabolic process (GO:0042157)	38	2	1.04	+	1.92	2.89E-01	1.00E00
positive regulation of cyclin-dependent protein kinase activity (GO:1904031)	19	1	.52	+	1.92	4.18E-01	1.00E00
response to ischemia (GO:0002931)	19	1	.52	+	1.92	4.18E-01	1.00E00
regulation of androgen receptor signaling pathway (GO:0060765)	19	1	.52	+	1.92	4.18E-01	1.00E00
long-term memory (GO:0007616)	19	1	.52	+	1.92	4.18E-01	1.00E00
body fluid secretion (GO:0007589)	19	1	.52	+	1.92	4.18E-01	1.00E00
regulation of response to biotic stimulus (GO:0002831)	154	8	4.22	+	1.89	8.05E-02	1.00E00
positive regulation of protein kinase B signaling (GO:0051897)	58	3	1.59	+	1.89	2.22E-01	1.00E00
gland morphogenesis (GO:0022612)	58	3	1.59	+	1.89	2.22E-01	1.00E00
positive regulation of intrinsic apoptotic signaling pathway (GO:2001244)	39	2	1.07	+	1.87	2.99E-01	1.00E00
regulation of DNA-templated transcription, initiation (GO:2000142)	39	2	1.07	+	1.87	2.99E-01	1.00E00
defense response to Gram-positive bacterium (GO:0050830)	39	2	1.07	+	1.87	2.99E-01	1.00E00
homologous recombination (GO:0035825)	39	2	1.07	+	1.87	2.99E-01	1.00E00
regulation of vascular associated smooth muscle cell proliferation (GO:1904705)	39	2	1.07	+	1.87	2.99E-01	1.00E00
endocrine system development (GO:0035270)	78	4	2.14	+	1.87	1.76E-01	1.00E00
regulation of response to cytokine stimulus (GO:0060759)	78	4	2.14	+	1.87	1.76E-01	1.00E00
lymphocyte differentiation (GO:0030098)	137	7	3.76	+	1.86	1.10E-01	1.00E00
tRNA processing (GO:0008033)	98	5	2.69	+	1.86	2.02E-01	1.00E00
cation transmembrane transport (GO:0098655)	59	3	1.62	+	1.85	2.29E-01	1.00E00
calcium ion homeostasis (GO:0055074)	118	6	3.24	+	1.85	1.48E-01	1.00E00
cellular divalent inorganic cation homeostasis (GO:0072503)	118	6	3.24	+	1.85	1.48E-01	1.00E00
immune effector process (GO:0002252)	218	11	5.98	+	1.84	5.72E-02	1.00E00
regulation of peptide hormone secretion (GO:0090276)	120	6	3.29	+	1.82	1.53E-01	1.00E00
positive regulation of smooth muscle cell proliferation (GO:0048661)	60	3	1.65	+	1.82	2.36E-01	1.00E00
complement activation, classical pathway (GO:0006958)	20	1	.55	+	1.82	4.34E-01	1.00E00
positive regulation of osteoblast differentiation (GO:0045669)	40	2	1.10	+	1.82	3.09E-01	1.00E00
leukocyte mediated immunity (GO:0002443)	80	4	2.19	+	1.82	2.88E-01	1.00E00
spinal cord motor neuron differentiation (GO:0021522)	20	1	.55	+	1.82	4.34E-01	1.00E00
folic acid-containing compound metabolic process (GO:0006760)	20	1	.55	+	1.82	4.34E-01	1.00E00
regulation of transforming growth factor beta production (GO:0071634)	20	1	.55	+	1.82	4.34E-01	1.00E00
mitotic metaphase plate congression (GO:0007080)	40	2	1.10	+	1.82	3.09E-01	1.00E00
lysosome organization (GO:0007040)	40	2	1.10	+	1.82	3.09E-01	1.00E00
regulation of chromatin assembly or disassembly (GO:0001672)	20	1	.55	+	1.82	4.34E-01	1.00E00
mRNA splice site selection (GO:0006376)	20	1	.55	+	1.82	4.34E-01	1.00E00
regulation of mast cell activation (GO:0033003)	20	1	.55	+	1.82	4.34E-01	1.00E00
protein phosphopantetheinylation (GO:0018215)	20	1	.55	+	1.82	4.34E-01	1.00E00
response to interleukin-6 (GO:0070741)	20	1	.55	+	1.82	4.34E-01	1.00E00
epidermis morphogenesis (GO:0048730)	20	1	.55	+	1.82	4.34E-01	1.00E00
postsynaptic signal transduction (GO:0098926)	20	1	.55	+	1.82	4.34E-01	1.00E00
brown fat cell differentiation (GO:0050873)	20	1	.55	+	1.82	4.34E-01	1.00E00
negative regulation of B cell activation (GO:0050869)	20	1	.55	+	1.82	4.34E-01	1.00E00
regulation of endocrine process (GO:0044060)	20	1	.55	+	1.82	4.34E-01	1.00E00
regulation of vascular associated smooth muscle cell migration (GO:1904752)	20	1	.55	+	1.82	4.34E-01	1.00E00
T cell homeostasis (GO:0043029)	20	1	.55	+	1.82	4.34E-01	1.00E00
attachment of spindle microtubules to kinetochore (GO:0008608)	20	1	.55	+	1.82	4.34E-01	1.00E00
regulation of hormone biosynthetic process (GO:0046885)	20	1	.55	+	1.82	4.34E-01	1.00E00
negative regulation of gene silencing (GO:0060969)	20	1	.55	+	1.82	4.34E-01	1.00E00
negative regulation of muscle cell apoptotic process (GO:0010656)	40	2	1.10	+	1.82	3.09E-01	1.00E00
negative regulation of cardiac muscle hypertrophy (GO:0010614)	20	1	.55	+	1.82	4.34E-01	1.00E00
regulation of cell fate commitment (GO:0010453)	20	1	.55	+	1.82	4.34E-01	1.00E00
pituitary gland development (GO:0021983)	20	1	.55	+	1.82	4.34E-01	1.00E00
rhythmic behavior (GO:0007622)	20	1	.55	+	1.82	4.34E-01	1.00E00
primary alcohol metabolic process (GO:0034308)	20	1	.55	+	1.82	4.34E-01	1.00E00
lytic vacuole organization (GO:0080171)	40	2	1.10	+	1.82	3.09E-01	1.00E00
negative regulation of cell cycle G1/S phase transition (GO:1902807)	40	2	1.10	+	1.82	3.09E-01	1.00E00
autophagy (GO:0006914)	141	7	3.87	+	1.81	1.19E-01	1.00E00
process utilizing autophagic mechanism (GO:0061919)	141	7	3.87	+	1.81	1.19E-01	1.00E00
adaptive immune response (GO:0002250)	121	6	3.32	+	1.81	1.56E-01	1.00E00
cytokine production (GO:0001816)	81	4	2.22	+	1.80	2.91E-01	1.00E00
negative regulation of lymphocyte activation (GO:0051250)	81	4	2.22	+	1.80	2.91E-01	1.00E00
regulation of viral life cycle (GO:1903900)	81	4	2.22	+	1.80	2.91E-01	1.00E00
signal release (GO:0023061)	81	4	2.22	+	1.80	2.91E-01	1.00E00
positive regulation of cell adhesion (GO:0045785)	223	11	6.12	+	1.80	6.15E-02	1.00E00
establishment of chromosome localization (GO:0051303)	61	3	1.67	+	1.79	2.44E-01	1.00E00
lipid modification (GO:0030258)	122	6	3.35	+	1.79	1.58E-01	1.00E00
regulation of ERK1 and ERK2 cascade (GO:0070372)	143	7	3.92	+	1.79	1.23E-01	1.00E00
inner ear receptor cell differentiation (GO:0060113)	41	2	1.12	+	1.78	3.19E-01	1.00E00
positive regulation of leukocyte differentiation (GO:1902107)	82	4	2.25	+	1.78	2.94E-01	1.00E00
purine nucleoside triphosphate metabolic process (GO:0009144)	41	2	1.12	+	1.78	3.19E-01	1.00E00
positive regulation of hemopoiesis (GO:1903708)	82	4	2.25	+	1.78	2.94E-01	1.00E00
negative regulation of epithelial cell migration (GO:0010633)	41	2	1.12	+	1.78	3.19E-01	1.00E00
endothelium development (GO:0003158)	41	2	1.12	+	1.78	3.19E-01	1.00E00
regulation of cell activation (GO:0050865)	288	14	7.90	+	1.77	4.31E-02	1.00E00
apoptotic signaling pathway (GO:0097190)	144	7	3.95	+	1.77	1.26E-01	1.00E00
negative regulation of cell-cell adhesion (GO:0022408)	103	5	2.82	+	1.77	2.15E-01	1.00E00
positive regulation of cytosolic calcium ion concentration (GO:0007204)	62	3	1.70	+	1.76	2.51E-01	1.00E00
export from cell (GO:0140352)	186	9	5.10	+	1.76	1.09E-01	1.00E00
regulation of blood vessel endothelial cell migration (GO:0043535)	62	3	1.70	+	1.76	2.51E-01	1.00E00
female gonad development (GO:0008585)	62	3	1.70	+	1.76	2.51E-01	1.00E00
regulation of T cell differentiation (GO:0045580)	83	4	2.28	+	1.76	2.97E-01	1.00E00
placenta development (GO:0001890)	104	5	2.85	+	1.75	2.18E-01	1.00E00
protein complex oligomerization (GO:0051259)	104	5	2.85	+	1.75	2.18E-01	1.00E00
regulation of cysteine-type endopeptidase activity (GO:2000116)	125	6	3.43	+	1.75	1.66E-01	1.00E00
divalent inorganic cation homeostasis (GO:0072507)	125	6	3.43	+	1.75	1.66E-01	1.00E00
negative regulation of blood pressure (GO:0045776)	21	1	.58	+	1.74	4.49E-01	1.00E00
positive regulation of cilium assembly (GO:0045724)	21	1	.58	+	1.74	4.49E-01	1.00E00
negative regulation of toll-like receptor signaling pathway (GO:0034122)	21	1	.58	+	1.74	4.49E-01	1.00E00
regulation of neuroblast proliferation (GO:1902692)	21	1	.58	+	1.74	4.49E-01	1.00E00
proton transmembrane transport (GO:1902600)	21	1	.58	+	1.74	4.49E-01	1.00E00
receptor signaling pathway via JAK-STAT (GO:0007259)	21	1	.58	+	1.74	4.49E-01	1.00E00
negative regulation of endothelial cell proliferation (GO:0001937)	21	1	.58	+	1.74	4.49E-01	1.00E00
NADH metabolic process (GO:0006734)	21	1	.58	+	1.74	4.49E-01	1.00E00
cell redox homeostasis (GO:0045454)	42	2	1.15	+	1.74	3.29E-01	1.00E00
regulation of natural killer cell activation (GO:0032814)	21	1	.58	+	1.74	4.49E-01	1.00E00
positive regulation of ATPase activity (GO:0032781)	21	1	.58	+	1.74	4.49E-01	1.00E00
cellular response to xenobiotic stimulus (GO:0071466)	21	1	.58	+	1.74	4.49E-01	1.00E00
regulation of bone resorption (GO:0045124)	21	1	.58	+	1.74	4.49E-01	1.00E00
motile cilium assembly (GO:0044458)	21	1	.58	+	1.74	4.49E-01	1.00E00
positive regulation of multicellular organism growth (GO:0040018)	21	1	.58	+	1.74	4.49E-01	1.00E00
regulation of release of cytochrome c from mitochondria (GO:0090199)	21	1	.58	+	1.74	4.49E-01	1.00E00
detoxification (GO:0098754)	21	1	.58	+	1.74	4.49E-01	1.00E00
lipopolysaccharide-mediated signaling pathway (GO:0031663)	21	1	.58	+	1.74	4.49E-01	1.00E00
necrotic cell death (GO:0070265)	21	1	.58	+	1.74	4.49E-01	1.00E00
negative regulation of lymphocyte apoptotic process (GO:0070229)	21	1	.58	+	1.74	4.49E-01	1.00E00
regulation of hair cycle (GO:0042634)	21	1	.58	+	1.74	4.49E-01	1.00E00
peptidyl-tyrosine dephosphorylation (GO:0035335)	21	1	.58	+	1.74	4.49E-01	1.00E00
hormone secretion (GO:0046879)	42	2	1.15	+	1.74	3.29E-01	1.00E00
lipid phosphorylation (GO:0046834)	42	2	1.15	+	1.74	3.29E-01	1.00E00
regulation of phospholipid metabolic process (GO:1903725)	21	1	.58	+	1.74	4.49E-01	1.00E00
development of primary female sexual characteristics (GO:0046545)	63	3	1.73	+	1.74	2.58E-01	1.00E00
placenta blood vessel development (GO:0060674)	21	1	.58	+	1.74	4.49E-01	1.00E00
regulation of membrane depolarization (GO:0003254)	21	1	.58	+	1.74	4.49E-01	1.00E00
deoxyribose phosphate catabolic process (GO:0046386)	21	1	.58	+	1.74	4.49E-01	1.00E00
cell differentiation involved in kidney development (GO:0061005)	21	1	.58	+	1.74	4.49E-01	1.00E00
positive regulation of regulated secretory pathway (GO:1903307)	21	1	.58	+	1.74	4.49E-01	1.00E00
pyrimidine-containing compound metabolic process (GO:0072527)	42	2	1.15	+	1.74	3.29E-01	1.00E00
defense response to other organism (GO:0098542)	383	18	10.50	+	1.71	2.65E-02	1.00E00
fatty acid metabolic process (GO:0006631)	149	7	4.09	+	1.71	2.00E-01	1.00E00
monocarboxylic acid catabolic process (GO:0072329)	64	3	1.76	+	1.71	2.65E-01	1.00E00
positive regulation of cytokine production (GO:0001819)	192	9	5.27	+	1.71	1.17E-01	1.00E00
protein-DNA complex subunit organization (GO:0071824)	107	5	2.93	+	1.70	2.27E-01	1.00E00
negative regulation of response to wounding (GO:1903035)	43	2	1.18	+	1.70	3.39E-01	1.00E00
neurotransmitter secretion (GO:0007269)	43	2	1.18	+	1.70	3.39E-01	1.00E00
response to purine-containing compound (GO:0014074)	43	2	1.18	+	1.70	3.39E-01	1.00E00
signal release from synapse (GO:0099643)	43	2	1.18	+	1.70	3.39E-01	1.00E00
leukocyte proliferation (GO:0070661)	43	2	1.18	+	1.70	3.39E-01	1.00E00
protein tetramerization (GO:0051262)	43	2	1.18	+	1.70	3.39E-01	1.00E00
nucleotide catabolic process (GO:0009166)	43	2	1.18	+	1.70	3.39E-01	1.00E00
intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630)	43	2	1.18	+	1.70	3.39E-01	1.00E00
mechanoreceptor differentiation (GO:0042490)	43	2	1.18	+	1.70	3.39E-01	1.00E00
multi-multicellular organism process (GO:0044706)	65	3	1.78	+	1.68	4.30E-01	1.00E00
regulation of muscle cell apoptotic process (GO:0010660)	65	3	1.78	+	1.68	4.30E-01	1.00E00
T cell activation (GO:0042110)	130	6	3.56	+	1.68	1.81E-01	1.00E00
cellular metal ion homeostasis (GO:0006875)	152	7	4.17	+	1.68	2.04E-01	1.00E00
response to steroid hormone (GO:0048545)	87	4	2.39	+	1.68	3.09E-01	1.00E00
cell-cell signaling (GO:0007267)	349	16	9.57	+	1.67	4.59E-02	1.00E00
negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736)	22	1	.60	+	1.66	4.64E-01	1.00E00
vesicle docking involved in exocytosis (GO:0006904)	22	1	.60	+	1.66	4.64E-01	1.00E00
regulation of leukocyte mediated cytotoxicity (GO:0001910)	22	1	.60	+	1.66	4.64E-01	1.00E00
regulation of glial cell proliferation (GO:0060251)	22	1	.60	+	1.66	4.64E-01	1.00E00
protein targeting to vacuole (GO:0006623)	22	1	.60	+	1.66	4.64E-01	1.00E00
peroxisome organization (GO:0007031)	22	1	.60	+	1.66	4.64E-01	1.00E00
cellular response to chemokine (GO:1990869)	22	1	.60	+	1.66	4.64E-01	1.00E00
response to chemokine (GO:1990868)	22	1	.60	+	1.66	4.64E-01	1.00E00
metanephros development (GO:0001656)	44	2	1.21	+	1.66	3.49E-01	1.00E00
positive regulation of interleukin-2 production (GO:0032743)	22	1	.60	+	1.66	4.64E-01	1.00E00
negative regulation of endothelial cell apoptotic process (GO:2000352)	22	1	.60	+	1.66	4.64E-01	1.00E00
regulation of protein targeting to membrane (GO:0090313)	22	1	.60	+	1.66	4.64E-01	1.00E00
purine nucleotide catabolic process (GO:0006195)	22	1	.60	+	1.66	4.64E-01	1.00E00
synaptic vesicle cycle (GO:0099504)	66	3	1.81	+	1.66	4.33E-01	1.00E00
regulation of histone H3-K9 methylation (GO:0051570)	22	1	.60	+	1.66	4.64E-01	1.00E00
response to corticosteroid (GO:0031960)	44	2	1.21	+	1.66	3.49E-01	1.00E00
response to glucocorticoid (GO:0051384)	44	2	1.21	+	1.66	3.49E-01	1.00E00
response to dsRNA (GO:0043331)	22	1	.60	+	1.66	4.64E-01	1.00E00
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059)	22	1	.60	+	1.66	4.64E-01	1.00E00
mRNA modification (GO:0016556)	22	1	.60	+	1.66	4.64E-01	1.00E00
selective autophagy (GO:0061912)	22	1	.60	+	1.66	4.64E-01	1.00E00
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771)	22	1	.60	+	1.66	4.64E-01	1.00E00
ribosomal large subunit assembly (GO:0000027)	22	1	.60	+	1.66	4.64E-01	1.00E00
deoxyribonucleotide catabolic process (GO:0009264)	22	1	.60	+	1.66	4.64E-01	1.00E00
lipid homeostasis (GO:0055088)	88	4	2.41	+	1.66	3.13E-01	1.00E00
receptor signaling pathway via STAT (GO:0097696)	22	1	.60	+	1.66	4.64E-01	1.00E00
regulation of necrotic cell death (GO:0010939)	22	1	.60	+	1.66	4.64E-01	1.00E00
inner ear auditory receptor cell differentiation (GO:0042491)	22	1	.60	+	1.66	4.64E-01	1.00E00
snRNA processing (GO:0016180)	22	1	.60	+	1.66	4.64E-01	1.00E00
response to antibiotic (GO:0046677)	22	1	.60	+	1.66	4.64E-01	1.00E00
female sex differentiation (GO:0046660)	66	3	1.81	+	1.66	4.33E-01	1.00E00
negative regulation of cyclin-dependent protein kinase activity (GO:1904030)	22	1	.60	+	1.66	4.64E-01	1.00E00
monosaccharide biosynthetic process (GO:0046364)	22	1	.60	+	1.66	4.64E-01	1.00E00
negative regulation of muscle hypertrophy (GO:0014741)	22	1	.60	+	1.66	4.64E-01	1.00E00
positive regulation of isotype switching (GO:0045830)	22	1	.60	+	1.66	4.64E-01	1.00E00
mononuclear cell differentiation (GO:1903131)	155	7	4.25	+	1.65	2.09E-01	1.00E00
regulation of reactive oxygen species metabolic process (GO:2000377)	111	5	3.04	+	1.64	2.41E-01	1.00E00
regulation of cell adhesion (GO:0030155)	378	17	10.37	+	1.64	5.31E-02	1.00E00
negative regulation of leukocyte activation (GO:0002695)	89	4	2.44	+	1.64	3.16E-01	1.00E00
positive regulation of peptide hormone secretion (GO:0090277)	67	3	1.84	+	1.63	4.37E-01	1.00E00
regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281)	112	5	3.07	+	1.63	2.44E-01	1.00E00
cell surface receptor signaling pathway involved in cell-cell signaling (GO:1905114)	157	7	4.31	+	1.63	2.13E-01	1.00E00
positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068)	45	2	1.23	+	1.62	3.58E-01	1.00E00
positive regulation of gliogenesis (GO:0014015)	45	2	1.23	+	1.62	3.58E-01	1.00E00
regulation of interleukin-1 production (GO:0032652)	45	2	1.23	+	1.62	3.58E-01	1.00E00
hormone transport (GO:0009914)	45	2	1.23	+	1.62	3.58E-01	1.00E00
negative regulation of peptidase activity (GO:0010466)	113	5	3.10	+	1.61	2.48E-01	1.00E00
protein localization to plasma membrane (GO:0072659)	113	5	3.10	+	1.61	2.48E-01	1.00E00
positive regulation of response to external stimulus (GO:0032103)	181	8	4.96	+	1.61	1.69E-01	1.00E00
negative regulation of cytokine production (GO:0001818)	136	6	3.73	+	1.61	2.82E-01	1.00E00
regulation of microtubule polymerization or depolymerization (GO:0031110)	68	3	1.86	+	1.61	4.40E-01	1.00E00
regulation of cellular response to transforming growth factor beta stimulus (GO:1903844)	68	3	1.86	+	1.61	4.40E-01	1.00E00
regulation of protein kinase B signaling (GO:0051896)	91	4	2.50	+	1.60	3.24E-01	1.00E00
positive regulation of intracellular protein transport (GO:0090316)	91	4	2.50	+	1.60	3.24E-01	1.00E00
negative regulation of endopeptidase activity (GO:0010951)	91	4	2.50	+	1.60	3.24E-01	1.00E00
intrinsic apoptotic signaling pathway (GO:0097193)	91	4	2.50	+	1.60	3.24E-01	1.00E00
negative regulation of defense response (GO:0031348)	114	5	3.13	+	1.60	2.51E-01	1.00E00
secretion by cell (GO:0032940)	183	8	5.02	+	1.59	1.73E-01	1.00E00
tRNA metabolic process (GO:0006399)	138	6	3.78	+	1.59	2.86E-01	1.00E00
regulation of DNA-binding transcription factor activity (GO:0051090)	253	11	6.94	+	1.59	1.22E-01	1.00E00
RNA modification (GO:0009451)	115	5	3.15	+	1.59	2.55E-01	1.00E00
lipid localization (GO:0010876)	115	5	3.15	+	1.59	2.55E-01	1.00E00
positive regulation of endothelial cell migration (GO:0010595)	69	3	1.89	+	1.59	4.43E-01	1.00E00
regulation of blood pressure (GO:0008217)	69	3	1.89	+	1.59	4.43E-01	1.00E00
positive regulation of ossification (GO:0045778)	23	1	.63	+	1.59	4.78E-01	1.00E00
striated muscle contraction (GO:0006941)	46	2	1.26	+	1.59	3.68E-01	1.00E00
leukocyte homeostasis (GO:0001776)	46	2	1.26	+	1.59	3.68E-01	1.00E00
regulation of polysaccharide biosynthetic process (GO:0032885)	23	1	.63	+	1.59	4.78E-01	1.00E00
glomerulus development (GO:0032835)	23	1	.63	+	1.59	4.78E-01	1.00E00
nuclear DNA replication (GO:0033260)	23	1	.63	+	1.59	4.78E-01	1.00E00
positive regulation of viral genome replication (GO:0045070)	23	1	.63	+	1.59	4.78E-01	1.00E00
response to toxic substance (GO:0009636)	46	2	1.26	+	1.59	3.68E-01	1.00E00
regulation of defense response to virus by host (GO:0050691)	23	1	.63	+	1.59	4.78E-01	1.00E00
positive regulation of purine nucleotide metabolic process (GO:1900544)	23	1	.63	+	1.59	4.78E-01	1.00E00
regulation of leukocyte degranulation (GO:0043300)	23	1	.63	+	1.59	4.78E-01	1.00E00
purine ribonucleoside triphosphate biosynthetic process (GO:0009206)	23	1	.63	+	1.59	4.78E-01	1.00E00
regulation of neurotransmitter secretion (GO:0046928)	46	2	1.26	+	1.59	3.68E-01	1.00E00
pteridine-containing compound metabolic process (GO:0042558)	23	1	.63	+	1.59	4.78E-01	1.00E00
DNA damage response, signal transduction by p53 class mediator (GO:0030330)	23	1	.63	+	1.59	4.78E-01	1.00E00
ncRNA catabolic process (GO:0034661)	23	1	.63	+	1.59	4.78E-01	1.00E00
positive regulation of muscle cell apoptotic process (GO:0010661)	23	1	.63	+	1.59	4.78E-01	1.00E00
positive regulation of nucleotide metabolic process (GO:0045981)	23	1	.63	+	1.59	4.78E-01	1.00E00
negative regulation of immune system process (GO:0002683)	207	9	5.68	+	1.59	1.93E-01	1.00E00
regulation of immune effector process (GO:0002697)	185	8	5.07	+	1.58	1.78E-01	1.00E00
negative regulation of cell motility (GO:2000146)	162	7	4.44	+	1.58	2.23E-01	1.00E00
cell-cell signaling by wnt (GO:0198738)	139	6	3.81	+	1.57	2.88E-01	1.00E00
Wnt signaling pathway (GO:0016055)	139	6	3.81	+	1.57	2.88E-01	1.00E00
membrane organization (GO:0061024)	278	12	7.62	+	1.57	1.34E-01	1.00E00
regulation of viral process (GO:0050792)	93	4	2.55	+	1.57	3.31E-01	1.00E00
cellular response to tumor necrosis factor (GO:0071356)	70	3	1.92	+	1.56	4.47E-01	1.00E00
positive regulation of translation (GO:0045727)	94	4	2.58	+	1.55	3.35E-01	1.00E00
neurotransmitter transport (GO:0006836)	47	2	1.29	+	1.55	3.78E-01	1.00E00
regulation of multicellular organism growth (GO:0040014)	47	2	1.29	+	1.55	3.78E-01	1.00E00
nucleoside phosphate catabolic process (GO:1901292)	47	2	1.29	+	1.55	3.78E-01	1.00E00
metaphase plate congression (GO:0051310)	47	2	1.29	+	1.55	3.78E-01	1.00E00
regulation of phagocytosis (GO:0050764)	47	2	1.29	+	1.55	3.78E-01	1.00E00
carboxylic acid transport (GO:0046942)	47	2	1.29	+	1.55	3.78E-01	1.00E00
protein localization to cell periphery (GO:1990778)	141	6	3.87	+	1.55	2.92E-01	1.00E00
regulation of epithelial cell migration (GO:0010632)	141	6	3.87	+	1.55	2.92E-01	1.00E00
cellular protein-containing complex assembly (GO:0034622)	448	19	12.29	+	1.55	7.47E-02	1.00E00
transmembrane transport (GO:0055085)	118	5	3.24	+	1.55	3.87E-01	1.00E00
positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123)	71	3	1.95	+	1.54	4.50E-01	1.00E00
regulation of leukocyte mediated immunity (GO:0002703)	95	4	2.61	+	1.54	3.39E-01	1.00E00
monocarboxylic acid metabolic process (GO:0032787)	238	10	6.53	+	1.53	1.63E-01	1.00E00
negative regulation of cellular component movement (GO:0051271)	167	7	4.58	+	1.53	2.34E-01	1.00E00
negative regulation of myeloid cell differentiation (GO:0045638)	48	2	1.32	+	1.52	3.87E-01	1.00E00
cellular iron ion homeostasis (GO:0006879)	24	1	.66	+	1.52	4.92E-01	1.00E00
regulation of extracellular matrix organization (GO:1903053)	24	1	.66	+	1.52	4.92E-01	1.00E00
acylglycerol metabolic process (GO:0006639)	48	2	1.32	+	1.52	3.87E-01	1.00E00
regulation of granulocyte chemotaxis (GO:0071622)	24	1	.66	+	1.52	4.92E-01	1.00E00
mitotic spindle assembly checkpoint (GO:0007094)	24	1	.66	+	1.52	4.92E-01	1.00E00
cell cycle DNA replication (GO:0044786)	24	1	.66	+	1.52	4.92E-01	1.00E00
negative regulation of interleukin-6 production (GO:0032715)	24	1	.66	+	1.52	4.92E-01	1.00E00
establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197)	24	1	.66	+	1.52	4.92E-01	1.00E00
biological process involved in interaction with symbiont (GO:0051702)	48	2	1.32	+	1.52	3.87E-01	1.00E00
spindle assembly checkpoint (GO:0071173)	24	1	.66	+	1.52	4.92E-01	1.00E00
regulation of cAMP-mediated signaling (GO:0043949)	24	1	.66	+	1.52	4.92E-01	1.00E00
regulation of intracellular pH (GO:0051453)	24	1	.66	+	1.52	4.92E-01	1.00E00
chromosome separation (GO:0051304)	24	1	.66	+	1.52	4.92E-01	1.00E00
positive regulation of nervous system process (GO:0031646)	24	1	.66	+	1.52	4.92E-01	1.00E00
killing of cells of other organism (GO:0031640)	24	1	.66	+	1.52	4.92E-01	1.00E00
response to cold (GO:0009409)	24	1	.66	+	1.52	4.92E-01	1.00E00
regulation of long-term synaptic potentiation (GO:1900271)	24	1	.66	+	1.52	4.92E-01	1.00E00
purine nucleoside triphosphate biosynthetic process (GO:0009145)	24	1	.66	+	1.52	4.92E-01	1.00E00
nucleobase metabolic process (GO:0009112)	24	1	.66	+	1.52	4.92E-01	1.00E00
negative regulation of hormone secretion (GO:0046888)	48	2	1.32	+	1.52	3.87E-01	1.00E00
eye photoreceptor cell development (GO:0042462)	24	1	.66	+	1.52	4.92E-01	1.00E00
positive regulation of ATP metabolic process (GO:1903580)	24	1	.66	+	1.52	4.92E-01	1.00E00
regulation of peptide secretion (GO:0002791)	168	7	4.61	+	1.52	2.37E-01	1.00E00
positive regulation of MAPK cascade (GO:0043410)	264	11	7.24	+	1.52	1.79E-01	1.00E00
regulation of lymphocyte activation (GO:0051249)	217	9	5.95	+	1.51	2.07E-01	1.00E00
negative regulation of locomotion (GO:0040013)	169	7	4.63	+	1.51	2.39E-01	1.00E00
regulation of biological process involved in symbiotic interaction (GO:0043903)	97	4	2.66	+	1.50	3.48E-01	1.00E00
nucleus organization (GO:0006997)	73	3	2.00	+	1.50	4.58E-01	1.00E00
monocarboxylic acid biosynthetic process (GO:0072330)	73	3	2.00	+	1.50	4.58E-01	1.00E00
phospholipid biosynthetic process (GO:0008654)	73	3	2.00	+	1.50	4.58E-01	1.00E00
protein-containing complex assembly (GO:0065003)	633	26	17.36	+	1.50	4.40E-02	1.00E00
cellular response to growth factor stimulus (GO:0071363)	244	10	6.69	+	1.49	2.30E-01	1.00E00
neutral lipid metabolic process (GO:0006638)	49	2	1.34	+	1.49	3.97E-01	1.00E00
mitochondrial membrane organization (GO:0007006)	49	2	1.34	+	1.49	3.97E-01	1.00E00
epithelium migration (GO:0090132)	49	2	1.34	+	1.49	3.97E-01	1.00E00
regulation of insulin secretion (GO:0050796)	98	4	2.69	+	1.49	3.52E-01	1.00E00
myelination (GO:0042552)	49	2	1.34	+	1.49	3.97E-01	1.00E00
regulation of protein import into nucleus (GO:0042306)	49	2	1.34	+	1.49	3.97E-01	1.00E00
positive regulation of epithelial cell migration (GO:0010634)	98	4	2.69	+	1.49	3.52E-01	1.00E00
epithelial cell migration (GO:0010631)	49	2	1.34	+	1.49	3.97E-01	1.00E00
mitochondrion organization (GO:0007005)	245	10	6.72	+	1.49	2.31E-01	1.00E00
response to other organism (GO:0051707)	545	22	14.94	+	1.47	7.89E-02	1.00E00
secretion (GO:0046903)	223	9	6.12	+	1.47	2.18E-01	1.00E00
chemical synaptic transmission (GO:0007268)	124	5	3.40	+	1.47	3.98E-01	1.00E00
anterograde trans-synaptic signaling (GO:0098916)	124	5	3.40	+	1.47	3.98E-01	1.00E00
response to external biotic stimulus (GO:0043207)	546	22	14.97	+	1.47	7.92E-02	1.00E00
positive regulation of immune response (GO:0050778)	224	9	6.14	+	1.47	2.20E-01	1.00E00
protein localization to membrane (GO:0072657)	224	9	6.14	+	1.47	2.20E-01	1.00E00
synaptic signaling (GO:0099536)	150	6	4.11	+	1.46	3.14E-01	1.00E00
positive regulation of catabolic process (GO:0009896)	300	12	8.23	+	1.46	2.07E-01	1.00E00
negative regulation of immune response (GO:0050777)	75	3	2.06	+	1.46	4.66E-01	1.00E00
negative regulation of inflammatory response (GO:0050728)	75	3	2.06	+	1.46	4.66E-01	1.00E00
vesicle-mediated transport in synapse (GO:0099003)	75	3	2.06	+	1.46	4.66E-01	1.00E00
ensheathment of neurons (GO:0007272)	50	2	1.37	+	1.46	6.50E-01	1.00E00
mononuclear cell migration (GO:0071674)	25	1	.69	+	1.46	5.06E-01	1.00E00
myeloid cell activation involved in immune response (GO:0002275)	25	1	.69	+	1.46	5.06E-01	1.00E00
regulation of synaptic transmission, glutamatergic (GO:0051966)	25	1	.69	+	1.46	5.06E-01	1.00E00
regulation of monooxygenase activity (GO:0032768)	25	1	.69	+	1.46	5.06E-01	1.00E00
positive regulation of interleukin-8 production (GO:0032757)	25	1	.69	+	1.46	5.06E-01	1.00E00
positive regulation of interferon-beta production (GO:0032728)	25	1	.69	+	1.46	5.06E-01	1.00E00
protein folding (GO:0006457)	100	4	2.74	+	1.46	3.61E-01	1.00E00
negative regulation of protein kinase B signaling (GO:0051898)	25	1	.69	+	1.46	5.06E-01	1.00E00
positive regulation of innate immune response (GO:0045089)	50	2	1.37	+	1.46	6.50E-01	1.00E00
endosome transport via multivesicular body sorting pathway (GO:0032509)	25	1	.69	+	1.46	5.06E-01	1.00E00
regulation of type I interferon production (GO:0032479)	50	2	1.37	+	1.46	6.50E-01	1.00E00
ncRNA transcription (GO:0098781)	25	1	.69	+	1.46	5.06E-01	1.00E00
regulation of smooth muscle cell differentiation (GO:0051150)	25	1	.69	+	1.46	5.06E-01	1.00E00
mitotic cytokinesis (GO:0000281)	50	2	1.37	+	1.46	6.50E-01	1.00E00
response to xenobiotic stimulus (GO:0009410)	25	1	.69	+	1.46	5.06E-01	1.00E00
establishment of mitotic spindle orientation (GO:0000132)	25	1	.69	+	1.46	5.06E-01	1.00E00
phospholipid catabolic process (GO:0009395)	25	1	.69	+	1.46	5.06E-01	1.00E00
antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844)	25	1	.69	+	1.46	5.06E-01	1.00E00
ribonucleotide catabolic process (GO:0009261)	25	1	.69	+	1.46	5.06E-01	1.00E00
metal ion homeostasis (GO:0055065)	175	7	4.80	+	1.46	3.45E-01	1.00E00
negative regulation of phosphatase activity (GO:0010923)	50	2	1.37	+	1.46	6.50E-01	1.00E00
serine family amino acid metabolic process (GO:0009069)	25	1	.69	+	1.46	5.06E-01	1.00E00
regulation of bone remodeling (GO:0046850)	25	1	.69	+	1.46	5.06E-01	1.00E00
axon ensheathment (GO:0008366)	50	2	1.37	+	1.46	6.50E-01	1.00E00
phosphatidylcholine metabolic process (GO:0046470)	25	1	.69	+	1.46	5.06E-01	1.00E00
dendritic spine organization (GO:0097061)	25	1	.69	+	1.46	5.06E-01	1.00E00
purine-containing compound catabolic process (GO:0072523)	25	1	.69	+	1.46	5.06E-01	1.00E00
negative regulation of leukocyte migration (GO:0002686)	25	1	.69	+	1.46	5.06E-01	1.00E00
positive regulation of peptide secretion (GO:0002793)	101	4	2.77	+	1.44	3.65E-01	1.00E00
humoral immune response (GO:0006959)	76	3	2.08	+	1.44	4.70E-01	1.00E00
protein homooligomerization (GO:0051260)	76	3	2.08	+	1.44	4.70E-01	1.00E00
regulation of circadian rhythm (GO:0042752)	76	3	2.08	+	1.44	4.70E-01	1.00E00
regulation of defense response (GO:0031347)	279	11	7.65	+	1.44	2.62E-01	1.00E00
lymphocyte activation (GO:0046649)	203	8	5.57	+	1.44	2.78E-01	1.00E00
cellular cation homeostasis (GO:0030003)	178	7	4.88	+	1.43	3.49E-01	1.00E00
programmed cell death (GO:0012501)	484	19	13.27	+	1.43	1.17E-01	1.00E00
defense response (GO:0006952)	510	20	13.99	+	1.43	1.25E-01	1.00E00
signal transduction by p53 class mediator (GO:0072331)	51	2	1.40	+	1.43	6.53E-01	1.00E00
lipid transport (GO:0006869)	102	4	2.80	+	1.43	3.70E-01	1.00E00
regulation of leukocyte differentiation (GO:1902105)	153	6	4.20	+	1.43	3.22E-01	1.00E00
positive regulation of cell division (GO:0051781)	51	2	1.40	+	1.43	6.53E-01	1.00E00
regulation of neurotransmitter transport (GO:0051588)	51	2	1.40	+	1.43	6.53E-01	1.00E00
tissue migration (GO:0090130)	51	2	1.40	+	1.43	6.53E-01	1.00E00
negative regulation of viral process (GO:0048525)	51	2	1.40	+	1.43	6.53E-01	1.00E00
anion transmembrane transport (GO:0098656)	51	2	1.40	+	1.43	6.53E-01	1.00E00
regulation of purine nucleotide metabolic process (GO:1900542)	51	2	1.40	+	1.43	6.53E-01	1.00E00
organic anion transport (GO:0015711)	51	2	1.40	+	1.43	6.53E-01	1.00E00
adult locomotory behavior (GO:0008344)	51	2	1.40	+	1.43	6.53E-01	1.00E00
response to growth factor (GO:0070848)	256	10	7.02	+	1.42	2.46E-01	1.00E00
trans-synaptic signaling (GO:0099537)	128	5	3.51	+	1.42	4.08E-01	1.00E00
immune response (GO:0006955)	461	18	12.64	+	1.42	1.43E-01	1.00E00
myeloid cell homeostasis (GO:0002262)	77	3	2.11	+	1.42	4.74E-01	1.00E00
negative regulation of cell migration (GO:0030336)	154	6	4.22	+	1.42	3.25E-01	1.00E00
cellular ion homeostasis (GO:0006873)	180	7	4.94	+	1.42	3.53E-01	1.00E00
apoptotic process (GO:0006915)	463	18	12.70	+	1.42	1.45E-01	1.00E00
response to biotic stimulus (GO:0009607)	566	22	15.52	+	1.42	1.11E-01	1.00E00
establishment of protein localization to membrane (GO:0090150)	103	4	2.82	+	1.42	5.36E-01	1.00E00
regulation of hormone secretion (GO:0046883)	155	6	4.25	+	1.41	3.28E-01	1.00E00
protein-containing complex subunit organization (GO:0043933)	727	28	19.94	+	1.40	7.64E-02	1.00E00
positive regulation of cellular catabolic process (GO:0031331)	260	10	7.13	+	1.40	2.52E-01	1.00E00
regulation of leukocyte activation (GO:0002694)	260	10	7.13	+	1.40	2.52E-01	1.00E00
regulation of smooth muscle contraction (GO:0006940)	26	1	.71	+	1.40	5.19E-01	1.00E00
negative regulation of mitotic sister chromatid separation (GO:2000816)	26	1	.71	+	1.40	5.19E-01	1.00E00
activation of JUN kinase activity (GO:0007257)	26	1	.71	+	1.40	5.19E-01	1.00E00
response to ethanol (GO:0045471)	26	1	.71	+	1.40	5.19E-01	1.00E00
positive regulation of gene silencing by miRNA (GO:2000637)	26	1	.71	+	1.40	5.19E-01	1.00E00
regulation of polysaccharide metabolic process (GO:0032881)	26	1	.71	+	1.40	5.19E-01	1.00E00
negative regulation of mitotic sister chromatid segregation (GO:0033048)	26	1	.71	+	1.40	5.19E-01	1.00E00
negative regulation of sister chromatid segregation (GO:0033046)	26	1	.71	+	1.40	5.19E-01	1.00E00
negative regulation of leukocyte apoptotic process (GO:2000107)	26	1	.71	+	1.40	5.19E-01	1.00E00
mitotic spindle checkpoint (GO:0071174)	26	1	.71	+	1.40	5.19E-01	1.00E00
regulation of nucleotide metabolic process (GO:0006140)	52	2	1.43	+	1.40	6.56E-01	1.00E00
negative regulation of cellular response to growth factor stimulus (GO:0090288)	52	2	1.43	+	1.40	6.56E-01	1.00E00
regulation of oligodendrocyte differentiation (GO:0048713)	26	1	.71	+	1.40	5.19E-01	1.00E00
regulation of hormone metabolic process (GO:0032350)	26	1	.71	+	1.40	5.19E-01	1.00E00
DNA synthesis involved in DNA repair (GO:0000731)	26	1	.71	+	1.40	5.19E-01	1.00E00
regulation of cell migration involved in sprouting angiogenesis (GO:0090049)	26	1	.71	+	1.40	5.19E-01	1.00E00
autophagy of mitochondrion (GO:0000422)	26	1	.71	+	1.40	5.19E-01	1.00E00
smooth muscle cell differentiation (GO:0051145)	26	1	.71	+	1.40	5.19E-01	1.00E00
gene silencing (GO:0016458)	104	4	2.85	+	1.40	5.38E-01	1.00E00
sulfur amino acid metabolic process (GO:0000096)	26	1	.71	+	1.40	5.19E-01	1.00E00
ribonucleoside triphosphate biosynthetic process (GO:0009201)	26	1	.71	+	1.40	5.19E-01	1.00E00
regulation of protein import (GO:1904589)	52	2	1.43	+	1.40	6.56E-01	1.00E00
mitochondrion disassembly (GO:0061726)	26	1	.71	+	1.40	5.19E-01	1.00E00
ventricular cardiac muscle tissue morphogenesis (GO:0055010)	26	1	.71	+	1.40	5.19E-01	1.00E00
regulation of phosphatase activity (GO:0010921)	78	3	2.14	+	1.40	4.79E-01	1.00E00
hair cell differentiation (GO:0035315)	26	1	.71	+	1.40	5.19E-01	1.00E00
hormone metabolic process (GO:0042445)	52	2	1.43	+	1.40	6.56E-01	1.00E00
production of miRNAs involved in gene silencing by miRNA (GO:0035196)	26	1	.71	+	1.40	5.19E-01	1.00E00
forelimb morphogenesis (GO:0035136)	26	1	.71	+	1.40	5.19E-01	1.00E00
negative regulation of insulin secretion (GO:0046676)	26	1	.71	+	1.40	5.19E-01	1.00E00
response to tumor necrosis factor (GO:0034612)	78	3	2.14	+	1.40	4.79E-01	1.00E00
cholesterol metabolic process (GO:0008203)	52	2	1.43	+	1.40	6.56E-01	1.00E00
T cell proliferation (GO:0042098)	26	1	.71	+	1.40	5.19E-01	1.00E00
positive regulation of immunoglobulin mediated immune response (GO:0002891)	26	1	.71	+	1.40	5.19E-01	1.00E00
regulation of alcohol biosynthetic process (GO:1902930)	26	1	.71	+	1.40	5.19E-01	1.00E00
positive regulation of B cell mediated immunity (GO:0002714)	26	1	.71	+	1.40	5.19E-01	1.00E00
negative regulation of mitotic metaphase/anaphase transition (GO:0045841)	26	1	.71	+	1.40	5.19E-01	1.00E00
regulation of endothelial cell migration (GO:0010594)	105	4	2.88	+	1.39	5.39E-01	1.00E00
retina development in camera-type eye (GO:0060041)	79	3	2.17	+	1.38	4.83E-01	1.00E00
cellular lipid metabolic process (GO:0044255)	369	14	10.12	+	1.38	2.54E-01	1.00E00
response to bacterium (GO:0009617)	264	10	7.24	+	1.38	3.36E-01	1.00E00
leukocyte differentiation (GO:0002521)	185	7	5.07	+	1.38	3.62E-01	1.00E00
anatomical structure homeostasis (GO:0060249)	185	7	5.07	+	1.38	3.62E-01	1.00E00
innate immune response (GO:0045087)	291	11	7.98	+	1.38	2.74E-01	1.00E00
protein targeting (GO:0006605)	106	4	2.91	+	1.38	5.41E-01	1.00E00
nephron epithelium development (GO:0072009)	53	2	1.45	+	1.38	6.59E-01	1.00E00
positive regulation of organelle assembly (GO:1902117)	53	2	1.45	+	1.38	6.59E-01	1.00E00
DNA modification (GO:0006304)	53	2	1.45	+	1.38	6.59E-01	1.00E00
response to interleukin-1 (GO:0070555)	53	2	1.45	+	1.38	6.59E-01	1.00E00
protein secretion (GO:0009306)	53	2	1.45	+	1.38	6.59E-01	1.00E00
establishment of protein localization to extracellular region (GO:0035592)	53	2	1.45	+	1.38	6.59E-01	1.00E00
sterol metabolic process (GO:0016125)	53	2	1.45	+	1.38	6.59E-01	1.00E00
negative regulation of response to biotic stimulus (GO:0002832)	53	2	1.45	+	1.38	6.59E-01	1.00E00
morphogenesis of a branching epithelium (GO:0061138)	106	4	2.91	+	1.38	5.41E-01	1.00E00
cell death (GO:0008219)	504	19	13.82	+	1.37	1.62E-01	1.00E00
oxoacid metabolic process (GO:0043436)	453	17	12.42	+	1.37	1.86E-01	1.00E00
mRNA transport (GO:0051028)	80	3	2.19	+	1.37	4.87E-01	1.00E00
nucleobase-containing small molecule metabolic process (GO:0055086)	267	10	7.32	+	1.37	3.39E-01	1.00E00
translation (GO:0006412)	215	8	5.90	+	1.36	3.95E-01	1.00E00
regulation of cytokine production (GO:0001817)	323	12	8.86	+	1.35	2.97E-01	1.00E00
ion transmembrane transport (GO:0034220)	108	4	2.96	+	1.35	5.45E-01	1.00E00
renal system process (GO:0003014)	27	1	.74	+	1.35	5.32E-01	1.00E00
ventral spinal cord development (GO:0021517)	27	1	.74	+	1.35	5.32E-01	1.00E00
positive regulation of posttranscriptional gene silencing (GO:0060148)	27	1	.74	+	1.35	5.32E-01	1.00E00
positive regulation of mononuclear cell migration (GO:0071677)	27	1	.74	+	1.35	5.32E-01	1.00E00
regulation of cell cycle checkpoint (GO:1901976)	27	1	.74	+	1.35	5.32E-01	1.00E00
production of small RNA involved in gene silencing by RNA (GO:0070918)	27	1	.74	+	1.35	5.32E-01	1.00E00
cytokinetic process (GO:0032506)	27	1	.74	+	1.35	5.32E-01	1.00E00
regulation of protein autophosphorylation (GO:0031952)	27	1	.74	+	1.35	5.32E-01	1.00E00
musculoskeletal movement (GO:0050881)	27	1	.74	+	1.35	5.32E-01	1.00E00
multicellular organismal movement (GO:0050879)	27	1	.74	+	1.35	5.32E-01	1.00E00
centrosome duplication (GO:0051298)	27	1	.74	+	1.35	5.32E-01	1.00E00
response to estrogen (GO:0043627)	27	1	.74	+	1.35	5.32E-01	1.00E00
cellular response to topologically incorrect protein (GO:0035967)	54	2	1.48	+	1.35	6.62E-01	1.00E00
spindle checkpoint (GO:0031577)	27	1	.74	+	1.35	5.32E-01	1.00E00
epithelial cell proliferation (GO:0050673)	54	2	1.48	+	1.35	6.62E-01	1.00E00
endoplasmic reticulum unfolded protein response (GO:0030968)	27	1	.74	+	1.35	5.32E-01	1.00E00
regulation of pattern recognition receptor signaling pathway (GO:0062207)	54	2	1.48	+	1.35	6.62E-01	1.00E00
dsRNA processing (GO:0031050)	27	1	.74	+	1.35	5.32E-01	1.00E00
nucleoside metabolic process (GO:0009116)	54	2	1.48	+	1.35	6.62E-01	1.00E00
negative regulation of BMP signaling pathway (GO:0030514)	27	1	.74	+	1.35	5.32E-01	1.00E00
positive regulation of substrate adhesion-dependent cell spreading (GO:1900026)	27	1	.74	+	1.35	5.32E-01	1.00E00
carbohydrate catabolic process (GO:0016052)	54	2	1.48	+	1.35	6.62E-01	1.00E00
positive regulation of epithelial to mesenchymal transition (GO:0010718)	27	1	.74	+	1.35	5.32E-01	1.00E00
dendritic spine development (GO:0060996)	27	1	.74	+	1.35	5.32E-01	1.00E00
regulation of mesenchymal cell proliferation (GO:0010464)	27	1	.74	+	1.35	5.32E-01	1.00E00
carboxylic acid catabolic process (GO:0046395)	135	5	3.70	+	1.35	4.27E-01	1.00E00
digestion (GO:0007586)	27	1	.74	+	1.35	5.32E-01	1.00E00
positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895)	27	1	.74	+	1.35	5.32E-01	1.00E00
regulation of hormone levels (GO:0010817)	244	9	6.69	+	1.35	3.25E-01	1.00E00
leukocyte activation (GO:0045321)	245	9	6.72	+	1.34	3.27E-01	1.00E00
positive regulation of cellular amide metabolic process (GO:0034250)	109	4	2.99	+	1.34	5.47E-01	1.00E00
organic acid metabolic process (GO:0006082)	464	17	12.72	+	1.34	2.43E-01	1.00E00
cellular modified amino acid metabolic process (GO:0006575)	82	3	2.25	+	1.33	4.96E-01	1.00E00
regulation of peptidyl-serine phosphorylation (GO:0033135)	82	3	2.25	+	1.33	4.96E-01	1.00E00
eye morphogenesis (GO:0048592)	82	3	2.25	+	1.33	4.96E-01	1.00E00
bone morphogenesis (GO:0060349)	55	2	1.51	+	1.33	6.65E-01	1.00E00
morphogenesis of a branching structure (GO:0001763)	110	4	3.02	+	1.33	5.50E-01	1.00E00
ribosomal large subunit biogenesis (GO:0042273)	55	2	1.51	+	1.33	6.65E-01	1.00E00
regulation of ATP metabolic process (GO:1903578)	55	2	1.51	+	1.33	6.65E-01	1.00E00
positive regulation of apoptotic process (GO:0043065)	331	12	9.08	+	1.32	3.06E-01	1.00E00
inflammatory response (GO:0006954)	166	6	4.55	+	1.32	4.68E-01	1.00E00
regulation of secretion (GO:0051046)	332	12	9.10	+	1.32	3.07E-01	1.00E00
cellular lipid catabolic process (GO:0044242)	111	4	3.04	+	1.31	5.52E-01	1.00E00
regulation of intracellular protein transport (GO:0033157)	139	5	3.81	+	1.31	4.39E-01	1.00E00
synapse organization (GO:0050808)	139	5	3.81	+	1.31	4.39E-01	1.00E00
regulation of inflammatory response (GO:0050727)	167	6	4.58	+	1.31	4.70E-01	1.00E00
regulation of epithelial cell proliferation (GO:0050678)	195	7	5.35	+	1.31	5.02E-01	1.00E00
complement activation (GO:0006956)	28	1	.77	+	1.30	5.44E-01	1.00E00
regulation of autophagosome assembly (GO:2000785)	28	1	.77	+	1.30	5.44E-01	1.00E00
positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261)	28	1	.77	+	1.30	5.44E-01	1.00E00
regulation of mitotic spindle organization (GO:0060236)	28	1	.77	+	1.30	5.44E-01	1.00E00
meiosis I (GO:0007127)	84	3	2.30	+	1.30	5.05E-01	1.00E00
myeloid leukocyte activation (GO:0002274)	56	2	1.54	+	1.30	6.68E-01	1.00E00
negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100)	28	1	.77	+	1.30	5.44E-01	1.00E00
chromatin silencing (GO:0006342)	28	1	.77	+	1.30	5.44E-01	1.00E00
cellular pigmentation (GO:0033059)	28	1	.77	+	1.30	5.44E-01	1.00E00
DNA duplex unwinding (GO:0032508)	28	1	.77	+	1.30	5.44E-01	1.00E00
chemical homeostasis (GO:0048878)	420	15	11.52	+	1.30	2.86E-01	1.00E00
establishment of mitotic spindle localization (GO:0040001)	28	1	.77	+	1.30	5.44E-01	1.00E00
negative regulation of chromosome separation (GO:1905819)	28	1	.77	+	1.30	5.44E-01	1.00E00
negative regulation of hydrolase activity (GO:0051346)	224	8	6.14	+	1.30	4.08E-01	1.00E00
spleen development (GO:0048536)	28	1	.77	+	1.30	5.44E-01	1.00E00
negative regulation of coagulation (GO:0050819)	28	1	.77	+	1.30	5.44E-01	1.00E00
protein homotetramerization (GO:0051289)	28	1	.77	+	1.30	5.44E-01	1.00E00
protein depolymerization (GO:0051261)	28	1	.77	+	1.30	5.44E-01	1.00E00
inorganic cation transmembrane transport (GO:0098662)	56	2	1.54	+	1.30	6.68E-01	1.00E00
regulation of actin nucleation (GO:0051125)	28	1	.77	+	1.30	5.44E-01	1.00E00
chromosome organization involved in meiotic cell cycle (GO:0070192)	56	2	1.54	+	1.30	6.68E-01	1.00E00
vesicle docking (GO:0048278)	28	1	.77	+	1.30	5.44E-01	1.00E00
platelet-derived growth factor receptor signaling pathway (GO:0048008)	28	1	.77	+	1.30	5.44E-01	1.00E00
regulation of cellular pH (GO:0030641)	28	1	.77	+	1.30	5.44E-01	1.00E00
regulation of cytokine production involved in inflammatory response (GO:1900015)	28	1	.77	+	1.30	5.44E-01	1.00E00
negative regulation of dephosphorylation (GO:0035305)	56	2	1.54	+	1.30	6.68E-01	1.00E00
negative regulation of blood coagulation (GO:0030195)	28	1	.77	+	1.30	5.44E-01	1.00E00
regulation of epithelial cell apoptotic process (GO:1904035)	56	2	1.54	+	1.30	6.68E-01	1.00E00
protein localization to chromosome (GO:0034502)	56	2	1.54	+	1.30	6.68E-01	1.00E00
mRNA destabilization (GO:0061157)	28	1	.77	+	1.30	5.44E-01	1.00E00
establishment of protein localization to vacuole (GO:0072666)	28	1	.77	+	1.30	5.44E-01	1.00E00
feeding behavior (GO:0007631)	28	1	.77	+	1.30	5.44E-01	1.00E00
negative regulation of myeloid leukocyte differentiation (GO:0002762)	28	1	.77	+	1.30	5.44E-01	1.00E00
positive regulation of proteolysis (GO:0045862)	196	7	5.37	+	1.30	5.03E-01	1.00E00
organic acid catabolic process (GO:0016054)	141	5	3.87	+	1.29	5.98E-01	1.00E00
gland development (GO:0048732)	226	8	6.20	+	1.29	4.12E-01	1.00E00
peptide biosynthetic process (GO:0043043)	226	8	6.20	+	1.29	4.12E-01	1.00E00
meiosis I cell cycle process (GO:0061982)	85	3	2.33	+	1.29	5.10E-01	1.00E00
positive regulation of programmed cell death (GO:0043068)	340	12	9.32	+	1.29	3.96E-01	1.00E00
second-messenger-mediated signaling (GO:0019932)	85	3	2.33	+	1.29	5.10E-01	1.00E00
regulation of hemopoiesis (GO:1903706)	199	7	5.46	+	1.28	5.07E-01	1.00E00
positive regulation of protein localization to membrane (GO:1905477)	57	2	1.56	+	1.28	6.72E-01	1.00E00
regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122)	114	4	3.13	+	1.28	5.59E-01	1.00E00
organic acid transport (GO:0015849)	57	2	1.56	+	1.28	6.72E-01	1.00E00
negative regulation of small molecule metabolic process (GO:0062014)	57	2	1.56	+	1.28	6.72E-01	1.00E00
organ growth (GO:0035265)	57	2	1.56	+	1.28	6.72E-01	1.00E00
erythrocyte differentiation (GO:0030218)	57	2	1.56	+	1.28	6.72E-01	1.00E00
reactive oxygen species metabolic process (GO:0072593)	57	2	1.56	+	1.28	6.72E-01	1.00E00
regulation of intracellular transport (GO:0032386)	200	7	5.48	+	1.28	5.08E-01	1.00E00
Golgi vesicle transport (GO:0048193)	143	5	3.92	+	1.28	6.00E-01	1.00E00
regulation of secretion by cell (GO:1903530)	315	11	8.64	+	1.27	3.82E-01	1.00E00
cell maturation (GO:0048469)	86	3	2.36	+	1.27	5.15E-01	1.00E00
lipid biosynthetic process (GO:0008610)	172	6	4.72	+	1.27	4.81E-01	1.00E00
regulation of immune response (GO:0050776)	317	11	8.69	+	1.27	3.85E-01	1.00E00
macromolecule methylation (GO:0043414)	173	6	4.74	+	1.26	4.83E-01	1.00E00
multivesicular body sorting pathway (GO:0071985)	29	1	.80	+	1.26	5.56E-01	1.00E00
positive regulation of glial cell differentiation (GO:0045687)	29	1	.80	+	1.26	5.56E-01	1.00E00
regulation of osteoclast differentiation (GO:0045670)	29	1	.80	+	1.26	5.56E-01	1.00E00
secondary alcohol metabolic process (GO:1902652)	58	2	1.59	+	1.26	6.75E-01	1.00E00
regulation of protein localization to plasma membrane (GO:1903076)	58	2	1.59	+	1.26	6.75E-01	1.00E00
unsaturated fatty acid metabolic process (GO:0033559)	29	1	.80	+	1.26	5.56E-01	1.00E00
regulation of vasoconstriction (GO:0019229)	29	1	.80	+	1.26	5.56E-01	1.00E00
protein localization to extracellular region (GO:0071692)	58	2	1.59	+	1.26	6.75E-01	1.00E00
toll-like receptor signaling pathway (GO:0002224)	29	1	.80	+	1.26	5.56E-01	1.00E00
negative regulation of microtubule depolymerization (GO:0007026)	29	1	.80	+	1.26	5.56E-01	1.00E00
cardiac muscle contraction (GO:0060048)	29	1	.80	+	1.26	5.56E-01	1.00E00
negative regulation of chromosome segregation (GO:0051985)	29	1	.80	+	1.26	5.56E-01	1.00E00
regulation of isotype switching (GO:0045191)	29	1	.80	+	1.26	5.56E-01	1.00E00
RNA methylation (GO:0001510)	58	2	1.59	+	1.26	6.75E-01	1.00E00
cellular response to steroid hormone stimulus (GO:0071383)	58	2	1.59	+	1.26	6.75E-01	1.00E00
regulation of microtubule cytoskeleton organization (GO:0070507)	116	4	3.18	+	1.26	5.64E-01	1.00E00
axonemal dynein complex assembly (GO:0070286)	29	1	.80	+	1.26	5.56E-01	1.00E00
nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)	29	1	.80	+	1.26	5.56E-01	1.00E00
regulation of microtubule depolymerization (GO:0031114)	29	1	.80	+	1.26	5.56E-01	1.00E00
cellular chemical homeostasis (GO:0055082)	232	8	6.36	+	1.26	5.38E-01	1.00E00
negative regulation of hemostasis (GO:1900047)	29	1	.80	+	1.26	5.56E-01	1.00E00
tRNA methylation (GO:0030488)	29	1	.80	+	1.26	5.56E-01	1.00E00
snRNA metabolic process (GO:0016073)	29	1	.80	+	1.26	5.56E-01	1.00E00
regulation of ossification (GO:0030278)	58	2	1.59	+	1.26	6.75E-01	1.00E00
positive regulation of histone acetylation (GO:0035066)	29	1	.80	+	1.26	5.56E-01	1.00E00
regulation of myeloid leukocyte mediated immunity (GO:0002886)	29	1	.80	+	1.26	5.56E-01	1.00E00
cellular response to lipopolysaccharide (GO:0071222)	87	3	2.39	+	1.26	5.19E-01	1.00E00
organophosphate catabolic process (GO:0046434)	87	3	2.39	+	1.26	5.19E-01	1.00E00
methylation (GO:0032259)	204	7	5.59	+	1.25	5.14E-01	1.00E00
biological process involved in interspecies interaction between organisms (GO:0044419)	642	22	17.60	+	1.25	2.63E-01	1.00E00
cation homeostasis (GO:0055080)	206	7	5.65	+	1.24	5.17E-01	1.00E00
carboxylic acid metabolic process (GO:0019752)	442	15	12.12	+	1.24	3.73E-01	1.00E00
negative regulation of extrinsic apoptotic signaling pathway (GO:2001237)	59	2	1.62	+	1.24	6.78E-01	1.00E00
negative regulation of leukocyte differentiation (GO:1902106)	59	2	1.62	+	1.24	6.78E-01	1.00E00
glycerophospholipid biosynthetic process (GO:0046474)	59	2	1.62	+	1.24	6.78E-01	1.00E00
nucleobase-containing small molecule biosynthetic process (GO:0034404)	59	2	1.62	+	1.24	6.78E-01	1.00E00
cellular component disassembly (GO:0022411)	148	5	4.06	+	1.23	6.08E-01	1.00E00
carbohydrate derivative catabolic process (GO:1901136)	89	3	2.44	+	1.23	7.38E-01	1.00E00
positive regulation of hormone secretion (GO:0046887)	89	3	2.44	+	1.23	7.38E-01	1.00E00
positive regulation of intracellular transport (GO:0032388)	119	4	3.26	+	1.23	5.72E-01	1.00E00
lipid metabolic process (GO:0006629)	478	16	13.11	+	1.22	3.90E-01	1.00E00
regulation of peptide transport (GO:0090087)	329	11	9.02	+	1.22	4.91E-01	1.00E00
synapse assembly (GO:0007416)	30	1	.82	+	1.22	5.68E-01	1.00E00
positive regulation of protein localization to plasma membrane (GO:1903078)	30	1	.82	+	1.22	5.68E-01	1.00E00
one-carbon metabolic process (GO:0006730)	30	1	.82	+	1.22	5.68E-01	1.00E00
embryonic placenta development (GO:0001892)	60	2	1.65	+	1.22	6.82E-01	1.00E00
sarcomere organization (GO:0045214)	30	1	.82	+	1.22	5.68E-01	1.00E00
positive regulation of peptidyl-serine phosphorylation (GO:0033138)	60	2	1.65	+	1.22	6.82E-01	1.00E00
regulation of endothelial cell apoptotic process (GO:2000351)	30	1	.82	+	1.22	5.68E-01	1.00E00
pyrimidine nucleotide metabolic process (GO:0006220)	30	1	.82	+	1.22	5.68E-01	1.00E00
cellular response to molecule of bacterial origin (GO:0071219)	90	3	2.47	+	1.22	7.39E-01	1.00E00
regulation of neural precursor cell proliferation (GO:2000177)	60	2	1.65	+	1.22	6.82E-01	1.00E00
telomere maintenance (GO:0000723)	60	2	1.65	+	1.22	6.82E-01	1.00E00
neuron projection organization (GO:0106027)	30	1	.82	+	1.22	5.68E-01	1.00E00
telomere organization (GO:0032200)	60	2	1.65	+	1.22	6.82E-01	1.00E00
establishment of spindle orientation (GO:0051294)	30	1	.82	+	1.22	5.68E-01	1.00E00
regulation of phosphoprotein phosphatase activity (GO:0043666)	30	1	.82	+	1.22	5.68E-01	1.00E00
inorganic ion homeostasis (GO:0098771)	210	7	5.76	+	1.22	5.23E-01	1.00E00
hormone-mediated signaling pathway (GO:0009755)	60	2	1.65	+	1.22	6.82E-01	1.00E00
RNA destabilization (GO:0050779)	30	1	.82	+	1.22	5.68E-01	1.00E00
inorganic ion transmembrane transport (GO:0098660)	60	2	1.65	+	1.22	6.82E-01	1.00E00
blood vessel diameter maintenance (GO:0097746)	60	2	1.65	+	1.22	6.82E-01	1.00E00
regulation of mitochondrial membrane permeability (GO:0046902)	30	1	.82	+	1.22	5.68E-01	1.00E00
positive regulation of mitochondrion organization (GO:0010822)	30	1	.82	+	1.22	5.68E-01	1.00E00
regulation of tube diameter (GO:0035296)	60	2	1.65	+	1.22	6.82E-01	1.00E00
regulation of tube size (GO:0035150)	60	2	1.65	+	1.22	6.82E-01	1.00E00
negative regulation of hemopoiesis (GO:1903707)	60	2	1.65	+	1.22	6.82E-01	1.00E00
establishment or maintenance of apical/basal cell polarity (GO:0035088)	30	1	.82	+	1.22	5.68E-01	1.00E00
establishment or maintenance of bipolar cell polarity (GO:0061245)	30	1	.82	+	1.22	5.68E-01	1.00E00
ventricular cardiac muscle tissue development (GO:0003229)	30	1	.82	+	1.22	5.68E-01	1.00E00
negative regulation of lipid metabolic process (GO:0045833)	60	2	1.65	+	1.22	6.82E-01	1.00E00
G protein-coupled receptor signaling pathway (GO:0007186)	151	5	4.14	+	1.21	6.13E-01	1.00E00
regulation of protein secretion (GO:0050708)	151	5	4.14	+	1.21	6.13E-01	1.00E00
regulation of proteolysis (GO:0030162)	393	13	10.78	+	1.21	4.34E-01	1.00E00
purine-containing compound metabolic process (GO:0072521)	182	6	4.99	+	1.20	6.43E-01	1.00E00
regulation of phosphatidylinositol 3-kinase signaling (GO:0014066)	61	2	1.67	+	1.20	6.85E-01	1.00E00
positive regulation of protein transport (GO:0051222)	183	6	5.02	+	1.20	6.44E-01	1.00E00
regulation of hydrolase activity (GO:0051336)	580	19	15.90	+	1.19	4.31E-01	1.00E00
negative regulation of response to external stimulus (GO:0032102)	184	6	5.05	+	1.19	6.45E-01	1.00E00
positive regulation of chromatin organization (GO:1905269)	92	3	2.52	+	1.19	7.42E-01	1.00E00
cellular homeostasis (GO:0019725)	307	10	8.42	+	1.19	5.92E-01	1.00E00
regulation of immune system process (GO:0002682)	616	20	16.89	+	1.18	4.44E-01	1.00E00
carbohydrate derivative metabolic process (GO:1901135)	370	12	10.15	+	1.18	5.16E-01	1.00E00
negative regulation of cell adhesion (GO:0007162)	155	5	4.25	+	1.18	6.20E-01	1.00E00
response to osmotic stress (GO:0006970)	31	1	.85	+	1.18	5.80E-01	1.00E00
ATP generation from ADP (GO:0006757)	31	1	.85	+	1.18	5.80E-01	1.00E00
fat cell differentiation (GO:0045444)	62	2	1.70	+	1.18	6.89E-01	1.00E00
regulation of synaptic vesicle exocytosis (GO:2000300)	31	1	.85	+	1.18	5.80E-01	1.00E00
DNA methylation (GO:0006306)	31	1	.85	+	1.18	5.80E-01	1.00E00
DNA alkylation (GO:0006305)	31	1	.85	+	1.18	5.80E-01	1.00E00
regulation of spindle organization (GO:0090224)	31	1	.85	+	1.18	5.80E-01	1.00E00
glycolytic process (GO:0006096)	31	1	.85	+	1.18	5.80E-01	1.00E00
regulation of potassium ion transmembrane transport (GO:1901379)	31	1	.85	+	1.18	5.80E-01	1.00E00
positive regulation of chemotaxis (GO:0050921)	62	2	1.70	+	1.18	6.89E-01	1.00E00
reproductive structure development (GO:0048608)	248	8	6.80	+	1.18	5.57E-01	1.00E00
leukocyte migration (GO:0050900)	62	2	1.70	+	1.18	6.89E-01	1.00E00
developmental cell growth (GO:0048588)	62	2	1.70	+	1.18	6.89E-01	1.00E00
negative regulation of protein binding (GO:0032091)	62	2	1.70	+	1.18	6.89E-01	1.00E00
endocrine pancreas development (GO:0031018)	31	1	.85	+	1.18	5.80E-01	1.00E00
regulation of striated muscle tissue development (GO:0016202)	31	1	.85	+	1.18	5.80E-01	1.00E00
regulation of mitochondrion organization (GO:0010821)	62	2	1.70	+	1.18	6.89E-01	1.00E00
regulation of peptidyl-threonine phosphorylation (GO:0010799)	31	1	.85	+	1.18	5.80E-01	1.00E00
negative regulation of cellular carbohydrate metabolic process (GO:0010677)	31	1	.85	+	1.18	5.80E-01	1.00E00
response to alcohol (GO:0097305)	62	2	1.70	+	1.18	6.89E-01	1.00E00
positive regulation of Ras protein signal transduction (GO:0046579)	31	1	.85	+	1.18	5.80E-01	1.00E00
steroid metabolic process (GO:0008202)	93	3	2.55	+	1.18	7.44E-01	1.00E00
positive regulation of intracellular signal transduction (GO:1902533)	497	16	13.63	+	1.17	4.81E-01	1.00E00
small molecule metabolic process (GO:0044281)	808	26	22.16	+	1.17	3.70E-01	1.00E00
response to external stimulus (GO:0009605)	964	31	26.43	+	1.17	3.50E-01	1.00E00
vacuolar transport (GO:0007034)	94	3	2.58	+	1.16	7.45E-01	1.00E00
organic hydroxy compound metabolic process (GO:1901615)	188	6	5.16	+	1.16	6.50E-01	1.00E00
protein acylation (GO:0043543)	94	3	2.58	+	1.16	7.45E-01	1.00E00
reproductive system development (GO:0061458)	251	8	6.88	+	1.16	6.93E-01	1.00E00
regulation of MAPK cascade (GO:0043408)	378	12	10.37	+	1.16	6.28E-01	1.00E00
negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101)	63	2	1.73	+	1.16	6.93E-01	1.00E00
positive regulation of cell death (GO:0010942)	379	12	10.39	+	1.15	6.29E-01	1.00E00
protein methylation (GO:0006479)	95	3	2.61	+	1.15	7.47E-01	1.00E00
regulation of neurotransmitter levels (GO:0001505)	95	3	2.61	+	1.15	7.47E-01	1.00E00
protein alkylation (GO:0008213)	95	3	2.61	+	1.15	7.47E-01	1.00E00
Unclassified (UNCLASSIFIED)	317	10	8.69	+	1.15	6.00E-01	1.00E00
cell activation (GO:0001775)	287	9	7.87	+	1.14	5.86E-01	1.00E00
erythrocyte homeostasis (GO:0034101)	64	2	1.76	+	1.14	6.96E-01	1.00E00
spermatid development (GO:0007286)	96	3	2.63	+	1.14	7.49E-01	1.00E00
cell differentiation in spinal cord (GO:0021515)	32	1	.88	+	1.14	5.91E-01	1.00E00
steroid biosynthetic process (GO:0006694)	32	1	.88	+	1.14	5.91E-01	1.00E00
inner ear receptor cell development (GO:0060119)	32	1	.88	+	1.14	5.91E-01	1.00E00
eye photoreceptor cell differentiation (GO:0001754)	32	1	.88	+	1.14	5.91E-01	1.00E00
tRNA aminoacylation for protein translation (GO:0006418)	32	1	.88	+	1.14	5.91E-01	1.00E00
regulation of heart rate (GO:0002027)	32	1	.88	+	1.14	5.91E-01	1.00E00
regulation of cell aging (GO:0090342)	32	1	.88	+	1.14	5.91E-01	1.00E00
histone H3 acetylation (GO:0043966)	32	1	.88	+	1.14	5.91E-01	1.00E00
organelle localization by membrane tethering (GO:0140056)	32	1	.88	+	1.14	5.91E-01	1.00E00
DNA geometric change (GO:0032392)	32	1	.88	+	1.14	5.91E-01	1.00E00
regulation of ubiquitin-protein transferase activity (GO:0051438)	32	1	.88	+	1.14	5.91E-01	1.00E00
camera-type eye morphogenesis (GO:0048593)	64	2	1.76	+	1.14	6.96E-01	1.00E00
dicarboxylic acid metabolic process (GO:0043648)	64	2	1.76	+	1.14	6.96E-01	1.00E00
maturation of 5.8S rRNA (GO:0000460)	32	1	.88	+	1.14	5.91E-01	1.00E00
intracellular steroid hormone receptor signaling pathway (GO:0030518)	32	1	.88	+	1.14	5.91E-01	1.00E00
monocarboxylic acid transport (GO:0015718)	32	1	.88	+	1.14	5.91E-01	1.00E00
cellular response to alcohol (GO:0097306)	32	1	.88	+	1.14	5.91E-01	1.00E00
glycerolipid catabolic process (GO:0046503)	32	1	.88	+	1.14	5.91E-01	1.00E00
negative regulation of epithelial cell apoptotic process (GO:1904036)	32	1	.88	+	1.14	5.91E-01	1.00E00
regulation of double-strand break repair via homologous recombination (GO:0010569)	32	1	.88	+	1.14	5.91E-01	1.00E00
positive regulation of DNA recombination (GO:0045911)	32	1	.88	+	1.14	5.91E-01	1.00E00
carboxylic acid biosynthetic process (GO:0046394)	128	4	3.51	+	1.14	7.82E-01	1.00E00
regulation of protein tyrosine kinase activity (GO:0061097)	32	1	.88	+	1.14	5.91E-01	1.00E00
cell surface receptor signaling pathway (GO:0007166)	769	24	21.09	+	1.14	4.90E-01	1.00E00
positive regulation of cell population proliferation (GO:0008284)	515	16	14.12	+	1.13	5.79E-01	1.00E00
regulation of smooth muscle cell proliferation (GO:0048660)	97	3	2.66	+	1.13	7.50E-01	1.00E00
regulation of muscle contraction (GO:0006937)	65	2	1.78	+	1.12	7.00E-01	1.00E00
regulation of gliogenesis (GO:0014013)	65	2	1.78	+	1.12	7.00E-01	1.00E00
glycosyl compound metabolic process (GO:1901657)	65	2	1.78	+	1.12	7.00E-01	1.00E00
amide biosynthetic process (GO:0043604)	260	8	7.13	+	1.12	6.99E-01	1.00E00
histone methylation (GO:0016571)	65	2	1.78	+	1.12	7.00E-01	1.00E00
regulation of carbohydrate biosynthetic process (GO:0043255)	65	2	1.78	+	1.12	7.00E-01	1.00E00
hemopoiesis (GO:0030097)	358	11	9.82	+	1.12	6.23E-01	1.00E00
hematopoietic or lymphoid organ development (GO:0048534)	391	12	10.72	+	1.12	6.36E-01	1.00E00
DNA-dependent DNA replication (GO:0006261)	98	3	2.69	+	1.12	7.52E-01	1.00E00
positive regulation of cell growth (GO:0030307)	98	3	2.69	+	1.12	7.52E-01	1.00E00
cation transport (GO:0006812)	131	4	3.59	+	1.11	7.84E-01	1.00E00
response to molecule of bacterial origin (GO:0002237)	131	4	3.59	+	1.11	7.84E-01	1.00E00
phospholipid metabolic process (GO:0006644)	164	5	4.50	+	1.11	8.07E-01	1.00E00
cellular nitrogen compound catabolic process (GO:0044270)	197	6	5.40	+	1.11	6.63E-01	1.00E00
negative regulation of mitotic cell cycle phase transition (GO:1901991)	99	3	2.71	+	1.11	7.54E-01	1.00E00
positive regulation of establishment of protein localization (GO:1904951)	198	6	5.43	+	1.11	8.24E-01	1.00E00
regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393)	33	1	.90	+	1.11	6.02E-01	1.00E00
sensory perception of pain (GO:0019233)	33	1	.90	+	1.11	6.02E-01	1.00E00
diencephalon development (GO:0021536)	33	1	.90	+	1.11	6.02E-01	1.00E00
positive regulation of cell-matrix adhesion (GO:0001954)	33	1	.90	+	1.11	6.02E-01	1.00E00
heart contraction (GO:0060047)	33	1	.90	+	1.11	6.02E-01	1.00E00
cytoplasmic translation (GO:0002181)	33	1	.90	+	1.11	6.02E-01	1.00E00
regulation of amine transport (GO:0051952)	33	1	.90	+	1.11	6.02E-01	1.00E00
mRNA export from nucleus (GO:0006406)	33	1	.90	+	1.11	6.02E-01	1.00E00
mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427)	33	1	.90	+	1.11	6.02E-01	1.00E00
positive regulation of type I interferon production (GO:0032481)	33	1	.90	+	1.11	6.02E-01	1.00E00
positive regulation of DNA-templated transcription, initiation (GO:2000144)	33	1	.90	+	1.11	6.02E-01	1.00E00
protein polymerization (GO:0051258)	66	2	1.81	+	1.11	7.04E-01	1.00E00
ncRNA 3'-end processing (GO:0043628)	33	1	.90	+	1.11	6.02E-01	1.00E00
regulation of postsynaptic membrane neurotransmitter receptor levels (GO:0099072)	33	1	.90	+	1.11	6.02E-01	1.00E00
regulation of protein binding (GO:0043393)	132	4	3.62	+	1.11	7.85E-01	1.00E00
regulation of transforming growth factor beta receptor signaling pathway (GO:0017015)	66	2	1.81	+	1.11	7.04E-01	1.00E00
2'-deoxyribonucleotide metabolic process (GO:0009394)	33	1	.90	+	1.11	6.02E-01	1.00E00
fatty acid transport (GO:0015908)	33	1	.90	+	1.11	6.02E-01	1.00E00
positive regulation of histone methylation (GO:0031062)	33	1	.90	+	1.11	6.02E-01	1.00E00
intracellular receptor signaling pathway (GO:0030522)	66	2	1.81	+	1.11	7.04E-01	1.00E00
phosphatidylinositol phosphorylation (GO:0046854)	33	1	.90	+	1.11	6.02E-01	1.00E00
positive regulation of smooth muscle cell migration (GO:0014911)	33	1	.90	+	1.11	6.02E-01	1.00E00
regulation of protein targeting (GO:1903533)	33	1	.90	+	1.11	6.02E-01	1.00E00
deoxyribose phosphate metabolic process (GO:0019692)	33	1	.90	+	1.11	6.02E-01	1.00E00
negative regulation of mitotic nuclear division (GO:0045839)	33	1	.90	+	1.11	6.02E-01	1.00E00
response to endogenous stimulus (GO:0009719)	595	18	16.32	+	1.10	6.06E-01	1.00E00
ion homeostasis (GO:0050801)	232	7	6.36	+	1.10	6.86E-01	1.00E00
nucleotide metabolic process (GO:0009117)	232	7	6.36	+	1.10	6.86E-01	1.00E00
positive regulation of immune system process (GO:0002684)	365	11	10.01	+	1.10	7.43E-01	1.00E00
cellular component assembly (GO:0022607)	1262	38	34.61	+	1.10	5.18E-01	1.00E00
regulation of body fluid levels (GO:0050878)	133	4	3.65	+	1.10	7.87E-01	1.00E00
organic acid biosynthetic process (GO:0016053)	133	4	3.65	+	1.10	7.87E-01	1.00E00
organophosphate metabolic process (GO:0019637)	433	13	11.87	+	1.09	6.54E-01	1.00E00
spermatid differentiation (GO:0048515)	100	3	2.74	+	1.09	7.56E-01	1.00E00
proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161)	200	6	5.48	+	1.09	8.25E-01	1.00E00
nephron development (GO:0072006)	67	2	1.84	+	1.09	7.07E-01	1.00E00
glycerolipid biosynthetic process (GO:0045017)	67	2	1.84	+	1.09	7.07E-01	1.00E00
alcohol metabolic process (GO:0006066)	134	4	3.67	+	1.09	7.88E-01	1.00E00
regulation of system process (GO:0044057)	268	8	7.35	+	1.09	7.06E-01	1.00E00
gene silencing by RNA (GO:0031047)	67	2	1.84	+	1.09	7.07E-01	1.00E00
negative regulation of ion transmembrane transport (GO:0034766)	67	2	1.84	+	1.09	7.07E-01	1.00E00
regulation of regulated secretory pathway (GO:1903305)	67	2	1.84	+	1.09	7.07E-01	1.00E00
cellular component biogenesis (GO:0044085)	1442	43	39.54	+	1.09	5.41E-01	1.00E00
immune system process (GO:0002376)	907	27	24.87	+	1.09	6.69E-01	1.00E00
spermatogenesis (GO:0007283)	303	9	8.31	+	1.08	7.22E-01	1.00E00
cell population proliferation (GO:0008283)	303	9	8.31	+	1.08	7.22E-01	1.00E00
nucleoside phosphate metabolic process (GO:0006753)	236	7	6.47	+	1.08	8.39E-01	1.00E00
regulation of striated muscle contraction (GO:0006942)	34	1	.93	+	1.07	6.13E-01	1.00E00
positive regulation of neuron differentiation (GO:0045666)	68	2	1.86	+	1.07	7.11E-01	1.00E00
regulation of pH (GO:0006885)	34	1	.93	+	1.07	6.13E-01	1.00E00
positive regulation of peptidyl-lysine acetylation (GO:2000758)	34	1	.93	+	1.07	6.13E-01	1.00E00
icosanoid metabolic process (GO:0006690)	34	1	.93	+	1.07	6.13E-01	1.00E00
centrosome cycle (GO:0007098)	68	2	1.86	+	1.07	7.11E-01	1.00E00
peptide metabolic process (GO:0006518)	272	8	7.46	+	1.07	8.49E-01	1.00E00
regulation of muscle tissue development (GO:1901861)	34	1	.93	+	1.07	6.13E-01	1.00E00
regulation of membrane permeability (GO:0090559)	34	1	.93	+	1.07	6.13E-01	1.00E00
nucleosome assembly (GO:0006334)	34	1	.93	+	1.07	6.13E-01	1.00E00
negative regulation of peptide hormone secretion (GO:0090278)	34	1	.93	+	1.07	6.13E-01	1.00E00
regulation of anion transport (GO:0044070)	476	14	13.05	+	1.07	7.73E-01	1.00E00
negative regulation of TOR signaling (GO:0032007)	34	1	.93	+	1.07	6.13E-01	1.00E00
regulation of protein localization to membrane (GO:1905475)	102	3	2.80	+	1.07	7.60E-01	1.00E00
regulation of ATPase activity (GO:0043462)	34	1	.93	+	1.07	6.13E-01	1.00E00
organelle fission (GO:0048285)	238	7	6.53	+	1.07	8.39E-01	1.00E00
regulation of cellular catabolic process (GO:0031329)	476	14	13.05	+	1.07	7.73E-01	1.00E00
response to alkaloid (GO:0043279)	34	1	.93	+	1.07	6.13E-01	1.00E00
negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124)	34	1	.93	+	1.07	6.13E-01	1.00E00
organic hydroxy compound transport (GO:0015850)	34	1	.93	+	1.07	6.13E-01	1.00E00
cellular transition metal ion homeostasis (GO:0046916)	34	1	.93	+	1.07	6.13E-01	1.00E00
regulation of bone mineralization (GO:0030500)	34	1	.93	+	1.07	6.13E-01	1.00E00
cytoskeleton-dependent cytokinesis (GO:0061640)	68	2	1.86	+	1.07	7.11E-01	1.00E00
myeloid leukocyte migration (GO:0097529)	34	1	.93	+	1.07	6.13E-01	1.00E00
ubiquitin-dependent ERAD pathway (GO:0030433)	34	1	.93	+	1.07	6.13E-01	1.00E00
negative regulation of transmembrane transport (GO:0034763)	68	2	1.86	+	1.07	7.11E-01	1.00E00
cell growth (GO:0016049)	68	2	1.86	+	1.07	7.11E-01	1.00E00
coronary vasculature development (GO:0060976)	34	1	.93	+	1.07	6.13E-01	1.00E00
negative regulation of gene expression, epigenetic (GO:0045814)	34	1	.93	+	1.07	6.13E-01	1.00E00
organonitrogen compound biosynthetic process (GO:1901566)	546	16	14.97	+	1.07	7.87E-01	1.00E00
homeostatic process (GO:0042592)	751	22	20.59	+	1.07	7.27E-01	1.00E00
regulation of intrinsic apoptotic signaling pathway (GO:2001242)	103	3	2.82	+	1.06	7.62E-01	1.00E00
glycerophospholipid metabolic process (GO:0006650)	138	4	3.78	+	1.06	7.92E-01	1.00E00
regulation of DNA recombination (GO:0000018)	69	2	1.89	+	1.06	7.15E-01	1.00E00
immune system development (GO:0002520)	414	12	11.35	+	1.06	7.59E-01	1.00E00
small molecule catabolic process (GO:0044282)	207	6	5.68	+	1.06	8.29E-01	1.00E00
regulation of protein transport (GO:0051223)	311	9	8.53	+	1.06	8.59E-01	1.00E00
developmental process involved in reproduction (GO:0003006)	553	16	15.16	+	1.06	7.88E-01	1.00E00
negative regulation of proteolysis (GO:0045861)	173	5	4.74	+	1.05	8.13E-01	1.00E00
tissue homeostasis (GO:0001894)	104	3	2.85	+	1.05	7.64E-01	1.00E00
limb development (GO:0060173)	104	3	2.85	+	1.05	7.64E-01	1.00E00
appendage development (GO:0048736)	104	3	2.85	+	1.05	7.64E-01	1.00E00
regulation of dephosphorylation (GO:0035303)	104	3	2.85	+	1.05	7.64E-01	1.00E00
negative regulation of apoptotic signaling pathway (GO:2001234)	139	4	3.81	+	1.05	7.94E-01	1.00E00
negative regulation of multicellular organismal process (GO:0051241)	556	16	15.25	+	1.05	7.89E-01	1.00E00
positive regulation of kinase activity (GO:0033674)	279	8	7.65	+	1.05	8.52E-01	1.00E00
negative regulation of cell population proliferation (GO:0008285)	384	11	10.53	+	1.04	8.73E-01	1.00E00
chromosome segregation (GO:0007059)	210	6	5.76	+	1.04	8.30E-01	1.00E00
regulation of catalytic activity (GO:0050790)	1085	31	29.75	+	1.04	7.68E-01	1.00E00
regulation of exocytosis (GO:0017157)	105	3	2.88	+	1.04	7.66E-01	1.00E00
ADP metabolic process (GO:0046031)	35	1	.96	+	1.04	6.23E-01	1.00E00
negative regulation of cytokine-mediated signaling pathway (GO:0001960)	35	1	.96	+	1.04	6.23E-01	1.00E00
modulation by host of symbiont process (GO:0051851)	35	1	.96	+	1.04	6.23E-01	1.00E00
positive regulation of RNA splicing (GO:0033120)	35	1	.96	+	1.04	6.23E-01	1.00E00
regulation of response to endoplasmic reticulum stress (GO:1905897)	35	1	.96	+	1.04	6.23E-01	1.00E00
detection of stimulus involved in sensory perception (GO:0050906)	35	1	.96	+	1.04	6.23E-01	1.00E00
positive regulation of oxidoreductase activity (GO:0051353)	35	1	.96	+	1.04	6.23E-01	1.00E00
regulation of vacuole organization (GO:0044088)	35	1	.96	+	1.04	6.23E-01	1.00E00
endothelial cell migration (GO:0043542)	35	1	.96	+	1.04	6.23E-01	1.00E00
spliceosomal complex assembly (GO:0000245)	35	1	.96	+	1.04	6.23E-01	1.00E00
G2/M transition of mitotic cell cycle (GO:0000086)	35	1	.96	+	1.04	6.23E-01	1.00E00
tRNA aminoacylation (GO:0043039)	35	1	.96	+	1.04	6.23E-01	1.00E00
amino acid activation (GO:0043038)	35	1	.96	+	1.04	6.23E-01	1.00E00
positive regulation of protein localization to cell periphery (GO:1904377)	35	1	.96	+	1.04	6.23E-01	1.00E00
photoreceptor cell development (GO:0042461)	35	1	.96	+	1.04	6.23E-01	1.00E00
positive regulation of protein import into nucleus (GO:0042307)	35	1	.96	+	1.04	6.23E-01	1.00E00
negative regulation of endothelial cell migration (GO:0010596)	35	1	.96	+	1.04	6.23E-01	1.00E00
myeloid cell differentiation (GO:0030099)	140	4	3.84	+	1.04	7.95E-01	1.00E00
regulation of immunoglobulin mediated immune response (GO:0002889)	35	1	.96	+	1.04	6.23E-01	1.00E00
cellular monovalent inorganic cation homeostasis (GO:0030004)	35	1	.96	+	1.04	6.23E-01	1.00E00
negative regulation of carbohydrate metabolic process (GO:0045912)	35	1	.96	+	1.04	6.23E-01	1.00E00
protein localization to vacuole (GO:0072665)	35	1	.96	+	1.04	6.23E-01	1.00E00
regulation of B cell mediated immunity (GO:0002712)	35	1	.96	+	1.04	6.23E-01	1.00E00
chaperone-mediated protein folding (GO:0061077)	35	1	.96	+	1.04	6.23E-01	1.00E00
regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893)	35	1	.96	+	1.04	6.23E-01	1.00E00
cellular biosynthetic process (GO:0044249)	1156	33	31.70	+	1.04	7.74E-01	1.00E00
regulation of ion transport (GO:0043269)	631	18	17.30	+	1.04	8.01E-01	1.00E00
response to hormone (GO:0009725)	316	9	8.67	+	1.04	8.60E-01	1.00E00
regulation of apoptotic process (GO:0042981)	843	24	23.12	+	1.04	8.25E-01	1.00E00
positive regulation of anion transport (GO:1903793)	281	8	7.71	+	1.04	8.52E-01	1.00E00
regulation of catabolic process (GO:0009894)	565	16	15.49	+	1.03	8.94E-01	1.00E00
RNA transport (GO:0050658)	106	3	2.91	+	1.03	7.68E-01	1.00E00
nucleic acid transport (GO:0050657)	106	3	2.91	+	1.03	7.68E-01	1.00E00
regulation of kinase activity (GO:0043549)	460	13	12.61	+	1.03	8.83E-01	1.00E00
positive regulation of secretion by cell (GO:1903532)	177	5	4.85	+	1.03	8.17E-01	1.00E00
nitrogen compound transport (GO:0071705)	816	23	22.38	+	1.03	9.11E-01	1.00E00
protein-containing complex disassembly (GO:0032984)	71	2	1.95	+	1.03	7.22E-01	1.00E00
activation of protein kinase activity (GO:0032147)	142	4	3.89	+	1.03	7.97E-01	1.00E00
male gamete generation (GO:0048232)	320	9	8.78	+	1.03	8.62E-01	1.00E00
multicellular organismal reproductive process (GO:0048609)	463	13	12.70	+	1.02	8.84E-01	1.00E00
regulation of response to external stimulus (GO:0032101)	429	12	11.76	+	1.02	8.80E-01	1.00E00
cellular response to endogenous stimulus (GO:0071495)	501	14	13.74	+	1.02	8.88E-01	1.00E00
regulation of programmed cell death (GO:0043067)	861	24	23.61	+	1.02	9.13E-01	1.00E00
biosynthetic process (GO:0009058)	1220	34	33.45	+	1.02	9.25E-01	1.00E00
multicellular organism reproduction (GO:0032504)	467	13	12.81	+	1.02	8.85E-01	1.00E00
positive regulation of response to wounding (GO:1903036)	36	1	.99	+	1.01	1.00E00	1.00E00
cell killing (GO:0001906)	36	1	.99	+	1.01	1.00E00	1.00E00
lymphocyte homeostasis (GO:0002260)	36	1	.99	+	1.01	1.00E00	1.00E00
kidney epithelium development (GO:0072073)	72	2	1.97	+	1.01	1.00E00	1.00E00
meiotic chromosome segregation (GO:0045132)	72	2	1.97	+	1.01	1.00E00	1.00E00
regulation of organelle assembly (GO:1902115)	144	4	3.95	+	1.01	8.00E-01	1.00E00
regulation of mitotic sister chromatid segregation (GO:0033047)	36	1	.99	+	1.01	1.00E00	1.00E00
cellular response to biotic stimulus (GO:0071216)	108	3	2.96	+	1.01	1.00E00	1.00E00
establishment of spindle localization (GO:0051293)	36	1	.99	+	1.01	1.00E00	1.00E00
establishment of RNA localization (GO:0051236)	108	3	2.96	+	1.01	1.00E00	1.00E00
cellular protein complex disassembly (GO:0043624)	36	1	.99	+	1.01	1.00E00	1.00E00
response to topologically incorrect protein (GO:0035966)	72	2	1.97	+	1.01	1.00E00	1.00E00
steroid hormone mediated signaling pathway (GO:0043401)	36	1	.99	+	1.01	1.00E00	1.00E00
negative regulation of microtubule polymerization or depolymerization (GO:0031111)	36	1	.99	+	1.01	1.00E00	1.00E00
cardiac muscle tissue morphogenesis (GO:0055008)	36	1	.99	+	1.01	1.00E00	1.00E00
nucleoside triphosphate biosynthetic process (GO:0009142)	36	1	.99	+	1.01	1.00E00	1.00E00
leukocyte chemotaxis (GO:0030595)	36	1	.99	+	1.01	1.00E00	1.00E00
regulation of membrane potential (GO:0042391)	144	4	3.95	+	1.01	8.00E-01	1.00E00
gene silencing by miRNA (GO:0035195)	36	1	.99	+	1.01	1.00E00	1.00E00
proteasomal protein catabolic process (GO:0010498)	216	6	5.92	+	1.01	8.35E-01	1.00E00
organic substance transport (GO:0071702)	907	25	24.87	+	1.01	9.15E-01	1.00E00
negative regulation of protein phosphorylation (GO:0001933)	218	6	5.98	+	1.00	1.00E00	1.00E00
nucleobase-containing compound transport (GO:0015931)	109	3	2.99	+	1.00	1.00E00	1.00E00
organelle assembly (GO:0070925)	509	14	13.96	+	1.00	1.00E00	1.00E00
positive regulation of secretion (GO:0051047)	182	5	4.99	+	1.00	1.00E00	1.00E00
regulation of translation (GO:0006417)	255	7	6.99	+	1.00	1.00E00	1.00E00
positive regulation of chromosome organization (GO:2001252)	146	4	4.00	-	1.00	1.00E00	1.00E00
regulation of mitotic nuclear division (GO:0007088)	73	2	2.00	-	1.00	1.00E00	1.00E00
cytokinesis (GO:0000910)	73	2	2.00	-	1.00	1.00E00	1.00E00
regulation of protein localization to cell periphery (GO:1904375)	73	2	2.00	-	1.00	1.00E00	1.00E00
cellular catabolic process (GO:0044248)	953	26	26.13	-	.99	1.00E00	1.00E00
biological_process (GO:0008150)	9128	249	250.31	-	.99	6.00E-01	1.00E00
ribosome biogenesis (GO:0042254)	220	6	6.03	-	.99	1.00E00	1.00E00
anion transport (GO:0006820)	918	25	25.17	-	.99	1.00E00	1.00E00
regulation of cell population proliferation (GO:0042127)	918	25	25.17	-	.99	1.00E00	1.00E00
establishment of localization (GO:0051234)	1580	43	43.33	-	.99	1.00E00	1.00E00
gene expression (GO:0010467)	1251	34	34.30	-	.99	1.00E00	1.00E00
organic substance biosynthetic process (GO:1901576)	1180	32	32.36	-	.99	1.00E00	1.00E00
regulation of protein metabolic process (GO:0051246)	1478	40	40.53	-	.99	1.00E00	1.00E00
positive regulation of protein metabolic process (GO:0051247)	850	23	23.31	-	.99	1.00E00	1.00E00
endochondral bone morphogenesis (GO:0060350)	37	1	1.01	-	.99	1.00E00	1.00E00
regulation of cell-matrix adhesion (GO:0001952)	74	2	2.03	-	.99	1.00E00	1.00E00
endothelial cell differentiation (GO:0045446)	37	1	1.01	-	.99	1.00E00	1.00E00
mitochondrial transmembrane transport (GO:1990542)	37	1	1.01	-	.99	1.00E00	1.00E00
regulation of G1/S transition of mitotic cell cycle (GO:2000045)	74	2	2.03	-	.99	1.00E00	1.00E00
cellular aldehyde metabolic process (GO:0006081)	37	1	1.01	-	.99	1.00E00	1.00E00
response to oxygen levels (GO:0070482)	111	3	3.04	-	.99	1.00E00	1.00E00
deoxyribonucleotide metabolic process (GO:0009262)	37	1	1.01	-	.99	1.00E00	1.00E00
negative regulation of catalytic activity (GO:0043086)	407	11	11.16	-	.99	1.00E00	1.00E00
purine ribonucleoside diphosphate metabolic process (GO:0009179)	37	1	1.01	-	.99	1.00E00	1.00E00
purine nucleoside diphosphate metabolic process (GO:0009135)	37	1	1.01	-	.99	1.00E00	1.00E00
regulation of anion transmembrane transport (GO:1903959)	74	2	2.03	-	.99	1.00E00	1.00E00
regulation of gene silencing by miRNA (GO:0060964)	37	1	1.01	-	.99	1.00E00	1.00E00
cellular response to unfolded protein (GO:0034620)	37	1	1.01	-	.99	1.00E00	1.00E00
membrane docking (GO:0022406)	37	1	1.01	-	.99	1.00E00	1.00E00
cardiac ventricle development (GO:0003231)	74	2	2.03	-	.99	1.00E00	1.00E00
regulation of protein kinase activity (GO:0045859)	407	11	11.16	-	.99	1.00E00	1.00E00
transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169)	186	5	5.10	-	.98	1.00E00	1.00E00
response to peptide (GO:1901652)	186	5	5.10	-	.98	1.00E00	1.00E00
negative regulation of neuron death (GO:1901215)	149	4	4.09	-	.98	1.00E00	1.00E00
positive regulation of transport (GO:0051050)	485	13	13.30	-	.98	1.00E00	1.00E00
muscle system process (GO:0003012)	112	3	3.07	-	.98	1.00E00	1.00E00
negative regulation of cell cycle phase transition (GO:1901988)	112	3	3.07	-	.98	1.00E00	1.00E00
regulation of cell division (GO:0051302)	112	3	3.07	-	.98	1.00E00	1.00E00
cellular response to reactive oxygen species (GO:0034614)	75	2	2.06	-	.97	1.00E00	1.00E00
sensory perception of sound (GO:0007605)	75	2	2.06	-	.97	1.00E00	1.00E00
ion transport (GO:0006811)	1013	27	27.78	-	.97	1.00E00	1.00E00
regulation of transport (GO:0051049)	863	23	23.67	-	.97	1.00E00	1.00E00
regulation of establishment of protein localization (GO:0070201)	338	9	9.27	-	.97	1.00E00	1.00E00
regulation of molecular function (GO:0065009)	1466	39	40.20	-	.97	9.31E-01	1.00E00
transport (GO:0006810)	1467	39	40.23	-	.97	9.31E-01	1.00E00
gonad development (GO:0008406)	113	3	3.10	-	.97	1.00E00	1.00E00
muscle cell differentiation (GO:0042692)	151	4	4.14	-	.97	1.00E00	1.00E00
regulation of phosphorylation (GO:0042325)	755	20	20.70	-	.97	1.00E00	1.00E00
catabolic process (GO:0009056)	1098	29	30.11	-	.96	9.22E-01	1.00E00
vesicle budding from membrane (GO:0006900)	38	1	1.04	-	.96	1.00E00	1.00E00
regulation of response to wounding (GO:1903034)	76	2	2.08	-	.96	1.00E00	1.00E00
translational initiation (GO:0006413)	38	1	1.04	-	.96	1.00E00	1.00E00
negative regulation of nuclear division (GO:0051784)	38	1	1.04	-	.96	1.00E00	1.00E00
regulation of gluconeogenesis (GO:0006111)	38	1	1.04	-	.96	1.00E00	1.00E00
regulation of coagulation (GO:0050818)	38	1	1.04	-	.96	1.00E00	1.00E00
negative regulation of protein secretion (GO:0050709)	38	1	1.04	-	.96	1.00E00	1.00E00
establishment of protein localization to plasma membrane (GO:0061951)	38	1	1.04	-	.96	1.00E00	1.00E00
positive regulation of protein import (GO:1904591)	38	1	1.04	-	.96	1.00E00	1.00E00
purine ribonucleotide metabolic process (GO:0009150)	152	4	4.17	-	.96	1.00E00	1.00E00
regulation of substrate adhesion-dependent cell spreading (GO:1900024)	38	1	1.04	-	.96	1.00E00	1.00E00
cardiocyte differentiation (GO:0035051)	76	2	2.08	-	.96	1.00E00	1.00E00
regulation of blood coagulation (GO:0030193)	38	1	1.04	-	.96	1.00E00	1.00E00
negative regulation of response to cytokine stimulus (GO:0060761)	38	1	1.04	-	.96	1.00E00	1.00E00
negative regulation of wound healing (GO:0061045)	38	1	1.04	-	.96	1.00E00	1.00E00
regulation of biological quality (GO:0065008)	1869	49	51.25	-	.96	8.12E-01	1.00E00
regulation of cell death (GO:0010941)	954	25	26.16	-	.96	9.17E-01	1.00E00
regulation of cell migration (GO:0030334)	497	13	13.63	-	.95	1.00E00	1.00E00
positive regulation of cellular protein metabolic process (GO:0032270)	803	21	22.02	-	.95	9.10E-01	1.00E00
mitotic cell cycle (GO:0000278)	421	11	11.54	-	.95	1.00E00	1.00E00
anatomical structure maturation (GO:0071695)	115	3	3.15	-	.95	1.00E00	1.00E00
development of primary sexual characteristics (GO:0045137)	115	3	3.15	-	.95	1.00E00	1.00E00
negative regulation of supramolecular fiber organization (GO:1902904)	115	3	3.15	-	.95	1.00E00	1.00E00
cellular macromolecule biosynthetic process (GO:0034645)	691	18	18.95	-	.95	9.04E-01	1.00E00
small molecule biosynthetic process (GO:0044283)	269	7	7.38	-	.95	1.00E00	1.00E00
sulfur compound metabolic process (GO:0006790)	154	4	4.22	-	.95	1.00E00	1.00E00
nuclear-transcribed mRNA catabolic process (GO:0000956)	77	2	2.11	-	.95	1.00E00	1.00E00
protein processing (GO:0016485)	77	2	2.11	-	.95	1.00E00	1.00E00
microtubule organizing center organization (GO:0031023)	77	2	2.11	-	.95	1.00E00	1.00E00
negative regulation of secretion by cell (GO:1903531)	77	2	2.11	-	.95	1.00E00	1.00E00
regulation of cellular protein metabolic process (GO:0032268)	1388	36	38.06	-	.95	7.90E-01	1.00E00
DNA conformation change (GO:0071103)	116	3	3.18	-	.94	1.00E00	1.00E00
negative regulation of DNA-binding transcription factor activity (GO:0043433)	116	3	3.18	-	.94	1.00E00	1.00E00
macromolecule biosynthetic process (GO:0009059)	696	18	19.09	-	.94	9.04E-01	1.00E00
macromolecule localization (GO:0033036)	1315	34	36.06	-	.94	7.85E-01	1.00E00
negative regulation of molecular function (GO:0044092)	619	16	16.97	-	.94	8.99E-01	1.00E00
regulation of protein phosphorylation (GO:0001932)	658	17	18.04	-	.94	9.02E-01	1.00E00
regulation of phosphate metabolic process (GO:0019220)	852	22	23.36	-	.94	9.12E-01	1.00E00
regulation of phosphorus metabolic process (GO:0051174)	852	22	23.36	-	.94	9.12E-01	1.00E00
organonitrogen compound catabolic process (GO:1901565)	620	16	17.00	-	.94	8.99E-01	1.00E00
blood circulation (GO:0008015)	155	4	4.25	-	.94	1.00E00	1.00E00
peripheral nervous system development (GO:0007422)	39	1	1.07	-	.94	1.00E00	1.00E00
heart process (GO:0003015)	39	1	1.07	-	.94	1.00E00	1.00E00
homologous chromosome pairing at meiosis (GO:0007129)	39	1	1.07	-	.94	1.00E00	1.00E00
cell cycle G2/M phase transition (GO:0044839)	39	1	1.07	-	.94	1.00E00	1.00E00
multi-organism reproductive process (GO:0044703)	507	13	13.90	-	.94	1.00E00	1.00E00
protein glycosylation (GO:0006486)	39	1	1.07	-	.94	1.00E00	1.00E00
regulation of interleukin-2 production (GO:0032663)	39	1	1.07	-	.94	1.00E00	1.00E00
mitochondrial translation (GO:0032543)	39	1	1.07	-	.94	1.00E00	1.00E00
carbohydrate derivative biosynthetic process (GO:1901137)	156	4	4.28	-	.94	1.00E00	1.00E00
cellular response to hydrogen peroxide (GO:0070301)	39	1	1.07	-	.94	1.00E00	1.00E00
regulation of alternative mRNA splicing, via spliceosome (GO:0000381)	39	1	1.07	-	.94	1.00E00	1.00E00
positive regulation of DNA metabolic process (GO:0051054)	156	4	4.28	-	.94	1.00E00	1.00E00
macromolecule glycosylation (GO:0043413)	39	1	1.07	-	.94	1.00E00	1.00E00
iron ion homeostasis (GO:0055072)	39	1	1.07	-	.94	1.00E00	1.00E00
cardiac muscle cell development (GO:0055013)	39	1	1.07	-	.94	1.00E00	1.00E00
negative regulation of neuron projection development (GO:0010977)	78	2	2.14	-	.94	1.00E00	1.00E00
regulation of hemostasis (GO:1900046)	39	1	1.07	-	.94	1.00E00	1.00E00
lymphocyte proliferation (GO:0046651)	39	1	1.07	-	.94	1.00E00	1.00E00
heterocycle catabolic process (GO:0046700)	196	5	5.37	-	.93	1.00E00	1.00E00
sensory organ morphogenesis (GO:0090596)	157	4	4.31	-	.93	1.00E00	1.00E00
multicellular organismal homeostasis (GO:0048871)	157	4	4.31	-	.93	1.00E00	1.00E00
regulation of carbohydrate metabolic process (GO:0006109)	118	3	3.24	-	.93	1.00E00	1.00E00
meiotic nuclear division (GO:0140013)	118	3	3.24	-	.93	1.00E00	1.00E00
positive regulation of signal transduction (GO:0009967)	787	20	21.58	-	.93	8.20E-01	1.00E00
positive regulation of hydrolase activity (GO:0051345)	315	8	8.64	-	.93	1.00E00	1.00E00
eye development (GO:0001654)	197	5	5.40	-	.93	1.00E00	1.00E00
microtubule cytoskeleton organization (GO:0000226)	394	10	10.80	-	.93	1.00E00	1.00E00
positive regulation of phosphorylation (GO:0042327)	473	12	12.97	-	.93	8.86E-01	1.00E00
positive regulation of ion transport (GO:0043270)	355	9	9.73	-	.92	1.00E00	1.00E00
vascular process in circulatory system (GO:0003018)	79	2	2.17	-	.92	1.00E00	1.00E00
rRNA processing (GO:0006364)	158	4	4.33	-	.92	1.00E00	1.00E00
double-strand break repair via homologous recombination (GO:0000724)	79	2	2.17	-	.92	1.00E00	1.00E00
cellular process (GO:0009987)	7348	186	201.50	-	.92	2.81E-02	1.00E00
visual system development (GO:0150063)	198	5	5.43	-	.92	1.00E00	1.00E00
negative regulation of phosphorus metabolic process (GO:0010563)	317	8	8.69	-	.92	1.00E00	1.00E00
negative regulation of phosphate metabolic process (GO:0045936)	317	8	8.69	-	.92	1.00E00	1.00E00
negative regulation of cytoskeleton organization (GO:0051494)	119	3	3.26	-	.92	1.00E00	1.00E00
multi-organism process (GO:0051704)	516	13	14.15	-	.92	8.90E-01	1.00E00
establishment of localization in cell (GO:0051649)	913	23	25.04	-	.92	7.49E-01	1.00E00
regulation of cellular response to growth factor stimulus (GO:0090287)	159	4	4.36	-	.92	1.00E00	1.00E00
positive regulation of growth (GO:0045927)	159	4	4.36	-	.92	1.00E00	1.00E00
cellular protein localization (GO:0034613)	875	22	23.99	-	.92	7.45E-01	1.00E00
regulation of small molecule metabolic process (GO:0062012)	199	5	5.46	-	.92	1.00E00	1.00E00
regulation of myoblast differentiation (GO:0045661)	40	1	1.10	-	.91	1.00E00	1.00E00
multicellular organismal response to stress (GO:0033555)	40	1	1.10	-	.91	1.00E00	1.00E00
gamete generation (GO:0007276)	400	10	10.97	-	.91	8.76E-01	1.00E00
regulation of posttranscriptional gene silencing (GO:0060147)	40	1	1.10	-	.91	1.00E00	1.00E00
mononuclear cell proliferation (GO:0032943)	40	1	1.10	-	.91	1.00E00	1.00E00
regulation of translational initiation (GO:0006446)	40	1	1.10	-	.91	1.00E00	1.00E00
regulation of focal adhesion assembly (GO:0051893)	40	1	1.10	-	.91	1.00E00	1.00E00
maintenance of protein location in cell (GO:0032507)	40	1	1.10	-	.91	1.00E00	1.00E00
spindle localization (GO:0051653)	40	1	1.10	-	.91	1.00E00	1.00E00
sensory system development (GO:0048880)	200	5	5.48	-	.91	1.00E00	1.00E00
exocytic process (GO:0140029)	40	1	1.10	-	.91	1.00E00	1.00E00
recombinational repair (GO:0000725)	80	2	2.19	-	.91	1.00E00	1.00E00
aminoglycan metabolic process (GO:0006022)	40	1	1.10	-	.91	1.00E00	1.00E00
regulation of cell-substrate junction assembly (GO:0090109)	40	1	1.10	-	.91	1.00E00	1.00E00
positive regulation of neuron apoptotic process (GO:0043525)	40	1	1.10	-	.91	1.00E00	1.00E00
regulation of morphogenesis of an epithelium (GO:1905330)	40	1	1.10	-	.91	1.00E00	1.00E00
positive regulation of receptor-mediated endocytosis (GO:0048260)	40	1	1.10	-	.91	1.00E00	1.00E00
response to temperature stimulus (GO:0009266)	80	2	2.19	-	.91	1.00E00	1.00E00
ribonucleoside diphosphate metabolic process (GO:0009185)	40	1	1.10	-	.91	1.00E00	1.00E00
positive regulation of histone modification (GO:0031058)	80	2	2.19	-	.91	1.00E00	1.00E00
lipid catabolic process (GO:0016042)	160	4	4.39	-	.91	1.00E00	1.00E00
regulation of morphogenesis of a branching structure (GO:0060688)	40	1	1.10	-	.91	1.00E00	1.00E00
cardiac ventricle morphogenesis (GO:0003208)	40	1	1.10	-	.91	1.00E00	1.00E00
cell communication (GO:0007154)	1881	47	51.58	-	.91	5.28E-01	1.00E00
cellular macromolecule localization (GO:0070727)	883	22	24.21	-	.91	7.45E-01	1.00E00
ncRNA processing (GO:0034470)	281	7	7.71	-	.91	1.00E00	1.00E00
signaling (GO:0023052)	1812	45	49.69	-	.91	5.22E-01	1.00E00
regulation of muscle system process (GO:0090257)	121	3	3.32	-	.90	1.00E00	1.00E00
regulation of localization (GO:0032879)	1412	35	38.72	-	.90	5.96E-01	1.00E00
cellular response to cytokine stimulus (GO:0071345)	323	8	8.86	-	.90	1.00E00	1.00E00
cellular component organization (GO:0016043)	2988	74	81.94	-	.90	3.10E-01	1.00E00
regulation of cell motility (GO:2000145)	525	13	14.40	-	.90	8.90E-01	1.00E00
regulation of cellular amide metabolic process (GO:0034248)	283	7	7.76	-	.90	1.00E00	1.00E00
regulation of transferase activity (GO:0051338)	526	13	14.42	-	.90	8.90E-01	1.00E00
negative regulation of apoptotic process (GO:0043066)	526	13	14.42	-	.90	8.90E-01	1.00E00
cellular response to organic substance (GO:0071310)	931	23	25.53	-	.90	6.73E-01	1.00E00
circulatory system process (GO:0003013)	162	4	4.44	-	.90	1.00E00	1.00E00
muscle contraction (GO:0006936)	81	2	2.22	-	.90	1.00E00	1.00E00
positive regulation of protein serine/threonine kinase activity (GO:0071902)	162	4	4.44	-	.90	1.00E00	1.00E00
DNA packaging (GO:0006323)	81	2	2.22	-	.90	1.00E00	1.00E00
response to wounding (GO:0009611)	162	4	4.44	-	.90	1.00E00	1.00E00
embryonic limb morphogenesis (GO:0030326)	81	2	2.22	-	.90	1.00E00	1.00E00
embryonic appendage morphogenesis (GO:0035113)	81	2	2.22	-	.90	1.00E00	1.00E00
organelle organization (GO:0006996)	2107	52	57.78	-	.90	4.49E-01	1.00E00
signal transduction (GO:0007165)	1703	42	46.70	-	.90	5.12E-01	1.00E00
cellular component organization or biogenesis (GO:0071840)	3143	77	86.19	-	.89	2.56E-01	1.00E00
response to stress (GO:0006950)	1633	40	44.78	-	.89	5.05E-01	1.00E00
regulation of multicellular organismal process (GO:0051239)	1391	34	38.14	-	.89	5.33E-01	1.00E00
response to lipopolysaccharide (GO:0032496)	123	3	3.37	-	.89	1.00E00	1.00E00
protein stabilization (GO:0050821)	123	3	3.37	-	.89	1.00E00	1.00E00
locomotory behavior (GO:0007626)	123	3	3.37	-	.89	1.00E00	1.00E00
germ cell development (GO:0007281)	164	4	4.50	-	.89	1.00E00	1.00E00
pattern recognition receptor signaling pathway (GO:0002221)	41	1	1.12	-	.89	1.00E00	1.00E00
somitogenesis (GO:0001756)	41	1	1.12	-	.89	1.00E00	1.00E00
nucleoside diphosphate phosphorylation (GO:0006165)	41	1	1.12	-	.89	1.00E00	1.00E00
generation of precursor metabolites and energy (GO:0006091)	164	4	4.50	-	.89	1.00E00	1.00E00
positive regulation of transferase activity (GO:0051347)	328	8	8.99	-	.89	8.64E-01	1.00E00
negative regulation of canonical Wnt signaling pathway (GO:0090090)	82	2	2.25	-	.89	1.00E00	1.00E00
negative regulation of muscle cell differentiation (GO:0051148)	41	1	1.12	-	.89	1.00E00	1.00E00
actin cytoskeleton reorganization (GO:0031532)	41	1	1.12	-	.89	1.00E00	1.00E00
mRNA splicing, via spliceosome (GO:0000398)	164	4	4.50	-	.89	1.00E00	1.00E00
RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)	164	4	4.50	-	.89	1.00E00	1.00E00
RNA splicing, via transesterification reactions (GO:0000375)	164	4	4.50	-	.89	1.00E00	1.00E00
regulation of generation of precursor metabolites and energy (GO:0043467)	82	2	2.25	-	.89	1.00E00	1.00E00
embryonic digit morphogenesis (GO:0042733)	41	1	1.12	-	.89	1.00E00	1.00E00
microtubule polymerization or depolymerization (GO:0031109)	41	1	1.12	-	.89	1.00E00	1.00E00
actomyosin structure organization (GO:0031032)	82	2	2.25	-	.89	1.00E00	1.00E00
chromatin organization involved in negative regulation of transcription (GO:0097549)	41	1	1.12	-	.89	1.00E00	1.00E00
regulation of centrosome duplication (GO:0010824)	41	1	1.12	-	.89	1.00E00	1.00E00
positive regulation of cell-substrate adhesion (GO:0010811)	82	2	2.25	-	.89	1.00E00	1.00E00
regulation of gene silencing by RNA (GO:0060966)	41	1	1.12	-	.89	1.00E00	1.00E00
endosome to lysosome transport (GO:0008333)	41	1	1.12	-	.89	1.00E00	1.00E00
establishment of cell polarity (GO:0030010)	82	2	2.25	-	.89	1.00E00	1.00E00
reproductive process (GO:0022414)	780	19	21.39	-	.89	7.30E-01	1.00E00
reproduction (GO:0000003)	781	19	21.42	-	.89	7.31E-01	1.00E00
cellular nitrogen compound biosynthetic process (GO:0044271)	740	18	20.29	-	.89	7.24E-01	1.00E00
cellular response to chemical stimulus (GO:0070887)	1152	28	31.59	-	.89	5.63E-01	1.00E00
regulation of protein localization (GO:0032880)	535	13	14.67	-	.89	7.85E-01	1.00E00
regulation of cell growth (GO:0001558)	247	6	6.77	-	.89	1.00E00	1.00E00
response to stimulus (GO:0050896)	3379	82	92.66	-	.88	1.89E-01	1.00E00
response to cytokine (GO:0034097)	371	9	10.17	-	.88	8.71E-01	1.00E00
organic substance metabolic process (GO:0071704)	4164	101	114.18	-	.88	1.13E-01	1.00E00
negative regulation of programmed cell death (GO:0043069)	536	13	14.70	-	.88	7.85E-01	1.00E00
rRNA metabolic process (GO:0016072)	165	4	4.52	-	.88	1.00E00	1.00E00
metabolic process (GO:0008152)	4379	106	120.08	-	.88	8.81E-02	1.00E00
developmental growth (GO:0048589)	248	6	6.80	-	.88	1.00E00	1.00E00
negative regulation of organelle organization (GO:0010639)	248	6	6.80	-	.88	1.00E00	1.00E00
cellular response to lipid (GO:0071396)	207	5	5.68	-	.88	1.00E00	1.00E00
cellular amide metabolic process (GO:0043603)	373	9	10.23	-	.88	8.71E-01	1.00E00
regulation of DNA replication (GO:0006275)	83	2	2.28	-	.88	1.00E00	1.00E00
homeostasis of number of cells (GO:0048872)	166	4	4.55	-	.88	1.00E00	1.00E00
regulation of lipid transport (GO:0032368)	83	2	2.28	-	.88	1.00E00	1.00E00
regulation of nucleocytoplasmic transport (GO:0046822)	83	2	2.28	-	.88	1.00E00	1.00E00
learning (GO:0007612)	83	2	2.28	-	.88	1.00E00	1.00E00
mitotic cell cycle process (GO:1903047)	374	9	10.26	-	.88	8.71E-01	1.00E00
aromatic compound catabolic process (GO:0019439)	208	5	5.70	-	.88	1.00E00	1.00E00
organic substance catabolic process (GO:1901575)	957	23	26.24	-	.88	6.01E-01	1.00E00
regulation of locomotion (GO:0040012)	541	13	14.84	-	.88	7.85E-01	1.00E00
cilium organization (GO:0044782)	250	6	6.86	-	.88	1.00E00	1.00E00
positive regulation of protein kinase activity (GO:0045860)	250	6	6.86	-	.88	1.00E00	1.00E00
purine nucleotide metabolic process (GO:0006163)	167	4	4.58	-	.87	1.00E00	1.00E00
nuclear chromosome segregation (GO:0098813)	167	4	4.58	-	.87	1.00E00	1.00E00
localization (GO:0051179)	2216	53	60.77	-	.87	2.97E-01	1.00E00
macromolecule catabolic process (GO:0009057)	586	14	16.07	-	.87	6.95E-01	1.00E00
posttranscriptional regulation of gene expression (GO:0010608)	335	8	9.19	-	.87	8.64E-01	1.00E00
positive regulation of cell communication (GO:0010647)	880	21	24.13	-	.87	5.87E-01	1.00E00
organophosphate biosynthetic process (GO:0090407)	210	5	5.76	-	.87	1.00E00	1.00E00
amide transport (GO:0042886)	756	18	20.73	-	.87	6.41E-01	1.00E00
regulation of osteoblast differentiation (GO:0045667)	84	2	2.30	-	.87	1.00E00	1.00E00
positive regulation of fat cell differentiation (GO:0045600)	42	1	1.15	-	.87	1.00E00	1.00E00
positive regulation of protein acetylation (GO:1901985)	42	1	1.15	-	.87	1.00E00	1.00E00
RNA localization (GO:0006403)	126	3	3.46	-	.87	1.00E00	1.00E00
cellular response to interleukin-1 (GO:0071347)	42	1	1.15	-	.87	1.00E00	1.00E00
cellular response to peptide (GO:1901653)	126	3	3.46	-	.87	1.00E00	1.00E00
sensory perception of mechanical stimulus (GO:0050954)	84	2	2.30	-	.87	1.00E00	1.00E00
positive regulation of viral process (GO:0048524)	42	1	1.15	-	.87	1.00E00	1.00E00
striated muscle cell differentiation (GO:0051146)	126	3	3.46	-	.87	1.00E00	1.00E00
regulation of potassium ion transport (GO:0043266)	42	1	1.15	-	.87	1.00E00	1.00E00
receptor metabolic process (GO:0043112)	42	1	1.15	-	.87	1.00E00	1.00E00
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146)	42	1	1.15	-	.87	1.00E00	1.00E00
ribonucleotide metabolic process (GO:0009259)	168	4	4.61	-	.87	1.00E00	1.00E00
cardiac cell development (GO:0055006)	42	1	1.15	-	.87	1.00E00	1.00E00
camera-type eye development (GO:0043010)	168	4	4.61	-	.87	1.00E00	1.00E00
adult behavior (GO:0030534)	84	2	2.30	-	.87	1.00E00	1.00E00
post-transcriptional gene silencing by RNA (GO:0035194)	42	1	1.15	-	.87	1.00E00	1.00E00
ribosome assembly (GO:0042255)	42	1	1.15	-	.87	1.00E00	1.00E00
gliogenesis (GO:0042063)	126	3	3.46	-	.87	1.00E00	1.00E00
biological regulation (GO:0065007)	5893	140	161.60	-	.87	7.64E-03	1.00E00
positive regulation of signaling (GO:0023056)	884	21	24.24	-	.87	5.88E-01	1.00E00
ncRNA metabolic process (GO:0034660)	337	8	9.24	-	.87	8.64E-01	1.00E00
positive regulation of cellular metabolic process (GO:0031325)	1939	46	53.17	-	.87	3.10E-01	1.00E00
growth (GO:0040007)	253	6	6.94	-	.86	1.00E00	1.00E00
sexual reproduction (GO:0019953)	464	11	12.72	-	.86	7.70E-01	1.00E00
positive regulation of multicellular organismal process (GO:0051240)	760	18	20.84	-	.86	6.42E-01	1.00E00
positive regulation of MAP kinase activity (GO:0043406)	127	3	3.48	-	.86	1.00E00	1.00E00
positive regulation of molecular function (GO:0044093)	847	20	23.23	-	.86	5.80E-01	1.00E00
cellular metabolic process (GO:0044237)	3991	94	109.44	-	.86	5.59E-02	1.00E00
positive regulation of catalytic activity (GO:0043085)	637	15	17.47	-	.86	6.16E-01	1.00E00
negative regulation of secretion (GO:0051048)	85	2	2.33	-	.86	1.00E00	1.00E00
regulation of glucose metabolic process (GO:0010906)	85	2	2.33	-	.86	1.00E00	1.00E00
positive regulation of mitotic cell cycle (GO:0045931)	85	2	2.33	-	.86	1.00E00	1.00E00
cytoskeleton organization (GO:0007010)	809	19	22.18	-	.86	5.73E-01	1.00E00
cellular nitrogen compound metabolic process (GO:0034641)	1959	46	53.72	-	.86	2.76E-01	1.00E00
carbohydrate metabolic process (GO:0005975)	213	5	5.84	-	.86	1.00E00	1.00E00
meiotic cell cycle process (GO:1903046)	128	3	3.51	-	.85	1.00E00	1.00E00
negative regulation of anion transport (GO:1903792)	128	3	3.51	-	.85	1.00E00	1.00E00
response to organic cyclic compound (GO:0014070)	299	7	8.20	-	.85	8.57E-01	1.00E00
glycerolipid metabolic process (GO:0046486)	171	4	4.69	-	.85	1.00E00	1.00E00
positive regulation of phosphorus metabolic process (GO:0010562)	513	12	14.07	-	.85	6.77E-01	1.00E00
positive regulation of phosphate metabolic process (GO:0045937)	513	12	14.07	-	.85	6.77E-01	1.00E00
positive regulation of protein phosphorylation (GO:0001934)	428	10	11.74	-	.85	7.61E-01	1.00E00
response to extracellular stimulus (GO:0009991)	214	5	5.87	-	.85	1.00E00	1.00E00
cellular localization (GO:0051641)	1286	30	35.26	-	.85	4.07E-01	1.00E00
regulation of response to stress (GO:0080134)	686	16	18.81	-	.85	6.26E-01	1.00E00
regulation of cell communication (GO:0010646)	1759	41	48.24	-	.85	2.92E-01	1.00E00
positive regulation of apoptotic signaling pathway (GO:2001235)	86	2	2.36	-	.85	1.00E00	1.00E00
JNK cascade (GO:0007254)	43	1	1.18	-	.85	1.00E00	1.00E00
DNA methylation or demethylation (GO:0044728)	43	1	1.18	-	.85	1.00E00	1.00E00
cellular response to interferon-gamma (GO:0071346)	43	1	1.18	-	.85	1.00E00	1.00E00
histone H4 acetylation (GO:0043967)	43	1	1.18	-	.85	1.00E00	1.00E00
regulation of mRNA stability (GO:0043488)	86	2	2.36	-	.85	1.00E00	1.00E00
detection of abiotic stimulus (GO:0009582)	43	1	1.18	-	.85	1.00E00	1.00E00
detection of external stimulus (GO:0009581)	43	1	1.18	-	.85	1.00E00	1.00E00
negative regulation of actin filament polymerization (GO:0030837)	43	1	1.18	-	.85	1.00E00	1.00E00
monovalent inorganic cation homeostasis (GO:0055067)	43	1	1.18	-	.85	1.00E00	1.00E00
protein localization to cilium (GO:0061512)	43	1	1.18	-	.85	1.00E00	1.00E00
photoreceptor cell differentiation (GO:0046530)	43	1	1.18	-	.85	1.00E00	1.00E00
positive regulation of mRNA catabolic process (GO:0061014)	43	1	1.18	-	.85	1.00E00	1.00E00
positive regulation of leukocyte chemotaxis (GO:0002690)	43	1	1.18	-	.85	1.00E00	1.00E00
regulation of cell cycle G1/S phase transition (GO:1902806)	86	2	2.36	-	.85	1.00E00	1.00E00
intracellular protein transport (GO:0006886)	473	11	12.97	-	.85	6.66E-01	1.00E00
regulation of signaling (GO:0023051)	1765	41	48.40	-	.85	2.58E-01	1.00E00
response to chemical (GO:0042221)	1551	36	42.53	-	.85	3.07E-01	1.00E00
positive regulation of metabolic process (GO:0009893)	2157	50	59.15	-	.85	2.01E-01	1.00E00
regulation of neuron death (GO:1901214)	216	5	5.92	-	.84	1.00E00	1.00E00
protein catabolic process (GO:0030163)	432	10	11.85	-	.84	7.62E-01	1.00E00
negative regulation of cell death (GO:0060548)	606	14	16.62	-	.84	6.07E-01	1.00E00
organonitrogen compound metabolic process (GO:1901564)	2555	59	70.06	-	.84	1.36E-01	1.00E00
establishment or maintenance of cell polarity (GO:0007163)	130	3	3.56	-	.84	1.00E00	1.00E00
negative regulation of phosphorylation (GO:0042326)	260	6	7.13	-	.84	8.47E-01	1.00E00
cellular carbohydrate metabolic process (GO:0044262)	87	2	2.39	-	.84	1.00E00	1.00E00
regulation of cellular process (GO:0050794)	5438	125	149.12	-	.84	3.33E-03	1.00E00
blood vessel morphogenesis (GO:0048514)	218	5	5.98	-	.84	8.35E-01	1.00E00
cellular protein catabolic process (GO:0044257)	393	9	10.78	-	.84	7.51E-01	1.00E00
protein localization (GO:0008104)	1179	27	32.33	-	.84	3.90E-01	1.00E00
ribose phosphate metabolic process (GO:0019693)	175	4	4.80	-	.83	1.00E00	1.00E00
response to oxidative stress (GO:0006979)	219	5	6.01	-	.83	8.35E-01	1.00E00
organic cyclic compound catabolic process (GO:1901361)	219	5	6.01	-	.83	8.35E-01	1.00E00
primary metabolic process (GO:0044238)	3906	89	107.11	-	.83	2.50E-02	1.00E00
regulation of biological process (GO:0050789)	5666	129	155.37	-	.83	1.28E-03	1.00E00
regulation of signal transduction (GO:0009966)	1584	36	43.44	-	.83	2.38E-01	1.00E00
regulation of cellular component movement (GO:0051270)	572	13	15.69	-	.83	5.96E-01	1.00E00
muscle tissue morphogenesis (GO:0060415)	44	1	1.21	-	.83	1.00E00	1.00E00
cellular response to hormone stimulus (GO:0032870)	220	5	6.03	-	.83	8.35E-01	1.00E00
protein acetylation (GO:0006473)	88	2	2.41	-	.83	1.00E00	1.00E00
negative regulation of reactive oxygen species metabolic process (GO:2000378)	44	1	1.21	-	.83	1.00E00	1.00E00
regulation of viral genome replication (GO:0045069)	44	1	1.21	-	.83	1.00E00	1.00E00
dendrite morphogenesis (GO:0048813)	44	1	1.21	-	.83	1.00E00	1.00E00
regulation of steroid biosynthetic process (GO:0050810)	44	1	1.21	-	.83	1.00E00	1.00E00
positive regulation of protein secretion (GO:0050714)	88	2	2.41	-	.83	1.00E00	1.00E00
glycosylation (GO:0070085)	44	1	1.21	-	.83	1.00E00	1.00E00
positive regulation of fibroblast proliferation (GO:0048146)	44	1	1.21	-	.83	1.00E00	1.00E00
cortical cytoskeleton organization (GO:0030865)	44	1	1.21	-	.83	1.00E00	1.00E00
mitotic sister chromatid segregation (GO:0000070)	88	2	2.41	-	.83	1.00E00	1.00E00
nucleotide phosphorylation (GO:0046939)	44	1	1.21	-	.83	1.00E00	1.00E00
regulation of centrosome cycle (GO:0046605)	44	1	1.21	-	.83	1.00E00	1.00E00
ventricular septum development (GO:0003281)	44	1	1.21	-	.83	1.00E00	1.00E00
negative regulation of peptide secretion (GO:0002792)	44	1	1.21	-	.83	1.00E00	1.00E00
cell cycle process (GO:0022402)	617	14	16.92	-	.83	6.08E-01	1.00E00
positive regulation of cellular process (GO:0048522)	3131	71	85.86	-	.83	5.24E-02	1.00E00
peptide transport (GO:0015833)	750	17	20.57	-	.83	4.84E-01	1.00E00
regulation of protein modification process (GO:0031399)	928	21	25.45	-	.83	3.98E-01	1.00E00
regulation of ion transmembrane transport (GO:0034765)	221	5	6.06	-	.83	8.35E-01	1.00E00
regulation of neuron differentiation (GO:0045664)	133	3	3.65	-	.82	1.00E00	1.00E00
regulation of transmembrane transport (GO:0034762)	222	5	6.09	-	.82	8.35E-01	1.00E00
ribonucleoprotein complex biogenesis (GO:0022613)	311	7	8.53	-	.82	7.25E-01	1.00E00
nitrogen compound metabolic process (GO:0006807)	3647	82	100.01	-	.82	2.34E-02	1.00E00
response to organic substance (GO:0010033)	1201	27	32.93	-	.82	2.98E-01	1.00E00
regulation of innate immune response (GO:0045088)	89	2	2.44	-	.82	1.00E00	1.00E00
regulation of protein serine/threonine kinase activity (GO:0071900)	267	6	7.32	-	.82	8.48E-01	1.00E00
regulation of DNA metabolic process (GO:0051052)	267	6	7.32	-	.82	8.48E-01	1.00E00
positive regulation of nitrogen compound metabolic process (GO:0051173)	1830	41	50.18	-	.82	1.74E-01	1.00E00
regulation of cell-substrate adhesion (GO:0010810)	134	3	3.67	-	.82	1.00E00	1.00E00
nucleobase-containing compound catabolic process (GO:0034655)	179	4	4.91	-	.81	1.00E00	1.00E00
cilium assembly (GO:0060271)	224	5	6.14	-	.81	8.35E-01	1.00E00
nuclear division (GO:0000280)	224	5	6.14	-	.81	8.35E-01	1.00E00
positive regulation of protein catabolic process (GO:0045732)	135	3	3.70	-	.81	1.00E00	1.00E00
SMAD protein signal transduction (GO:0060395)	45	1	1.23	-	.81	1.00E00	1.00E00
ERAD pathway (GO:0036503)	45	1	1.23	-	.81	1.00E00	1.00E00
signal transduction in response to DNA damage (GO:0042770)	45	1	1.23	-	.81	1.00E00	1.00E00
regulation of cell-substrate junction organization (GO:0150116)	45	1	1.23	-	.81	1.00E00	1.00E00
limb morphogenesis (GO:0035108)	90	2	2.47	-	.81	1.00E00	1.00E00
appendage morphogenesis (GO:0035107)	90	2	2.47	-	.81	1.00E00	1.00E00
myofibril assembly (GO:0030239)	45	1	1.23	-	.81	1.00E00	1.00E00
cellular response to oxidative stress (GO:0034599)	135	3	3.70	-	.81	1.00E00	1.00E00
regulation of blood circulation (GO:1903522)	90	2	2.47	-	.81	1.00E00	1.00E00
establishment of protein localization to organelle (GO:0072594)	180	4	4.94	-	.81	1.00E00	1.00E00
proteolysis (GO:0006508)	632	14	17.33	-	.81	5.26E-01	1.00E00
cell junction organization (GO:0034330)	226	5	6.20	-	.81	8.36E-01	1.00E00
developmental maturation (GO:0021700)	136	3	3.73	-	.80	1.00E00	1.00E00
regulation of actin polymerization or depolymerization (GO:0008064)	136	3	3.73	-	.80	1.00E00	1.00E00
regulation of extrinsic apoptotic signaling pathway (GO:2001236)	91	2	2.50	-	.80	1.00E00	1.00E00
maintenance of location (GO:0051235)	91	2	2.50	-	.80	1.00E00	1.00E00
positive regulation of response to stimulus (GO:0048584)	1047	23	28.71	-	.80	3.14E-01	1.00E00
circulatory system development (GO:0072359)	501	11	13.74	-	.80	5.72E-01	1.00E00
behavior (GO:0007610)	319	7	8.75	-	.80	7.26E-01	1.00E00
regulation of apoptotic signaling pathway (GO:2001233)	228	5	6.25	-	.80	8.36E-01	1.00E00
positive regulation of protein modification process (GO:0031401)	594	13	16.29	-	.80	5.14E-01	1.00E00
cellular response to stimulus (GO:0051716)	2710	59	74.31	-	.79	4.28E-02	1.00E00
negative regulation of protein kinase activity (GO:0006469)	138	3	3.78	-	.79	1.00E00	1.00E00
regulation of actin filament length (GO:0030832)	138	3	3.78	-	.79	1.00E00	1.00E00
regulation of glial cell differentiation (GO:0045685)	46	1	1.26	-	.79	1.00E00	1.00E00
hair follicle development (GO:0001942)	46	1	1.26	-	.79	1.00E00	1.00E00
blastocyst development (GO:0001824)	92	2	2.52	-	.79	1.00E00	1.00E00
positive regulation of calcium ion transport (GO:0051928)	46	1	1.26	-	.79	1.00E00	1.00E00
ribonucleoprotein complex export from nucleus (GO:0071426)	46	1	1.26	-	.79	1.00E00	1.00E00
positive regulation of biological process (GO:0048518)	3358	73	92.08	-	.79	1.47E-02	1.00E00
posttranscriptional gene silencing (GO:0016441)	46	1	1.26	-	.79	1.00E00	1.00E00
negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154)	46	1	1.26	-	.79	1.00E00	1.00E00
regulation of cardiac muscle hypertrophy (GO:0010611)	46	1	1.26	-	.79	1.00E00	1.00E00
negative regulation of autophagy (GO:0010507)	46	1	1.26	-	.79	1.00E00	1.00E00
positive regulation of exocytosis (GO:0045921)	46	1	1.26	-	.79	1.00E00	1.00E00
cell division (GO:0051301)	369	8	10.12	-	.79	6.25E-01	1.00E00
positive regulation of RNA metabolic process (GO:0051254)	1107	24	30.36	-	.79	2.79E-01	1.00E00
organic cyclic compound metabolic process (GO:1901360)	1800	39	49.36	-	.79	1.08E-01	1.00E00
intracellular transport (GO:0046907)	741	16	20.32	-	.79	4.10E-01	1.00E00
sex differentiation (GO:0007548)	139	3	3.81	-	.79	1.00E00	1.00E00
cellular aromatic compound metabolic process (GO:0006725)	1715	37	47.03	-	.79	1.20E-01	1.00E00
mitochondrial transport (GO:0006839)	93	2	2.55	-	.78	1.00E00	1.00E00
negative regulation of protein-containing complex assembly (GO:0031333)	93	2	2.55	-	.78	1.00E00	1.00E00
MAPK cascade (GO:0000165)	93	2	2.55	-	.78	1.00E00	1.00E00
muscle structure development (GO:0061061)	279	6	7.65	-	.78	7.09E-01	1.00E00
response to nitrogen compound (GO:1901698)	419	9	11.49	-	.78	5.41E-01	1.00E00
regulation of cytoskeleton organization (GO:0051493)	373	8	10.23	-	.78	6.25E-01	1.00E00
cellular response to extracellular stimulus (GO:0031668)	140	3	3.84	-	.78	1.00E00	1.00E00
phosphorus metabolic process (GO:0006793)	1028	22	28.19	-	.78	2.64E-01	1.00E00
protein metabolic process (GO:0019538)	2057	44	56.41	-	.78	6.65E-02	1.00E00
calcium ion transport (GO:0006816)	47	1	1.29	-	.78	1.00E00	1.00E00
organelle disassembly (GO:1903008)	47	1	1.29	-	.78	1.00E00	1.00E00
nephron tubule development (GO:0072080)	47	1	1.29	-	.78	1.00E00	1.00E00
regulation of microtubule-based process (GO:0032886)	188	4	5.16	-	.78	8.21E-01	1.00E00
plasma membrane organization (GO:0007009)	47	1	1.29	-	.78	1.00E00	1.00E00
modulation of process of other organism involved in symbiotic interaction (GO:0051817)	47	1	1.29	-	.78	1.00E00	1.00E00
ribonucleoprotein complex localization (GO:0071166)	47	1	1.29	-	.78	1.00E00	1.00E00
negative regulation of protein metabolic process (GO:0051248)	611	13	16.75	-	.78	4.40E-01	1.00E00
regulation of biomineral tissue development (GO:0070167)	47	1	1.29	-	.78	1.00E00	1.00E00
response to amino acid (GO:0043200)	47	1	1.29	-	.78	1.00E00	1.00E00
hair cycle (GO:0042633)	47	1	1.29	-	.78	1.00E00	1.00E00
regulation of protein localization to nucleus (GO:1900180)	94	2	2.58	-	.78	1.00E00	1.00E00
pancreas development (GO:0031016)	47	1	1.29	-	.78	1.00E00	1.00E00
molting cycle (GO:0042303)	47	1	1.29	-	.78	1.00E00	1.00E00
hair cycle process (GO:0022405)	47	1	1.29	-	.78	1.00E00	1.00E00
molting cycle process (GO:0022404)	47	1	1.29	-	.78	1.00E00	1.00E00
positive regulation of carbohydrate metabolic process (GO:0045913)	47	1	1.29	-	.78	1.00E00	1.00E00
learning or memory (GO:0007611)	141	3	3.87	-	.78	1.00E00	1.00E00
positive regulation of gene expression (GO:0010628)	1416	30	38.83	-	.77	1.33E-01	1.00E00
cellular response to organic cyclic compound (GO:0071407)	189	4	5.18	-	.77	8.21E-01	1.00E00
RNA processing (GO:0006396)	615	13	16.86	-	.77	4.41E-01	1.00E00
macromolecule metabolic process (GO:0043170)	3317	70	90.96	-	.77	6.71E-03	1.00E00
response to organonitrogen compound (GO:0010243)	380	8	10.42	-	.77	6.28E-01	1.00E00
regulation of nuclear division (GO:0051783)	95	2	2.61	-	.77	1.00E00	1.00E00
regulation of RNA stability (GO:0043487)	95	2	2.61	-	.77	1.00E00	1.00E00
positive regulation of lipid metabolic process (GO:0045834)	95	2	2.61	-	.77	1.00E00	1.00E00
positive regulation of protein modification by small protein conjugation or removal (GO:1903322)	95	2	2.61	-	.77	1.00E00	1.00E00
nucleobase-containing compound metabolic process (GO:0006139)	1617	34	44.34	-	.77	9.40E-02	1.00E00
ubiquitin-dependent protein catabolic process (GO:0006511)	333	7	9.13	-	.77	6.07E-01	1.00E00
protein polyubiquitination (GO:0000209)	143	3	3.92	-	.77	1.00E00	1.00E00
cell projection assembly (GO:0030031)	286	6	7.84	-	.77	7.10E-01	1.00E00
cellular protein metabolic process (GO:0044267)	1816	38	49.80	-	.76	6.57E-02	1.00E00
regulation of nitrogen compound metabolic process (GO:0051171)	3156	66	86.54	-	.76	7.39E-03	1.00E00
regulation of organelle organization (GO:0033043)	813	17	22.29	-	.76	3.10E-01	1.00E00
ameboidal-type cell migration (GO:0001667)	96	2	2.63	-	.76	1.00E00	1.00E00
cellular response to ionizing radiation (GO:0071479)	48	1	1.32	-	.76	1.00E00	1.00E00
regulation of mitochondrial membrane potential (GO:0051881)	48	1	1.32	-	.76	1.00E00	1.00E00
mRNA catabolic process (GO:0006402)	96	2	2.63	-	.76	1.00E00	1.00E00
homologous chromosome segregation (GO:0045143)	48	1	1.32	-	.76	1.00E00	1.00E00
DNA replication (GO:0006260)	144	3	3.95	-	.76	1.00E00	1.00E00
regulation of chemotaxis (GO:0050920)	96	2	2.63	-	.76	1.00E00	1.00E00
skin epidermis development (GO:0098773)	48	1	1.32	-	.76	1.00E00	1.00E00
regulation of protein stability (GO:0031647)	192	4	5.27	-	.76	8.21E-01	1.00E00
inositol lipid-mediated signaling (GO:0048017)	48	1	1.32	-	.76	1.00E00	1.00E00
glycoprotein biosynthetic process (GO:0009101)	48	1	1.32	-	.76	1.00E00	1.00E00
regulation of protein dephosphorylation (GO:0035304)	48	1	1.32	-	.76	1.00E00	1.00E00
regulation of gene silencing (GO:0060968)	48	1	1.32	-	.76	1.00E00	1.00E00
regulation of histone acetylation (GO:0035065)	48	1	1.32	-	.76	1.00E00	1.00E00
regulation of cation transmembrane transport (GO:1904062)	144	3	3.95	-	.76	1.00E00	1.00E00
negative regulation of Wnt signaling pathway (GO:0030178)	96	2	2.63	-	.76	1.00E00	1.00E00
regulation of mitotic metaphase/anaphase transition (GO:0030071)	48	1	1.32	-	.76	1.00E00	1.00E00
regulation of muscle hypertrophy (GO:0014743)	48	1	1.32	-	.76	1.00E00	1.00E00
respiratory system development (GO:0060541)	144	3	3.95	-	.76	1.00E00	1.00E00
regulation of leukocyte migration (GO:0002685)	96	2	2.63	-	.76	1.00E00	1.00E00
cellular macromolecule catabolic process (GO:0044265)	528	11	14.48	-	.76	4.11E-01	1.00E00
regulation of cellular localization (GO:0060341)	481	10	13.19	-	.76	4.71E-01	1.00E00
regulation of response to stimulus (GO:0048583)	2021	42	55.42	-	.76	4.53E-02	1.00E00
regulation of cellular metabolic process (GO:0031323)	3369	70	92.38	-	.76	3.75E-03	1.00E00
system process (GO:0003008)	626	13	17.17	-	.76	3.73E-01	1.00E00
negative regulation of biological process (GO:0048519)	3036	63	83.25	-	.76	8.29E-03	1.00E00
heterocycle metabolic process (GO:0046483)	1689	35	46.32	-	.76	7.01E-02	1.00E00
regulation of intracellular signal transduction (GO:1902531)	917	19	25.15	-	.76	2.40E-01	1.00E00
chromosome organization (GO:0051276)	676	14	18.54	-	.76	3.27E-01	1.00E00
modification-dependent protein catabolic process (GO:0019941)	338	7	9.27	-	.76	6.08E-01	1.00E00
multicellular organismal process (GO:0032501)	3192	66	87.53	-	.75	5.02E-03	1.00E00
developmental process (GO:0032502)	3001	62	82.29	-	.75	6.71E-03	1.00E00
regulation of metabolic process (GO:0019222)	3679	76	100.89	-	.75	1.86E-03	1.00E00
regulation of primary metabolic process (GO:0080090)	3247	67	89.04	-	.75	4.23E-03	1.00E00
monosaccharide metabolic process (GO:0005996)	97	2	2.66	-	.75	1.00E00	1.00E00
muscle cell development (GO:0055001)	97	2	2.66	-	.75	1.00E00	1.00E00
microtubule cytoskeleton organization involved in mitosis (GO:1902850)	97	2	2.66	-	.75	1.00E00	1.00E00
vasculature development (GO:0001944)	292	6	8.01	-	.75	5.86E-01	1.00E00
negative regulation of developmental process (GO:0051093)	537	11	14.73	-	.75	4.12E-01	1.00E00
intracellular signal transduction (GO:0035556)	782	16	21.44	-	.75	2.52E-01	1.00E00
positive regulation of nucleic acid-templated transcription (GO:1903508)	1027	21	28.16	-	.75	1.86E-01	1.00E00
positive regulation of transcription, DNA-templated (GO:0045893)	1027	21	28.16	-	.75	1.86E-01	1.00E00
positive regulation of RNA biosynthetic process (GO:1902680)	1028	21	28.19	-	.74	1.86E-01	1.00E00
positive regulation of macromolecule metabolic process (GO:0010604)	2008	41	55.06	-	.74	3.69E-02	1.00E00
ATP metabolic process (GO:0046034)	98	2	2.69	-	.74	1.00E00	1.00E00
regulation of biomineralization (GO:0110149)	49	1	1.34	-	.74	1.00E00	1.00E00
cell fate commitment (GO:0045165)	147	3	4.03	-	.74	8.00E-01	1.00E00
regulation of cilium assembly (GO:1902017)	49	1	1.34	-	.74	1.00E00	1.00E00
response to heat (GO:0009408)	49	1	1.34	-	.74	1.00E00	1.00E00
kidney morphogenesis (GO:0060993)	49	1	1.34	-	.74	1.00E00	1.00E00
somite development (GO:0061053)	49	1	1.34	-	.74	1.00E00	1.00E00
regulation of cellular protein localization (GO:1903827)	343	7	9.41	-	.74	6.10E-01	1.00E00
positive regulation of nucleobase-containing compound metabolic process (GO:0045935)	1228	25	33.67	-	.74	1.32E-01	1.00E00
animal organ development (GO:0048513)	1673	34	45.88	-	.74	5.70E-02	1.00E00
protein transport (GO:0015031)	739	15	20.26	-	.74	2.88E-01	1.00E00
negative regulation of cell cycle (GO:0045786)	296	6	8.12	-	.74	5.86E-01	1.00E00
kidney development (GO:0001822)	148	3	4.06	-	.74	8.00E-01	1.00E00
modification-dependent macromolecule catabolic process (GO:0043632)	346	7	9.49	-	.74	5.03E-01	1.00E00
anatomical structure development (GO:0048856)	2770	56	75.96	-	.74	6.77E-03	1.00E00
regulation of lipid localization (GO:1905952)	99	2	2.71	-	.74	1.00E00	1.00E00
cardiac chamber development (GO:0003205)	99	2	2.71	-	.74	1.00E00	1.00E00
enzyme linked receptor protein signaling pathway (GO:0007167)	298	6	8.17	-	.73	5.86E-01	1.00E00
establishment of protein localization (GO:0045184)	796	16	21.83	-	.73	2.54E-01	1.00E00
cellular macromolecule metabolic process (GO:0044260)	2589	52	71.00	-	.73	8.71E-03	1.00E00
alcohol biosynthetic process (GO:0046165)	50	1	1.37	-	.73	1.00E00	1.00E00
DNA biosynthetic process (GO:0071897)	50	1	1.37	-	.73	1.00E00	1.00E00
roof of mouth development (GO:0060021)	50	1	1.37	-	.73	1.00E00	1.00E00
cellular glucose homeostasis (GO:0001678)	50	1	1.37	-	.73	1.00E00	1.00E00
response to hypoxia (GO:0001666)	100	2	2.74	-	.73	1.00E00	1.00E00
muscle organ morphogenesis (GO:0048644)	50	1	1.37	-	.73	1.00E00	1.00E00
T cell receptor signaling pathway (GO:0050852)	50	1	1.37	-	.73	1.00E00	1.00E00
negative regulation of ERK1 and ERK2 cascade (GO:0070373)	50	1	1.37	-	.73	1.00E00	1.00E00
postsynapse organization (GO:0099173)	50	1	1.37	-	.73	1.00E00	1.00E00
transition metal ion homeostasis (GO:0055076)	50	1	1.37	-	.73	1.00E00	1.00E00
regeneration (GO:0031099)	50	1	1.37	-	.73	1.00E00	1.00E00
nucleoside diphosphate metabolic process (GO:0009132)	50	1	1.37	-	.73	1.00E00	1.00E00
regulation of BMP signaling pathway (GO:0030510)	50	1	1.37	-	.73	1.00E00	1.00E00
positive regulation of cell development (GO:0010720)	200	4	5.48	-	.73	6.64E-01	1.00E00
renal tubule development (GO:0061326)	50	1	1.37	-	.73	1.00E00	1.00E00
regulation of anatomical structure size (GO:0090066)	301	6	8.25	-	.73	5.87E-01	1.00E00
cell differentiation (GO:0030154)	1907	38	52.29	-	.73	2.76E-02	1.00E00
positive regulation of organelle organization (GO:0010638)	402	8	11.02	-	.73	4.34E-01	1.00E00
sensory perception (GO:0007600)	201	4	5.51	-	.73	6.64E-01	1.00E00
microtubule-based process (GO:0007017)	554	11	15.19	-	.72	3.45E-01	1.00E00
regulation of growth (GO:0040008)	404	8	11.08	-	.72	4.35E-01	1.00E00
DNA metabolic process (GO:0006259)	505	10	13.85	-	.72	3.97E-01	1.00E00
system development (GO:0048731)	2227	44	61.07	-	.72	1.39E-02	1.00E00
response to lipid (GO:0033993)	305	6	8.36	-	.72	5.89E-01	1.00E00
sensory organ development (GO:0007423)	306	6	8.39	-	.72	5.89E-01	1.00E00
smoothened signaling pathway (GO:0007224)	51	1	1.40	-	.72	1.00E00	1.00E00
regulation of metaphase/anaphase transition of cell cycle (GO:1902099)	51	1	1.40	-	.72	1.00E00	1.00E00
positive regulation of reproductive process (GO:2000243)	51	1	1.40	-	.72	1.00E00	1.00E00
maintenance of location in cell (GO:0051651)	51	1	1.40	-	.72	1.00E00	1.00E00
negative regulation of cysteine-type endopeptidase activity (GO:2000117)	51	1	1.40	-	.72	1.00E00	1.00E00
pyruvate metabolic process (GO:0006090)	51	1	1.40	-	.72	1.00E00	1.00E00
positive regulation of insulin secretion (GO:0032024)	51	1	1.40	-	.72	1.00E00	1.00E00
regulation of neuron apoptotic process (GO:0043523)	153	3	4.20	-	.72	8.01E-01	1.00E00
positive regulation of JUN kinase activity (GO:0043507)	51	1	1.40	-	.72	1.00E00	1.00E00
energy derivation by oxidation of organic compounds (GO:0015980)	102	2	2.80	-	.72	1.00E00	1.00E00
cellular response to chemical stress (GO:0062197)	153	3	4.20	-	.72	8.01E-01	1.00E00
regulation of mitotic sister chromatid separation (GO:0010965)	51	1	1.40	-	.72	1.00E00	1.00E00
positive regulation of nucleocytoplasmic transport (GO:0046824)	51	1	1.40	-	.72	1.00E00	1.00E00
regulation of cellular carbohydrate metabolic process (GO:0010675)	102	2	2.80	-	.72	1.00E00	1.00E00
regulation of smooth muscle cell migration (GO:0014910)	51	1	1.40	-	.72	1.00E00	1.00E00
cellular developmental process (GO:0048869)	1940	38	53.20	-	.71	1.90E-02	1.00E00
positive regulation of macromolecule biosynthetic process (GO:0010557)	1175	23	32.22	-	.71	1.03E-01	1.00E00
regulation of gene expression (GO:0010468)	2658	52	72.89	-	.71	3.93E-03	1.00E00
cell cycle (GO:0007049)	869	17	23.83	-	.71	1.56E-01	1.00E00
regulation of RNA metabolic process (GO:0051252)	2097	41	57.50	-	.71	1.48E-02	1.00E00
positive regulation of cellular biosynthetic process (GO:0031328)	1228	24	33.67	-	.71	9.00E-02	1.00E00
negative regulation of cellular process (GO:0048523)	2819	55	77.30	-	.71	2.36E-03	1.00E00
positive regulation of neurogenesis (GO:0050769)	154	3	4.22	-	.71	8.01E-01	1.00E00
regulation of macromolecule metabolic process (GO:0060255)	3443	67	94.41	-	.71	3.88E-04	1.00E00
vesicle-mediated transport (GO:0016192)	619	12	16.97	-	.71	2.51E-01	1.00E00
regulation of nucleobase-containing compound metabolic process (GO:0019219)	2271	44	62.28	-	.71	7.73E-03	1.00E00
multicellular organism development (GO:0007275)	2581	50	70.78	-	.71	3.62E-03	1.00E00
negative regulation of nitrogen compound metabolic process (GO:0051172)	1446	28	39.65	-	.71	5.29E-02	1.00E00
negative regulation of mitotic cell cycle (GO:0045930)	155	3	4.25	-	.71	8.02E-01	1.00E00
muscle organ development (GO:0007517)	155	3	4.25	-	.71	8.02E-01	1.00E00
negative regulation of response to stimulus (GO:0048585)	931	18	25.53	-	.71	1.37E-01	1.00E00
negative regulation of metabolic process (GO:0009892)	1811	35	49.66	-	.70	2.00E-02	1.00E00
cellular response to DNA damage stimulus (GO:0006974)	519	10	14.23	-	.70	3.30E-01	1.00E00
RNA export from nucleus (GO:0006405)	52	1	1.43	-	.70	1.00E00	1.00E00
response to peptide hormone (GO:0043434)	156	3	4.28	-	.70	8.02E-01	1.00E00
modulation of process of other organism (GO:0035821)	52	1	1.43	-	.70	1.00E00	1.00E00
response to decreased oxygen levels (GO:0036293)	104	2	2.85	-	.70	1.00E00	1.00E00
cytoplasmic microtubule organization (GO:0031122)	52	1	1.43	-	.70	1.00E00	1.00E00
chromatin organization involved in regulation of transcription (GO:0034401)	52	1	1.43	-	.70	1.00E00	1.00E00
regulation of mRNA catabolic process (GO:0061013)	104	2	2.85	-	.70	1.00E00	1.00E00
positive regulation of biosynthetic process (GO:0009891)	1250	24	34.28	-	.70	6.23E-02	1.00E00
RNA splicing (GO:0008380)	261	5	7.16	-	.70	5.62E-01	1.00E00
negative regulation of cell communication (GO:0010648)	784	15	21.50	-	.70	1.69E-01	1.00E00
negative regulation of kinase activity (GO:0033673)	157	3	4.31	-	.70	8.02E-01	1.00E00
cellular response to external stimulus (GO:0071496)	157	3	4.31	-	.70	8.02E-01	1.00E00
cognition (GO:0050890)	157	3	4.31	-	.70	8.02E-01	1.00E00
negative regulation of cell cycle process (GO:0010948)	157	3	4.31	-	.70	8.02E-01	1.00E00
negative regulation of signaling (GO:0023057)	785	15	21.53	-	.70	1.69E-01	1.00E00
negative regulation of signal transduction (GO:0009968)	733	14	20.10	-	.70	1.93E-01	1.00E00
regulation of biosynthetic process (GO:0009889)	2357	45	64.63	-	.70	4.40E-03	1.00E00
cellular response to nitrogen compound (GO:1901699)	262	5	7.18	-	.70	5.62E-01	1.00E00
negative regulation of macromolecule metabolic process (GO:0010605)	1677	32	45.99	-	.70	2.52E-02	1.00E00
actin cytoskeleton organization (GO:0030036)	367	7	10.06	-	.70	4.13E-01	1.00E00
cardiac muscle tissue development (GO:0048738)	105	2	2.88	-	.69	1.00E00	1.00E00
organic cyclic compound biosynthetic process (GO:1901362)	525	10	14.40	-	.69	2.71E-01	1.00E00
negative regulation of neuron apoptotic process (GO:0043524)	105	2	2.88	-	.69	1.00E00	1.00E00
negative regulation of binding (GO:0051100)	105	2	2.88	-	.69	1.00E00	1.00E00
regulation of RNA splicing (GO:0043484)	105	2	2.88	-	.69	1.00E00	1.00E00
negative regulation of cell projection organization (GO:0031345)	105	2	2.88	-	.69	1.00E00	1.00E00
regulation of synaptic plasticity (GO:0048167)	105	2	2.88	-	.69	1.00E00	1.00E00
regulation of cellular biosynthetic process (GO:0031326)	2317	44	63.54	-	.69	5.15E-03	1.00E00
renal system development (GO:0072001)	158	3	4.33	-	.69	8.03E-01	1.00E00
angiogenesis (GO:0001525)	158	3	4.33	-	.69	8.03E-01	1.00E00
positive regulation of cell differentiation (GO:0045597)	527	10	14.45	-	.69	2.71E-01	1.00E00
regulation of transcription, DNA-templated (GO:0006355)	1902	36	52.16	-	.69	1.17E-02	1.00E00
mRNA metabolic process (GO:0016071)	423	8	11.60	-	.69	3.58E-01	1.00E00
negative regulation of cellular protein metabolic process (GO:0032269)	582	11	15.96	-	.69	2.37E-01	1.00E00
regulation of nucleic acid-templated transcription (GO:1903506)	1905	36	52.24	-	.69	1.16E-02	1.00E00
regulation of RNA biosynthetic process (GO:2001141)	1907	36	52.29	-	.69	1.16E-02	1.00E00
regulation of cellular macromolecule biosynthetic process (GO:2000112)	2225	42	61.01	-	.69	5.74E-03	1.00E00
glial cell development (GO:0021782)	53	1	1.45	-	.69	1.00E00	1.00E00
negative regulation of neuron differentiation (GO:0045665)	53	1	1.45	-	.69	1.00E00	1.00E00
regulation of mononuclear cell migration (GO:0071675)	53	1	1.45	-	.69	1.00E00	1.00E00
response to insulin (GO:0032868)	106	2	2.91	-	.69	1.00E00	1.00E00
negative regulation of protein polymerization (GO:0032272)	53	1	1.45	-	.69	1.00E00	1.00E00
positive regulation of axonogenesis (GO:0050772)	53	1	1.45	-	.69	1.00E00	1.00E00
glucose homeostasis (GO:0042593)	106	2	2.91	-	.69	1.00E00	1.00E00
negative regulation of gene expression (GO:0010629)	1219	23	33.43	-	.69	5.89E-02	1.00E00
positive regulation of JNK cascade (GO:0046330)	53	1	1.45	-	.69	1.00E00	1.00E00
response to interferon-gamma (GO:0034341)	53	1	1.45	-	.69	1.00E00	1.00E00
regulation of chromatin organization (GO:1902275)	159	3	4.36	-	.69	8.03E-01	1.00E00
in utero embryonic development (GO:0001701)	319	6	8.75	-	.69	4.81E-01	1.00E00
organelle localization (GO:0051640)	319	6	8.75	-	.69	4.81E-01	1.00E00
regulation of cellular component organization (GO:0051128)	1492	28	40.91	-	.68	2.99E-02	1.00E00
regulation of macromolecule biosynthetic process (GO:0010556)	2239	42	61.40	-	.68	4.65E-03	1.00E00
phosphate-containing compound metabolic process (GO:0006796)	1016	19	27.86	-	.68	8.26E-02	1.00E00
carbohydrate homeostasis (GO:0033500)	107	2	2.93	-	.68	1.00E00	1.00E00
regulation of lipid biosynthetic process (GO:0046890)	107	2	2.93	-	.68	1.00E00	1.00E00
heterocycle biosynthetic process (GO:0018130)	483	9	13.24	-	.68	3.13E-01	1.00E00
negative regulation of transcription, DNA-templated (GO:0045892)	805	15	22.07	-	.68	1.40E-01	1.00E00
macromolecule modification (GO:0043412)	1558	29	42.72	-	.68	2.14E-02	1.00E00
negative regulation of nucleic acid-templated transcription (GO:1903507)	808	15	22.16	-	.68	1.40E-01	1.00E00
negative regulation of RNA biosynthetic process (GO:1902679)	809	15	22.18	-	.68	1.40E-01	1.00E00
positive regulation of nervous system development (GO:0051962)	162	3	4.44	-	.68	8.05E-01	1.00E00
rhythmic process (GO:0048511)	162	3	4.44	-	.68	8.05E-01	1.00E00
response to unfolded protein (GO:0006986)	54	1	1.48	-	.68	1.00E00	1.00E00
inner ear development (GO:0048839)	108	2	2.96	-	.68	1.00E00	1.00E00
sister chromatid segregation (GO:0000819)	108	2	2.96	-	.68	1.00E00	1.00E00
oogenesis (GO:0048477)	54	1	1.48	-	.68	1.00E00	1.00E00
pigmentation (GO:0043473)	54	1	1.48	-	.68	1.00E00	1.00E00
metal ion transport (GO:0030001)	54	1	1.48	-	.68	1.00E00	1.00E00
proteolysis involved in cellular protein catabolic process (GO:0051603)	379	7	10.39	-	.67	4.17E-01	1.00E00
nucleic acid metabolic process (GO:0090304)	1356	25	37.18	-	.67	3.05E-02	1.00E00
regulation of myeloid cell differentiation (GO:0045637)	109	2	2.99	-	.67	7.72E-01	1.00E00
response to reactive oxygen species (GO:0000302)	109	2	2.99	-	.67	7.72E-01	1.00E00
blood vessel development (GO:0001568)	273	5	7.49	-	.67	4.52E-01	1.00E00
nucleobase-containing compound biosynthetic process (GO:0034654)	437	8	11.98	-	.67	2.92E-01	1.00E00
modulation of chemical synaptic transmission (GO:0050804)	219	4	6.01	-	.67	5.31E-01	1.00E00
regulation of trans-synaptic signaling (GO:0099177)	219	4	6.01	-	.67	5.31E-01	1.00E00
activation of immune response (GO:0002253)	110	2	3.02	-	.66	7.72E-01	1.00E00
positive regulation of DNA biosynthetic process (GO:2000573)	55	1	1.51	-	.66	1.00E00	1.00E00
cellular response to oxygen levels (GO:0071453)	55	1	1.51	-	.66	1.00E00	1.00E00
stress-activated MAPK cascade (GO:0051403)	55	1	1.51	-	.66	1.00E00	1.00E00
response to acid chemical (GO:0001101)	55	1	1.51	-	.66	1.00E00	1.00E00
positive regulation of protein binding (GO:0032092)	55	1	1.51	-	.66	1.00E00	1.00E00
segmentation (GO:0035282)	55	1	1.51	-	.66	1.00E00	1.00E00
regulation of epithelial to mesenchymal transition (GO:0010717)	55	1	1.51	-	.66	1.00E00	1.00E00
positive regulation of leukocyte migration (GO:0002687)	55	1	1.51	-	.66	1.00E00	1.00E00
plasma membrane bounded cell projection assembly (GO:0120031)	276	5	7.57	-	.66	4.52E-01	1.00E00
mRNA processing (GO:0006397)	332	6	9.10	-	.66	3.89E-01	1.00E00
positive regulation of transcription by RNA polymerase II (GO:0045944)	830	15	22.76	-	.66	9.42E-02	1.00E00
actin filament-based process (GO:0030029)	388	7	10.64	-	.66	3.37E-01	1.00E00
negative regulation of biosynthetic process (GO:0009890)	999	18	27.39	-	.66	6.37E-02	1.00E00
negative regulation of RNA metabolic process (GO:0051253)	889	16	24.38	-	.66	8.27E-02	1.00E00
myeloid leukocyte differentiation (GO:0002573)	56	1	1.54	-	.65	1.00E00	1.00E00
spinal cord development (GO:0021510)	56	1	1.54	-	.65	1.00E00	1.00E00
ureteric bud development (GO:0001657)	56	1	1.54	-	.65	1.00E00	1.00E00
mitotic cell cycle phase transition (GO:0044772)	112	2	3.07	-	.65	7.72E-01	1.00E00
DNA recombination (GO:0006310)	168	3	4.61	-	.65	6.32E-01	1.00E00
regulation of chromosome separation (GO:1905818)	56	1	1.54	-	.65	1.00E00	1.00E00
regulation of oxidoreductase activity (GO:0051341)	56	1	1.54	-	.65	1.00E00	1.00E00
skin development (GO:0043588)	112	2	3.07	-	.65	7.72E-01	1.00E00
axo-dendritic transport (GO:0008088)	56	1	1.54	-	.65	1.00E00	1.00E00
negative regulation of protein modification process (GO:0031400)	337	6	9.24	-	.65	3.91E-01	1.00E00
positive regulation of cell cycle process (GO:0090068)	169	3	4.63	-	.65	6.32E-01	1.00E00
positive regulation of cellular protein localization (GO:1903829)	169	3	4.63	-	.65	6.32E-01	1.00E00
regulation of protein modification by small protein conjugation or removal (GO:1903320)	169	3	4.63	-	.65	6.32E-01	1.00E00
RNA catabolic process (GO:0006401)	113	2	3.10	-	.65	7.72E-01	1.00E00
meiotic cell cycle (GO:0051321)	170	3	4.66	-	.64	6.33E-01	1.00E00
negative regulation of nucleobase-containing compound metabolic process (GO:0045934)	968	17	26.54	-	.64	5.95E-02	1.00E00
purine nucleoside bisphosphate metabolic process (GO:0034032)	57	1	1.56	-	.64	1.00E00	1.00E00
mesonephric tubule development (GO:0072164)	57	1	1.56	-	.64	1.00E00	1.00E00
mesonephric epithelium development (GO:0072163)	57	1	1.56	-	.64	1.00E00	1.00E00
regulation of sister chromatid segregation (GO:0033045)	57	1	1.56	-	.64	1.00E00	1.00E00
alpha-amino acid catabolic process (GO:1901606)	57	1	1.56	-	.64	1.00E00	1.00E00
positive regulation of developmental growth (GO:0048639)	114	2	3.13	-	.64	7.72E-01	1.00E00
ribonucleoside bisphosphate metabolic process (GO:0033875)	57	1	1.56	-	.64	1.00E00	1.00E00
nucleoside bisphosphate metabolic process (GO:0033865)	57	1	1.56	-	.64	1.00E00	1.00E00
response to abiotic stimulus (GO:0009628)	513	9	14.07	-	.64	2.08E-01	1.00E00
nervous system process (GO:0050877)	402	7	11.02	-	.64	2.72E-01	1.00E00
cell-cell adhesion (GO:0098609)	115	2	3.15	-	.63	7.72E-01	1.00E00
tube morphogenesis (GO:0035239)	403	7	11.05	-	.63	2.72E-01	1.00E00
negative regulation of cellular biosynthetic process (GO:0031327)	980	17	26.87	-	.63	4.81E-02	1.00E00
cellular process involved in reproduction in multicellular organism (GO:0022412)	231	4	6.33	-	.63	5.35E-01	1.00E00
positive regulation of developmental process (GO:0051094)	751	13	20.59	-	.63	1.00E-01	1.00E00
negative regulation of cellular component organization (GO:0051129)	463	8	12.70	-	.63	2.38E-01	1.00E00
post-Golgi vesicle-mediated transport (GO:0006892)	58	1	1.59	-	.63	1.00E00	1.00E00
regulation of peptidyl-lysine acetylation (GO:2000756)	58	1	1.59	-	.63	1.00E00	1.00E00
positive regulation of mitotic cell cycle phase transition (GO:1901992)	58	1	1.59	-	.63	1.00E00	1.00E00
regulation of neurogenesis (GO:0050767)	232	4	6.36	-	.63	5.35E-01	1.00E00
chromatin assembly (GO:0031497)	58	1	1.59	-	.63	1.00E00	1.00E00
positive regulation of cell migration (GO:0030335)	290	5	7.95	-	.63	3.61E-01	1.00E00
membrane fusion (GO:0061025)	58	1	1.59	-	.63	1.00E00	1.00E00
regulation of leukocyte chemotaxis (GO:0002688)	58	1	1.59	-	.63	1.00E00	1.00E00
negative regulation of cellular metabolic process (GO:0031324)	1568	27	43.00	-	.63	6.47E-03	1.00E00
RNA metabolic process (GO:0016070)	930	16	25.50	-	.63	5.50E-02	1.00E00
cellular response to organonitrogen compound (GO:0071417)	233	4	6.39	-	.63	5.36E-01	1.00E00
cellular response to oxygen-containing compound (GO:1901701)	467	8	12.81	-	.62	2.40E-01	1.00E00
epithelial cell development (GO:0002064)	117	2	3.21	-	.62	7.73E-01	1.00E00
epithelium development (GO:0060429)	586	10	16.07	-	.62	1.47E-01	1.00E00
negative regulation of transferase activity (GO:0051348)	176	3	4.83	-	.62	6.36E-01	1.00E00
regulation of chromosome organization (GO:0033044)	235	4	6.44	-	.62	4.20E-01	1.00E00
anatomical structure formation involved in morphogenesis (GO:0048646)	529	9	14.51	-	.62	1.68E-01	1.00E00
mesonephros development (GO:0001823)	59	1	1.62	-	.62	1.00E00	1.00E00
positive regulation of synaptic transmission (GO:0050806)	59	1	1.62	-	.62	1.00E00	1.00E00
mammary gland development (GO:0030879)	59	1	1.62	-	.62	1.00E00	1.00E00
cardiac muscle cell differentiation (GO:0055007)	59	1	1.62	-	.62	1.00E00	1.00E00
response to endoplasmic reticulum stress (GO:0034976)	118	2	3.24	-	.62	7.73E-01	1.00E00
regulation of neuron projection development (GO:0010975)	295	5	8.09	-	.62	3.62E-01	1.00E00
regulation of smoothened signaling pathway (GO:0008589)	59	1	1.62	-	.62	1.00E00	1.00E00
nucleosome organization (GO:0034728)	59	1	1.62	-	.62	1.00E00	1.00E00
regulation of signaling receptor activity (GO:0010469)	59	1	1.62	-	.62	1.00E00	1.00E00
protein localization to organelle (GO:0033365)	414	7	11.35	-	.62	2.18E-01	1.00E00
regulation of plasma membrane bounded cell projection organization (GO:0120035)	414	7	11.35	-	.62	2.18E-01	1.00E00
anatomical structure morphogenesis (GO:0009653)	1245	21	34.14	-	.62	1.48E-02	1.00E00
endocytosis (GO:0006897)	178	3	4.88	-	.61	6.37E-01	1.00E00
regulation of MAP kinase activity (GO:0043405)	178	3	4.88	-	.61	6.37E-01	1.00E00
negative regulation of cellular macromolecule biosynthetic process (GO:2000113)	950	16	26.05	-	.61	4.47E-02	1.00E00
cell cycle phase transition (GO:0044770)	119	2	3.26	-	.61	7.74E-01	1.00E00
establishment of organelle localization (GO:0051656)	238	4	6.53	-	.61	4.20E-01	1.00E00
wound healing (GO:0042060)	119	2	3.26	-	.61	7.74E-01	1.00E00
positive regulation of cell motility (GO:2000147)	298	5	8.17	-	.61	3.62E-01	1.00E00
regulation of protein-containing complex assembly (GO:0043254)	298	5	8.17	-	.61	3.62E-01	1.00E00
response to oxygen-containing compound (GO:1901700)	656	11	17.99	-	.61	1.04E-01	1.00E00
tube development (GO:0035295)	537	9	14.73	-	.61	1.69E-01	1.00E00
positive regulation of cellular component organization (GO:0051130)	717	12	19.66	-	.61	9.27E-02	1.00E00
negative regulation of macromolecule biosynthetic process (GO:0010558)	957	16	26.24	-	.61	3.56E-02	1.00E00
mesoderm development (GO:0007498)	60	1	1.65	-	.61	1.00E00	1.00E00
bone development (GO:0060348)	120	2	3.29	-	.61	7.74E-01	1.00E00
cell chemotaxis (GO:0060326)	60	1	1.65	-	.61	1.00E00	1.00E00
negative regulation of intrinsic apoptotic signaling pathway (GO:2001243)	60	1	1.65	-	.61	1.00E00	1.00E00
regulation of double-strand break repair (GO:2000779)	60	1	1.65	-	.61	1.00E00	1.00E00
cellular amino acid metabolic process (GO:0006520)	180	3	4.94	-	.61	6.38E-01	1.00E00
negative regulation of protein depolymerization (GO:1901880)	60	1	1.65	-	.61	1.00E00	1.00E00
urogenital system development (GO:0001655)	180	3	4.94	-	.61	6.38E-01	1.00E00
DNA repair (GO:0006281)	360	6	9.87	-	.61	2.49E-01	1.00E00
positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436)	60	1	1.65	-	.61	1.00E00	1.00E00
positive regulation of neuron projection development (GO:0010976)	120	2	3.29	-	.61	7.74E-01	1.00E00
positive regulation of cell morphogenesis involved in differentiation (GO:0010770)	60	1	1.65	-	.61	1.00E00	1.00E00
regulation of cellular component biogenesis (GO:0044087)	601	10	16.48	-	.61	1.18E-01	1.00E00
positive regulation of locomotion (GO:0040017)	301	5	8.25	-	.61	3.64E-01	1.00E00
regulation of protein catabolic process (GO:0042176)	241	4	6.61	-	.61	4.20E-01	1.00E00
tissue morphogenesis (GO:0048729)	362	6	9.93	-	.60	2.49E-01	1.00E00
aromatic compound biosynthetic process (GO:0019438)	483	8	13.24	-	.60	1.93E-01	1.00E00
regulation of cell projection organization (GO:0031344)	424	7	11.63	-	.60	2.19E-01	1.00E00
morphogenesis of an epithelium (GO:0002009)	303	5	8.31	-	.60	3.65E-01	1.00E00
striated muscle tissue development (GO:0014706)	182	3	4.99	-	.60	4.93E-01	1.00E00
cellular response to stress (GO:0033554)	971	16	26.63	-	.60	2.85E-02	1.00E00
Golgi organization (GO:0007030)	61	1	1.67	-	.60	1.00E00	1.00E00
regulation of cellular component size (GO:0032535)	244	4	6.69	-	.60	4.22E-01	1.00E00
negative regulation of transport (GO:0051051)	244	4	6.69	-	.60	4.22E-01	1.00E00
response to hydrogen peroxide (GO:0042542)	61	1	1.67	-	.60	1.00E00	1.00E00
regulation of proteasomal protein catabolic process (GO:0061136)	122	2	3.35	-	.60	7.75E-01	1.00E00
regulation of wound healing (GO:0061041)	61	1	1.67	-	.60	1.00E00	1.00E00
generation of neurons (GO:0048699)	735	12	20.16	-	.60	5.89E-02	1.00E00
regulation of binding (GO:0051098)	245	4	6.72	-	.60	4.22E-01	1.00E00
neurogenesis (GO:0022008)	797	13	21.86	-	.59	5.21E-02	1.00E00
regulation of multicellular organismal development (GO:2000026)	738	12	20.24	-	.59	5.89E-02	1.00E00
regulation of actin filament polymerization (GO:0030833)	123	2	3.37	-	.59	7.76E-01	1.00E00
lung development (GO:0030324)	123	2	3.37	-	.59	7.76E-01	1.00E00
regulation of vesicle-mediated transport (GO:0060627)	308	5	8.45	-	.59	2.86E-01	1.00E00
negative regulation of ion transport (GO:0043271)	185	3	5.07	-	.59	4.93E-01	1.00E00
positive regulation of cell projection organization (GO:0031346)	247	4	6.77	-	.59	4.23E-01	1.00E00
positive regulation of cellular component movement (GO:0051272)	309	5	8.47	-	.59	2.86E-01	1.00E00
cellular protein modification process (GO:0006464)	1424	23	39.05	-	.59	4.52E-03	1.00E00
protein modification process (GO:0036211)	1424	23	39.05	-	.59	4.52E-03	1.00E00
regulation of steroid metabolic process (GO:0019218)	62	1	1.70	-	.59	1.00E00	1.00E00
peptidyl-amino acid modification (GO:0018193)	496	8	13.60	-	.59	1.54E-01	1.00E00
glucose metabolic process (GO:0006006)	62	1	1.70	-	.59	1.00E00	1.00E00
regulation of JUN kinase activity (GO:0043506)	62	1	1.70	-	.59	1.00E00	1.00E00
regulation of histone methylation (GO:0031060)	62	1	1.70	-	.59	1.00E00	1.00E00
chordate embryonic development (GO:0043009)	496	8	13.60	-	.59	1.54E-01	1.00E00
regulation of myeloid leukocyte differentiation (GO:0002761)	62	1	1.70	-	.59	1.00E00	1.00E00
mitotic nuclear division (GO:0140014)	125	2	3.43	-	.58	7.77E-01	1.00E00
respiratory tube development (GO:0030323)	125	2	3.43	-	.58	7.77E-01	1.00E00
cell development (GO:0048468)	941	15	25.80	-	.58	2.58E-02	1.00E00
regulation of mitotic cell cycle phase transition (GO:1901990)	189	3	5.18	-	.58	4.94E-01	1.00E00
ear development (GO:0043583)	126	2	3.46	-	.58	7.78E-01	1.00E00
regulation of muscle adaptation (GO:0043502)	63	1	1.73	-	.58	1.00E00	1.00E00
regulation of fibroblast proliferation (GO:0048145)	63	1	1.73	-	.58	1.00E00	1.00E00
inner ear morphogenesis (GO:0042472)	63	1	1.73	-	.58	1.00E00	1.00E00
nervous system development (GO:0007399)	1138	18	31.21	-	.58	1.11E-02	1.00E00
regulation of transcription by RNA polymerase II (GO:0006357)	1457	23	39.95	-	.58	2.80E-03	1.00E00
embryo development ending in birth or egg hatching (GO:0009792)	507	8	13.90	-	.58	1.21E-01	1.00E00
regulation of cell development (GO:0060284)	317	5	8.69	-	.58	2.88E-01	1.00E00
alpha-amino acid metabolic process (GO:1901605)	127	2	3.48	-	.57	5.88E-01	1.00E00
regulation of plasma membrane bounded cell projection assembly (GO:0120032)	127	2	3.48	-	.57	5.88E-01	1.00E00
dephosphorylation (GO:0016311)	127	2	3.48	-	.57	5.88E-01	1.00E00
connective tissue development (GO:0061448)	127	2	3.48	-	.57	5.88E-01	1.00E00
regulation of developmental process (GO:0050793)	1400	22	38.39	-	.57	3.21E-03	1.00E00
cell projection organization (GO:0030030)	700	11	19.20	-	.57	5.29E-02	1.00E00
regulation of cell projection assembly (GO:0060491)	128	2	3.51	-	.57	5.88E-01	1.00E00
phagocytosis (GO:0006909)	64	1	1.76	-	.57	1.00E00	1.00E00
spindle organization (GO:0007051)	128	2	3.51	-	.57	5.88E-01	1.00E00
lysosomal transport (GO:0007041)	64	1	1.76	-	.57	1.00E00	1.00E00
maintenance of protein location (GO:0045185)	64	1	1.76	-	.57	1.00E00	1.00E00
mitochondrial gene expression (GO:0140053)	64	1	1.76	-	.57	1.00E00	1.00E00
antigen receptor-mediated signaling pathway (GO:0050851)	64	1	1.76	-	.57	1.00E00	1.00E00
striated muscle cell development (GO:0055002)	64	1	1.76	-	.57	1.00E00	1.00E00
purine ribonucleotide biosynthetic process (GO:0009152)	64	1	1.76	-	.57	1.00E00	1.00E00
neuron differentiation (GO:0030182)	576	9	15.80	-	.57	8.49E-02	1.00E00
heart development (GO:0007507)	320	5	8.78	-	.57	2.89E-01	1.00E00
animal organ morphogenesis (GO:0009887)	577	9	15.82	-	.57	8.50E-02	1.00E00
regulation of actin filament organization (GO:0110053)	193	3	5.29	-	.57	4.97E-01	1.00E00
regulation of histone modification (GO:0031056)	129	2	3.54	-	.57	5.88E-01	1.00E00
ribonucleoprotein complex assembly (GO:0022618)	129	2	3.54	-	.57	5.88E-01	1.00E00
regulation of cell differentiation (GO:0045595)	904	14	24.79	-	.56	2.32E-02	1.00E00
endomembrane system organization (GO:0010256)	194	3	5.32	-	.56	4.98E-01	1.00E00
negative regulation of chromosome organization (GO:2001251)	65	1	1.78	-	.56	1.00E00	1.00E00
negative regulation of protein-containing complex disassembly (GO:0043242)	65	1	1.78	-	.56	1.00E00	1.00E00
cellular component assembly involved in morphogenesis (GO:0010927)	65	1	1.78	-	.56	1.00E00	1.00E00
cardiac septum development (GO:0003279)	65	1	1.78	-	.56	1.00E00	1.00E00
memory (GO:0007613)	65	1	1.78	-	.56	1.00E00	1.00E00
muscle tissue development (GO:0060537)	196	3	5.37	-	.56	4.99E-01	1.00E00
ossification (GO:0001503)	131	2	3.59	-	.56	5.88E-01	1.00E00
epidermis development (GO:0008544)	131	2	3.59	-	.56	5.88E-01	1.00E00
response to nutrient levels (GO:0031667)	197	3	5.40	-	.56	5.00E-01	1.00E00
regulation of mRNA metabolic process (GO:1903311)	197	3	5.40	-	.56	5.00E-01	1.00E00
liver development (GO:0001889)	66	1	1.81	-	.55	1.00E00	1.00E00
regulation of nervous system development (GO:0051960)	264	4	7.24	-	.55	3.32E-01	1.00E00
negative regulation of developmental growth (GO:0048640)	66	1	1.81	-	.55	1.00E00	1.00E00
cellular amino acid catabolic process (GO:0009063)	66	1	1.81	-	.55	1.00E00	1.00E00
plasma membrane bounded cell projection organization (GO:0120036)	662	10	18.15	-	.55	4.69E-02	1.00E00
neuron development (GO:0048666)	465	7	12.75	-	.55	1.08E-01	1.00E00
tissue development (GO:0009888)	931	14	25.53	-	.55	1.43E-02	1.00E00
regulation of supramolecular fiber organization (GO:1902903)	267	4	7.32	-	.55	3.34E-01	1.00E00
immune response-activating cell surface receptor signaling pathway (GO:0002429)	67	1	1.84	-	.54	1.00E00	1.00E00
regulation of protein acetylation (GO:1901983)	67	1	1.84	-	.54	1.00E00	1.00E00
positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060)	67	1	1.84	-	.54	1.00E00	1.00E00
positive regulation of neuron death (GO:1901216)	67	1	1.84	-	.54	1.00E00	1.00E00
positive regulation of protein localization to nucleus (GO:1900182)	67	1	1.84	-	.54	1.00E00	1.00E00
regulation of extent of cell growth (GO:0061387)	67	1	1.84	-	.54	1.00E00	1.00E00
immune response-activating signal transduction (GO:0002757)	67	1	1.84	-	.54	1.00E00	1.00E00
regulation of cell cycle (GO:0051726)	671	10	18.40	-	.54	4.73E-02	1.00E00
anterior/posterior pattern specification (GO:0009952)	135	2	3.70	-	.54	5.90E-01	1.00E00
regulation of lipid metabolic process (GO:0019216)	203	3	5.57	-	.54	3.81E-01	1.00E00
cell migration (GO:0016477)	406	6	11.13	-	.54	1.57E-01	1.00E00
ribonucleoprotein complex subunit organization (GO:0071826)	136	2	3.73	-	.54	5.91E-01	1.00E00
hematopoietic progenitor cell differentiation (GO:0002244)	68	1	1.86	-	.54	1.00E00	1.00E00
positive regulation of proteasomal protein catabolic process (GO:1901800)	68	1	1.86	-	.54	1.00E00	1.00E00
stress-activated protein kinase signaling cascade (GO:0031098)	68	1	1.86	-	.54	1.00E00	1.00E00
axoneme assembly (GO:0035082)	68	1	1.86	-	.54	1.00E00	1.00E00
immune response-regulating cell surface receptor signaling pathway (GO:0002768)	68	1	1.86	-	.54	1.00E00	1.00E00
regulation of heart contraction (GO:0008016)	68	1	1.86	-	.54	1.00E00	1.00E00
epithelial cell differentiation (GO:0030855)	273	4	7.49	-	.53	2.56E-01	1.00E00
regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092)	137	2	3.76	-	.53	5.91E-01	1.00E00
regulation of cell cycle process (GO:0010564)	411	6	11.27	-	.53	1.21E-01	1.00E00
positive regulation of cell cycle phase transition (GO:1901989)	69	1	1.89	-	.53	1.00E00	1.00E00
positive regulation of stress-activated MAPK cascade (GO:0032874)	69	1	1.89	-	.53	1.00E00	1.00E00
regulation of chromosome segregation (GO:0051983)	69	1	1.89	-	.53	1.00E00	1.00E00
regulation of protein depolymerization (GO:1901879)	69	1	1.89	-	.53	1.00E00	1.00E00
regulation of animal organ morphogenesis (GO:2000027)	69	1	1.89	-	.53	1.00E00	1.00E00
activation of MAPK activity (GO:0000187)	69	1	1.89	-	.53	1.00E00	1.00E00
immune response-regulating signaling pathway (GO:0002764)	69	1	1.89	-	.53	1.00E00	1.00E00
hepaticobiliary system development (GO:0061008)	69	1	1.89	-	.53	1.00E00	1.00E00
biological process involved in symbiotic interaction (GO:0044403)	139	2	3.81	-	.52	5.93E-01	1.00E00
phosphorylation (GO:0016310)	626	9	17.17	-	.52	4.11E-02	1.00E00
regulation of developmental growth (GO:0048638)	209	3	5.73	-	.52	3.84E-01	1.00E00
positive regulation of stress-activated protein kinase signaling cascade (GO:0070304)	70	1	1.92	-	.52	1.00E00	1.00E00
RNA 3'-end processing (GO:0031123)	70	1	1.92	-	.52	1.00E00	1.00E00
vesicle organization (GO:0016050)	140	2	3.84	-	.52	5.94E-01	1.00E00
cardiac chamber morphogenesis (GO:0003206)	70	1	1.92	-	.52	1.00E00	1.00E00
positive regulation of mRNA metabolic process (GO:1903313)	70	1	1.92	-	.52	1.00E00	1.00E00
supramolecular fiber organization (GO:0097435)	352	5	9.65	-	.52	1.77E-01	1.00E00
regulation of proteolysis involved in cellular protein catabolic process (GO:1903050)	141	2	3.87	-	.52	5.95E-01	1.00E00
skeletal system morphogenesis (GO:0048705)	141	2	3.87	-	.52	5.95E-01	1.00E00
regulation of protein ubiquitination (GO:0031396)	141	2	3.87	-	.52	5.95E-01	1.00E00
protein export from nucleus (GO:0006611)	71	1	1.95	-	.51	1.00E00	1.00E00
protein import into nucleus (GO:0006606)	71	1	1.95	-	.51	1.00E00	1.00E00
chromatin assembly or disassembly (GO:0006333)	71	1	1.95	-	.51	1.00E00	1.00E00
purine nucleotide biosynthetic process (GO:0006164)	71	1	1.95	-	.51	1.00E00	1.00E00
post-embryonic development (GO:0009791)	71	1	1.95	-	.51	1.00E00	1.00E00
positive regulation of plasma membrane bounded cell projection assembly (GO:0120034)	71	1	1.95	-	.51	1.00E00	1.00E00
regulation of GTPase activity (GO:0043087)	213	3	5.84	-	.51	3.87E-01	1.00E00
embryo development (GO:0009790)	713	10	19.55	-	.51	2.23E-02	1.00E00
regulation of cell cycle phase transition (GO:1901987)	214	3	5.87	-	.51	2.91E-01	1.00E00
cell adhesion (GO:0007155)	287	4	7.87	-	.51	1.97E-01	1.00E00
regulation of telomere maintenance (GO:0032204)	72	1	1.97	-	.51	1.00E00	1.00E00
histone acetylation (GO:0016573)	72	1	1.97	-	.51	1.00E00	1.00E00
ribonucleotide biosynthetic process (GO:0009260)	72	1	1.97	-	.51	1.00E00	1.00E00
regulation of cell morphogenesis involved in differentiation (GO:0010769)	72	1	1.97	-	.51	1.00E00	1.00E00
positive regulation of endocytosis (GO:0045807)	72	1	1.97	-	.51	1.00E00	1.00E00
biological adhesion (GO:0022610)	289	4	7.92	-	.50	1.97E-01	1.00E00
protein modification by small protein conjugation (GO:0032446)	363	5	9.95	-	.50	1.36E-01	1.00E00
neural tube closure (GO:0001843)	73	1	2.00	-	.50	7.25E-01	1.00E00
detection of stimulus (GO:0051606)	73	1	2.00	-	.50	7.25E-01	1.00E00
regulation of TOR signaling (GO:0032006)	73	1	2.00	-	.50	7.25E-01	1.00E00
regulation of G protein-coupled receptor signaling pathway (GO:0008277)	73	1	2.00	-	.50	7.25E-01	1.00E00
visual perception (GO:0007601)	73	1	2.00	-	.50	7.25E-01	1.00E00
tube closure (GO:0060606)	73	1	2.00	-	.50	7.25E-01	1.00E00
chromatin organization (GO:0006325)	440	6	12.07	-	.50	9.52E-02	1.00E00
cell morphogenesis involved in differentiation (GO:0000904)	294	4	8.06	-	.50	1.98E-01	1.00E00
cell morphogenesis involved in neuron differentiation (GO:0048667)	221	3	6.06	-	.50	2.92E-01	1.00E00
negative regulation of transcription by RNA polymerase II (GO:0000122)	591	8	16.21	-	.49	3.54E-02	1.00E00
regulation of dendrite development (GO:0050773)	74	1	2.03	-	.49	7.25E-01	1.00E00
regulation of receptor-mediated endocytosis (GO:0048259)	74	1	2.03	-	.49	7.25E-01	1.00E00
regulation of mRNA splicing, via spliceosome (GO:0048024)	74	1	2.03	-	.49	7.25E-01	1.00E00
digestive system development (GO:0055123)	74	1	2.03	-	.49	7.25E-01	1.00E00
double-strand break repair (GO:0006302)	149	2	4.09	-	.49	4.44E-01	1.00E00
mitotic spindle organization (GO:0007052)	75	1	2.06	-	.49	7.25E-01	1.00E00
cellular response to transforming growth factor beta stimulus (GO:0071560)	75	1	2.06	-	.49	7.25E-01	1.00E00
internal protein amino acid acetylation (GO:0006475)	75	1	2.06	-	.49	7.25E-01	1.00E00
internal peptidyl-lysine acetylation (GO:0018393)	75	1	2.06	-	.49	7.25E-01	1.00E00
sensory perception of light stimulus (GO:0050953)	75	1	2.06	-	.49	7.25E-01	1.00E00
negative regulation of protein transport (GO:0051224)	75	1	2.06	-	.49	7.25E-01	1.00E00
import into nucleus (GO:0051170)	75	1	2.06	-	.49	7.25E-01	1.00E00
regulation of canonical Wnt signaling pathway (GO:0060828)	150	2	4.11	-	.49	4.44E-01	1.00E00
developmental growth involved in morphogenesis (GO:0060560)	75	1	2.06	-	.49	7.25E-01	1.00E00
purine-containing compound biosynthetic process (GO:0072522)	75	1	2.06	-	.49	7.25E-01	1.00E00
protein modification by small protein conjugation or removal (GO:0070647)	452	6	12.39	-	.48	7.28E-02	1.00E00
neuron projection development (GO:0031175)	377	5	10.34	-	.48	1.04E-01	1.00E00
neuron migration (GO:0001764)	76	1	2.08	-	.48	7.25E-01	1.00E00
positive regulation of protein ubiquitination (GO:0031398)	76	1	2.08	-	.48	7.25E-01	1.00E00
nucleocytoplasmic transport (GO:0006913)	154	2	4.22	-	.47	4.47E-01	1.00E00
positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052)	77	1	2.11	-	.47	7.25E-01	1.00E00
negative regulation of nervous system development (GO:0051961)	77	1	2.11	-	.47	7.25E-01	1.00E00
peptidyl-lysine acetylation (GO:0018394)	77	1	2.11	-	.47	7.25E-01	1.00E00
organic hydroxy compound biosynthetic process (GO:1901617)	77	1	2.11	-	.47	7.25E-01	1.00E00
spindle assembly (GO:0051225)	77	1	2.11	-	.47	7.25E-01	1.00E00
negative regulation of neurogenesis (GO:0050768)	77	1	2.11	-	.47	7.25E-01	1.00E00
nuclear transport (GO:0051169)	154	2	4.22	-	.47	4.47E-01	1.00E00
ribose phosphate biosynthetic process (GO:0046390)	77	1	2.11	-	.47	7.25E-01	1.00E00
regulation of mitotic cell cycle (GO:0007346)	310	4	8.50	-	.47	1.51E-01	1.00E00
negative regulation of cell differentiation (GO:0045596)	388	5	10.64	-	.47	7.94E-02	1.00E00
response to inorganic substance (GO:0010035)	233	3	6.39	-	.47	2.21E-01	1.00E00
activation of GTPase activity (GO:0090630)	78	1	2.14	-	.47	7.26E-01	1.00E00
epidermal cell differentiation (GO:0009913)	78	1	2.14	-	.47	7.26E-01	1.00E00
positive regulation of cellular component biogenesis (GO:0044089)	312	4	8.56	-	.47	1.52E-01	1.00E00
dendrite development (GO:0016358)	78	1	2.14	-	.47	7.26E-01	1.00E00
regulation of cellular ketone metabolic process (GO:0010565)	78	1	2.14	-	.47	7.26E-01	1.00E00
phosphatidylinositol metabolic process (GO:0046488)	78	1	2.14	-	.47	7.26E-01	1.00E00
positive regulation of cell cycle (GO:0045787)	236	3	6.47	-	.46	2.21E-01	1.00E00
response to transforming growth factor beta (GO:0071559)	79	1	2.17	-	.46	7.26E-01	1.00E00
ear morphogenesis (GO:0042471)	79	1	2.17	-	.46	7.26E-01	1.00E00
negative regulation of cellular protein localization (GO:1903828)	79	1	2.17	-	.46	7.26E-01	1.00E00
regulation of response to DNA damage stimulus (GO:2001020)	160	2	4.39	-	.46	3.31E-01	1.00E00
regulation of cell junction assembly (GO:1901888)	80	1	2.19	-	.46	7.27E-01	1.00E00
primary neural tube formation (GO:0014020)	80	1	2.19	-	.46	7.27E-01	1.00E00
regulation of gene expression, epigenetic (GO:0040029)	80	1	2.19	-	.46	7.27E-01	1.00E00
nuclear export (GO:0051168)	80	1	2.19	-	.46	7.27E-01	1.00E00
negative regulation of establishment of protein localization (GO:1904950)	80	1	2.19	-	.46	7.27E-01	1.00E00
regulation of cellular protein catabolic process (GO:1903362)	160	2	4.39	-	.46	3.31E-01	1.00E00
extracellular matrix organization (GO:0030198)	161	2	4.41	-	.45	3.31E-01	1.00E00
localization of cell (GO:0051674)	485	6	13.30	-	.45	4.26E-02	1.00E00
cell motility (GO:0048870)	485	6	13.30	-	.45	4.26E-02	1.00E00
axonogenesis (GO:0007409)	162	2	4.44	-	.45	3.31E-01	1.00E00
determination of left/right symmetry (GO:0007368)	81	1	2.22	-	.45	7.27E-01	1.00E00
cellular response to insulin stimulus (GO:0032869)	81	1	2.22	-	.45	7.27E-01	1.00E00
external encapsulating structure organization (GO:0045229)	162	2	4.44	-	.45	3.31E-01	1.00E00
extracellular structure organization (GO:0043062)	162	2	4.44	-	.45	3.31E-01	1.00E00
locomotion (GO:0040011)	569	7	15.60	-	.45	2.26E-02	1.00E00
negative regulation of protein serine/threonine kinase activity (GO:0071901)	82	1	2.25	-	.44	7.28E-01	1.00E00
glycoprotein metabolic process (GO:0009100)	82	1	2.25	-	.44	7.28E-01	1.00E00
regulation of actin cytoskeleton organization (GO:0032956)	248	3	6.80	-	.44	1.66E-01	1.00E00
regulation of protein polymerization (GO:0032271)	166	2	4.55	-	.44	3.32E-01	1.00E00
fertilization (GO:0009566)	83	1	2.28	-	.44	7.29E-01	1.00E00
regulation of JNK cascade (GO:0046328)	83	1	2.28	-	.44	7.29E-01	1.00E00
skeletal muscle tissue development (GO:0007519)	83	1	2.28	-	.44	7.29E-01	1.00E00
histone modification (GO:0016570)	250	3	6.86	-	.44	1.66E-01	1.00E00
negative regulation of intracellular signal transduction (GO:1902532)	334	4	9.16	-	.44	8.64E-02	1.00E00
protein ubiquitination (GO:0016567)	337	4	9.24	-	.43	8.64E-02	1.00E00
covalent chromatin modification (GO:0016569)	254	3	6.97	-	.43	1.67E-01	1.00E00
hexose metabolic process (GO:0019318)	85	1	2.33	-	.43	7.31E-01	1.00E00
Ras protein signal transduction (GO:0007265)	85	1	2.33	-	.43	7.31E-01	1.00E00
determination of bilateral symmetry (GO:0009855)	85	1	2.33	-	.43	7.31E-01	1.00E00
positive regulation of angiogenesis (GO:0045766)	86	1	2.36	-	.42	7.32E-01	1.00E00
branching morphogenesis of an epithelial tube (GO:0048754)	86	1	2.36	-	.42	7.32E-01	1.00E00
specification of symmetry (GO:0009799)	86	1	2.36	-	.42	7.32E-01	1.00E00
response to radiation (GO:0009314)	258	3	7.07	-	.42	1.68E-01	1.00E00
positive regulation of vasculature development (GO:1904018)	86	1	2.36	-	.42	7.32E-01	1.00E00
skeletal muscle organ development (GO:0060538)	86	1	2.36	-	.42	7.32E-01	1.00E00
chemotaxis (GO:0006935)	174	2	4.77	-	.42	3.37E-01	1.00E00
neural tube formation (GO:0001841)	87	1	2.39	-	.42	7.33E-01	1.00E00
negative regulation of epithelial cell proliferation (GO:0050680)	87	1	2.39	-	.42	7.33E-01	1.00E00
regulation of protein-containing complex disassembly (GO:0043244)	88	1	2.41	-	.41	7.34E-01	1.00E00
positive regulation of small molecule metabolic process (GO:0062013)	88	1	2.41	-	.41	7.34E-01	1.00E00
taxis (GO:0042330)	176	2	4.83	-	.41	3.40E-01	1.00E00
axon development (GO:0061564)	177	2	4.85	-	.41	2.45E-01	1.00E00
protein dephosphorylation (GO:0006470)	89	1	2.44	-	.41	7.35E-01	1.00E00
regulation of DNA biosynthetic process (GO:2000278)	89	1	2.44	-	.41	7.35E-01	1.00E00
response to drug (GO:0042493)	89	1	2.44	-	.41	7.35E-01	1.00E00
circadian rhythm (GO:0007623)	89	1	2.44	-	.41	7.35E-01	1.00E00
regulation of actin filament-based process (GO:0032970)	267	3	7.32	-	.41	1.24E-01	1.00E00
regulation of small GTPase mediated signal transduction (GO:0051056)	179	2	4.91	-	.41	2.45E-01	1.00E00
response to light stimulus (GO:0009416)	179	2	4.91	-	.41	2.45E-01	1.00E00
regulation of anatomical structure morphogenesis (GO:0022603)	538	6	14.75	-	.41	1.87E-02	1.00E00
pattern specification process (GO:0007389)	270	3	7.40	-	.41	1.25E-01	1.00E00
actin filament organization (GO:0007015)	180	2	4.94	-	.41	2.45E-01	1.00E00
positive regulation of cellular protein catabolic process (GO:1903364)	90	1	2.47	-	.41	5.22E-01	1.00E00
regulation of fat cell differentiation (GO:0045598)	91	1	2.50	-	.40	5.22E-01	1.00E00
regulation of DNA repair (GO:0006282)	91	1	2.50	-	.40	5.22E-01	1.00E00
regulation of axonogenesis (GO:0050770)	91	1	2.50	-	.40	5.22E-01	1.00E00
brain development (GO:0007420)	366	4	10.04	-	.40	4.85E-02	1.00E00
cellular response to inorganic substance (GO:0071241)	92	1	2.52	-	.40	5.22E-01	1.00E00
negative regulation of DNA metabolic process (GO:0051053)	92	1	2.52	-	.40	5.22E-01	1.00E00
regulation of Wnt signaling pathway (GO:0030111)	184	2	5.05	-	.40	2.47E-01	1.00E00
skeletal system development (GO:0001501)	279	3	7.65	-	.39	9.24E-02	1.00E00
protein modification by small protein removal (GO:0070646)	93	1	2.55	-	.39	5.22E-01	1.00E00
mitotic cell cycle checkpoint (GO:0007093)	94	1	2.58	-	.39	5.23E-01	1.00E00
regulation of cell shape (GO:0008360)	94	1	2.58	-	.39	5.23E-01	1.00E00
cell junction assembly (GO:0034329)	94	1	2.58	-	.39	5.23E-01	1.00E00
regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434)	95	1	2.61	-	.38	5.23E-01	1.00E00
stem cell population maintenance (GO:0019827)	95	1	2.61	-	.38	5.23E-01	1.00E00
response to ionizing radiation (GO:0010212)	96	1	2.63	-	.38	5.24E-01	1.00E00
female gamete generation (GO:0007292)	96	1	2.63	-	.38	5.24E-01	1.00E00
microtubule bundle formation (GO:0001578)	96	1	2.63	-	.38	5.24E-01	1.00E00
embryonic organ development (GO:0048568)	288	3	7.90	-	.38	9.33E-02	1.00E00
regulation of muscle cell differentiation (GO:0051147)	96	1	2.63	-	.38	5.24E-01	1.00E00
cell morphogenesis (GO:0000902)	385	4	10.56	-	.38	3.60E-02	1.00E00
central nervous system development (GO:0007417)	485	5	13.30	-	.38	1.42E-02	1.00E00
maintenance of cell number (GO:0098727)	97	1	2.66	-	.38	5.24E-01	1.00E00
cartilage development (GO:0051216)	97	1	2.66	-	.38	5.24E-01	1.00E00
response to UV (GO:0009411)	98	1	2.69	-	.37	5.25E-01	1.00E00
regulation of cellular response to stress (GO:0080135)	397	4	10.89	-	.37	3.73E-02	1.00E00
protein import (GO:0017038)	100	1	2.74	-	.36	5.27E-01	1.00E00
regulation of cell morphogenesis (GO:0022604)	200	2	5.48	-	.36	1.82E-01	1.00E00
head development (GO:0060322)	401	4	11.00	-	.36	2.67E-02	1.00E00
embryonic epithelial tube formation (GO:0001838)	102	1	2.80	-	.36	5.30E-01	1.00E00
forebrain development (GO:0030900)	204	2	5.59	-	.36	1.84E-01	1.00E00
regionalization (GO:0003002)	206	2	5.65	-	.35	1.85E-01	1.00E00
glial cell differentiation (GO:0010001)	103	1	2.82	-	.35	5.31E-01	1.00E00
negative regulation of translation (GO:0017148)	103	1	2.82	-	.35	5.31E-01	1.00E00
negative regulation of cell development (GO:0010721)	103	1	2.82	-	.35	5.31E-01	1.00E00
epithelial tube formation (GO:0072175)	105	1	2.88	-	.35	5.34E-01	1.00E00
regulation of calcium ion transport (GO:0051924)	105	1	2.88	-	.35	5.34E-01	1.00E00
cellular response to radiation (GO:0071478)	105	1	2.88	-	.35	5.34E-01	1.00E00
regulation of cell size (GO:0008361)	106	1	2.91	-	.34	3.74E-01	1.00E00
cellular component morphogenesis (GO:0032989)	319	3	8.75	-	.34	5.07E-02	1.00E00
movement of cell or subcellular component (GO:0006928)	745	7	20.43	-	.34	8.66E-04	1.00E00
cellular response to peptide hormone stimulus (GO:0071375)	107	1	2.93	-	.34	3.74E-01	1.00E00
regulation of mRNA processing (GO:0050684)	107	1	2.93	-	.34	3.74E-01	1.00E00
regulation of metal ion transport (GO:0010959)	108	1	2.96	-	.34	3.74E-01	1.00E00
nucleotide biosynthetic process (GO:0009165)	109	1	2.99	-	.33	3.74E-01	1.00E00
epithelial tube morphogenesis (GO:0060562)	219	2	6.01	-	.33	1.34E-01	1.00E00
transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178)	110	1	3.02	-	.33	3.74E-01	1.00E00
regulation of stress-activated MAPK cascade (GO:0032872)	110	1	3.02	-	.33	3.74E-01	1.00E00
negative regulation of cellular amide metabolic process (GO:0034249)	110	1	3.02	-	.33	3.74E-01	1.00E00
transcription, DNA-templated (GO:0006351)	221	2	6.06	-	.33	1.35E-01	1.00E00
regulation of reproductive process (GO:2000241)	111	1	3.04	-	.33	3.75E-01	1.00E00
regulation of ubiquitin-dependent protein catabolic process (GO:2000058)	111	1	3.04	-	.33	3.75E-01	1.00E00
regulation of stress-activated protein kinase signaling cascade (GO:0070302)	111	1	3.04	-	.33	3.75E-01	1.00E00
nucleic acid-templated transcription (GO:0097659)	222	2	6.09	-	.33	1.36E-01	1.00E00
central nervous system neuron differentiation (GO:0021953)	111	1	3.04	-	.33	3.75E-01	1.00E00
protein phosphorylation (GO:0006468)	450	4	12.34	-	.32	1.06E-02	1.00E00
nucleoside phosphate biosynthetic process (GO:1901293)	113	1	3.10	-	.32	3.76E-01	1.00E00
RNA biosynthetic process (GO:0032774)	227	2	6.22	-	.32	9.60E-02	1.00E00
transport along microtubule (GO:0010970)	114	1	3.13	-	.32	3.77E-01	1.00E00
exocytosis (GO:0006887)	115	1	3.15	-	.32	3.78E-01	1.00E00
negative regulation of MAPK cascade (GO:0043409)	115	1	3.15	-	.32	3.78E-01	1.00E00
morphogenesis of embryonic epithelium (GO:0016331)	115	1	3.15	-	.32	3.78E-01	1.00E00
tube formation (GO:0035148)	115	1	3.15	-	.32	3.78E-01	1.00E00
positive regulation of binding (GO:0051099)	120	1	3.29	-	.30	3.84E-01	1.00E00
mesenchyme development (GO:0060485)	122	1	3.35	-	.30	2.66E-01	1.00E00
neuron projection morphogenesis (GO:0048812)	244	2	6.69	-	.30	6.96E-02	1.00E00
cell cycle checkpoint (GO:0000075)	123	1	3.37	-	.30	2.66E-01	1.00E00
response to starvation (GO:0042594)	123	1	3.37	-	.30	2.66E-01	1.00E00
plasma membrane bounded cell projection morphogenesis (GO:0120039)	247	2	6.77	-	.30	7.00E-02	1.00E00
cell projection morphogenesis (GO:0048858)	248	2	6.80	-	.29	7.02E-02	1.00E00
cellular response to nutrient levels (GO:0031669)	125	1	3.43	-	.29	2.66E-01	1.00E00
transcription by RNA polymerase II (GO:0006366)	126	1	3.46	-	.29	2.67E-01	1.00E00
protein localization to nucleus (GO:0034504)	126	1	3.46	-	.29	2.67E-01	1.00E00
embryonic morphogenesis (GO:0048598)	380	3	10.42	-	.29	1.42E-02	1.00E00
neural tube development (GO:0021915)	128	1	3.51	-	.28	2.67E-01	1.00E00
regulation of endocytosis (GO:0030100)	129	1	3.54	-	.28	2.68E-01	1.00E00
cell part morphogenesis (GO:0032990)	262	2	7.18	-	.28	5.04E-02	1.00E00
protein autophosphorylation (GO:0046777)	135	1	3.70	-	.27	2.74E-01	1.00E00
cytoskeleton-dependent intracellular transport (GO:0030705)	137	1	3.76	-	.27	2.76E-01	1.00E00
microtubule-based transport (GO:0099111)	142	1	3.89	-	.26	1.89E-01	1.00E00
heart morphogenesis (GO:0003007)	143	1	3.92	-	.26	1.90E-01	1.00E00
protein-containing complex localization (GO:0031503)	143	1	3.92	-	.26	1.90E-01	1.00E00
small GTPase mediated signal transduction (GO:0007264)	147	1	4.03	-	.25	1.92E-01	1.00E00
regulation of angiogenesis (GO:0045765)	149	1	4.09	-	.24	1.93E-01	1.00E00
cellular response to abiotic stimulus (GO:0071214)	149	1	4.09	-	.24	1.93E-01	1.00E00
peptidyl-serine phosphorylation (GO:0018105)	149	1	4.09	-	.24	1.93E-01	1.00E00
cellular response to environmental stimulus (GO:0104004)	149	1	4.09	-	.24	1.93E-01	1.00E00
regulation of vasculature development (GO:1901342)	150	1	4.11	-	.24	1.94E-01	1.00E00
positive regulation of protein-containing complex assembly (GO:0031334)	153	1	4.20	-	.24	1.97E-01	1.00E00
positive regulation of GTPase activity (GO:0043547)	157	1	4.31	-	.23	1.34E-01	1.00E00
endosomal transport (GO:0016197)	157	1	4.31	-	.23	1.34E-01	1.00E00
regulation of Ras protein signal transduction (GO:0046578)	159	1	4.36	-	.23	1.34E-01	1.00E00
negative regulation of cellular catabolic process (GO:0031330)	160	1	4.39	-	.23	1.34E-01	1.00E00
peptidyl-serine modification (GO:0018209)	162	1	4.44	-	.23	1.35E-01	1.00E00
negative regulation of growth (GO:0045926)	162	1	4.44	-	.23	1.35E-01	1.00E00
peptidyl-lysine modification (GO:0018205)	181	1	4.96	-	.20	9.72E-02	1.00E00
embryonic organ morphogenesis (GO:0048562)	191	1	5.24	-	.19	6.66E-02	1.00E00
negative regulation of catabolic process (GO:0009895)	200	1	5.48	-	.18	4.61E-02	1.00E00
microtubule-based movement (GO:0007018)	244	1	6.69	-	.15	2.38E-02	1.00E00
respiratory burst involved in defense response (GO:0002679)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
response to lead ion (GO:0010288)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of chronic inflammatory response (GO:0002678)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
heat acclimation (GO:0010286)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
carbohydrate transmembrane transport (GO:0034219)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
protein hexamerization (GO:0034214)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
quinolinate catabolic process (GO:0034213)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of T cell anergy (GO:0002669)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of T cell anergy (GO:0002667)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
positive regulation of T cell tolerance induction (GO:0002666)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of T cell tolerance induction (GO:0002664)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
detoxification of copper ion (GO:0010273)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of B cell tolerance induction (GO:0002663)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of B cell tolerance induction (GO:0002661)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of peripheral tolerance induction (GO:0002660)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
amyloid-beta formation (GO:0034205)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to oleic acid (GO:0034201)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to selenium ion (GO:0010269)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of peripheral tolerance induction (GO:0002658)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
SCF complex assembly (GO:0010265)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of tolerance induction dependent upon immune response (GO:0002654)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of tolerance induction dependent upon immune response (GO:0002652)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
animal organ senescence (GO:0010260)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of chromatin assembly or disassembly (GO:0045798)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of intestinal cholesterol absorption (GO:0045797)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell volume (GO:0045794)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of cell size (GO:0045793)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell size (GO:0045792)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
multicellular organism aging (GO:0010259)	27	0	.74	-	 < 0.01	1.00E00	1.00E00
positive regulation of central tolerance induction (GO:0002648)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of central tolerance induction (GO:0002646)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
glucose mediated signaling pathway (GO:0010255)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of tolerance induction (GO:0002645)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of tolerance induction (GO:0002643)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
positive regulation of bone resorption (GO:0045780)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
positive regulation of germinal center formation (GO:0002636)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of germinal center formation (GO:0002635)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of germinal center formation (GO:0002634)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of granuloma formation (GO:0002632)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of granuloma formation (GO:0002631)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of axon extension (GO:0045773)	30	0	.82	-	 < 0.01	1.00E00	1.00E00
positive regulation of asymmetric cell division (GO:0045770)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of asymmetric cell division (GO:0045769)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of cellular amino acid metabolic process (GO:0045764)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of adenylate cyclase activity (GO:0045762)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of adenylate cyclase activity (GO:0045761)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of action potential (GO:0045760)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
response to lithium ion (GO:0010226)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
response to UV-B (GO:0010224)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
negative regulation of action potential (GO:0045759)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of Toll signaling pathway (GO:0045751)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
maintenance of DNA methylation (GO:0010216)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
positive regulation of dendritic cell antigen processing and presentation (GO:0002606)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of dendritic cell antigen processing and presentation (GO:0002605)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of dendritic cell antigen processing and presentation (GO:0002604)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of hexokinase activity (GO:1903299)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway (GO:1903298)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of hypoxia-induced intrinsic apoptotic signaling pathway (GO:1903297)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of Notch signaling pathway (GO:0045747)	23	0	.63	-	 < 0.01	1.00E00	1.00E00
positive regulation of glutamate secretion, neurotransmission (GO:1903296)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of Notch signaling pathway (GO:0045746)	20	0	.55	-	 < 0.01	1.00E00	1.00E00
regulation of glutamate secretion, neurotransmission (GO:1903294)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of G protein-coupled receptor signaling pathway (GO:0045744)	30	0	.82	-	 < 0.01	1.00E00	1.00E00
positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
positive regulation of epidermal growth factor-activated receptor activity (GO:0045741)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of DNA repair (GO:0045739)	52	0	1.43	-	 < 0.01	4.05E-01	1.00E00
positive regulation of potassium ion import across plasma membrane (GO:1903288)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of DNA repair (GO:0045738)	23	0	.63	-	 < 0.01	1.00E00	1.00E00
arginine catabolic process to proline (GO:0019493)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of potassium ion import (GO:1903286)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
positive regulation of hydrogen peroxide catabolic process (GO:1903285)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of glutathione peroxidase activity (GO:1903284)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of glutathione peroxidase activity (GO:1903282)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cerebral cortex radially oriented cell migration (GO:0021799)	21	0	.58	-	 < 0.01	1.00E00	1.00E00
forebrain dorsal/ventral pattern formation (GO:0021798)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
forebrain anterior/posterior pattern specification (GO:0021797)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cerebral cortex regionalization (GO:0021796)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cerebral cortex cell migration (GO:0021795)	28	0	.77	-	 < 0.01	1.00E00	1.00E00
thalamus development (GO:0021794)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
beta-alanine biosynthetic process (GO:0019483)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
beta-alanine metabolic process (GO:0019482)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of integrin biosynthetic process (GO:0045726)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
L-alanine catabolic process, by transamination (GO:0019481)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of glycogen biosynthetic process (GO:0045725)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
positive regulation of fatty acid biosynthetic process (GO:0045723)	17	0	.47	-	 < 0.01	1.00E00	1.00E00
positive regulation of gluconeogenesis (GO:0045722)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
negative regulation of integrin biosynthetic process (GO:0045720)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
ribosome localization (GO:0033750)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
postganglionic parasympathetic fiber development (GO:0021784)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
preganglionic parasympathetic fiber development (GO:0021783)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
D-amino acid catabolic process (GO:0019478)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
glial cell fate commitment (GO:0021781)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
L-lysine catabolic process (GO:0019477)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
glial cell fate specification (GO:0021780)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of glycogen biosynthetic process (GO:0045719)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
L-lysine catabolic process to acetyl-CoA (GO:0019474)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of fatty acid biosynthetic process (GO:0045717)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
4-hydroxyproline metabolic process (GO:0019471)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
4-hydroxyproline catabolic process (GO:0019470)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
oligodendrocyte cell fate commitment (GO:0021779)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
oligodendrocyte cell fate specification (GO:0021778)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
smoothened signaling pathway involved in spinal cord motor neuron cell fate specification (GO:0021776)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
smoothened signaling pathway involved in ventral spinal cord interneuron specification (GO:0021775)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
striatal medium spiny neuron differentiation (GO:0021773)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
olfactory bulb development (GO:0021772)	19	0	.52	-	 < 0.01	1.00E00	1.00E00
exon-exon junction complex disassembly (GO:1903259)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
glycine decarboxylation via glycine cleavage system (GO:0019464)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
ectoderm and mesoderm interaction (GO:0007499)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
endodermal cell fate determination (GO:0007493)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
endoderm development (GO:0007492)	50	0	1.37	-	 < 0.01	6.45E-01	1.00E00
nucleus accumbens development (GO:0021768)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mammillary body development (GO:0021767)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
hippocampus development (GO:0021766)	44	0	1.21	-	 < 0.01	6.32E-01	1.00E00
amygdala development (GO:0021764)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
subthalamic nucleus development (GO:0021763)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
substantia nigra development (GO:0021762)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
limbic system development (GO:0021761)	55	0	1.51	-	 < 0.01	4.06E-01	1.00E00
positive regulation of cardiac muscle hypertrophy in response to stress (GO:1903244)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
U2-type prespliceosome assembly (GO:1903241)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
globus pallidus development (GO:0021759)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
striatum development (GO:0021756)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
facial nucleus development (GO:0021754)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
pronephric nephron tubule development (GO:0039020)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
L-cysteine catabolic process to hypotaurine (GO:0019449)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of leukocyte tethering or rolling (GO:1903238)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of leukocyte tethering or rolling (GO:1903237)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of leukocyte tethering or rolling (GO:1903236)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
tryptophan catabolic process to acetyl-CoA (GO:0019442)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
tryptophan catabolic process to kynurenine (GO:0019441)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of calcium ion-dependent exocytosis of neurotransmitter (GO:1903233)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
pronephric nephron development (GO:0039019)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
pattern specification involved in pronephros development (GO:0039017)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cochlear nucleus development (GO:0021747)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
embryonic skeletal joint development (GO:0072498)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
principal sensory nucleus of trigeminal nerve development (GO:0021740)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mesenchymal stem cell differentiation (GO:0072497)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
triglyceride catabolic process (GO:0019433)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
positive regulation of endodermal cell differentiation (GO:1903226)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
triglyceride biosynthetic process (GO:0019432)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
negative regulation of endodermal cell differentiation (GO:1903225)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of endodermal cell differentiation (GO:1903224)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
removal of superoxide radicals (GO:0019430)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
positive regulation of oxidative stress-induced neuron death (GO:1903223)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
DNA integration (GO:0015074)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
pronephric nephron tubule morphogenesis (GO:0039008)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
pronephric nephron morphogenesis (GO:0039007)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
phospholipid efflux (GO:0033700)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
pronephric field specification (GO:0039003)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
midbrain-hindbrain boundary maturation (GO:0021732)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
acetyl-CoA biosynthetic process from acetate (GO:0019427)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
trigeminal sensory nucleus development (GO:0021730)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein processing involved in protein targeting to mitochondrion (GO:1903217)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of protein processing involved in protein targeting to mitochondrion (GO:1903216)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein targeting to mitochondrion (GO:1903215)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of protein targeting to mitochondrion (GO:1903214)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
renal sodium ion transport (GO:0003096)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
glomerular filtration (GO:0003094)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
renal water homeostasis (GO:0003091)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
medullary reticular formation development (GO:0021723)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
superior olivary nucleus maturation (GO:0021722)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
sulfide oxidation (GO:0019418)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
sulfur oxidation (GO:0019417)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of oxidative stress-induced cell death (GO:1903209)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
negative regulation of hydrogen peroxide-induced neuron death (GO:1903208)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of hydrogen peroxide-induced neuron death (GO:1903207)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
acetate biosynthetic process (GO:0019413)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of hydrogen peroxide-induced cell death (GO:1903206)	18	0	.49	-	 < 0.01	1.00E00	1.00E00
regulation of hydrogen peroxide-induced cell death (GO:1903205)	24	0	.66	-	 < 0.01	1.00E00	1.00E00
negative regulation of oxidative stress-induced neuron death (GO:1903204)	19	0	.52	-	 < 0.01	1.00E00	1.00E00
regulation of oxidative stress-induced neuron death (GO:1903203)	23	0	.63	-	 < 0.01	1.00E00	1.00E00
negative regulation of oxidative stress-induced cell death (GO:1903202)	40	0	1.10	-	 < 0.01	6.28E-01	1.00E00
regulation of oxidative stress-induced cell death (GO:1903201)	55	0	1.51	-	 < 0.01	4.06E-01	1.00E00
positive regulation of L-dopa decarboxylase activity (GO:1903200)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
hindgut morphogenesis (GO:0007442)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
foregut morphogenesis (GO:0007440)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
superior olivary nucleus development (GO:0021718)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of behavioral fear response (GO:2000987)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of behavioral fear response (GO:2000986)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
hexitol catabolic process (GO:0019407)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
hexitol biosynthetic process (GO:0019406)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of ATP citrate synthase activity (GO:2000984)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
alditol catabolic process (GO:0019405)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of ATP citrate synthase activity (GO:2000983)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of inner ear receptor cell differentiation (GO:2000982)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of inner ear receptor cell differentiation (GO:2000981)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
galactitol metabolic process (GO:0019402)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of inner ear receptor cell differentiation (GO:2000980)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
alditol biosynthetic process (GO:0019401)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
alditol metabolic process (GO:0019400)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
ectodermal digestive tract development (GO:0007439)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
lung induction (GO:0060492)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure (GO:0003072)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cerebellar granule cell differentiation (GO:0021707)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of systemic arterial blood pressure by neurotransmitter (GO:0003070)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of forebrain neuron differentiation (GO:2000979)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of forebrain neuron differentiation (GO:2000978)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cerebellar Purkinje cell differentiation (GO:0021702)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
regulation of forebrain neuron differentiation (GO:2000977)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of pro-B cell differentiation (GO:2000974)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of pro-B cell differentiation (GO:2000973)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of detection of glucose (GO:2000971)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of detection of glucose (GO:2000970)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
lung epithelial cell differentiation (GO:0060487)	20	0	.55	-	 < 0.01	1.00E00	1.00E00
club cell differentiation (GO:0060486)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
lung-associated mesenchyme development (GO:0060484)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
lobar bronchus development (GO:0060482)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
lobar bronchus epithelium development (GO:0060481)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
acetylcholine-mediated vasodilation involved in regulation of systemic arterial blood pressure (GO:0003069)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
lung goblet cell differentiation (GO:0060480)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of systemic arterial blood pressure by acetylcholine (GO:0003068)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of AMPA receptor activity (GO:2000969)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
lung cell differentiation (GO:0060479)	21	0	.58	-	 < 0.01	1.00E00	1.00E00
ventral midline development (GO:0007418)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
acrosomal vesicle exocytosis (GO:0060478)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
axonal fasciculation (GO:0007413)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
axon target recognition (GO:0007412)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
axon guidance (GO:0007411)	92	0	2.52	-	 < 0.01	1.81E-01	1.00E00
positive regulation of cytosolic calcium ion concentration involved in egg activation (GO:0060470)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of the force of heart contraction by chemical signal (GO:0003057)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of vascular associated smooth muscle contraction (GO:0003056)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
angiotensin-mediated drinking behavior (GO:0003051)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of systemic arterial blood pressure by atrial natriuretic peptide (GO:0003050)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
signal transduction involved in mitotic G2 DNA damage checkpoint (GO:0072434)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
prevention of polyspermy (GO:0060468)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of fertilization (GO:0060467)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
heparan sulfate proteoglycan biosynthetic process, enzymatic modification (GO:0015015)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
activation of meiosis involved in egg activation (GO:0060466)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
neuroblast proliferation (GO:0007405)	17	0	.47	-	 < 0.01	1.00E00	1.00E00
heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0015014)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
pharynx development (GO:0060465)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
lung lobe formation (GO:0060464)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
glial cell fate determination (GO:0007403)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
heparan sulfate proteoglycan biosynthetic process (GO:0015012)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
lung lobe morphogenesis (GO:0060463)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
lung lobe development (GO:0060462)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
left lung morphogenesis (GO:0060460)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
phenol-containing compound biosynthetic process (GO:0046189)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
aldehyde catabolic process (GO:0046185)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
response to intra-S DNA damage checkpoint signaling (GO:0072429)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
aldehyde biosynthetic process (GO:0046184)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
signal transduction involved in intra-S DNA damage checkpoint (GO:0072428)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
signal transduction involved in G2 DNA damage checkpoint (GO:0072425)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
response to DNA damage checkpoint signaling (GO:0072423)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
signal transduction involved in DNA damage checkpoint (GO:0072422)	19	0	.52	-	 < 0.01	1.00E00	1.00E00
left lung development (GO:0060459)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of digestive system process (GO:0060457)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
positive regulation of digestive system process (GO:0060456)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
somatic sex determination (GO:0018993)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of gastric acid secretion (GO:0060455)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
germ-line sex determination (GO:0018992)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of gastric acid secretion (GO:0060453)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of cardiac muscle contraction (GO:0060452)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
detection of oxygen (GO:0003032)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
D-gluconate catabolic process (GO:0046177)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
aldonic acid catabolic process (GO:0046176)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
polyol catabolic process (GO:0046174)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
polyol biosynthetic process (GO:0046173)	31	0	.85	-	 < 0.01	1.00E00	1.00E00
signal transduction involved in mitotic cell cycle checkpoint (GO:0072413)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
bud elongation involved in lung branching (GO:0060449)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
dichotomous subdivision of terminal units involved in lung branching (GO:0060448)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
branching involved in mammary gland duct morphogenesis (GO:0060444)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
mitochondrial large ribosomal subunit assembly (GO:1902775)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
mammary gland morphogenesis (GO:0060443)	24	0	.66	-	 < 0.01	1.00E00	1.00E00
late endosome to lysosome transport (GO:1902774)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
branching involved in prostate gland morphogenesis (GO:0060442)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
epithelial tube branching involved in lung morphogenesis (GO:0060441)	17	0	.47	-	 < 0.01	1.00E00	1.00E00
trachea formation (GO:0060440)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
glycerol-3-phosphate catabolic process (GO:0046168)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
glycerol-3-phosphate biosynthetic process (GO:0046167)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
glyceraldehyde-3-phosphate biosynthetic process (GO:0046166)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
alcohol catabolic process (GO:0046164)	25	0	.69	-	 < 0.01	1.00E00	1.00E00
activation of protein kinase A activity (GO:0034199)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to amino acid starvation (GO:0034198)	34	0	.93	-	 < 0.01	1.00E00	1.00E00
response to DNA integrity checkpoint signaling (GO:0072402)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
triglyceride transport (GO:0034197)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
signal transduction involved in DNA integrity checkpoint (GO:0072401)	19	0	.52	-	 < 0.01	1.00E00	1.00E00
acylglycerol transport (GO:0034196)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
trachea morphogenesis (GO:0060439)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
trachea development (GO:0060438)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
isoprenoid biosynthetic process via mevalonate (GO:1902767)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
bronchiole development (GO:0060435)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
bronchus morphogenesis (GO:0060434)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
bronchus development (GO:0060433)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
primary lung bud formation (GO:0060431)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
lung saccule development (GO:0060430)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
lymph circulation (GO:0003017)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
respiratory system process (GO:0003016)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
involuntary skeletal muscle contraction (GO:0003011)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
voluntary skeletal muscle contraction (GO:0003010)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
mRNA methylation (GO:0080009)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
positive regulation of sterol import (GO:2000911)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of sterol import (GO:2000910)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of maintenance of mitotic sister chromatid cohesion (GO:0034184)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
lung epithelium development (GO:0060428)	27	0	.74	-	 < 0.01	1.00E00	1.00E00
negative regulation of maintenance of mitotic sister chromatid cohesion (GO:0034183)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of maintenance of mitotic sister chromatid cohesion (GO:0034182)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
lung vasculature development (GO:0060426)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
lung morphogenesis (GO:0060425)	35	0	.96	-	 < 0.01	1.00E00	1.00E00
4-nitrophenol metabolic process (GO:0018960)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
nuclear pore organization (GO:0006999)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
positive regulation of heart growth (GO:0060421)	27	0	.74	-	 < 0.01	1.00E00	1.00E00
regulation of heart growth (GO:0060420)	45	0	1.23	-	 < 0.01	6.34E-01	1.00E00
positive regulation of cell cycle G2/M phase transition (GO:1902751)	19	0	.52	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell cycle G2/M phase transition (GO:1902750)	46	0	1.26	-	 < 0.01	6.36E-01	1.00E00
cellular response to nitrogen starvation (GO:0006995)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
response to sterol depletion (GO:0006991)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response (GO:0006990)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
pigment catabolic process (GO:0046149)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
pigment biosynthetic process (GO:0046148)	23	0	.63	-	 < 0.01	1.00E00	1.00E00
regulation of sterol import (GO:2000909)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
tetrahydrobiopterin metabolic process (GO:0046146)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
D-alanine family amino acid metabolic process (GO:0046144)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
heart growth (GO:0060419)	22	0	.60	-	 < 0.01	1.00E00	1.00E00
regulation of cell cycle G2/M phase transition (GO:1902749)	73	0	2.00	-	 < 0.01	2.68E-01	1.00E00
positive regulation of lens fiber cell differentiation (GO:1902748)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
response to growth hormone (GO:0060416)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
negative regulation of lens fiber cell differentiation (GO:1902747)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of lens fiber cell differentiation (GO:1902746)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
aorta smooth muscle tissue morphogenesis (GO:0060414)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of lamellipodium organization (GO:1902745)	26	0	.71	-	 < 0.01	1.00E00	1.00E00
atrial septum morphogenesis (GO:0060413)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
negative regulation of lamellipodium organization (GO:1902744)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
imidazole-containing compound metabolic process (GO:0052803)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
ventricular septum morphogenesis (GO:0060412)	21	0	.58	-	 < 0.01	1.00E00	1.00E00
regulation of lamellipodium organization (GO:1902743)	32	0	.88	-	 < 0.01	1.00E00	1.00E00
cardiac septum morphogenesis (GO:0060411)	39	0	1.07	-	 < 0.01	6.27E-01	1.00E00
apoptotic process involved in development (GO:1902742)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
ER-nucleus signaling pathway (GO:0006984)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
ER overload response (GO:0006983)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
response to lipid hydroperoxide (GO:0006982)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of vitamin metabolic process (GO:0046137)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
positive regulation of vitamin metabolic process (GO:0046136)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
pyrimidine nucleoside catabolic process (GO:0046135)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
pyrimidine ribonucleoside catabolic process (GO:0046133)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
pyrimidine ribonucleoside metabolic process (GO:0046131)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
purine ribonucleoside catabolic process (GO:0046130)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
positive regulation of toll-like receptor 9 signaling pathway (GO:0034165)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of toll-like receptor 9 signaling pathway (GO:0034164)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of toll-like receptor 9 signaling pathway (GO:0034163)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of penile erection (GO:0060407)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
toll-like receptor 9 signaling pathway (GO:0034162)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
positive regulation of penile erection (GO:0060406)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of toll-like receptor 8 signaling pathway (GO:0034161)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of penile erection (GO:0060405)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
axonemal microtubule depolymerization (GO:0060404)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
calcium ion transport into cytosol (GO:0060402)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
cytosolic calcium ion transport (GO:0060401)	17	0	.47	-	 < 0.01	1.00E00	1.00E00
positive regulation of chondrocyte proliferation (GO:1902732)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
negative regulation of growth hormone receptor signaling pathway (GO:0060400)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of chondrocyte proliferation (GO:1902731)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of proteoglycan biosynthetic process (GO:1902730)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
DNA damage induced protein phosphorylation (GO:0006975)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
hyperosmotic response (GO:0006972)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
hypotonic response (GO:0006971)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
purine ribonucleoside biosynthetic process (GO:0046129)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
pyrimidine deoxyribonucleoside catabolic process (GO:0046127)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
pyrimidine deoxyribonucleoside metabolic process (GO:0046125)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
purine deoxyribonucleoside catabolic process (GO:0046124)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
purine deoxyribonucleoside metabolic process (GO:0046122)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
deoxyribonucleoside catabolic process (GO:0046121)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of toll-like receptor 8 signaling pathway (GO:0034159)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of toll-like receptor 7 signaling pathway (GO:0034157)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of toll-like receptor 7 signaling pathway (GO:0034155)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
toll-like receptor 7 signaling pathway (GO:0034154)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of growth factor dependent skeletal muscle satellite cell proliferation (GO:1902728)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of satellite cell differentiation (GO:1902725)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
naphthalene metabolic process (GO:0018931)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of skeletal muscle satellite cell proliferation (GO:1902724)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of skeletal muscle satellite cell proliferation (GO:1902723)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of prolactin secretion (GO:1902722)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular defense response (GO:0006968)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of prolactin secretion (GO:1902721)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria (GO:0006965)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of antibacterial peptide biosynthetic process (GO:0006963)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
nucleobase catabolic process (GO:0046113)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
nucleobase biosynthetic process (GO:0046112)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
xanthine biosynthetic process (GO:0046111)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
xanthine metabolic process (GO:0046110)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of toll-like receptor 5 signaling pathway (GO:0034148)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of toll-like receptor 5 signaling pathway (GO:0034147)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein localization to spindle pole body (GO:0071988)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of toll-like receptor 4 signaling pathway (GO:0034145)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
negative regulation of toll-like receptor 4 signaling pathway (GO:0034144)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of toll-like receptor 4 signaling pathway (GO:0034143)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
positive regulation of toll-like receptor 3 signaling pathway (GO:0034141)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of toll-like receptor 3 signaling pathway (GO:0034140)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
complement activation, alternative pathway (GO:0006957)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
uridine metabolic process (GO:0046108)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
thymidine metabolic process (GO:0046104)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
inosine biosynthetic process (GO:0046103)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
inosine metabolic process (GO:0046102)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
hypoxanthine biosynthetic process (GO:0046101)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
hypoxanthine metabolic process (GO:0046100)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of toll-like receptor 3 signaling pathway (GO:0034139)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
toll-like receptor 3 signaling pathway (GO:0034138)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of toll-like receptor 2 signaling pathway (GO:0034137)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of toll-like receptor 2 signaling pathway (GO:0034136)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of toll-like receptor 2 signaling pathway (GO:0034135)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
nitrobenzene metabolic process (GO:0018916)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
syncytium formation (GO:0006949)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II (GO:0002581)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II (GO:0002580)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034128)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of toll-like receptor signaling pathway (GO:0034123)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
ether metabolic process (GO:0018904)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
establishment or maintenance of cell polarity regulating cell shape (GO:0071963)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
mitotic sister chromatid cohesion, centromeric (GO:0071962)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
dichloromethane metabolic process (GO:0018900)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
smooth muscle contraction (GO:0006939)	18	0	.49	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell adhesion involved in substrate-bound cell migration (GO:0006933)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
substrate-dependent cell migration, cell attachment to substrate (GO:0006931)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
vitamin E biosynthetic process (GO:0010189)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of antigen processing and presentation (GO:0002579)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
substrate-dependent cell migration, cell extension (GO:0006930)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of antigen processing and presentation (GO:0002578)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of antigen processing and presentation (GO:0002577)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
platelet degranulation (GO:0002576)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
sugar mediated signaling pathway (GO:0010182)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
pro-T cell differentiation (GO:0002572)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of heterotypic cell-cell adhesion (GO:0034116)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
heterotypic cell-cell adhesion (GO:0034113)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
recycling endosome to Golgi transport (GO:0071955)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of homotypic cell-cell adhesion (GO:0034112)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
chemokine (C-C motif) ligand 11 production (GO:0071954)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
conversion of methionyl-tRNA to N-formyl-methionyl-tRNA (GO:0071951)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
activation-induced cell death of T cells (GO:0006924)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
somatic diversification of T cell receptor genes (GO:0002568)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
somatic diversification of immune receptors via somatic mutation (GO:0002566)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
embryonic body morphogenesis (GO:0010172)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
somatic diversification of immune receptors via germline recombination within a single locus (GO:0002562)	29	0	.80	-	 < 0.01	1.00E00	1.00E00
body morphogenesis (GO:0010171)	32	0	.88	-	 < 0.01	1.00E00	1.00E00
basophil degranulation (GO:0002561)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
basophil mediated immunity (GO:0002560)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of tissue remodeling (GO:0034105)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
protein deubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0071947)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
nitrogen cycle metabolic process (GO:0071941)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
phagocytosis, engulfment (GO:0006911)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
phagocytosis, recognition (GO:0006910)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
response to X-ray (GO:0010165)	21	0	.58	-	 < 0.01	1.00E00	1.00E00
serotonin secretion by platelet (GO:0002554)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
histamine secretion by mast cell (GO:0002553)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
vitamin A import (GO:0071939)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
vitamin A transport (GO:0071938)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
replication fork reversal (GO:0071932)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0071931)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0071930)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
pinocytosis (GO:0006907)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
vesicle fusion (GO:0006906)	38	0	1.04	-	 < 0.01	6.27E-01	1.00E00
vesicle targeting (GO:0006903)	24	0	.66	-	 < 0.01	1.00E00	1.00E00
vesicle coating (GO:0006901)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
specification of animal organ position (GO:0010159)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
chronic inflammatory response (GO:0002544)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
Factor XII activation (GO:0002542)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
leukotriene production involved in inflammatory response (GO:0002540)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of glial cell differentiation (GO:0045686)	19	0	.52	-	 < 0.01	1.00E00	1.00E00
alpha-tubulin acetylation (GO:0071929)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of epidermis development (GO:0045684)	17	0	.47	-	 < 0.01	1.00E00	1.00E00
negative regulation of epidermis development (GO:0045683)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
regulation of epidermis development (GO:0045682)	41	0	1.12	-	 < 0.01	6.28E-01	1.00E00
regulation of cohesin loading (GO:0071922)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
cohesin loading (GO:0071921)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
prostaglandin production involved in inflammatory response (GO:0002539)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
arachidonic acid metabolite production involved in inflammatory response (GO:0002538)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
respiratory burst involved in inflammatory response (GO:0002536)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cytokine production involved in inflammatory response (GO:0002534)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
farnesyl diphosphate biosynthetic process, mevalonate pathway (GO:0010142)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
production of molecular mediator involved in inflammatory response (GO:0002532)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
G-quadruplex DNA formation (GO:0071919)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of osteoclast differentiation (GO:0045672)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
determination of liver left/right asymmetry (GO:0071910)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
pyrimidine ribonucleotide salvage (GO:0010138)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of vascular permeability involved in acute inflammatory response (GO:0002528)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
acute inflammatory response to non-antigenic stimulus (GO:0002525)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
proline catabolic process to glutamate (GO:0010133)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of osteoblast differentiation (GO:0045668)	34	0	.93	-	 < 0.01	1.00E00	1.00E00
determination of stomach left/right asymmetry (GO:0071909)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
determination of intestine left/right asymmetry (GO:0071908)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of myoblast differentiation (GO:0045663)	19	0	.52	-	 < 0.01	1.00E00	1.00E00
determination of digestive tract left/right asymmetry (GO:0071907)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of myoblast differentiation (GO:0045662)	17	0	.47	-	 < 0.01	1.00E00	1.00E00
positive regulation of neutrophil differentiation (GO:0045660)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
neurofilament bundle assembly (GO:0033693)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of osteoblast proliferation (GO:0033690)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
lymphocyte chemotaxis across high endothelial venule (GO:0002518)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
T cell tolerance induction (GO:0002517)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
phenylacetate catabolic process (GO:0010124)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
tolerance induction to self antigen (GO:0002513)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
arginine catabolic process to proline via ornithine (GO:0010121)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of neutrophil differentiation (GO:0045659)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of neutrophil differentiation (GO:0045658)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of monocyte differentiation (GO:0045657)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of monocyte differentiation (GO:0045656)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of monocyte differentiation (GO:0045655)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
positive regulation of megakaryocyte differentiation (GO:0045654)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
positive regulation of macrophage differentiation (GO:0045651)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
negative regulation of macrophage differentiation (GO:0045650)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of osteoblast proliferation (GO:0033689)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
regulation of osteoblast proliferation (GO:0033688)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
osteoblast proliferation (GO:0033687)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
nucleotide-excision repair, DNA incision (GO:0033683)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
central tolerance induction to self antigen (GO:0002509)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
central tolerance induction (GO:0002508)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
tolerance induction (GO:0002507)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
antigen processing and presentation of peptide or polysaccharide antigen via MHC class II (GO:0002504)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
peptide antigen assembly with MHC class I protein complex (GO:0002502)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
peptide antigen assembly with MHC protein complex (GO:0002501)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of macrophage differentiation (GO:0045649)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
regulation of L-dopa decarboxylase activity (GO:1903198)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of erythrocyte differentiation (GO:0045648)	17	0	.47	-	 < 0.01	1.00E00	1.00E00
positive regulation of L-dopa biosynthetic process (GO:1903197)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of erythrocyte differentiation (GO:0045647)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
regulation of erythrocyte differentiation (GO:0045646)	28	0	.77	-	 < 0.01	1.00E00	1.00E00
regulation of L-dopa biosynthetic process (GO:1903195)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of eosinophil differentiation (GO:0045645)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of eosinophil differentiation (GO:0045643)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
glyoxal metabolic process (GO:1903189)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of myeloid cell differentiation (GO:0045639)	53	0	1.45	-	 < 0.01	4.05E-01	1.00E00
positive regulation of melanocyte differentiation (GO:0045636)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
glucuronoside catabolic process (GO:0019391)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of melanocyte differentiation (GO:0045634)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
positive regulation of mechanoreceptor differentiation (GO:0045633)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of mechanoreceptor differentiation (GO:0045632)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of dopamine biosynthetic process (GO:1903181)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of mechanoreceptor differentiation (GO:0045631)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
cerebellar cortex maturation (GO:0021699)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cerebellar cortex structural organization (GO:0021698)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cerebellar cortex formation (GO:0021697)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
cerebellar cortex morphogenesis (GO:0021696)	24	0	.66	-	 < 0.01	1.00E00	1.00E00
cerebellar cortex development (GO:0021695)	38	0	1.04	-	 < 0.01	6.27E-01	1.00E00
cerebellar Purkinje cell layer formation (GO:0021694)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
cerebellar Purkinje cell layer structural organization (GO:0021693)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
glucuronoside metabolic process (GO:0019389)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cerebellar Purkinje cell layer morphogenesis (GO:0021692)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
galactose catabolic process (GO:0019388)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
cerebellar Purkinje cell layer maturation (GO:0021691)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of dopamine biosynthetic process (GO:1903179)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of T-helper 2 cell differentiation (GO:0045629)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
positive regulation of tyrosine 3-monooxygenase activity (GO:1903178)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of tyrosine 3-monooxygenase activity (GO:1903176)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of T-helper 1 cell differentiation (GO:0045626)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of calcium ion transmembrane transport (GO:1903170)	18	0	.49	-	 < 0.01	1.00E00	1.00E00
cerebellar molecular layer morphogenesis (GO:0021687)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cerebellar granular layer structural organization (GO:0021685)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cerebellar granular layer formation (GO:0021684)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cerebellar granular layer morphogenesis (GO:0021683)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
cerebellar granular layer development (GO:0021681)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
glycolipid catabolic process (GO:0019377)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
cerebellar Purkinje cell layer development (GO:0021680)	21	0	.58	-	 < 0.01	1.00E00	1.00E00
galactolipid catabolic process (GO:0019376)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of calcium ion transmembrane transport (GO:1903169)	66	0	1.81	-	 < 0.01	4.25E-01	1.00E00
positive regulation of pyrroline-5-carboxylate reductase activity (GO:1903168)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
galactolipid metabolic process (GO:0019374)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of keratinocyte differentiation (GO:0045618)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
regulation of pyrroline-5-carboxylate reductase activity (GO:1903167)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
epoxygenase P450 pathway (GO:0019373)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of keratinocyte differentiation (GO:0045617)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
cellular response to polycyclic arene (GO:1903166)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
lipoxygenase pathway (GO:0019372)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of keratinocyte differentiation (GO:0045616)	21	0	.58	-	 < 0.01	1.00E00	1.00E00
response to polycyclic arene (GO:1903165)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cyclooxygenase pathway (GO:0019371)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
leukotriene biosynthetic process (GO:0019370)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
cerebellar molecular layer development (GO:0021679)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
third ventricle development (GO:0021678)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
nerve development (GO:0021675)	35	0	.96	-	 < 0.01	1.00E00	1.00E00
lysobisphosphatidic acid metabolic process (GO:2001311)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
arachidonic acid metabolic process (GO:0019369)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
lateral ventricle development (GO:0021670)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
pyridine nucleotide salvage (GO:0019365)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of inner ear auditory receptor cell differentiation (GO:0045609)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
pyridine nucleotide catabolic process (GO:0019364)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
negative regulation of inner ear auditory receptor cell differentiation (GO:0045608)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
pyridine nucleotide biosynthetic process (GO:0019363)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
regulation of inner ear auditory receptor cell differentiation (GO:0045607)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
pyridine nucleotide metabolic process (GO:0019362)	23	0	.63	-	 < 0.01	1.00E00	1.00E00
positive regulation of epidermal cell differentiation (GO:0045606)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
negative regulation of epidermal cell differentiation (GO:0045605)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
regulation of epidermal cell differentiation (GO:0045604)	36	0	.99	-	 < 0.01	1.00E00	1.00E00
positive regulation of endothelial cell differentiation (GO:0045603)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
ectoderm development (GO:0007398)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
negative regulation of endothelial cell differentiation (GO:0045602)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of endothelial cell differentiation (GO:0045601)	23	0	.63	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell-cell adhesion mediated by integrin (GO:0033633)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cell-cell adhesion mediated by integrin (GO:0033631)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
lipoxin B4 biosynthetic process (GO:2001306)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
lipoxin B4 metabolic process (GO:2001304)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
rhombomere 5 formation (GO:0021666)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
lipoxin A4 biosynthetic process (GO:2001303)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
rhombomere 5 structural organization (GO:0021665)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
lipoxin A4 metabolic process (GO:2001302)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
rhombomere 5 morphogenesis (GO:0021664)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
lipoxin biosynthetic process (GO:2001301)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
lipoxin metabolic process (GO:2001300)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
nicotinamide nucleotide biosynthetic process (GO:0019359)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
nicotinate nucleotide salvage (GO:0019358)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
nicotinate nucleotide biosynthetic process (GO:0019357)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
rhombomere 3 formation (GO:0021660)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of autophagy of mitochondrion (GO:1903147)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of autophagy of mitochondrion (GO:1903146)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
positive regulation of establishment of endothelial barrier (GO:1903142)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of establishment of endothelial barrier (GO:1903140)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
compartment pattern specification (GO:0007386)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell adhesion mediated by integrin (GO:0033629)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
cell adhesion mediated by integrin (GO:0033627)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of integrin activation (GO:0033624)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
integrin activation (GO:0033622)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
rhombomere 3 structural organization (GO:0021659)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
rhombomere 3 morphogenesis (GO:0021658)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
vestibulocochlear nerve formation (GO:0021650)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
transsulfuration (GO:0019346)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
cysteine biosynthetic process (GO:0019344)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cysteine biosynthetic process via cystathionine (GO:0019343)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
segment specification (GO:0007379)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
membrane protein proteolysis (GO:0033619)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
mitochondrial proton-transporting ATP synthase complex assembly (GO:0033615)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
vestibulocochlear nerve morphogenesis (GO:0021648)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
phenol-containing compound catabolic process (GO:0019336)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
response to cell cycle checkpoint signaling (GO:0072396)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
signal transduction involved in cell cycle checkpoint (GO:0072395)	21	0	.58	-	 < 0.01	1.00E00	1.00E00
negative regulation of centriole-centriole cohesion (GO:1903126)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of thioredoxin peroxidase activity by peptidyl-threonine phosphorylation (GO:1903125)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
gastrulation (GO:0007369)	92	0	2.52	-	 < 0.01	1.81E-01	1.00E00
negative regulation of TRAIL-activated apoptotic signaling pathway (GO:1903122)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of TRAIL-activated apoptotic signaling pathway (GO:1903121)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
oxalate metabolic process (GO:0033609)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of catecholamine secretion (GO:0033605)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of catecholamine secretion (GO:0033604)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of dopamine secretion (GO:0033603)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of dopamine secretion (GO:0033602)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of mammary gland epithelial cell proliferation (GO:0033601)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of mammary gland epithelial cell proliferation (GO:0033600)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
optic nerve structural organization (GO:0021633)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
flavin adenine dinucleotide catabolic process (GO:0072389)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
optic nerve morphogenesis (GO:0021631)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
flavin adenine dinucleotide biosynthetic process (GO:0072388)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
flavin adenine dinucleotide metabolic process (GO:0072387)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
plus-end-directed organelle transport along microtubule (GO:0072386)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
protein localization to actin cytoskeleton (GO:1903119)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
minus-end-directed organelle transport along microtubule (GO:0072385)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
urate homeostasis (GO:1903118)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
organelle transport along microtubule (GO:0072384)	49	0	1.34	-	 < 0.01	6.42E-01	1.00E00
pentose catabolic process (GO:0019323)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
plus-end-directed vesicle transport along microtubule (GO:0072383)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
pentose biosynthetic process (GO:0019322)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
minus-end-directed vesicle transport along microtubule (GO:0072382)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of actin filament-based movement (GO:1903115)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
pentose metabolic process (GO:0019321)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
thorax and anterior abdomen determination (GO:0007356)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
zygotic determination of anterior/posterior axis, embryo (GO:0007354)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
zygotic specification of dorsal/ventral axis (GO:0007352)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
tripartite regional subdivision (GO:0007351)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
blastoderm segmentation (GO:0007350)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
olfactory nerve structural organization (GO:0021629)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
olfactory nerve morphogenesis (GO:0021627)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
central nervous system maturation (GO:0021626)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
hexose biosynthetic process (GO:0019319)	17	0	.47	-	 < 0.01	1.00E00	1.00E00
blood coagulation, fibrin clot formation (GO:0072378)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
blood coagulation, common pathway (GO:0072377)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein activation cascade (GO:0072376)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
positive regulation of mitochondrial transcription (GO:1903109)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of mitochondrial transcription (GO:1903108)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
inositol catabolic process (GO:0019310)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
1-phosphatidyl-1D-myo-inositol 3,5-bisphosphate metabolic process (GO:1903100)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
egg activation (GO:0007343)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
fusion of sperm to egg plasma membrane involved in single fertilization (GO:0007342)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
penetration of zona pellucida (GO:0007341)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
acrosome reaction (GO:0007340)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
hypoglossal nerve morphogenesis (GO:0021618)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
glossopharyngeal nerve morphogenesis (GO:0021615)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
mannose catabolic process (GO:0019309)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
facial nerve structural organization (GO:0021612)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
facial nerve morphogenesis (GO:0021610)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
D-ribose catabolic process (GO:0019303)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of dipeptide transport (GO:2000880)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
binding of sperm to zona pellucida (GO:0007339)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
positive regulation of growth hormone receptor signaling pathway (GO:0060399)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
single fertilization (GO:0007338)	61	0	1.67	-	 < 0.01	4.13E-01	1.00E00
regulation of growth hormone receptor signaling pathway (GO:0060398)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
growth hormone receptor signaling pathway via JAK-STAT (GO:0060397)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
growth hormone receptor signaling pathway (GO:0060396)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
negative regulation of SMAD protein signal transduction (GO:0060392)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of SMAD protein signal transduction (GO:0060391)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
regulation of SMAD protein signal transduction (GO:0060390)	20	0	.55	-	 < 0.01	1.00E00	1.00E00
cranial nerve structural organization (GO:0021604)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
cranial nerve formation (GO:0021603)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of oligopeptide transport (GO:2000878)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cranial nerve morphogenesis (GO:0021602)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
chromosome passenger complex localization to kinetochore (GO:0072356)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
histone H3-T3 phosphorylation (GO:0072355)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of progesterone secretion (GO:2000872)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of progesterone secretion (GO:2000870)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
tricarboxylic acid metabolic process (GO:0072350)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
pathway-restricted SMAD protein phosphorylation (GO:0060389)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
synapse assembly involved in innervation (GO:0060386)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
axonogenesis involved in innervation (GO:0060385)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
innervation (GO:0060384)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
regulation of DNA strand elongation (GO:0060382)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of single-stranded telomeric DNA binding (GO:0060381)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
insemination (GO:0007320)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of single-stranded telomeric DNA binding (GO:0060380)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
sulfur compound transport (GO:0072348)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
positive regulation of estradiol secretion (GO:2000866)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of estradiol secretion (GO:2000864)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
rescue of stalled ribosome (GO:0072344)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
positive regulation of aldosterone secretion (GO:2000860)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cardiac muscle cell myoblast differentiation (GO:0060379)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
regulation of brood size (GO:0060378)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of mast cell differentiation (GO:0060376)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
pole plasm assembly (GO:0007315)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of mast cell differentiation (GO:0060375)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
oocyte anterior/posterior axis specification (GO:0007314)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mast cell differentiation (GO:0060374)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of ventricular cardiac muscle cell membrane depolarization (GO:0060373)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of atrial cardiac muscle cell membrane repolarization (GO:0060372)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
guanine metabolic process (GO:0046098)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of aldosterone secretion (GO:2000858)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of mineralocorticoid secretion (GO:2000857)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
modified amino acid transport (GO:0072337)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of mineralocorticoid secretion (GO:2000855)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
deoxycytidine metabolic process (GO:0046092)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of corticosterone secretion (GO:2000854)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
deoxyadenosine metabolic process (GO:0046090)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of corticosterone secretion (GO:2000852)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of glucocorticoid secretion (GO:2000851)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of glucocorticoid secretion (GO:2000850)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of Fc receptor mediated stimulatory signaling pathway (GO:0060369)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
oocyte axis specification (GO:0007309)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of Fc receptor mediated stimulatory signaling pathway (GO:0060368)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
oocyte construction (GO:0007308)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
sagittal suture morphogenesis (GO:0060367)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
lambdoid suture morphogenesis (GO:0060366)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
frontal suture morphogenesis (GO:0060364)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cranial suture morphogenesis (GO:0060363)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of NAD metabolic process (GO:1902690)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cytidine metabolic process (GO:0046087)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of glucocorticoid secretion (GO:2000849)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of corticosteroid hormone secretion (GO:2000848)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of corticosteroid hormone secretion (GO:2000847)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
adenine biosynthetic process (GO:0046084)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of corticosteroid hormone secretion (GO:2000846)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
adenine metabolic process (GO:0046083)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of testosterone secretion (GO:2000845)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of testosterone secretion (GO:2000844)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
dUTP catabolic process (GO:0046081)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of testosterone secretion (GO:2000843)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
dUTP metabolic process (GO:0046080)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
chaperone-mediated protein transport (GO:0072321)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
response to ammonium ion (GO:0060359)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of NAD metabolic process (GO:1902689)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of NAD metabolic process (GO:1902688)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
inositol phosphorylation (GO:0052746)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of cell adhesion molecule production (GO:0060355)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell adhesion molecule production (GO:0060354)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of cell adhesion molecule production (GO:0060353)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
cell adhesion molecule production (GO:0060352)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of receptor localization to synapse (GO:1902683)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
cartilage development involved in endochondral bone morphogenesis (GO:0060351)	22	0	.60	-	 < 0.01	1.00E00	1.00E00
dUMP catabolic process (GO:0046079)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
dUMP metabolic process (GO:0046078)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
dUDP metabolic process (GO:0046077)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
dTTP metabolic process (GO:0046075)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
vesicle uncoating (GO:0072319)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
dTMP catabolic process (GO:0046074)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
clathrin coat disassembly (GO:0072318)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
positive regulation of androgen secretion (GO:2000836)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
dTMP metabolic process (GO:0046073)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
dTDP metabolic process (GO:0046072)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of androgen secretion (GO:2000834)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of steroid hormone secretion (GO:2000833)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
dGTP metabolic process (GO:0046070)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of steroid hormone secretion (GO:2000832)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
metanephric glomerular epithelial cell development (GO:0072313)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of steroid hormone secretion (GO:2000831)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
metanephric glomerular epithelial cell differentiation (GO:0072312)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of parathyroid hormone secretion (GO:2000830)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
glomerular epithelial cell differentiation (GO:0072311)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
glomerular epithelial cell development (GO:0072310)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
heart trabecula formation (GO:0060347)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
bone trabecula formation (GO:0060346)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
trabecula formation (GO:0060343)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
cGMP catabolic process (GO:0046069)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cGMP metabolic process (GO:0046068)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
dGDP catabolic process (GO:0046067)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
dGDP metabolic process (GO:0046066)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of parathyroid hormone secretion (GO:2000828)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis (GO:0072309)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mitochondrial RNA surveillance (GO:2000827)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of heart morphogenesis (GO:2000826)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
dCMP metabolic process (GO:0046063)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of androgen receptor activity (GO:2000825)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
dCDP metabolic process (GO:0046062)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
dATP catabolic process (GO:0046061)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis (GO:0072305)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
dATP metabolic process (GO:0046060)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis (GO:0072304)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of behavioral fear response (GO:2000822)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
positive regulation of glomerular metanephric mesangial cell proliferation (GO:0072303)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of grooming behavior (GO:2000821)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation (GO:2000820)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of metanephric glomerular mesangial cell proliferation (GO:0072301)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of metanephric glomerulus development (GO:0072300)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of type I interferon-mediated signaling pathway (GO:0060339)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
positive regulation of axon guidance (GO:1902669)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of axon guidance (GO:1902668)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of maintenance of sister chromatid cohesion (GO:0034093)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of interferon-gamma-mediated signaling pathway (GO:0060336)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of axon guidance (GO:1902667)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
negative regulation of maintenance of sister chromatid cohesion (GO:0034092)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of interferon-gamma-mediated signaling pathway (GO:0060335)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of maintenance of sister chromatid cohesion (GO:0034091)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of interferon-gamma-mediated signaling pathway (GO:0060334)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
arsonoacetate metabolic process (GO:0018872)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
interferon-gamma-mediated signaling pathway (GO:0060333)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of response to interferon-gamma (GO:0060332)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of response to interferon-gamma (GO:0060331)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of response to interferon-gamma (GO:0060330)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
positive regulation of glucose mediated signaling pathway (GO:1902661)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
dAMP catabolic process (GO:0046059)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cAMP metabolic process (GO:0046058)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
dADP catabolic process (GO:0046057)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of nucleotide-excision repair (GO:2000819)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
dADP metabolic process (GO:0046056)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
dGMP catabolic process (GO:0046055)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
dGMP metabolic process (GO:0046054)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
dAMP metabolic process (GO:0046053)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of mRNA stability involved in response to oxidative stress (GO:2000815)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of barbed-end actin filament capping (GO:2000814)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
UTP metabolic process (GO:0046051)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of barbed-end actin filament capping (GO:2000813)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
UMP catabolic process (GO:0046050)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of barbed-end actin filament capping (GO:2000812)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of anoikis (GO:2000811)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of bicellular tight junction assembly (GO:2000810)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
maintenance of mitotic sister chromatid cohesion (GO:0034088)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
establishment of mitotic sister chromatid cohesion (GO:0034087)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
maintenance of sister chromatid cohesion (GO:0034086)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
establishment of sister chromatid cohesion (GO:0034085)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of glucose mediated signaling pathway (GO:1902659)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cytoplasmic actin-based contraction involved in cell motility (GO:0060327)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
face morphogenesis (GO:0060325)	24	0	.66	-	 < 0.01	1.00E00	1.00E00
face development (GO:0060324)	38	0	1.04	-	 < 0.01	6.27E-01	1.00E00
CENP-A containing nucleosome assembly (GO:0034080)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
head morphogenesis (GO:0060323)	26	0	.71	-	 < 0.01	1.00E00	1.00E00
secondary alcohol biosynthetic process (GO:1902653)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
receptor-mediated endocytosis (GO:0006898)	56	0	1.54	-	 < 0.01	4.07E-01	1.00E00
Golgi to endosome transport (GO:0006895)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
Golgi to plasma membrane transport (GO:0006893)	34	0	.93	-	 < 0.01	1.00E00	1.00E00
UMP metabolic process (GO:0046049)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
UDP metabolic process (GO:0046048)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of synaptic vesicle clustering (GO:2000809)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of synaptic vesicle clustering (GO:2000808)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of synaptic vesicle clustering (GO:2000807)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled (GO:2000806)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of termination of RNA polymerase II transcription, poly(A)-coupled (GO:2000805)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of termination of RNA polymerase II transcription, poly(A)-coupled (GO:2000804)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
IMP metabolic process (GO:0046040)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
primitive erythrocyte differentiation (GO:0060319)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
definitive erythrocyte differentiation (GO:0060318)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cardiac epithelial to mesenchymal transition (GO:0060317)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of blood vessel remodeling (GO:0060313)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
tertiary alcohol metabolic process (GO:1902644)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of blood vessel remodeling (GO:0060312)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cell volume homeostasis (GO:0006884)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
cellular sodium ion homeostasis (GO:0006883)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
cellular zinc ion homeostasis (GO:0006882)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
GTP metabolic process (GO:0046039)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
GMP catabolic process (GO:0046038)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
GMP metabolic process (GO:0046037)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
CTP metabolic process (GO:0046036)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
CMP metabolic process (GO:0046035)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
AMP metabolic process (GO:0046033)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
ADP catabolic process (GO:0046032)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
protein localization to Golgi apparatus (GO:0034067)	18	0	.49	-	 < 0.01	1.00E00	1.00E00
methylguanosine-cap decapping (GO:0110156)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
elastin catabolic process (GO:0060309)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
NAD-cap decapping (GO:0110155)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
RNA decapping (GO:0110154)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
stress granule assembly (GO:0034063)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
regulation of membrane repolarization (GO:0060306)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
regulation of cell diameter (GO:0060305)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of biomineralization (GO:0110151)	20	0	.55	-	 < 0.01	1.00E00	1.00E00
regulation of phosphatidylinositol dephosphorylation (GO:0060304)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of biomineralization (GO:0110150)	17	0	.47	-	 < 0.01	1.00E00	1.00E00
1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate biosynthetic process (GO:1902635)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate metabolic process (GO:1902633)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of membrane hyperpolarization (GO:1902632)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of membrane hyperpolarization (GO:1902631)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular copper ion homeostasis (GO:0006878)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of membrane hyperpolarization (GO:1902630)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
biomineralization (GO:0110148)	46	0	1.26	-	 < 0.01	6.36E-01	1.00E00
endosomal vesicle fusion (GO:0034058)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
negative regulation of estrogen receptor binding (GO:0071899)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of estrogen receptor binding (GO:0071898)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
protein localization to adherens junction (GO:0071896)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of mRNA stability involved in cellular response to UV (GO:1902629)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
odontoblast differentiation (GO:0071895)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
histone H2B conserved C-terminal lysine ubiquitination (GO:0071894)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
BMP signaling pathway involved in nephric duct formation (GO:0071893)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
assembly of large subunit precursor of preribosome (GO:1902626)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
programmed cell death induced by symbiont (GO:0034050)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of neutrophil migration (GO:1902624)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
negative regulation of neutrophil migration (GO:1902623)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of neutrophil migration (GO:1902622)	18	0	.49	-	 < 0.01	1.00E00	1.00E00
nucleotide transport (GO:0006862)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of transcription by glucose (GO:0046016)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of transcription by glucose (GO:0046015)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
macrophage apoptotic process (GO:0071888)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
Norrin signaling pathway (GO:0110135)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to fluoride (GO:1902618)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to fluoride (GO:1902617)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
extracellular transport (GO:0006858)	32	0	.88	-	 < 0.01	1.00E00	1.00E00
oligopeptide transport (GO:0006857)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mitochondrial calcium ion transmembrane transport (GO:0006851)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
mitochondrial pyruvate transmembrane transport (GO:0006850)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of activated T cell proliferation (GO:0046007)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
antigen processing and presentation of peptide antigen via MHC class II (GO:0002495)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
positive regulation of circadian sleep/wake cycle, REM sleep (GO:0046005)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071879)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
purine ribonucleoside bisphosphate biosynthetic process (GO:0034036)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071878)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway (GO:0071877)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
purine nucleoside bisphosphate catabolic process (GO:0034034)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
purine nucleoside bisphosphate biosynthetic process (GO:0034033)	20	0	.55	-	 < 0.01	1.00E00	1.00E00
adrenergic receptor signaling pathway (GO:0071875)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of large conductance calcium-activated potassium channel activity (GO:1902607)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of large conductance calcium-activated potassium channel activity (GO:1902606)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
ribonucleoside bisphosphate catabolic process (GO:0034031)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
response to norepinephrine (GO:0071873)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
heterotrimeric G-protein complex assembly (GO:1902605)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
ribonucleoside bisphosphate biosynthetic process (GO:0034030)	20	0	.55	-	 < 0.01	1.00E00	1.00E00
cellular response to epinephrine stimulus (GO:0071872)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
response to epinephrine (GO:0071871)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
cellular response to catecholamine stimulus (GO:0071870)	23	0	.63	-	 < 0.01	1.00E00	1.00E00
pyruvate transport (GO:0006848)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
acyl carnitine transport (GO:0006844)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
mitochondrial citrate transmembrane transport (GO:0006843)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
tricarboxylic acid transport (GO:0006842)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent (GO:0002486)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway (GO:0002484)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
antigen processing and presentation of endogenous peptide antigen (GO:0002483)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
specification of animal organ identity (GO:0010092)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
response to catecholamine (GO:0071869)	24	0	.66	-	 < 0.01	1.00E00	1.00E00
cellular response to monoamine stimulus (GO:0071868)	23	0	.63	-	 < 0.01	1.00E00	1.00E00
response to monoamine (GO:0071867)	24	0	.66	-	 < 0.01	1.00E00	1.00E00
negative regulation of lipid transporter activity (GO:0110114)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of apoptotic process in bone marrow cell (GO:0071866)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of lipid transporter activity (GO:0110113)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of apoptotic process in bone marrow cell (GO:0071865)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of lipid transporter activity (GO:0110112)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of animal organ morphogenesis (GO:0110111)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of animal organ morphogenesis (GO:0110110)	22	0	.60	-	 < 0.01	1.00E00	1.00E00
serotonin transport (GO:0006837)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
water transport (GO:0006833)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
antigen processing and presentation of exogenous peptide antigen (GO:0002478)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
antigen processing and presentation of endogenous peptide antigen via MHC class Ib (GO:0002476)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
polarity specification of proximal/distal axis (GO:0010085)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
antigen processing and presentation via MHC class Ib (GO:0002475)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
antigen processing and presentation of peptide antigen via MHC class I (GO:0002474)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
mRNA alternative polyadenylation (GO:0110104)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
response to triglyceride (GO:0034014)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mitotic cell cycle arrest (GO:0071850)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
zinc ion transport (GO:0006829)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
iron ion transport (GO:0006826)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
copper ion transport (GO:0006825)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
cobalt ion transport (GO:0006824)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
chloride transport (GO:0006821)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
dendritic cell antigen processing and presentation (GO:0002468)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
peripheral tolerance induction (GO:0002465)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
tolerance induction dependent upon immune response (GO:0002461)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
zygote asymmetric cell division (GO:0010070)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
TNFSF11-mediated signaling pathway (GO:0071847)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
actin filament debranching (GO:0071846)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
corpus callosum development (GO:0022038)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
metencephalon development (GO:0022037)	67	0	1.84	-	 < 0.01	4.27E-01	1.00E00
phosphate ion transport (GO:0006817)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
sodium ion transport (GO:0006814)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
telencephalon glial cell migration (GO:0022030)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
peripheral T cell tolerance induction (GO:0002458)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
T cell antigen processing and presentation (GO:0002457)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of fat cell differentiation (GO:0045599)	33	0	.90	-	 < 0.01	1.00E00	1.00E00
positive regulation of regulatory T cell differentiation (GO:0045591)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
negative regulation of regulatory T cell differentiation (GO:0045590)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
telencephalon cell migration (GO:0022029)	35	0	.96	-	 < 0.01	1.00E00	1.00E00
intermediate-density lipoprotein particle clearance (GO:0071831)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
tangential migration from the subventricular zone to the olfactory bulb (GO:0022028)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
triglyceride-rich lipoprotein particle clearance (GO:0071830)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
nitric oxide biosynthetic process (GO:0006809)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
interkinetic nuclear migration (GO:0022027)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
regulation of nitrogen utilization (GO:0006808)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
malonyl-CoA catabolic process (GO:2001294)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
superoxide metabolic process (GO:0006801)	21	0	.58	-	 < 0.01	1.00E00	1.00E00
malonyl-CoA metabolic process (GO:2001293)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mast cell mediated immunity (GO:0002448)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
neutrophil mediated immunity (GO:0002446)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
myeloid leukocyte mediated immunity (GO:0002444)	20	0	.55	-	 < 0.01	1.00E00	1.00E00
serotonin secretion involved in inflammatory response (GO:0002442)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
histamine secretion involved in inflammatory response (GO:0002441)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of regulatory T cell differentiation (GO:0045589)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
positive regulation of gamma-delta T cell differentiation (GO:0045588)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of gamma-delta T cell differentiation (GO:0045586)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
positive regulation of cytotoxic T cell differentiation (GO:0045585)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of cytotoxic T cell differentiation (GO:0045583)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
plasma lipoprotein particle organization (GO:0071827)	19	0	.52	-	 < 0.01	1.00E00	1.00E00
protein-lipid complex subunit organization (GO:0071825)	22	0	.60	-	 < 0.01	1.00E00	1.00E00
lateral ganglionic eminence cell proliferation (GO:0022018)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of caveolin-mediated endocytosis (GO:2001288)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
pallium cell proliferation in forebrain (GO:0022013)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of caveolin-mediated endocytosis (GO:2001287)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
subpallium cell proliferation in forebrain (GO:0022012)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of caveolin-mediated endocytosis (GO:2001286)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
myelination in peripheral nervous system (GO:0022011)	17	0	.47	-	 < 0.01	1.00E00	1.00E00
central nervous system myelination (GO:0022010)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
chronic inflammatory response to antigenic stimulus (GO:0002439)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
acute inflammatory response to antigenic stimulus (GO:0002438)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
inflammatory response to antigenic stimulus (GO:0002437)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
response to mycotoxin (GO:0010046)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of unsaturated fatty acid biosynthetic process (GO:2001280)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
response to aluminum ion (GO:0010044)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
immune complex clearance (GO:0002434)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to zinc ion (GO:0010043)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
response to manganese ion (GO:0010042)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
granuloma formation (GO:0002432)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to iron(III) ion (GO:0010041)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
Fc receptor mediated stimulatory signaling pathway (GO:0002431)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
response to iron(II) ion (GO:0010040)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
complement receptor mediated signaling pathway (GO:0002430)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of B cell differentiation (GO:0045578)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
mast cell activation (GO:0045576)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
basophil activation (GO:0045575)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
tail-anchored membrane protein insertion into ER membrane (GO:0071816)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
central nervous system vasculogenesis (GO:0022009)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
convergent extension involved in neural plate elongation (GO:0022007)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of unsaturated fatty acid biosynthetic process (GO:2001279)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
midbrain-hindbrain boundary maturation during brain development (GO:0022004)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to iron ion (GO:0010039)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
response to metal ion (GO:0010038)	135	0	3.70	-	 < 0.01	5.33E-02	1.00E00
positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:2001272)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
antigen processing and presentation of peptide antigen via MHC class Ib (GO:0002428)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:2001271)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:2001270)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
meiotic chromosome condensation (GO:0010032)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
protein transmembrane transport (GO:0071806)	25	0	.69	-	 < 0.01	1.00E00	1.00E00
regulation of mammary gland epithelial cell proliferation (GO:0033599)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
positive regulation of podosome assembly (GO:0071803)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
mammary gland epithelial cell proliferation (GO:0033598)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of podosome assembly (GO:0071802)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of podosome assembly (GO:0071801)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
podosome assembly (GO:0071800)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001269)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001268)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
positive regulation of semaphorin-plexin signaling pathway (GO:2001262)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
immune response to tumor cell (GO:0002418)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of semaphorin-plexin signaling pathway (GO:2001260)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
antigen transcytosis by M cells in mucosal-associated lymphoid tissue (GO:0002412)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of cation channel activity (GO:2001259)	28	0	.77	-	 < 0.01	1.00E00	1.00E00
negative regulation of cation channel activity (GO:2001258)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
regulation of cation channel activity (GO:2001257)	66	0	1.81	-	 < 0.01	4.25E-01	1.00E00
regulation of store-operated calcium entry (GO:2001256)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
positive regulation of histone H3-K36 trimethylation (GO:2001255)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of histone H3-K36 trimethylation (GO:2001253)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
myeloid dendritic cell chemotaxis (GO:0002408)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
dendritic cell chemotaxis (GO:0002407)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of ammonia assimilation cycle (GO:2001250)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
antigen sampling by M cells in mucosal-associated lymphoid tissue (GO:0002406)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
antigen sampling in mucosal-associated lymphoid tissue (GO:0002404)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein localization to meiotic spindle midzone (GO:1903096)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein K48-linked deubiquitination (GO:1903094)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of protein K48-linked deubiquitination (GO:1903093)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of cholesterol biosynthetic process (GO:0045542)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of cholesterol biosynthetic process (GO:0045541)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of cholesterol biosynthetic process (GO:0045540)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
response to testosterone (GO:0033574)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
transferrin transport (GO:0033572)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of ammonia assimilation cycle (GO:2001248)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of phosphatidylcholine biosynthetic process (GO:2001247)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of phosphatidylcholine biosynthetic process (GO:2001245)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240)	19	0	.52	-	 < 0.01	1.00E00	1.00E00
cardioblast differentiation (GO:0010002)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
tyrosine biosynthetic process, by oxidation of phenylalanine (GO:0019293)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
siderophore biosynthetic process (GO:0019290)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
DNA replication, Okazaki fragment processing (GO:0033567)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
gamma-tubulin complex localization (GO:0033566)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
dorsal/ventral axon guidance (GO:0033563)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239)	26	0	.71	-	 < 0.01	1.00E00	1.00E00
positive regulation of extrinsic apoptotic signaling pathway (GO:2001238)	29	0	.80	-	 < 0.01	1.00E00	1.00E00
abducens nerve formation (GO:0021599)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
abducens nerve morphogenesis (GO:0021598)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
rhombomere structural organization (GO:0021595)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
rhombomere formation (GO:0021594)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
rhombomere morphogenesis (GO:0021593)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
fourth ventricle development (GO:0021592)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
ventricular system development (GO:0021591)	21	0	.58	-	 < 0.01	1.00E00	1.00E00
isopentenyl diphosphate biosynthetic process, mevalonate pathway (GO:0019287)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cerebellum maturation (GO:0021590)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
glycine betaine biosynthetic process from choline (GO:0019285)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein localization to plasma membrane (GO:1903077)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
negative regulation of death-inducing signaling complex assembly (GO:1903073)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of death-inducing signaling complex assembly (GO:1903072)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903071)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903070)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of response to gamma radiation (GO:2001229)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of response to gamma radiation (GO:2001228)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of chloride transport (GO:2001226)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cerebellum structural organization (GO:0021589)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of chloride transport (GO:2001225)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cerebellum formation (GO:0021588)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of neuron migration (GO:2001224)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
cerebellum morphogenesis (GO:0021587)	33	0	.90	-	 < 0.01	1.00E00	1.00E00
negative regulation of neuron migration (GO:2001223)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
pons maturation (GO:0021586)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of neuron migration (GO:2001222)	27	0	.74	-	 < 0.01	1.00E00	1.00E00
regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903069)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein lipidation (GO:1903061)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
hindbrain maturation (GO:0021578)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of vasculogenesis (GO:2001214)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
hindbrain structural organization (GO:0021577)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of vasculogenesis (GO:2001213)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
hindbrain formation (GO:0021576)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of vasculogenesis (GO:2001212)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
hindbrain morphogenesis (GO:0021575)	36	0	.99	-	 < 0.01	1.00E00	1.00E00
rhombomere 5 development (GO:0021571)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
rhombomere 4 development (GO:0021570)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of protein lipidation (GO:1903059)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure (GO:0001999)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
glycine biosynthetic process, by transamination of glyoxylate (GO:0019265)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
angiotensin-mediated vasoconstriction involved in regulation of systemic arterial blood pressure (GO:0001998)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
glycine biosynthetic process from serine (GO:0019264)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of melanosome organization (GO:1903056)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
N-acetylneuraminate catabolic process (GO:0019262)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of extracellular matrix organization (GO:1903054)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051)	42	0	1.15	-	 < 0.01	6.30E-01	1.00E00
regulation of systemic arterial blood pressure by circulatory renin-angiotensin (GO:0001991)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of systemic arterial blood pressure by hormone (GO:0001990)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
vitellogenesis (GO:0007296)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
spermatid nucleus elongation (GO:0007290)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
rhombomere 3 development (GO:0021569)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of osteoclast development (GO:2001205)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
rhombomere 2 development (GO:0021568)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of osteoclast development (GO:2001204)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
hypoglossal nerve development (GO:0021566)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
vagus nerve development (GO:0021564)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of dendritic cell differentiation (GO:2001200)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
glossopharyngeal nerve development (GO:0021563)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
vestibulocochlear nerve development (GO:0021562)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
facial nerve development (GO:0021561)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
abducens nerve development (GO:0021560)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
glucose 1-phosphate metabolic process (GO:0019255)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
carnitine metabolic process, CoA-linked (GO:0019254)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
spermatid nucleus differentiation (GO:0007289)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
sperm axoneme assembly (GO:0007288)	19	0	.52	-	 < 0.01	1.00E00	1.00E00
regulation of systemic arterial blood pressure by ischemic conditions (GO:0001980)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
spermatogonial cell division (GO:0007284)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
histone H2B ubiquitination (GO:0033523)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
histone H2A ubiquitination (GO:0033522)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
trigeminal nerve development (GO:0021559)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
trochlear nerve development (GO:0021558)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
oculomotor nerve development (GO:0021557)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
midbrain-hindbrain boundary morphogenesis (GO:0021555)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
optic nerve development (GO:0021554)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
olfactory nerve development (GO:0021553)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
lactate biosynthetic process (GO:0019249)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
central nervous system morphogenesis (GO:0021551)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
medulla oblongata development (GO:0021550)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
lactate biosynthetic process from pyruvate (GO:0019244)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione (GO:0019243)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
response to amphetamine (GO:0001975)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of microtubule plus-end binding (GO:1903033)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
blood vessel remodeling (GO:0001974)	21	0	.58	-	 < 0.01	1.00E00	1.00E00
citrulline biosynthetic process (GO:0019240)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
G protein-coupled adenosine receptor signaling pathway (GO:0001973)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of microtubule plus-end binding (GO:1903031)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of activation of membrane attack complex (GO:0001970)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
synaptic transmission, cholinergic (GO:0007271)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
neuron-neuron synaptic transmission (GO:0007270)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
L-lysine catabolic process to acetyl-CoA via L-pipecolate (GO:0033514)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cerebellum development (GO:0021549)	61	0	1.67	-	 < 0.01	4.13E-01	1.00E00
pons development (GO:0021548)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
midbrain-hindbrain boundary initiation (GO:0021547)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
rhombomere development (GO:0021546)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
cranial nerve development (GO:0021545)	23	0	.63	-	 < 0.01	1.00E00	1.00E00
subpallium development (GO:0021544)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
pallium development (GO:0021543)	93	0	2.55	-	 < 0.01	1.83E-01	1.00E00
dentate gyrus development (GO:0021542)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
regulation of metanephric glomerulus development (GO:0072298)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
corpus callosum morphogenesis (GO:0021540)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of opsonization (GO:1903028)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of activation of membrane attack complex (GO:0001969)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of opsonization (GO:1903027)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1903026)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
suckling behavior (GO:0001967)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1903025)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
thigmotaxis (GO:0001966)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
startle response (GO:0001964)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
proprioception (GO:0019230)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
synaptic transmission, dopaminergic (GO:0001963)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
Rho protein signal transduction (GO:0007266)	35	0	.96	-	 < 0.01	1.00E00	1.00E00
nitric oxide mediated signal transduction (GO:0007263)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
floor plate morphogenesis (GO:0033505)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
floor plate development (GO:0033504)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
subthalamus development (GO:0021539)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
epithalamus development (GO:0021538)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
telencephalon development (GO:0021537)	134	0	3.67	-	 < 0.01	5.29E-02	1.00E00
cell migration in hindbrain (GO:0021535)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
cell proliferation in hindbrain (GO:0021534)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
cell differentiation in hindbrain (GO:0021533)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
neural tube patterning (GO:0021532)	26	0	.71	-	 < 0.01	1.00E00	1.00E00
metanephric nephron tubule formation (GO:0072289)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
neuronal action potential (GO:0019228)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
spinal cord oligodendrocyte cell fate specification (GO:0021530)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
transmission of nerve impulse (GO:0019226)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
endochondral ossification (GO:0001958)	19	0	.52	-	 < 0.01	1.00E00	1.00E00
intramembranous ossification (GO:0001957)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
metanephric renal vesicle morphogenesis (GO:0072283)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
positive regulation of neurotransmitter secretion (GO:0001956)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
metanephric nephron tubule morphogenesis (GO:0072282)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
blood vessel maturation (GO:0001955)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of bone development (GO:1903012)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell-matrix adhesion (GO:0001953)	27	0	.74	-	 < 0.01	1.00E00	1.00E00
negative regulation of bone development (GO:1903011)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
JUN phosphorylation (GO:0007258)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of bone development (GO:1903010)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
intestinal D-glucose absorption (GO:0001951)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
activation of JNKK activity (GO:0007256)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
cytoplasmic sequestering of NF-kappaB (GO:0007253)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
I-kappaB phosphorylation (GO:0007252)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
spinal cord oligodendrocyte cell differentiation (GO:0021529)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
commissural neuron differentiation in spinal cord (GO:0021528)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
medial motor column neuron differentiation (GO:0021526)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
visceral motor neuron differentiation (GO:0021524)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of amniotic stem cell differentiation (GO:2000798)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
somatic motor neuron differentiation (GO:0021523)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of amniotic stem cell differentiation (GO:2000797)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
ventral spinal cord interneuron specification (GO:0021521)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of epithelial cell proliferation involved in lung morphogenesis (GO:2000795)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of fatty acid metabolic process (GO:0019217)	57	0	1.56	-	 < 0.01	4.07E-01	1.00E00
spinal cord motor neuron cell fate specification (GO:0021520)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
metanephric glomerular capillary formation (GO:0072277)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
metanephric glomerulus vasculature morphogenesis (GO:0072276)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
metanephric glomerulus morphogenesis (GO:0072275)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of Lys63-specific deubiquitinase activity (GO:1903007)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
metanephric glomerular basement membrane development (GO:0072274)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein K63-linked deubiquitination (GO:1903006)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of mesenchymal cell proliferation involved in lung development (GO:2000791)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
heart looping (GO:0001947)	37	0	1.01	-	 < 0.01	6.26E-01	1.00E00
metanephric nephron morphogenesis (GO:0072273)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
regulation of mesenchymal cell proliferation involved in lung development (GO:2000790)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
lymphangiogenesis (GO:0001946)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of protein K63-linked deubiquitination (GO:1903004)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein deubiquitination (GO:1903003)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
positive regulation of lipid transport across blood-brain barrier (GO:1903002)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of lipid transport across blood-brain barrier (GO:1903001)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of lipid transport across blood-brain barrier (GO:1903000)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
postsynaptic membrane organization (GO:0001941)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
spinal cord dorsal/ventral patterning (GO:0021513)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
positive regulation of autophagosome assembly (GO:2000786)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
spinal cord patterning (GO:0021511)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
pattern specification involved in metanephros development (GO:0072268)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of establishment of cell polarity regulating cell shape (GO:2000784)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of establishment of cell polarity regulating cell shape (GO:2000782)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of double-strand break repair (GO:2000781)	30	0	.82	-	 < 0.01	1.00E00	1.00E00
negative regulation of double-strand break repair (GO:2000780)	22	0	.60	-	 < 0.01	1.00E00	1.00E00
endothelial cell proliferation (GO:0001935)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
positive regulation of sarcomere organization (GO:0060298)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of sarcomere organization (GO:0060297)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
regulation of cilium beat frequency involved in ciliary motility (GO:0060296)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of cilium movement involved in cell motility (GO:0060295)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
cilium movement involved in cell motility (GO:0060294)	58	0	1.59	-	 < 0.01	4.09E-01	1.00E00
long-term synaptic depression (GO:0060292)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
osmosensory signaling pathway (GO:0007231)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
long-term synaptic potentiation (GO:0060291)	23	0	.63	-	 < 0.01	1.00E00	1.00E00
transdifferentiation (GO:0060290)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
floor plate formation (GO:0021508)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
anterior neuropore closure (GO:0021506)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
neural fold bending (GO:0021503)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia (GO:2000777)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
neural fold elevation formation (GO:0021502)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
metanephric interstitial fibroblast development (GO:0072259)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
prechordal plate formation (GO:0021501)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
metanephric interstitial fibroblast differentiation (GO:0072258)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of cellular senescence (GO:2000774)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of cellular senescence (GO:2000773)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
regulation of cellular senescence (GO:2000772)	26	0	.71	-	 < 0.01	1.00E00	1.00E00
positive regulation of establishment or maintenance of cell polarity regulating cell shape (GO:2000771)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
B-1 B cell differentiation (GO:0001923)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
integrin-mediated signaling pathway (GO:0007229)	31	0	.85	-	 < 0.01	1.00E00	1.00E00
B-1 B cell homeostasis (GO:0001922)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
positive regulation of hh target transcription factor activity (GO:0007228)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of receptor recycling (GO:0001921)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
signal transduction downstream of smoothened (GO:0007227)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
negative regulation of receptor recycling (GO:0001920)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cilium-dependent cell motility (GO:0060285)	66	0	1.81	-	 < 0.01	4.25E-01	1.00E00
negative regulation of oocyte development (GO:0060283)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of oocyte development (GO:0060282)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of transcription of Notch receptor target (GO:0007221)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of oocyte development (GO:0060281)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of establishment or maintenance of cell polarity regulating cell shape (GO:2000769)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of cytoplasmic translation (GO:2000767)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
metanephric glomerular visceral epithelial cell development (GO:0072249)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of cytoplasmic translation (GO:2000766)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
metanephric glomerular visceral epithelial cell differentiation (GO:0072248)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of cytoplasmic translation (GO:2000765)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
positive regulation of semaphorin-plexin signaling pathway involved in outflow tract morphogenesis (GO:2000764)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of transcription from RNA polymerase II promoter involved in norepinephrine biosynthetic process (GO:2000763)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of receptor recycling (GO:0001919)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
positive regulation of T cell mediated cytotoxicity (GO:0001916)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of T cell mediated cytotoxicity (GO:0001915)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of T cell mediated cytotoxicity (GO:0001914)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
T cell mediated cytotoxicity (GO:0001913)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
Notch signaling pathway (GO:0007219)	63	0	1.73	-	 < 0.01	4.17E-01	1.00E00
positive regulation of ovulation (GO:0060279)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of ovulation (GO:0060278)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of leukocyte mediated cytotoxicity (GO:0001911)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
tachykinin receptor signaling pathway (GO:0007217)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
G protein-coupled glutamate receptor signaling pathway (GO:0007216)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
glutamate receptor signaling pathway (GO:0007215)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
gamma-aminobutyric acid signaling pathway (GO:0007214)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
G protein-coupled acetylcholine receptor signaling pathway (GO:0007213)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
dopamine receptor signaling pathway (GO:0007212)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
embryonic skeletal joint morphogenesis (GO:0060272)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
negative regulation of peptidyl-lysine acetylation (GO:2000757)	17	0	.47	-	 < 0.01	1.00E00	1.00E00
positive regulation of sphingomyelin catabolic process (GO:2000755)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of sphingomyelin catabolic process (GO:2000754)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
metanephric loop of Henle development (GO:0072236)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of glucosylceramide catabolic process (GO:2000753)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
leukocyte mediated cytotoxicity (GO:0001909)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
regulation of glucosylceramide catabolic process (GO:2000752)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
killing by symbiont of host cells (GO:0001907)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
metanephric thick ascending limb development (GO:0072233)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
activation of membrane attack complex (GO:0001905)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of respiratory burst (GO:0060268)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of respiratory burst (GO:0060267)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of respiratory burst involved in inflammatory response (GO:0060266)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of respiratory burst involved in inflammatory response (GO:0060265)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of DNA replication origin binding (GO:1902595)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of respiratory burst involved in inflammatory response (GO:0060264)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of respiratory burst (GO:0060263)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
activation of phospholipase C activity (GO:0007202)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
cyclic purine nucleotide metabolic process (GO:0052652)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
positive regulation of anterior head development (GO:2000744)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of anterior head development (GO:2000742)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of mesenchymal stem cell differentiation (GO:2000741)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of mesenchymal stem cell differentiation (GO:2000740)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of feeding behavior (GO:0060259)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
alditol phosphate metabolic process (GO:0052646)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of glial cell proliferation (GO:0060253)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
regulation of mesenchymal stem cell differentiation (GO:2000739)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
positive regulation of stem cell differentiation (GO:2000738)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
negative regulation of stem cell differentiation (GO:2000737)	18	0	.49	-	 < 0.01	1.00E00	1.00E00
regulation of stem cell differentiation (GO:2000736)	44	0	1.21	-	 < 0.01	6.32E-01	1.00E00
metanephric ascending thin limb development (GO:0072218)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of metanephros development (GO:0072217)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation (GO:2000734)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of metanephros development (GO:0072216)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation (GO:2000733)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of metanephros development (GO:0072215)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of calcium import into the mitochondrion (GO:0110099)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of calcium import into the mitochondrion (GO:0110097)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular response to aldehyde (GO:0110096)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
cellular detoxification of aldehyde (GO:0110095)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
multi-organism localization (GO:1902579)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of hippocampal neuron apoptotic process (GO:0110091)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of nuclear cell cycle DNA replication (GO:1902576)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
detection of cell density (GO:0060245)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell proliferation involved in contact inhibition (GO:0060244)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
contact inhibition (GO:0060242)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of serine-type peptidase activity (GO:1902572)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of serine-type peptidase activity (GO:1902571)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
protein localization to nucleolus (GO:1902570)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of mesenchymal cell proliferation involved in ureter development (GO:2000729)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of cardiac muscle cell differentiation (GO:2000727)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
negative regulation of cardiac muscle cell differentiation (GO:2000726)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
metanephric smooth muscle tissue development (GO:0072208)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of cardiac muscle cell differentiation (GO:2000725)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
positive regulation of cardiac vascular smooth muscle cell differentiation (GO:2000724)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of cardiac vascular smooth muscle cell differentiation (GO:2000723)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of cardiac vascular smooth muscle cell differentiation (GO:2000722)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cell-cell signaling involved in metanephros development (GO:0072204)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of hippocampal neuron apoptotic process (GO:0110089)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation (GO:2000721)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of mesenchymal cell proliferation involved in ureter development (GO:0072200)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of activation of Janus kinase activity (GO:1902569)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
lens induction in camera-type eye (GO:0060235)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
positive regulation of neutrophil activation (GO:1902565)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
neuroblast delamination (GO:0060234)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of neutrophil activation (GO:1902564)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of neutrophil activation (GO:1902563)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
delamination (GO:0060232)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
mesenchymal to epithelial transition (GO:0060231)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
negative regulation of retinal cone cell fate commitment (GO:0060226)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
retinal rod cell fate commitment (GO:0060223)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of catalase activity (GO:1902553)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of retinal cone cell fate commitment (GO:0060222)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
retinal rod cell differentiation (GO:0060221)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
regulation of catalase activity (GO:1902551)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
camera-type eye photoreceptor cell fate commitment (GO:0060220)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of dense core granule biogenesis (GO:2000707)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of dense core granule biogenesis (GO:2000706)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of dense core granule biogenesis (GO:2000705)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation (GO:2000703)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation (GO:2000702)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
camera-type eye photoreceptor cell differentiation (GO:0060219)	18	0	.49	-	 < 0.01	1.00E00	1.00E00
hematopoietic stem cell differentiation (GO:0060218)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
hemangioblast cell differentiation (GO:0060217)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
definitive hemopoiesis (GO:0060216)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
regulation of angiotensin-activated signaling pathway (GO:0110061)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of DNA N-glycosylase activity (GO:1902546)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
primitive hemopoiesis (GO:0060215)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
endocardium formation (GO:0060214)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of DNA N-glycosylase activity (GO:1902544)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
negative regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060212)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
porphyrin-containing compound catabolic process (GO:0006787)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
heme biosynthetic process (GO:0006783)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
protoporphyrinogen IX biosynthetic process (GO:0006782)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
uroporphyrinogen III biosynthetic process (GO:0006780)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of blood vessel endothelial cell differentiation (GO:0110059)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of blood vessel endothelial cell differentiation (GO:0110057)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
porphyrin-containing compound biosynthetic process (GO:0006779)	18	0	.49	-	 < 0.01	1.00E00	1.00E00
porphyrin-containing compound metabolic process (GO:0006778)	23	0	.63	-	 < 0.01	1.00E00	1.00E00
vitamin A metabolic process (GO:0006776)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
fat-soluble vitamin metabolic process (GO:0006775)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
riboflavin metabolic process (GO:0006771)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein monoubiquitination (GO:1902527)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of protein monoubiquitination (GO:1902525)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein K48-linked ubiquitination (GO:1902524)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein K63-linked ubiquitination (GO:1902523)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
biotin metabolic process (GO:0006768)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
endoplasmic reticulum tubular network organization (GO:0071786)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of G2/MI transition of meiotic cell cycle (GO:0110032)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of G2/MI transition of meiotic cell cycle (GO:0110030)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of organelle transport along microtubule (GO:1902513)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
negative regulation of apoptotic DNA fragmentation (GO:1902511)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
glutathione catabolic process (GO:0006751)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
glutathione biosynthetic process (GO:0006750)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
MHC class I protein complex assembly (GO:0002397)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
MHC protein complex assembly (GO:0002396)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
immune response in nasopharyngeal-associated lymphoid tissue (GO:0002395)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of DNA strand resection involved in replication fork processing (GO:0110026)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
DNA strand resection involved in replication fork processing (GO:0110025)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of cardiac muscle myoblast proliferation (GO:0110024)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of cardiac muscle myoblast proliferation (GO:0110022)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to BMP stimulus (GO:0071773)	53	0	1.45	-	 < 0.01	4.05E-01	1.00E00
response to BMP (GO:0071772)	53	0	1.45	-	 < 0.01	4.05E-01	1.00E00
regulation of actomyosin structure organization (GO:0110020)	68	0	1.86	-	 < 0.01	2.66E-01	1.00E00
regulation of signal transduction involved in mitotic G2 DNA damage checkpoint (GO:1902504)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
glutathione metabolic process (GO:0006749)	25	0	.69	-	 < 0.01	1.00E00	1.00E00
FAD biosynthetic process (GO:0006747)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
ubiquinone biosynthetic process (GO:0006744)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
ubiquinone metabolic process (GO:0006743)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
NADP catabolic process (GO:0006742)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
NADP biosynthetic process (GO:0006741)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
NADPH regeneration (GO:0006740)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
immune response in gut-associated lymphoid tissue (GO:0002387)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
immunoglobulin production involved in immunoglobulin-mediated immune response (GO:0002381)	18	0	.49	-	 < 0.01	1.00E00	1.00E00
nuclear inner membrane organization (GO:0071765)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
nuclear membrane organization (GO:0071763)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of basement membrane organization (GO:0110011)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
NADP metabolic process (GO:0006739)	24	0	.66	-	 < 0.01	1.00E00	1.00E00
formin-nucleated actin cable organization (GO:0110009)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
ncRNA deadenylation (GO:0110008)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
tetrahydrobiopterin biosynthetic process (GO:0006729)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
CD4-positive, CD25-positive, alpha-beta regulatory T cell lineage commitment (GO:0002362)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation (GO:0002361)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
androgen catabolic process (GO:0006710)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
B cell homeostatic proliferation (GO:0002358)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
defense response to tumor cell (GO:0002357)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
plasma kallikrein-kinin cascade (GO:0002353)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
serotonin production involved in inflammatory response (GO:0002351)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
photoreceptor cell maintenance (GO:0045494)	20	0	.55	-	 < 0.01	1.00E00	1.00E00
transcriptional activation by promoter-enhancer looping (GO:0071733)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular response to nitric oxide (GO:0071732)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
response to nitric oxide (GO:0071731)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
cholesterol catabolic process (GO:0006707)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of dendritic cell differentiation (GO:2001199)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
steroid catabolic process (GO:0006706)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
regulation of dendritic cell differentiation (GO:2001198)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mineralocorticoid biosynthetic process (GO:0006705)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
glucocorticoid biosynthetic process (GO:0006704)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
progesterone biosynthetic process (GO:0006701)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
histamine production involved in inflammatory response (GO:0002349)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
C21-steroid hormone biosynthetic process (GO:0006700)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
response to tumor cell (GO:0002347)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
B cell affinity maturation (GO:0002344)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
peripheral B cell selection (GO:0002343)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to triacyl bacterial lipopeptide (GO:0071727)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to diacyl bacterial lipopeptide (GO:0071726)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to triacyl bacterial lipopeptide (GO:0071725)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to diacyl bacterial lipopeptide (GO:0071724)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell (GO:2001189)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell (GO:2001188)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of CD8-positive, alpha-beta T cell activation (GO:2001187)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of CD8-positive, alpha-beta T cell activation (GO:2001186)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of CD8-positive, alpha-beta T cell activation (GO:2001185)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
B cell selection (GO:0002339)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
B-1a B cell differentiation (GO:0002337)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
transitional one stage B cell differentiation (GO:0002333)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
transitional stage B cell differentiation (GO:0002332)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
pre-B cell allelic exclusion (GO:0002331)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
locomotor rhythm (GO:0045475)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
response to ether (GO:0045472)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
icosanoid transport (GO:0071715)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
ER-associated misfolded protein catabolic process (GO:0071712)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
basement membrane organization (GO:0071711)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
positive regulation of mediator complex assembly (GO:2001178)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of mediator complex assembly (GO:2001176)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of histone H2B conserved C-terminal lysine ubiquitination (GO:2001173)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
pro-B cell differentiation (GO:0002328)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of ATP biosynthetic process (GO:2001170)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
B cell lineage commitment (GO:0002326)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
natural killer cell activation involved in immune response (GO:0002323)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
B cell proliferation involved in immune response (GO:0002322)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
lymphoid progenitor cell differentiation (GO:0002320)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
immunoglobulin heavy chain V-D-J recombination (GO:0071707)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
tumor necrosis factor superfamily cytokine production (GO:0071706)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
galactose catabolic process via UDP-galactose (GO:0033499)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of MAPK export from nucleus (GO:0071701)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of histone H2B ubiquitination (GO:2001168)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of histone H2B ubiquitination (GO:2001166)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
positive regulation of histone H3-K79 methylation (GO:2001162)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
myeloid progenitor cell differentiation (GO:0002318)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of histone H3-K79 methylation (GO:2001161)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of histone H3-K79 methylation (GO:2001160)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
follicular B cell differentiation (GO:0002316)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
bone resorption (GO:0045453)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
nitric oxide homeostasis (GO:0033484)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
gas homeostasis (GO:0033483)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
T cell proliferation involved in immune response (GO:0002309)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of dipeptide transmembrane transport (GO:2001150)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
CD8-positive, alpha-beta T cell differentiation involved in immune response (GO:0002302)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
myoblast differentiation (GO:0045445)	26	0	.71	-	 < 0.01	1.00E00	1.00E00
S-methylmethionine metabolic process (GO:0033477)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of dipeptide transmembrane transport (GO:2001148)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity (GO:2001145)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity (GO:2001144)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of phospholipid transport (GO:2001140)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of phospholipid transport (GO:2001139)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of phospholipid transport (GO:2001138)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of endocytic recycling (GO:2001137)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of endocytic recycling (GO:2001135)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
protein-lipid complex assembly (GO:0065005)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
intracellular protein transmembrane transport (GO:0065002)	25	0	.69	-	 < 0.01	1.00E00	1.00E00
specification of axis polarity (GO:0065001)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
nonribosomal peptide biosynthetic process (GO:0019184)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of translational frameshifting (GO:2001125)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of translational frameshifting (GO:2001124)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of cellular response to hepatocyte growth factor stimulus (GO:2001113)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of cellular response to hepatocyte growth factor stimulus (GO:2001112)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
retina homeostasis (GO:0001895)	26	0	.71	-	 < 0.01	1.00E00	1.00E00
G protein-coupled receptor signaling pathway coupled to cGMP nucleotide second messenger (GO:0007199)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
adenylate cyclase-inhibiting dopamine receptor signaling pathway (GO:0007195)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of adenylate cyclase activity (GO:0007194)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of Rho guanyl-nucleotide exchange factor activity (GO:2001107)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
endothelial cell morphogenesis (GO:0001886)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
endothelial cell development (GO:0001885)	26	0	.71	-	 < 0.01	1.00E00	1.00E00
receptor recycling (GO:0001881)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
Mullerian duct regression (GO:0001880)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
SMAD protein complex assembly (GO:0007183)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
common-partner SMAD protein phosphorylation (GO:0007182)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
transforming growth factor beta receptor complex assembly (GO:0007181)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
transforming growth factor beta receptor signaling pathway (GO:0007179)	49	0	1.34	-	 < 0.01	6.42E-01	1.00E00
regulation of epidermal growth factor-activated receptor activity (GO:0007176)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
negative regulation of epidermal growth factor-activated receptor activity (GO:0007175)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
epidermal growth factor catabolic process (GO:0007174)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
epidermal growth factor receptor signaling pathway (GO:0007173)	24	0	.66	-	 < 0.01	1.00E00	1.00E00
signal complex assembly (GO:0007172)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of mesenchymal cell proliferation involved in ureter development (GO:0072199)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
mesenchymal cell proliferation involved in ureter development (GO:0072198)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
ureter morphogenesis (GO:0072197)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
negative regulation of complement activation, lectin pathway (GO:0001869)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
kidney smooth muscle cell differentiation (GO:0072195)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of complement activation, lectin pathway (GO:0001868)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
kidney smooth muscle tissue development (GO:0072194)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
ureter smooth muscle cell differentiation (GO:0072193)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
NK T cell proliferation (GO:0001866)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
ureter epithelial cell differentiation (GO:0072192)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
NK T cell differentiation (GO:0001865)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
ureter smooth muscle development (GO:0072191)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
ureter urothelium development (GO:0072190)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
receptor guanylyl cyclase signaling pathway (GO:0007168)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
establishment of tissue polarity (GO:0007164)	17	0	.47	-	 < 0.01	1.00E00	1.00E00
calcium-independent cell-matrix adhesion (GO:0007161)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cell-matrix adhesion (GO:0007160)	62	0	1.70	-	 < 0.01	4.15E-01	1.00E00
ureter development (GO:0072189)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
metanephric cap morphogenesis (GO:0072186)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
metanephric cap development (GO:0072185)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
renal vesicle progenitor cell differentiation (GO:0072184)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of nephron tubule epithelial cell differentiation (GO:0072183)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of nephron tubule epithelial cell differentiation (GO:0072182)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
mesonephric duct formation (GO:0072181)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mesonephric duct morphogenesis (GO:0072180)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
neuron cell-cell adhesion (GO:0007158)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
positive regulation of epithelial cell differentiation involved in kidney development (GO:2000698)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of epithelial cell differentiation involved in kidney development (GO:2000697)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
nephric duct formation (GO:0072179)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of epithelial cell differentiation involved in kidney development (GO:2000696)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
nephric duct morphogenesis (GO:0072178)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
mesonephric duct development (GO:0072177)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
nephric duct development (GO:0072176)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
metanephric tubule formation (GO:0072174)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of cardiac muscle cell myoblast differentiation (GO:2000691)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
metanephric tubule morphogenesis (GO:0072173)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of cardiac muscle cell myoblast differentiation (GO:2000690)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mesonephric tubule formation (GO:0072172)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
phagolysosome assembly (GO:0001845)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
mesonephric tubule morphogenesis (GO:0072171)	37	0	1.01	-	 < 0.01	6.26E-01	1.00E00
neural fold formation (GO:0001842)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
female meiosis II (GO:0007147)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
neural plate development (GO:0001840)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
meiotic recombination nodule assembly (GO:0007146)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
female meiosis I (GO:0007144)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
female meiotic nuclear division (GO:0007143)	32	0	.88	-	 < 0.01	1.00E00	1.00E00
male meiosis I (GO:0007141)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
male meiotic nuclear division (GO:0007140)	35	0	.96	-	 < 0.01	1.00E00	1.00E00
specification of posterior mesonephric tubule identity (GO:0072169)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
specification of anterior mesonephric tubule identity (GO:0072168)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
specification of mesonephric tubule identity (GO:0072167)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
posterior mesonephric tubule development (GO:0072166)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of cellular response to X-ray (GO:2000683)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
neural plate morphogenesis (GO:0001839)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
anterior mesonephric tubule development (GO:0072165)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
epithelial to mesenchymal transition (GO:0001837)	43	0	1.18	-	 < 0.01	6.31E-01	1.00E00
male somatic sex determination (GO:0019102)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
metanephric mesenchymal cell differentiation (GO:0072162)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
mesenchymal cell differentiation involved in kidney development (GO:0072161)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
trophectodermal cell proliferation (GO:0001834)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
male germ-line sex determination (GO:0019100)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
nephron tubule epithelial cell differentiation (GO:0072160)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
inner cell mass cell proliferation (GO:0001833)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
blastocyst growth (GO:0001832)	23	0	.63	-	 < 0.01	1.00E00	1.00E00
trophectodermal cellular morphogenesis (GO:0001831)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cloacal septation (GO:0060197)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
trophectodermal cell fate commitment (GO:0001830)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
meiosis II (GO:0007135)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
positive regulation of lipase activity (GO:0060193)	30	0	.82	-	 < 0.01	1.00E00	1.00E00
negative regulation of lipase activity (GO:0060192)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
regulation of lipase activity (GO:0060191)	42	0	1.15	-	 < 0.01	6.30E-01	1.00E00
synaptonemal complex assembly (GO:0007130)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
positive regulation of transcription regulatory region DNA binding (GO:2000679)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
negative regulation of transcription regulatory region DNA binding (GO:2000678)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
regulation of transcription regulatory region DNA binding (GO:2000677)	31	0	.85	-	 < 0.01	1.00E00	1.00E00
positive regulation of type B pancreatic cell apoptotic process (GO:2000676)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of type B pancreatic cell apoptotic process (GO:2000675)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of type B pancreatic cell apoptotic process (GO:2000674)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
distal tubule morphogenesis (GO:0072156)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
trophectodermal cell differentiation (GO:0001829)	18	0	.49	-	 < 0.01	1.00E00	1.00E00
negative regulation of motor neuron apoptotic process (GO:2000672)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
inner cell mass cellular morphogenesis (GO:0001828)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of motor neuron apoptotic process (GO:2000671)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
inner cell mass cell fate commitment (GO:0001827)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of dendritic cell apoptotic process (GO:2000670)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
inner cell mass cell differentiation (GO:0001826)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
blastocyst formation (GO:0001825)	40	0	1.10	-	 < 0.01	6.28E-01	1.00E00
meiotic prophase I (GO:0007128)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
histamine secretion (GO:0001821)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
serotonin secretion (GO:0001820)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cell cycle switching (GO:0060184)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
female mating behavior (GO:0060180)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of dendritic cell apoptotic process (GO:2000669)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of dendritic cell apoptotic process (GO:2000668)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
renal interstitial fibroblast development (GO:0072141)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
male mating behavior (GO:0060179)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
positive regulation of type I hypersensitivity (GO:0001812)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of exocyst localization (GO:0060178)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of angiotensin metabolic process (GO:0060177)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of type I hypersensitivity (GO:0001810)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
limb bud formation (GO:0060174)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
male meiosis cytokinesis (GO:0007112)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
ribonucleoprotein complex disassembly (GO:0032988)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
protein-DNA complex disassembly (GO:0032986)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
negative regulation of apolipoprotein binding (GO:2000657)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of apolipoprotein binding (GO:2000656)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mesenchymal cell proliferation involved in ureteric bud development (GO:0072138)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of cellular response to testosterone stimulus (GO:2000655)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
condensed mesenchymal cell proliferation (GO:0072137)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of cellular response to testosterone stimulus (GO:2000654)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
metanephric mesenchymal cell proliferation involved in metanephros development (GO:0072136)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of genetic imprinting (GO:2000653)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
kidney mesenchymal cell proliferation (GO:0072135)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
nephrogenic mesenchyme morphogenesis (GO:0072134)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of sodium ion transmembrane transporter activity (GO:2000651)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
metanephric mesenchyme morphogenesis (GO:0072133)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of sodium ion transmembrane transporter activity (GO:2000650)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
mesenchyme morphogenesis (GO:0072132)	30	0	.82	-	 < 0.01	1.00E00	1.00E00
positive regulation of type III hypersensitivity (GO:0001805)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
kidney mesenchyme morphogenesis (GO:0072131)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of type III hypersensitivity (GO:0001803)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of adenosine receptor signaling pathway (GO:0060169)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein autoubiquitination (GO:1902499)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of protein autoubiquitination (GO:1902498)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
olfactory pit development (GO:0060166)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of timing of neuron differentiation (GO:0060164)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of dopamine receptor signaling pathway (GO:0060161)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
mitotic centrosome separation (GO:0007100)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of dopamine receptor signaling pathway (GO:0060160)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
protein insertion into mitochondrial inner membrane from matrix (GO:0032979)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein insertion into membrane from inner side (GO:0032978)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of sodium ion transmembrane transporter activity (GO:2000649)	25	0	.69	-	 < 0.01	1.00E00	1.00E00
regulation of muscle filament sliding speed (GO:0032972)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of stem cell proliferation (GO:2000648)	21	0	.58	-	 < 0.01	1.00E00	1.00E00
regulation of muscle filament sliding (GO:0032971)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of stem cell proliferation (GO:2000647)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
positive regulation of receptor catabolic process (GO:2000646)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of receptor catabolic process (GO:2000645)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of receptor catabolic process (GO:2000644)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
positive regulation of early endosome to late endosome transport (GO:2000643)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of glomerular mesangial cell proliferation (GO:0072125)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of early endosome to late endosome transport (GO:2000642)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of early endosome to late endosome transport (GO:2000641)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
regulation of dopamine receptor signaling pathway (GO:0060159)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
phospholipase C-activating dopamine receptor signaling pathway (GO:0060158)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
urinary bladder development (GO:0060157)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
platelet dense granule organization (GO:0060155)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cytotoxic T cell pyroptotic process (GO:1902483)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
microtubule-based peroxisome localization (GO:0060152)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
peroxisome localization (GO:0060151)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
protein localization to mitotic spindle (GO:1902480)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
collagen biosynthetic process (GO:0032964)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
collagen metabolic process (GO:0032963)	35	0	.96	-	 < 0.01	1.00E00	1.00E00
positive regulation of inositol trisphosphate biosynthetic process (GO:0032962)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of inositol trisphosphate biosynthetic process (GO:0032960)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of pre-miRNA processing (GO:2000632)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
pronephros morphogenesis (GO:0072114)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of pre-miRNA processing (GO:2000631)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of miRNA metabolic process (GO:2000630)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
glomerular visceral epithelial cell differentiation (GO:0072112)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein localization to synapse (GO:1902474)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of protein localization to synapse (GO:1902473)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
inositol trisphosphate biosynthetic process (GO:0032959)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
inositol phosphate biosynthetic process (GO:0032958)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
inositol trisphosphate metabolic process (GO:0032957)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
regulation of cytokinetic process (GO:0032954)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of miRNA metabolic process (GO:2000629)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of miRNA metabolic process (GO:2000628)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
positive regulation of miRNA catabolic process (GO:2000627)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of miRNA catabolic process (GO:2000626)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0072108)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of miRNA catabolic process (GO:2000625)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of ureteric bud formation (GO:0072107)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of ureteric bud formation (GO:0072106)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:2000623)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
ureteric peristalsis (GO:0072105)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:2000622)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
glomerular capillary formation (GO:0072104)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
glomerulus vasculature morphogenesis (GO:0072103)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of histone H4-K16 acetylation (GO:2000620)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
glomerulus morphogenesis (GO:0072102)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway (GO:0072101)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
specification of ureteric bud anterior/posterior symmetry (GO:0072100)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of apoptotic process by virus (GO:0060139)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
embryonic process involved in female pregnancy (GO:0060136)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
positive regulation of histone H3-K27 trimethylation (GO:1902466)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
prepulse inhibition (GO:0060134)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of histone H3-K27 trimethylation (GO:1902464)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
somatotropin secreting cell development (GO:0060133)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein localization to cell leading edge (GO:1902463)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of mesenchymal stem cell proliferation (GO:1902462)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of mesenchymal stem cell proliferation (GO:1902460)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of histone H4-K16 acetylation (GO:2000619)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of histone H4-K16 acetylation (GO:2000618)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
secretion by tissue (GO:0032941)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of histone H3-K9 acetylation (GO:2000617)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
negative regulation of histone H3-K9 acetylation (GO:2000616)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of histone H3-K9 acetylation (GO:2000615)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
positive regulation of thyroid-stimulating hormone secretion (GO:2000614)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of thyroid-stimulating hormone secretion (GO:2000612)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of thyroid hormone generation (GO:2000611)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
thyroid-stimulating hormone-secreting cell differentiation (GO:0060129)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of stem cell population maintenance (GO:1902459)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
corticotropin hormone secreting cell differentiation (GO:0060128)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
somatotropin secreting cell differentiation (GO:0060126)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of growth hormone secretion (GO:0060125)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of stem cell population maintenance (GO:1902455)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
inner ear receptor cell stereocilium organization (GO:0060122)	28	0	.77	-	 < 0.01	1.00E00	1.00E00
bile acid biosynthetic process (GO:0006699)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
inner ear receptor cell fate commitment (GO:0060120)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
ergosterol biosynthetic process (GO:0006696)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cholesterol biosynthetic process (GO:0006695)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
negative regulation of translation in response to oxidative stress (GO:0032938)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
leukotriene metabolic process (GO:0006691)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
SREBP signaling pathway (GO:0032933)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of thyroid hormone generation (GO:2000609)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell proliferation involved in mesonephros development (GO:2000607)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of superoxide anion generation (GO:0032930)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
regulation of cell proliferation involved in mesonephros development (GO:2000606)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of Arp2/3 complex-mediated actin nucleation (GO:2000601)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
regulation of mitochondrial membrane permeability involved in programmed necrotic cell death (GO:1902445)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of ripoptosome assembly involved in necroptotic process (GO:1902443)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of ripoptosome assembly involved in necroptotic process (GO:1902442)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
ganglioside catabolic process (GO:0006689)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
glycosphingolipid biosynthetic process (GO:0006688)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein localization to mitotic spindle pole body (GO:1902440)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
glycosphingolipid metabolic process (GO:0006687)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
sphingomyelin biosynthetic process (GO:0006686)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
sphingomyelin catabolic process (GO:0006685)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of superoxide anion generation (GO:0032929)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
sphingomyelin metabolic process (GO:0006684)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of superoxide anion generation (GO:0032928)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
galactosylceramide catabolic process (GO:0006683)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of activin receptor signaling pathway (GO:0032927)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of activin receptor signaling pathway (GO:0032926)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
galactosylceramide metabolic process (GO:0006681)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of activin receptor signaling pathway (GO:0032925)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
glucosylceramide catabolic process (GO:0006680)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
activin receptor signaling pathway (GO:0032924)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
circadian regulation of gene expression (GO:0032922)	50	0	1.37	-	 < 0.01	6.45E-01	1.00E00
putrescine acetylation (GO:0032920)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of male mating behavior (GO:1902437)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of male mating behavior (GO:1902435)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
glucosylceramide metabolic process (GO:0006678)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of phagocytosis, engulfment (GO:0060100)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of amyloid-beta formation (GO:1902430)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
glycosylceramide metabolic process (GO:0006677)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
spermine acetylation (GO:0032919)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
spermidine acetylation (GO:0032918)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
polyamine acetylation (GO:0032917)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
ceramide metabolic process (GO:0006672)	20	0	.55	-	 < 0.01	1.00E00	1.00E00
positive regulation of transforming growth factor beta3 production (GO:0032916)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of transforming growth factor beta2 production (GO:0032915)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
sphingosine metabolic process (GO:0006670)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of transforming growth factor beta1 production (GO:0032914)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of transforming growth factor beta1 production (GO:0032911)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
olfactory placode morphogenesis (GO:0071699)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
olfactory placode development (GO:0071698)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
ectodermal placode morphogenesis (GO:0071697)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
ectodermal placode development (GO:0071696)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
maintenance of protein location in extracellular region (GO:0071694)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
positive regulation of attachment of mitotic spindle microtubules to kinetochore (GO:1902425)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cardiac muscle thin filament assembly (GO:0071691)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of attachment of mitotic spindle microtubules to kinetochore (GO:1902423)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
sphinganine-1-phosphate biosynthetic process (GO:0006669)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
sphinganine-1-phosphate metabolic process (GO:0006668)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
sphinganine metabolic process (GO:0006667)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
sphingolipid metabolic process (GO:0006665)	28	0	.77	-	 < 0.01	1.00E00	1.00E00
regulation of transforming growth factor beta2 production (GO:0032909)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
glycolipid metabolic process (GO:0006664)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
regulation of transforming growth factor beta1 production (GO:0032908)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
platelet activating factor biosynthetic process (GO:0006663)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
glycerol ether metabolic process (GO:0006662)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
phosphatidylinositol biosynthetic process (GO:0006661)	22	0	.60	-	 < 0.01	1.00E00	1.00E00
nerve growth factor production (GO:0032902)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
TORC2 signaling (GO:0038203)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
TORC1 signaling (GO:0038202)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
striated muscle myosin thick filament assembly (GO:0071688)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of mRNA binding (GO:1902416)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
protein localization to cell junction (GO:1902414)	57	0	1.56	-	 < 0.01	4.07E-01	1.00E00
cellular response to indole-3-methanol (GO:0071681)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
response to indole-3-methanol (GO:0071680)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of mitotic cytokinesis (GO:1902412)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
CDP-choline pathway (GO:0006657)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
phosphatidylglycerol biosynthetic process (GO:0006655)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
diacylglycerol biosynthetic process (GO:0006651)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell (GO:0002291)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
commissural neuron axon guidance (GO:0071679)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of mononuclear cell migration (GO:0071676)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
positive regulation of smooth muscle cell chemotaxis (GO:0071673)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of smooth muscle cell chemotaxis (GO:0071672)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of smooth muscle cell chemotaxis (GO:0071671)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
smooth muscle cell chemotaxis (GO:0071670)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
signal transduction involved in mitotic DNA damage checkpoint (GO:1902402)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
phosphatidylethanolamine biosynthetic process (GO:0006646)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
membrane lipid metabolic process (GO:0006643)	32	0	.88	-	 < 0.01	1.00E00	1.00E00
triglyceride mobilization (GO:0006642)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
triglyceride metabolic process (GO:0006641)	33	0	.90	-	 < 0.01	1.00E00	1.00E00
monoacylglycerol biosynthetic process (GO:0006640)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
neutrophil activation involved in immune response (GO:0002283)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
positive regulation of granzyme B production (GO:0071663)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of granzyme B production (GO:0071661)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
acyl-CoA metabolic process (GO:0006637)	46	0	1.26	-	 < 0.01	6.36E-01	1.00E00
unsaturated fatty acid biosynthetic process (GO:0006636)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
tRNA demethylation (GO:1990983)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mast cell activation involved in immune response (GO:0002279)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
myeloid dendritic cell activation involved in immune response (GO:0002277)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
basophil activation involved in immune response (GO:0002276)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
plasmacytoid dendritic cell differentiation (GO:0002273)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
plasmacytoid dendritic cell activation (GO:0002270)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of granulocyte colony-stimulating factor production (GO:0071657)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of granulocyte colony-stimulating factor production (GO:0071655)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of chemokine (C-C motif) ligand 5 production (GO:0071651)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of chemokine (C-C motif) ligand 5 production (GO:0071650)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
protein processing involved in protein targeting to mitochondrion (GO:0006627)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
protein targeting to mitochondrion (GO:0006626)	26	0	.71	-	 < 0.01	1.00E00	1.00E00
protein targeting to peroxisome (GO:0006625)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
vacuolar protein processing (GO:0006624)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
protein targeting to lysosome (GO:0006622)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
protein retention in ER lumen (GO:0006621)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
leukocyte activation involved in inflammatory response (GO:0002269)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
astrocyte activation involved in immune response (GO:0002265)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
endothelial cell activation involved in immune response (GO:0002264)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of chemokine (C-C motif) ligand 5 production (GO:0071649)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of chemokine (C-C motif) ligand 4 production (GO:0071644)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of chemokine (C-C motif) ligand 4 production (GO:0071643)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of macrophage inflammatory protein 1 alpha production (GO:0071641)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of macrophage inflammatory protein 1 alpha production (GO:0071640)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
modulation by host of viral RNA-binding transcription factor activity (GO:1990969)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition (GO:0006617)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
modulation by host of RNA binding by virus (GO:1990968)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
SRP-dependent cotranslational protein targeting to membrane, translocation (GO:0006616)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
ATP generation from poly-ADP-D-ribose (GO:1990966)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
ribosomal protein import into nucleus (GO:0006610)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
kinin cascade (GO:0002254)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of monocyte chemotactic protein-1 production (GO:0071639)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of transforming growth factor beta production (GO:0071636)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
nuclear protein quality control by the ubiquitin-proteasome system (GO:0071630)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
homogentisate metabolic process (GO:1901999)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
toxin transport (GO:1901998)	22	0	.60	-	 < 0.01	1.00E00	1.00E00
NLS-bearing protein import into nucleus (GO:0006607)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of meiotic cell cycle phase transition (GO:1901995)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of meiotic cell cycle phase transition (GO:1901994)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
phosphocreatine metabolic process (GO:0006603)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of meiotic cell cycle phase transition (GO:1901993)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
intramanchette transport (GO:1990953)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
creatine biosynthetic process (GO:0006601)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
creatine metabolic process (GO:0006600)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
connective tissue replacement involved in inflammatory response wound healing (GO:0002248)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
wound healing involved in inflammatory response (GO:0002246)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cytoplasm protein quality control by the ubiquitin-proteasome system (GO:0071629)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mastication (GO:0071626)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
vocalization behavior (GO:0071625)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
negative regulation of granulocyte chemotaxis (GO:0071623)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
granulocyte chemotaxis (GO:0071621)	22	0	.60	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein acetylation (GO:1901984)	19	0	.52	-	 < 0.01	1.00E00	1.00E00
response to molecule of fungal origin (GO:0002238)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
leukocyte chemotaxis involved in inflammatory response (GO:0002232)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
acyl-CoA biosynthetic process (GO:0071616)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
regulation of inward rectifier potassium channel activity (GO:1901979)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of cell cycle checkpoint (GO:1901978)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
natural killer cell mediated immunity (GO:0002228)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
positive regulation of antimicrobial peptide production (GO:0002225)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
chemokine (C-C motif) ligand 5 production (GO:0071609)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
macrophage inflammatory protein-1 alpha production (GO:0071608)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
transforming growth factor beta production (GO:0071604)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
endothelial cell-cell adhesion (GO:0071603)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
beta-alanine biosynthetic process via 3-ureidopropionate (GO:0033396)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
otic vesicle morphogenesis (GO:0071600)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
response to amino acid starvation (GO:1990928)	37	0	1.01	-	 < 0.01	6.26E-01	1.00E00
short-term synaptic potentiation (GO:1990926)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of cell proliferation involved in outflow tract morphogenesis (GO:1901964)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of cell proliferation involved in outflow tract morphogenesis (GO:1901963)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
activation of innate immune response (GO:0002218)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
defense response to nematode (GO:0002215)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
putrescine biosynthetic process from arginine, using agmatinase (GO:0033389)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
putrescine biosynthetic process from arginine (GO:0033388)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
putrescine biosynthetic process from ornithine (GO:0033387)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
double-strand break repair involved in meiotic recombination (GO:1990918)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of retrograde dense core granule transport (GO:1901956)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
reactive nitrogen species metabolic process (GO:2001057)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
regulation of retrograde dense core granule transport (GO:1901954)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of anterograde dense core granule transport (GO:1901953)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of mesenchymal cell apoptotic process (GO:2001055)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of mesenchymal cell apoptotic process (GO:2001054)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
regulation of anterograde dense core granule transport (GO:1901951)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of mesenchymal cell apoptotic process (GO:2001053)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
behavioral defense response (GO:0002209)	22	0	.60	-	 < 0.01	1.00E00	1.00E00
dense core granule transport (GO:1901950)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
response to psychosocial stress (GO:1990911)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
somatic diversification of immunoglobulins involved in immune response (GO:0002208)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
somatic recombination of immunoglobulin genes involved in immune response (GO:0002204)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
somatic diversification of immune receptors (GO:0002200)	36	0	.99	-	 < 0.01	1.00E00	1.00E00
negative regulation of MHC class II biosynthetic process (GO:0045347)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of MHC class I biosynthetic process (GO:0045344)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of integrin-mediated signaling pathway (GO:2001046)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of integrin-mediated signaling pathway (GO:2001045)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of integrin-mediated signaling pathway (GO:2001044)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
reproductive behavior (GO:0019098)	23	0	.63	-	 < 0.01	1.00E00	1.00E00
farnesyl diphosphate metabolic process (GO:0045338)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
farnesyl diphosphate biosynthetic process (GO:0045337)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cellular respiration (GO:0045333)	68	0	1.86	-	 < 0.01	2.66E-01	1.00E00
protein localization to secretory granule (GO:0033366)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
mast cell secretory granule organization (GO:0033364)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
secretory granule organization (GO:0033363)	19	0	.52	-	 < 0.01	1.00E00	1.00E00
regulation of cellular response to drug (GO:2001038)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
negative regulation of double-strand break repair via nonhomologous end joining (GO:2001033)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of double-strand break repair via nonhomologous end joining (GO:2001032)	23	0	.63	-	 < 0.01	1.00E00	1.00E00
positive regulation of cellular glucuronidation (GO:2001031)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
transformation of host cell by virus (GO:0019087)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
late viral transcription (GO:0019086)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
early viral transcription (GO:0019085)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
carnitine biosynthetic process (GO:0045329)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
viral transcription (GO:0019083)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
viral translation (GO:0019081)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
viral gene expression (GO:0019080)	17	0	.47	-	 < 0.01	1.00E00	1.00E00
S-adenosylmethionine cycle (GO:0033353)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of cellular glucuronidation (GO:2001029)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of endothelial cell chemotaxis (GO:2001027)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of response to drug (GO:2001025)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of response to drug (GO:2001023)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of response to DNA damage stimulus (GO:2001022)	80	0	2.19	-	 < 0.01	2.79E-01	1.00E00
negative regulation of response to DNA damage stimulus (GO:2001021)	54	0	1.48	-	 < 0.01	4.05E-01	1.00E00
viral genome replication (GO:0019079)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
viral release from host cell (GO:0019076)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
virus maturation (GO:0019075)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
viral RNA genome packaging (GO:0019074)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
viral genome packaging (GO:0019072)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
asparagine catabolic process via L-aspartate (GO:0033345)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cholesterol efflux (GO:0033344)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
positive regulation of retrograde axon cargo transport (GO:2001019)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of collagen binding (GO:0033342)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of collagen binding (GO:0033341)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of retrograde axon cargo transport (GO:2001017)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of skeletal muscle cell differentiation (GO:2001016)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of skeletal muscle cell differentiation (GO:2001015)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of skeletal muscle cell differentiation (GO:2001014)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
epithelial cell proliferation involved in renal tubule morphogenesis (GO:2001013)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
mesenchymal cell differentiation involved in renal system development (GO:2001012)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
virion assembly (GO:0019068)	17	0	.47	-	 < 0.01	1.00E00	1.00E00
receptor-mediated endocytosis of virus by host cell (GO:0019065)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
fusion of virus membrane with host plasma membrane (GO:0019064)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
virion attachment to host cell (GO:0019062)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
centriole replication (GO:0007099)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
nuclear migration (GO:0007097)	17	0	.47	-	 < 0.01	1.00E00	1.00E00
mitotic G2 DNA damage checkpoint (GO:0007095)	19	0	.52	-	 < 0.01	1.00E00	1.00E00
metaphase/anaphase transition of mitotic cell cycle (GO:0007091)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
viral life cycle (GO:0019058)	46	0	1.26	-	 < 0.01	6.36E-01	1.00E00
modulation by virus of host cellular process (GO:0019054)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
natural killer cell proliferation (GO:0001787)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
traversing start control point of mitotic cell cycle (GO:0007089)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
B cell homeostasis (GO:0001782)	21	0	.58	-	 < 0.01	1.00E00	1.00E00
Leydig cell differentiation (GO:0033327)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
cerebrospinal fluid secretion (GO:0033326)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
modulation by virus of host process (GO:0019048)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
release from viral latency (GO:0019046)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
natural killer cell differentiation (GO:0001779)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
latent virus replication (GO:0019045)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
plasma membrane repair (GO:0001778)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
establishment of viral latency (GO:0019043)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
viral latency (GO:0019042)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
telomere maintenance via telomere trimming (GO:0090737)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
mitotic chromosome movement towards spindle pole (GO:0007079)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
immunological synapse formation (GO:0001771)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
positive regulation of transcription involved in exit from mitosis (GO:0007072)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
meiotic spindle assembly checkpoint (GO:0033316)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mitotic DNA replication checkpoint (GO:0033314)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
meiotic cell cycle checkpoint (GO:0033313)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
anterior/posterior pattern specification involved in ureteric bud development (GO:0072099)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
anterior/posterior pattern specification involved in kidney development (GO:0072098)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway (GO:0072097)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of branch elongation involved in ureteric bud branching (GO:0072096)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of branch elongation involved in ureteric bud branching (GO:0072095)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
establishment of T cell polarity (GO:0001768)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
establishment of lymphocyte polarity (GO:0001767)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
metanephric renal vesicle formation (GO:0072093)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
membrane raft polarization (GO:0001766)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
ureteric bud invasion (GO:0072092)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of stem cell proliferation (GO:0072091)	36	0	.99	-	 < 0.01	1.00E00	1.00E00
female meiosis sister chromatid cohesion (GO:0007066)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
primary adaptive immune response involving T cells and B cells (GO:0090721)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
male meiosis sister chromatid cohesion (GO:0007065)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
primary adaptive immune response (GO:0090720)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mitotic sister chromatid cohesion (GO:0007064)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
regulation of sister chromatid cohesion (GO:0007063)	19	0	.52	-	 < 0.01	1.00E00	1.00E00
sister chromatid cohesion (GO:0007062)	35	0	.96	-	 < 0.01	1.00E00	1.00E00
male meiosis chromosome segregation (GO:0007060)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cell cycle comprising mitosis without cytokinesis (GO:0033301)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
stem cell proliferation (GO:0072089)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
nephron epithelium morphogenesis (GO:0072088)	42	0	1.15	-	 < 0.01	6.30E-01	1.00E00
renal vesicle development (GO:0072087)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
organ induction (GO:0001759)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
neural crest cell migration (GO:0001755)	24	0	.66	-	 < 0.01	1.00E00	1.00E00
specification of nephron tubule identity (GO:0072081)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
immunological memory formation process (GO:0090715)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
immunological memory process (GO:0090713)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
spindle assembly involved in female meiosis I (GO:0007057)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
spindle assembly involved in female meiosis (GO:0007056)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
cell cycle arrest (GO:0007050)	63	0	1.73	-	 < 0.01	4.17E-01	1.00E00
positive regulation of optic nerve formation (GO:2000597)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
nephron tubule formation (GO:0072079)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
nephron tubule morphogenesis (GO:0072078)	41	0	1.12	-	 < 0.01	6.28E-01	1.00E00
regulation of optic nerve formation (GO:2000595)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
renal vesicle morphogenesis (GO:0072077)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
positive regulation of metanephric DCT cell differentiation (GO:2000594)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
nephrogenic mesenchyme development (GO:0072076)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
metanephric mesenchyme development (GO:0072075)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
regulation of metanephric DCT cell differentiation (GO:2000592)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
kidney mesenchyme development (GO:0072074)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
negative regulation of metanephric mesenchymal cell migration (GO:2000590)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
kidney interstitial fibroblast differentiation (GO:0072071)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
loop of Henle development (GO:0072070)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
optic placode formation (GO:0001743)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cell-substrate junction assembly (GO:0007044)	28	0	.77	-	 < 0.01	1.00E00	1.00E00
cell-cell junction assembly (GO:0007043)	35	0	.96	-	 < 0.01	1.00E00	1.00E00
positive regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000588)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000587)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000586)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of platelet-derived growth factor receptor-alpha signaling pathway (GO:2000584)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of platelet-derived growth factor receptor-alpha signaling pathway (GO:2000583)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
positive regulation of ATP-dependent microtubule motor activity, plus-end-directed (GO:2000582)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
morphogenesis of a polarized epithelium (GO:0001738)	25	0	.69	-	 < 0.01	1.00E00	1.00E00
regulation of ATP-dependent microtubule motor activity, plus-end-directed (GO:2000580)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
establishment of planar polarity (GO:0001736)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
inner medullary collecting duct development (GO:0072061)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of phagocytosis, engulfment (GO:0060099)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
formation of cytoplasmic translation initiation complex (GO:0001732)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
formation of translation preinitiation complex (GO:0001731)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
mitotic cytokinesis checkpoint (GO:0044878)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
endosome organization (GO:0007032)	35	0	.96	-	 < 0.01	1.00E00	1.00E00
lipoprotein localization (GO:0044872)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
negative regulation of ATP-dependent microtubule motor activity, minus-end-directed (GO:2000578)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of ATP-dependent microtubule motor activity, minus-end-directed (GO:2000577)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of microtubule motor activity (GO:2000576)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of microtubule motor activity (GO:2000575)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of microtubule motor activity (GO:2000574)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
positive regulation of interleukin-4-dependent isotype switching to IgE isotypes (GO:2000572)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
renal outer medulla development (GO:0072054)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of interleukin-4-dependent isotype switching to IgE isotypes (GO:2000571)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
renal inner medulla development (GO:0072053)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of T-helper 2 cell activation (GO:2000570)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
juxtaglomerular apparatus development (GO:0072051)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
S-shaped body morphogenesis (GO:0072050)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
endoplasmic reticulum organization (GO:0007029)	26	0	.71	-	 < 0.01	1.00E00	1.00E00
cytoplasm organization (GO:0007028)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
auditory receptor cell stereocilium organization (GO:0060088)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
relaxation of vascular associated smooth muscle (GO:0060087)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
circadian temperature homeostasis (GO:0060086)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
membrane hyperpolarization (GO:0060081)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
microtubule nucleation (GO:0007020)	18	0	.49	-	 < 0.01	1.00E00	1.00E00
inhibitory postsynaptic potential (GO:0060080)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
protein transport into plasma membrane raft (GO:0044861)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
neurotrophin production (GO:0032898)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of viral transcription (GO:0032897)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
regulation of T-helper 2 cell activation (GO:2000569)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of organic acid transport (GO:0032892)	20	0	.55	-	 < 0.01	1.00E00	1.00E00
positive regulation of memory T cell activation (GO:2000568)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of organic acid transport (GO:0032891)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
regulation of memory T cell activation (GO:2000567)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of organic acid transport (GO:0032890)	36	0	.99	-	 < 0.01	1.00E00	1.00E00
comma-shaped body morphogenesis (GO:0072049)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of CD8-positive, alpha-beta T cell proliferation (GO:2000566)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
urokinase plasminogen activator signaling pathway (GO:0038195)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
renal system pattern specification (GO:0072048)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
proximal/distal pattern formation involved in nephron development (GO:0072047)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of CD8-positive, alpha-beta T cell proliferation (GO:2000564)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
positive regulation of CD4-positive, alpha-beta T cell proliferation (GO:2000563)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of CD24 production (GO:2000560)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
endodermal cell fate specification (GO:0001714)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis (GO:0072040)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
ectodermal cell fate commitment (GO:0001712)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
endodermal cell fate commitment (GO:0001711)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
mesodermal cell fate commitment (GO:0001710)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
plasma membrane raft organization (GO:0044857)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of resting membrane potential (GO:0060075)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
synapse maturation (GO:0060074)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
micturition (GO:0060073)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
plasma membrane raft assembly (GO:0044854)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
Wnt signaling pathway, planar cell polarity pathway (GO:0060071)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
canonical Wnt signaling pathway (GO:0060070)	43	0	1.18	-	 < 0.01	6.31E-01	1.00E00
hair cycle phase (GO:0044851)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
regulation of vacuole fusion, non-autophagic (GO:0032889)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of mitotic spindle elongation (GO:0032888)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of spindle elongation (GO:0032887)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
neuropilin signaling pathway (GO:0038189)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of CD24 production (GO:2000559)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of immunoglobulin production in mucosal tissue (GO:2000558)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of immunoglobulin production in mucosal tissue (GO:2000557)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis (GO:0072039)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of T-helper 1 cell cytokine production (GO:2000556)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
intracellular bile acid receptor signaling pathway (GO:0038185)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mesenchymal stem cell maintenance involved in nephron morphogenesis (GO:0072038)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of T-helper 1 cell cytokine production (GO:2000554)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
bile acid signaling pathway (GO:0038183)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cell fate determination (GO:0001709)	24	0	.66	-	 < 0.01	1.00E00	1.00E00
negative regulation of T-helper 2 cell cytokine production (GO:2000552)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cell fate specification (GO:0001708)	49	0	1.34	-	 < 0.01	6.42E-01	1.00E00
renal vesicle induction (GO:0072034)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
mesoderm formation (GO:0001707)	39	0	1.07	-	 < 0.01	6.27E-01	1.00E00
nerve growth factor signaling pathway (GO:0038180)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
renal vesicle formation (GO:0072033)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
endoderm formation (GO:0001706)	23	0	.63	-	 < 0.01	1.00E00	1.00E00
ectoderm formation (GO:0001705)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
formation of primary germ layer (GO:0001704)	61	0	1.67	-	 < 0.01	4.13E-01	1.00E00
gastrulation with mouth forming second (GO:0001702)	17	0	.47	-	 < 0.01	1.00E00	1.00E00
outer mitochondrial membrane organization (GO:0007008)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
vagina development (GO:0060068)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
inner mitochondrial membrane organization (GO:0007007)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
estrous cycle (GO:0044849)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
biological phase (GO:0044848)	24	0	.66	-	 < 0.01	1.00E00	1.00E00
oviduct development (GO:0060066)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein localization to bicellular tight junction (GO:1902396)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
uterus development (GO:0060065)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
telomere maintenance via telomerase (GO:0007004)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
cell cycle G1/S phase transition (GO:0044843)	59	0	1.62	-	 < 0.01	4.10E-01	1.00E00
Spemann organizer formation (GO:0060061)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
nucleolus organization (GO:0007000)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
post-embryonic retina morphogenesis in camera-type eye (GO:0060060)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of DNA endoreduplication (GO:0032877)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of DNA endoreduplication (GO:0032876)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of DNA endoreduplication (GO:0032875)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of stress-activated MAPK cascade (GO:0032873)	33	0	.90	-	 < 0.01	1.00E00	1.00E00
neurotrophin signaling pathway (GO:0038179)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
positive regulation of dendritic cell dendrite assembly (GO:2000549)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of dendritic cell dendrite assembly (GO:2000547)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of endothelial cell chemotaxis to fibroblast growth factor (GO:2000546)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
nephron morphogenesis (GO:0072028)	42	0	1.15	-	 < 0.01	6.30E-01	1.00E00
negative regulation of endothelial cell chemotaxis to fibroblast growth factor (GO:2000545)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of endothelial cell chemotaxis to fibroblast growth factor (GO:2000544)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of gastrulation (GO:2000543)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
thick ascending limb development (GO:0072023)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
ascending thin limb development (GO:0072021)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
embryonic retina morphogenesis in camera-type eye (GO:0060059)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
ceramide 1-phosphate transport (GO:1902389)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of apoptotic process involved in mammary gland involution (GO:0060058)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cell quiescence (GO:0044838)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
mammary gland involution (GO:0060056)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
actomyosin contractile ring organization (GO:0044837)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
angiogenesis involved in wound healing (GO:0060055)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
neurofilament cytoskeleton organization (GO:0060052)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein glycosylation (GO:0060051)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein glycosylation (GO:0060050)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
modulation by host of viral RNA genome replication (GO:0044830)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
epidermal growth factor receptor signaling pathway via I-kappaB kinase/NF-kappaB cascade (GO:0038168)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of B cell chemotaxis (GO:2000538)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
epidermal growth factor receptor signaling pathway via positive regulation of NF-kappaB transcription factor activity (GO:0038167)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of B cell chemotaxis (GO:2000537)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
angiotensin-activated signaling pathway (GO:0038166)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
oncostatin-M-mediated signaling pathway (GO:0038165)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of entry of bacterium into host cell (GO:2000535)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of renal albumin absorption (GO:2000534)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
glomerular visceral epithelial cell development (GO:0072015)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of renal albumin absorption (GO:2000532)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
proximal tubule development (GO:0072014)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of protein glycosylation (GO:0060049)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
positive regulation by host of viral genome replication (GO:0044829)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation by host of viral genome replication (GO:0044828)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of acrosome reaction (GO:0060046)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
modulation by host of viral genome replication (GO:0044827)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
positive regulation of cardiac muscle cell proliferation (GO:0060045)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
negative regulation of cardiac muscle cell proliferation (GO:0060044)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
regulation of rRNA catabolic process (GO:1902374)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of cardiac muscle cell proliferation (GO:0060043)	25	0	.69	-	 < 0.01	1.00E00	1.00E00
negative regulation of mRNA catabolic process (GO:1902373)	47	0	1.29	-	 < 0.01	6.38E-01	1.00E00
negative regulation of tRNA catabolic process (GO:1902371)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
retinal bipolar neuron differentiation (GO:0060040)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
regulation of tRNA catabolic process (GO:1902370)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
interleukin-3-mediated signaling pathway (GO:0038156)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of T cell costimulation (GO:2000525)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of T cell costimulation (GO:2000523)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
kidney field specification (GO:0072004)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of immunological synapse formation (GO:2000521)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
kidney rudiment formation (GO:0072003)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of immunological synapse formation (GO:2000520)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
pericardium development (GO:0060039)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
negative regulation of RNA catabolic process (GO:1902369)	55	0	1.51	-	 < 0.01	4.06E-01	1.00E00
cardiac muscle cell proliferation (GO:0060038)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
mitotic G1/S transition checkpoint (GO:0044819)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
pharyngeal system development (GO:0060037)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
negative regulation of Notch signaling pathway involved in somitogenesis (GO:1902367)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mitotic G2/M transition checkpoint (GO:0044818)	30	0	.82	-	 < 0.01	1.00E00	1.00E00
regulation of Notch signaling pathway involved in somitogenesis (GO:1902366)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein localization to spindle pole body (GO:1902365)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
anatomical structure regression (GO:0060033)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of protein localization to spindle pole body (GO:1902363)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
notochord regression (GO:0060032)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of cellular pH reduction (GO:0032849)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of cellular pH reduction (GO:0032847)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of T-helper 1 cell activation (GO:2000518)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of T-helper 1 cell activation (GO:2000517)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
chemokine (C-X-C motif) ligand 12 signaling pathway (GO:0038146)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
macrophage colony-stimulating factor signaling pathway (GO:0038145)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of granzyme A production (GO:2000513)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of granzyme A production (GO:2000511)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of dendritic cell chemotaxis (GO:2000510)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
convergent extension involved in organogenesis (GO:0060029)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
metabolism by host of substance in symbiont (GO:0052419)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
convergent extension involved in axis elongation (GO:0060028)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
metabolism by organism of protein in other organism involved in symbiotic interaction (GO:0052418)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
convergent extension involved in gastrulation (GO:0060027)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
metabolism by host of symbiont protein (GO:0052417)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
convergent extension (GO:0060026)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
metabolism by host of symbiont macromolecule (GO:0052416)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of synaptic activity (GO:0060025)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
G-quadruplex DNA unwinding (GO:0044806)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
rhythmic synaptic transmission (GO:0060024)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
late nucleophagy (GO:0044805)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
soft palate development (GO:0060023)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
hard palate development (GO:0060022)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
phosphagen metabolic process (GO:0006599)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
multi-organism membrane organization (GO:0044803)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
polyamine catabolic process (GO:0006598)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
Bergmann glial cell differentiation (GO:0060020)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
cellular response to chloroquine (GO:1902350)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
multi-organism membrane fusion (GO:0044800)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
ornithine catabolic process (GO:0006593)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
ornithine biosynthetic process (GO:0006592)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
glomerular basement membrane development (GO:0032836)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
ornithine metabolic process (GO:0006591)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
thyroid hormone generation (GO:0006590)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of dendritic cell chemotaxis (GO:2000508)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation (GO:0032831)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of blood vessel remodeling (GO:2000504)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
ERBB2-ERBB3 signaling pathway (GO:0038133)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of natural killer cell chemotaxis (GO:2000503)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of natural killer cell chemotaxis (GO:2000501)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
radial glial cell differentiation (GO:0060019)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
response to chloroquine (GO:1902349)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
astrocyte fate commitment (GO:0060018)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
granulosa cell development (GO:0060016)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
granulosa cell differentiation (GO:0060014)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
righting reflex (GO:0060013)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
octopamine biosynthetic process (GO:0006589)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
Sertoli cell proliferation (GO:0060011)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
Sertoli cell fate commitment (GO:0060010)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
serotonin biosynthetic process from tryptophan (GO:0006587)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
indolalkylamine metabolic process (GO:0006586)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
dopamine biosynthetic process from tyrosine (GO:0006585)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation (GO:0032829)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of natural killer cell differentiation involved in immune response (GO:0032827)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
melanin metabolic process (GO:0006582)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of natural killer cell differentiation involved in immune response (GO:0032826)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
ethanolamine metabolic process (GO:0006580)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of natural killer cell differentiation (GO:0032824)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
ERBB3 signaling pathway (GO:0038129)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
ERBB2 signaling pathway (GO:0038128)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
ERBB signaling pathway (GO:0038127)	27	0	.74	-	 < 0.01	1.00E00	1.00E00
Sertoli cell development (GO:0060009)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
positive regulation of apoptotic process involved in morphogenesis (GO:1902339)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
Sertoli cell differentiation (GO:0060008)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
negative regulation of apoptotic process involved in morphogenesis (GO:1902338)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of apoptotic process involved in morphogenesis (GO:1902337)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
positive regulation of retinal ganglion cell axon guidance (GO:1902336)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
vestibular reflex (GO:0060005)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
reflex (GO:0060004)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
copper ion export (GO:0060003)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
amino-acid betaine catabolic process (GO:0006579)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
amino-acid betaine biosynthetic process (GO:0006578)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
amino-acid betaine metabolic process (GO:0006577)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
positive regulation of natural killer cell proliferation (GO:0032819)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
valine catabolic process (GO:0006574)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
valine metabolic process (GO:0006573)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of natural killer cell proliferation (GO:0032817)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
tyrosine catabolic process (GO:0006572)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
tyrosine biosynthetic process (GO:0006571)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of natural killer cell activation (GO:0032815)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
tyrosine metabolic process (GO:0006570)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
positive regulation of epinephrine secretion (GO:0032812)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of epinephrine secretion (GO:0032811)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
chemokine (C-C motif) ligand 21 signaling pathway (GO:0038116)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
interleukin-2-mediated signaling pathway (GO:0038110)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
otic vesicle development (GO:0071599)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
ubiquitin-dependent protein catabolic process via the N-end rule pathway (GO:0071596)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
lymphocyte aggregation (GO:0071593)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
tryptophan catabolic process (GO:0006569)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
tryptophan metabolic process (GO:0006568)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
threonine catabolic process (GO:0006567)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
threonine metabolic process (GO:0006566)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
L-serine catabolic process (GO:0006565)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
L-serine biosynthetic process (GO:0006564)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
lacrimal gland development (GO:0032808)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
L-serine metabolic process (GO:0006563)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
proline catabolic process (GO:0006562)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
proline biosynthetic process (GO:0006561)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of low-density lipoprotein particle receptor catabolic process (GO:0032805)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
proline metabolic process (GO:0006560)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
negative regulation of low-density lipoprotein particle receptor catabolic process (GO:0032804)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of low-density lipoprotein particle receptor catabolic process (GO:0032803)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
Kit signaling pathway (GO:0038109)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of appetite by leptin-mediated signaling pathway (GO:0038108)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
nodal signaling pathway involved in determination of left/right asymmetry (GO:0038107)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
sequestering of nodal from receptor via nodal binding (GO:0038101)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
DNA strand elongation involved in nuclear cell cycle DNA replication (GO:1902319)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of zinc ion transmembrane transport (GO:0071583)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
nuclear cell cycle DNA replication initiation (GO:1902315)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of zinc ion transport (GO:0071582)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of zinc ion transmembrane transport (GO:0071580)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
L-phenylalanine catabolic process (GO:0006559)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
L-phenylalanine metabolic process (GO:0006558)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
positive regulation of peptidyl-serine dephosphorylation (GO:1902310)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
S-adenosylmethionine biosynthetic process (GO:0006556)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
methionine metabolic process (GO:0006555)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
lysine catabolic process (GO:0006554)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
lysine metabolic process (GO:0006553)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
leucine catabolic process (GO:0006552)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
leucine metabolic process (GO:0006551)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
isoleucine catabolic process (GO:0006550)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
hepatocyte cell migration (GO:0002194)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cap-dependent translational initiation (GO:0002191)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of zinc ion transport (GO:0071579)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of peptidyl-serine dephosphorylation (GO:1902309)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of peptidyl-serine dephosphorylation (GO:1902308)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of sodium ion transmembrane transport (GO:1902307)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
negative regulation of sodium ion transmembrane transport (GO:1902306)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
regulation of sodium ion transmembrane transport (GO:1902305)	29	0	.80	-	 < 0.01	1.00E00	1.00E00
isoleucine metabolic process (GO:0006549)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
histidine catabolic process (GO:0006548)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
histidine metabolic process (GO:0006547)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
glycine catabolic process (GO:0006546)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
glycine biosynthetic process (GO:0006545)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
glycine metabolic process (GO:0006544)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
glutamine catabolic process (GO:0006543)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
glutamine metabolic process (GO:0006541)	17	0	.47	-	 < 0.01	1.00E00	1.00E00
translation reinitiation (GO:0002188)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cytoplasmic translational termination (GO:0002184)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cytoplasmic translational initiation (GO:0002183)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
protein ufmylation (GO:0071569)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
glutamate catabolic process (GO:0006538)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
glutamate biosynthetic process (GO:0006537)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of attachment of spindle microtubules to kinetochore (GO:0051988)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
glutamate metabolic process (GO:0006536)	18	0	.49	-	 < 0.01	1.00E00	1.00E00
positive regulation of attachment of spindle microtubules to kinetochore (GO:0051987)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
cysteine biosynthetic process from serine (GO:0006535)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
aspartate catabolic process (GO:0006533)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
RNA acetylation (GO:1990884)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
aspartate biosynthetic process (GO:0006532)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
aspartate metabolic process (GO:0006531)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
rRNA acetylation (GO:1990882)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
asparagine catabolic process (GO:0006530)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein localization to paranode region of axon (GO:0002175)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
histone H3-K27 demethylation (GO:0071557)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cell wall organization or biogenesis (GO:0071554)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
death-inducing signaling complex assembly (GO:0071550)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
asparagine biosynthetic process (GO:0006529)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
asparagine metabolic process (GO:0006528)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
arginine catabolic process (GO:0006527)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
arginine biosynthetic process (GO:0006526)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
lysophospholipid transport (GO:0051977)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
arginine metabolic process (GO:0006525)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
alanine catabolic process (GO:0006524)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of telomerase activity (GO:0051974)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
alanine metabolic process (GO:0006522)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of telomerase activity (GO:0051973)	24	0	.66	-	 < 0.01	1.00E00	1.00E00
regulation of cellular amino acid metabolic process (GO:0006521)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of telomerase activity (GO:0051972)	36	0	.99	-	 < 0.01	1.00E00	1.00E00
cellular response to dexamethasone stimulus (GO:0071549)	18	0	.49	-	 < 0.01	1.00E00	1.00E00
response to dexamethasone (GO:0071548)	20	0	.55	-	 < 0.01	1.00E00	1.00E00
inositol phosphate catabolic process (GO:0071545)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
dopaminergic neuron differentiation (GO:0071542)	19	0	.52	-	 < 0.01	1.00E00	1.00E00
protein deglycosylation (GO:0006517)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
positive regulation of synaptic transmission, glutamatergic (GO:0051968)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
glycoprotein catabolic process (GO:0006516)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
negative regulation of synaptic transmission, glutamatergic (GO:0051967)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
protein quality control for misfolded or incompletely synthesized proteins (GO:0006515)	21	0	.58	-	 < 0.01	1.00E00	1.00E00
positive regulation of synapse assembly (GO:0051965)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
protein monoubiquitination (GO:0006513)	55	0	1.51	-	 < 0.01	4.06E-01	1.00E00
negative regulation of synapse assembly (GO:0051964)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of synapse assembly (GO:0051963)	27	0	.74	-	 < 0.01	1.00E00	1.00E00
desmosome assembly (GO:0002159)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of thyroid hormone mediated signaling pathway (GO:0002155)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
thyroid hormone mediated signaling pathway (GO:0002154)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
otolith mineralization (GO:0045299)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
protein localization to centrosome (GO:0071539)	20	0	.55	-	 < 0.01	1.00E00	1.00E00
membrane protein ectodomain proteolysis (GO:0006509)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of relaxation of cardiac muscle (GO:1901898)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular response to endothelin (GO:1990859)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
GPI anchor release (GO:0006507)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of relaxation of cardiac muscle (GO:1901897)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
GPI anchor biosynthetic process (GO:0006506)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of amino acid transport (GO:0051957)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
positive regulation of ATPase-coupled calcium transmembrane transporter activity (GO:1901896)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
GPI anchor metabolic process (GO:0006505)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of amino acid transport (GO:0051956)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
negative regulation of ATPase-coupled calcium transmembrane transporter activity (GO:1901895)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of amino acid transport (GO:0051955)	18	0	.49	-	 < 0.01	1.00E00	1.00E00
regulation of ATPase-coupled calcium transmembrane transporter activity (GO:1901894)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of amine transport (GO:0051954)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
negative regulation of amine transport (GO:0051953)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
positive regulation of cell junction assembly (GO:1901890)	32	0	.88	-	 < 0.01	1.00E00	1.00E00
tRNA re-export from nucleus (GO:0071528)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
semaphorin-plexin signaling pathway (GO:0071526)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell junction assembly (GO:1901889)	20	0	.55	-	 < 0.01	1.00E00	1.00E00
negative regulation of catecholamine uptake involved in synaptic transmission (GO:0051945)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
adaptive thermogenesis (GO:1990845)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein depolymerization (GO:1901881)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
retinoic acid biosynthetic process (GO:0002138)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of catecholamine uptake involved in synaptic transmission (GO:0051940)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
maintenance of imprinting at mating-type locus (GO:0071517)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
genetic imprinting at mating-type locus (GO:0071515)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
genetic imprinting (GO:0071514)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
gamma-aminobutyric acid import (GO:0051939)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to endothelin (GO:1990839)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of post-translational protein modification (GO:1901874)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
catecholamine uptake involved in synaptic transmission (GO:0051934)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of post-translational protein modification (GO:1901873)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
response to odorant (GO:1990834)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
synaptic transmission, GABAergic (GO:0051932)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cellular response to leukemia inhibitory factor (GO:1990830)	81	0	2.22	-	 < 0.01	2.81E-01	1.00E00
cellular response to heparin (GO:0071504)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
secretion of lysosomal enzymes (GO:0033299)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
response to heparin (GO:0071503)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
cellular response to sterol depletion (GO:0071501)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
cellular response to nitrosative stress (GO:0071500)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
T-tubule organization (GO:0033292)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of calcium ion transport (GO:0051926)	27	0	.74	-	 < 0.01	1.00E00	1.00E00
positive regulation of muscle tissue development (GO:1901863)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
response to leukemia inhibitory factor (GO:1990823)	81	0	2.22	-	 < 0.01	2.81E-01	1.00E00
basic amino acid transmembrane transport (GO:1990822)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of mitochondrial DNA metabolic process (GO:1901860)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
aggressive behavior (GO:0002118)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
store-operated calcium entry (GO:0002115)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of mitochondrial DNA metabolic process (GO:1901859)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of fibrinolysis (GO:0051919)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of mitochondrial DNA metabolic process (GO:1901858)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of fibrinolysis (GO:0051918)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
regulation of fibrinolysis (GO:0051917)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
negative regulation of cellular respiration (GO:1901856)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
response to vitamin D (GO:0033280)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
tRNA wobble adenosine to inosine editing (GO:0002100)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cell proliferation in midbrain (GO:0033278)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
abortive mitotic cell cycle (GO:0033277)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
actin-myosin filament sliding (GO:0033275)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
response to vitamin (GO:0033273)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
establishment of pigment granule localization (GO:0051905)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
pigment granule transport (GO:0051904)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
positive regulation of high voltage-gated calcium channel activity (GO:1901843)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of high voltage-gated calcium channel activity (GO:1901842)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of high voltage-gated calcium channel activity (GO:1901841)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
positive regulation of mitochondrial depolarization (GO:0051901)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
RNA localization to nucleus (GO:0090685)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
positive regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901838)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
negative regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901837)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of nuclear cell cycle DNA replication (GO:0033262)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
positive regulation of deadenylation-independent decapping of nuclear-transcribed mRNA (GO:1901835)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of deadenylation-independent decapping of nuclear-transcribed mRNA (GO:1901834)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of CD4 production (GO:0045225)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of CD4 production (GO:0045223)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
endothelial cell-matrix adhesion (GO:0090673)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
telomerase RNA localization (GO:0090672)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
telomerase RNA localization to Cajal body (GO:0090671)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
RNA localization to Cajal body (GO:0090670)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
zeaxanthin biosynthetic process (GO:1901827)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
zeaxanthin metabolic process (GO:1901825)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
zonula adherens maintenance (GO:0045218)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
telomerase RNA stabilization (GO:0090669)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cell-cell junction maintenance (GO:0045217)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
endothelial cell chemotaxis to vascular endothelial growth factor (GO:0090668)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cell-cell junction organization (GO:0045216)	64	0	1.76	-	 < 0.01	4.20E-01	1.00E00
cell chemotaxis to vascular endothelial growth factor (GO:0090667)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
scaRNA localization to Cajal body (GO:0090666)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
neurotransmitter receptor metabolic process (GO:0045213)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cerebrospinal fluid circulation (GO:0090660)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
positive regulation of cellular amine metabolic process (GO:0033240)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
beta-carotene metabolic process (GO:1901810)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
walking behavior (GO:0090659)	18	0	.49	-	 < 0.01	1.00E00	1.00E00
gastric acid secretion (GO:0001696)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
telomeric loop disassembly (GO:0090657)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
t-circle formation (GO:0090656)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
histamine biosynthetic process (GO:0001694)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
MAPK export from nucleus (GO:0045204)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
histamine metabolic process (GO:0001692)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
establishment of neuroblast polarity (GO:0045200)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of cellular amine metabolic process (GO:0033239)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to oxygen-glucose deprivation (GO:0090650)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of cellular amine metabolic process (GO:0033238)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein sumoylation (GO:0033234)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
beta-glucoside catabolic process (GO:1901805)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
beta-glucoside metabolic process (GO:1901804)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to oxygen-glucose deprivation (GO:0090649)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
response to environmental enrichment (GO:0090648)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
modulation of age-related behavioral decline (GO:0090647)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mitochondrial tRNA processing (GO:0090646)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
dsRNA transport (GO:0033227)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
long-chain fatty acid metabolic process (GO:0001676)	24	0	.66	-	 < 0.01	1.00E00	1.00E00
acrosome assembly (GO:0001675)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
iron import into cell (GO:0033212)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
adiponectin-activated signaling pathway (GO:0033211)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
mRNA cleavage involved in gene silencing by siRNA (GO:0090625)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
behavioral fear response (GO:0001662)	21	0	.58	-	 < 0.01	1.00E00	1.00E00
conditioned taste aversion (GO:0001661)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
fever generation (GO:0001660)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
tumor necrosis factor-mediated signaling pathway (GO:0033209)	21	0	.58	-	 < 0.01	1.00E00	1.00E00
meiotic cytokinesis (GO:0033206)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
GCN2-mediated signaling (GO:0140469)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
HRI-mediated signaling (GO:0140468)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
integrated stress response signaling (GO:0140467)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
temperature homeostasis (GO:0001659)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
branching involved in ureteric bud morphogenesis (GO:0001658)	27	0	.74	-	 < 0.01	1.00E00	1.00E00
DNA clamp unloading (GO:0090618)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
pericentric heterochromatin organization (GO:0140462)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
mitochondrial mRNA processing (GO:0090615)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway (GO:0090611)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation by host of viral process (GO:0044794)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
positive regulation by host of viral release from host cell (GO:0044791)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of interleukin-18-mediated signaling pathway (GO:2000494)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
osteoblast differentiation (GO:0001649)	58	0	1.59	-	 < 0.01	4.09E-01	1.00E00
regulation of interleukin-18-mediated signaling pathway (GO:2000492)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cytoplasm protein quality control (GO:0140455)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
modulation by host of viral release from host cell (GO:0044789)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
metaphase/anaphase transition of cell cycle (GO:0044784)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
G1 DNA damage checkpoint (GO:0044783)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
negative regulation of glutamine transport (GO:2000486)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of glutamine transport (GO:2000485)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
signaling receptor ligand precursor processing (GO:0140448)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
cytokine precursor processing (GO:0140447)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of cAMP-dependent protein kinase activity (GO:2000481)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of cAMP-dependent protein kinase activity (GO:2000480)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
meiotic spindle checkpoint (GO:0044779)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
meiotic DNA integrity checkpoint (GO:0044778)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mitotic DNA integrity checkpoint (GO:0044774)	50	0	1.37	-	 < 0.01	6.45E-01	1.00E00
mitotic DNA damage checkpoint (GO:0044773)	45	0	1.23	-	 < 0.01	6.34E-01	1.00E00
meiotic cell cycle phase transition (GO:0044771)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of cAMP-dependent protein kinase activity (GO:2000479)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
positive regulation of metanephric glomerular visceral epithelial cell development (GO:2000478)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of metanephric glomerular visceral epithelial cell development (GO:2000477)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of opioid receptor signaling pathway (GO:2000474)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of peroxidase activity (GO:2000470)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
multi-organism transport (GO:0044766)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
multi-organism cellular process (GO:0044764)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
suppression of symbiont entry into host by host (GO:0052373)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
uropod organization (GO:0032796)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of CREB transcription factor activity (GO:0032793)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
negative regulation of CREB transcription factor activity (GO:0032792)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
sequestering of BMP from receptor via BMP binding (GO:0038098)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of peroxidase activity (GO:2000468)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of mast cell activation by Fc-epsilon receptor signaling pathway (GO:0038097)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of glycogen (starch) synthase activity (GO:2000467)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
ribosome disassembly (GO:0032790)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
Fc-epsilon receptor signaling pathway (GO:0038095)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
Fc receptor signaling pathway (GO:0038093)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of excitatory postsynaptic potential (GO:2000463)	17	0	.47	-	 < 0.01	1.00E00	1.00E00
nodal signaling pathway (GO:0038092)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
endocytic heme import into cell (GO:0140421)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
heme import into cell (GO:0140420)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
catabolism by host of substance in symbiont (GO:0052364)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
catabolism by organism of protein in other organism involved in symbiotic interaction (GO:0052363)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
catabolism by host of symbiont protein (GO:0052362)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
catabolism by organism of macromolecule in other organism involved in symbiotic interaction (GO:0052361)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
catabolism by host of symbiont macromolecule (GO:0052360)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of DNA-templated transcription, elongation (GO:0032786)	24	0	.66	-	 < 0.01	1.00E00	1.00E00
negative regulation of DNA-templated transcription, elongation (GO:0032785)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
regulation of DNA-templated transcription, elongation (GO:0032784)	40	0	1.10	-	 < 0.01	6.28E-01	1.00E00
bile acid secretion (GO:0032782)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of ATPase activity (GO:0032780)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
positive regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation (GO:2000454)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
peptidyl-tyrosine autophosphorylation (GO:0038083)	26	0	.71	-	 < 0.01	1.00E00	1.00E00
regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation (GO:2000452)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of CD8-positive, alpha-beta T cell extravasation (GO:2000451)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
pre-replicative complex assembly involved in cell cycle DNA replication (GO:1902299)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
DNA strand elongation involved in cell cycle DNA replication (GO:1902296)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cell cycle DNA replication initiation (GO:1902292)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
protein transmembrane import into intracellular organelle (GO:0044743)	20	0	.55	-	 < 0.01	1.00E00	1.00E00
DNA methylation on cytosine (GO:0032776)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
DNA methylation on adenine (GO:0032775)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of CD8-positive, alpha-beta T cell extravasation (GO:2000449)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of macrophage migration inhibitory factor signaling pathway (GO:2000446)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
semaphorin-plexin signaling pathway involved in axon guidance (GO:1902287)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
neuron projection extension involved in neuron projection guidance (GO:1902284)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of monooxygenase activity (GO:0032769)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
positive regulation of mast cell cytokine production (GO:0032765)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of mast cell cytokine production (GO:0032764)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of mast cell cytokine production (GO:0032763)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of monocyte extravasation (GO:2000439)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of monocyte extravasation (GO:2000438)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of monocyte extravasation (GO:2000437)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
p38MAPK cascade (GO:0038066)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein neddylation (GO:2000436)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
collagen-activated signaling pathway (GO:0038065)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein neddylation (GO:2000435)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of protein neddylation (GO:2000434)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
collagen-activated tyrosine kinase receptor signaling pathway (GO:0038063)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of cytokinesis, actomyosin contractile ring assembly (GO:2000431)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of pancreatic amylase secretion (GO:1902277)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of pancreatic amylase secretion (GO:1902276)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
DNA demethylation of male pronucleus (GO:0044727)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
chromatin reprogramming in the zygote (GO:0044725)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of interleukin-3 production (GO:0032752)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of polyamine transmembrane transport (GO:1902269)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
apoptotic process involved in embryonic digit morphogenesis (GO:1902263)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
apoptotic process involved in blood vessel morphogenesis (GO:1902262)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of delayed rectifier potassium channel activity (GO:1902261)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of delayed rectifier potassium channel activity (GO:1902260)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of interleukin-23 production (GO:0032747)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of interleukin-18 production (GO:0032741)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of thymocyte migration (GO:2000412)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of thymocyte migration (GO:2000410)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of delayed rectifier potassium channel activity (GO:1902259)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of apoptotic process involved in outflow tract morphogenesis (GO:1902256)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902255)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253)	17	0	.47	-	 < 0.01	1.00E00	1.00E00
N-terminal protein myristoylation (GO:0006499)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
N-terminal protein lipidation (GO:0006498)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein O-linked glycosylation (GO:0006493)	18	0	.49	-	 < 0.01	1.00E00	1.00E00
N-glycan processing (GO:0006491)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of interleukin-12 production (GO:0032735)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
positive regulation of T cell extravasation (GO:2000409)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of T cell extravasation (GO:2000408)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of T cell extravasation (GO:2000407)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of interleukin-1 alpha production (GO:0032730)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of T cell migration (GO:2000406)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
negative regulation of T cell migration (GO:2000405)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of T cell migration (GO:2000404)	20	0	.55	-	 < 0.01	1.00E00	1.00E00
positive regulation of lymphocyte migration (GO:2000403)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
termination of G protein-coupled receptor signaling pathway (GO:0038032)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of lymphocyte migration (GO:2000402)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
non-canonical Wnt signaling pathway via JNK cascade (GO:0038031)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of lymphocyte migration (GO:2000401)	27	0	.74	-	 < 0.01	1.00E00	1.00E00
non-canonical Wnt signaling pathway via MAPK cascade (GO:0038030)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
protein demethylation (GO:0006482)	26	0	.71	-	 < 0.01	1.00E00	1.00E00
C-terminal protein methylation (GO:0006481)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
N-terminal protein amino acid methylation (GO:0006480)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of connective tissue growth factor production (GO:0032723)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
insulin receptor signaling pathway via phosphatidylinositol 3-kinase (GO:0038028)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
reelin-mediated signaling pathway (GO:0038026)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of positive thymic T cell selection (GO:1902232)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902231)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
peptidyl-tyrosine sulfation (GO:0006478)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
protein sulfation (GO:0006477)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
protein deacetylation (GO:0006476)	38	0	1.04	-	 < 0.01	6.27E-01	1.00E00
negative regulation of interleukin-5 production (GO:0032714)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of interleukin-4 production (GO:0032713)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cellular response to laminar fluid shear stress (GO:0071499)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cellular response to fluid shear stress (GO:0071498)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
cellular response to freezing (GO:0071497)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229)	24	0	.66	-	 < 0.01	1.00E00	1.00E00
negative regulation of macrophage colony-stimulating factor signaling pathway (GO:1902227)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to UV-C (GO:0071494)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of macrophage colony-stimulating factor signaling pathway (GO:1902226)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to UV-B (GO:0071493)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
cellular response to UV-A (GO:0071492)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
ketone body metabolic process (GO:1902224)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
response to amine (GO:0014075)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
signal peptide processing (GO:0006465)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
steroid hormone receptor complex assembly (GO:0006463)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to isoquinoline alkaloid (GO:0014072)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
negative regulation of interleukin-2 production (GO:0032703)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
negative regulation of interleukin-18 production (GO:0032701)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
netrin-activated signaling pathway (GO:0038007)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of interleukin-17 production (GO:0032700)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
endocrine signaling (GO:0038002)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress (GO:1902219)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular response to high light intensity (GO:0071486)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of intrinsic apoptotic signaling pathway in response to osmotic stress (GO:1902218)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
peptidyl-glutamic acid poly-ADP-ribosylation (GO:0018424)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to light intensity (GO:0071484)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of interleukin-4-mediated signaling pathway (GO:1902216)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to light stimulus (GO:0071482)	63	0	1.73	-	 < 0.01	4.17E-01	1.00E00
regulation of interleukin-4-mediated signaling pathway (GO:1902214)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to X-ray (GO:0071481)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
positive regulation of prolactin signaling pathway (GO:1902213)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to gamma radiation (GO:0071480)	19	0	.52	-	 < 0.01	1.00E00	1.00E00
regulation of prolactin signaling pathway (GO:1902211)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
phosphatidylinositol 3-kinase signaling (GO:0014065)	22	0	.60	-	 < 0.01	1.00E00	1.00E00
positive regulation of serotonin secretion (GO:0014064)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of serotonin secretion (GO:0014063)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of serotonin secretion (GO:0014062)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
translational frameshifting (GO:0006452)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of norepinephrine secretion (GO:0014061)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
translational readthrough (GO:0006451)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of epinephrine secretion (GO:0014060)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of translational fidelity (GO:0006450)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of receptor internalization (GO:0002092)	20	0	.55	-	 < 0.01	1.00E00	1.00E00
negative regulation of receptor internalization (GO:0002091)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
regulation of receptor internalization (GO:0002090)	43	0	1.18	-	 < 0.01	6.31E-01	1.00E00
cellular hypotonic response (GO:0071476)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
cellular hyperosmotic salinity response (GO:0071475)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cellular hyperosmotic response (GO:0071474)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
cellular response to salt stress (GO:0071472)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
positive regulation of hepatocyte growth factor receptor signaling pathway (GO:1902204)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to non-ionic osmotic stress (GO:0071471)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of hepatocyte growth factor receptor signaling pathway (GO:1902203)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to osmotic stress (GO:0071470)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
regulation of hepatocyte growth factor receptor signaling pathway (GO:1902202)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of translational termination (GO:0006449)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
regulation of translational elongation (GO:0006448)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
membrane depolarization (GO:0051899)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
regulation of translational initiation by iron (GO:0006447)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of gamma-aminobutyric acid secretion (GO:0014054)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of gamma-aminobutyric acid secretion (GO:0014053)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of focal adhesion assembly (GO:0051895)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
regulation of gamma-aminobutyric acid secretion (GO:0014052)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of focal adhesion assembly (GO:0051894)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
gamma-aminobutyric acid secretion (GO:0014051)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of glutamate secretion (GO:0014050)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of cardioblast differentiation (GO:0051892)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to glial cell derived neurotrophic factor (GO:1990792)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
lens morphogenesis in camera-type eye (GO:0002089)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
positive regulation of cardioblast differentiation (GO:0051891)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
dorsal root ganglion development (GO:1990791)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
lens development in camera-type eye (GO:0002088)	35	0	.96	-	 < 0.01	1.00E00	1.00E00
regulation of cardioblast differentiation (GO:0051890)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
response to glial cell derived neurotrophic factor (GO:1990790)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of respiratory gaseous exchange by nervous system process (GO:0002087)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
diaphragm contraction (GO:0002086)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
inhibition of neuroepithelial cell differentiation (GO:0002085)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
protein depalmitoylation (GO:0002084)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
cellular response to acidic pH (GO:0071468)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
cellular response to pH (GO:0071467)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
cellular response to hydrostatic pressure (GO:0071464)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to water stimulus (GO:0071462)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
peptidyl-proline hydroxylation to 4-hydroxy-L-proline (GO:0018401)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
positive regulation of glutamate secretion (GO:0014049)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
peptidyl-proline hydroxylation to 3-hydroxy-L-proline (GO:0018400)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to cell-matrix adhesion (GO:0071460)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of glutamate secretion (GO:0014048)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
valyl-tRNA aminoacylation (GO:0006438)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
glutamate secretion (GO:0014047)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
tyrosyl-tRNA aminoacylation (GO:0006437)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
tryptophanyl-tRNA aminoacylation (GO:0006436)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
establishment of endothelial blood-brain barrier (GO:0014045)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
threonyl-tRNA aminoacylation (GO:0006435)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
Schwann cell development (GO:0014044)	20	0	.55	-	 < 0.01	1.00E00	1.00E00
negative regulation of timing of anagen (GO:0051886)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to dsDNA (GO:1990786)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
seryl-tRNA aminoacylation (GO:0006434)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of neuron maturation (GO:0014043)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of timing of anagen (GO:0051885)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to water-immersion restraint stress (GO:1990785)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
prolyl-tRNA aminoacylation (GO:0006433)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of neuron maturation (GO:0014042)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of timing of anagen (GO:0051884)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
response to dsDNA (GO:1990784)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
phenylalanyl-tRNA aminoacylation (GO:0006432)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of neuron maturation (GO:0014041)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
methionyl-tRNA aminoacylation (GO:0006431)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of Schwann cell differentiation (GO:0014040)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
mitochondrial depolarization (GO:0051882)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
lysyl-tRNA aminoacylation (GO:0006430)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
acrosome matrix dispersal (GO:0002077)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
osteoblast development (GO:0002076)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
extraocular skeletal muscle development (GO:0002074)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
optic cup morphogenesis involved in camera-type eye development (GO:0002072)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
glandular epithelial cell maturation (GO:0002071)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
epithelial cell maturation (GO:0002070)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
cellular response to hypoxia (GO:0071456)	45	0	1.23	-	 < 0.01	6.34E-01	1.00E00
cellular response to hyperoxia (GO:0071455)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
leucyl-tRNA aminoacylation (GO:0006429)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of Schwann cell differentiation (GO:0014038)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
isoleucyl-tRNA aminoacylation (GO:0006428)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
Schwann cell differentiation (GO:0014037)	24	0	.66	-	 < 0.01	1.00E00	1.00E00
neural crest cell fate specification (GO:0014036)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
lateral element assembly (GO:0051878)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
glycyl-tRNA aminoacylation (GO:0006426)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
glutaminyl-tRNA aminoacylation (GO:0006425)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
neural crest cell fate commitment (GO:0014034)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
response to angiotensin (GO:1990776)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
glutamyl-tRNA aminoacylation (GO:0006424)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
neural crest cell differentiation (GO:0014033)	43	0	1.18	-	 < 0.01	6.31E-01	1.00E00
pigment granule localization (GO:0051875)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
cysteinyl-tRNA aminoacylation (GO:0006423)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
neural crest cell development (GO:0014032)	37	0	1.01	-	 < 0.01	6.26E-01	1.00E00
aspartyl-tRNA aminoacylation (GO:0006422)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mesenchymal cell development (GO:0014031)	40	0	1.10	-	 < 0.01	6.28E-01	1.00E00
columnar/cuboidal epithelial cell maturation (GO:0002069)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
arginyl-tRNA aminoacylation (GO:0006420)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
glandular epithelial cell development (GO:0002068)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
glandular epithelial cell differentiation (GO:0002067)	24	0	.66	-	 < 0.01	1.00E00	1.00E00
columnar/cuboidal epithelial cell development (GO:0002066)	19	0	.52	-	 < 0.01	1.00E00	1.00E00
columnar/cuboidal epithelial cell differentiation (GO:0002065)	46	0	1.26	-	 < 0.01	6.36E-01	1.00E00
chondrocyte development (GO:0002063)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
chondrocyte differentiation (GO:0002062)	39	0	1.07	-	 < 0.01	6.27E-01	1.00E00
cellular response to hydroperoxide (GO:0071447)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of histone H3-K14 acetylation (GO:0071442)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of histone H3-K14 acetylation (GO:0071441)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
neural crest formation (GO:0014029)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of histone H3-K14 acetylation (GO:0071440)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
alanyl-tRNA aminoacylation (GO:0006419)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
notochord formation (GO:0014028)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
translational termination (GO:0006415)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
general adaptation syndrome (GO:0051866)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
translational elongation (GO:0006414)	26	0	.71	-	 < 0.01	1.00E00	1.00E00
protein autoubiquitination (GO:0051865)	47	0	1.29	-	 < 0.01	6.38E-01	1.00E00
neural plate elongation (GO:0014022)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
myofibroblast contraction (GO:1990764)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of mesenchymal cell proliferation (GO:0002053)	21	0	.58	-	 < 0.01	1.00E00	1.00E00
positive regulation of neuroblast proliferation (GO:0002052)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
osteoblast fate commitment (GO:0002051)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
establishment of epithelial cell apical/basal polarity (GO:0045198)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
establishment or maintenance of neuroblast polarity (GO:0045196)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
isotype switching (GO:0045190)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
tRNA export from nucleus (GO:0006409)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of proteasomal protein catabolic process (GO:1901799)	33	0	.90	-	 < 0.01	1.00E00	1.00E00
snRNA export from nucleus (GO:0006408)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of signal transduction by p53 class mediator (GO:1901798)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
rRNA export from nucleus (GO:0006407)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of signal transduction by p53 class mediator (GO:1901797)	21	0	.58	-	 < 0.01	1.00E00	1.00E00
mitotic sister chromatid biorientation (GO:1990758)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of signal transduction by p53 class mediator (GO:1901796)	46	0	1.26	-	 < 0.01	6.36E-01	1.00E00
negative regulation of gliogenesis (GO:0014014)	25	0	.69	-	 < 0.01	1.00E00	1.00E00
RNA import into nucleus (GO:0006404)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
peripheral nervous system axon regeneration (GO:0014012)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
Schwann cell proliferation (GO:0014010)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:0002043)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cell migration involved in sprouting angiogenesis (GO:0002042)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
intussusceptive angiogenesis (GO:0002041)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
sprouting angiogenesis (GO:0002040)	34	0	.93	-	 < 0.01	1.00E00	1.00E00
zonula adherens assembly (GO:0045186)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
rRNA-containing ribonucleoprotein complex export from nucleus (GO:0071428)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
hematopoietic stem cell proliferation (GO:0071425)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
malate transmembrane transport (GO:0071423)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
succinate transmembrane transport (GO:0071422)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
cellular response to histamine (GO:0071420)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of microglia differentiation (GO:0014008)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of microglia differentiation (GO:0014006)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular detoxification (GO:1990748)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
microglia differentiation (GO:0014004)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
oligodendrocyte development (GO:0014003)	21	0	.58	-	 < 0.01	1.00E00	1.00E00
astrocyte development (GO:0014002)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
primary miRNA methylation (GO:1990744)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of L-glutamate import across plasma membrane (GO:0002036)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
brain renin-angiotensin system (GO:0002035)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
maintenance of blood vessel diameter homeostasis by renin-angiotensin (GO:0002034)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
angiotensin-mediated vasodilation involved in regulation of systemic arterial blood pressure (GO:0002033)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
desensitization of G protein-coupled receptor signaling pathway by arrestin (GO:0002032)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
G protein-coupled receptor internalization (GO:0002031)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
apical protein localization (GO:0045176)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
basal protein localization (GO:0045175)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to purine-containing compound (GO:0071415)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cytolysis by host of symbiont cells (GO:0051838)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of synapse structural plasticity (GO:0051835)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
desensitization of G protein-coupled receptor signaling pathway (GO:0002029)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
UV-damage excision repair, DNA incision (GO:1990731)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of sodium ion transport (GO:0002028)	44	0	1.21	-	 < 0.01	6.32E-01	1.00E00
regulation of the force of heart contraction (GO:0002026)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
diet induced thermogenesis (GO:0002024)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
reduction of food intake in response to dietary excess (GO:0002023)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
response to dietary excess (GO:0002021)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
cell-cell signaling involved in cell fate commitment (GO:0045168)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
clustering of voltage-gated potassium channels (GO:0045163)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
clustering of voltage-gated sodium channels (GO:0045162)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
neuronal ion channel clustering (GO:0045161)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
cellular response to low-density lipoprotein particle stimulus (GO:0071404)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
response to ATP (GO:0033198)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
cellular response to lipoprotein particle stimulus (GO:0071402)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
response to vitamin E (GO:0033197)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular response to triglyceride (GO:0071401)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to hydroperoxide (GO:0033194)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
primary miRNA modification (GO:1990729)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of synapse structural plasticity (GO:0051823)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of renal output by angiotensin (GO:0002019)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
renin-angiotensin regulation of aldosterone production (GO:0002018)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of blood volume by renal aldosterone (GO:0002017)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of blood volume by renin-angiotensin (GO:0002016)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
vasoconstriction of artery involved in ischemic response to lowering of systemic arterial blood pressure (GO:0002014)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
morphogenesis of an epithelial sheet (GO:0002011)	23	0	.63	-	 < 0.01	1.00E00	1.00E00
response to vitamin A (GO:0033189)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of histone ubiquitination (GO:0033184)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of histone ubiquitination (GO:0033183)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of histone ubiquitination (GO:0033182)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
leukotriene A4 biosynthetic process (GO:1901753)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
leukotriene A4 metabolic process (GO:1901751)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
xylulose metabolic process (GO:0005997)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
trehalose catabolic process (GO:0005993)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of angiotensin levels in blood (GO:0002002)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
trehalose metabolic process (GO:0005991)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
male anatomical structure morphogenesis (GO:0090598)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
meiotic sister chromatid segregation (GO:0045144)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
inflammatory response to wounding (GO:0090594)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
presynaptic active zone organization (GO:1990709)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
calcineurin-NFAT signaling cascade (GO:0033173)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
cytolysis in other organism involved in symbiotic interaction (GO:0051801)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
nucleolar chromatin organization (GO:1990700)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
sucrose biosynthetic process (GO:0005986)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
sucrose metabolic process (GO:0005985)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
disaccharide metabolic process (GO:0005984)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of glycogen catabolic process (GO:0005981)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
glycogen catabolic process (GO:0005980)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
development of secondary sexual characteristics (GO:0045136)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
histone H3-K9 demethylation (GO:0033169)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
conversion of ds siRNA to ss siRNA involved in RNA interference (GO:0033168)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of glycogen biosynthetic process (GO:0005979)	18	0	.49	-	 < 0.01	1.00E00	1.00E00
positive regulation of platelet aggregation (GO:1901731)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
dsDNA loop formation (GO:0090579)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cellular extravasation (GO:0045123)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
T cell receptor V(D)J recombination (GO:0033153)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
NADPH oxidation (GO:0070995)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of histone deacetylase activity (GO:1901727)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
immunoglobulin V(D)J recombination (GO:0033152)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
detection of oxidative stress (GO:0070994)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of histone deacetylase activity (GO:1901726)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
V(D)J recombination (GO:0033151)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
regulation of histone deacetylase activity (GO:1901725)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell proliferation involved in kidney development (GO:1901723)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
azole transmembrane transport (GO:0045117)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
protein neddylation (GO:0045116)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of integrin biosynthetic process (GO:0045113)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
intermediate filament bundle assembly (GO:0045110)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of intracellular estrogen receptor signaling pathway (GO:0033148)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
oxidative demethylation (GO:0070989)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
demethylation (GO:0070988)	40	0	1.10	-	 < 0.01	6.28E-01	1.00E00
positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
error-free translesion synthesis (GO:0070987)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144)	30	0	.82	-	 < 0.01	1.00E00	1.00E00
left/right axis specification (GO:0070986)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
positive regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033141)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033140)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
L-asparagine metabolic process (GO:0070982)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
intermediate filament organization (GO:0045109)	17	0	.47	-	 < 0.01	1.00E00	1.00E00
establishment of endothelial intestinal barrier (GO:0090557)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
intermediate filament polymerization or depolymerization (GO:0045105)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
intermediate filament cytoskeleton organization (GO:0045104)	34	0	.93	-	 < 0.01	1.00E00	1.00E00
intermediate filament-based process (GO:0045103)	34	0	.93	-	 < 0.01	1.00E00	1.00E00
regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033139)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
protein K11-linked ubiquitination (GO:0070979)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
bone maturation (GO:0070977)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
positive regulation of glucokinase activity (GO:0033133)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of glucokinase activity (GO:0033132)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
mesenchymal cell differentiation involved in bone development (GO:1901706)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of glucokinase activity (GO:0033131)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
protein localization to endoplasmic reticulum exit site (GO:0070973)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of histone phosphorylation (GO:0033129)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
negative regulation of histone phosphorylation (GO:0033128)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of histone phosphorylation (GO:0033127)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
nuclear-transcribed mRNA catabolic process, no-go decay (GO:0070966)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of neutrophil mediated killing of fungus (GO:0070965)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of neutrophil mediated killing of symbiont cell (GO:0070961)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of neutrophil mediated cytotoxicity (GO:0070960)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
ganglioside biosynthetic process (GO:0001574)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
ganglioside metabolic process (GO:0001573)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
vasculogenesis (GO:0001570)	43	0	1.18	-	 < 0.01	6.31E-01	1.00E00
negative regulation of RNA splicing (GO:0033119)	22	0	.60	-	 < 0.01	1.00E00	1.00E00
regulation of neutrophil mediated killing of fungus (GO:0070953)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
branching involved in blood vessel morphogenesis (GO:0001569)	21	0	.58	-	 < 0.01	1.00E00	1.00E00
cell septum assembly (GO:0090529)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
antiviral innate immune response (GO:0140374)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
actin filament reorganization (GO:0090527)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
fatty acid alpha-oxidation (GO:0001561)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
vesicle tethering involved in exocytosis (GO:0090522)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
sphingolipid mediated signaling pathway (GO:0090520)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of neutrophil mediated killing of symbiont cell (GO:0070949)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of neutrophil mediated cytotoxicity (GO:0070948)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
neutrophil-mediated killing of fungus (GO:0070947)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
neutrophil-mediated killing of gram-positive bacterium (GO:0070946)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
neutrophil-mediated killing of gram-negative bacterium (GO:0070945)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
neutrophil-mediated killing of bacterium (GO:0070944)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
neutrophil-mediated killing of symbiont cell (GO:0070943)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
neutrophil mediated cytotoxicity (GO:0070942)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
dephosphorylation of RNA polymerase II C-terminal domain (GO:0070940)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
oocyte maturation (GO:0001556)	17	0	.47	-	 < 0.01	1.00E00	1.00E00
oocyte growth (GO:0001555)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
luteinization (GO:0001553)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
ovarian follicle atresia (GO:0001552)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
tooth eruption (GO:0044691)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
3'-UTR-mediated mRNA stabilization (GO:0070935)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
CRD-mediated mRNA stabilization (GO:0070934)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
histone H4 deacetylation (GO:0070933)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
histone H3 deacetylation (GO:0070932)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
positive regulation of ubiquitin-dependent endocytosis (GO:2000397)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of ubiquitin-dependent endocytosis (GO:2000395)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of lamellipodium morphogenesis (GO:2000394)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of lamellipodium morphogenesis (GO:2000393)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of lamellipodium morphogenesis (GO:2000392)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of neutrophil extravasation (GO:2000391)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
lipid import into cell (GO:0140354)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
preantral ovarian follicle growth (GO:0001546)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
lipid export from cell (GO:0140353)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
primary ovarian follicle growth (GO:0001545)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
initiation of primordial ovarian follicle growth (GO:0001544)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
epiboly involved in wound healing (GO:0090505)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
ovarian follicle rupture (GO:0001543)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
epiboly (GO:0090504)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
ovulation from ovarian follicle (GO:0001542)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)	26	0	.71	-	 < 0.01	1.00E00	1.00E00
RNA phosphodiester bond hydrolysis (GO:0090501)	58	0	1.59	-	 < 0.01	4.09E-01	1.00E00
endocardial cushion to mesenchymal transition (GO:0090500)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of ATP:ADP antiporter activity (GO:0070926)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
small RNA loading onto RISC (GO:0070922)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
regulation of neutrophil extravasation (GO:2000389)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of ovarian follicle development (GO:2000386)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of ectoderm development (GO:2000384)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of ectoderm development (GO:2000383)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cilium or flagellum-dependent cell motility (GO:0001539)	66	0	1.81	-	 < 0.01	4.25E-01	1.00E00
negative regulation of mesoderm development (GO:2000381)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of mesoderm development (GO:2000380)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
UV-damage excision repair (GO:0070914)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
positive regulation of oxygen metabolic process (GO:2000376)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of oxygen metabolic process (GO:2000374)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000373)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000371)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of clathrin-dependent endocytosis (GO:2000370)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
mitochondrial tRNA methylation (GO:0070901)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of interleukin-13 production (GO:0032696)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
mitochondrial tRNA modification (GO:0070900)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of interleukin-12 production (GO:0032695)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
negative regulation of interleukin-10 production (GO:0032693)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of clathrin-dependent endocytosis (GO:2000369)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
negative regulation of interleukin-1 production (GO:0032692)	18	0	.49	-	 < 0.01	1.00E00	1.00E00
positive regulation of acrosomal vesicle exocytosis (GO:2000368)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of interleukin-1 beta production (GO:0032691)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
regulation of acrosomal vesicle exocytosis (GO:2000367)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of prostaglandin-E synthase activity (GO:2000363)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of prostaglandin-E synthase activity (GO:2000361)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of binding of sperm to zona pellucida (GO:2000360)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
prostaglandin biosynthetic process (GO:0001516)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
selenocysteine incorporation (GO:0001514)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation by symbiont of host autophagy (GO:0140321)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
adhesion of symbiont to host cell (GO:0044650)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of interferon-beta production (GO:0032688)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
negative regulation of interferon-alpha production (GO:0032687)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of binding of sperm to zona pellucida (GO:2000359)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of ovarian follicle development (GO:2000355)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of ovarian follicle development (GO:2000354)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of endothelial cell apoptotic process (GO:2000353)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
action potential (GO:0001508)	17	0	.47	-	 < 0.01	1.00E00	1.00E00
neurotransmitter uptake (GO:0001504)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cartilage condensation (GO:0001502)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
histone H3-K4 dimethylation (GO:0044648)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of CD40 signaling pathway (GO:2000349)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of interleukin-3 production (GO:0032672)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of CD40 signaling pathway (GO:2000348)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of hepatocyte proliferation (GO:2000347)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of hepatocyte proliferation (GO:2000346)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of hepatocyte proliferation (GO:2000345)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of acrosome reaction (GO:2000344)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000342)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of viral release from host cell (GO:1902188)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine (GO:0018395)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of viral release from host cell (GO:1902187)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
regulation of viral release from host cell (GO:1902186)	21	0	.58	-	 < 0.01	1.00E00	1.00E00
regulation of interleukin-23 production (GO:0032667)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of chemokine (C-X-C motif) ligand 1 production (GO:2000338)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of interleukin-18 production (GO:0032661)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of terminal button organization (GO:2000331)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of T-helper 17 cell lineage commitment (GO:2000330)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902177)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175)	21	0	.58	-	 < 0.01	1.00E00	1.00E00
positive regulation of keratinocyte apoptotic process (GO:1902174)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of keratinocyte apoptotic process (GO:1902173)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of keratinocyte apoptotic process (GO:1902172)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
cellular response to reactive nitrogen species (GO:1902170)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
regulation of interleukin-12 production (GO:0032655)	25	0	.69	-	 < 0.01	1.00E00	1.00E00
negative regulation of T-helper 17 cell lineage commitment (GO:2000329)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of T-helper 17 cell lineage commitment (GO:2000328)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of interleukin-1 alpha production (GO:0032650)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of glucocorticoid receptor signaling pathway (GO:2000324)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of glucocorticoid receptor signaling pathway (GO:2000323)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of glucocorticoid receptor signaling pathway (GO:2000322)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
positive regulation of T-helper 17 cell differentiation (GO:2000321)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
protein myristoylation (GO:0018377)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
metabolism of macromolecule in other organism involved in symbiotic interaction (GO:0052229)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902167)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
catabolism of substance in other organism involved in symbiotic interaction (GO:0052227)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:1902164)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:1902163)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:1902162)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
regulation of connective tissue growth factor production (GO:0032643)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of T-helper 17 type immune response (GO:2000318)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
tumor necrosis factor production (GO:0032640)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation (GO:2000314)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation (GO:2000313)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of kainate selective glutamate receptor activity (GO:2000312)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of AMPA receptor activity (GO:2000311)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of NMDA receptor activity (GO:2000310)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
peptidyl-glutamine methylation (GO:0018364)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
metabolism of substance in other organism involved in symbiotic interaction (GO:0052214)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of response to DNA damage checkpoint signaling (GO:1902153)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of response to DNA integrity checkpoint signaling (GO:1902151)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mRNA 3'-end processing by stem-loop binding and cleavage (GO:0006398)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
termination of mitochondrial transcription (GO:0006393)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
interleukin-8 production (GO:0032637)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
transcription elongation from mitochondrial promoter (GO:0006392)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
transcription initiation from mitochondrial promoter (GO:0006391)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
interleukin-6 production (GO:0032635)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
mitochondrial transcription (GO:0006390)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
interleukin-5 production (GO:0032634)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
interleukin-4 production (GO:0032633)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of ceramide biosynthetic process (GO:2000304)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of ceramide biosynthetic process (GO:2000303)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of synaptic vesicle exocytosis (GO:2000302)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of synaptic vesicle exocytosis (GO:2000301)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of response to cell cycle checkpoint signaling (GO:1902145)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein-pyridoxal-5-phosphate linkage (GO:0018352)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
induction of synaptic vesicle exocytosis by positive regulation of presynaptic cytosolic calcium ion concentration (GO:0099703)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
transcription initiation from RNA polymerase III promoter (GO:0006384)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
adenosine to inosine editing (GO:0006382)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
interleukin-2 production (GO:0032623)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
interleukin-18 production (GO:0032621)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
interleukin-17 production (GO:0032620)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
protein geranylgeranylation (GO:0018344)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
protein farnesylation (GO:0018343)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
protein prenylation (GO:0018342)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
mRNA cleavage (GO:0006379)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
mRNA polyadenylation (GO:0006378)	23	0	.63	-	 < 0.01	1.00E00	1.00E00
interleukin-15 production (GO:0032618)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
interleukin-13 production (GO:0032616)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
interleukin-12 production (GO:0032615)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
7-methylguanosine mRNA capping (GO:0006370)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
interleukin-10 production (GO:0032613)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
interleukin-1 production (GO:0032612)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
interleukin-1 beta production (GO:0032611)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
interleukin-1 alpha production (GO:0032610)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to fatty acid (GO:0071398)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
cellular response to cholesterol (GO:0071397)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
protein succinylation (GO:0018335)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cellular response to testosterone stimulus (GO:0071394)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
cellular response to progesterone stimulus (GO:0071393)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular response to estradiol stimulus (GO:0071392)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
cellular response to estrogen stimulus (GO:0071391)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
termination of RNA polymerase II transcription (GO:0006369)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
transcription elongation from RNA polymerase II promoter (GO:0006368)	20	0	.55	-	 < 0.01	1.00E00	1.00E00
transcription initiation from RNA polymerase II promoter (GO:0006367)	26	0	.71	-	 < 0.01	1.00E00	1.00E00
interferon-gamma production (GO:0032609)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
termination of RNA polymerase I transcription (GO:0006363)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
transcription elongation from RNA polymerase I promoter (GO:0006362)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
transcription initiation from RNA polymerase I promoter (GO:0006361)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
transcription by RNA polymerase I (GO:0006360)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
chemokine production (GO:0032602)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
cellular response to mineralocorticoid stimulus (GO:0071389)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular response to cortisol stimulus (GO:0071387)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to corticosterone stimulus (GO:0071386)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to glucocorticoid stimulus (GO:0071385)	26	0	.71	-	 < 0.01	1.00E00	1.00E00
cellular response to corticosteroid stimulus (GO:0071384)	26	0	.71	-	 < 0.01	1.00E00	1.00E00
negative regulation of organelle assembly (GO:1902116)	31	0	.85	-	 < 0.01	1.00E00	1.00E00
protein tyrosinylation (GO:0018322)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to prostaglandin E stimulus (GO:0071380)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of transcription by RNA polymerase I (GO:0006356)	24	0	.66	-	 < 0.01	1.00E00	1.00E00
DNA-templated transcription, elongation (GO:0006354)	25	0	.69	-	 < 0.01	1.00E00	1.00E00
DNA-templated transcription, termination (GO:0006353)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
DNA-templated transcription, initiation (GO:0006352)	46	0	1.26	-	 < 0.01	6.36E-01	1.00E00
intracellular transport of virus (GO:0075733)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
viral penetration into host nucleus (GO:0075732)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to prostaglandin stimulus (GO:0071379)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
cellular response to growth hormone stimulus (GO:0071378)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
negative regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902109)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular response to corticotropin-releasing hormone stimulus (GO:0071376)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902108)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
cellular response to parathyroid hormone stimulus (GO:0071374)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
peptidyl-serine ADP-ribosylation (GO:0018312)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cellular response to follicle-stimulating hormone stimulus (GO:0071372)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of metaphase/anaphase transition of meiotic cell cycle (GO:1902104)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to gonadotropin stimulus (GO:0071371)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
negative regulation of metaphase/anaphase transition of meiotic cell cycle (GO:1902103)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of metaphase/anaphase transition of meiotic cell cycle (GO:1902102)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of gene expression by genetic imprinting (GO:0006349)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
chromatin silencing at telomere (GO:0006348)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of hair follicle development (GO:0051798)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
DNA methylation-dependent heterochromatin assembly (GO:0006346)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
protein depalmitoleylation (GO:1990697)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of timing of catagen (GO:0051795)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of timing of catagen (GO:0051794)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
medium-chain fatty acid catabolic process (GO:0051793)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
short-chain fatty acid biosynthetic process (GO:0051790)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cellular response to epidermal growth factor stimulus (GO:0071364)	32	0	.88	-	 < 0.01	1.00E00	1.00E00
cellular response to ether (GO:0071362)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
cellular response to ethanol (GO:0071361)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cellular response to exogenous dsRNA (GO:0071360)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
chromatin remodeling (GO:0006338)	107	0	2.93	-	 < 0.01	1.21E-01	1.00E00
nucleosome disassembly (GO:0006337)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
DNA replication-independent nucleosome assembly (GO:0006336)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
DNA replication-dependent nucleosome assembly (GO:0006335)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell division (GO:0051782)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
cellular response to dsRNA (GO:0071359)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
cellular response to interleukin-4 (GO:0071353)	18	0	.49	-	 < 0.01	1.00E00	1.00E00
cellular response to interleukin-2 (GO:0071352)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to interleukin-15 (GO:0071350)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
histone H4-K12 deacetylation (GO:1990679)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to redox state (GO:0051775)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of nitric-oxide synthase biosynthetic process (GO:0051771)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cellular response to interleukin-12 (GO:0071349)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular response to interleukin-11 (GO:0071348)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
skeletal muscle acetylcholine-gated channel clustering (GO:0071340)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
transposition, DNA-mediated (GO:0006313)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
actin crosslink formation (GO:0051764)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
meiotic gene conversion (GO:0006311)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of hair follicle cell proliferation (GO:0071336)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
hair follicle cell proliferation (GO:0071335)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to glucose stimulus (GO:0071333)	31	0	.85	-	 < 0.01	1.00E00	1.00E00
cellular response to hexose stimulus (GO:0071331)	31	0	.85	-	 < 0.01	1.00E00	1.00E00
apoptotic DNA fragmentation (GO:0006309)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
DNA catabolic process (GO:0006308)	17	0	.47	-	 < 0.01	1.00E00	1.00E00
DNA dealkylation involved in DNA repair (GO:0006307)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
double-strand break repair via nonhomologous end joining (GO:0006303)	31	0	.85	-	 < 0.01	1.00E00	1.00E00
meiotic sister chromatid cohesion, centromeric (GO:0051754)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
postreplication repair (GO:0006301)	18	0	.49	-	 < 0.01	1.00E00	1.00E00
cellular response to monosaccharide stimulus (GO:0071326)	32	0	.88	-	 < 0.01	1.00E00	1.00E00
cellular response to carbohydrate stimulus (GO:0071322)	39	0	1.07	-	 < 0.01	6.27E-01	1.00E00
cellular response to cGMP (GO:0071321)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to cAMP (GO:0071320)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
response to iron ion starvation (GO:1990641)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to ATP (GO:0071318)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
cellular response to isoquinoline alkaloid (GO:0071317)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular response to nicotine (GO:0071316)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of viral genome replication (GO:0045071)	22	0	.60	-	 < 0.01	1.00E00	1.00E00
cellular response to morphine (GO:0071315)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to cocaine (GO:0071314)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to caffeine (GO:0071313)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
nucleotide transmembrane transport (GO:1901679)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
iron coordination entity transport (GO:1901678)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of histone H3-K27 acetylation (GO:1901676)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
reproductive senescence (GO:1990636)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of histone H3-K27 acetylation (GO:1901674)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of superoxide dismutase activity (GO:1901671)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulatory T cell differentiation (GO:0045066)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
cellular response to vitamin K (GO:0071307)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
thymic T cell selection (GO:0045061)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
cellular response to vitamin D (GO:0071305)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative thymic T cell selection (GO:0045060)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
cellular response to retinoic acid (GO:0071300)	29	0	.80	-	 < 0.01	1.00E00	1.00E00
germline cell cycle switching, mitotic to meiotic cell cycle (GO:0051729)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of superoxide dismutase activity (GO:1901668)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
cell cycle switching, mitotic to meiotic cell cycle (GO:0051728)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of immature T cell proliferation in thymus (GO:0033092)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of NAD+ ADP-ribosyltransferase activity (GO:1901666)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of NAD+ ADP-ribosyltransferase activity (GO:1901664)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
quinone biosynthetic process (GO:1901663)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
quinone catabolic process (GO:1901662)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
quinone metabolic process (GO:1901661)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
positive thymic T cell selection (GO:0045059)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
transcytosis (GO:0045056)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
regulated exocytosis (GO:0045055)	55	0	1.51	-	 < 0.01	4.06E-01	1.00E00
constitutive secretory pathway (GO:0045054)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
protein retention in Golgi apparatus (GO:0045053)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of T cell differentiation in thymus (GO:0033089)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of immature T cell proliferation in thymus (GO:0033088)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of immature T cell proliferation (GO:0033087)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
glycosyl compound biosynthetic process (GO:1901659)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
regulation of immature T cell proliferation in thymus (GO:0033084)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
glycosyl compound catabolic process (GO:1901658)	23	0	.63	-	 < 0.01	1.00E00	1.00E00
regulation of extrathymic T cell differentiation (GO:0033082)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
glycoside transport (GO:1901656)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to ketone (GO:1901655)	45	0	1.23	-	 < 0.01	6.34E-01	1.00E00
cytolysis in other organism (GO:0051715)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
response to ketone (GO:1901654)	63	0	1.73	-	 < 0.01	4.17E-01	1.00E00
mitochondrial membrane fusion (GO:1990613)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of killing of cells of other organism (GO:0051712)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
protein insertion into ER membrane (GO:0045048)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
protein import into peroxisome membrane (GO:0045046)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
dopamine uptake (GO:0090494)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
catecholamine uptake (GO:0090493)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
protein import into mitochondrial intermembrane space (GO:0045041)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
protein insertion into mitochondrial outer membrane (GO:0045040)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
T cell differentiation in thymus (GO:0033077)	32	0	.88	-	 < 0.01	1.00E00	1.00E00
regulation of killing of cells of other organism (GO:0051709)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
positive regulation of synoviocyte proliferation (GO:1901647)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of synoviocyte proliferation (GO:1901645)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
biological process involved in intraspecies interaction between organisms (GO:0051703)	26	0	.71	-	 < 0.01	1.00E00	1.00E00
biological process involved in interaction with host (GO:0051701)	37	0	1.01	-	 < 0.01	6.26E-01	1.00E00
protein insertion into mitochondrial inner membrane (GO:0045039)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of presynaptic membrane organization (GO:1901631)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
plasma membrane fusion (GO:0045026)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
early endosome to late endosome transport (GO:0045022)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
mitochondrial tRNA wobble uridine modification (GO:0070899)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
RNA polymerase III preinitiation complex assembly (GO:0070898)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
transcription preinitiation complex assembly (GO:0070897)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
regulation of presynaptic membrane organization (GO:1901629)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of postsynaptic membrane organization (GO:1901628)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of postsynaptic membrane organization (GO:1901627)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of postsynaptic membrane organization (GO:1901626)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of lymphocyte chemotaxis (GO:1901624)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of lymphocyte chemotaxis (GO:1901623)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
positive regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning (GO:1901622)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning (GO:1901621)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning (GO:1901620)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
actin nucleation (GO:0045010)	21	0	.58	-	 < 0.01	1.00E00	1.00E00
glutamate homeostasis (GO:0090461)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
platelet alpha granule organization (GO:0070889)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of calcineurin-NFAT signaling cascade (GO:0070885)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
organic hydroxy compound catabolic process (GO:1901616)	33	0	.90	-	 < 0.01	1.00E00	1.00E00
positive regulation of vesicle transport along microtubule (GO:1901610)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
DNA replication proofreading (GO:0045004)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
double-strand break repair via single-strand annealing (GO:0045002)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of myeloid cell apoptotic process (GO:0033034)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of vesicle transport along microtubule (GO:1901608)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of myeloid cell apoptotic process (GO:0033033)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
positive regulation of glycogen metabolic process (GO:0070875)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
alpha-amino acid biosynthetic process (GO:1901607)	43	0	1.18	-	 < 0.01	6.31E-01	1.00E00
regulation of myeloid cell apoptotic process (GO:0033032)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
negative regulation of glycogen metabolic process (GO:0070874)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of neutrophil apoptotic process (GO:0033031)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of glycogen metabolic process (GO:0070873)	21	0	.58	-	 < 0.01	1.00E00	1.00E00
peptidyl-glutamate ADP-deribosylation (GO:0140291)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of neutrophil apoptotic process (GO:0033029)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
heterochromatin organization involved in chromatin silencing (GO:0070868)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein exit from endoplasmic reticulum (GO:0070863)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein exit from endoplasmic reticulum (GO:0070862)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of protein exit from endoplasmic reticulum (GO:0070861)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
protein mono-ADP-ribosylation (GO:0140289)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
endosome fission (GO:0140285)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
protein localization to nuclear envelope (GO:0090435)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
positive regulation of bile acid biosynthetic process (GO:0070859)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of bile acid biosynthetic process (GO:0070858)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
tetrapyrrole catabolic process (GO:0033015)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of bile acid biosynthetic process (GO:0070857)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
tetrapyrrole biosynthetic process (GO:0033014)	18	0	.49	-	 < 0.01	1.00E00	1.00E00
tetrapyrrole metabolic process (GO:0033013)	28	0	.77	-	 < 0.01	1.00E00	1.00E00
activation of meiosis (GO:0090427)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
acinar cell differentiation (GO:0090425)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
naphthalene-containing compound metabolic process (GO:0090420)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of mast cell activation involved in immune response (GO:0033007)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
response to epidermal growth factor (GO:0070849)	35	0	.96	-	 < 0.01	1.00E00	1.00E00
negative regulation of mast cell activation (GO:0033004)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
Hsp90 deacetylation (GO:0070846)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
polyubiquitinated misfolded protein transport (GO:0070845)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
muscle cell proliferation (GO:0033002)	18	0	.49	-	 < 0.01	1.00E00	1.00E00
polyubiquitinated protein transport (GO:0070844)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
misfolded protein transport (GO:0070843)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
aggresome assembly (GO:0070842)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
inclusion body assembly (GO:0070841)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
doxorubicin metabolic process (GO:0044598)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
daunorubicin metabolic process (GO:0044597)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
metal ion export (GO:0070839)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
caveola assembly (GO:0070836)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
basement membrane assembly (GO:0070831)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
bicellular tight junction assembly (GO:0070830)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
negative regulation of Rho-dependent protein serine/threonine kinase activity (GO:2000299)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of Rho-dependent protein serine/threonine kinase activity (GO:2000298)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of synapse maturation (GO:2000297)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of hydrogen peroxide catabolic process (GO:2000296)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of hydrogen peroxide catabolic process (GO:2000295)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of myoblast proliferation (GO:2000291)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
regulation of myotome development (GO:2000290)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cell-cell fusion (GO:0140253)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
oxidative stress-induced premature senescence (GO:0090403)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
stress-induced premature senescence (GO:0090400)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
heterochromatin maintenance (GO:0070829)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
heterochromatin organization (GO:0070828)	27	0	.74	-	 < 0.01	1.00E00	1.00E00
chromatin maintenance (GO:0070827)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
butyryl-CoA catabolic process (GO:0044580)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of myoblast proliferation (GO:2000288)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
positive regulation of myotome development (GO:2000287)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
receptor internalization involved in canonical Wnt signaling pathway (GO:2000286)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of cellular amino acid biosynthetic process (GO:2000284)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein catabolic process at synapse (GO:0140246)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of cellular amino acid biosynthetic process (GO:2000282)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of translation at postsynapse (GO:0140245)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of translation at presynapse (GO:0140244)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of translation at synapse (GO:0140243)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
phosphorylation of RNA polymerase II C-terminal domain (GO:0070816)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
[2Fe-2S] cluster assembly (GO:0044571)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
hydrogen sulfide biosynthetic process (GO:0070814)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
hydrogen sulfide metabolic process (GO:0070813)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of DNA biosynthetic process (GO:2000279)	32	0	.88	-	 < 0.01	1.00E00	1.00E00
positive regulation of oxidative phosphorylation uncoupler activity (GO:2000277)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of oxidative phosphorylation uncoupler activity (GO:2000276)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
postsynaptic endocytosis (GO:0140239)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of oxidative phosphorylation uncoupler activity (GO:2000275)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of signaling receptor activity (GO:2000273)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
negative regulation of signaling receptor activity (GO:2000272)	17	0	.47	-	 < 0.01	1.00E00	1.00E00
positive regulation of fibroblast apoptotic process (GO:2000271)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of fibroblast apoptotic process (GO:2000270)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
lateral line system development (GO:0048925)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
dendritic cell proliferation (GO:0044565)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
protein transport into membrane raft (GO:0032596)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of fibroblast apoptotic process (GO:2000269)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
regulation of blood coagulation, intrinsic pathway (GO:2000266)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
relaxation of smooth muscle (GO:0044557)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
secondary metabolite biosynthetic process (GO:0044550)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
ER-dependent peroxisome organization (GO:0032581)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of protein activation cascade (GO:2000257)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of male germ cell proliferation (GO:2000255)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of feeding behavior (GO:2000253)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of feeding behavior (GO:2000252)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
positive regulation of actin cytoskeleton reorganization (GO:2000251)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
positive regulation of long-chain fatty acid import into cell (GO:0140214)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of actin cytoskeleton reorganization (GO:2000250)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of long-chain fatty acid import into cell (GO:0140213)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of long-chain fatty acid import into cell (GO:0140212)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
NLRP3 inflammasome complex assembly (GO:0044546)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of flagellated sperm motility (GO:1902093)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation by symbiont of host apoptotic process (GO:0052151)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
modulation by symbiont of host apoptotic process (GO:0052150)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of actin cytoskeleton reorganization (GO:2000249)	26	0	.71	-	 < 0.01	1.00E00	1.00E00
response to vitamin K (GO:0032571)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
response to progesterone (GO:0032570)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
apoptotic process in response to mitochondrial fragmentation (GO:0140208)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of reproductive process (GO:2000242)	40	0	1.10	-	 < 0.01	6.28E-01	1.00E00
protein-chromophore linkage (GO:0018298)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
long-chain fatty acid import into cell (GO:0044539)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein-FAD linkage (GO:0018293)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of circulating fibrinogen levels (GO:0044537)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
neurotransmitter receptor localization to postsynaptic specialization membrane (GO:0099645)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
negative regulation of peptidyl-cysteine S-nitrosylation (GO:1902083)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
retrograde axonal protein transport (GO:0099642)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
anterograde axonal protein transport (GO:0099641)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
axo-dendritic protein transport (GO:0099640)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
snRNA methylation (GO:0106349)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of rRNA processing (GO:2000233)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of pancreatic stellate cell proliferation (GO:2000230)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
neurotransmitter receptor transport, endosome to plasma membrane (GO:0099639)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
endosome to plasma membrane protein transport (GO:0099638)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
neurotransmitter receptor transport (GO:0099637)	24	0	.66	-	 < 0.01	1.00E00	1.00E00
iron incorporation into metallo-sulfur cluster (GO:0018283)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular response to salt (GO:1902075)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
metal incorporation into metallo-sulfur cluster (GO:0018282)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
response to salt (GO:1902074)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
protein localization to postsynaptic specialization membrane (GO:0099633)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
protein sulfhydration (GO:0044524)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of hypoxia-inducible factor-1alpha signaling pathway (GO:1902072)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of pancreatic stellate cell proliferation (GO:2000229)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of pancreatic A cell differentiation (GO:2000227)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of pancreatic A cell differentiation (GO:2000226)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of testosterone biosynthetic process (GO:2000225)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of testosterone biosynthetic process (GO:2000224)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein N-linked glycosylation via asparagine (GO:0018279)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
neurotransmitter receptor diffusion trapping (GO:0099628)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
movement in host environment (GO:0052126)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
response to L-glutamate (GO:1902065)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine (GO:0018272)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of cardiac muscle cell membrane repolarization (GO:0099623)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of glutamate metabolic process (GO:2000213)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of glutamate metabolic process (GO:2000211)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of anoikis (GO:2000210)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
isopeptide cross-linking (GO:0018262)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein localization to axon (GO:0099612)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
mismatch repair (GO:0006298)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
nucleotide-excision repair, DNA gap filling (GO:0006297)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
modulation of signal transduction in other organism (GO:0044501)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of cell projection size (GO:0032536)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
pyrimidine dimer repair (GO:0006290)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
regulation of microvillus assembly (GO:0032534)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of anoikis (GO:2000209)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
regulation of microvillus length (GO:0032532)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of ribosomal small subunit export from nucleus (GO:2000208)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of microvillus organization (GO:0032530)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
regulation of ribosomal small subunit export from nucleus (GO:2000206)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of ribosomal subunit export from nucleus (GO:2000202)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of ribosomal subunit export from nucleus (GO:2000200)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
lateral attachment of mitotic spindle microtubules to kinetochore (GO:0099607)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
microtubule plus-end directed mitotic chromosome migration (GO:0099606)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902043)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
nucleotide-excision repair (GO:0006289)	40	0	1.10	-	 < 0.01	6.28E-01	1.00E00
regulation of neurotransmitter receptor activity (GO:0099601)	27	0	.74	-	 < 0.01	1.00E00	1.00E00
regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041)	24	0	.66	-	 < 0.01	1.00E00	1.00E00
base-excision repair, DNA ligation (GO:0006288)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
base-excision repair, gap-filling (GO:0006287)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
base-excision repair, AP site formation (GO:0006285)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
base-excision repair (GO:0006284)	31	0	.85	-	 < 0.01	1.00E00	1.00E00
microvillus organization (GO:0032528)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
transcription-coupled nucleotide-excision repair (GO:0006283)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
protein exit from endoplasmic reticulum (GO:0032527)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
response to retinoic acid (GO:0032526)	48	0	1.32	-	 < 0.01	6.40E-01	1.00E00
somite rostral/caudal axis specification (GO:0032525)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
protein-DNA covalent cross-linking repair (GO:0106300)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of hematopoietic stem cell differentiation (GO:1902037)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of hematopoietic stem cell differentiation (GO:1902036)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
protein O-linked glycosylation via threonine (GO:0018243)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of hematopoietic stem cell proliferation (GO:1902035)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
protein O-linked glycosylation via serine (GO:0018242)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of hematopoietic stem cell proliferation (GO:1902033)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery (GO:0000973)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of NADP metabolic process (GO:1902031)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery (GO:0000972)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
RNA-dependent DNA biosynthetic process (GO:0006278)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
tRNA exon ligation utilizing 2',3' cyclic phosphate of 5'-exon as source of linkage phosphate (GO:0000971)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
lagging strand elongation (GO:0006273)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
leading strand elongation (GO:0006272)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of phosphoprotein phosphatase activity (GO:0032516)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
DNA strand elongation involved in DNA replication (GO:0006271)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
negative regulation of phosphoprotein phosphatase activity (GO:0032515)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
DNA replication initiation (GO:0006270)	24	0	.66	-	 < 0.01	1.00E00	1.00E00
late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
endosome to lysosome transport via multivesicular body sorting pathway (GO:0032510)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
cellular response to vitamin (GO:0071295)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
tRNA exon ligation (GO:0000968)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to zinc ion (GO:0071294)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
rRNA 5'-end processing (GO:0000967)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
mitochondrial RNA 3'-end processing (GO:0000965)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
L-arginine transport (GO:1902023)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mitochondrial RNA 5'-end processing (GO:0000964)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
L-lysine transport (GO:1902022)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mitochondrial RNA processing (GO:0000963)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
DNA replication, synthesis of RNA primer (GO:0006269)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of mitochondrial RNA catabolic process (GO:0000962)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of cilium-dependent cell motility (GO:1902020)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of mitochondrial RNA catabolic process (GO:0000961)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
pre-replicative complex assembly involved in nuclear cell cycle DNA replication (GO:0006267)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
regulation of mitochondrial RNA catabolic process (GO:0000960)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
DNA ligation (GO:0006266)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
DNA topological change (GO:0006265)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
mitochondrial DNA replication (GO:0006264)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
cellular response to mercury ion (GO:0071288)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to manganese ion (GO:0071287)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of cilium-dependent cell motility (GO:1902019)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
cellular response to magnesium ion (GO:0071286)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of cilium assembly (GO:1902018)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
mitochondrial RNA metabolic process (GO:0000959)	32	0	.88	-	 < 0.01	1.00E00	1.00E00
cellular response to lithium ion (GO:0071285)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
mitochondrial mRNA catabolic process (GO:0000958)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
mitochondrial RNA catabolic process (GO:0000957)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular response to iron(III) ion (GO:0071283)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to iron(II) ion (GO:0071282)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to iron ion (GO:0071281)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
cellular response to copper ion (GO:0071280)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
UDP-glucose catabolic process (GO:0006258)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of translation in response to endoplasmic reticulum stress (GO:1902010)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to cobalt ion (GO:0071279)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to calcium ion (GO:0071277)	37	0	1.01	-	 < 0.01	6.26E-01	1.00E00
cellular response to cadmium ion (GO:0071276)	17	0	.47	-	 < 0.01	1.00E00	1.00E00
positive regulation of amyloid-beta formation (GO:1902004)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
regulation of amyloid-beta formation (GO:1902003)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
peptidyl-threonine modification (GO:0018210)	60	0	1.65	-	 < 0.01	4.12E-01	1.00E00
dCMP catabolic process (GO:0006249)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
CMP catabolic process (GO:0006248)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
homogentisate catabolic process (GO:1902000)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein delipidation (GO:0051697)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
actin filament uncapping (GO:0051695)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
pointed-end actin filament capping (GO:0051694)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
actin filament capping (GO:0051693)	26	0	.71	-	 < 0.01	1.00E00	1.00E00
CTP biosynthetic process (GO:0006241)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
cellular oligosaccharide catabolic process (GO:0051692)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein K69-linked ufmylation (GO:1990592)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
dCDP biosynthetic process (GO:0006240)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular oligosaccharide metabolic process (GO:0051691)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
peptidyl-proline modification (GO:0018208)	29	0	.80	-	 < 0.01	1.00E00	1.00E00
L-methionine salvage (GO:0071267)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
L-methionine biosynthetic process (GO:0071265)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of translational initiation in response to starvation (GO:0071264)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
peptidyl-histidine modification (GO:0018202)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
regulation of translational initiation in response to starvation (GO:0071262)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
peptidyl-glycine modification (GO:0018201)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to mechanical stimulus (GO:0071260)	17	0	.47	-	 < 0.01	1.00E00	1.00E00
CMP salvage (GO:0006238)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
dTTP biosynthetic process (GO:0006235)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
establishment of ER localization (GO:0051686)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
maintenance of ER location (GO:0051685)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
dTDP biosynthetic process (GO:0006233)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
maintenance of Golgi location (GO:0051684)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
establishment of Golgi localization (GO:0051683)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
dTMP biosynthetic process (GO:0006231)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cellular response to electrical stimulus (GO:0071257)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
UTP biosynthetic process (GO:0006228)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
peptidyl-serine trans-autophosphorylation (GO:1990579)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
dUDP biosynthetic process (GO:0006227)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
dUMP biosynthetic process (GO:0006226)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
UDP biosynthetic process (GO:0006225)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mitochondrial L-ornithine transmembrane transport (GO:1990575)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
UMP biosynthetic process (GO:0006222)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
membrane disruption in other organism (GO:0051673)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
pyrimidine nucleotide biosynthetic process (GO:0006221)	18	0	.49	-	 < 0.01	1.00E00	1.00E00
cellular response to metal ion (GO:0071248)	77	0	2.11	-	 < 0.01	2.73E-01	1.00E00
division septum assembly (GO:0000917)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to arsenic-containing substance (GO:0071243)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
cellular response to ammonium ion (GO:0071242)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
actomyosin contractile ring assembly (GO:0000915)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
glutamatergic neuron differentiation (GO:1905962)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
assembly of actomyosin apparatus involved in cytokinesis (GO:0000912)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
uridine catabolic process (GO:0006218)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cytidine catabolic process (GO:0006216)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
actin cortical patch localization (GO:0051666)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
thymidine catabolic process (GO:0006214)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
membrane raft localization (GO:0051665)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
pyrimidine nucleoside metabolic process (GO:0006213)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
protein polyufmylation (GO:1990564)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
uracil catabolic process (GO:0006212)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
5-methylcytosine catabolic process (GO:0006211)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
thymine catabolic process (GO:0006210)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
maintenance of centrosome location (GO:0051661)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
establishment of centrosome localization (GO:0051660)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
cellular response to antibiotic (GO:0071236)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
regulation of cellular response to alcohol (GO:1905957)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of endothelial tube morphogenesis (GO:1905956)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to leucine (GO:0071233)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
positive regulation of lipid localization (GO:1905954)	61	0	1.67	-	 < 0.01	4.13E-01	1.00E00
negative regulation of lipid localization (GO:1905953)	30	0	.82	-	 < 0.01	1.00E00	1.00E00
cellular response to amino acid stimulus (GO:0071230)	42	0	1.15	-	 < 0.01	6.30E-01	1.00E00
pyrimidine nucleobase catabolic process (GO:0006208)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
maintenance of mitochondrion location (GO:0051659)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
'de novo' pyrimidine nucleobase biosynthetic process (GO:0006207)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
pyrimidine nucleobase metabolic process (GO:0006206)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
maintenance of organelle location (GO:0051657)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
IMP catabolic process (GO:0006204)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
dGTP catabolic process (GO:0006203)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
establishment of mitochondrion localization (GO:0051654)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
establishment of vesicle localization (GO:0051650)	103	0	2.82	-	 < 0.01	1.18E-01	1.00E00
mitochondrial alpha-ketoglutarate transmembrane transport (GO:1990550)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to acid chemical (GO:0071229)	47	0	1.29	-	 < 0.01	6.38E-01	1.00E00
cellular response to tumor cell (GO:0071228)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to molecule of fungal origin (GO:0071226)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular response to bacterial lipopeptide (GO:0071221)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to bacterial lipoprotein (GO:0071220)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of gonad development (GO:1905941)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of gonad development (GO:1905940)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
vesicle localization (GO:0051648)	111	0	3.04	-	 < 0.01	1.25E-01	1.00E00
mitochondrial FAD transmembrane transport (GO:1990548)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
nucleus localization (GO:0051647)	20	0	.55	-	 < 0.01	1.00E00	1.00E00
mitochondrion localization (GO:0051646)	31	0	.85	-	 < 0.01	1.00E00	1.00E00
mitochondrial tricarboxylic acid transmembrane transport (GO:1990546)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
Golgi localization (GO:0051645)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
endoplasmic reticulum localization (GO:0051643)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of telomeric RNA transcription from RNA pol II promoter (GO:1901582)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
centrosome localization (GO:0051642)	24	0	.66	-	 < 0.01	1.00E00	1.00E00
negative regulation of telomeric RNA transcription from RNA pol II promoter (GO:1901581)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of telomeric RNA transcription from RNA pol II promoter (GO:1901580)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of gonad development (GO:1905939)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of germ cell proliferation (GO:1905937)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell fate determination (GO:1905934)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of cell fate determination (GO:1905933)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein targeting to vacuole involved in autophagy (GO:0071211)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching (GO:1905932)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching (GO:1905931)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching (GO:1905930)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
actin filament network formation (GO:0051639)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
barbed-end actin filament uncapping (GO:0051638)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
neuron projection maintenance (GO:1990535)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
fatty acid derivative biosynthetic process (GO:1901570)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
protein localization to juxtaparanode region of axon (GO:0071205)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
fatty acid derivative catabolic process (GO:1901569)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
fatty acid derivative metabolic process (GO:1901568)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
bone regeneration (GO:1990523)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of norepinephrine uptake (GO:0051622)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to benomyl (GO:1901561)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of norepinephrine uptake (GO:0051621)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of cell differentiation involved in phenotypic switching (GO:1905917)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell differentiation involved in phenotypic switching (GO:1905916)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of cell differentiation involved in phenotypic switching (GO:1905915)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of calcium ion export across plasma membrane (GO:1905912)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of endothelial cell development (GO:1901552)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of serotonin uptake (GO:0051612)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of serotonin uptake (GO:0051611)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of endothelial cell development (GO:1901550)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
piRNA biosynthetic process (GO:1990511)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
replicative senescence (GO:0090399)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
cellular senescence (GO:0090398)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
negative regulation of excitatory postsynaptic potential (GO:0090394)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of amyloid fibril formation (GO:1905907)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of amyloid fibril formation (GO:1905906)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
histamine transport (GO:0051608)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
response to raffinose (GO:1901545)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
dense core granule exocytosis (GO:1990504)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
response to electrical stimulus (GO:0051602)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
dense core granule maturation (GO:1990502)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
exocyst localization (GO:0051601)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
phagosome-lysosome fusion involved in apoptotic cell clearance (GO:0090389)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
phagolysosome assembly involved in apoptotic cell clearance (GO:0090387)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
phagosome maturation involved in apoptotic cell clearance (GO:0090386)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
phagosome-lysosome fusion (GO:0090385)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
phagosome acidification (GO:0090383)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
phagosome maturation (GO:0090382)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
regulation of heart induction (GO:0090381)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
changes to DNA methylation involved in embryo development (GO:1901538)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of DNA demethylation (GO:1901537)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of DNA demethylation (GO:1901536)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of DNA demethylation (GO:1901535)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of hematopoietic progenitor cell differentiation (GO:1901534)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of hematopoietic progenitor cell differentiation (GO:1901533)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
regulation of hematopoietic progenitor cell differentiation (GO:1901532)	22	0	.60	-	 < 0.01	1.00E00	1.00E00
negative regulation of cholesterol efflux (GO:0090370)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of anion channel activity (GO:1901529)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of mitophagy (GO:1901526)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of mitophagy (GO:1901525)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of mitophagy (GO:1901524)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
icosanoid catabolic process (GO:1901523)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522)	17	0	.47	-	 < 0.01	1.00E00	1.00E00
negative regulation of mRNA modification (GO:0090367)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of mRNA modification (GO:0090366)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of mRNA modification (GO:0090365)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of platelet-derived growth factor production (GO:0090362)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of platelet-derived growth factor production (GO:0090361)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
response to biotin (GO:0070781)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
efferent axon development in a lateral line nerve (GO:0048894)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
lateral line nerve development (GO:0048892)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
D-aspartate import across plasma membrane (GO:0070779)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
D-aspartate transport (GO:0070777)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of endothelial tube morphogenesis (GO:1901509)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of acylglycerol transport (GO:1901508)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of acylglycerol transport (GO:1901506)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
ether biosynthetic process (GO:1901503)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
ether catabolic process (GO:1901502)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process (GO:0140199)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process (GO:0140196)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process (GO:0140194)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process (GO:0140193)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process (GO:0140192)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell aging (GO:0090344)	21	0	.58	-	 < 0.01	1.00E00	1.00E00
negative regulation of secretion of lysosomal enzymes (GO:0090341)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of secretion of lysosomal enzymes (GO:0090340)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
host-mediated regulation of intestinal microbiota composition (GO:0048874)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of brown fat cell differentiation (GO:0090336)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
homeostasis of number of cells within a tissue (GO:0048873)	21	0	.58	-	 < 0.01	1.00E00	1.00E00
regulation of brown fat cell differentiation (GO:0090335)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
negative regulation of platelet aggregation (GO:0090331)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
regulation of DNA-dependent DNA replication (GO:0090329)	38	0	1.04	-	 < 0.01	6.27E-01	1.00E00
stem cell fate specification (GO:0048866)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
stem cell fate commitment (GO:0048865)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of locomotion involved in locomotory behavior (GO:0090327)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
stem cell development (GO:0048864)	38	0	1.04	-	 < 0.01	6.27E-01	1.00E00
positive regulation of locomotion involved in locomotory behavior (GO:0090326)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
stem cell differentiation (GO:0048863)	93	0	2.55	-	 < 0.01	1.83E-01	1.00E00
regulation of locomotion involved in locomotory behavior (GO:0090325)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of oxidative phosphorylation (GO:0090324)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
leukemia inhibitory factor signaling pathway (GO:0048861)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of superoxide metabolic process (GO:0090322)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
positive regulation of chylomicron remnant clearance (GO:0090321)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of chylomicron remnant clearance (GO:0090320)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
formation of anatomical boundary (GO:0048859)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
neural nucleus development (GO:0048857)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
positive regulation of chylomicron remodeling (GO:0090319)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of chylomicron remodeling (GO:0090318)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of intracellular protein transport (GO:0090317)	29	0	.80	-	 < 0.01	1.00E00	1.00E00
brain morphogenesis (GO:0048854)	31	0	.85	-	 < 0.01	1.00E00	1.00E00
forebrain morphogenesis (GO:0048853)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein targeting to membrane (GO:0090315)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
diencephalon morphogenesis (GO:0048852)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein deacetylation (GO:0090312)	19	0	.52	-	 < 0.01	1.00E00	1.00E00
regulation of protein deacetylation (GO:0090311)	39	0	1.07	-	 < 0.01	6.27E-01	1.00E00
negative regulation of DNA methylation-dependent heterochromatin assembly (GO:0090310)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
histone H3-K27 methylation (GO:0070734)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of ribonucleoprotein complex localization (GO:2000199)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of ribonucleoprotein complex localization (GO:2000197)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of female gonad development (GO:2000196)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of female gonad development (GO:2000195)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of female gonad development (GO:2000194)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of fatty acid transport (GO:2000193)	17	0	.47	-	 < 0.01	1.00E00	1.00E00
negative regulation of fatty acid transport (GO:2000192)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
regulation of fatty acid transport (GO:2000191)	29	0	.80	-	 < 0.01	1.00E00	1.00E00
axon extension involved in axon guidance (GO:0048846)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
venous blood vessel morphogenesis (GO:0048845)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
mitotic spindle assembly (GO:0090307)	41	0	1.12	-	 < 0.01	6.28E-01	1.00E00
artery morphogenesis (GO:0048844)	31	0	.85	-	 < 0.01	1.00E00	1.00E00
spindle assembly involved in meiosis (GO:0090306)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
negative regulation of axon extension involved in axon guidance (GO:0048843)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
nucleic acid phosphodiester bond hydrolysis (GO:0090305)	91	0	2.50	-	 < 0.01	1.80E-01	1.00E00
positive regulation of axon extension involved in axon guidance (GO:0048842)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of axon extension involved in axon guidance (GO:0048841)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of wound healing (GO:0090303)	27	0	.74	-	 < 0.01	1.00E00	1.00E00
otolith development (GO:0048840)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of neural crest formation (GO:0090301)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
neurotransmitter receptor internalization (GO:0099590)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
response to cholesterol (GO:0070723)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
positive regulation of progesterone biosynthetic process (GO:2000184)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of progesterone biosynthetic process (GO:2000182)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of blood vessel morphogenesis (GO:2000181)	51	0	1.40	-	 < 0.01	6.47E-01	1.00E00
positive regulation of postsynaptic cytosolic calcium concentration (GO:0099588)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mismatch repair involved in maintenance of fidelity involved in DNA-dependent DNA replication (GO:0070716)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of neural precursor cell proliferation (GO:2000179)	34	0	.93	-	 < 0.01	1.00E00	1.00E00
negative regulation of deadenylation-dependent decapping of nuclear-transcribed mRNA (GO:0106289)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of deadenylation-dependent decapping of nuclear-transcribed mRNA (GO:0106288)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of pro-T cell differentiation (GO:2000176)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of pro-T cell differentiation (GO:2000174)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of branching morphogenesis of a nerve (GO:2000173)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of branching morphogenesis of a nerve (GO:2000172)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
positive regulation of peptidyl-cysteine S-nitrosylation (GO:2000170)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
formation of extrachromosomal circular DNA (GO:0001325)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of lymphocyte chemotaxis (GO:0140131)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
enucleate erythrocyte development (GO:0048822)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
erythrocyte development (GO:0048821)	21	0	.58	-	 < 0.01	1.00E00	1.00E00
regulation of translation at postsynapse, modulating synaptic transmission (GO:0099578)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
hair follicle maturation (GO:0048820)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
regulation of translation at presynapse, modulating synaptic transmission (GO:0099577)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of protein catabolic process at postsynapse, modulating synaptic transmission (GO:0099576)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of protein catabolic process at presynapse, modulating synaptic transmission (GO:0099575)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
detection of peptidoglycan (GO:0032499)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
detection of muramyl dipeptide (GO:0032498)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
detection of lipopolysaccharide (GO:0032497)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to bacterial lipoprotein (GO:0032493)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of peptidyl-cysteine S-nitrosylation (GO:2000169)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
detection of molecule of bacterial origin (GO:0032490)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of hair follicle maturation (GO:0048819)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
positive regulation of hair follicle maturation (GO:0048818)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of hair follicle maturation (GO:0048817)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
age-dependent response to reactive oxygen species (GO:0001315)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of dendrite morphogenesis (GO:0048814)	52	0	1.43	-	 < 0.01	4.05E-01	1.00E00
regulation of postsynaptic cytosolic calcium ion concentration (GO:0099566)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
modification of synaptic structure, modulating synaptic transmission (GO:0099564)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
maintenance of postsynaptic density structure (GO:0099562)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
synaptic membrane adhesion (GO:0099560)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of Cdc42 protein signal transduction (GO:0032489)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
Cdc42 protein signal transduction (GO:0032488)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of Rap protein signal transduction (GO:0032487)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
Rap protein signal transduction (GO:0032486)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of Ral protein signal transduction (GO:0032485)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
Ral protein signal transduction (GO:0032484)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of Rab protein signal transduction (GO:0032483)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
Rab protein signal transduction (GO:0032482)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of ubiquitin-specific protease activity (GO:2000158)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of ubiquitin-specific protease activity (GO:2000157)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of type I interferon production (GO:0032480)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
regulation of retrograde vesicle-mediated transport, Golgi to ER (GO:2000156)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of cilium-dependent cell motility (GO:2000155)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
male genitalia morphogenesis (GO:0048808)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of ubiquitin-specific protease activity (GO:2000152)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
female genitalia morphogenesis (GO:0048807)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
genitalia development (GO:0048806)	23	0	.63	-	 < 0.01	1.00E00	1.00E00
age-dependent response to oxidative stress (GO:0001306)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
extracellular vesicle biogenesis (GO:0140112)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
maintenance of synapse structure (GO:0099558)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
trans-synaptic signaling by nitric oxide, modulating synaptic transmission (GO:0099555)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
trans-synaptic signaling by soluble gas, modulating synaptic transmission (GO:0099554)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
trans-synaptic signaling by endocannabinoid, modulating synaptic transmission (GO:0099553)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
trans-synaptic signaling by lipid, modulating synaptic transmission (GO:0099552)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
trans-synaptic signaling, modulating synaptic transmission (GO:0099550)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
otolith morphogenesis (GO:0032474)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of DNA-templated transcription, initiation (GO:2000143)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
peptidyl-glutamine modification (GO:0018199)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
peptidyl-asparagine modification (GO:0018196)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
trans-synaptic signaling by nitric oxide (GO:0099548)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of translation at synapse, modulating synaptic transmission (GO:0099547)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
peptidyl-alanine modification (GO:0018194)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein catabolic process, modulating synaptic transmission (GO:0099546)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
trans-synaptic signaling by soluble gas (GO:0099543)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
trans-synaptic signaling by endocannabinoid (GO:0099542)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation by symbiont of host programmed cell death (GO:0052042)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
trans-synaptic signaling by lipid (GO:0099541)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
modulation by symbiont of host programmed cell death (GO:0052040)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
endoplasmic reticulum calcium ion homeostasis (GO:0032469)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
positive regulation of cytokinesis (GO:0032467)	20	0	.55	-	 < 0.01	1.00E00	1.00E00
negative regulation of cytokinesis (GO:0032466)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of cytokinesis (GO:0032465)	55	0	1.51	-	 < 0.01	4.06E-01	1.00E00
positive regulation of protein homooligomerization (GO:0032464)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein homooligomerization (GO:0032463)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of protein homooligomerization (GO:0032462)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of cell proliferation involved in heart morphogenesis (GO:2000138)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein oligomerization (GO:0032461)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell proliferation involved in heart morphogenesis (GO:2000137)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein oligomerization (GO:0032460)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of cell proliferation involved in heart morphogenesis (GO:2000136)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
synaptic signaling via neuropeptide (GO:0099538)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of presynaptic cytosolic calcium concentration (GO:0099533)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
synaptic vesicle endosomal processing (GO:0099532)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of protein oligomerization (GO:0032459)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
slow endocytic recycling (GO:0032458)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
endocytic recycling (GO:0032456)	33	0	.90	-	 < 0.01	1.00E00	1.00E00
regulation of endocannabinoid signaling pathway (GO:2000124)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of removal of superoxide radicals (GO:2000121)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of sodium-dependent phosphate transport (GO:2000120)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein depropionylation (GO:0106230)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
postsynapse to nucleus signaling pathway (GO:0099527)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
modulation by symbiont of host signal transduction pathway (GO:0052027)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
presynapse to nucleus signaling pathway (GO:0099526)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
translocation of molecules into host (GO:0044417)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
presynaptic dense core vesicle exocytosis (GO:0099525)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
peptidyl-cysteine oxidation (GO:0018171)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of sodium-dependent phosphate transport (GO:2000119)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of sodium-dependent phosphate transport (GO:2000118)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
peptidyl-lysine glutarylation (GO:0106227)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of macrophage apoptotic process (GO:2000111)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of macrophage apoptotic process (GO:2000110)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
dense core granule cytoskeletal transport (GO:0099519)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
C-terminal protein-tyrosinylation (GO:0018166)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
vesicle cytoskeletal trafficking (GO:0099518)	54	0	1.48	-	 < 0.01	4.05E-01	1.00E00
entry into host (GO:0044409)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
synaptic vesicle transport along microtubule (GO:0099517)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
actin filament-based transport (GO:0099515)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
adhesion of symbiont to host (GO:0044406)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
synaptic vesicle cytoskeletal transport (GO:0099514)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
peptidyl-pyrromethane cofactor linkage (GO:0018160)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cAMP catabolic process (GO:0006198)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
AMP catabolic process (GO:0006196)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435)	27	0	.74	-	 < 0.01	1.00E00	1.00E00
regulation of macrophage apoptotic process (GO:2000109)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
positive regulation of phospholipase A2 activity (GO:0032430)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of DNA-dependent DNA replication (GO:2000105)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
negative regulation of DNA-dependent DNA replication (GO:2000104)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
positive regulation of mammary stem cell proliferation (GO:2000103)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of mammary stem cell proliferation (GO:2000101)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein oxidation (GO:0018158)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine (GO:0018153)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
'de novo' IMP biosynthetic process (GO:0006189)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
IMP biosynthetic process (GO:0006188)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
vesicle fusion to plasma membrane (GO:0099500)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
dGDP biosynthetic process (GO:0006185)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of phospholipase A2 activity (GO:0032429)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
polar body extrusion after meiotic divisions (GO:0040038)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
GTP biosynthetic process (GO:0006183)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
cGMP biosynthetic process (GO:0006182)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of mismatch repair (GO:0032425)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of development, heterochronic (GO:0040034)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
negative regulation of translation, ncRNA-mediated (GO:0040033)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
regulation of mismatch repair (GO:0032423)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
snRNA modification (GO:0040031)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of molecular function, epigenetic (GO:0040030)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
peptide cross-linking (GO:0018149)	20	0	.55	-	 < 0.01	1.00E00	1.00E00
keratan sulfate biosynthetic process (GO:0018146)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
nucleic acid-protein covalent cross-linking (GO:0018143)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein-DNA covalent cross-linking (GO:0018142)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
GMP biosynthetic process (GO:0006177)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
dATP biosynthetic process (GO:0006175)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
lysosome localization (GO:0032418)	27	0	.74	-	 < 0.01	1.00E00	1.00E00
positive regulation of sodium:proton antiporter activity (GO:0032417)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
ADP biosynthetic process (GO:0006172)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of sodium:proton antiporter activity (GO:0032416)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cAMP biosynthetic process (GO:0006171)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of sodium:proton antiporter activity (GO:0032415)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of ion transmembrane transporter activity (GO:0032414)	48	0	1.32	-	 < 0.01	6.40E-01	1.00E00
negative regulation of ion transmembrane transporter activity (GO:0032413)	30	0	.82	-	 < 0.01	1.00E00	1.00E00
regulation of ion transmembrane transporter activity (GO:0032412)	104	0	2.85	-	 < 0.01	1.19E-01	1.00E00
positive regulation of transporter activity (GO:0032411)	53	0	1.45	-	 < 0.01	4.05E-01	1.00E00
regulation of meiotic nuclear division (GO:0040020)	25	0	.69	-	 < 0.01	1.00E00	1.00E00
negative regulation of transporter activity (GO:0032410)	35	0	.96	-	 < 0.01	1.00E00	1.00E00
adenine salvage (GO:0006168)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
AMP biosynthetic process (GO:0006167)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
purine ribonucleoside salvage (GO:0006166)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of embryonic development (GO:0040019)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
regulation of transporter activity (GO:0032409)	113	0	3.10	-	 < 0.01	7.76E-02	1.00E00
embryonic cleavage (GO:0040016)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
melanosome transport (GO:0032402)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
establishment of melanosome localization (GO:0032401)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
positive regulation of growth rate (GO:0040010)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
melanosome localization (GO:0032400)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
protein hydroxylation (GO:0018126)	25	0	.69	-	 < 0.01	1.00E00	1.00E00
deoxyadenosine catabolic process (GO:0006157)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of growth rate (GO:0040009)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
adenosine catabolic process (GO:0006154)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
purine nucleoside catabolic process (GO:0006152)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
histone H2A-S1 phosphorylation (GO:0043990)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
peptidyl-cysteine S-nitrosylation (GO:0018119)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of cellular response to very-low-density lipoprotein particle stimulus (GO:1905890)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
inosine catabolic process (GO:0006148)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
response to hydrostatic pressure (GO:0051599)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
guanine catabolic process (GO:0006147)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
meiotic recombination checkpoint (GO:0051598)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
histone H3-S28 phosphorylation (GO:0043988)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
response to methylmercury (GO:0051597)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
purine nucleobase catabolic process (GO:0006145)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
histone H3-S10 phosphorylation (GO:0043987)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
methylglyoxal catabolic process (GO:0051596)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
response to methylglyoxal (GO:0051595)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
histone H4-R3 methylation (GO:0043985)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
detection of glucose (GO:0051594)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
histone H4-K16 acetylation (GO:0043984)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
response to folic acid (GO:0051593)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
histone H4-K12 acetylation (GO:0043983)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
response to calcium ion (GO:0051592)	60	0	1.65	-	 < 0.01	4.12E-01	1.00E00
histone H4-K8 acetylation (GO:0043982)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
histone H4-K5 acetylation (GO:0043981)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
positive regulation of neurotransmitter transport (GO:0051590)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
histone H2B-K12 acetylation (GO:0043980)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
viral translational termination-reinitiation (GO:0075525)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
viral translational frameshifting (GO:0075523)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
IRES-dependent viral translational initiation (GO:0075522)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
establishment of protein localization to chromatin (GO:0071169)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
peptidyl-threonine phosphorylation (GO:0018107)	59	0	1.62	-	 < 0.01	4.10E-01	1.00E00
positive regulation of triglyceride transport (GO:1905885)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
DNA replication preinitiation complex assembly (GO:0071163)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of triglyceride transport (GO:1905883)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein citrullination (GO:0018101)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of neurotransmitter transport (GO:0051589)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
histone H2A-K5 acetylation (GO:0043977)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of dopamine uptake involved in synaptic transmission (GO:0051585)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of dopamine uptake involved in synaptic transmission (GO:0051584)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
dopamine uptake involved in synaptic transmission (GO:0051583)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
histone H3-K4 acetylation (GO:0043973)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of neurotransmitter uptake (GO:0051581)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of neurotransmitter uptake (GO:0051580)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
histone H3-K9 acetylation (GO:0043970)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of cell cycle arrest (GO:0071158)	24	0	.66	-	 < 0.01	1.00E00	1.00E00
regulation of oogenesis (GO:1905879)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell cycle arrest (GO:0071157)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
regulation of cell cycle arrest (GO:0071156)	39	0	1.07	-	 < 0.01	6.27E-01	1.00E00
negative regulation of postsynaptic density organization (GO:1905875)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of postsynaptic density organization (GO:1905874)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein localization to cell leading edge (GO:1905873)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein localization to cell leading edge (GO:1905872)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of protein localization to cell leading edge (GO:1905871)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of 3'-UTR-mediated mRNA stabilization (GO:1905870)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of arginine metabolic process (GO:0000821)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
glycerophosphate shuttle (GO:0006127)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
histone H2B acetylation (GO:0043969)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of glutamine family amino acid metabolic process (GO:0000820)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
histone H2A acetylation (GO:0043968)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of histone H3-K9 methylation (GO:0051573)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
mitochondrial electron transport, succinate to ubiquinone (GO:0006121)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of histone H3-K4 methylation (GO:0051572)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
mitochondrial electron transport, NADH to ubiquinone (GO:0006120)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
positive regulation of histone H3-K4 methylation (GO:0051571)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
negative regulation of fatty acid beta-oxidation (GO:0031999)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
endocytosis involved in viral entry into host cell (GO:0075509)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of fatty acid beta-oxidation (GO:0031998)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
entry of viral genome into host nucleus through nuclear pore complex via importin (GO:0075506)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mRNA export from nucleus in response to heat stress (GO:0031990)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of 3'-UTR-mediated mRNA stabilization (GO:1905869)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of 3'-UTR-mediated mRNA stabilization (GO:1905868)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
epididymis development (GO:1905867)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
resolution of mitotic recombination intermediates (GO:0071140)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
oxidative phosphorylation (GO:0006119)	40	0	1.10	-	 < 0.01	6.28E-01	1.00E00
positive regulation of heparan sulfate proteoglycan binding (GO:1905860)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of histone H3-K4 methylation (GO:0051569)	26	0	.71	-	 < 0.01	1.00E00	1.00E00
acetaldehyde metabolic process (GO:0006117)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
histone H3-K4 methylation (GO:0051568)	20	0	.55	-	 < 0.01	1.00E00	1.00E00
NADH oxidation (GO:0006116)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
histone H3-K9 methylation (GO:0051567)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
glycerol biosynthetic process (GO:0006114)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
cellular component maintenance (GO:0043954)	35	0	.96	-	 < 0.01	1.00E00	1.00E00
negative regulation of mitochondrial calcium ion concentration (GO:0051562)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of glycolytic process (GO:0006110)	32	0	.88	-	 < 0.01	1.00E00	1.00E00
positive regulation of mitochondrial calcium ion concentration (GO:0051561)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of cAMP-mediated signaling (GO:0043951)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
mitochondrial calcium ion homeostasis (GO:0051560)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
locomotion involved in locomotory behavior (GO:0031987)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
resolution of recombination intermediates (GO:0071139)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of heparan sulfate proteoglycan binding (GO:1905858)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of pentose-phosphate shunt (GO:1905856)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of heparan sulfate binding (GO:1905855)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of heparan sulfate binding (GO:1905853)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
malate metabolic process (GO:0006108)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
oxaloacetate metabolic process (GO:0006107)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
fumarate metabolic process (GO:0006106)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
succinate metabolic process (GO:0006105)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
mitochondrion-endoplasmic reticulum membrane tethering (GO:1990456)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
succinyl-CoA metabolic process (GO:0006104)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
2-oxoglutarate metabolic process (GO:0006103)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
isocitrate metabolic process (GO:0006102)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of lymphangiogenesis (GO:1901492)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
citrate metabolic process (GO:0006101)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of lymphangiogenesis (GO:1901491)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of lymphangiogenesis (GO:1901490)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of cellular response to gamma radiation (GO:1905843)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of keratinocyte migration (GO:0051548)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
keratinocyte migration (GO:0051546)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of transcription factor catabolic process (GO:1901485)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of transcription factor catabolic process (GO:1901483)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
peptidyl-threonine autophosphorylation (GO:1990443)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
intrinsic apoptotic signaling pathway in response to nitrosative stress (GO:1990442)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
elastin metabolic process (GO:0051541)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990441)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
ossification involved in bone maturation (GO:0043931)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of telomeric D-loop disassembly (GO:1905839)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of telomeric D-loop disassembly (GO:1905838)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of spindle assembly (GO:1905832)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
histone biotinylation (GO:0071110)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
U6 2'-O-snRNA methylation (GO:1990438)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
exonucleolytic catabolism of deadenylated mRNA (GO:0043928)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
snRNA 2'-O-methylation (GO:1990437)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
pyruvate transmembrane transport (GO:1901475)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation by host of viral transcription (GO:0043923)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
negative regulation by host of viral transcription (GO:0043922)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
modulation by host of viral transcription (GO:0043921)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
mineralocorticoid receptor signaling pathway (GO:0031959)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
corticosteroid receptor signaling pathway (GO:0031958)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein autophosphorylation (GO:0031953)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
superior temporal gyrus development (GO:0071109)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein K48-linked deubiquitination (GO:0071108)	20	0	.55	-	 < 0.01	1.00E00	1.00E00
response to parathyroid hormone (GO:0071107)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of prostaglandin catabolic process (GO:1905828)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to interleukin-11 (GO:0071105)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
response to interleukin-9 (GO:0071104)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
miRNA transport (GO:1990428)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of tetrapyrrole biosynthetic process (GO:1901463)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of chromatin silencing at telomere (GO:0031940)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to brain-derived neurotrophic factor stimulus (GO:1990416)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of multi-organism process (GO:0043902)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
negative regulation of unidimensional cell growth (GO:0051511)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of multi-organism process (GO:0043901)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
regulation of unidimensional cell growth (GO:0051510)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
adrenomedullin receptor signaling pathway (GO:1990410)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of multi-organism process (GO:0043900)	26	0	.71	-	 < 0.01	1.00E00	1.00E00
regulation of chromatin silencing at telomere (GO:0031938)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of chromatin silencing (GO:0031937)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of chromatin silencing (GO:0031936)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of chromatin silencing (GO:0031935)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
regulation of neural crest formation (GO:0090299)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of mitochondrial DNA replication (GO:0090298)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of mitochondrial DNA replication (GO:0090297)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mitochondria-nucleus signaling pathway (GO:0031930)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of mitochondrial DNA replication (GO:0090296)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of synapse organization (GO:1905809)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
nitrogen catabolite activation of transcription (GO:0090294)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
nitrogen catabolite regulation of transcription (GO:0090293)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of osteoclast proliferation (GO:0090291)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of osteoclast proliferation (GO:0090290)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
adenine nucleotide transport (GO:0051503)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
embryonic brain development (GO:1990403)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
embryonic liver development (GO:1990402)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
embryonic lung development (GO:1990401)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
TOR signaling (GO:0031929)	23	0	.63	-	 < 0.01	1.00E00	1.00E00
regulation of osteoclast proliferation (GO:0090289)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein glycosylation in Golgi (GO:0090284)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of protein glycosylation in Golgi (GO:0090283)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of transcription involved in G2/M transition of mitotic cell cycle (GO:0090282)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of calcium ion import (GO:0090281)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of synaptic plasticity (GO:0031915)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
negative regulation of synaptic plasticity (GO:0031914)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of somatostatin secretion (GO:0090275)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of somatostatin secretion (GO:0090274)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of somatostatin secretion (GO:0090273)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of fibroblast growth factor production (GO:0090272)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of fibroblast growth factor production (GO:0090271)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of fibroblast growth factor production (GO:0090270)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090267)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of immune complex clearance by monocytes and macrophages (GO:0090265)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of immune complex clearance by monocytes and macrophages (GO:0090264)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of canonical Wnt signaling pathway (GO:0090263)	65	0	1.78	-	 < 0.01	4.22E-01	1.00E00
positive regulation of inclusion body assembly (GO:0090261)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of retinal ganglion cell axon guidance (GO:0090260)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of response to alcohol (GO:1901419)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
seminal clot liquefaction (GO:0070684)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
proteasome regulatory particle assembly (GO:0070682)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
glutaminyl-tRNAGln biosynthesis via transamidation (GO:0070681)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
animal organ maturation (GO:0048799)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
regulation of retinal ganglion cell axon guidance (GO:0090259)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of mitochondrial fission (GO:0090258)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
pronephros development (GO:0048793)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
spontaneous exocytosis of neurotransmitter (GO:0048792)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
calcium ion-regulated exocytosis of neurotransmitter (GO:0048791)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
maintenance of presynaptic active zone structure (GO:0048790)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein localization involved in establishment of planar polarity (GO:0090251)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
intralumenal vesicle formation (GO:0070676)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of phosphorylation of RNA polymerase II C-terminal domain (GO:1901407)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to interleukin-15 (GO:0070672)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of tetrapyrrole metabolic process (GO:1901403)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to interleukin-4 (GO:0070670)	20	0	.55	-	 < 0.01	1.00E00	1.00E00
regulation of tetrapyrrole metabolic process (GO:1901401)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of cell migration involved in somitogenic axis elongation (GO:0090249)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
convergent extension involved in somitogenesis (GO:0090246)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
axis elongation involved in somitogenesis (GO:0090245)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
Wnt signaling pathway involved in somitogenesis (GO:0090244)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
retinoic acid receptor signaling pathway involved in somitogenesis (GO:0090242)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of histone H4 acetylation (GO:0090241)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of histone H4 acetylation (GO:0090240)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
response to interleukin-2 (GO:0070669)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of mast cell proliferation (GO:0070668)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of mast cell proliferation (GO:0070667)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of mast cell proliferation (GO:0070666)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of histone H4 acetylation (GO:0090239)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
positive regulation of arachidonic acid secretion (GO:0090238)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of arachidonic acid secretion (GO:0090237)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
erythrophore differentiation (GO:0048773)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of metaphase plate congression (GO:0090235)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
regulation of kinetochore assembly (GO:0090234)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
tissue remodeling (GO:0048771)	56	0	1.54	-	 < 0.01	4.07E-01	1.00E00
positive regulation of spindle checkpoint (GO:0090232)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of centromere complex assembly (GO:0090230)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
nonfunctional rRNA decay (GO:0070651)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
actin filament bundle distribution (GO:0070650)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
sarcomerogenesis (GO:0048769)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cardiac endothelial to mesenchymal transition (GO:0140074)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mesenchymal cell differentiation (GO:0048762)	85	0	2.33	-	 < 0.01	1.76E-01	1.00E00
centrosome-templated microtubule nucleation (GO:0090222)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
formin-nucleated actin cable assembly (GO:0070649)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
vitamin D3 metabolic process (GO:0070640)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
peptidyl-lysine butyrylation (GO:0140067)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
peptidyl-lysine crotonylation (GO:0140066)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
pigment granule maturation (GO:0048757)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
negative regulation of lipid kinase activity (GO:0090219)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
branching morphogenesis of a nerve (GO:0048755)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity (GO:0090217)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity (GO:0090216)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity (GO:0090215)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
semicircular canal morphogenesis (GO:0048752)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
spongiotrophoblast layer developmental growth (GO:0090214)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of establishment of blood-brain barrier (GO:0090212)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of establishment of blood-brain barrier (GO:0090210)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
transepithelial transport (GO:0070633)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of smooth muscle cell-matrix adhesion (GO:2000098)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of smooth muscle cell-matrix adhesion (GO:2000097)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000096)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
dendrite arborization (GO:0140059)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
neuron projection arborization (GO:0140058)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
muscle fiber development (GO:0048747)	25	0	.69	-	 < 0.01	1.00E00	1.00E00
negative regulation of triglyceride metabolic process (GO:0090209)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
positive regulation of triglyceride metabolic process (GO:0090208)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
smooth muscle tissue development (GO:0048745)	17	0	.47	-	 < 0.01	1.00E00	1.00E00
regulation of triglyceride metabolic process (GO:0090207)	27	0	.74	-	 < 0.01	1.00E00	1.00E00
negative regulation of cholesterol metabolic process (GO:0090206)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of skeletal muscle fiber development (GO:0048743)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of cholesterol metabolic process (GO:0090205)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of skeletal muscle fiber development (GO:0048742)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
protein localization to nuclear pore (GO:0090204)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
skeletal muscle fiber development (GO:0048741)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
gene looping (GO:0090202)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein kinase activity by regulation of protein phosphorylation (GO:0044387)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
positive regulation of release of cytochrome c from mitochondria (GO:0090200)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
protein localization to cytoskeleton (GO:0044380)	38	0	1.04	-	 < 0.01	6.27E-01	1.00E00
cardiac muscle fiber development (GO:0048739)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation (GO:2000080)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
lipid droplet formation (GO:0140042)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
sebaceous gland development (GO:0048733)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
cellular detoxification of methylglyoxal (GO:0140041)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of protein processing (GO:0070613)	37	0	1.01	-	 < 0.01	6.26E-01	1.00E00
regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation (GO:2000079)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of type B pancreatic cell development (GO:2000078)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of type B pancreatic cell development (GO:2000074)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of centromeric sister chromatid cohesion (GO:0070602)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
centromeric sister chromatid cohesion (GO:0070601)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of oligodendrocyte differentiation (GO:0048715)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
negative regulation of astrocyte differentiation (GO:0048712)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
positive regulation of astrocyte differentiation (GO:0048711)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
regulation of astrocyte differentiation (GO:0048710)	18	0	.49	-	 < 0.01	1.00E00	1.00E00
regulation of rRNA stability (GO:0044357)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
macropinocytosis (GO:0044351)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of intracellular transport (GO:0032387)	38	0	1.04	-	 < 0.01	6.27E-01	1.00E00
positive regulation of intracellular cholesterol transport (GO:0032385)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059)	35	0	.96	-	 < 0.01	1.00E00	1.00E00
positive regulation of intracellular sterol transport (GO:0032382)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of cytoplasmic translational fidelity (GO:0140018)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification (GO:2000054)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
oligodendrocyte differentiation (GO:0048709)	36	0	.99	-	 < 0.01	1.00E00	1.00E00
regulation of Wnt signaling pathway involved in dorsal/ventral axis specification (GO:2000053)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
astrocyte differentiation (GO:0048708)	29	0	.80	-	 < 0.01	1.00E00	1.00E00
positive regulation of non-canonical Wnt signaling pathway (GO:2000052)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
negative regulation of non-canonical Wnt signaling pathway (GO:2000051)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
histone displacement (GO:0001207)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
embryonic skeletal system development (GO:0048706)	79	0	2.17	-	 < 0.01	2.77E-01	1.00E00
regulation of non-canonical Wnt signaling pathway (GO:2000050)	19	0	.52	-	 < 0.01	1.00E00	1.00E00
embryonic skeletal system morphogenesis (GO:0048704)	63	0	1.73	-	 < 0.01	4.17E-01	1.00E00
embryonic viscerocranium morphogenesis (GO:0048703)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
embryonic neurocranium morphogenesis (GO:0048702)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
embryonic cranial skeleton morphogenesis (GO:0048701)	26	0	.71	-	 < 0.01	1.00E00	1.00E00
fibroblast apoptotic process (GO:0044346)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
stromal-epithelial cell signaling involved in prostate gland development (GO:0044345)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
type B pancreatic cell proliferation (GO:0044342)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
canonical Wnt signaling pathway involved in regulation of cell proliferation (GO:0044340)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of intracellular lipid transport (GO:0032379)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of cholesterol transport (GO:0032376)	18	0	.49	-	 < 0.01	1.00E00	1.00E00
negative regulation of cholesterol transport (GO:0032375)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
positive regulation of sterol transport (GO:0032373)	18	0	.49	-	 < 0.01	1.00E00	1.00E00
positive regulation of cell-cell adhesion mediated by cadherin (GO:2000049)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of sterol transport (GO:0032372)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
regulation of cell-cell adhesion mediated by cadherin (GO:2000047)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
positive regulation of lipid transport (GO:0032370)	50	0	1.37	-	 < 0.01	6.45E-01	1.00E00
regulation of cardiac cell fate specification (GO:2000043)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of double-strand break repair via homologous recombination (GO:2000042)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
negative regulation of planar cell polarity pathway involved in axis elongation (GO:2000041)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of planar cell polarity pathway involved in axis elongation (GO:2000040)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
protein polyglutamylation (GO:0018095)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
protein polyglycylation (GO:0018094)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation (GO:0044338)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
canonical Wnt signaling pathway involved in positive regulation of apoptotic process (GO:0044337)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
canonical Wnt signaling pathway involved in negative regulation of apoptotic process (GO:0044336)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition (GO:0044334)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cell-cell adhesion mediated by cadherin (GO:0044331)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of lipid transport (GO:0032369)	21	0	.58	-	 < 0.01	1.00E00	1.00E00
intracellular cholesterol transport (GO:0032367)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
intracellular sterol transport (GO:0032366)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
intracellular lipid transport (GO:0032365)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
oxygen homeostasis (GO:0032364)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
pyridoxal phosphate catabolic process (GO:0032361)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of stem cell population maintenance (GO:2000036)	28	0	.77	-	 < 0.01	1.00E00	1.00E00
regulation of stem cell division (GO:2000035)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
response to estradiol (GO:0032355)	25	0	.69	-	 < 0.01	1.00E00	1.00E00
response to follicle-stimulating hormone (GO:0032354)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of hormone metabolic process (GO:0032352)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
negative regulation of glycine import across plasma membrane (GO:1900924)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of glycine import across plasma membrane (GO:1900923)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of cardiac muscle cell contraction (GO:0106135)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of male gonad development (GO:2000020)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
N-terminal peptidyl-lysine acetylation (GO:0018076)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
wound healing, spreading of cells (GO:0044319)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
protein K27-linked ubiquitination (GO:0044314)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
protein K6-linked deubiquitination (GO:0044313)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of aldosterone biosynthetic process (GO:0032349)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of aldosterone metabolic process (GO:0032346)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of male gonad development (GO:2000018)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of determination of dorsal identity (GO:2000017)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of determination of dorsal identity (GO:2000016)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of determination of dorsal identity (GO:2000015)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of adaxial/abaxial pattern formation (GO:2000011)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of cobalamin metabolic process (GO:0106121)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein localization to cell surface (GO:2000010)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of sterol biosynthetic process (GO:0106120)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
cytochrome c-heme linkage (GO:0018063)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
tricarboxylic acid cycle (GO:0006099)	23	0	.63	-	 < 0.01	1.00E00	1.00E00
pentose-phosphate shunt (GO:0006098)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
glyoxylate cycle (GO:0006097)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
gluconeogenesis (GO:0006094)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein localization to cell surface (GO:2000009)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
positive regulation of chondrocyte differentiation (GO:0032332)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
negative regulation of sterol biosynthetic process (GO:0106119)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of protein localization to cell surface (GO:2000008)	18	0	.49	-	 < 0.01	1.00E00	1.00E00
negative regulation of chondrocyte differentiation (GO:0032331)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
regulation of sterol biosynthetic process (GO:0106118)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
negative regulation of metanephric comma-shaped body morphogenesis (GO:2000007)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of chondrocyte differentiation (GO:0032330)	33	0	.90	-	 < 0.01	1.00E00	1.00E00
regulation of metanephric comma-shaped body morphogenesis (GO:2000006)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of metanephric S-shaped body morphogenesis (GO:2000005)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of metanephric S-shaped body morphogenesis (GO:2000004)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of DNA damage checkpoint (GO:2000003)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of DNA damage checkpoint (GO:2000002)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of DNA damage checkpoint (GO:2000001)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
peptidyl-lysine oxidation (GO:0018057)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
lactate metabolic process (GO:0006089)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
acetyl-CoA biosynthetic process from pyruvate (GO:0006086)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
acetyl-CoA biosynthetic process (GO:0006085)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
serine transport (GO:0032329)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
acetyl-CoA metabolic process (GO:0006084)	24	0	.66	-	 < 0.01	1.00E00	1.00E00
acetate metabolic process (GO:0006083)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
molybdopterin cofactor biosynthetic process (GO:0032324)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of glutamate receptor clustering (GO:0106104)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
ER-dependent peroxisome localization (GO:0106101)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
glycerol-3-phosphate metabolic process (GO:0006072)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
glycerol metabolic process (GO:0006071)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
prostaglandin secretion (GO:0032310)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
syncytium formation by plasma membrane fusion (GO:0000768)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
ethanol oxidation (GO:0006069)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
ethanol catabolic process (GO:0006068)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
ethanol metabolic process (GO:0006067)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
UDP-glucuronate biosynthetic process (GO:0006065)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
icosanoid secretion (GO:0032309)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
glucuronate catabolic process (GO:0006064)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of prostaglandin secretion (GO:0032308)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
uronic acid metabolic process (GO:0006063)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of prostaglandin secretion (GO:0032307)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
sorbitol catabolic process (GO:0006062)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of prostaglandin secretion (GO:0032306)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
sorbitol biosynthetic process (GO:0006061)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of icosanoid secretion (GO:0032305)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
sorbitol metabolic process (GO:0006060)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of icosanoid secretion (GO:0032304)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of icosanoid secretion (GO:0032303)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
peptidyl-lysine dimethylation (GO:0018027)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
peptidyl-lysine monomethylation (GO:0018026)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
peptidyl-lysine trimethylation (GO:0018023)	24	0	.66	-	 < 0.01	1.00E00	1.00E00
peptidyl-lysine methylation (GO:0018022)	57	0	1.56	-	 < 0.01	4.07E-01	1.00E00
peptidyl-histidine methylation (GO:0018021)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
hexitol metabolic process (GO:0006059)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
mannoprotein biosynthetic process (GO:0006057)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mannoprotein metabolic process (GO:0006056)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
N-acetylneuraminate metabolic process (GO:0006054)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
N-acetylmannosamine metabolic process (GO:0006051)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mannosamine metabolic process (GO:0006050)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of intraciliary retrograde transport (GO:1905799)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
N-terminal peptidyl-proline dimethylation (GO:0018016)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
RNA 3' uridylation (GO:0071076)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
N-terminal peptidyl-glycine methylation (GO:0018013)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of phospholipid biosynthetic process (GO:0071073)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
N-terminal peptidyl-alanine trimethylation (GO:0018012)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein localization to pericentriolar material (GO:1905793)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
N-terminal peptidyl-alanine methylation (GO:0018011)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
UDP-N-acetylglucosamine biosynthetic process (GO:0006048)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
UDP-N-acetylglucosamine metabolic process (GO:0006047)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
N-acetylglucosamine catabolic process (GO:0006046)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of stress fiber assembly (GO:0051497)	17	0	.47	-	 < 0.01	1.00E00	1.00E00
positive regulation of stress fiber assembly (GO:0051496)	35	0	.96	-	 < 0.01	1.00E00	1.00E00
N-acetylglucosamine metabolic process (GO:0006044)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
positive regulation of cytoskeleton organization (GO:0051495)	146	0	4.00	-	 < 0.01	3.49E-02	1.00E00
glucosamine catabolic process (GO:0006043)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
glucosamine biosynthetic process (GO:0006042)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
glucosamine metabolic process (GO:0006041)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of stress fiber assembly (GO:0051492)	58	0	1.59	-	 < 0.01	4.09E-01	1.00E00
positive regulation of filopodium assembly (GO:0051491)	18	0	.49	-	 < 0.01	1.00E00	1.00E00
negative regulation of filopodium assembly (GO:0051490)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
protein K33-linked ubiquitination (GO:1990390)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of detection of mechanical stimulus involved in sensory perception of touch (GO:1905788)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of detection of mechanical stimulus involved in sensory perception of touch (GO:1905787)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of anaphase-promoting complex-dependent catabolic process (GO:1905786)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
DNA catabolic process, exonucleolytic (GO:0000738)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
DNA catabolic process, endonucleolytic (GO:0000737)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
regulation of anaphase-promoting complex-dependent catabolic process (GO:1905784)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
removal of nonhomologous ends (GO:0000735)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
DNA strand renaturation (GO:0000733)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
NMDA selective glutamate receptor signaling pathway (GO:0098989)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
strand displacement (GO:0000732)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of filopodium assembly (GO:0051489)	29	0	.80	-	 < 0.01	1.00E00	1.00E00
hyaloid vascular plexus regression (GO:1990384)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of cytosolic calcium ion concentration (GO:0051481)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of exonuclease activity (GO:1905778)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of exonuclease activity (GO:1905777)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
DNA double-strand break processing (GO:0000729)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
positive regulation of DNA helicase activity (GO:1905776)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of DNA helicase activity (GO:1905775)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
double-strand break repair via break-induced replication (GO:0000727)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
regulation of DNA helicase activity (GO:1905774)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
non-recombinational repair (GO:0000726)	35	0	.96	-	 < 0.01	1.00E00	1.00E00
sno(s)RNA polyadenylation (GO:0071050)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of mesodermal cell differentiation (GO:1905771)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
proteoglycan metabolic process (GO:0006029)	21	0	.58	-	 < 0.01	1.00E00	1.00E00
regulation of mesodermal cell differentiation (GO:1905770)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
glycosaminoglycan catabolic process (GO:0006027)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
pyrimidine dimer repair by nucleotide-excision repair (GO:0000720)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
excitatory chemical synaptic transmission (GO:0098976)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
glycosaminoglycan biosynthetic process (GO:0006024)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
postsynaptic actin cytoskeleton organization (GO:0098974)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
aminoglycan biosynthetic process (GO:0006023)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
anterograde dendritic transport of mitochondrion (GO:0098972)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
inositol biosynthetic process (GO:0006021)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
anterograde dendritic transport of neurotransmitter receptor complex (GO:0098971)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
inositol metabolic process (GO:0006020)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
postsynaptic neurotransmitter receptor diffusion trapping (GO:0098970)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription (GO:0071049)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
nuclear retention of unspliced pre-mRNA at the site of transcription (GO:0071048)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
polyadenylation-dependent mRNA catabolic process (GO:0071047)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of double-stranded telomeric DNA binding (GO:1905768)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
nuclear polyadenylation-dependent ncRNA catabolic process (GO:0071046)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of double-stranded telomeric DNA binding (GO:1905767)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of protection from non-homologous end joining at telomere (GO:1905765)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
nucleotide-excision repair, DNA duplex unwinding (GO:0000717)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
CUT metabolic process (GO:0071043)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of protection from non-homologous end joining at telomere (GO:1905764)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
nuclear polyadenylation-dependent mRNA catabolic process (GO:0071042)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
nucleotide-excision repair, DNA damage recognition (GO:0000715)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
antisense RNA transcript catabolic process (GO:0071041)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
nuclear polyadenylation-dependent antisense transcript catabolic process (GO:0071040)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
neurotransmitter receptor transport to postsynaptic membrane (GO:0098969)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
meiotic DNA repair synthesis (GO:0000711)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
exocytic insertion of neurotransmitter receptor to postsynaptic membrane (GO:0098967)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
meiotic mismatch repair (GO:0000710)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
5-phosphoribose 1-diphosphate biosynthetic process (GO:0006015)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of corticotropin-releasing hormone secretion (GO:0051466)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
D-ribose metabolic process (GO:0006014)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
anterograde dendritic transport of messenger ribonucleoprotein complex (GO:0098964)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
mannose metabolic process (GO:0006013)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
positive regulation of cortisol secretion (GO:0051464)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
dendritic transport of messenger ribonucleoprotein complex (GO:0098963)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
galactose metabolic process (GO:0006012)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of cortisol secretion (GO:0051463)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of postsynaptic neurotransmitter receptor activity (GO:0098962)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
UDP-glucose metabolic process (GO:0006011)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of cortisol secretion (GO:0051462)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
dendritic transport of ribonucleoprotein complex (GO:0098961)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of corticotropin secretion (GO:0051461)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
nuclear polyadenylation-dependent CUT catabolic process (GO:0071039)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
nuclear polyadenylation-dependent tRNA catabolic process (GO:0071038)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
nuclear polyadenylation-dependent snRNA catabolic process (GO:0071037)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
nuclear polyadenylation-dependent snoRNA catabolic process (GO:0071036)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
nuclear polyadenylation-dependent rRNA catabolic process (GO:0071035)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
CUT catabolic process (GO:0071034)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
meiotic DNA recombinase assembly (GO:0000707)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
nuclear retention of pre-mRNA at the site of transcription (GO:0071033)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
meiotic DNA double-strand break processing (GO:0000706)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
nuclear mRNA surveillance of mRNA 3'-end processing (GO:0071031)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
nuclear mRNA surveillance of spliceosomal pre-mRNA splicing (GO:0071030)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of endosome to plasma membrane protein transport (GO:1905751)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of corticotropin secretion (GO:0051459)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
retrograde axonal transport of mitochondrion (GO:0098958)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell fate specification (GO:0009996)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
anterograde axonal transport of mitochondrion (GO:0098957)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
maintenance of protein location in nucleus (GO:0051457)	20	0	.55	-	 < 0.01	1.00E00	1.00E00
oocyte differentiation (GO:0009994)	26	0	.71	-	 < 0.01	1.00E00	1.00E00
fucose metabolic process (GO:0006004)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
monopolar spindle attachment to meiosis I kinetochore (GO:0051455)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
fructose 2,6-bisphosphate metabolic process (GO:0006003)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
cellular water homeostasis (GO:0009992)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
receptor diffusion trapping (GO:0098953)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
fructose 6-phosphate metabolic process (GO:0006002)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
fructose catabolic process (GO:0006001)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
fructose metabolic process (GO:0006000)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
myoblast migration (GO:0051451)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
myoblast proliferation (GO:0051450)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
nuclear ncRNA surveillance (GO:0071029)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of endosome to plasma membrane protein transport (GO:1905749)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
hard palate morphogenesis (GO:1905748)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cytoplasmic RNA surveillance (GO:0071026)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of saliva secretion (GO:1905747)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cell-cell recognition (GO:0009988)	24	0	.66	-	 < 0.01	1.00E00	1.00E00
negative regulation of transforming growth factor beta activation (GO:1901389)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of transforming growth factor beta activation (GO:1901388)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of voltage-gated calcium channel activity (GO:1901387)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
negative regulation of meiotic cell cycle (GO:0051447)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
negative regulation of voltage-gated calcium channel activity (GO:1901386)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of meiotic cell cycle (GO:0051446)	20	0	.55	-	 < 0.01	1.00E00	1.00E00
regulation of voltage-gated calcium channel activity (GO:1901385)	19	0	.52	-	 < 0.01	1.00E00	1.00E00
regulation of meiotic cell cycle (GO:0051445)	41	0	1.12	-	 < 0.01	6.28E-01	1.00E00
negative regulation of ubiquitin-protein transferase activity (GO:0051444)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
neurotransmitter receptor transport, postsynaptic endosome to lysosome (GO:0098943)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of chorionic trophoblast cell proliferation (GO:1901383)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of ubiquitin-protein transferase activity (GO:0051443)	18	0	.49	-	 < 0.01	1.00E00	1.00E00
positive regulation of potassium ion transmembrane transport (GO:1901381)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
negative regulation of potassium ion transmembrane transport (GO:1901380)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
telomeric 3' overhang formation (GO:0031860)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
dendritic transport of mitochondrion (GO:0098939)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
organic heteropentacyclic compound catabolic process (GO:1901377)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
organic heteropentacyclic compound metabolic process (GO:1901376)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
acetate ester transport (GO:1901374)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cytidine deamination (GO:0009972)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
lipid hydroperoxide transport (GO:1901373)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
axonal transport (GO:0098930)	40	0	1.10	-	 < 0.01	6.28E-01	1.00E00
protein localization to microtubule end (GO:1905725)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
presynaptic signal transduction (GO:0098928)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
vesicle-mediated transport between endosomal compartments (GO:0098927)	17	0	.47	-	 < 0.01	1.00E00	1.00E00
retrograde trans-synaptic signaling by nitric oxide, modulating synaptic transmission (GO:0098925)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
retrograde trans-synaptic signaling by nitric oxide (GO:0098924)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
retrograde trans-synaptic signaling by soluble gas (GO:0098923)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
protection from non-homologous end joining at telomere (GO:0031848)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
protein localization to perinuclear region of cytoplasm (GO:1905719)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of membrane permeability (GO:1905710)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
epidermal cell fate specification (GO:0009957)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
microtubule nucleation by microtubule organizing center (GO:0051418)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
retrograde trans-synaptic signaling (GO:0098917)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
proximal/distal pattern formation (GO:0009954)	17	0	.47	-	 < 0.01	1.00E00	1.00E00
response to rapamycin (GO:1901355)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
dorsal/ventral pattern formation (GO:0009953)	51	0	1.40	-	 < 0.01	6.47E-01	1.00E00
microtubule nucleation by interphase microtubule organizing center (GO:0051415)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to cortisol (GO:0051414)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to insulin-like growth factor stimulus (GO:1990314)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
membrane depolarization during atrial cardiac muscle cell action potential (GO:0098912)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
dorsal/ventral axis specification (GO:0009950)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
response to corticosterone (GO:0051412)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of ventricular cardiac muscle cell action potential (GO:0098911)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of atrial cardiac muscle cell action potential (GO:0098910)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
detoxification of nitrogen compound (GO:0051410)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of membrane permeability (GO:1905709)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of glomerulus development (GO:0090194)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of glomerulus development (GO:0090193)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of glomerulus development (GO:0090192)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of branching involved in ureteric bud morphogenesis (GO:0090191)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
polarity specification of anterior/posterior axis (GO:0009949)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
anterior/posterior axis specification (GO:0009948)	32	0	.88	-	 < 0.01	1.00E00	1.00E00
regulation of cardiac muscle cell action potential involved in regulation of contraction (GO:0098909)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to nitrosative stress (GO:0051409)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of neuronal action potential (GO:0098908)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
proximal/distal axis specification (GO:0009946)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of SA node cell action potential (GO:0098907)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of vasculature development involved in avascular cornea development in camera-type eye (GO:1901346)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of AV node cell action potential (GO:0098904)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to leptomycin B (GO:1901344)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of membrane repolarization during action potential (GO:0098903)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of vasculature development (GO:1901343)	52	0	1.43	-	 < 0.01	4.05E-01	1.00E00
regulation of membrane depolarization during action potential (GO:0098902)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of cardiac muscle cell action potential (GO:0098901)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of store-operated calcium channel activity (GO:1901341)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of action potential (GO:0098900)	19	0	.52	-	 < 0.01	1.00E00	1.00E00
negative regulation of store-operated calcium channel activity (GO:1901340)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of branching involved in ureteric bud morphogenesis (GO:0090189)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
negative regulation of pancreatic juice secretion (GO:0090188)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
positive regulation of pancreatic juice secretion (GO:0090187)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of pancreatic juice secretion (GO:0090186)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
negative regulation of kidney development (GO:0090185)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of kidney development (GO:0090184)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of kidney development (GO:0090183)	22	0	.60	-	 < 0.01	1.00E00	1.00E00
regulation of secretion of lysosomal enzymes (GO:0090182)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of cholesterol metabolic process (GO:0090181)	18	0	.49	-	 < 0.01	1.00E00	1.00E00
regulation of store-operated calcium channel activity (GO:1901339)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
positive regulation of odontoblast differentiation (GO:1901331)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
planar cell polarity pathway involved in neural tube closure (GO:0090179)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of establishment of planar polarity involved in neural tube closure (GO:0090178)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
microtubule cytoskeleton organization involved in establishment of planar polarity (GO:0090176)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of establishment of planar polarity (GO:0090175)	20	0	.55	-	 < 0.01	1.00E00	1.00E00
organelle membrane fusion (GO:0090174)	43	0	1.18	-	 < 0.01	6.31E-01	1.00E00
microtubule cytoskeleton organization involved in homologous chromosome segregation (GO:0090172)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of Golgi inheritance (GO:0090170)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of odontoblast differentiation (GO:1901329)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
dendrite self-avoidance (GO:0070593)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
Golgi reassembly (GO:0090168)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
Golgi disassembly (GO:0090166)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
asymmetric Golgi ribbon formation (GO:0090164)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
establishment of epithelial cell polarity (GO:0090162)	19	0	.52	-	 < 0.01	1.00E00	1.00E00
Golgi ribbon formation (GO:0090161)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
Golgi to lysosome transport (GO:0090160)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
cellular component macromolecule biosynthetic process (GO:0070589)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
calcium ion transmembrane transport (GO:0070588)	24	0	.66	-	 < 0.01	1.00E00	1.00E00
cell-cell adhesion involved in gastrulation (GO:0070586)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein localization to mitochondrion (GO:0070585)	37	0	1.01	-	 < 0.01	6.26E-01	1.00E00
negative regulation of flagellated sperm motility (GO:1901318)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mitochondrion morphogenesis (GO:0070584)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
regulation of flagellated sperm motility (GO:1901317)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
negative regulation of histone H2A K63-linked ubiquitination (GO:1901315)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
auditory receptor cell fate commitment (GO:0009912)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of histone H2A K63-linked ubiquitination (GO:1901314)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of collateral sprouting in absence of injury (GO:0048698)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of collateral sprouting in absence of injury (GO:0048696)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular sphingolipid homeostasis (GO:0090156)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of sphingolipid biosynthetic process (GO:0090155)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter (GO:0001193)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of axon extension involved in regeneration (GO:0048692)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of sphingolipid biosynthetic process (GO:0090154)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
maintenance of transcriptional fidelity during DNA-templated transcription elongation (GO:0001192)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of axon extension involved in regeneration (GO:0048691)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of sphingolipid biosynthetic process (GO:0090153)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
regulation of axon extension involved in regeneration (GO:0048690)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
establishment of protein localization to mitochondrial membrane involved in mitochondrial fission (GO:0090152)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
establishment of protein localization to mitochondrial membrane (GO:0090151)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
positive regulation of spermidine biosynthetic process (GO:1901307)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of neuron projection regeneration (GO:0070572)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
negative regulation of neuron projection regeneration (GO:0070571)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of spermidine biosynthetic process (GO:1901304)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of neuron projection regeneration (GO:0070570)	17	0	.47	-	 < 0.01	1.00E00	1.00E00
negative regulation of cargo loading into COPII-coated vesicle (GO:1901303)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of cargo loading into COPII-coated vesicle (GO:1901301)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of hydrogen peroxide-mediated programmed cell death (GO:1901300)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of lipid catabolic process (GO:0050996)	17	0	.47	-	 < 0.01	1.00E00	1.00E00
negative regulation of lipid catabolic process (GO:0050995)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
regulation of lipid catabolic process (GO:0050994)	36	0	.99	-	 < 0.01	1.00E00	1.00E00
negative regulation of sprouting of injured axon (GO:0048688)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
RNA polymerase I preinitiation complex assembly (GO:0001188)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of sprouting of injured axon (GO:0048687)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
mitochondrial membrane fission (GO:0090149)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of sprouting of injured axon (GO:0048686)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
membrane fission (GO:0090148)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
sprouting of injured axon (GO:0048682)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mitochondrial nucleoid organization (GO:0090144)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of axon regeneration (GO:0048681)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
nucleoid organization (GO:0090143)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of axon regeneration (GO:0048680)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
positive regulation of mitochondrial fission (GO:0090141)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of mitochondrial fission (GO:0090140)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
positive regulation of vitamin D receptor signaling pathway (GO:0070564)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of vitamin D receptor signaling pathway (GO:0070563)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of vitamin D receptor signaling pathway (GO:0070562)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
vitamin D receptor signaling pathway (GO:0070561)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein secretion by platelet (GO:0070560)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of axon regeneration (GO:0048679)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
detection of mechanical stimulus (GO:0050982)	18	0	.49	-	 < 0.01	1.00E00	1.00E00
response to axon injury (GO:0048678)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
axon extension involved in regeneration (GO:0048677)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
axon extension (GO:0048675)	21	0	.58	-	 < 0.01	1.00E00	1.00E00
epithelial cell-cell adhesion (GO:0090136)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
transcriptional start site selection at RNA polymerase II promoter (GO:0001174)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
actin filament branching (GO:0090135)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
DNA-templated transcriptional start site selection (GO:0001173)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
transcription, RNA-templated (GO:0001172)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of collateral sprouting (GO:0048671)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
sensory perception of touch (GO:0050975)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
detection of mechanical stimulus involved in sensory perception (GO:0050974)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
detection of mechanical stimulus involved in equilibrioception (GO:0050973)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of synapse maturation (GO:0090129)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of synapse maturation (GO:0090128)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
neuron fate specification (GO:0048665)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
neuron fate determination (GO:0048664)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
neuron fate commitment (GO:0048663)	38	0	1.04	-	 < 0.01	6.27E-01	1.00E00
negative regulation of smooth muscle cell proliferation (GO:0048662)	33	0	.90	-	 < 0.01	1.00E00	1.00E00
histone H3-K36 demethylation (GO:0070544)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
response to fatty acid (GO:0070542)	18	0	.49	-	 < 0.01	1.00E00	1.00E00
detection of chemical stimulus involved in sensory perception of pain (GO:0050968)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
detection of mechanical stimulus involved in sensory perception of pain (GO:0050966)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
smooth muscle cell proliferation (GO:0048659)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
detection of light stimulus involved in sensory perception (GO:0050962)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
vesicle-mediated cholesterol transport (GO:0090119)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
receptor-mediated endocytosis involved in cholesterol transport (GO:0090118)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
C-5 methylation of cytosine (GO:0090116)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of ER to Golgi vesicle-mediated transport by GTP hydrolysis (GO:0090113)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
histone H2A K63-linked deubiquitination (GO:0070537)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
protein K63-linked deubiquitination (GO:0070536)	26	0	.71	-	 < 0.01	1.00E00	1.00E00
histone H2A K63-linked ubiquitination (GO:0070535)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein K63-linked ubiquitination (GO:0070534)	25	0	.69	-	 < 0.01	1.00E00	1.00E00
equilibrioception (GO:0050957)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
thermoception (GO:0050955)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of high-density lipoprotein particle assembly (GO:0090108)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
animal organ formation (GO:0048645)	22	0	.60	-	 < 0.01	1.00E00	1.00E00
regulation of high-density lipoprotein particle assembly (GO:0090107)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of skeletal muscle tissue development (GO:0048643)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
pancreatic epsilon cell differentiation (GO:0090104)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cochlea morphogenesis (GO:0090103)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
cochlea development (GO:0090102)	25	0	.69	-	 < 0.01	1.00E00	1.00E00
positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100)	68	0	1.86	-	 < 0.01	2.66E-01	1.00E00
platelet aggregation (GO:0070527)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
positive regulation of pigment cell differentiation (GO:0050942)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
positive regulation of muscle organ development (GO:0048636)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
positive regulation of skeletal muscle tissue growth (GO:0048633)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of skeletal muscle tissue growth (GO:0048632)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of skeletal muscle tissue growth (GO:0048631)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
cellular carbohydrate catabolic process (GO:0044275)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
sulfur compound biosynthetic process (GO:0044272)	48	0	1.32	-	 < 0.01	6.40E-01	1.00E00
regulation of pigment cell differentiation (GO:0050932)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
pigment cell differentiation (GO:0050931)	20	0	.55	-	 < 0.01	1.00E00	1.00E00
myoblast development (GO:0048627)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
induction of positive chemotaxis (GO:0050930)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
myoblast fate commitment (GO:0048625)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
post-embryonic digestive tract morphogenesis (GO:0048621)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
glycerol ether catabolic process (GO:0044269)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
protein-DNA complex remodeling (GO:0001120)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
calcium ion import (GO:0070509)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
cholesterol import (GO:0070508)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of DNA-dependent DNA replication initiation (GO:0032298)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
poly-gamma-glutamate metabolic process (GO:0070500)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
induction of negative chemotaxis (GO:0050929)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
peripheral nervous system axon ensheathment (GO:0032292)	17	0	.47	-	 < 0.01	1.00E00	1.00E00
positive regulation of positive chemotaxis (GO:0050927)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
axon ensheathment in central nervous system (GO:0032291)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
regulation of positive chemotaxis (GO:0050926)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
peripheral nervous system myelin formation (GO:0032290)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of negative chemotaxis (GO:0050925)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
histone succinylation (GO:0106077)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of negative chemotaxis (GO:0050924)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mitochondrial RNA modification (GO:1900864)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of negative chemotaxis (GO:0050923)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
embryonic hindgut morphogenesis (GO:0048619)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of chemotaxis (GO:0050922)	21	0	.58	-	 < 0.01	1.00E00	1.00E00
aminoacyl-tRNA metabolism involved in translational fidelity (GO:0106074)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
embryonic foregut morphogenesis (GO:0048617)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0106072)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0106071)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0106070)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
transcription open complex formation at RNA polymerase II promoter (GO:0001113)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
DNA-templated transcription open complex formation (GO:0001112)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
embryonic ectodermal digestive tract development (GO:0048611)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
central nervous system myelin formation (GO:0032289)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
myelin assembly (GO:0032288)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
peripheral nervous system myelin maintenance (GO:0032287)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
central nervous system myelin maintenance (GO:0032286)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative chemotaxis (GO:0050919)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
sensory perception of umami taste (GO:0050917)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
sensory perception of sweet taste (GO:0050916)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
sensory perception of sour taste (GO:0050915)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
sensory perception of bitter taste (GO:0050913)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
detection of chemical stimulus involved in sensory perception of taste (GO:0050912)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of cobalamin metabolic process (GO:0106064)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
detection of mechanical stimulus involved in sensory perception of sound (GO:0050910)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
negative regulation of exit from mitosis (GO:0001100)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular polysaccharide catabolic process (GO:0044247)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
lipid digestion (GO:0044241)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of gonadotropin secretion (GO:0032277)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
luteinizing hormone secretion (GO:0032275)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
gonadotropin secretion (GO:0032274)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
sensory perception of taste (GO:0050909)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein polymerization (GO:0032273)	85	0	2.33	-	 < 0.01	1.76E-01	1.00E00
detection of light stimulus involved in visual perception (GO:0050908)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
detection of chemical stimulus involved in sensory perception (GO:0050907)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
neuromuscular process (GO:0050905)	62	0	1.70	-	 < 0.01	4.15E-01	1.00E00
negative regulation of calcineurin-mediated signaling (GO:0106057)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
diapedesis (GO:0050904)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
leukocyte tethering or rolling (GO:0050901)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
IMP salvage (GO:0032264)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
pyrimidine nucleotide salvage (GO:0032262)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of cellular response to osmotic stress (GO:0106049)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
purine nucleotide salvage (GO:0032261)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
spermidine deacetylation (GO:0106048)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
polyamine deacetylation (GO:0106047)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
guanine deglycation, glyoxal removal (GO:0106046)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
guanine deglycation, methylglyoxal removal (GO:0106045)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
guanine deglycation (GO:0106044)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
establishment of secretory granule localization (GO:0032254)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
dense core granule localization (GO:0032253)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
secretory granule localization (GO:0032252)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
positive regulation of membrane depolarization during cardiac muscle cell action potential (GO:1900827)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of membrane depolarization during cardiac muscle cell action potential (GO:1900825)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
neuron projection fasciculation (GO:0106030)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
positive regulation of nucleobase-containing compound transport (GO:0032241)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of nucleobase-containing compound transport (GO:0032240)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of vesicle docking (GO:0106022)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of vesicle docking (GO:0106020)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
AMP salvage (GO:0044209)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
'de novo' AMP biosynthetic process (GO:0044208)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
UMP salvage (GO:0044206)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
'de novo' UMP biosynthetic process (GO:0044205)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of nucleobase-containing compound transport (GO:0032239)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
activation of store-operated calcium channel activity (GO:0032237)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of actin filament bundle assembly (GO:0032233)	45	0	1.23	-	 < 0.01	6.34E-01	1.00E00
negative regulation of actin filament bundle assembly (GO:0032232)	20	0	.55	-	 < 0.01	1.00E00	1.00E00
regulation of actin filament bundle assembly (GO:0032231)	71	0	1.95	-	 < 0.01	2.67E-01	1.00E00
positive regulation of synaptic transmission, GABAergic (GO:0032230)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of synaptic transmission, GABAergic (GO:0032229)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of synaptic transmission, GABAergic (GO:0032228)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
negative regulation of synaptic transmission, dopaminergic (GO:0032227)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of synaptic transmission, dopaminergic (GO:0032226)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of synaptic transmission, dopaminergic (GO:0032225)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of synaptic transmission, cholinergic (GO:0032224)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of synaptic transmission, cholinergic (GO:0032222)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
intestinal hexose absorption (GO:0106001)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of telomere maintenance via telomerase (GO:0032212)	27	0	.74	-	 < 0.01	1.00E00	1.00E00
negative regulation of telomere maintenance via telomerase (GO:0032211)	17	0	.47	-	 < 0.01	1.00E00	1.00E00
regulation of telomere maintenance via telomerase (GO:0032210)	43	0	1.18	-	 < 0.01	6.31E-01	1.00E00
negative regulation of telomere maintenance via recombination (GO:0032208)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of telomere maintenance via recombination (GO:0032207)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of telomere maintenance (GO:0032206)	44	0	1.21	-	 < 0.01	6.32E-01	1.00E00
negative regulation of telomere maintenance (GO:0032205)	31	0	.85	-	 < 0.01	1.00E00	1.00E00
telomere formation via telomerase (GO:0032203)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
telomere assembly (GO:0032202)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
telomere maintenance via semi-conservative replication (GO:0032201)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of polysome binding (GO:1905698)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of polysome binding (GO:1905696)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of phosphatidic acid biosynthetic process (GO:1905695)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of phosphatidic acid biosynthetic process (GO:1905693)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of plasma membrane repair (GO:1905684)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of neurotrophin TRK receptor signaling pathway (GO:0051388)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
neurotransmitter receptor transport, endosome to postsynaptic membrane (GO:0098887)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
negative regulation of neurotrophin TRK receptor signaling pathway (GO:0051387)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
modification of dendritic spine (GO:0098886)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of neurotrophin TRK receptor signaling pathway (GO:0051386)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
response to mineralocorticoid (GO:0051385)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
postsynaptic neurotransmitter receptor internalization (GO:0098884)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
synapse pruning (GO:0098883)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
maintenance of postsynaptic specialization structure (GO:0098880)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
RNA localization to chromatin (GO:1990280)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of lysosome organization (GO:1905673)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of lysosome organization (GO:1905672)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of lysosome organization (GO:1905671)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
neurotransmitter receptor transport to plasma membrane (GO:0098877)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
vesicle-mediated transport to the plasma membrane (GO:0098876)	59	0	1.62	-	 < 0.01	4.10E-01	1.00E00
positive regulation of protein localization to endosome (GO:1905668)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein localization to endosome (GO:1905667)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of protein localization to endosome (GO:1905666)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
regulation of calcium ion import across plasma membrane (GO:1905664)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of telomerase RNA reverse transcriptase activity (GO:1905663)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of telomerase RNA reverse transcriptase activity (GO:1905662)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular oxidant detoxification (GO:0098869)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
regulation of telomerase RNA reverse transcriptase activity (GO:1905661)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
bone growth (GO:0098868)	18	0	.49	-	 < 0.01	1.00E00	1.00E00
intramembranous bone growth (GO:0098867)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to transition metal nanoparticle (GO:1990267)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to potassium ion starvation (GO:0051365)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
neutrophil migration (GO:1990266)	24	0	.66	-	 < 0.01	1.00E00	1.00E00
peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity (GO:1990264)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
pre-mRNA catabolic process (GO:1990261)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of artery morphogenesis (GO:1905653)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of artery morphogenesis (GO:1905651)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of hydrogen peroxide-mediated programmed cell death (GO:1901299)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of hydrogen peroxide-mediated programmed cell death (GO:1901298)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
intestinal lipid absorption (GO:0098856)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment (GO:1901297)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
histone glutamine methylation (GO:1990258)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment (GO:1901295)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of oxidoreductase activity (GO:0051354)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
negative regulation of ligase activity (GO:0051352)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to leucine starvation (GO:1990253)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
positive regulation of ligase activity (GO:0051351)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of lyase activity (GO:0051350)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of DNA methylation (GO:1905643)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of DNA methylation (GO:1905642)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of lyase activity (GO:0051349)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
post-embryonic animal morphogenesis (GO:0009886)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
regulation of transcription from RNA polymerase II promoter in response to DNA damage (GO:1990248)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of cyclic-nucleotide phosphodiesterase activity (GO:0051344)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
histone H2A-T120 phosphorylation (GO:1990245)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of cyclic-nucleotide phosphodiesterase activity (GO:0051343)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
embryonic pattern specification (GO:0009880)	29	0	.80	-	 < 0.01	1.00E00	1.00E00
regulation of cyclic-nucleotide phosphodiesterase activity (GO:0051342)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
protein transport along microtubule (GO:0098840)	54	0	1.48	-	 < 0.01	4.05E-01	1.00E00
regulation of ligase activity (GO:0051340)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1905636)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of protein localization to chromatin (GO:1905634)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
cellular response to glyceraldehyde (GO:1905631)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of lyase activity (GO:0051339)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
folate transmembrane transport (GO:0098838)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to glyceraldehyde (GO:1905630)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of serotonin biosynthetic process (GO:1905627)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mitotic interphase (GO:0051329)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
modulation of inhibitory postsynaptic potential (GO:0098828)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
paranodal junction maintenance (GO:1990227)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
interphase (GO:0051325)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
prophase (GO:0051324)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
carbohydrate derivative transport (GO:1901264)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
metaphase (GO:0051323)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of miRNA mediated inhibition of translation (GO:1905618)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of miRNA mediated inhibition of translation (GO:1905616)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
G2 phase (GO:0051319)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
G1 phase (GO:0051318)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of macrophage colony-stimulating factor production (GO:1901258)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
attachment of spindle microtubules to kinetochore involved in meiotic chromosome segregation (GO:0051316)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
modulation of excitatory postsynaptic potential (GO:0098815)	23	0	.63	-	 < 0.01	1.00E00	1.00E00
regulation of macrophage colony-stimulating factor production (GO:1901256)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
spontaneous synaptic transmission (GO:0098814)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
nucleotide-excision repair involved in interstrand cross-link repair (GO:1901255)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of intracellular transport of viral material (GO:1901254)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of intracellular transport of viral material (GO:1901252)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
meiotic metaphase plate congression (GO:0051311)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
neurotransmitter reuptake (GO:0098810)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of lung goblet cell differentiation (GO:1901250)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of metanephric cap mesenchymal cell proliferation (GO:0090096)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of metanephric cap mesenchymal cell proliferation (GO:0090095)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
metanephric cap mesenchymal cell proliferation involved in metanephros development (GO:0090094)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of smooth muscle cell-matrix adhesion (GO:1905609)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of presynapse assembly (GO:1905606)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
positive regulation of blood-brain barrier permeability (GO:1905605)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of blood-brain barrier permeability (GO:1905604)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of blood-brain barrier permeability (GO:1905603)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
positive regulation of receptor-mediated endocytosis involved in cholesterol transport (GO:1905602)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
female meiosis chromosome separation (GO:0051309)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of lung goblet cell differentiation (GO:1901249)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of receptor-mediated endocytosis involved in cholesterol transport (GO:1905600)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
male meiosis chromosome separation (GO:0051308)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of lung ciliated cell differentiation (GO:1901248)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mitotic sister chromatid separation (GO:0051306)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of lung ciliated cell differentiation (GO:1901246)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
chromosome movement towards spindle pole (GO:0051305)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of dipeptide transport (GO:0090089)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of oligopeptide transport (GO:0090088)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein deubiquitination (GO:0090086)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of protein deubiquitination (GO:0090085)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
negative regulation of inclusion body assembly (GO:0090084)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of inclusion body assembly (GO:0090083)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
regulation of heart induction by regulation of canonical Wnt signaling pathway (GO:0090081)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
abscission (GO:0009838)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of convergent extension involved in axis elongation (GO:1901233)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of convergent extension involved in axis elongation (GO:1901232)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of non-canonical Wnt signaling pathway via JNK cascade (GO:1901231)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
relaxation of skeletal muscle (GO:0090076)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
relaxation of muscle (GO:0090075)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
negative regulation of ribosome biogenesis (GO:0090071)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
interleukin-1-mediated signaling pathway (GO:0070498)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
regulation of non-canonical Wnt signaling pathway via JNK cascade (GO:1901229)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
unidimensional cell growth (GO:0009826)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of thrombin-activated receptor signaling pathway (GO:0070495)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of transcription from RNA polymerase II promoter involved in heart development (GO:1901228)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of thrombin-activated receptor signaling pathway (GO:0070494)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
thrombin-activated receptor signaling pathway (GO:0070493)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of NIK/NF-kappaB signaling (GO:1901224)	39	0	1.07	-	 < 0.01	6.27E-01	1.00E00
negative regulation of NIK/NF-kappaB signaling (GO:1901223)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
regulation of NIK/NF-kappaB signaling (GO:1901222)	58	0	1.59	-	 < 0.01	4.09E-01	1.00E00
regulation of ribosome biogenesis (GO:0090069)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of production of siRNA involved in RNA interference (GO:0090065)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of microtubule nucleation (GO:0090063)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
T cell aggregation (GO:0070489)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
monocyte aggregation (GO:0070487)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
leukocyte aggregation (GO:0070486)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
detection of hypoxia (GO:0070483)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
flavonoid metabolic process (GO:0009812)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
nuclear-transcribed mRNA catabolic process, non-stop decay (GO:0070481)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of transcription from RNA polymerase II promoter involved in heart development (GO:1901213)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
stilbene metabolic process (GO:0009810)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
oocyte development (GO:0048599)	24	0	.66	-	 < 0.01	1.00E00	1.00E00
post-embryonic camera-type eye morphogenesis (GO:0048597)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
embryonic camera-type eye morphogenesis (GO:0048596)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay (GO:0070478)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of uterine smooth muscle contraction (GO:0070474)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
coumarin metabolic process (GO:0009804)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of uterine smooth muscle contraction (GO:0070472)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
uterine smooth muscle contraction (GO:0070471)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of extracellular matrix assembly (GO:1901203)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
regulation of extracellular matrix assembly (GO:1901201)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
determination of affect (GO:0050894)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
sensory processing (GO:0050893)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
intestinal absorption (GO:0050892)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
positive regulation of deacetylase activity (GO:0090045)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
positive regulation of tubulin deacetylation (GO:0090044)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of tubulin deacetylation (GO:0090043)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
tubulin deacetylation (GO:0090042)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
nitrogen catabolite activation of transcription from RNA polymerase II promoter (GO:0001080)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
plus-end specific microtubule depolymerization (GO:0070462)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
endocrine process (GO:0050886)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
neuromuscular process controlling balance (GO:0050885)	34	0	.93	-	 < 0.01	1.00E00	1.00E00
neuromuscular process controlling posture (GO:0050884)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
voluntary musculoskeletal movement (GO:0050882)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
nitrogen catabolite regulation of transcription from RNA polymerase II promoter (GO:0001079)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein kinase C signaling (GO:0090038)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein kinase C signaling (GO:0090037)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of protein kinase C signaling (GO:0090036)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
positive regulation of chaperone-mediated protein complex assembly (GO:0090035)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of chaperone-mediated protein complex assembly (GO:0090034)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
notochord morphogenesis (GO:0048570)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
positive regulation of steroid hormone biosynthetic process (GO:0090031)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
prolactin secretion (GO:0070459)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular detoxification of nitrogen compound (GO:0070458)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of heme biosynthetic process (GO:0070453)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
post-embryonic animal organ development (GO:0048569)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
white fat cell differentiation (GO:0050872)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
embryonic digestive tract development (GO:0048566)	20	0	.55	-	 < 0.01	1.00E00	1.00E00
digestive tract development (GO:0048565)	68	0	1.86	-	 < 0.01	2.66E-01	1.00E00
negative regulation of monocyte chemotaxis (GO:0090027)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of monocyte chemotaxis (GO:0090026)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
post-embryonic animal organ morphogenesis (GO:0048563)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of monocyte chemotaxis (GO:0090025)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
negative regulation of neutrophil chemotaxis (GO:0090024)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
establishment of animal organ orientation (GO:0048561)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of neutrophil chemotaxis (GO:0090023)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
establishment of anatomical structure orientation (GO:0048560)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of neutrophil chemotaxis (GO:0090022)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
positive regulation of oligodendrocyte progenitor proliferation (GO:0070447)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of oligodendrocyte progenitor proliferation (GO:0070446)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of oligodendrocyte progenitor proliferation (GO:0070445)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of T cell receptor signaling pathway (GO:0050862)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
positive regulation of B cell receptor signaling pathway (GO:0050861)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
embryonic digestive tract morphogenesis (GO:0048557)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
negative regulation of T cell receptor signaling pathway (GO:0050860)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
negative regulation of pinocytosis (GO:0048550)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
transforming growth factor beta receptor signaling pathway involved in primitive streak formation (GO:0090010)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070434)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070433)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070432)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of B cell receptor signaling pathway (GO:0050859)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of antigen receptor-mediated signaling pathway (GO:0050858)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
positive regulation of antigen receptor-mediated signaling pathway (GO:0050857)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
regulation of T cell receptor signaling pathway (GO:0050856)	27	0	.74	-	 < 0.01	1.00E00	1.00E00
regulation of B cell receptor signaling pathway (GO:0050855)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
regulation of antigen receptor-mediated signaling pathway (GO:0050854)	36	0	.99	-	 < 0.01	1.00E00	1.00E00
B cell receptor signaling pathway (GO:0050853)	20	0	.55	-	 < 0.01	1.00E00	1.00E00
positive regulation of pinocytosis (GO:0048549)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of pinocytosis (GO:0048548)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
primitive streak formation (GO:0090009)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
digestive tract morphogenesis (GO:0048546)	34	0	.93	-	 < 0.01	1.00E00	1.00E00
Peyer's patch development (GO:0048541)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway (GO:0070429)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway (GO:0070428)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of nucleotide-binding oligomerization domain containing signaling pathway (GO:0070426)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of nucleotide-binding oligomerization domain containing signaling pathway (GO:0070425)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of nucleotide-binding oligomerization domain containing signaling pathway (GO:0070424)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
antibiotic metabolic process (GO:0016999)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cell wall macromolecule catabolic process (GO:0016998)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of calcium-mediated signaling (GO:0050849)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
progesterone receptor signaling pathway (GO:0050847)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
bone marrow development (GO:0048539)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
mucosa-associated lymphoid tissue development (GO:0048537)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
lymph node development (GO:0048535)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
anatomical structure arrangement (GO:0048532)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
cellular response to cold (GO:0070417)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
negative regulation of heterochromatin organization (GO:0120262)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
trehalose metabolism in response to stress (GO:0070413)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of behavior (GO:0048521)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
olefinic compound catabolic process (GO:0120256)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
carbamoyl phosphate biosynthetic process (GO:0070409)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
olefinic compound biosynthetic process (GO:0120255)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
carbamoyl phosphate metabolic process (GO:0070408)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
olefinic compound metabolic process (GO:0120254)	35	0	.96	-	 < 0.01	1.00E00	1.00E00
oxidation-dependent protein catabolic process (GO:0070407)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
hydrocarbon catabolic process (GO:0120253)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
hydrocarbon metabolic process (GO:0120252)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
transposition (GO:0032196)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
defense response to Gram-negative bacterium (GO:0050829)	20	0	.55	-	 < 0.01	1.00E00	1.00E00
regulation of liquid surface tension (GO:0050828)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
poly(A)+ mRNA export from nucleus (GO:0016973)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
response to freezing (GO:0050826)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of coagulation (GO:0050820)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
histone H3-K14 acetylation (GO:0044154)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
septin cytoskeleton organization (GO:0032185)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
coagulation (GO:0050817)	59	0	1.62	-	 < 0.01	4.10E-01	1.00E00
doxorubicin transport (GO:1900753)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of acyl-CoA biosynthetic process (GO:0050812)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of timing of cell differentiation (GO:0048505)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
negative regulation of development of symbiont involved in interaction with host (GO:0044147)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
modulation of development of symbiont involved in interaction with host (GO:0044145)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
glutathione deglycation (GO:0036531)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of vascular endothelial growth factor signaling pathway (GO:1900748)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of synapse organization (GO:0050807)	109	0	2.99	-	 < 0.01	1.23E-01	1.00E00
negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of vascular endothelial growth factor signaling pathway (GO:1900746)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
negative regulation of synaptic transmission (GO:0050805)	25	0	.69	-	 < 0.01	1.00E00	1.00E00
positive regulation of p38MAPK cascade (GO:1900745)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
regulation of p38MAPK cascade (GO:1900744)	26	0	.71	-	 < 0.01	1.00E00	1.00E00
regulation of synapse structure or activity (GO:0050803)	114	0	3.13	-	 < 0.01	7.77E-02	1.00E00
positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein localization to motile cilium (GO:0120229)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein deglycation, glyoxal removal (GO:0036529)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
peptidyl-lysine deglycation (GO:0036528)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
peptidyl-arginine deglycation (GO:0036527)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
peptidyl-cysteine deglycation (GO:0036526)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein deglycation (GO:0036525)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
larynx development (GO:0120224)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
larynx morphogenesis (GO:0120223)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of blastocyst development (GO:0120222)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
maintenance of ciliary planar beating movement pattern (GO:0120221)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
astrocyte-dopaminergic neuron signaling (GO:0036520)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of phospholipase C-activating G protein-coupled receptor signaling pathway (GO:1900738)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of phospholipase C-activating G protein-coupled receptor signaling pathway (GO:1900737)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of phospholipase C-activating G protein-coupled receptor signaling pathway (GO:1900736)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
proacrosomal vesicle fusion (GO:0120211)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of uterine smooth muscle relaxation (GO:1900721)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
trimming of terminal mannose on B branch (GO:0036509)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein alpha-1,2-demannosylation (GO:0036508)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein demannosylation (GO:0036507)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
maintenance of unfolded protein (GO:0036506)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
protein desumoylation (GO:0016926)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of uterine smooth muscle relaxation (GO:1900719)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein sumoylation (GO:0016925)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
cellular alcohol biosynthetic process (GO:0044108)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cellular alcohol metabolic process (GO:0044107)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
embryonic axis specification (GO:0000578)	23	0	.63	-	 < 0.01	1.00E00	1.00E00
positive regulation of response to nutrient levels (GO:0032109)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of response to nutrient levels (GO:0032108)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
regulation of response to nutrient levels (GO:0032107)	18	0	.49	-	 < 0.01	1.00E00	1.00E00
positive regulation of response to extracellular stimulus (GO:0032106)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of response to extracellular stimulus (GO:0032105)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
regulation of response to extracellular stimulus (GO:0032104)	18	0	.49	-	 < 0.01	1.00E00	1.00E00
positive regulation of appetite (GO:0032100)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cell dedifferentiation (GO:0043697)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
dedifferentiation (GO:0043696)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
reverse cholesterol transport (GO:0043691)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
positive regulation of low-density lipoprotein receptor activity (GO:1905599)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of low-density lipoprotein receptor activity (GO:1905598)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of low-density lipoprotein particle receptor binding (GO:1905597)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of low-density lipoprotein particle receptor binding (GO:1905595)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of optical nerve axon regeneration (GO:1905593)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of optical nerve axon regeneration (GO:1905591)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
centrosome separation (GO:0051299)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
fibronectin fibril organization (GO:1905590)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
establishment of meiotic spindle orientation (GO:0051296)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mRNA cleavage involved in gene silencing (GO:0098795)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
co-translational protein modification (GO:0043686)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
establishment of meiotic spindle localization (GO:0051295)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
nuclear pore complex assembly (GO:0051292)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
positive regulation of L-arginine import across plasma membrane (GO:1905589)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
pre-mRNA cleavage required for polyadenylation (GO:0098789)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
positive regulation of low-density lipoprotein particle clearance (GO:1905581)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
mRNA cleavage involved in mRNA processing (GO:0098787)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
positive regulation of sequestering of calcium ion (GO:0051284)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of sequestering of calcium ion (GO:0051283)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
regulation of sequestering of calcium ion (GO:0051282)	40	0	1.10	-	 < 0.01	6.28E-01	1.00E00
positive regulation of release of sequestered calcium ion into cytosol (GO:0051281)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
response to mitochondrial depolarisation (GO:0098780)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
exosomal secretion (GO:1990182)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of release of sequestered calcium ion into cytosol (GO:0051280)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
mitochondrial tRNA 3'-end processing (GO:1990180)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
ganglioside GM1 transport to membrane (GO:1905572)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of mitophagy in response to mitochondrial depolarization (GO:0098779)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of release of sequestered calcium ion into cytosol (GO:0051279)	31	0	.85	-	 < 0.01	1.00E00	1.00E00
protein localization to nucleoplasm (GO:1990173)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
G protein-coupled receptor catabolic process (GO:1990172)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of vascular endothelial cell proliferation (GO:1905564)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
negative regulation of vascular endothelial cell proliferation (GO:1905563)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of vascular endothelial cell proliferation (GO:1905562)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
meiotic prometaphase I (GO:0098768)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
stress response to copper ion (GO:1990169)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
protein K33-linked deubiquitination (GO:1990168)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
protein K27-linked deubiquitination (GO:1990167)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
meiosis I cell cycle phase (GO:0098764)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
protein localization to site of double-strand break (GO:1990166)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
mitotic cell cycle phase (GO:0098763)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
recognition of apoptotic cell (GO:0043654)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
meiotic cell cycle phase (GO:0098762)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
histone H2A phosphorylation (GO:1990164)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
mitochondrial fragmentation involved in apoptotic process (GO:0043653)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
cellular response to interleukin-7 (GO:0098761)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
engulfment of apoptotic cell (GO:0043652)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
response to interleukin-7 (GO:0098760)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
linoleic acid metabolic process (GO:0043651)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
dicarboxylic acid biosynthetic process (GO:0043650)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
positive regulation of blood vessel branching (GO:1905555)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of blood vessel branching (GO:1905553)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
axis specification (GO:0009798)	52	0	1.43	-	 < 0.01	4.05E-01	1.00E00
cellular response to interleukin-8 (GO:0098759)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to interleukin-8 (GO:0098758)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
meiotic spindle midzone assembly (GO:0051257)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
inositol phosphate metabolic process (GO:0043647)	26	0	.71	-	 < 0.01	1.00E00	1.00E00
mitotic spindle midzone assembly (GO:0051256)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
spindle midzone assembly (GO:0051255)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
bone cell development (GO:0098751)	17	0	.47	-	 < 0.01	1.00E00	1.00E00
cellular response to nutrient (GO:0031670)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
positive regulation of subtelomeric heterochromatin assembly (GO:1905549)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of subtelomeric heterochromatin assembly (GO:1905547)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of abscisic acid-activated signaling pathway (GO:0009789)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cerebellar neuron development (GO:0098749)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of L-arginine import across plasma membrane (GO:1905541)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of abscisic acid-activated signaling pathway (GO:0009787)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of ephrin receptor signaling pathway (GO:1901189)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of asymmetric cell division (GO:0009786)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of ephrin receptor signaling pathway (GO:1901187)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of ERBB signaling pathway (GO:1901186)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
negative regulation of ERBB signaling pathway (GO:1901185)	17	0	.47	-	 < 0.01	1.00E00	1.00E00
cell aggregation (GO:0098743)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
regulation of ERBB signaling pathway (GO:1901184)	37	0	1.01	-	 < 0.01	6.26E-01	1.00E00
maintenance of translational fidelity (GO:1990145)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
polyadenylation-dependent ncRNA catabolic process (GO:0043634)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
intrinsic apoptotic signaling pathway in response to hypoxia (GO:1990144)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
polyadenylation-dependent RNA catabolic process (GO:0043633)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
RNA polyadenylation (GO:0043631)	24	0	.66	-	 < 0.01	1.00E00	1.00E00
ncRNA polyadenylation involved in polyadenylation-dependent ncRNA catabolic process (GO:0043630)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of lipopolysaccharide-mediated signaling pathway (GO:0031666)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
import across plasma membrane (GO:0098739)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
ncRNA polyadenylation (GO:0043629)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
neuron projection extension (GO:1990138)	41	0	1.12	-	 < 0.01	6.28E-01	1.00E00
positive regulation of the force of heart contraction (GO:0098735)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
macromolecule depalmitoylation (GO:0098734)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
macromolecule deacylation (GO:0098732)	47	0	1.29	-	 < 0.01	6.38E-01	1.00E00
meiotic spindle elongation (GO:0051232)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cortical microtubule organization (GO:0043622)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
spindle elongation (GO:0051231)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
spindle disassembly (GO:0051230)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of DNA-templated transcription in response to stress (GO:0043620)	33	0	.90	-	 < 0.01	1.00E00	1.00E00
positive regulation of heat generation (GO:0031652)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of heat generation (GO:0031651)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of heat generation (GO:0031650)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
positive regulation of Golgi lumen acidification (GO:1905528)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of Golgi lumen acidification (GO:1905526)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein autoubiquitination (GO:1905524)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of macrophage migration (GO:1905523)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
negative regulation of macrophage migration (GO:1905522)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of macrophage migration (GO:1905521)	17	0	.47	-	 < 0.01	1.00E00	1.00E00
germline stem cell asymmetric division (GO:0098728)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043619)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
mitotic spindle disassembly (GO:0051228)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618)	29	0	.80	-	 < 0.01	1.00E00	1.00E00
symmetric cell division (GO:0098725)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
neural crest cell migration involved in autonomic nervous system development (GO:1901166)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
keratinocyte proliferation (GO:0043616)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
positive regulation of trophoblast cell migration (GO:1901165)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
retrograde transport, endosome to plasma membrane (GO:1990126)	23	0	.63	-	 < 0.01	1.00E00	1.00E00
astrocyte cell migration (GO:0043615)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of trophoblast cell migration (GO:1901164)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
asymmetric stem cell division (GO:0098722)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of trophoblast cell migration (GO:1901163)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
primary amino compound biosynthetic process (GO:1901162)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cytoplasmic sequestering of protein (GO:0051220)	17	0	.47	-	 < 0.01	1.00E00	1.00E00
primary amino compound metabolic process (GO:1901160)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
messenger ribonucleoprotein complex assembly (GO:1990120)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
heat generation (GO:0031649)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
protein destabilization (GO:0031648)	33	0	.90	-	 < 0.01	1.00E00	1.00E00
positive regulation of myelination (GO:0031643)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
negative regulation of myelination (GO:0031642)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of myelination (GO:0031641)	35	0	.96	-	 < 0.01	1.00E00	1.00E00
macrophage migration (GO:1905517)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of fertilization (GO:1905516)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
non-motile cilium assembly (GO:1905515)	43	0	1.18	-	 < 0.01	6.31E-01	1.00E00
hexose mediated signaling (GO:0009757)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
carbohydrate mediated signaling (GO:0009756)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
formamide metabolic process (GO:0043606)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
ribosome-associated ubiquitin-dependent protein catabolic process (GO:1990116)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
RNA polymerase II core complex assembly (GO:1990114)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to fructose (GO:0009750)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
plasminogen activation (GO:0031639)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
regulation of synaptic vesicle fusion to presynaptic active zone membrane (GO:0031630)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
protein localization to microtubule organizing center (GO:1905508)	21	0	.58	-	 < 0.01	1.00E00	1.00E00
positive regulation of motile cilium assembly (GO:1905505)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of motile cilium assembly (GO:1905503)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
response to glucose (GO:0009749)	63	0	1.73	-	 < 0.01	4.17E-01	1.00E00
release of sequestered calcium ion into cytosol (GO:0051209)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
response to hexose (GO:0009746)	64	0	1.76	-	 < 0.01	4.20E-01	1.00E00
sequestering of calcium ion (GO:0051208)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein linear deubiquitination (GO:1990108)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
response to sucrose (GO:0009744)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to carbohydrate (GO:0009743)	76	0	2.08	-	 < 0.01	2.72E-01	1.00E00
protein insertion into membrane (GO:0051205)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
protein insertion into mitochondrial membrane (GO:0051204)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
neurotransmitter loading into synaptic vesicle (GO:0098700)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
telomeric loop formation (GO:0031627)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
receptor internalization (GO:0031623)	23	0	.63	-	 < 0.01	1.00E00	1.00E00
positive regulation of fever generation (GO:0031622)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of fever generation (GO:0031620)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
detection of hexose stimulus (GO:0009732)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
detection of carbohydrate stimulus (GO:0009730)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
homologous chromosome orientation involved in meiotic metaphase I plate congression (GO:0031619)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
tRNA-guanine transglycosylation (GO:0101030)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
Harderian gland development (GO:0070384)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
DNA cytosine deamination (GO:0070383)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
catechol-containing compound biosynthetic process (GO:0009713)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
synaptic vesicle membrane organization (GO:0048499)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
maintenance of animal organ identity (GO:0048496)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
anterograde synaptic vesicle transport (GO:0048490)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
positive regulation of ERK5 cascade (GO:0070378)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of ERK5 cascade (GO:0070377)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of ERK5 cascade (GO:0070376)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
ERK5 cascade (GO:0070375)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
ERK1 and ERK2 cascade (GO:0070371)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
cellular heat acclimation (GO:0070370)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
activated T cell proliferation (GO:0050798)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
synaptic vesicle transport (GO:0048489)	30	0	.82	-	 < 0.01	1.00E00	1.00E00
parasympathetic nervous system development (GO:0048486)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
sympathetic nervous system development (GO:0048485)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
enteric nervous system development (GO:0048484)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
autonomic nervous system development (GO:0048483)	26	0	.71	-	 < 0.01	1.00E00	1.00E00
positive regulation of hepatocyte differentiation (GO:0070368)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of hepatocyte differentiation (GO:0070367)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of hepatocyte differentiation (GO:0070366)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
hepatocyte differentiation (GO:0070365)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
detoxification of mercury ion (GO:0050787)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
replication fork protection (GO:0048478)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
actin polymerization-dependent cell motility (GO:0070358)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of dendrite morphogenesis (GO:0050775)	32	0	.88	-	 < 0.01	1.00E00	1.00E00
negative regulation of dendrite morphogenesis (GO:0050774)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of axonogenesis (GO:0050771)	28	0	.77	-	 < 0.01	1.00E00	1.00E00
PERK-mediated unfolded protein response (GO:0036499)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
IRE1-mediated unfolded protein response (GO:0036498)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
mucociliary clearance (GO:0120197)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of translation initiation in response to endoplasmic reticulum stress (GO:0036494)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
tight junction organization (GO:0120193)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
positive regulation of translation in response to endoplasmic reticulum stress (GO:0036493)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of fat cell proliferation (GO:0070346)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
tight junction assembly (GO:0120192)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
eiF2alpha phosphorylation in response to endoplasmic reticulum stress (GO:0036492)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of termination of RNA polymerase II transcription (GO:0120191)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of translation initiation in response to endoplasmic reticulum stress (GO:0036491)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of translation in response to endoplasmic reticulum stress (GO:0036490)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of phagocytosis (GO:0050765)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein localization to chromatin (GO:0120187)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to bacterial lipopeptide (GO:0070339)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of focal adhesion disassembly (GO:0120183)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of focal adhesion disassembly (GO:0120182)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
focal adhesion disassembly (GO:0120181)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
intrinsic apoptotic signaling pathway in response to hydrogen peroxide (GO:0036481)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of vacuole organization (GO:0044090)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
cell-substrate junction disassembly (GO:0120180)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
neuron death in response to oxidative stress (GO:0036475)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
triglyceride homeostasis (GO:0070328)	24	0	.66	-	 < 0.01	1.00E00	1.00E00
cell death in response to hydrogen peroxide (GO:0036474)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
thyroid hormone transport (GO:0070327)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
trans-synaptic signaling by BDNF (GO:0099191)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular response to glyoxal (GO:0036471)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of lipoprotein metabolic process (GO:0050748)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of lipoprotein metabolic process (GO:0050747)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of lipoprotein metabolic process (GO:0050746)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
postsynaptic cytoskeleton organization (GO:0099188)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
presynaptic cytoskeleton organization (GO:0099187)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
synaptic vesicle recycling via endosome (GO:0036466)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
trans-synaptic signaling by BDNF, modulating synaptic transmission (GO:0099183)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of G0 to G1 transition (GO:0070318)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of G0 to G1 transition (GO:0070317)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of G0 to G1 transition (GO:0070316)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
TRAIL-activated apoptotic signaling pathway (GO:0036462)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
G1 to G0 transition involved in cell differentiation (GO:0070315)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
G1 to G0 transition (GO:0070314)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
olefin metabolic process (GO:1900673)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732)	35	0	.96	-	 < 0.01	1.00E00	1.00E00
regulation of synaptic membrane adhesion (GO:0099179)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of retrograde trans-synaptic signaling by endocanabinoid (GO:0099178)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
modulation by symbiont of host cellular process (GO:0044068)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
regulation of postsynapse organization (GO:0099175)	56	0	1.54	-	 < 0.01	4.07E-01	1.00E00
regulation of presynapse organization (GO:0099174)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
regulation of respiratory system process (GO:0044065)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
lens fiber cell morphogenesis (GO:0070309)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
presynapse organization (GO:0099172)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
lens fiber cell development (GO:0070307)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
presynaptic modulation of chemical synaptic transmission (GO:0099171)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
regulation of excretion (GO:0044062)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
lens fiber cell differentiation (GO:0070306)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
postsynaptic modulation of chemical synaptic transmission (GO:0099170)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
response to cGMP (GO:0070305)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cap mRNA methylation (GO:0036451)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of appetite (GO:0032099)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
negative regulation of stress-activated protein kinase signaling cascade (GO:0070303)	33	0	.90	-	 < 0.01	1.00E00	1.00E00
regulation of appetite (GO:0032098)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
positive regulation of response to food (GO:0032097)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of response to food (GO:0032096)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
regulation of response to food (GO:0032095)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
regulation of digestive system process (GO:0044058)	22	0	.60	-	 < 0.01	1.00E00	1.00E00
synaptic signaling by nitric oxide (GO:0099163)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
neuronal stem cell division (GO:0036445)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
calcium import into the mitochondrion (GO:0036444)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
translocation of peptides or proteins into host cell cytoplasm (GO:0044053)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of modification of postsynaptic structure (GO:0099159)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
regulation of recycling endosome localization within postsynapse (GO:0099158)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cell-cell signaling via exosome (GO:0099156)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
maintenance of lens transparency (GO:0036438)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
synaptic transmission, serotonergic (GO:0099153)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane (GO:0099152)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of postsynaptic density assembly (GO:0099151)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of postsynaptic specialization assembly (GO:0099150)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
positive regulation of endodeoxyribonuclease activity (GO:0032079)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of endodeoxyribonuclease activity (GO:0032078)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of deoxyribonuclease activity (GO:0032077)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of deoxyribonuclease activity (GO:0032076)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of nuclease activity (GO:0032075)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of nuclease activity (GO:0032074)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of endodeoxyribonuclease activity (GO:0032071)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
regulation of deoxyribonuclease activity (GO:0032070)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
regulation of postsynaptic neurotransmitter receptor internalization (GO:0099149)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
regulation of synaptic vesicle docking (GO:0099148)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cell wall macromolecule biosynthetic process (GO:0044038)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cell wall macromolecule metabolic process (GO:0044036)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
response to copper ion starvation (GO:0120126)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
multi-organism catabolic process (GO:0044035)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
multi-organism metabolic process (GO:0044033)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
presynaptic actin cytoskeleton organization (GO:0099140)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of DNA methylation (GO:0044030)	19	0	.52	-	 < 0.01	1.00E00	1.00E00
regulation of nuclease activity (GO:0032069)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
bleb assembly (GO:0032060)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
hypomethylation of CpG island (GO:0044029)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
DNA hypomethylation (GO:0044028)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
hypermethylation of CpG island (GO:0044027)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
DNA hypermethylation (GO:0044026)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
tRNA stabilization (GO:0036416)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of tRNA stability (GO:0036415)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
histone citrullination (GO:0036414)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
histone H3-R26 citrullination (GO:0036413)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of translational initiation in response to stress (GO:0032058)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of translational initiation in response to stress (GO:0032057)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of translation in response to stress (GO:0032056)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of translation in response to stress (GO:0032055)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
ciliary basal body organization (GO:0032053)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of monocyte aggregation (GO:1900625)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of monocyte aggregation (GO:1900623)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
acetate ester biosynthetic process (GO:1900620)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
conversion of ds siRNA to ss siRNA (GO:0036404)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cardiolipin biosynthetic process (GO:0032049)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
cardiolipin metabolic process (GO:0032048)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
acetate ester metabolic process (GO:1900619)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mitochondrial DNA metabolic process (GO:0032042)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
microtubule-based protein transport (GO:0099118)	54	0	1.48	-	 < 0.01	4.05E-01	1.00E00
box H/ACA RNA 3'-end processing (GO:0000495)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
box C/D RNA 3'-end processing (GO:0000494)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
box H/ACA snoRNP assembly (GO:0000493)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
modulation by symbiont of host process (GO:0044003)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
box C/D snoRNP assembly (GO:0000492)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
small nucleolar ribonucleoprotein complex assembly (GO:0000491)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
maturation of 5S rRNA (GO:0000481)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000480)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
response to magnesium ion (GO:0032026)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
response to cobalt ion (GO:0032025)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
ISG15-protein conjugation (GO:0032020)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
endonucleolytic cleavage involved in rRNA processing (GO:0000478)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000472)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
maturation of LSU-rRNA (GO:0000470)	25	0	.69	-	 < 0.01	1.00E00	1.00E00
positive regulation of ARF protein signal transduction (GO:0032014)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of ARF protein signal transduction (GO:0032013)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of ARF protein signal transduction (GO:0032012)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
ARF protein signal transduction (GO:0032011)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cleavage involved in rRNA processing (GO:0000469)	22	0	.60	-	 < 0.01	1.00E00	1.00E00
exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000467)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)	22	0	.60	-	 < 0.01	1.00E00	1.00E00
maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)	29	0	.80	-	 < 0.01	1.00E00	1.00E00
endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000461)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
tetrahydrofolate interconversion (GO:0035999)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
positive regulation of TOR signaling (GO:0032008)	31	0	.85	-	 < 0.01	1.00E00	1.00E00
detection of muscle stretch (GO:0035995)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
response to muscle stretch (GO:0035994)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
deltoid tuberosity development (GO:0035993)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
tendon formation (GO:0035992)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
tendon cell differentiation (GO:0035990)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of fatty acid beta-oxidation (GO:0032000)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
exonucleolytic trimming involved in rRNA processing (GO:0000459)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
enzyme-directed rRNA pseudouridine synthesis (GO:0000455)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
snoRNA guided rRNA pseudouridine synthesis (GO:0000454)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
rRNA 2'-O-methylation (GO:0000451)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
tendon development (GO:0035989)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
chondrocyte proliferation (GO:0035988)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
endodermal cell differentiation (GO:0035987)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
cellular response to trichostatin A (GO:0035984)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
response to trichostatin A (GO:0035983)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
endocytic hemoglobin import into cell (GO:0020028)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
hemoglobin metabolic process (GO:0020027)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000448)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000447)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
positive regulation of branching morphogenesis of a nerve (GO:1905492)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
postsynaptic specialization assembly (GO:0098698)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
skin morphogenesis (GO:0043589)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of neurotransmitter receptor localization to postsynaptic specialization membrane (GO:0098696)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
histone H2A-S139 phosphorylation (GO:0035978)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein deglycosylation involved in glycoprotein catabolic process (GO:0035977)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of synaptic vesicle cycle (GO:0098693)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
nose development (GO:0043584)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
aggrephagy (GO:0035973)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
calcium-dependent self proteolysis (GO:1990092)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
sodium-dependent self proteolysis (GO:1990091)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
peptidyl-histidine dephosphorylation (GO:0035971)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
peptidyl-threonine dephosphorylation (GO:0035970)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
carbon catabolite activation of transcription from RNA polymerase II promoter (GO:0000436)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of transcription from RNA polymerase II promoter by galactose (GO:0000435)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of transcription from RNA polymerase II promoter by glucose (GO:0000432)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of transcription from RNA polymerase II promoter by galactose (GO:0000431)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of transcription from RNA polymerase II promoter by glucose (GO:0000430)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of respiratory gaseous exchange (GO:0043576)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
lens fiber cell apoptotic process (GO:1990086)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cardiolipin acyl-chain remodeling (GO:0035965)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
peroxisomal transport (GO:0043574)	17	0	.47	-	 < 0.01	1.00E00	1.00E00
COPI-coated vesicle budding (GO:0035964)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cellular response to interleukin-13 (GO:0035963)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to interleukin-13 (GO:0035962)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
vitamin transport (GO:0051180)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
maintenance of DNA repeat elements (GO:0043570)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
carbon catabolite regulation of transcription from RNA polymerase II promoter (GO:0000429)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein localization to membrane (GO:1905476)	17	0	.47	-	 < 0.01	1.00E00	1.00E00
pexophagy (GO:0000425)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mitophagy (GO:0000423)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
negative regulation of insulin-like growth factor receptor signaling pathway (GO:0043569)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
cartilage homeostasis (GO:1990079)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of insulin-like growth factor receptor signaling pathway (GO:0043568)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
meiotic sister chromatid cohesion (GO:0051177)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
regulation of insulin-like growth factor receptor signaling pathway (GO:0043567)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
positive regulation of sulfur metabolic process (GO:0051176)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
polyuridylation-dependent mRNA catabolic process (GO:1990074)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular response to nitrogen levels (GO:0043562)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
wybutosine biosynthetic process (GO:0031591)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
wybutosine metabolic process (GO:0031590)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of histone H3-K36 methylation (GO:0000416)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of DNA duplex unwinding (GO:1905464)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of histone H3-K36 methylation (GO:0000415)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of DNA duplex unwinding (GO:1905463)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of histone H3-K36 methylation (GO:0000414)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of DNA duplex unwinding (GO:1905462)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
protein peptidyl-prolyl isomerization (GO:0000413)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
positive regulation of vascular associated smooth muscle cell apoptotic process (GO:1905461)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of vascular associated smooth muscle cell apoptotic process (GO:1905460)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of transcription by galactose (GO:0000411)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of translational initiation in response to stress (GO:0043558)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of translation in response to oxidative stress (GO:0043556)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mitochondrial mRNA surveillance (GO:0035946)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of translation in response to stress (GO:0043555)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
L-xylitol metabolic process (GO:0051164)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mitochondrial ncRNA surveillance (GO:0035945)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of phosphatidylinositol 3-kinase activity (GO:0043553)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
inorganic anion transmembrane transport (GO:0098661)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
L-xylitol catabolic process (GO:0051160)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cell-substrate adhesion (GO:0031589)	93	0	2.55	-	 < 0.01	1.83E-01	1.00E00
positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity (GO:0031587)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity (GO:0031585)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
activation of phospholipase D activity (GO:0031584)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
phospholipase D-activating G protein-coupled receptor signaling pathway (GO:0031583)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
hemidesmosome assembly (GO:0031581)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
membrane raft distribution (GO:0031580)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of vascular associated smooth muscle cell apoptotic process (GO:1905459)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
positive regulation of lymphoid progenitor cell differentiation (GO:1905458)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of transcription by galactose (GO:0000409)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of lymphoid progenitor cell differentiation (GO:1905457)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of lymphoid progenitor cell differentiation (GO:1905456)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
negative regulation of myeloid progenitor cell differentiation (GO:1905454)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of myeloid progenitor cell differentiation (GO:1905453)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
phenylpropanoid metabolic process (GO:0009698)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis (GO:1905451)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of signal transduction in absence of ligand (GO:1901099)	19	0	.52	-	 < 0.01	1.00E00	1.00E00
negative regulation of Fc-gamma receptor signaling pathway involved in phagocytosis (GO:1905450)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
import into cell (GO:0098657)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
positive regulation of autophagosome maturation (GO:1901098)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of autophagosome maturation (GO:1901097)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
glucose 6-phosphate metabolic process (GO:0051156)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
regulation of autophagosome maturation (GO:1901096)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
positive regulation of striated muscle cell differentiation (GO:0051155)	36	0	.99	-	 < 0.01	1.00E00	1.00E00
negative regulation of striated muscle cell differentiation (GO:0051154)	24	0	.66	-	 < 0.01	1.00E00	1.00E00
regulation of striated muscle cell differentiation (GO:0051153)	63	0	1.73	-	 < 0.01	4.17E-01	1.00E00
positive regulation of smooth muscle cell differentiation (GO:0051152)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
activation of protein kinase C activity (GO:1990051)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
intra-S DNA damage checkpoint (GO:0031573)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
G2 DNA damage checkpoint (GO:0031572)	28	0	.77	-	 < 0.01	1.00E00	1.00E00
mitotic G1 DNA damage checkpoint (GO:0031571)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
DNA integrity checkpoint (GO:0031570)	80	0	2.19	-	 < 0.01	2.79E-01	1.00E00
regulation of Fc-gamma receptor signaling pathway involved in phagocytosis (GO:1905449)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of mitochondrial ATP synthesis coupled electron transport (GO:1905448)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of mitochondrial ATP synthesis coupled electron transport (GO:1905447)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of mitochondrial ATP synthesis coupled electron transport (GO:1905446)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of clathrin coat assembly (GO:1905445)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of clathrin coat assembly (GO:1905443)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of muscle cell differentiation (GO:0051149)	48	0	1.32	-	 < 0.01	6.40E-01	1.00E00
retrograde neuronal dense core vesicle transport (GO:1990049)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
steroid hormone secretion (GO:0035929)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of actin phosphorylation (GO:0043538)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
anterograde neuronal dense core vesicle transport (GO:1990048)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
rRNA import into mitochondrion (GO:0035928)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of blood vessel endothelial cell migration (GO:0043537)	21	0	.58	-	 < 0.01	1.00E00	1.00E00
RNA import into mitochondrion (GO:0035927)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
stress-induced mitochondrial fusion (GO:1990046)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
induced systemic resistance (GO:0009682)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
blood vessel endothelial cell migration (GO:0043534)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
positive regulation of NK T cell proliferation (GO:0051142)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of relaxation of smooth muscle (GO:1901082)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of relaxation of smooth muscle (GO:1901081)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
foramen ovale closure (GO:0035922)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of NK T cell proliferation (GO:0051140)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of relaxation of smooth muscle (GO:1901080)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
desmosome disassembly (GO:0035921)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of histone H3-K4 trimethylation (GO:1905437)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of histone H3-K4 trimethylation (GO:1905435)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of relaxation of muscle (GO:1901079)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to glycine (GO:1905430)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of NK T cell differentiation (GO:0051138)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of relaxation of muscle (GO:1901078)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of relaxation of muscle (GO:1901077)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
regulation of NK T cell differentiation (GO:0051136)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
positive regulation of NK T cell activation (GO:0051135)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
pore formation in membrane of other organism (GO:0035915)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of NK T cell activation (GO:0051133)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
glucosamine-containing compound biosynthetic process (GO:1901073)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
skeletal muscle cell differentiation (GO:0035914)	42	0	1.15	-	 < 0.01	6.30E-01	1.00E00
NK T cell activation (GO:0051132)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
chaperone-mediated protein complex assembly (GO:0051131)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
dorsal aorta morphogenesis (GO:0035912)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
guanosine-containing compound biosynthetic process (GO:1901070)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
ascending aorta morphogenesis (GO:0035910)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of DNA-templated transcription, termination (GO:0031554)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of brain-derived neurotrophic factor-activated receptor activity (GO:0031552)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of brain-derived neurotrophic factor-activated receptor activity (GO:0031551)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to glycine (GO:1905429)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of Wnt-mediated midbrain dopaminergic neuron differentiation (GO:1905426)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of Wnt-mediated midbrain dopaminergic neuron differentiation (GO:1905424)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
trans-Golgi network membrane organization (GO:0098629)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
guanosine-containing compound catabolic process (GO:1901069)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of myosin II filament organization (GO:0043519)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
guanosine-containing compound metabolic process (GO:1901068)	21	0	.58	-	 < 0.01	1.00E00	1.00E00
aorta morphogenesis (GO:0035909)	17	0	.47	-	 < 0.01	1.00E00	1.00E00
negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
positive regulation of actin nucleation (GO:0051127)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
dorsal aorta development (GO:0035907)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)	23	0	.63	-	 < 0.01	1.00E00	1.00E00
descending aorta development (GO:0035906)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
synaptic growth at neuromuscular junction (GO:0051124)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
ascending aorta development (GO:0035905)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
RNA polymerase II preinitiation complex assembly (GO:0051123)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
aorta development (GO:0035904)	33	0	.90	-	 < 0.01	1.00E00	1.00E00
hepoxilin biosynthetic process (GO:0051122)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
hepoxilin metabolic process (GO:0051121)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
response to immobilization stress (GO:0035902)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of brain-derived neurotrophic factor receptor signaling pathway (GO:0031549)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of brain-derived neurotrophic factor receptor signaling pathway (GO:0031548)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
brain-derived neurotrophic factor receptor signaling pathway (GO:0031547)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of dense core granule exocytosis (GO:1905413)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of JUN kinase activity (GO:0043508)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
response to salt stress (GO:0009651)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
mitochondrial DNA repair (GO:0043504)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
UV protection (GO:0009650)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
skeletal muscle fiber adaptation (GO:0043503)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
sarcosine metabolic process (GO:1901052)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
skeletal muscle adaptation (GO:0043501)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of exit from mitosis (GO:0031536)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of creatine transmembrane transporter activity (GO:1905408)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of creatine transmembrane transporter activity (GO:1905407)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of mitotic cohesin loading (GO:1905406)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of mitotic cohesin loading (GO:1905405)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of activated CD8-positive, alpha-beta T cell apoptotic process (GO:1905403)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of activated CD8-positive, alpha-beta T cell apoptotic process (GO:1905402)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
retinal cell apoptotic process (GO:1990009)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
response to high light intensity (GO:0009644)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
response to light intensity (GO:0009642)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
DNA ligation involved in DNA repair (GO:0051103)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
DNA ligation involved in DNA recombination (GO:0051102)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of DNA binding (GO:0051101)	74	0	2.03	-	 < 0.01	2.69E-01	1.00E00
inhibition of cysteine-type endopeptidase activity involved in apoptotic process (GO:1990001)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
amyloid fibril formation (GO:1990000)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
ruffle organization (GO:0031529)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
response to blue light (GO:0009637)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cold acclimation (GO:0009631)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of response to reactive oxygen species (GO:1901033)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of response to reactive oxygen species (GO:1901032)	18	0	.49	-	 < 0.01	1.00E00	1.00E00
regulation of response to reactive oxygen species (GO:1901031)	30	0	.82	-	 < 0.01	1.00E00	1.00E00
sarcoplasmic reticulum calcium ion transport (GO:0070296)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
renal sodium ion absorption (GO:0070294)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
response to nematode (GO:0009624)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
renal absorption (GO:0070293)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
ripoptosome assembly involved in necroptotic process (GO:1901026)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
N-acylphosphatidylethanolamine metabolic process (GO:0070292)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
N-acylethanolamine metabolic process (GO:0070291)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of calcium ion transmembrane transporter activity (GO:1901021)	18	0	.49	-	 < 0.01	1.00E00	1.00E00
negative regulation of calcium ion transmembrane transporter activity (GO:1901020)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
pericentric heterochromatin assembly (GO:0031508)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
heterochromatin assembly (GO:0031507)	17	0	.47	-	 < 0.01	1.00E00	1.00E00
cell wall glycoprotein biosynthetic process (GO:0031506)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of calcium ion transmembrane transporter activity (GO:1901019)	35	0	.96	-	 < 0.01	1.00E00	1.00E00
positive regulation of potassium ion transmembrane transporter activity (GO:1901018)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of potassium ion transmembrane transporter activity (GO:1901017)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
regulation of potassium ion transmembrane transporter activity (GO:1901016)	18	0	.49	-	 < 0.01	1.00E00	1.00E00
response to mechanical stimulus (GO:0009612)	56	0	1.54	-	 < 0.01	4.07E-01	1.00E00
intermediate mesodermal cell differentiation (GO:0048392)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
intermediate mesoderm formation (GO:0048391)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
intermediate mesoderm morphogenesis (GO:0048390)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
extracellular matrix constituent secretion (GO:0070278)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of leukocyte adhesion to arterial endothelial cell (GO:1904999)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of leukocyte adhesion to arterial endothelial cell (GO:1904997)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
ubiquinone-6 biosynthetic process (GO:1901006)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of leukocyte adhesion to vascular endothelial cell (GO:1904995)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
ubiquinone-6 metabolic process (GO:1901004)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of fermentation (GO:1901003)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway (GO:1904992)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway (GO:1904990)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of response to salt stress (GO:1901000)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
intermediate mesoderm development (GO:0048389)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of retinoic acid receptor signaling pathway (GO:0048387)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of retinoic acid receptor signaling pathway (GO:0048386)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
retinoic acid receptor signaling pathway (GO:0048384)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
mesendoderm development (GO:0048382)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
cornification (GO:0070268)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
necroptotic process (GO:0070266)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
negative regulation of quinolinate biosynthetic process (GO:1904985)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
peptidyl-serine dephosphorylation (GO:0070262)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of quinolinate biosynthetic process (GO:1904984)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of defense response to virus by host (GO:0050689)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of endosome organization (GO:1904980)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of mRNA processing (GO:0050686)	27	0	.74	-	 < 0.01	1.00E00	1.00E00
positive regulation of mRNA processing (GO:0050685)	27	0	.74	-	 < 0.01	1.00E00	1.00E00
positive regulation of mucus secretion (GO:0070257)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of mucus secretion (GO:0070256)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of endosome organization (GO:1904978)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to bleomycin (GO:1904976)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
somatostatin secretion (GO:0070253)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
response to bleomycin (GO:1904975)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
actin-mediated cell contraction (GO:0070252)	22	0	.60	-	 < 0.01	1.00E00	1.00E00
positive regulation of viral translation (GO:1904973)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of viral translation (GO:1904971)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
brush border assembly (GO:1904970)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
lateral mesoderm development (GO:0048368)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
TCR signalosome assembly (GO:0036399)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of peptidyl-lysine crotonylation (GO:0120094)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of peptidyl-lysine crotonylation (GO:0120093)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of thymocyte apoptotic process (GO:0070244)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
thymocyte apoptotic process (GO:0070242)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of cytochrome-c oxidase activity (GO:1904960)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
homocysteine metabolic process (GO:0050667)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
pre-replicative complex assembly (GO:0036388)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
positive regulation of activation-induced cell death of T cells (GO:0070237)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of cytochrome-c oxidase activity (GO:1904959)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of midbrain dopaminergic neuron differentiation (GO:1904958)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of midbrain dopaminergic neuron differentiation (GO:1904956)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904954)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
T cell apoptotic process (GO:0070231)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
dermatan sulfate proteoglycan metabolic process (GO:0050655)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
chondroitin sulfate proteoglycan metabolic process (GO:0050654)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
dermatan sulfate proteoglycan biosynthetic process (GO:0050651)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
chondroitin sulfate proteoglycan biosynthetic process (GO:0050650)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
paraxial mesoderm formation (GO:0048341)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
paraxial mesoderm morphogenesis (GO:0048340)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
calcitriol biosynthetic process from calciol (GO:0036378)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
midbrain dopaminergic neuron differentiation (GO:1904948)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
opsin transport (GO:0036372)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
folate import into mitochondrion (GO:1904947)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein localization to T-tubule (GO:0036371)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
sulfide oxidation, using sulfide:quinone oxidoreductase (GO:0070221)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
paraxial mesoderm development (GO:0048339)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
mesodermal cell differentiation (GO:0048333)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
mesoderm morphogenesis (GO:0048332)	41	0	1.12	-	 < 0.01	6.28E-01	1.00E00
establishment of endoplasmic reticulum localization to postsynapse (GO:0099089)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
axonal transport of messenger ribonucleoprotein complex (GO:0099088)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
anterograde axonal transport of messenger ribonucleoprotein complex (GO:0099087)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
transcription factor catabolic process (GO:0036369)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
light adaption (GO:0036367)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
postsynaptic specialization organization (GO:0099084)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
transforming growth factor beta activation (GO:0036363)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
interneuron migration (GO:1904936)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
protein auto-ADP-ribosylation (GO:0070213)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
protein poly-ADP-ribosylation (GO:0070212)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
axial mesodermal cell fate specification (GO:0048327)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
axial mesodermal cell fate commitment (GO:0048322)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
axial mesodermal cell differentiation (GO:0048321)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
axial mesoderm formation (GO:0048320)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
renal potassium excretion (GO:0036359)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of small intestinal transit (GO:0120058)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mitochondrion-derived vesicle mediated transport (GO:0099075)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of small intestinal transit (GO:0120057)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mitochondrion to lysosome transport (GO:0099074)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
protein heterotrimerization (GO:0070208)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
histone H2A-K119 monoubiquitination (GO:0036353)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
histone H2A-K15 ubiquitination (GO:0036352)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
histone H2A-K13 ubiquitination (GO:0036351)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of establishment of protein localization to telomere (GO:0070203)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization (GO:1904925)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
regulation of establishment of protein localization to chromosome (GO:0070202)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
regulation of autophagy of mitochondrion in response to mitochondrial depolarization (GO:1904923)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
establishment of protein localization to telomere (GO:0070200)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
axial mesoderm morphogenesis (GO:0048319)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
axial mesoderm development (GO:0048318)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
Golgi inheritance (GO:0048313)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
intracellular distribution of mitochondria (GO:0048312)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
mitochondrion distribution (GO:0048311)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
postsynapse assembly (GO:0099068)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
snRNA (adenine-N6)-methylation (GO:0120049)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
stereocilium maintenance (GO:0120045)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
platelet maturation (GO:0036345)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
psychomotor behavior (GO:0036343)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
post-anal tail morphogenesis (GO:0036342)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
positive regulation of macrophage proliferation (GO:0120041)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of establishment of RNA localization to telomere (GO:1904911)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of establishment of RNA localization to telomere (GO:1904910)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
organelle inheritance (GO:0048308)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
Fas signaling pathway (GO:0036337)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
presynapse assembly (GO:0099054)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
dendritic cell migration (GO:0036336)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
intestinal stem cell homeostasis (GO:0036335)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
epidermal stem cell homeostasis (GO:0036334)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of plasma membrane bounded cell projection assembly (GO:0120033)	22	0	.60	-	 < 0.01	1.00E00	1.00E00
vesicle scission (GO:0099050)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric (GO:1904908)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of maintenance of mitotic sister chromatid cohesion, telomeric (GO:1904907)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
avascular cornea development in camera-type eye (GO:0036331)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of endothelial cell-matrix adhesion via fibronectin (GO:1904906)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of endothelial cell-matrix adhesion via fibronectin (GO:1904904)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of purine nucleotide metabolic process (GO:1900543)	17	0	.47	-	 < 0.01	1.00E00	1.00E00
vascular endothelial growth factor receptor-2 signaling pathway (GO:0036324)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
vesicle tethering to Golgi (GO:0099041)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
vascular endothelial growth factor receptor-1 signaling pathway (GO:0036323)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to sterol (GO:0036315)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
response to sterol (GO:0036314)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
intermembrane sphingolipid transfer (GO:0120012)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein localization to M-band (GO:0036309)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
plasma membrane invagination (GO:0099024)	19	0	.52	-	 < 0.01	1.00E00	1.00E00
embryonic heart tube elongation (GO:0036306)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
ameloblast differentiation (GO:0036305)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
vesicle tethering (GO:0099022)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
umbilical cord morphogenesis (GO:0036304)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
atrioventricular canal development (GO:0036302)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
spliceosomal conformational changes to generate catalytic conformation (GO:0000393)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
neuronal dense core vesicle exocytosis (GO:0099011)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
spliceosomal complex disassembly (GO:0000390)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
modulation by symbiont of host autophagy (GO:0075071)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
mRNA 3'-splice site recognition (GO:0000389)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
spliceosome conformational change to release U4 (or U4atac) and U1 (or U11) (GO:0000388)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
spliceosomal snRNP assembly (GO:0000387)	27	0	.74	-	 < 0.01	1.00E00	1.00E00
calmodulin dependent kinase signaling pathway (GO:0099004)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
tRNA-type intron splice site recognition and cleavage (GO:0000379)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
RNA exon ligation (GO:0000378)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
parathyroid hormone secretion (GO:0035898)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
exit from host cell (GO:0035891)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
exit from host (GO:0035890)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation by symbiont of host autophagy (GO:0075044)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
generation of catalytic spliceosome for second transesterification step (GO:0000350)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
aortic smooth muscle cell differentiation (GO:0035887)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
enteroendocrine cell differentiation (GO:0035883)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
protein kinase B signaling (GO:0043491)	25	0	.69	-	 < 0.01	1.00E00	1.00E00
amacrine cell differentiation (GO:0035881)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
malate-aspartate shuttle (GO:0043490)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
embryonic nail plate morphogenesis (GO:0035880)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
generation of catalytic spliceosome for first transesterification step (GO:0000349)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular response to flavonoid (GO:1905396)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to flavonoid (GO:1905395)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
learned vocalization behavior or vocal learning (GO:0098598)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
RNA stabilization (GO:0043489)	44	0	1.21	-	 < 0.01	6.32E-01	1.00E00
observational learning (GO:0098597)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
plasma membrane lactate transport (GO:0035879)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of helicase activity (GO:0051097)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
imitative learning (GO:0098596)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
nail development (GO:0035878)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of helicase activity (GO:0051096)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
histone exchange (GO:0043486)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
regulation of helicase activity (GO:0051095)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
endosome to pigment granule transport (GO:0043485)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
cellular response to copper ion starvation (GO:0035874)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
lactate transmembrane transport (GO:0035873)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular pigment accumulation (GO:0043482)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
protein K11-linked deubiquitination (GO:0035871)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
protein localization to presynapse (GO:1905383)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
positive regulation of snRNA transcription by RNA polymerase II (GO:1905382)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of snRNA transcription by RNA polymerase II (GO:1905381)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of snRNA transcription by RNA polymerase II (GO:1905380)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
chaperone mediated protein folding independent of cofactor (GO:0051086)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
pigment accumulation (GO:0043476)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
learned vocalization behavior (GO:0098583)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to potassium ion (GO:0035865)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
innate vocalization behavior (GO:0098582)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
response to potassium ion (GO:0035864)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
detection of external biotic stimulus (GO:0098581)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
nuclear envelope disassembly (GO:0051081)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of cellular carbohydrate catabolic process (GO:0043471)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
regulation of carbohydrate catabolic process (GO:0043470)	36	0	.99	-	 < 0.01	1.00E00	1.00E00
glial cell-derived neurotrophic factor receptor signaling pathway (GO:0035860)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
re-entry into mitotic cell cycle (GO:0000320)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of fermentation (GO:0043465)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
megakaryocyte development (GO:0035855)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
eosinophil fate commitment (GO:0035854)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
proton-transporting ATP synthase complex assembly (GO:0043461)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
chromatin disassembly (GO:0031498)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
regulation of mating type switching (GO:0031494)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of endosomal vesicle fusion (GO:1905364)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
dihydrolipoamide metabolic process (GO:0051068)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
dihydrobiopterin metabolic process (GO:0051066)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of pentose-phosphate shunt (GO:0043456)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of secondary metabolic process (GO:0043455)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
photoreceptor cell outer segment organization (GO:0035845)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
cloaca development (GO:0035844)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
protein localization to meiotic spindle (GO:1905359)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
spine apparatus assembly (GO:1905355)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to singlet oxygen (GO:0000304)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
detection of virus (GO:0009597)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of small GTPase mediated signal transduction (GO:0051058)	44	0	1.21	-	 < 0.01	6.32E-01	1.00E00
detection of biotic stimulus (GO:0009595)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
detection of chemical stimulus (GO:0009593)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
ciliary transition zone assembly (GO:1905349)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
prostaglandin catabolic process (GO:1905344)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
detection of UV (GO:0009589)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein localization to kinetochore (GO:1905342)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein localization to kinetochore (GO:1905341)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of protein localization to kinetochore (GO:1905340)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
detection of visible light (GO:0009584)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
detection of light stimulus (GO:0009583)	20	0	.55	-	 < 0.01	1.00E00	1.00E00
negative regulation of membrane protein ectodomain proteolysis (GO:0051045)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to corticotropin-releasing hormone (GO:0043435)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of membrane protein ectodomain proteolysis (GO:0051044)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
detection of other organism (GO:0098543)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
regulation of membrane protein ectodomain proteolysis (GO:0051043)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
gene conversion (GO:0035822)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of aggrephagy (GO:1905337)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of aggrephagy (GO:1905335)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of gastric motility (GO:1905333)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of morphogenesis of an epithelium (GO:1905332)	24	0	.66	-	 < 0.01	1.00E00	1.00E00
negative regulation of morphogenesis of an epithelium (GO:1905331)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase (GO:0017186)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of transcription involved in meiotic cell cycle (GO:0051039)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
peptidyl-lysine hydroxylation (GO:0017185)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
regulation of transcription involved in meiotic cell cycle (GO:0051037)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
peptidyl-diphthamide biosynthetic process from peptidyl-histidine (GO:0017183)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of endosome size (GO:0051036)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
de novo centriole assembly involved in multi-ciliated epithelial cell differentiation (GO:0098535)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
peptidyl-diphthamide metabolic process (GO:0017182)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
centriole assembly (GO:0098534)	19	0	.52	-	 < 0.01	1.00E00	1.00E00
positive regulation of renal sodium excretion (GO:0035815)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
histone H3-K27 trimethylation (GO:0098532)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of renal sodium excretion (GO:0035813)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
tRNA transport (GO:0051031)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of strand invasion (GO:0098530)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
renal sodium excretion (GO:0035812)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
snRNA transport (GO:0051030)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of urine volume (GO:0035811)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
anthranilate metabolic process (GO:0043420)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of urine volume (GO:0035810)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
glycine betaine biosynthetic process (GO:0031456)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
glycine betaine metabolic process (GO:0031455)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of heterochromatin assembly (GO:0031452)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
telomerase holoenzyme complex assembly (GO:1905323)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of mesenchymal stem cell migration (GO:1905322)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
rRNA transport (GO:0051029)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
skeletal muscle fiber differentiation (GO:0098528)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of mesenchymal stem cell migration (GO:1905320)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of urine volume (GO:0035809)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
homocysteine catabolic process (GO:0043418)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of skeletal muscle tissue regeneration (GO:0043417)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
chiasma assembly (GO:0051026)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of skeletal muscle tissue regeneration (GO:0043416)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of skeletal muscle tissue regeneration (GO:0043415)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
adrenal cortex development (GO:0035801)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of fast-twitch skeletal muscle fiber contraction (GO:0031448)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of fast-twitch skeletal muscle fiber contraction (GO:0031446)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
slow-twitch skeletal muscle fiber contraction (GO:0031444)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
fast-twitch skeletal muscle fiber contraction (GO:0031443)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of mRNA 3'-end processing (GO:0031442)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
negative regulation of mRNA 3'-end processing (GO:0031441)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
regulation of mRNA 3'-end processing (GO:0031440)	22	0	.60	-	 < 0.01	1.00E00	1.00E00
semi-lunar valve development (GO:1905314)	20	0	.55	-	 < 0.01	1.00E00	1.00E00
transforming growth factor beta receptor signaling pathway involved in heart development (GO:1905313)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis (GO:1905312)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis (GO:1905310)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
actin filament bundle assembly (GO:0051017)	41	0	1.12	-	 < 0.01	6.28E-01	1.00E00
negative regulation of MAP kinase activity (GO:0043407)	49	0	1.34	-	 < 0.01	6.42E-01	1.00E00
barbed-end actin filament capping (GO:0051016)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
actin filament severing (GO:0051014)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
microtubule severing (GO:0051013)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
skeletal muscle tissue regeneration (GO:0043403)	18	0	.49	-	 < 0.01	1.00E00	1.00E00
microtubule sliding (GO:0051012)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
glucocorticoid mediated signaling pathway (GO:0043402)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of cohesin loading (GO:1905309)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of cardiac myofibril assembly (GO:1905305)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of cardiac myofibril assembly (GO:1905304)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of macropinocytosis (GO:1905303)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of calcium ion-dependent exocytosis (GO:0017158)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
regulation of macropinocytosis (GO:1905301)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
calcium-ion regulated exocytosis (GO:0017156)	17	0	.47	-	 < 0.01	1.00E00	1.00E00
polynucleotide 5' dephosphorylation (GO:0098507)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of lipoprotein lipase activity (GO:0051006)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
negative regulation of lipoprotein lipase activity (GO:0051005)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of lipoprotein lipase activity (GO:0051004)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
negative regulation of nitric-oxide synthase activity (GO:0051001)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
response to methotrexate (GO:0031427)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
keratinization (GO:0031424)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
stem cell division (GO:0017145)	18	0	.49	-	 < 0.01	1.00E00	1.00E00
drug metabolic process (GO:0017144)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
establishment of protein localization to chromosome (GO:0070199)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
protein localization to chromosome, telomeric region (GO:0070198)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
synaptonemal complex disassembly (GO:0070194)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
synaptonemal complex organization (GO:0070193)	17	0	.47	-	 < 0.01	1.00E00	1.00E00
kynurenine metabolic process (GO:0070189)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
nucleologenesis (GO:0017126)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
mitochondrial tyrosyl-tRNA aminoacylation (GO:0070184)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mitochondrial tryptophanyl-tRNA aminoacylation (GO:0070183)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of Golgi to plasma membrane CFTR protein transport (GO:0042999)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of Golgi to plasma membrane protein transport (GO:0042998)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of Golgi to plasma membrane protein transport (GO:0042997)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of Golgi to plasma membrane protein transport (GO:0042996)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
cytoplasmic sequestering of transcription factor (GO:0042994)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
positive regulation of isotype switching to IgA isotypes (GO:0048298)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of isotype switching to IgA isotypes (GO:0048297)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of isotype switching to IgA isotypes (GO:0048296)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of isotype switching to IgE isotypes (GO:0048294)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
isotype switching to IgG isotypes (GO:0048291)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
D-serine biosynthetic process (GO:0070179)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
D-serine metabolic process (GO:0070178)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of enamel mineralization (GO:0070175)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of enamel mineralization (GO:0070173)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of tooth mineralization (GO:0070172)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of tooth mineralization (GO:0070171)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of tooth mineralization (GO:0070170)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
amyloid precursor protein catabolic process (GO:0042987)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of amyloid precursor protein biosynthetic process (GO:0042985)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
amyloid precursor protein metabolic process (GO:0042982)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
lung alveolus development (GO:0048286)	30	0	.82	-	 < 0.01	1.00E00	1.00E00
organelle fusion (GO:0048284)	47	0	1.29	-	 < 0.01	6.38E-01	1.00E00
vesicle fusion with Golgi apparatus (GO:0048280)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of biomineral tissue development (GO:0070169)	19	0	.52	-	 < 0.01	1.00E00	1.00E00
negative regulation of biomineral tissue development (GO:0070168)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
regulation of excitatory synapse assembly (GO:1904889)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
enamel mineralization (GO:0070166)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cranial skeletal system development (GO:1904888)	39	0	1.07	-	 < 0.01	6.27E-01	1.00E00
positive regulation of adiponectin secretion (GO:0070165)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
Wnt signalosome assembly (GO:1904887)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of adiponectin secretion (GO:0070164)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of adiponectin secretion (GO:0070163)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of telomerase catalytic core complex assembly (GO:1904884)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of telomerase catalytic core complex assembly (GO:1904882)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular response to hydrogen sulfide (GO:1904881)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to hydrogen sulfide (GO:1904880)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mitochondrial seryl-tRNA aminoacylation (GO:0070158)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1904879)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1904878)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of DNA ligase activity (GO:1904877)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of DNA ligase activity (GO:1904875)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of telomerase RNA localization to Cajal body (GO:1904874)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
mitochondrial glycyl-tRNA aminoacylation (GO:0070150)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of telomerase RNA localization to Cajal body (GO:1904872)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein localization to Cajal body (GO:1904871)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
clathrin coat assembly (GO:0048268)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
behavioral response to pain (GO:0048266)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
determination of ventral identity (GO:0048264)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of centriole-centriole cohesion (GO:0030997)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
determination of dorsal identity (GO:0048263)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
determination of dorsal/ventral asymmetry (GO:0048262)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of receptor-mediated endocytosis (GO:0048261)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
recombinational interstrand cross-link repair (GO:0036298)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular response to decreased oxygen levels (GO:0036294)	49	0	1.34	-	 < 0.01	6.42E-01	1.00E00
regulation of protein localization to Cajal body (GO:1904869)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
DNA rewinding (GO:0036292)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein localization to Cajal body (GO:1904867)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein trans-autophosphorylation (GO:0036290)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mitochondrial alanyl-tRNA aminoacylation (GO:0070143)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
synaptic vesicle budding (GO:0070142)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of beta-catenin-TCF complex assembly (GO:1904864)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
response to UV-A (GO:0070141)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of beta-catenin-TCF complex assembly (GO:1904863)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
inhibitory synapse assembly (GO:1904862)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
excitatory synapse assembly (GO:1904861)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
lipoprotein transport (GO:0042953)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
mRNA stabilization (GO:0048255)	38	0	1.04	-	 < 0.01	6.27E-01	1.00E00
snoRNA localization (GO:0048254)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
elastic fiber assembly (GO:0048251)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
iron import into the mitochondrion (GO:0048250)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
peptidyl-serine autophosphorylation (GO:0036289)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
negative regulation of mitochondrial translation (GO:0070130)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of establishment of protein localization to telomere (GO:1904851)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
negative regulation of establishment of protein localization to telomere (GO:1904850)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
D-serine transport (GO:0042942)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
lymphocyte chemotaxis (GO:0048247)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
D-amino acid transport (GO:0042940)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
macrophage chemotaxis (GO:0048246)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
eosinophil chemotaxis (GO:0048245)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
thiamine pyrophosphate transmembrane transport (GO:0030974)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
retrograde protein transport, ER to cytosol (GO:0030970)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
response to 5-fluorouracil (GO:0036275)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
tRNA aminoacylation for mitochondrial protein translation (GO:0070127)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of cell chemotaxis to fibroblast growth factor (GO:1904849)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
mitochondrial translational termination (GO:0070126)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell chemotaxis to fibroblast growth factor (GO:1904848)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mitochondrial translational elongation (GO:0070125)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of cell chemotaxis to fibroblast growth factor (GO:1904847)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
mitochondrial translational initiation (GO:0070124)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to L-glutamine (GO:1904844)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
ciliary neurotrophic factor-mediated signaling pathway (GO:0070120)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of male germ-line stem cell asymmetric division (GO:1904840)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
tripeptide transport (GO:0042939)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of DNA recombination at telomere (GO:0048239)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of diacylglycerol biosynthetic process (GO:1900480)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
swimming behavior (GO:0036269)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
swimming (GO:0036268)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
peptidyl-arginine hydroxylation (GO:0030961)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of male germ-line stem cell asymmetric division (GO:1904838)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
7-methylguanosine cap hypermethylation (GO:0036261)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
RNA capping (GO:0036260)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of aortic smooth muscle cell differentiation (GO:1904831)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter (GO:1900477)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
glucocorticoid receptor signaling pathway (GO:0042921)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
plasma membrane to endosome transport (GO:0048227)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
astral microtubule nucleation (GO:0030954)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
astral microtubule organization (GO:0030953)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
multivesicular body assembly (GO:0036258)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
multivesicular body organization (GO:0036257)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
establishment or maintenance of actin cytoskeleton polarity (GO:0030950)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of aortic smooth muscle cell differentiation (GO:1904829)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of hydrogen sulfide biosynthetic process (GO:1904828)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of interleukin-6-mediated signaling pathway (GO:0070105)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of hydrogen sulfide biosynthetic process (GO:1904826)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of interleukin-6-mediated signaling pathway (GO:0070103)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
protein localization to microtubule plus-end (GO:1904825)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of chemokine-mediated signaling pathway (GO:0070101)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of chemokine-mediated signaling pathway (GO:0070100)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
inter-Golgi cisterna vesicle-mediated transport (GO:0048219)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947)	18	0	.49	-	 < 0.01	1.00E00	1.00E00
Golgi vesicle docking (GO:0048211)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
Golgi vesicle fusion to target membrane (GO:0048210)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein localization to chromosome, telomeric region (GO:1904816)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein localization to chromosome, telomeric region (GO:1904815)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of protein localization to chromosome, telomeric region (GO:1904814)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
rRNA acetylation involved in maturation of SSU-rRNA (GO:1904812)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of dense core granule transport (GO:1904811)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of long-term synaptic depression (GO:1900454)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
9-cis-retinoic acid metabolic process (GO:0042905)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of long-term synaptic depression (GO:1900453)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
9-cis-retinoic acid biosynthetic process (GO:0042904)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of glutamate receptor signaling pathway (GO:1900451)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
COPII vesicle coating (GO:0048208)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
vesicle targeting, rough ER to cis-Golgi (GO:0048207)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
COPI coating of Golgi vesicle (GO:0048205)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
vesicle targeting, trans-Golgi to endosome (GO:0048203)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
Golgi transport vesicle coating (GO:0048200)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of dense core granule transport (GO:1904809)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
granulocyte activation (GO:0036230)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
regulation of glutamate receptor signaling pathway (GO:1900449)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of neuron remodeling (GO:1904800)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein localization to nuclear inner membrane (GO:0036228)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
midbrain-hindbrain boundary development (GO:0030917)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
otic vesicle formation (GO:0030916)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
paranodal junction assembly (GO:0030913)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
olfactory placode formation (GO:0030910)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
cellular response to stem cell factor stimulus (GO:0036216)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to stem cell factor (GO:0036215)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of defense response to bacterium (GO:1900426)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
negative regulation of defense response to bacterium (GO:1900425)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of defense response to bacterium (GO:1900424)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
protein splicing (GO:0030908)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
notochord development (GO:0030903)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
hindbrain development (GO:0030902)	96	0	2.63	-	 < 0.01	1.87E-01	1.00E00
midbrain development (GO:0030901)	26	0	.71	-	 < 0.01	1.00E00	1.00E00
nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay (GO:0000294)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
deadenylation-dependent decapping of nuclear-transcribed mRNA (GO:0000290)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
negative regulation of cellular response to oxidative stress (GO:1900408)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of cellular response to oxidative stress (GO:1900407)	60	0	1.65	-	 < 0.01	4.12E-01	1.00E00
Rac protein signal transduction (GO:0016601)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
M phase (GO:0000279)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
polysaccharide catabolic process (GO:0000272)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
peptidoglycan metabolic process (GO:0000270)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
ureter maturation (GO:0035799)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of mitochondrial membrane permeability (GO:0035795)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of mitochondrial membrane permeability (GO:0035794)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
allantoin metabolic process (GO:0000255)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of corticotropin-releasing hormone secretion (GO:0043397)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
CD4-positive, alpha-beta T cell costimulation (GO:0035783)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of DNA binding (GO:0043392)	34	0	.93	-	 < 0.01	1.00E00	1.00E00
mature natural killer cell chemotaxis (GO:0035782)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
spliceosomal tri-snRNP complex assembly (GO:0000244)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
negative regulation of CAMKK-AMPK signaling cascade (GO:1905290)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of DNA binding (GO:0043388)	34	0	.93	-	 < 0.01	1.00E00	1.00E00
mycotoxin catabolic process (GO:0043387)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mycotoxin metabolic process (GO:0043385)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774)	22	0	.60	-	 < 0.01	1.00E00	1.00E00
negative T cell selection (GO:0043383)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
insulin secretion involved in cellular response to glucose stimulus (GO:0035773)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of memory T cell differentiation (GO:0043382)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
interleukin-4-mediated signaling pathway (GO:0035771)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of memory T cell differentiation (GO:0043380)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of CAMKK-AMPK signaling cascade (GO:1905289)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
pachytene (GO:0000239)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
leptotene (GO:0000237)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
positive regulation of retrograde transport, endosome to Golgi (GO:1905281)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of retrograde transport, endosome to Golgi (GO:1905280)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
memory T cell differentiation (GO:0043379)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
B cell chemotaxis across high endothelial venule (GO:0035769)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of CD8-positive, alpha-beta T cell differentiation (GO:0043378)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
endothelial cell chemotaxis to fibroblast growth factor (GO:0035768)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of CD8-positive, alpha-beta T cell differentiation (GO:0043377)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
endothelial cell chemotaxis (GO:0035767)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
regulation of CD8-positive, alpha-beta T cell differentiation (GO:0043376)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
cell chemotaxis to fibroblast growth factor (GO:0035766)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of retrograde transport, endosome to Golgi (GO:1905279)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
positive regulation of epithelial tube formation (GO:1905278)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of epithelial tube formation (GO:1905276)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of modification of postsynaptic actin cytoskeleton (GO:1905274)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
beta selection (GO:0043366)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
B cell chemotaxis (GO:0035754)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
protein localization to myelin sheath abaxonal region (GO:0035750)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein ubiquitination (GO:0031397)	55	0	1.51	-	 < 0.01	4.06E-01	1.00E00
positive regulation of prostaglandin biosynthetic process (GO:0031394)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of prostaglandin biosynthetic process (GO:0031393)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of prostaglandin biosynthetic process (GO:0031392)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
negative regulation of chromatin organization (GO:1905268)	43	0	1.18	-	 < 0.01	6.31E-01	1.00E00
endonucleolytic cleavage involved in tRNA processing (GO:1905267)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
meiotic spindle organization (GO:0000212)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
natural killer cell chemotaxis (GO:0035747)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
enucleate erythrocyte differentiation (GO:0043353)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway (GO:1905259)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway (GO:1905258)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
intraciliary transport involved in cilium assembly (GO:0035735)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
hepatic stellate cell activation (GO:0035733)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of aspartic-type peptidase activity (GO:1905247)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of aspartic-type peptidase activity (GO:1905246)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of aspartic-type peptidase activity (GO:1905245)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of modification of synaptic structure (GO:1905244)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
cellular response to 3,3',5-triiodo-L-thyronine (GO:1905243)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to 3,3',5-triiodo-L-thyronine (GO:1905242)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of canonical Wnt signaling pathway involved in osteoblast differentiation (GO:1905240)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
common myeloid progenitor cell proliferation (GO:0035726)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
protein unfolding (GO:0043335)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
sodium ion transmembrane transport (GO:0035725)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
interleukin-15-mediated signaling pathway (GO:0035723)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
interleukin-12-mediated signaling pathway (GO:0035722)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
intraciliary retrograde transport (GO:0035721)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
intraciliary anterograde transport (GO:0035720)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of canonical Wnt signaling pathway involved in osteoblast differentiation (GO:1905239)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to L-glutamate (GO:1905232)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
response to insecticide (GO:0017085)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043328)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
cellular response to nitrogen dioxide (GO:0035714)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of natural killer cell degranulation (GO:0043323)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to nitrogen dioxide (GO:0035713)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of natural killer cell degranulation (GO:0043322)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
T-helper 2 cell activation (GO:0035712)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of natural killer cell degranulation (GO:0043321)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
natural killer cell degranulation (GO:0043320)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of adhesion of symbiont to host epithelial cell (GO:1905226)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
clathrin-coated pit assembly (GO:1905224)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
epicardium morphogenesis (GO:1905223)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of platelet formation (GO:1905221)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
memory T cell activation (GO:0035709)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cytotoxic T cell degranulation (GO:0043316)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of neutrophil degranulation (GO:0043314)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of neutrophil degranulation (GO:0043313)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
neutrophil degranulation (GO:0043312)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
hematopoietic stem cell migration (GO:0035701)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of vesicle fusion (GO:0031340)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
regulation of platelet formation (GO:1905219)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to astaxanthin (GO:1905217)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of RNA binding (GO:1905216)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
respiratory chain complex III assembly (GO:0017062)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
7-methylguanosine RNA capping (GO:0009452)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of mast cell degranulation (GO:0043305)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
gamma-aminobutyric acid catabolic process (GO:0009450)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
mast cell degranulation (GO:0043303)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
negative regulation of leukocyte degranulation (GO:0043301)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of vesicle fusion (GO:0031339)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of vesicle fusion (GO:0031338)	18	0	.49	-	 < 0.01	1.00E00	1.00E00
positive regulation of cardiocyte differentiation (GO:1905209)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
negative regulation of cardiocyte differentiation (GO:1905208)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of cardiocyte differentiation (GO:1905207)	19	0	.52	-	 < 0.01	1.00E00	1.00E00
positive regulation of hydrogen peroxide-induced cell death (GO:1905206)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of connective tissue replacement (GO:1905205)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of connective tissue replacement (GO:1905204)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of connective tissue replacement (GO:1905203)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
gamma-aminobutyric acid biosynthetic process (GO:0009449)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
gamma-aminobutyric acid metabolic process (GO:0009448)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
putrescine catabolic process (GO:0009447)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
putrescine biosynthetic process (GO:0009446)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0017055)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
putrescine metabolic process (GO:0009445)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
pyruvate oxidation (GO:0009444)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
pyridoxal 5'-phosphate salvage (GO:0009443)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
glycolate metabolic process (GO:0009441)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
methylglyoxal metabolic process (GO:0009438)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
carnitine metabolic process (GO:0009437)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
glyoxylate catabolic process (GO:0009436)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
NAD biosynthetic process (GO:0009435)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
regulation of chemokine-mediated signaling pathway (GO:0070099)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of glucagon secretion (GO:0070094)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of glucagon secretion (GO:0070093)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
ubiquitin-dependent endocytosis (GO:0070086)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to water (GO:0009415)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
response to water deprivation (GO:0009414)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
vesicle targeting, to, from or within Golgi (GO:0048199)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
Golgi vesicle budding (GO:0048194)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
regulation of neuron remodeling (GO:1904799)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of core promoter binding (GO:1904798)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
toxin catabolic process (GO:0009407)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
histone lysine demethylation (GO:0070076)	22	0	.60	-	 < 0.01	1.00E00	1.00E00
negative regulation of core promoter binding (GO:1904797)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of core promoter binding (GO:1904796)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
protein nitrosylation (GO:0017014)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
toxin metabolic process (GO:0009404)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of euchromatin binding (GO:1904793)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of shelterin complex assembly (GO:1904792)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of shelterin complex assembly (GO:1904790)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cysteine transport (GO:0042883)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein-tetrapyrrole linkage (GO:0017006)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein-heme linkage (GO:0017003)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of NMDA glutamate receptor activity (GO:1904783)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of NMDA glutamate receptor activity (GO:1904782)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
'de novo' actin filament nucleation (GO:0070060)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein localization to centrosome (GO:1904781)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
arachidonic acid secretion (GO:0050482)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
regulation of short-term neuronal synaptic plasticity (GO:0048172)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
positive regulation of long-term neuronal synaptic plasticity (GO:0048170)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein localization to cell cortex (GO:1904778)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein localization to cell cortex (GO:1904777)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of protein localization to cell cortex (GO:1904776)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
mRNA splicing, via endonucleolytic cleavage and ligation (GO:0070054)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
antisense RNA metabolic process (GO:0042868)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
pyruvate biosynthetic process (GO:0042866)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of long-term neuronal synaptic plasticity (GO:0048169)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
regulation of neuronal synaptic plasticity (GO:0048168)	28	0	.77	-	 < 0.01	1.00E00	1.00E00
multi-layer follicle stage (GO:0048162)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of macroautophagy by TORC1 signaling (GO:1904766)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of myofibroblast differentiation (GO:1904762)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of myofibroblast differentiation (GO:1904761)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of myofibroblast differentiation (GO:1904760)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
L-alanine catabolic process (GO:0042853)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
L-alanine metabolic process (GO:0042851)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of vascular associated smooth muscle cell migration (GO:1904753)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein localization to nucleolus (GO:1904751)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
behavioral response to ethanol (GO:0048149)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
behavioral response to cocaine (GO:0048148)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
negative regulation of fibroblast proliferation (GO:0048147)	18	0	.49	-	 < 0.01	1.00E00	1.00E00
D-glucuronate catabolic process (GO:0042840)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
thyroid gland development (GO:0030878)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
fibroblast proliferation (GO:0048144)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
astrocyte activation (GO:0048143)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of protein localization to nucleolus (GO:1904749)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of apoptotic process involved in development (GO:1904748)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
positive regulation of apoptotic process involved in development (GO:1904747)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of apoptotic process involved in development (GO:1904746)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of telomeric DNA binding (GO:1904744)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of telomeric DNA binding (GO:1904743)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of telomeric DNA binding (GO:1904742)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
protein arginylation (GO:0016598)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
D-glucuronate metabolic process (GO:0042839)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of synaptic plasticity by receptor localization to synapse (GO:1900383)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
spermatocyte division (GO:0048137)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
male germ-line stem cell asymmetric division (GO:0048133)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cortical actin cytoskeleton organization (GO:0030866)	30	0	.82	-	 < 0.01	1.00E00	1.00E00
female germ-line stem cell asymmetric division (GO:0048132)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of polarized epithelial cell differentiation (GO:0030862)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of polarized epithelial cell differentiation (GO:0030860)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
phenotypic switching (GO:0036166)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
vascular associated smooth muscle cell migration (GO:1904738)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:1904736)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:1904735)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of electron transfer activity (GO:1904734)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of electron transfer activity (GO:1904733)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of electron transfer activity (GO:1904732)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
positive regulation of intestinal lipid absorption (GO:1904731)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of secondary metabolite biosynthetic process (GO:1900378)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
nucleosome positioning (GO:0016584)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of secondary metabolite biosynthetic process (GO:1900376)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
amyloid-beta metabolic process (GO:0050435)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of viral transcription (GO:0050434)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of purine nucleotide biosynthetic process (GO:1900372)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
pyridoxal phosphate biosynthetic process (GO:0042823)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
pyridoxal phosphate metabolic process (GO:0042822)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of RNA interference (GO:1900370)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
vitamin B6 catabolic process (GO:0042820)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
polarized epithelial cell differentiation (GO:0030859)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
positive regulation of epithelial cell differentiation (GO:0030858)	38	0	1.04	-	 < 0.01	6.27E-01	1.00E00
negative regulation of epithelial cell differentiation (GO:0030857)	32	0	.88	-	 < 0.01	1.00E00	1.00E00
regulation of epithelial cell differentiation (GO:0030856)	96	0	2.63	-	 < 0.01	1.87E-01	1.00E00
positive regulation of granulocyte differentiation (GO:0030854)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
negative regulation of granulocyte differentiation (GO:0030853)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
inner dynein arm assembly (GO:0036159)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
regulation of granulocyte differentiation (GO:0030852)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
outer dynein arm assembly (GO:0036158)	17	0	.47	-	 < 0.01	1.00E00	1.00E00
granulocyte differentiation (GO:0030851)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
prostate gland development (GO:0030850)	26	0	.71	-	 < 0.01	1.00E00	1.00E00
regulation of intestinal lipid absorption (GO:1904729)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
phosphatidylethanolamine acyl-chain remodeling (GO:0036152)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
phosphatidylcholine acyl-chain remodeling (GO:0036151)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
phosphatidylserine acyl-chain remodeling (GO:0036150)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein deubiquitination (GO:0016579)	79	0	2.17	-	 < 0.01	2.77E-01	1.00E00
histone deubiquitination (GO:0016578)	17	0	.47	-	 < 0.01	1.00E00	1.00E00
histone demethylation (GO:0016577)	22	0	.60	-	 < 0.01	1.00E00	1.00E00
negative regulation of RNA interference (GO:1900369)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
histone dephosphorylation (GO:0016576)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of RNA interference (GO:1900368)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
histone deacetylation (GO:0016575)	35	0	.96	-	 < 0.01	1.00E00	1.00E00
vitamin B6 biosynthetic process (GO:0042819)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
3'-phosphoadenosine 5'-phosphosulfate biosynthetic process (GO:0050428)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
histone ubiquitination (GO:0016574)	30	0	.82	-	 < 0.01	1.00E00	1.00E00
positive regulation of mRNA polyadenylation (GO:1900365)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
histone phosphorylation (GO:0016572)	19	0	.52	-	 < 0.01	1.00E00	1.00E00
vitamin B6 metabolic process (GO:0042816)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of mRNA polyadenylation (GO:1900364)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
regulation of mRNA polyadenylation (GO:1900363)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
phospholipase C-inhibiting G protein-coupled receptor signaling pathway (GO:0030845)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
phosphatidylglycerol acyl-chain remodeling (GO:0036148)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of AMPA glutamate receptor clustering (GO:1904719)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of AMPA glutamate receptor clustering (GO:1904717)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
positive regulation of chaperone-mediated autophagy (GO:1904716)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of chaperone-mediated autophagy (GO:1904715)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of chaperone-mediated autophagy (GO:1904714)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
protein import into peroxisome matrix, translocation (GO:0016561)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
protein import into peroxisome matrix, docking (GO:0016560)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of actin filament polymerization (GO:0030838)	58	0	1.59	-	 < 0.01	4.09E-01	1.00E00
somatic stem cell division (GO:0048103)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of actin filament depolymerization (GO:0030836)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
autophagic cell death (GO:0048102)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of actin filament depolymerization (GO:0030835)	32	0	.88	-	 < 0.01	1.00E00	1.00E00
regulation of actin filament depolymerization (GO:0030834)	41	0	1.12	-	 < 0.01	6.28E-01	1.00E00
peptidyl-histidine hydroxylation (GO:0036138)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
regulation of protein localization to adherens junction (GO:1904702)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein import into peroxisome matrix (GO:0016558)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
peroxisome membrane biogenesis (GO:0016557)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cytidine to uridine editing (GO:0016554)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
base conversion or substitution editing (GO:0016553)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
histone H3-K9 trimethylation (GO:0036124)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
histone H3-K9 dimethylation (GO:0036123)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular response to platelet-derived growth factor stimulus (GO:0036120)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
regulation of cardiac endothelial to mesenchymal transition (GO:0061999)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to platelet-derived growth factor (GO:0036119)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
fatty-acyl-CoA catabolic process (GO:0036115)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
medium-chain fatty-acyl-CoA catabolic process (GO:0036114)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
medium-chain fatty-acyl-CoA metabolic process (GO:0036112)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
very long-chain fatty-acyl-CoA metabolic process (GO:0036111)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
intein-mediated protein splicing (GO:0016539)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of transcription from RNA polymerase II promoter by glucose (GO:0061987)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of transcription by glucose (GO:0061986)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
meiosis II cell cycle process (GO:0061983)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
negative regulation of nucleotide biosynthetic process (GO:0030809)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of angiogenesis (GO:0016525)	51	0	1.40	-	 < 0.01	6.47E-01	1.00E00
articular cartilage development (GO:0061975)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
establishment of left/right asymmetry (GO:0061966)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
inactivation of MAPK activity (GO:0000188)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
activation of MAPKK activity (GO:0000186)	22	0	.60	-	 < 0.01	1.00E00	1.00E00
activation of MAPKKK activity (GO:0000185)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)	26	0	.71	-	 < 0.01	1.00E00	1.00E00
rDNA heterochromatin assembly (GO:0000183)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
penetration of cumulus oophorus (GO:0061956)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of protein K48-linked ubiquitination (GO:0061945)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein K48-linked ubiquitination (GO:0061944)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
CD8-positive, alpha-beta T cell extravasation (GO:0035697)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mitophagy by induced vacuole formation (GO:0035695)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mitochondrial protein catabolic process (GO:0035694)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein localization to somatodendritic compartment (GO:0061938)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to drug (GO:0035690)	27	0	.74	-	 < 0.01	1.00E00	1.00E00
positive regulation of erythrocyte enucleation (GO:0061931)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of erythrocyte enucleation (GO:0061930)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
leukocyte degranulation (GO:0043299)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
T-helper 1 cell diapedesis (GO:0035688)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
apical junction assembly (GO:0043297)	19	0	.52	-	 < 0.01	1.00E00	1.00E00
T-helper 1 cell extravasation (GO:0035687)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
helper T cell diapedesis (GO:0035685)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
helper T cell extravasation (GO:0035684)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
peptidyl-lysine propionylation (GO:0061921)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
manchette disassembly (GO:1905199)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
manchette assembly (GO:1905198)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
tricarboxylic acid transmembrane transport (GO:0035674)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
autophagosome-endosome fusion (GO:0061910)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of metaphase/anaphase transition of meiosis I (GO:1905188)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of metaphase/anaphase transition of meiosis I (GO:1905186)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
TRAM-dependent toll-like receptor 4 signaling pathway (GO:0035669)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
response to morphine (GO:0043278)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
TRAM-dependent toll-like receptor signaling pathway (GO:0035668)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
apoptotic cell clearance (GO:0043277)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
anoikis (GO:0043276)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
TRIF-dependent toll-like receptor signaling pathway (GO:0035666)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
autophagosome-lysosome fusion (GO:0061909)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of cardiac muscle tissue regeneration (GO:1905179)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of cardiac muscle tissue regeneration (GO:1905178)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein localization to phagocytic vesicle (GO:1905171)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of potassium ion transport (GO:0043268)	19	0	.52	-	 < 0.01	1.00E00	1.00E00
negative regulation of potassium ion transport (GO:0043267)	19	0	.52	-	 < 0.01	1.00E00	1.00E00
membrane protein intracellular domain proteolysis (GO:0031293)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
Ran protein signal transduction (GO:0031291)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
retinal ganglion cell axon guidance (GO:0031290)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of protein localization to phagocytic vesicle (GO:1905169)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of double-strand break repair via homologous recombination (GO:1905168)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
negative regulation of lysosomal protein catabolic process (GO:1905166)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of lysosomal protein catabolic process (GO:1905165)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of transcription involved in G2/M transition of mitotic cell cycle (GO:0000117)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of phagosome maturation (GO:1905164)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of phagosome maturation (GO:1905162)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
endosome to melanosome transport (GO:0035646)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
phosphoanandamide dephosphorylation (GO:0035644)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
locomotory exploration behavior (GO:0035641)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
exploration behavior (GO:0035640)	20	0	.55	-	 < 0.01	1.00E00	1.00E00
positive regulation of guanylate cyclase activity (GO:0031284)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of guanylate cyclase activity (GO:0031282)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of cyclase activity (GO:0031281)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
negative regulation of cyclase activity (GO:0031280)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of membrane invagination (GO:1905155)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of membrane invagination (GO:1905153)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
histidine biosynthetic process (GO:0000105)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of voltage-gated sodium channel activity (GO:1905152)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
sulfate assimilation (GO:0000103)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
FMN biosynthetic process (GO:0009398)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of voltage-gated sodium channel activity (GO:1905150)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
sulfur amino acid transport (GO:0000101)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
folic acid-containing compound biosynthetic process (GO:0009396)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
erythrocyte maturation (GO:0043249)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
telomere maintenance in response to DNA damage (GO:0043247)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
multicellular organismal signaling (GO:0035637)	18	0	.49	-	 < 0.01	1.00E00	1.00E00
response to stilbenoid (GO:0035634)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein-containing complex disassembly (GO:0043243)	20	0	.55	-	 < 0.01	1.00E00	1.00E00
regulation of cyclase activity (GO:0031279)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
bone mineralization involved in bone maturation (GO:0035630)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of lateral pseudopodium assembly (GO:0031275)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of pseudopodium assembly (GO:0031274)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of pseudopodium assembly (GO:0031272)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
translational attenuation (GO:0009386)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
renal glucose absorption (GO:0035623)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
intrahepatic bile duct development (GO:0035622)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
ER to Golgi ceramide transport (GO:0035621)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
pseudopodium assembly (GO:0031269)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of meiotic chromosome separation (GO:1905134)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of meiotic chromosome separation (GO:1905133)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of meiotic chromosome separation (GO:1905132)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
stress granule disassembly (GO:0035617)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
histone H2B conserved C-terminal lysine deubiquitination (GO:0035616)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
protein branching point deglutamylation (GO:0035611)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein side chain deglutamylation (GO:0035610)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of axo-dendritic protein transport (GO:1905128)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of axo-dendritic protein transport (GO:1905126)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
C-terminal protein deglutamylation (GO:0035609)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
protein deglutamylation (GO:0035608)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
myelin maintenance (GO:0043217)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
peptidyl-cysteine S-trans-nitrosylation (GO:0035606)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein deacylation (GO:0035601)	47	0	1.29	-	 < 0.01	6.38E-01	1.00E00
actin rod assembly (GO:0031247)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of lateral attachment of mitotic spindle microtubules to kinetochore (GO:1905116)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of lateral attachment of mitotic spindle microtubules to kinetochore (GO:1905115)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to leucine (GO:0043201)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
auditory behavior (GO:0031223)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
biomineral tissue development (GO:0031214)	46	0	1.26	-	 < 0.01	6.36E-01	1.00E00
posttranslational protein targeting to membrane, translocation (GO:0031204)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
oligosaccharide biosynthetic process (GO:0009312)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
amine catabolic process (GO:0009310)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
tRNA transcription by RNA polymerase III (GO:0042797)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
nucleolar large rRNA transcription by RNA polymerase I (GO:0042790)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
chromatin-mediated maintenance of transcription (GO:0048096)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
protein biotinylation (GO:0009305)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
tRNA transcription (GO:0009304)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of vascular associated smooth muscle contraction (GO:1904694)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
rRNA transcription (GO:0009303)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
midbrain morphogenesis (GO:1904693)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of type B pancreatic cell proliferation (GO:1904691)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of cytoplasmic translational initiation (GO:1904690)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
mRNA transcription by RNA polymerase II (GO:0042789)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
positive regulation of developmental pigmentation (GO:0048087)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
tRNA 3'-end processing (GO:0042780)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of cytoplasmic translational initiation (GO:1904688)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of metalloendopeptidase activity (GO:1904684)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular response to 3-methylcholanthrene (GO:1904682)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to 3-methylcholanthrene (GO:1904681)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
tRNA 3'-trailer cleavage (GO:0042779)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
mitochondrial ATP synthesis coupled proton transport (GO:0042776)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
mitochondrial ATP synthesis coupled electron transport (GO:0042775)	24	0	.66	-	 < 0.01	1.00E00	1.00E00
ATP synthesis coupled electron transport (GO:0042773)	25	0	.69	-	 < 0.01	1.00E00	1.00E00
DNA damage response, signal transduction resulting in transcription (GO:0042772)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
regulation of developmental pigmentation (GO:0048070)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
positive regulation of somatic stem cell division (GO:1904677)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of somatic stem cell division (GO:1904675)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of somatic stem cell population maintenance (GO:1904674)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of somatic stem cell population maintenance (GO:1904673)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of somatic stem cell population maintenance (GO:1904672)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
DNA damage response, detection of DNA damage (GO:0042769)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
nucleosome mobilization (GO:0042766)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
eye pigmentation (GO:0048069)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of sulfur metabolic process (GO:0042762)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
very long-chain fatty acid catabolic process (GO:0042760)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
developmental pigmentation (GO:0048066)	25	0	.69	-	 < 0.01	1.00E00	1.00E00
male germ-line stem cell population maintenance (GO:0036098)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of ubiquitin protein ligase activity (GO:1904668)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
germ cell proliferation (GO:0036093)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of ubiquitin protein ligase activity (GO:1904667)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0036091)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
cleavage furrow ingression (GO:0036090)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
long-chain fatty acid biosynthetic process (GO:0042759)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
long-chain fatty acid catabolic process (GO:0042758)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
drinking behavior (GO:0042756)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
eating behavior (GO:0042755)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
negative regulation of circadian rhythm (GO:0042754)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
post-embryonic eye morphogenesis (GO:0048050)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cleavage furrow formation (GO:0036089)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
D-serine catabolic process (GO:0036088)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
glucose transmembrane transport (GO:1904659)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of fat cell apoptotic process (GO:1904651)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
hydrogen peroxide catabolic process (GO:0042744)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
embryonic eye morphogenesis (GO:0048048)	18	0	.49	-	 < 0.01	1.00E00	1.00E00
focal adhesion assembly (GO:0048041)	22	0	.60	-	 < 0.01	1.00E00	1.00E00
replacement ossification (GO:0036075)	19	0	.52	-	 < 0.01	1.00E00	1.00E00
regulation of fat cell apoptotic process (GO:1904649)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
direct ossification (GO:0036072)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
cellular response to amyloid-beta (GO:1904646)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
response to amyloid-beta (GO:1904645)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
exogenous drug catabolic process (GO:0042738)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
drug catabolic process (GO:0042737)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
positive regulation of CD4-positive, alpha-beta T cell costimulation (GO:1900281)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
D-xylose metabolic process (GO:0042732)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
fibrinolysis (GO:0042730)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
protein O-linked fucosylation (GO:0036066)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
fucosylation (GO:0036065)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cellular response to ionomycin (GO:1904637)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
response to ionomycin (GO:1904636)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of glomerular visceral epithelial cell apoptotic process (GO:1904635)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of glomerular visceral epithelial cell apoptotic process (GO:1904633)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular response to glucoside (GO:1904632)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to glucoside (GO:1904631)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of CD4-positive, alpha-beta T cell costimulation (GO:1900279)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to diterpene (GO:1904630)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
peptide hormone processing (GO:0016486)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
flavin-containing compound catabolic process (GO:0042728)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of proteinase activated receptor activity (GO:1900276)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
flavin-containing compound biosynthetic process (GO:0042727)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of phospholipase C activity (GO:1900275)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cytosolic transport (GO:0016482)	94	0	2.58	-	 < 0.01	1.84E-01	1.00E00
flavin-containing compound metabolic process (GO:0042726)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of phospholipase C activity (GO:1900274)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
positive regulation of long-term synaptic potentiation (GO:1900273)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
negative regulation of transcription by RNA polymerase III (GO:0016480)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of long-term synaptic potentiation (GO:1900272)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of mRNA splicing, via spliceosome (GO:0048026)	19	0	.52	-	 < 0.01	1.00E00	1.00E00
negative regulation of mRNA splicing, via spliceosome (GO:0048025)	20	0	.55	-	 < 0.01	1.00E00	1.00E00
positive regulation of melanin biosynthetic process (GO:0048023)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of melanin biosynthetic process (GO:0048021)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
response to diterpene (GO:1904629)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to phorbol 13-acetate 12-myristate (GO:1904628)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
response to phorbol 13-acetate 12-myristate (GO:1904627)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of transcription by RNA polymerase I (GO:0016479)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
positive regulation of DNA-directed DNA polymerase activity (GO:1900264)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
regulation of DNA-directed DNA polymerase activity (GO:1900262)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
negative regulation of RNA-directed 5'-3' RNA polymerase activity (GO:1900260)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
maternal behavior (GO:0042711)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
inositol phosphate-mediated signaling (GO:0048016)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
phosphatidylinositol-mediated signaling (GO:0048015)	44	0	1.21	-	 < 0.01	6.32E-01	1.00E00
Tie signaling pathway (GO:0048014)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
ephrin receptor signaling pathway (GO:0048013)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
hepatocyte growth factor receptor signaling pathway (GO:0048012)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
neurotrophin TRK receptor signaling pathway (GO:0048011)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
peptidyl-lysine desuccinylation (GO:0036049)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
protein desuccinylation (GO:0036048)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
peptidyl-lysine demalonylation (GO:0036047)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein demalonylation (GO:0036046)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of actin binding (GO:1904618)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of actin binding (GO:1904617)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of actin binding (GO:1904616)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular response to 2,3,7,8-tetrachlorodibenzodioxine (GO:1904613)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
response to 2,3,7,8-tetrachlorodibenzodioxine (GO:1904612)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of RNA-directed 5'-3' RNA polymerase activity (GO:1900259)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
eye photoreceptor cell fate commitment (GO:0042706)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
insulin-like growth factor receptor signaling pathway (GO:0048009)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
progesterone secretion (GO:0042701)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
antigen processing and presentation, exogenous lipid antigen via MHC class Ib (GO:0048007)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
antigen processing and presentation of lipid antigen via MHC class Ib (GO:0048003)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
antigen processing and presentation of peptide antigen (GO:0048002)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
sequestering of triglyceride (GO:0030730)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
osteoclast development (GO:0036035)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
cellular response to monosodium L-glutamate (GO:1904609)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to monosodium L-glutamate (GO:1904608)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
neural crest cell delamination (GO:0036032)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of cytoplasmic translational elongation (GO:1900248)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of cytoplasmic translational elongation (GO:1900247)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of RIG-I signaling pathway (GO:1900246)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of MDA-5 signaling pathway (GO:1900245)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of synaptic vesicle endocytosis (GO:1900244)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
regulation of synaptic vesicle endocytosis (GO:1900242)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
negative regulation of phenotypic switching (GO:1900240)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
ovulation (GO:0030728)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
embryonic skeletal limb joint morphogenesis (GO:0036023)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
limb joint morphogenesis (GO:0036022)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
somatic recombination of immunoglobulin gene segments (GO:0016447)	21	0	.58	-	 < 0.01	1.00E00	1.00E00
regulation of phenotypic switching (GO:1900239)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
somatic hypermutation of immunoglobulin genes (GO:0016446)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
somatic diversification of immunoglobulins (GO:0016445)	27	0	.74	-	 < 0.01	1.00E00	1.00E00
somatic cell DNA recombination (GO:0016444)	29	0	.80	-	 < 0.01	1.00E00	1.00E00
negative regulation of Kit signaling pathway (GO:1900235)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of Kit signaling pathway (GO:1900234)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
germ-line stem cell population maintenance (GO:0030718)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
cellular response to interleukin-3 (GO:0036016)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
response to interleukin-3 (GO:0036015)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
protein localization to endosome (GO:0036010)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of single-species biofilm formation in or on host organism (GO:1900229)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of single-species biofilm formation in or on host organism (GO:1900228)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of NLRP3 inflammasome complex assembly (GO:1900227)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of mini excitatory postsynaptic potential (GO:0061885)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of NLRP3 inflammasome complex assembly (GO:1900226)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of mini excitatory postsynaptic potential (GO:0061884)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of NLRP3 inflammasome complex assembly (GO:1900225)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry (GO:1900224)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of anterograde axonal transport of mitochondrion (GO:0061881)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of amyloid-beta clearance (GO:1900222)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of anterograde axonal transport of mitochondrion (GO:0061880)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis (GO:1900220)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to macrophage colony-stimulating factor stimulus (GO:0036006)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
response to macrophage colony-stimulating factor (GO:0036005)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
negative regulation of apoptotic process involved in metanephric nephron tubule development (GO:1900218)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of apoptotic process involved in metanephric nephron tubule development (GO:1900217)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of hepatic stellate cell contraction (GO:0061875)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of apoptotic process involved in metanephric collecting duct development (GO:1900215)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of hepatic stellate cell contraction (GO:0061873)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of apoptotic process involved in metanephric collecting duct development (GO:1900214)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of mesenchymal cell apoptotic process involved in metanephros development (GO:1900212)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of mesenchymal cell apoptotic process involved in metanephros development (GO:1900211)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of cardiolipin metabolic process (GO:1900210)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
sulfur amino acid biosynthetic process (GO:0000097)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
regulation of cardiolipin metabolic process (GO:1900208)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
mitotic metaphase (GO:0000089)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
mitotic M phase (GO:0000087)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
mitotic G2 phase (GO:0000085)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083)	17	0	.47	-	 < 0.01	1.00E00	1.00E00
G1/S transition of mitotic cell cycle (GO:0000082)	57	0	1.56	-	 < 0.01	4.07E-01	1.00E00
mitotic G1 phase (GO:0000080)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
endoplasmic reticulum stress-induced pre-emptive quality control (GO:0061857)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
DNA damage checkpoint (GO:0000077)	73	0	2.00	-	 < 0.01	2.68E-01	1.00E00
DNA replication checkpoint (GO:0000076)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
response to cholecystokinin (GO:0061847)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
microtubule organizing center localization (GO:0061842)	25	0	.69	-	 < 0.01	1.00E00	1.00E00
purinergic nucleotide receptor signaling pathway (GO:0035590)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein localization to tricellular tight junction (GO:0061833)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
ribosomal small subunit export from nucleus (GO:0000056)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
ribosomal large subunit export from nucleus (GO:0000055)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
ribosomal subunit export from nucleus (GO:0000054)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
argininosuccinate metabolic process (GO:0000053)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
citrulline metabolic process (GO:0000052)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
urea cycle (GO:0000050)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
G protein-coupled purinergic receptor signaling pathway (GO:0035588)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
calcium-mediated signaling using extracellular calcium source (GO:0035585)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
calcium-mediated signaling using intracellular calcium source (GO:0035584)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
sequestering of TGFbeta in extracellular matrix (GO:0035583)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
sequestering of BMP in extracellular matrix (GO:0035582)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
sequestering of extracellular ligand from receptor (GO:0035581)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
telomeric D-loop disassembly (GO:0061820)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
negative regulation of guanyl-nucleotide exchange factor activity (GO:1905098)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of guanyl-nucleotide exchange factor activity (GO:1905097)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization (GO:1905090)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
transition metal ion transport (GO:0000041)	22	0	.60	-	 < 0.01	1.00E00	1.00E00
telomeric DNA-containing double minutes formation (GO:0061819)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
histone H4-K20 demethylation (GO:0035574)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
N-terminal peptidyl-serine trimethylation (GO:0035573)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
N-terminal peptidyl-serine dimethylation (GO:0035572)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
N-terminal peptidyl-serine methylation (GO:0035570)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization (GO:1905089)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
electron transport coupled proton transport (GO:0015990)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cell wall mannoprotein biosynthetic process (GO:0000032)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
rhythmic excitation (GO:0043179)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
N-terminal peptidyl-proline methylation (GO:0035568)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
non-canonical Wnt signaling pathway (GO:0035567)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
regulation of metanephros size (GO:0035566)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of pronephros size (GO:0035565)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
nucleoside salvage (GO:0043174)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of kidney size (GO:0035564)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
nucleotide salvage (GO:0043173)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
positive regulation of chromatin binding (GO:0035563)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
negative regulation of chromatin binding (GO:0035562)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
peptide catabolic process (GO:0043171)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
regulation of chromatin binding (GO:0035561)	22	0	.60	-	 < 0.01	1.00E00	1.00E00
energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
ATP synthesis coupled proton transport (GO:0015986)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
energy coupled proton transport, down electrochemical gradient (GO:0015985)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
ribosomal small subunit assembly (GO:0000028)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
positive regulation of tight junction disassembly (GO:1905075)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of tight junction disassembly (GO:1905073)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mitotic spindle elongation (GO:0000022)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
D-alanine catabolic process (GO:0055130)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cell envelope organization (GO:0043163)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
oxidative single-stranded RNA demethylation (GO:0035553)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162)	17	0	.47	-	 < 0.01	1.00E00	1.00E00
oxidative single-stranded DNA demethylation (GO:0035552)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
allantois development (GO:1905069)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
L-proline biosynthetic process (GO:0055129)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of canonical Wnt signaling pathway involved in heart development (GO:1905068)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of mitotic recombination (GO:0000019)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of canonical Wnt signaling pathway involved in heart development (GO:1905066)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of vascular associated smooth muscle cell differentiation (GO:1905065)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
single strand break repair (GO:0000012)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
negative regulation of SNARE complex assembly (GO:0035544)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of SNARE complex assembly (GO:0035543)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
induction of bacterial agglutination (GO:0043152)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of SNARE complex assembly (GO:0035542)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
diadenosine tetraphosphate biosynthetic process (GO:0015966)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
diadenosine tetraphosphate metabolic process (GO:0015965)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
diadenosine polyphosphate biosynthetic process (GO:0015960)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
relaxation of cardiac muscle (GO:0055119)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of cardiac muscle contraction (GO:0055118)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of cardiac muscle contraction (GO:0055117)	25	0	.69	-	 < 0.01	1.00E00	1.00E00
positive regulation of base-excision repair (GO:1905053)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
mRNA transcription (GO:0009299)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
regulation of base-excision repair (GO:1905051)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
GDP-mannose biosynthetic process (GO:0009298)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
mitochondrial genome maintenance (GO:0000002)	17	0	.47	-	 < 0.01	1.00E00	1.00E00
stress fiber assembly (GO:0043149)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
regulation of translation by machinery localization (GO:0043143)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
diadenosine polyphosphate metabolic process (GO:0015959)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of metallopeptidase activity (GO:1905049)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
Golgi to transport vesicle transport (GO:0055108)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
Golgi to secretory granule transport (GO:0055107)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of epithelium regeneration (GO:1905043)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of epithelium regeneration (GO:1905042)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of epithelium regeneration (GO:1905041)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
DNA replication, removal of RNA primer (GO:0043137)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
retrograde transport, plasma membrane to Golgi (GO:0035526)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein K29-linked deubiquitination (GO:0035523)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
monoubiquitinated histone H2A deubiquitination (GO:0035522)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
monoubiquitinated histone deubiquitination (GO:0035521)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
monoubiquitinated protein deubiquitination (GO:0035520)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
metallo-sulfur cluster assembly (GO:0031163)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
phosphatidylinositol catabolic process (GO:0031161)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
formate metabolic process (GO:0015942)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of membrane lipid metabolic process (GO:1905038)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
positive regulation of antifungal innate immune response (GO:1905036)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of antifungal innate immune response (GO:1905034)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of membrane repolarization during cardiac muscle cell action potential (GO:1905033)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of membrane repolarization during cardiac muscle cell action potential (GO:1905031)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
protein K29-linked ubiquitination (GO:0035519)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
histone H2A monoubiquitination (GO:0035518)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
oxidative RNA demethylation (GO:0035513)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
oxidative DNA demethylation (GO:0035511)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
DNA dealkylation (GO:0035510)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
pantothenate metabolic process (GO:0015939)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
coenzyme A catabolic process (GO:0015938)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
coenzyme A biosynthetic process (GO:0015937)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
coenzyme A metabolic process (GO:0015936)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
positive regulation of membrane repolarization during ventricular cardiac muscle cell action potential (GO:1905026)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of membrane repolarization during ventricular cardiac muscle cell action potential (GO:1905024)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to pH (GO:0009268)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
cellular response to starvation (GO:0009267)	110	0	3.02	-	 < 0.01	1.24E-01	1.00E00
2'-deoxyribonucleotide biosynthetic process (GO:0009265)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
negative regulation of myosin-light-chain-phosphatase activity (GO:0035509)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of myosin-light-chain-phosphatase activity (GO:0035508)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of vascular permeability (GO:0043117)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
deoxyribonucleotide biosynthetic process (GO:0009263)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
regulation of myosin-light-chain-phosphatase activity (GO:0035507)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of vascular permeability (GO:0043116)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
positive regulation of myosin light chain kinase activity (GO:0035505)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of vascular permeability (GO:0043114)	21	0	.58	-	 < 0.01	1.00E00	1.00E00
regulation of myosin light chain kinase activity (GO:0035504)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
receptor clustering (GO:0043113)	22	0	.60	-	 < 0.01	1.00E00	1.00E00
replication fork arrest (GO:0043111)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
anaphase-promoting complex-dependent catabolic process (GO:0031145)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
lipopolysaccharide transport (GO:0015920)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
10-formyltetrahydrofolate biosynthetic process (GO:0009257)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of L-lysine import across plasma membrane (GO:1905010)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
peptidoglycan catabolic process (GO:0009253)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of GTP cyclohydrolase I activity (GO:0043105)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
glucan catabolic process (GO:0009251)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
hypoxanthine salvage (GO:0043103)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
amino acid salvage (GO:0043102)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
purine-containing compound salvage (GO:0043101)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
peroxisomal membrane transport (GO:0015919)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
sterol transport (GO:0015918)	25	0	.69	-	 < 0.01	1.00E00	1.00E00
sister chromatid biorientation (GO:0031134)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of axon diameter (GO:0031133)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
long-chain fatty acid import into peroxisome (GO:0015910)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of L-lysine import across plasma membrane (GO:1905008)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905007)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905006)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905005)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein lipoylation (GO:0009249)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
glycolipid biosynthetic process (GO:0009247)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of membrane repolarization during atrial cardiac muscle cell action potential (GO:1905000)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
isopentenyl diphosphate biosynthetic process (GO:0009240)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
inductive cell-cell signaling (GO:0031129)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
developmental induction (GO:0031128)	24	0	.66	-	 < 0.01	1.00E00	1.00E00
long-chain fatty acid transport (GO:0015909)	22	0	.60	-	 < 0.01	1.00E00	1.00E00
rRNA 3'-end processing (GO:0031125)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
mRNA 3'-end processing (GO:0031124)	34	0	.93	-	 < 0.01	1.00E00	1.00E00
snRNA pseudouridine synthesis (GO:0031120)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
siderophore metabolic process (GO:0009237)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cobalamin metabolic process (GO:0009235)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
riboflavin biosynthetic process (GO:0009231)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
tRNA pseudouridine synthesis (GO:0031119)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
rRNA pseudouridine synthesis (GO:0031118)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
positive regulation of microtubule depolymerization (GO:0031117)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of microtubule polymerization (GO:0031116)	23	0	.63	-	 < 0.01	1.00E00	1.00E00
negative regulation of microtubule polymerization (GO:0031115)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
regulation of microtubule polymerization (GO:0031113)	39	0	1.07	-	 < 0.01	6.27E-01	1.00E00
positive regulation of microtubule polymerization or depolymerization (GO:0031112)	25	0	.69	-	 < 0.01	1.00E00	1.00E00
thiamine diphosphate biosynthetic process (GO:0009229)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
nucleotide-sugar catabolic process (GO:0009227)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
CMP biosynthetic process (GO:0009224)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
pyrimidine ribonucleotide catabolic process (GO:0009222)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
pyrimidine deoxyribonucleotide biosynthetic process (GO:0009221)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
pyrimidine ribonucleotide biosynthetic process (GO:0009220)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
septin ring organization (GO:0031106)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
axon regeneration (GO:0031103)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
neuron projection regeneration (GO:0031102)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
pyrimidine ribonucleotide metabolic process (GO:0009218)	19	0	.52	-	 < 0.01	1.00E00	1.00E00
purine deoxyribonucleoside triphosphate catabolic process (GO:0009217)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
purine deoxyribonucleoside triphosphate biosynthetic process (GO:0009216)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
purine deoxyribonucleoside triphosphate metabolic process (GO:0009215)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
cyclic nucleotide catabolic process (GO:0009214)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
pyrimidine deoxyribonucleoside triphosphate biosynthetic process (GO:0009212)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
follicle-stimulating hormone signaling pathway (GO:0042699)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
menopause (GO:0042697)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
thelarche (GO:0042695)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
muscle cell fate specification (GO:0042694)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
muscle cell fate commitment (GO:0042693)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
pyrimidine ribonucleoside triphosphate biosynthetic process (GO:0009209)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
pyrimidine ribonucleoside triphosphate metabolic process (GO:0009208)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
positive regulation of termination of RNA polymerase II transcription (GO:1904595)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of termination of RNA polymerase II transcription (GO:1904594)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
deoxyribonucleoside triphosphate biosynthetic process (GO:0009202)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein import (GO:1904590)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
response to glycoprotein (GO:1904587)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular response to putrescine (GO:1904586)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to putrescine (GO:1904585)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of intracellular mRNA localization (GO:1904582)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of intracellular mRNA localization (GO:1904580)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
retinal cone cell differentiation (GO:0042670)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
cellular response to thapsigargin (GO:1904579)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to thapsigargin (GO:1904578)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of selenocysteine incorporation (GO:1904571)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of inner ear auditory receptor cell fate specification (GO:0042669)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
auditory receptor cell fate determination (GO:0042668)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
auditory receptor cell fate specification (GO:0042667)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of endodermal cell fate specification (GO:0042664)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of endodermal cell fate specification (GO:0042663)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of mesodermal cell fate specification (GO:0042662)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of mesodermal cell fate specification (GO:0042661)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of cell fate specification (GO:0042660)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of selenocysteine incorporation (GO:1904569)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein localization to postsynapse (GO:0062237)	27	0	.74	-	 < 0.01	1.00E00	1.00E00
platelet activating factor catabolic process (GO:0062234)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
prostanoid catabolic process (GO:0062232)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
phosphatidylinositol 5-phosphate metabolic process (GO:1904562)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
response to arachidonic acid (GO:1904550)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of oocyte maturation (GO:1900195)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
membrane bending (GO:0097753)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of oocyte maturation (GO:1900194)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of oocyte maturation (GO:1900193)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of DNA stability (GO:0097752)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
endosome membrane tubulation (GO:0097750)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of single-species biofilm formation (GO:1900191)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of single-species biofilm formation (GO:1900190)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
anagen (GO:0042640)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
membrane tubulation (GO:0097749)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
mitochondrial tRNA 5'-end processing (GO:0097745)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of clathrin-dependent endocytosis (GO:1900186)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
catagen (GO:0042637)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of hair cycle (GO:0042635)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
de novo centriole assembly (GO:0097742)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein localization to nucleus (GO:1900181)	20	0	.55	-	 < 0.01	1.00E00	1.00E00
cellular response to water deprivation (GO:0042631)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of pattern recognition receptor signaling pathway (GO:0062208)	22	0	.60	-	 < 0.01	1.00E00	1.00E00
positive regulation of telomeric loop disassembly (GO:1904535)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of telomeric loop disassembly (GO:1904534)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of telomeric loop disassembly (GO:1904533)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of actin filament binding (GO:1904531)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of actin filament binding (GO:1904530)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mating plug formation (GO:0042628)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry (GO:1900176)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
extracellular exosome biogenesis (GO:0097734)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry (GO:1900175)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of glucocorticoid mediated signaling pathway (GO:1900170)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of vitamin metabolic process (GO:0030656)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of actin filament binding (GO:1904529)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of microtubule binding (GO:1904528)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of microtubule binding (GO:1904527)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of microtubule binding (GO:1904526)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
regulation of glucocorticoid mediated signaling pathway (GO:1900169)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry (GO:1900164)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
sperm motility (GO:0097722)	56	0	1.54	-	 < 0.01	4.07E-01	1.00E00
positive regulation of phospholipid scramblase activity (GO:1900163)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
calcineurin-mediated signaling (GO:0097720)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
regulation of phospholipid scramblase activity (GO:1900161)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
aminoglycoside antibiotic metabolic process (GO:0030647)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cellular chloride ion homeostasis (GO:0030644)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cellular phosphate ion homeostasis (GO:0030643)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of TORC2 signaling (GO:1904515)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of bone mineralization involved in bone maturation (GO:1900159)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of bone mineralization involved in bone maturation (GO:1900158)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of bone mineralization involved in bone maturation (GO:1900157)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of bone trabecula formation (GO:1900155)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of bone trabecula formation (GO:1900154)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
vesicle targeting, trans-Golgi to periciliary membrane compartment (GO:0097712)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900152)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
regulation of defense response to fungus (GO:1900150)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
polyketide metabolic process (GO:0030638)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of telomere maintenance in response to DNA damage (GO:1904506)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of telomere maintenance in response to DNA damage (GO:1904505)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of lipophagy (GO:1904504)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of lipophagy (GO:1904502)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
connective tissue replacement (GO:0097709)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of chromatin-mediated maintenance of transcription (GO:1904501)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of Schwann cell migration (GO:1900149)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of Schwann cell migration (GO:1900147)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of nodal signaling pathway involved in determination of left/right asymmetry (GO:1900146)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of nodal signaling pathway involved in determination of left/right asymmetry (GO:1900145)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of oligodendrocyte apoptotic process (GO:1900142)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of oligodendrocyte apoptotic process (GO:1900141)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of arachidonic acid secretion (GO:1900139)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of phospholipase A2 activity (GO:1900138)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
meiotic chromosome movement towards spindle pole (GO:0016344)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
secretory granule maturation (GO:0061792)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of lipid binding (GO:1900131)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of lipid binding (GO:1900130)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
dense core granule priming (GO:0061789)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of hyaluronan biosynthetic process (GO:1900126)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
establishment or maintenance of polarity of embryonic epithelium (GO:0016332)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of receptor binding (GO:1900122)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of receptor binding (GO:1900121)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
positive regulation of DNA repair by transcription from RNA polymerase II promoter (GO:0100026)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of execution phase of apoptosis (GO:1900118)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
extracellular negative regulation of signal transduction (GO:1900116)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
extracellular regulation of signal transduction (GO:1900115)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
female meiosis chromosome segregation (GO:0016321)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
negative regulation of histone H3-K9 trimethylation (GO:1900113)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
response to caloric restriction (GO:0061771)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
endoplasmic reticulum membrane fusion (GO:0016320)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of histone H3-K9 dimethylation (GO:1900111)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of histone H3-K9 dimethylation (GO:1900110)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
mitochondrion transport along microtubule (GO:0047497)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
vesicle transport along microtubule (GO:0047496)	35	0	.96	-	 < 0.01	1.00E00	1.00E00
regulation of histone H3-K9 dimethylation (GO:1900109)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of lung blood pressure (GO:0061767)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of nodal signaling pathway (GO:1900108)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of nodal signaling pathway (GO:1900107)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of hyaluranon cable assembly (GO:1900106)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
multivesicular body-lysosome fusion (GO:0061763)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
CAMKK-AMPK signaling cascade (GO:0061762)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of hyaluranon cable assembly (GO:1900104)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
antifungal innate immune response (GO:0061760)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
low-density lipoprotein particle mediated signaling (GO:0055096)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
lipoprotein particle mediated signaling (GO:0055095)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
response to lipoprotein particle (GO:0055094)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
response to hyperoxia (GO:0055093)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of response to osmotic stress (GO:0047484)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
phospholipid homeostasis (GO:0055091)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
acylglycerol homeostasis (GO:0055090)	24	0	.66	-	 < 0.01	1.00E00	1.00E00
leukocyte adhesion to vascular endothelial cell (GO:0061756)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
substrate localization to autophagosome (GO:0061753)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
fatty acid homeostasis (GO:0055089)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
monovalent inorganic anion homeostasis (GO:0055083)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
anion homeostasis (GO:0055081)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
motor behavior (GO:0061744)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
motor learning (GO:0061743)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
sodium ion homeostasis (GO:0055078)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
potassium ion homeostasis (GO:0055075)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cadmium ion homeostasis (GO:0055073)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
copper ion homeostasis (GO:0055070)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
carnosine biosynthetic process (GO:0035499)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
carnosine metabolic process (GO:0035498)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
protein lipidation involved in autophagosome assembly (GO:0061739)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
SNARE complex disassembly (GO:0035494)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
late endosomal microautophagy (GO:0061738)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
SNARE complex assembly (GO:0035493)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
leukotriene signaling pathway (GO:0061737)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
engulfment of target by autophagosome (GO:0061736)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of leukotriene production involved in inflammatory response (GO:0035491)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization (GO:0061734)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of leukotriene production involved in inflammatory response (GO:0035490)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mitochondrial acetyl-CoA biosynthetic process from pyruvate (GO:0061732)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
zinc ion homeostasis (GO:0055069)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
chloride ion homeostasis (GO:0055064)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
phosphate ion homeostasis (GO:0055062)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
purine nucleobase salvage (GO:0043096)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of GTP cyclohydrolase I activity (GO:0043095)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular metabolic compound salvage (GO:0043094)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
methylglyoxal catabolic process to lactate (GO:0061727)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
gastric emptying (GO:0035483)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
gastric motility (GO:0035482)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of Notch signaling pathway involved in heart induction (GO:0035481)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
lipophagy (GO:0061724)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of Notch signaling pathway involved in heart induction (GO:0035480)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
glycophagy (GO:0061723)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
asymmetric neuroblast division (GO:0055059)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
neuroblast division (GO:0055057)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
miRNA 2'-O-methylation (GO:0061715)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of vascular wound healing (GO:0035470)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
anterior neural tube closure (GO:0061713)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
amiloride transport (GO:0015898)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
drug transport (GO:0015893)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
anastral spindle assembly (GO:0055048)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
determination of pancreatic left/right asymmetry (GO:0035469)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
reticulophagy (GO:0061709)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
vitamin transmembrane transport (GO:0035461)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cobalamin transport (GO:0015889)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
heme transport (GO:0015886)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
folic acid transport (GO:0015884)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
FAD transport (GO:0015883)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to interferon-beta (GO:0035458)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
cellular response to interferon-alpha (GO:0035457)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
response to interferon-beta (GO:0035456)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
response to interferon-alpha (GO:0035455)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
intercellular bridge organization (GO:0043063)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
meiotic metaphase I plate congression (GO:0043060)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
carnitine transport (GO:0015879)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
dopamine transport (GO:0015872)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
choline transport (GO:0015871)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
acetylcholine transport (GO:0015870)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of cardiac muscle tissue development (GO:0055026)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of cardiac muscle tissue development (GO:0055025)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of cardiac muscle tissue development (GO:0055024)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of cardiac muscle tissue growth (GO:0055023)	26	0	.71	-	 < 0.01	1.00E00	1.00E00
negative regulation of cardiac muscle tissue growth (GO:0055022)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
regulation of cardiac muscle tissue growth (GO:0055021)	42	0	1.15	-	 < 0.01	6.30E-01	1.00E00
positive regulation of cardiac muscle fiber development (GO:0055020)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
deadenylation-independent decapping of nuclear-transcribed mRNA (GO:0031087)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
nuclear-transcribed mRNA catabolic process, deadenylation-independent decay (GO:0031086)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
purine ribonucleotide transport (GO:0015868)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
ATP transport (GO:0015867)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
purine nucleotide transport (GO:0015865)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of cardiac muscle fiber development (GO:0055018)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cardiac muscle tissue growth (GO:0055017)	21	0	.58	-	 < 0.01	1.00E00	1.00E00
atrial cardiac muscle cell development (GO:0055014)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
atrial cardiac muscle cell differentiation (GO:0055011)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
pyrimidine deoxyribonucleoside diphosphate biosynthetic process (GO:0009197)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
pyrimidine deoxyribonucleoside diphosphate metabolic process (GO:0009196)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
pyrimidine ribonucleoside diphosphate biosynthetic process (GO:0009194)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
DNA methylation involved in gamete generation (GO:0043046)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
pyrimidine ribonucleoside diphosphate metabolic process (GO:0009193)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
maintenance of protein localization in endoplasmic reticulum (GO:0035437)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
DNA methylation involved in embryo development (GO:0043045)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
deoxyribonucleoside diphosphate catabolic process (GO:0009192)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
ATP-dependent chromatin remodeling (GO:0043044)	33	0	.90	-	 < 0.01	1.00E00	1.00E00
phosphate ion transmembrane transport (GO:0035435)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
ribonucleoside diphosphate catabolic process (GO:0009191)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
cyclic nucleotide biosynthetic process (GO:0009190)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
copper ion transmembrane transport (GO:0035434)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
post-embryonic camera-type eye development (GO:0031077)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
embryonic camera-type eye development (GO:0031076)	23	0	.63	-	 < 0.01	1.00E00	1.00E00
atrial cardiac muscle tissue morphogenesis (GO:0055009)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
ventricular cardiac myofibril assembly (GO:0055005)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cardiac myofibril assembly (GO:0055003)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
deoxyribonucleoside diphosphate biosynthetic process (GO:0009189)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
ribonucleoside diphosphate biosynthetic process (GO:0009188)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
cyclic nucleotide metabolic process (GO:0009187)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
deoxyribonucleoside diphosphate metabolic process (GO:0009186)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
purine deoxyribonucleoside diphosphate catabolic process (GO:0009184)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
purine deoxyribonucleoside diphosphate biosynthetic process (GO:0009183)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
purine deoxyribonucleoside diphosphate metabolic process (GO:0009182)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
extracellular matrix-cell signaling (GO:0035426)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
purine ribonucleoside diphosphate catabolic process (GO:0009181)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
purine ribonucleoside diphosphate biosynthetic process (GO:0009180)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of histone deacetylation (GO:0031065)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
negative regulation of histone deacetylation (GO:0031064)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of histone deacetylation (GO:0031063)	21	0	.58	-	 < 0.01	1.00E00	1.00E00
negative regulation of histone methylation (GO:0031061)	19	0	.52	-	 < 0.01	1.00E00	1.00E00
aminergic neurotransmitter loading into synaptic vesicle (GO:0015842)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
pyrimidine deoxyribonucleoside monophosphate catabolic process (GO:0009178)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
pyrimidine deoxyribonucleoside monophosphate biosynthetic process (GO:0009177)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
pyrimidine deoxyribonucleoside monophosphate metabolic process (GO:0009176)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
pyrimidine ribonucleoside monophosphate catabolic process (GO:0009175)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
protein localization to synapse (GO:0035418)	43	0	1.18	-	 < 0.01	6.31E-01	1.00E00
pyrimidine ribonucleoside monophosphate biosynthetic process (GO:0009174)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
pyrimidine ribonucleoside monophosphate metabolic process (GO:0009173)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
purine deoxyribonucleoside monophosphate catabolic process (GO:0009172)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
purine deoxyribonucleoside monophosphate metabolic process (GO:0009170)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
negative regulation of histone modification (GO:0031057)	35	0	.96	-	 < 0.01	1.00E00	1.00E00
amino-acid betaine transport (GO:0015838)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
chromatin remodeling at centromere (GO:0031055)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
amine transport (GO:0015837)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
pre-miRNA processing (GO:0031054)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
primary miRNA processing (GO:0031053)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
chromosome breakage (GO:0031052)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
purine ribonucleoside monophosphate catabolic process (GO:0009169)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
purine ribonucleoside monophosphate biosynthetic process (GO:0009168)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
purine ribonucleoside monophosphate metabolic process (GO:0009167)	23	0	.63	-	 < 0.01	1.00E00	1.00E00
histone H3-Y41 phosphorylation (GO:0035409)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
histone H3-T6 phosphorylation (GO:0035408)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
nucleoside catabolic process (GO:0009164)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
nucleoside biosynthetic process (GO:0009163)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
histone H3-T11 phosphorylation (GO:0035407)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
deoxyribonucleoside monophosphate metabolic process (GO:0009162)	21	0	.58	-	 < 0.01	1.00E00	1.00E00
histone-tyrosine phosphorylation (GO:0035406)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
histone-threonine phosphorylation (GO:0035405)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
ribonucleoside monophosphate metabolic process (GO:0009161)	34	0	.93	-	 < 0.01	1.00E00	1.00E00
histone-serine phosphorylation (GO:0035404)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
programmed DNA elimination (GO:0031049)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
heterochromatin assembly by small RNA (GO:0031048)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
ornithine transport (GO:0015822)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
leucine transport (GO:0015820)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
deoxyribonucleoside monophosphate catabolic process (GO:0009159)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
ribonucleoside monophosphate catabolic process (GO:0009158)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
deoxyribonucleoside monophosphate biosynthetic process (GO:0009157)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
ribonucleoside monophosphate biosynthetic process (GO:0009156)	18	0	.49	-	 < 0.01	1.00E00	1.00E00
purine deoxyribonucleotide catabolic process (GO:0009155)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
purine deoxyribonucleotide biosynthetic process (GO:0009153)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
purine deoxyribonucleotide metabolic process (GO:0009151)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
cytoplasmic sequestering of CFTR protein (GO:0043004)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of Golgi to plasma membrane CFTR protein transport (GO:0043002)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
Golgi to plasma membrane protein transport (GO:0043001)	21	0	.58	-	 < 0.01	1.00E00	1.00E00
Golgi to plasma membrane CFTR protein transport (GO:0043000)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
myosin filament assembly (GO:0031034)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
myosin filament organization (GO:0031033)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
gamma-aminobutyric acid transport (GO:0015812)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
aspartate transmembrane transport (GO:0015810)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
negative regulation of hemoglobin biosynthetic process (GO:0046986)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of hemoglobin biosynthetic process (GO:0046985)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of hemoglobin biosynthetic process (GO:0046984)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
arginine transport (GO:0015809)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
basic amino acid transport (GO:0015802)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
aromatic amino acid transport (GO:0015801)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
pyrimidine nucleoside diphosphate biosynthetic process (GO:0009139)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
pyrimidine nucleoside diphosphate metabolic process (GO:0009138)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
purine nucleoside diphosphate catabolic process (GO:0009137)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
purine nucleoside diphosphate biosynthetic process (GO:0009136)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
nucleoside diphosphate catabolic process (GO:0009134)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
nucleoside diphosphate biosynthetic process (GO:0009133)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
pyrimidine nucleoside monophosphate catabolic process (GO:0009131)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
exocrine pancreas development (GO:0031017)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
pyrimidine nucleoside monophosphate metabolic process (GO:0009129)	17	0	.47	-	 < 0.01	1.00E00	1.00E00
purine nucleoside monophosphate catabolic process (GO:0009128)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
purine nucleoside monophosphate biosynthetic process (GO:0009127)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
purine nucleoside monophosphate metabolic process (GO:0009126)	24	0	.66	-	 < 0.01	1.00E00	1.00E00
nucleoside monophosphate catabolic process (GO:0009125)	18	0	.49	-	 < 0.01	1.00E00	1.00E00
nucleoside monophosphate biosynthetic process (GO:0009124)	22	0	.60	-	 < 0.01	1.00E00	1.00E00
nucleoside monophosphate metabolic process (GO:0009123)	42	0	1.15	-	 < 0.01	6.30E-01	1.00E00
deoxyribonucleoside metabolic process (GO:0009120)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
response to caffeine (GO:0031000)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
radial spoke assembly (GO:0062177)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
R-loop disassembly (GO:0062176)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
xanthine catabolic process (GO:0009115)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
hypoxanthine catabolic process (GO:0009114)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
brexanolone metabolic process (GO:0062173)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
purine nucleobase biosynthetic process (GO:0009113)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
vitamin catabolic process (GO:0009111)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
ketone body catabolic process (GO:0046952)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
ketone body biosynthetic process (GO:0046951)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular ketone body metabolic process (GO:0046950)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
fear response (GO:0042596)	22	0	.60	-	 < 0.01	1.00E00	1.00E00
behavioral response to starvation (GO:0042595)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
G protein-coupled receptor signaling pathway involved in heart process (GO:0086103)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
peptidyl-lysine deacetylation (GO:0034983)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
mitochondrial protein processing (GO:0034982)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
endothelin receptor signaling pathway (GO:0086100)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of chromatin-mediated maintenance of transcription (GO:1904499)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
lipoate biosynthetic process (GO:0009107)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
fatty-acyl-CoA biosynthetic process (GO:0046949)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
lipoate metabolic process (GO:0009106)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
hydroxylysine biosynthetic process (GO:0046947)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
hydroxylysine metabolic process (GO:0046946)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
protein localization to ciliary transition zone (GO:1904491)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
telomere maintenance via base-excision repair (GO:0097698)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
establishment of RNA localization to telomere (GO:0097694)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
protein folding in endoplasmic reticulum (GO:0034975)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
histone H3-K4 monomethylation (GO:0097692)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
histone H3-R26 methylation (GO:0034972)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to tetrahydrofolate (GO:1904482)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to tetrahydrofolate (GO:1904481)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
glutamate receptor clustering (GO:0097688)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of intestinal absorption (GO:1904480)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
histone lysine methylation (GO:0034968)	45	0	1.23	-	 < 0.01	6.34E-01	1.00E00
retinal metabolic process (GO:0042574)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
double-strand break repair via alternative nonhomologous end joining (GO:0097681)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
box H/ACA RNA processing (GO:0034964)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
double-strand break repair via classical nonhomologous end joining (GO:0097680)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
retinol metabolic process (GO:0042572)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
box C/D RNA processing (GO:0034963)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of transport across blood-brain barrier (GO:0150202)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of transport across blood-brain barrier (GO:0150201)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of transport across blood-brain barrier (GO:0150200)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of neurotransmitter secretion (GO:0046929)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of intestinal absorption (GO:1904478)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
histone H3-K36 dimethylation (GO:0097676)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
neutrophil chemotaxis (GO:0030593)	21	0	.58	-	 < 0.01	1.00E00	1.00E00
DNA ADP-ribosylation (GO:0030592)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of matrix metallopeptidase secretion (GO:1904465)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of matrix metallopeptidase secretion (GO:1904464)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
pteridine-containing compound biosynthetic process (GO:0042559)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
superoxide anion generation (GO:0042554)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
positive regulation of neuronal action potential (GO:1904457)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of potassium:proton exchanging ATPase activity (GO:1904453)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of potassium:proton exchanging ATPase activity (GO:1904451)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
tetrahydrofolylpolyglutamate biosynthetic process (GO:0046901)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of aspartate secretion (GO:1904450)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
tetrahydrofolylpolyglutamate metabolic process (GO:0046900)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of dosage compensation by inactivation of X chromosome (GO:1900095)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cell wall biogenesis (GO:0042546)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry (GO:1900094)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
hemoglobin biosynthetic process (GO:0042541)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
ubiquitin-dependent SMAD protein catabolic process (GO:0030579)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
PML body organization (GO:0030578)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
Cajal body organization (GO:0030576)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
nuclear body organization (GO:0030575)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
collagen catabolic process (GO:0030574)	18	0	.49	-	 < 0.01	1.00E00	1.00E00
bile acid catabolic process (GO:0030573)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of eIF2 alpha phosphorylation by heme (GO:0010999)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of aspartate secretion (GO:1904448)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of translational initiation by eIF2 alpha phosphorylation (GO:0010998)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to auditory stimulus (GO:0010996)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of establishment of Sertoli cell barrier (GO:1904445)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
free ubiquitin chain polymerization (GO:0010994)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of establishment of Sertoli cell barrier (GO:1904444)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
ubiquitin recycling (GO:0010992)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
negative regulation of thyroid gland epithelial cell proliferation (GO:1904442)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of SMAD protein complex assembly (GO:0010991)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of thyroid gland epithelial cell proliferation (GO:1904441)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of SMAD protein complex assembly (GO:0010990)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
amylin receptor signaling pathway (GO:0097647)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
hyperosmotic salinity response (GO:0042538)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of G1/S transition of mitotic cell cycle (GO:1900087)	25	0	.69	-	 < 0.01	1.00E00	1.00E00
calcitonin family receptor signaling pathway (GO:0097646)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
benzene-containing compound metabolic process (GO:0042537)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
positive regulation of peptidyl-tyrosine autophosphorylation (GO:1900086)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of peptidyl-tyrosine autophosphorylation (GO:1900084)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
negative regulation of iron ion import across plasma membrane (GO:1904439)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of low-density lipoprotein particle clearance (GO:0010989)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of low-density lipoprotein particle clearance (GO:0010988)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
regulation of iron ion import across plasma membrane (GO:1904438)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of high-density lipoprotein particle clearance (GO:0010987)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of lipoprotein particle clearance (GO:0010986)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of lipoprotein particle clearance (GO:0010985)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
double-stranded RNA biosynthetic process (GO:0062103)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of lipoprotein particle clearance (GO:0010984)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
positive regulation of high-density lipoprotein particle clearance (GO:0010983)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of high-density lipoprotein particle clearance (GO:0010982)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of t-circle formation (GO:1904431)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of programmed necrotic cell death (GO:0062100)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of t-circle formation (GO:1904430)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of vitamin D 24-hydroxylase activity (GO:0010980)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of cellular response to insulin stimulus (GO:1900078)	18	0	.49	-	 < 0.01	1.00E00	1.00E00
negative regulation of cellular response to insulin stimulus (GO:1900077)	29	0	.80	-	 < 0.01	1.00E00	1.00E00
regulation of cellular response to insulin stimulus (GO:1900076)	49	0	1.34	-	 < 0.01	6.42E-01	1.00E00
positive regulation of neuromuscular synaptic transmission (GO:1900075)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of neuromuscular synaptic transmission (GO:1900073)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of t-circle formation (GO:1904429)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of vitamin D 24-hydroxylase activity (GO:0010979)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of tubulin deacetylation (GO:1904428)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
positive regulation of calcium ion transmembrane transport (GO:1904427)	30	0	.82	-	 < 0.01	1.00E00	1.00E00
positive regulation of GTP binding (GO:1904426)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of GTP binding (GO:1904425)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of GTP binding (GO:1904424)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
negative regulation of G2/M transition of mitotic cell cycle (GO:0010972)	37	0	1.01	-	 < 0.01	6.26E-01	1.00E00
positive regulation of G2/M transition of mitotic cell cycle (GO:0010971)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
regulation of cellular hyperosmotic salinity response (GO:1900069)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
potassium ion export across plasma membrane (GO:0097623)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of peroxisome organization (GO:1900063)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of ceramide biosynthetic process (GO:1900060)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
female genitalia development (GO:0030540)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of microtubule nucleation (GO:0010968)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of polyamine biosynthetic process (GO:0010967)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of phosphate transport (GO:0010966)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of L-arginine import (GO:0010963)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of glucan biosynthetic process (GO:0010962)	18	0	.49	-	 < 0.01	1.00E00	1.00E00
cellular magnesium ion homeostasis (GO:0010961)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of secretory granule organization (GO:1904411)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
O-glycan processing (GO:0016266)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
magnesium ion homeostasis (GO:0010960)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
pyrimidine-containing compound salvage (GO:0008655)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
gap junction assembly (GO:0016264)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular amino acid biosynthetic process (GO:0008652)	43	0	1.18	-	 < 0.01	6.31E-01	1.00E00
selenocysteine biosynthetic process (GO:0016260)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
serine phosphorylation of STAT protein (GO:0042501)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
male genitalia development (GO:0030539)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
embryonic genitalia morphogenesis (GO:0030538)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of secretory granule organization (GO:1904409)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of amino acid import across plasma membrane (GO:0010958)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of vitamin D biosynthetic process (GO:0010957)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of calcidiol 1-monooxygenase activity (GO:0010956)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein processing (GO:0010955)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein processing (GO:0010954)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
selenocysteine metabolic process (GO:0016259)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of hemostasis (GO:1900048)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
hexose transmembrane transport (GO:0008645)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
carbohydrate transport (GO:0008643)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein K63-linked ubiquitination (GO:1900045)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
regulation of protein K63-linked ubiquitination (GO:1900044)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
androgen receptor signaling pathway (GO:0030521)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
negative regulation of transcription by competitive promoter binding (GO:0010944)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
protein deglutarylation (GO:0061698)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
RNA interference (GO:0016246)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
positive regulation of necrotic cell death (GO:0010940)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of cellular response to hypoxia (GO:1900038)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
regulation of cellular response to hypoxia (GO:1900037)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
negative regulation of macroautophagy (GO:0016242)	21	0	.58	-	 < 0.01	1.00E00	1.00E00
regulation of cellular response to heat (GO:1900034)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
autophagosome membrane docking (GO:0016240)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of axon extension (GO:0030517)	17	0	.47	-	 < 0.01	1.00E00	1.00E00
regulation of axon extension (GO:0030516)	57	0	1.56	-	 < 0.01	4.07E-01	1.00E00
positive regulation of BMP signaling pathway (GO:0030513)	22	0	.60	-	 < 0.01	1.00E00	1.00E00
respiratory electron transport chain (GO:0022904)	36	0	.99	-	 < 0.01	1.00E00	1.00E00
positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511)	19	0	.52	-	 < 0.01	1.00E00	1.00E00
electron transport chain (GO:0022900)	39	0	1.07	-	 < 0.01	6.27E-01	1.00E00
cytoplasmic microtubule depolymerization (GO:0010938)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of macrophage cytokine production (GO:0010936)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of macrophage cytokine production (GO:0010935)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
macrophage cytokine production (GO:0010934)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
lysosomal microautophagy (GO:0016237)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
hormone-mediated apoptotic signaling pathway (GO:0008628)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of ruffle assembly (GO:1900029)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
detoxification of inorganic compound (GO:0061687)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
intrinsic apoptotic signaling pathway in response to osmotic stress (GO:0008627)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of ruffle assembly (GO:1900028)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
granzyme-mediated apoptotic signaling pathway (GO:0008626)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
chaperone-mediated autophagy (GO:0061684)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
telomere capping (GO:0016233)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
negative regulation of substrate adhesion-dependent cell spreading (GO:1900025)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein kinase C activity (GO:1900020)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
BMP signaling pathway (GO:0030509)	43	0	1.18	-	 < 0.01	6.31E-01	1.00E00
negative regulation of bone mineralization (GO:0030502)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
positive regulation of bone mineralization (GO:0030501)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
positive regulation of inositol-polyphosphate 5-phosphatase activity (GO:0010925)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of inositol-polyphosphate 5-phosphatase activity (GO:0010924)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of phosphatase activity (GO:0010922)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
iron-sulfur cluster assembly (GO:0016226)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
regulation of protein kinase C activity (GO:1900019)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of inositol phosphate biosynthetic process (GO:0010920)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
pyridoxine biosynthetic process (GO:0008615)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
pyridoxine metabolic process (GO:0008614)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of cytokine production involved in inflammatory response (GO:1900016)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
peptidyl-lysine modification to peptidyl-hypusine (GO:0008612)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
ether lipid biosynthetic process (GO:0008611)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
evoked neurotransmitter secretion (GO:0061670)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of inositol phosphate biosynthetic process (GO:0010919)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of mitochondrial membrane potential (GO:0010918)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
negative regulation of mitochondrial membrane potential (GO:0010917)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
negative regulation of very-low-density lipoprotein particle clearance (GO:0010916)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of very-low-density lipoprotein particle clearance (GO:0010915)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
spontaneous neurotransmitter secretion (GO:0061669)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
positive regulation of isomerase activity (GO:0010912)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
mitochondrial ribosome assembly (GO:0061668)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of isomerase activity (GO:0010911)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of eating behavior (GO:1903999)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of eating behavior (GO:1903998)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903997)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903996)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of dendrite development (GO:1900006)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903995)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of serine-type endopeptidase activity (GO:1900004)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of serine-type endopeptidase activity (GO:1900003)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of heparan sulfate proteoglycan biosynthetic process (GO:0010909)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of heparan sulfate proteoglycan biosynthetic process (GO:0010908)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of glucose metabolic process (GO:0010907)	33	0	.90	-	 < 0.01	1.00E00	1.00E00
negative regulation of very-low-density lipoprotein particle remodeling (GO:0010903)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of very-low-density lipoprotein particle remodeling (GO:0010902)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of very-low-density lipoprotein particle remodeling (GO:0010901)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of TRAIL-activated apoptotic signaling pathway (GO:1903984)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of microglial cell activation (GO:1903980)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of microglial cell activation (GO:1903979)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
histone H3-K9 modification (GO:0061647)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
regulation of microglial cell activation (GO:1903978)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
positive regulation of glutamate neurotransmitter secretion in response to membrane depolarization (GO:0061646)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of glial cell migration (GO:1903977)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of glial cell migration (GO:1903976)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of glial cell migration (GO:1903975)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
chemorepulsion of axon (GO:0061643)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
chemoattraction of axon (GO:0061642)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
CENP-A containing chromatin organization (GO:0061641)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of cellular response to macrophage colony-stimulating factor stimulus (GO:1903972)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of response to macrophage colony-stimulating factor (GO:1903969)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
arachidonate transport (GO:1903963)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
positive regulation of anion transmembrane transport (GO:1903961)	39	0	1.07	-	 < 0.01	6.27E-01	1.00E00
Roundabout signaling pathway (GO:0035385)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
thioester biosynthetic process (GO:0035384)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
thioester metabolic process (GO:0035383)	46	0	1.26	-	 < 0.01	6.36E-01	1.00E00
pharyngeal arch artery morphogenesis (GO:0061626)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
glycolytic process through fructose-1-phosphate (GO:0061625)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein targeting to mitochondrion (GO:1903955)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate (GO:0061624)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
glycolytic process from galactose (GO:0061623)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
glycolytic process through glucose-1-phosphate (GO:0061622)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
sterol import (GO:0035376)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
glycolytic process from mannose through fructose-6-phosphate (GO:0061619)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein localization to microtubule (GO:0035372)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
negative regulation of ventricular cardiac muscle cell action potential (GO:1903946)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
pri-miRNA transcription by RNA polymerase II (GO:0061614)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of hepatocyte apoptotic process (GO:1903944)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of hepatocyte apoptotic process (GO:1903943)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
mannose to fructose-6-phosphate metabolic process (GO:0061611)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of TORC2 signaling (GO:1903939)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to sodium arsenite (GO:1903936)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035360)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
response to sodium arsenite (GO:1903935)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035359)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
peroxisome proliferator activated receptor signaling pathway (GO:0035357)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
cellular triglyceride homeostasis (GO:0035356)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
primary palate development (GO:1903929)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
FAD transmembrane transport (GO:0035350)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein processing in phagocytic vesicle (GO:1903923)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of protein processing in phagocytic vesicle (GO:1903921)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of actin filament severing (GO:1903920)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
viral budding via host ESCRT complex (GO:0039702)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
negative regulation of actin filament severing (GO:1903919)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of actin filament severing (GO:1903918)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
angiotensin-activated signaling pathway involved in heart process (GO:0086098)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
phospholipase C-activating angiotensin-activated signaling pathway (GO:0086097)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation (GO:1903912)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of heart rate by cardiac conduction (GO:0086091)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
valine biosynthetic process (GO:0009099)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
leucine biosynthetic process (GO:0009098)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
isoleucine biosynthetic process (GO:0009097)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
aromatic amino acid family biosynthetic process, prephenate pathway (GO:0009095)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
fatty-acyl-CoA metabolic process (GO:0035337)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
homoserine metabolic process (GO:0009092)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
long-chain fatty-acyl-CoA metabolic process (GO:0035336)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of hippo signaling (GO:0035332)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of hippo signaling (GO:0035331)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
regulation of plasma membrane raft polarization (GO:1903906)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of hippo signaling (GO:0035330)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
negative regulation of establishment of T cell polarity (GO:1903904)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
methionine catabolic process (GO:0009087)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
methionine biosynthetic process (GO:0009086)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
hippo signaling (GO:0035329)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
lysine biosynthetic process (GO:0009085)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
glutamine family amino acid biosynthetic process (GO:0009084)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
branched-chain amino acid catabolic process (GO:0009083)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
branched-chain amino acid biosynthetic process (GO:0009082)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
branched-chain amino acid metabolic process (GO:0009081)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
pyruvate family amino acid catabolic process (GO:0009080)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
monosaccharide transmembrane transport (GO:0015749)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
bundle of His cell-Purkinje myocyte adhesion involved in cell communication (GO:0086073)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
citrate transport (GO:0015746)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
succinate transport (GO:0015744)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
SA node cell to atrial cardiac muscle cell communication (GO:0086070)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
malate transport (GO:0015743)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
alpha-ketoglutarate transport (GO:0015742)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
C4-dicarboxylate transport (GO:0015740)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
pyruvate family amino acid metabolic process (GO:0009078)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
non-replicative transposition, DNA-mediated (GO:0098038)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
aromatic amino acid family catabolic process (GO:0009074)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
aromatic amino acid family biosynthetic process (GO:0009073)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
aromatic amino acid family metabolic process (GO:0009072)	21	0	.58	-	 < 0.01	1.00E00	1.00E00
serine family amino acid biosynthetic process (GO:0009070)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
wound healing, spreading of epidermal cells (GO:0035313)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
bundle of His cell to Purkinje myocyte communication (GO:0086069)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
AV node cell to bundle of His cell communication (GO:0086067)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
atrial cardiac muscle cell to AV node cell communication (GO:0086066)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cell communication involved in cardiac conduction (GO:0086065)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
prostaglandin transport (GO:0015732)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
aspartate family amino acid catabolic process (GO:0009068)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
aspartate family amino acid biosynthetic process (GO:0009067)	18	0	.49	-	 < 0.01	1.00E00	1.00E00
aspartate family amino acid metabolic process (GO:0009066)	34	0	.93	-	 < 0.01	1.00E00	1.00E00
glutamine family amino acid catabolic process (GO:0009065)	19	0	.52	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein dephosphorylation (GO:0035308)	19	0	.52	-	 < 0.01	1.00E00	1.00E00
glutamine family amino acid metabolic process (GO:0009064)	46	0	1.26	-	 < 0.01	6.36E-01	1.00E00
positive regulation of protein dephosphorylation (GO:0035307)	20	0	.55	-	 < 0.01	1.00E00	1.00E00
positive regulation of dephosphorylation (GO:0035306)	30	0	.82	-	 < 0.01	1.00E00	1.00E00
aerobic respiration (GO:0009060)	35	0	.96	-	 < 0.01	1.00E00	1.00E00
oxaloacetate transport (GO:0015729)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
lactate transport (GO:0015727)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
bile acid and bile salt transport (GO:0015721)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of phosphatidylcholine metabolic process (GO:0150173)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of phosphatidylcholine metabolic process (GO:0150172)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
pentose-phosphate shunt, non-oxidative branch (GO:0009052)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
pentose-phosphate shunt, oxidative branch (GO:0009051)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
membrane depolarization during bundle of His cell action potential (GO:0086048)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
membrane depolarization during AV node cell action potential (GO:0086045)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
bundle of His cell action potential (GO:0086043)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cardiac muscle cell-cardiac muscle cell adhesion (GO:0086042)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
dosage compensation by inactivation of X chromosome (GO:0009048)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
positive regulation of lipid biosynthetic process (GO:0046889)	58	0	1.59	-	 < 0.01	4.09E-01	1.00E00
positive regulation of hormone biosynthetic process (GO:0046886)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
negative regulation of follicle-stimulating hormone secretion (GO:0046882)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of follicle-stimulating hormone secretion (GO:0046881)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of follicle-stimulating hormone secretion (GO:0046880)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of cardiac muscle cell membrane potential (GO:0086036)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
thiosulfate transport (GO:0015709)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
iodide transport (GO:0015705)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
bicarbonate transport (GO:0015701)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of saliva secretion (GO:0046878)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of saliva secretion (GO:0046877)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
stomach development (GO:0062094)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
quinolinate metabolic process (GO:0046874)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
bundle of His cell to Purkinje myocyte signaling (GO:0086028)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
AV node cell to bundle of His cell signaling (GO:0086027)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
atrial cardiac muscle cell to AV node cell signaling (GO:0086026)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process (GO:0086023)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cell-cell junction disassembly (GO:0150147)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cell junction disassembly (GO:0150146)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
terpenoid transport (GO:0046865)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
isoprenoid transport (GO:0046864)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cell-cell signaling involved in cardiac conduction (GO:0086019)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
SA node cell to atrial cardiac muscle cell signaling (GO:0086018)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
AV node cell action potential (GO:0086016)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
SA node cell action potential (GO:0086015)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
atrial cardiac muscle cell action potential (GO:0086014)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
membrane depolarization during cardiac muscle cell action potential (GO:0086012)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
membrane depolarization during action potential (GO:0086010)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
phosphatidylinositol dephosphorylation (GO:0046856)	20	0	.55	-	 < 0.01	1.00E00	1.00E00
inositol phosphate dephosphorylation (GO:0046855)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
membrane repolarization (GO:0086009)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
ventricular cardiac muscle cell action potential (GO:0086005)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of cardiac muscle cell contraction (GO:0086004)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
cardiac muscle cell contraction (GO:0086003)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
cardiac muscle cell action potential involved in contraction (GO:0086002)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
gamma-delta T cell differentiation (GO:0042492)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cardiac muscle cell action potential (GO:0086001)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
bone remodeling (GO:0046849)	22	0	.60	-	 < 0.01	1.00E00	1.00E00
positive regulation of neuromuscular junction development (GO:1904398)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of neuromuscular junction development (GO:1904397)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of neuromuscular junction development (GO:1904396)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
filopodium assembly (GO:0046847)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
negative regulation of odontogenesis of dentin-containing tooth (GO:0042489)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of odontogenesis of dentin-containing tooth (GO:0042487)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
negative regulation of odontogenesis (GO:0042483)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of odontogenesis (GO:0042482)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of odontogenesis (GO:0042481)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell-substrate junction organization (GO:0150118)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
positive regulation of cell-substrate junction organization (GO:0150117)	20	0	.55	-	 < 0.01	1.00E00	1.00E00
cell-substrate junction organization (GO:0150115)	29	0	.80	-	 < 0.01	1.00E00	1.00E00
phospholipid dephosphorylation (GO:0046839)	21	0	.58	-	 < 0.01	1.00E00	1.00E00
cellular response to angiotensin (GO:1904385)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
glycolipid transport (GO:0046836)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
response to sodium phosphate (GO:1904383)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of RNA export from nucleus (GO:0046833)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
mannose trimming involved in glycoprotein ERAD pathway (GO:1904382)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of RNA export from nucleus (GO:0046832)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of RNA export from nucleus (GO:0046831)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
endoplasmic reticulum mannose trimming (GO:1904380)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
odontogenesis (GO:0042476)	53	0	1.45	-	 < 0.01	4.05E-01	1.00E00
odontogenesis of dentin-containing tooth (GO:0042475)	39	0	1.07	-	 < 0.01	6.27E-01	1.00E00
middle ear morphogenesis (GO:0042474)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
lamellipodium organization (GO:0097581)	32	0	.88	-	 < 0.01	1.00E00	1.00E00
outer ear morphogenesis (GO:0042473)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of transmembrane transporter activity (GO:0022898)	107	0	2.93	-	 < 0.01	1.21E-01	1.00E00
regulation of protein localization to cell-cell junction (GO:0150106)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein localization to cell-cell junction (GO:0150105)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
regulation of microtubule anchoring at centrosome (GO:0150101)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein localization to cytosolic proteasome complex involved in ERAD pathway (GO:1904379)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
maintenance of unfolded protein involved in ERAD pathway (GO:1904378)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein export from nucleus (GO:0046827)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein localization to cell periphery (GO:1904376)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein export from nucleus (GO:0046826)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of cardiac epithelial to mesenchymal transition (GO:0062044)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of protein export from nucleus (GO:0046825)	26	0	.71	-	 < 0.01	1.00E00	1.00E00
positive regulation of cardiac epithelial to mesenchymal transition (GO:0062043)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of cardiac epithelial to mesenchymal transition (GO:0062042)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of nucleocytoplasmic transport (GO:0046823)	17	0	.47	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein localization to actin cortical patch (GO:1904372)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of protein localization to actin cortical patch (GO:1904370)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
maturation of SSU-rRNA (GO:0030490)	39	0	1.07	-	 < 0.01	6.27E-01	1.00E00
receptor-mediated virion attachment to host cell (GO:0046813)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of stress granule assembly (GO:0062030)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
ribonucleoside biosynthetic process (GO:0042455)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
ribonucleoside catabolic process (GO:0042454)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
purine nucleoside biosynthetic process (GO:0042451)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
arginine biosynthetic process via ornithine (GO:0042450)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of stress granule assembly (GO:0062029)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of stress granule assembly (GO:0062028)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
positive regulation of telomere maintenance via telomere lengthening (GO:1904358)	30	0	.82	-	 < 0.01	1.00E00	1.00E00
negative regulation of telomere maintenance via telomere lengthening (GO:1904357)	23	0	.63	-	 < 0.01	1.00E00	1.00E00
negative regulation of SCF-dependent proteasomal ubiquitin-dependent catabolic process (GO:0062026)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of telomere maintenance via telomere lengthening (GO:1904356)	51	0	1.40	-	 < 0.01	6.47E-01	1.00E00
regulation of SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0062025)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of telomere capping (GO:1904355)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
negative regulation of telomere capping (GO:1904354)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
regulation of telomere capping (GO:1904353)	22	0	.60	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein catabolic process in the vacuole (GO:1904351)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of protein catabolic process in the vacuole (GO:1904350)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
progesterone metabolic process (GO:0042448)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
anterior/posterior axis specification, embryo (GO:0008595)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
hormone catabolic process (GO:0042447)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
photoreceptor cell morphogenesis (GO:0008594)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of Notch signaling pathway (GO:0008593)	52	0	1.43	-	 < 0.01	4.05E-01	1.00E00
calcium ion transmembrane import into cytosol (GO:0097553)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
regulation of Toll signaling pathway (GO:0008592)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
mitochondrial double-strand break repair via homologous recombination (GO:0097552)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mitochondrial double-strand break repair (GO:0097551)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
phenylethylamine metabolic process (GO:0042443)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
pigment metabolic process (GO:0042440)	27	0	.74	-	 < 0.01	1.00E00	1.00E00
positive regulation of small intestine smooth muscle contraction (GO:1904349)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of triglyceride catabolic process (GO:0010898)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
negative regulation of triglyceride catabolic process (GO:0010897)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of small intestine smooth muscle contraction (GO:1904347)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of triglyceride catabolic process (GO:0010896)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
positive regulation of gastric mucosal blood circulation (GO:1904346)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of gastric mucosal blood circulation (GO:1904344)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
axon midline choice point recognition (GO:0016199)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of steroid biosynthetic process (GO:0010893)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
axon choice point recognition (GO:0016198)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of sequestering of triglyceride (GO:0010891)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of sequestering of triglyceride (GO:0010890)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of dopaminergic neuron differentiation (GO:1904340)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
ethanolamine-containing compound metabolic process (GO:0042439)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
melanin biosynthetic process (GO:0042438)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
male gonad development (GO:0008584)	60	0	1.65	-	 < 0.01	4.12E-01	1.00E00
indole-containing compound catabolic process (GO:0042436)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
synaptic vesicle uncoating (GO:0016191)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of synaptic growth at neuromuscular junction (GO:0008582)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
indole-containing compound biosynthetic process (GO:0042435)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
indole-containing compound metabolic process (GO:0042430)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
secondary palate development (GO:0062009)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
regulation of sequestering of triglyceride (GO:0010889)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
negative regulation of dopaminergic neuron differentiation (GO:1904339)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of lipid storage (GO:0010888)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
regulation of dopaminergic neuron differentiation (GO:1904338)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of cholesterol storage (GO:0010887)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of cholesterol storage (GO:0010886)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of cholesterol storage (GO:0010885)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
positive regulation of lipid storage (GO:0010884)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
regulation of lipid storage (GO:0010883)	26	0	.71	-	 < 0.01	1.00E00	1.00E00
synaptic vesicle maturation (GO:0016188)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of cardiac endothelial to mesenchymal transition (GO:0062000)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
synaptic vesicle budding from presynaptic endocytic zone membrane (GO:0016185)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
thymus epithelium morphogenesis (GO:0097536)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
serotonin metabolic process (GO:0042428)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
lymphoid lineage cell migration into thymus (GO:0097535)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
serotonin biosynthetic process (GO:0042427)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
lymphoid lineage cell migration (GO:0097534)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
synaptic vesicle budding from endosome (GO:0016182)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
choline catabolic process (GO:0042426)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
catecholamine catabolic process (GO:0042424)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
catecholamine biosynthetic process (GO:0042423)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
mast cell migration (GO:0097531)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
granulocyte migration (GO:0097530)	26	0	.71	-	 < 0.01	1.00E00	1.00E00
norepinephrine biosynthetic process (GO:0042421)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
dopamine catabolic process (GO:0042420)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cholesterol transport involved in cholesterol storage (GO:0010879)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cholesterol storage (GO:0010878)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
lipid transport involved in lipid storage (GO:0010877)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
protein localization to cytosolic proteasome complex (GO:1904327)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of cholesterol efflux (GO:0010875)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
regulation of cholesterol efflux (GO:0010874)	17	0	.47	-	 < 0.01	1.00E00	1.00E00
positive regulation of cholesterol esterification (GO:0010873)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
regulation of cholesterol esterification (GO:0010872)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
cellular response to forskolin (GO:1904322)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
response to forskolin (GO:1904321)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
execution phase of necroptosis (GO:0097528)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
necroptotic signaling pathway (GO:0097527)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
epinephrine biosynthetic process (GO:0042418)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
dopamine biosynthetic process (GO:0042416)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
epinephrine metabolic process (GO:0042414)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
carnitine catabolic process (GO:0042413)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
taurine biosynthetic process (GO:0042412)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of complement activation (GO:0030449)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of triglyceride biosynthetic process (GO:0010868)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of triglyceride biosynthetic process (GO:0010867)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
regulation of triglyceride biosynthetic process (GO:0010866)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
positive regulation of phospholipase C activity (GO:0010863)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862)	29	0	.80	-	 < 0.01	1.00E00	1.00E00
cristae formation (GO:0042407)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
thyroid hormone metabolic process (GO:0042403)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
cellular biogenic amine catabolic process (GO:0042402)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
base-excision repair, AP site formation via deaminated base removal (GO:0097510)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
peristalsis (GO:0030432)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
positive regulation of gastro-intestinal system smooth muscle contraction (GO:1904306)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of gastro-intestinal system smooth muscle contraction (GO:1904304)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
visual learning (GO:0008542)	35	0	.96	-	 < 0.01	1.00E00	1.00E00
stress response to metal ion (GO:0097501)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
receptor localization to non-motile cilium (GO:0097500)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
targeting of mRNA for destruction involved in RNA interference (GO:0030423)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
production of siRNA involved in RNA interference (GO:0030422)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of proton-transporting ATPase activity, rotational mechanism (GO:0010849)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of chromatin disassembly (GO:0010848)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of reciprocal meiotic recombination (GO:0010845)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of keratinocyte proliferation (GO:0010839)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein ADP-ribosylation (GO:0010836)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of protein ADP-ribosylation (GO:0010835)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
glycoside catabolic process (GO:0016139)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
negative regulation of myotube differentiation (GO:0010832)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
glycoside metabolic process (GO:0016137)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
positive regulation of myotube differentiation (GO:0010831)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
regulation of myotube differentiation (GO:0010830)	28	0	.77	-	 < 0.01	1.00E00	1.00E00
positive regulation of transcription by transcription factor localization (GO:0061586)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
intestinal epithelial cell migration (GO:0061582)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
colon epithelial cell migration (GO:0061580)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
DNA-templated viral transcription (GO:0039695)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
viral RNA genome replication (GO:0039694)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
negative regulation of glucose transmembrane transport (GO:0010829)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
positive regulation of glucose transmembrane transport (GO:0010828)	34	0	.93	-	 < 0.01	1.00E00	1.00E00
single stranded viral RNA replication via double stranded DNA intermediate (GO:0039692)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of glucose transmembrane transport (GO:0010827)	57	0	1.56	-	 < 0.01	4.07E-01	1.00E00
negative regulation of centrosome duplication (GO:0010826)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
positive regulation of centrosome duplication (GO:0010825)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
phytosteroid biosynthetic process (GO:0016129)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
phytosteroid metabolic process (GO:0016128)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
sterol catabolic process (GO:0016127)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
sterol biosynthetic process (GO:0016126)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
positive regulation of T cell chemotaxis (GO:0010820)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
calcium ion transmembrane transport via high voltage-gated calcium channel (GO:0061577)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
xanthophyll biosynthetic process (GO:0016123)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
actin filament bundle retrograde transport (GO:0061573)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
xanthophyll metabolic process (GO:0016122)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
actin filament bundle organization (GO:0061572)	43	0	1.18	-	 < 0.01	6.31E-01	1.00E00
carotene catabolic process (GO:0016121)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative stranded viral RNA replication (GO:0039689)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of T cell chemotaxis (GO:0010819)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
T cell chemotaxis (GO:0010818)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
bradykinin catabolic process (GO:0010815)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
carotene metabolic process (GO:0016119)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
neuropeptide catabolic process (GO:0010813)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell-substrate adhesion (GO:0010812)	41	0	1.12	-	 < 0.01	6.28E-01	1.00E00
carotenoid biosynthetic process (GO:0016117)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of PERK-mediated unfolded protein response (GO:1903898)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
carotenoid metabolic process (GO:0016116)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
terpenoid catabolic process (GO:0016115)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
terpenoid biosynthetic process (GO:0016114)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
negative regulation of IRE1-mediated unfolded protein response (GO:1903895)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of IRE1-mediated unfolded protein response (GO:1903894)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of ATF6-mediated unfolded protein response (GO:1903893)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of ATF6-mediated unfolded protein response (GO:1903892)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of ATF6-mediated unfolded protein response (GO:1903891)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of synaptic vesicle priming (GO:0010808)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of synaptic vesicle priming (GO:0010807)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803)	24	0	.66	-	 < 0.01	1.00E00	1.00E00
tetraterpenoid biosynthetic process (GO:0016109)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
tetraterpenoid metabolic process (GO:0016108)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of peptidyl-threonine phosphorylation (GO:0010801)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
diterpenoid catabolic process (GO:0016103)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
diterpenoid biosynthetic process (GO:0016102)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
trigeminal ganglion development (GO:0061551)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cranial ganglion development (GO:0061550)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
membrane fusion involved in viral entry into host cell (GO:0039663)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
sympathetic ganglion development (GO:0061549)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
ganglion development (GO:0061548)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
glutamate secretion, neurotransmission (GO:0061535)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
gamma-aminobutyric acid secretion, neurotransmission (GO:0061534)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of oxidative phosphorylation (GO:1903862)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
positive regulation of dendrite extension (GO:1903861)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
negative regulation of dendrite extension (GO:1903860)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
brain segmentation (GO:0035284)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of dendrite extension (GO:1903859)	17	0	.47	-	 < 0.01	1.00E00	1.00E00
central nervous system segmentation (GO:0035283)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
hindgut development (GO:0061525)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
pre-miRNA export from nucleus (GO:0035281)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
miRNA loading onto RISC involved in gene silencing by miRNA (GO:0035280)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
cilium disassembly (GO:0061523)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of cristae formation (GO:1903852)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of cristae formation (GO:1903850)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
mRNA cleavage involved in gene silencing by miRNA (GO:0035279)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
miRNA mediated inhibition of translation (GO:0035278)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
macrophage homeostasis (GO:0061519)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of aorta morphogenesis (GO:1903849)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of aorta morphogenesis (GO:1903847)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
myeloid cell development (GO:0061515)	38	0	1.04	-	 < 0.01	6.27E-01	1.00E00
positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846)	19	0	.52	-	 < 0.01	1.00E00	1.00E00
interleukin-34-mediated signaling pathway (GO:0061514)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to arsenite ion (GO:1903843)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
centriole elongation (GO:0061511)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
inorganic anion transport (GO:0015698)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
response to arsenite ion (GO:1903842)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
quaternary ammonium group transport (GO:0015697)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
organic cation transport (GO:0015695)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
protein O-linked mannosylation (GO:0035269)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
multicellular organism growth (GO:0035264)	65	0	1.78	-	 < 0.01	4.22E-01	1.00E00
positive regulation of mRNA 3'-UTR binding (GO:1903839)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
gonad morphogenesis (GO:0035262)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of mRNA 3'-UTR binding (GO:1903837)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
external genitalia morphogenesis (GO:0035261)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
internal genitalia morphogenesis (GO:0035260)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
early endosome to recycling endosome transport (GO:0061502)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
arginine transmembrane transport (GO:1903826)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
carbon dioxide transport (GO:0015670)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
synaptic transmission, glutamatergic (GO:0035249)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
peptidyl-arginine omega-N-methylation (GO:0035247)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
peptidyl-arginine N-methylation (GO:0035246)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
positive regulation of voltage-gated potassium channel activity (GO:1903818)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of voltage-gated potassium channel activity (GO:1903817)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
ionotropic glutamate receptor signaling pathway (GO:0035235)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
ectopic germ cell programmed cell death (GO:0035234)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
positive regulation of glutamate-cysteine ligase activity (GO:0035229)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of glutamate-cysteine ligase activity (GO:0035227)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
glial cell-neuron signaling (GO:0150098)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
amyloid-beta clearance by cellular catabolic process (GO:0150094)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
amyloid-beta clearance by transcytosis (GO:0150093)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
cell competition in a multicellular organism (GO:0035212)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of neuroinflammatory response (GO:0150079)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of neuroinflammatory response (GO:0150078)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of neuroinflammatory response (GO:0150077)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
transport of virus (GO:0046794)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of deacetylase activity (GO:0150066)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of deacetylase activity (GO:0150065)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
vertebrate eye-specific patterning (GO:0150064)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
complement-mediated synapse pruning (GO:0150062)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
viral replication complex formation and maintenance (GO:0046786)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
microtubule polymerization (GO:0046785)	26	0	.71	-	 < 0.01	1.00E00	1.00E00
viral mRNA export from host cell nucleus (GO:0046784)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of viral transcription (GO:0046782)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein localization to lysosome (GO:0150033)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein localization to lysosome (GO:0150032)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of protein localization to lysosome (GO:0150031)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
viral budding (GO:0046755)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
cellular modified amino acid biosynthetic process (GO:0042398)	24	0	.66	-	 < 0.01	1.00E00	1.00E00
phosphagen biosynthetic process (GO:0042396)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of ERAD pathway (GO:1904294)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
viral capsid secondary envelopment (GO:0046745)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of ERAD pathway (GO:1904293)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of ERAD pathway (GO:1904292)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
positive regulation of mitotic DNA damage checkpoint (GO:1904291)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
endothelial tube lumen extension (GO:0097498)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of mitotic DNA damage checkpoint (GO:1904290)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of vesicle size (GO:0097494)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
response to histamine (GO:0034776)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
histone H4-K20 trimethylation (GO:0034773)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
histone H4-K20 methylation (GO:0034770)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
positive regulation of neuron projection arborization (GO:0150012)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of neuron projection arborization (GO:0150011)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
regulation of mitotic DNA damage checkpoint (GO:1904289)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
basement membrane disassembly (GO:0034769)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
neuron projection guidance (GO:0097485)	93	0	2.55	-	 < 0.01	1.83E-01	1.00E00
dendrite extension (GO:0097484)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
phylloquinone catabolic process (GO:0042376)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of ion transmembrane transport (GO:0034767)	105	0	2.88	-	 < 0.01	1.19E-01	1.00E00
phylloquinone metabolic process (GO:0042374)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of transmembrane transport (GO:0034764)	105	0	2.88	-	 < 0.01	1.19E-01	1.00E00
vitamin K metabolic process (GO:0042373)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of iron ion transmembrane transport (GO:0034760)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
clathrin-dependent synaptic vesicle endocytosis (GO:0150007)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation by virus of viral protein levels in host cell (GO:0046726)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
oxalic acid secretion (GO:0046724)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
synaptic vesicle localization (GO:0097479)	34	0	.93	-	 < 0.01	1.00E00	1.00E00
lactic acid secretion (GO:0046722)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
lateral motor column neuron migration (GO:0097477)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
vitamin D catabolic process (GO:0042369)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
citric acid secretion (GO:0046720)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
spinal cord motor neuron migration (GO:0097476)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of iron ion transmembrane transport (GO:0034759)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
vitamin D biosynthetic process (GO:0042368)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
motor neuron migration (GO:0097475)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cobalamin catabolic process (GO:0042366)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of iron ion transport (GO:0034757)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
retinal cone cell apoptotic process (GO:0097474)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
water-soluble vitamin catabolic process (GO:0042365)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of iron ion transport (GO:0034756)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
retinal rod cell apoptotic process (GO:0097473)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
iron ion transmembrane transport (GO:0034755)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
fat-soluble vitamin catabolic process (GO:0042363)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
fat-soluble vitamin biosynthetic process (GO:0042362)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
vitamin E metabolic process (GO:0042360)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
membrane disassembly (GO:0030397)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation by virus of viral protein levels in host cell (GO:0046719)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of Schwann cell chemotaxis (GO:1904268)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
viral entry into host cell (GO:0046718)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
acid secretion (GO:0046717)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
regulation of Schwann cell chemotaxis (GO:1904266)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of TORC1 signaling (GO:1904263)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
negative regulation of TORC1 signaling (GO:1904262)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
GDP catabolic process (GO:0046712)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904261)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
programmed cell death in response to reactive oxygen species (GO:0097468)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
GDP biosynthetic process (GO:0046711)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
GDP metabolic process (GO:0046710)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
vitamin D metabolic process (GO:0042359)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
ubiquitin-dependent glycoprotein ERAD pathway (GO:0097466)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
thiamine diphosphate metabolic process (GO:0042357)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
GDP-L-fucose salvage (GO:0042352)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
fructose 1,6-bisphosphate metabolic process (GO:0030388)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
sperm mitochondrion organization (GO:0030382)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904259)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
IDP catabolic process (GO:0046709)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
IDP metabolic process (GO:0046707)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
CDP biosynthetic process (GO:0046705)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
CDP metabolic process (GO:0046704)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of bile acid metabolic process (GO:1904253)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of bile acid metabolic process (GO:1904252)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of bile acid metabolic process (GO:1904251)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of multivesicular body size involved in endosome transport (GO:0010797)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of polynucleotide adenylyltransferase activity (GO:1904246)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of multivesicular body size (GO:0010796)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of ubiquinone biosynthetic process (GO:0010795)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of polynucleotide adenylyltransferase activity (GO:1904245)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of pancreatic trypsinogen secretion (GO:1904244)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of mRNA export from nucleus (GO:0010793)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
DNA double-strand break processing involved in repair via single-strand annealing (GO:0010792)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of pancreatic trypsinogen secretion (GO:1904242)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly (GO:1904240)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
keratan sulfate metabolic process (GO:0042339)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
histone H3-K79 methylation (GO:0034729)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
piecemeal microautophagy of the nucleus (GO:0034727)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
DNA replication-independent nucleosome organization (GO:0034724)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
DNA replication-dependent nucleosome organization (GO:0034723)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
histone H3-K4 demethylation (GO:0034720)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
meiotic sister chromatid cohesion involved in meiosis I (GO:0010789)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly (GO:1904239)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of substrate-dependent cell migration, cell attachment to substrate (GO:1904237)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of substrate-dependent cell migration, cell attachment to substrate (GO:1904235)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of aconitate hydratase activity (GO:1904234)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of aconitate hydratase activity (GO:1904232)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of succinate dehydrogenase activity (GO:1904231)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
meiotic DNA double-strand break formation involved in reciprocal meiotic recombination (GO:0010780)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
synaptic vesicle priming (GO:0016082)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
synaptic vesicle docking (GO:0016081)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
synaptic vesicle targeting (GO:0016080)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of circadian sleep/wake cycle, non-REM sleep (GO:0042323)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of circadian sleep/wake cycle, REM sleep (GO:0042322)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of circadian sleep/wake cycle, sleep (GO:0042321)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of circadian sleep/wake cycle, REM sleep (GO:0042320)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of succinate dehydrogenase activity (GO:1904229)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
synaptic vesicle exocytosis (GO:0016079)	27	0	.74	-	 < 0.01	1.00E00	1.00E00
tRNA catabolic process (GO:0016078)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell morphogenesis involved in differentiation (GO:0010771)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
sno(s)RNA catabolic process (GO:0016077)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
snRNA catabolic process (GO:0016076)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein kinase C deactivation (GO:0042313)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
vasoconstriction (GO:0042310)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage (GO:0010767)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of sodium ion transport (GO:0010766)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
positive regulation of sodium ion transport (GO:0010765)	28	0	.77	-	 < 0.01	1.00E00	1.00E00
positive regulation of fibroblast migration (GO:0010763)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
fibroblast migration (GO:0010761)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
negative regulation of macrophage chemotaxis (GO:0010760)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
homoiothermy (GO:0042309)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein import into nucleus (GO:0042308)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
adaptation of rhodopsin mediated signaling (GO:0016062)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of fatty acid biosynthetic process (GO:0042304)	27	0	.74	-	 < 0.01	1.00E00	1.00E00
hypoxia-inducible factor-1alpha signaling pathway (GO:0097411)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of macrophage chemotaxis (GO:0010759)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
regulation of macrophage chemotaxis (GO:0010758)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
negative regulation of plasminogen activation (GO:0010757)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of plasminogen activation (GO:0010756)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of plasminogen activation (GO:0010755)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
negative regulation of skeletal muscle hypertrophy (GO:1904205)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of skeletal muscle hypertrophy (GO:1904204)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of cGMP-mediated signaling (GO:0010754)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of cGMP-mediated signaling (GO:0010753)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of cGMP-mediated signaling (GO:0010752)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
negative regulation of nitric oxide mediated signal transduction (GO:0010751)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
rhodopsin mediated signaling pathway (GO:0016056)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of nitric oxide mediated signal transduction (GO:0010750)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cellular response to raffinose (GO:0097403)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
neuroblast migration (GO:0097402)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
interleukin-17-mediated signaling pathway (GO:0097400)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
prenylcysteine metabolic process (GO:0030329)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
prenylcysteine catabolic process (GO:0030328)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
prenylated protein catabolic process (GO:0030327)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
stabilization of membrane potential (GO:0030322)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular monovalent inorganic anion homeostasis (GO:0030320)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of nitric oxide mediated signal transduction (GO:0010749)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
negative regulation of long-chain fatty acid import across plasma membrane (GO:0010748)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of long-chain fatty acid import across plasma membrane (GO:0010746)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of macrophage derived foam cell differentiation (GO:0010745)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of macrophage derived foam cell differentiation (GO:0010744)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
regulation of macrophage derived foam cell differentiation (GO:0010743)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
macrophage derived foam cell differentiation (GO:0010742)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
detection of bacterium (GO:0016045)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
melanocyte differentiation (GO:0030318)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
flagellated sperm motility (GO:0030317)	54	0	1.48	-	 < 0.01	4.05E-01	1.00E00
osteoclast differentiation (GO:0030316)	20	0	.55	-	 < 0.01	1.00E00	1.00E00
poly-N-acetyllactosamine biosynthetic process (GO:0030311)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein kinase A signaling (GO:0010739)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of protein kinase A signaling (GO:0010738)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
protein kinase A signaling (GO:0010737)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
positive regulation of transcription via serum response element binding (GO:0010735)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein glutathionylation (GO:0010734)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of protein glutathionylation (GO:0010732)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of hydrogen peroxide biosynthetic process (GO:0010730)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
memory T cell proliferation (GO:0061485)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
hematopoietic stem cell homeostasis (GO:0061484)	18	0	.49	-	 < 0.01	1.00E00	1.00E00
viral process (GO:0016032)	84	0	2.30	-	 < 0.01	1.76E-01	1.00E00
response to TNF agonist (GO:0061481)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
poly-N-acetyllactosamine metabolic process (GO:0030309)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell growth (GO:0030308)	124	0	3.40	-	 < 0.01	8.22E-02	1.00E00
cholesterol transport (GO:0030301)	25	0	.69	-	 < 0.01	1.00E00	1.00E00
regulation of intestinal cholesterol absorption (GO:0030300)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of hydrogen peroxide biosynthetic process (GO:0010729)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of hydrogen peroxide biosynthetic process (GO:0010728)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of hydrogen peroxide metabolic process (GO:0010727)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
positive regulation of hydrogen peroxide metabolic process (GO:0010726)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of primitive erythrocyte differentiation (GO:0010725)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of definitive erythrocyte differentiation (GO:0010724)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of ferrochelatase activity (GO:0010722)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to anticoagulant (GO:0061476)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of epithelial to mesenchymal transition (GO:0010719)	21	0	.58	-	 < 0.01	1.00E00	1.00E00
regulation of type B pancreatic cell proliferation (GO:0061469)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
protein localization to lysosome (GO:0061462)	17	0	.47	-	 < 0.01	1.00E00	1.00E00
glycolysis from storage polysaccharide through glucose-1-phosphate (GO:0093001)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
meiotic DNA double-strand break processing involved in reciprocal meiotic recombination (GO:0010705)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of amino acid transmembrane transport (GO:1903789)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of norepinephrine secretion (GO:0010701)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of norepinephrine secretion (GO:0010700)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of glutathione biosynthetic process (GO:1903788)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of glutathione biosynthetic process (GO:1903786)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
retrotrapezoid nucleus neuron differentiation (GO:0061452)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
retrotrapezoid nucleus development (GO:0061451)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
charged-tRNA amino acid modification (GO:0019988)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of cardiac conduction (GO:1903779)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
translesion synthesis (GO:0019985)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
regulation of DNA double-strand break processing (GO:1903775)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of viral budding via host ESCRT complex (GO:1903774)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of viral budding via host ESCRT complex (GO:1903772)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of beta-galactosidase activity (GO:1903770)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
kidney vasculature morphogenesis (GO:0061439)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
renal system vasculature morphogenesis (GO:0061438)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell proliferation in bone marrow (GO:1903769)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of potassium ion export across plasma membrane (GO:1903766)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of potassium ion export across plasma membrane (GO:1903764)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular response to caloric restriction (GO:0061433)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1903762)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
bone trabecula morphogenesis (GO:0061430)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1903760)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061428)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of p38MAPK cascade (GO:1903753)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide (GO:1903751)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide (GO:1903750)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of RIG-I signaling pathway (GO:0039536)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of RIG-I signaling pathway (GO:0039535)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
negative regulation of MDA-5 signaling pathway (GO:0039534)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of MDA-5 signaling pathway (GO:0039533)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
MDA-5 signaling pathway (GO:0039530)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
social behavior (GO:0035176)	26	0	.71	-	 < 0.01	1.00E00	1.00E00
positive regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061419)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
positive regulation of establishment of protein localization to mitochondrion (GO:1903749)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of establishment of protein localization to mitochondrion (GO:1903748)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
regulation of establishment of protein localization to mitochondrion (GO:1903747)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
positive regulation of anterograde synaptic vesicle transport (GO:1903744)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of anterograde synaptic vesicle transport (GO:1903742)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
RIG-I signaling pathway (GO:0039529)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
cytoplasmic pattern recognition receptor signaling pathway in response to virus (GO:0039528)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
modulation by virus of host apoptotic process (GO:0039526)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
suppression by virus of host autophagy (GO:0039521)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
induction by virus of host autophagy (GO:0039520)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
post-embryonic hemopoiesis (GO:0035166)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of transcription from RNA polymerase II promoter in response to heat stress (GO:0061408)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
embryonic hemopoiesis (GO:0035162)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
positive regulation of transcription from RNA polymerase II promoter in response to acidic pH (GO:0061402)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of transcription from RNA polymerase II promoter in response to calcium ion (GO:0061400)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of phosphatidate phosphatase activity (GO:1903730)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
modulation by virus of host autophagy (GO:0039519)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of plasma membrane organization (GO:1903729)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
cGMP-mediated signaling (GO:0019934)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
positive regulation of phospholipid metabolic process (GO:1903727)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
positive regulation of centriole elongation (GO:1903724)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of centriole elongation (GO:1903723)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of centriole elongation (GO:1903722)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
positive regulation of I-kappaB phosphorylation (GO:1903721)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of I-kappaB phosphorylation (GO:1903719)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of aerobic respiration (GO:1903715)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
hindlimb morphogenesis (GO:0035137)	25	0	.69	-	 < 0.01	1.00E00	1.00E00
peptidyl-arginine methylation, to asymmetrical-dimethyl arginine (GO:0019919)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
peptidyl-arginine methylation, to symmetrical-dimethyl arginine (GO:0019918)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
uterine gland development (GO:1903709)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of production of siRNA involved in RNA interference (GO:1903704)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
substantia propria of cornea development (GO:1903701)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
post-embryonic forelimb morphogenesis (GO:0035128)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
post-embryonic limb morphogenesis (GO:0035127)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
post-embryonic appendage morphogenesis (GO:0035120)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of dendritic spine development (GO:0060999)	38	0	1.04	-	 < 0.01	6.27E-01	1.00E00
regulation of dendritic spine development (GO:0060998)	53	0	1.45	-	 < 0.01	4.05E-01	1.00E00
cell-cell signaling involved in kidney development (GO:0060995)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of transcription from RNA polymerase II promoter involved in kidney development (GO:0060994)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to fungicide (GO:0060992)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
embryonic hindlimb morphogenesis (GO:0035116)	21	0	.58	-	 < 0.01	1.00E00	1.00E00
genitalia morphogenesis (GO:0035112)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
lipid tube assembly (GO:0060988)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
endocrine hormone secretion (GO:0060986)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
epicardium-derived cardiac vascular smooth muscle cell differentiation (GO:0060983)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
coronary artery morphogenesis (GO:0060982)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
operant conditioning (GO:0035106)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
vasculogenesis involved in coronary vascular morphogenesis (GO:0060979)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
angiogenesis involved in coronary vascular morphogenesis (GO:0060978)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
coronary vasculature morphogenesis (GO:0060977)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
cell migration involved in heart development (GO:0060973)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
left/right pattern formation (GO:0060972)	17	0	.47	-	 < 0.01	1.00E00	1.00E00
embryonic heart tube left/right pattern formation (GO:0060971)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
response to mercury ion (GO:0046689)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
response to copper ion (GO:0046688)	17	0	.47	-	 < 0.01	1.00E00	1.00E00
response to cadmium ion (GO:0046686)	21	0	.58	-	 < 0.01	1.00E00	1.00E00
response to arsenic-containing substance (GO:0046685)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
endocardial cell differentiation (GO:0060956)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of retinal cell programmed cell death (GO:0046670)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cardiac vascular smooth muscle cell development (GO:0060948)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
epithelial to mesenchymal transition involved in cardiac fibroblast development (GO:0060940)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of retinal cell programmed cell death (GO:0046668)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
male sex differentiation (GO:0046661)	74	0	2.03	-	 < 0.01	2.69E-01	1.00E00
response to gonadotropin (GO:0034698)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
response to prostaglandin E (GO:0034695)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
epicardium-derived cardiac fibroblast cell development (GO:0060939)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to prostaglandin (GO:0034694)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
epicardium-derived cardiac fibroblast cell differentiation (GO:0060938)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cardiac fibroblast cell development (GO:0060936)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cardiac fibroblast cell differentiation (GO:0060935)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
His-Purkinje system cell differentiation (GO:0060932)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
sinoatrial node cell development (GO:0060931)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
sinoatrial node cell fate commitment (GO:0060930)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
folic acid metabolic process (GO:0046655)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
tetrahydrofolate biosynthetic process (GO:0046654)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
vocal learning (GO:0042297)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
atrioventricular node cell fate commitment (GO:0060929)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
atrioventricular node cell development (GO:0060928)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cardiac pacemaker cell fate commitment (GO:0060927)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cardiac pacemaker cell development (GO:0060926)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
cardiac muscle cell fate commitment (GO:0060923)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
atrioventricular node cell differentiation (GO:0060922)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
sinoatrial node cell differentiation (GO:0060921)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cardiac pacemaker cell differentiation (GO:0060920)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
positive regulation of gamma-delta T cell activation (GO:0046645)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of cholangiocyte apoptotic process (GO:1904193)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of gamma-delta T cell activation (GO:0046643)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
regulation of cholangiocyte apoptotic process (GO:1904192)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to interleukin-17 (GO:0097398)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to interleukin-17 (GO:0097396)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mesenchymal cell proliferation involved in lung development (GO:0060916)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
heart formation (GO:0060914)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
chemotaxis to arachidonic acid (GO:0034670)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cardiac cell fate determination (GO:0060913)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cardiac cell fate commitment (GO:0060911)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of transformation of host cell by virus (GO:1904188)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of transformation of host cell by virus (GO:1904187)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of pyruvate dehydrogenase activity (GO:1904184)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of pyruvate dehydrogenase activity (GO:1904182)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
alpha-beta T cell proliferation (GO:0046633)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of membrane depolarization (GO:1904181)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
cellular lipid biosynthetic process (GO:0097384)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
error-prone translesion synthesis (GO:0042276)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
ribosomal small subunit biogenesis (GO:0042274)	50	0	1.37	-	 < 0.01	6.45E-01	1.00E00
positive regulation of macrophage cytokine production (GO:0060907)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of meiosis I (GO:0060903)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
embryonic camera-type eye formation (GO:0060900)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of adipose tissue development (GO:1904179)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
gamma-delta T cell activation (GO:0046629)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of insulin receptor signaling pathway (GO:0046628)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
negative regulation of insulin receptor signaling pathway (GO:0046627)	25	0	.69	-	 < 0.01	1.00E00	1.00E00
regulation of insulin receptor signaling pathway (GO:0046626)	48	0	1.32	-	 < 0.01	6.40E-01	1.00E00
regulation of histone demethylase activity (H3-K4 specific) (GO:1904173)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of bleb assembly (GO:1904172)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of organ growth (GO:0046622)	35	0	.96	-	 < 0.01	1.00E00	1.00E00
negative regulation of bleb assembly (GO:1904171)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of organ growth (GO:0046621)	23	0	.63	-	 < 0.01	1.00E00	1.00E00
regulation of bleb assembly (GO:1904170)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of organ growth (GO:0046620)	63	0	1.73	-	 < 0.01	4.17E-01	1.00E00
regulation of cytolysis (GO:0042268)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
interneuron axon guidance (GO:0097376)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
natural killer cell mediated cytotoxicity (GO:0042267)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
nucleobase-containing small molecule catabolic process (GO:0034656)	17	0	.47	-	 < 0.01	1.00E00	1.00E00
peptidyl-asparagine hydroxylation (GO:0042265)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
peptidyl-aspartic acid hydroxylation (GO:0042264)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
retinoic acid catabolic process (GO:0034653)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein O-GlcNAcylation via threonine (GO:0097370)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cortisol metabolic process (GO:0034650)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
intestinal cholesterol absorption (GO:0030299)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
optic placode formation involved in camera-type eye formation (GO:0046619)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
DNA synthesis involved in UV-damage excision repair (GO:1904161)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
establishment of Sertoli cell barrier (GO:0097368)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
mature ribosome assembly (GO:0042256)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
cellular response to UV (GO:0034644)	56	0	1.54	-	 < 0.01	4.07E-01	1.00E00
establishment of mitochondrion localization, microtubule-mediated (GO:0034643)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
mitochondrion migration along actin filament (GO:0034642)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
bone mineralization (GO:0030282)	26	0	.71	-	 < 0.01	1.00E00	1.00E00
axonemal central apparatus assembly (GO:1904158)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of centrosome cycle (GO:0046606)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
positive regulation of retrograde protein transport, ER to cytosol (GO:1904154)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of retrograde protein transport, ER to cytosol (GO:1904153)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of retrograde protein transport, ER to cytosol (GO:1904152)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
positive regulation of microglial cell mediated cytotoxicity (GO:1904151)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of centriole replication (GO:0046601)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of centriole replication (GO:0046600)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
establishment of planar polarity of embryonic epithelium (GO:0042249)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein localization to heterochromatin (GO:0097355)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
phosphatidylcholine catabolic process (GO:0034638)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
prenylation (GO:0097354)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
tissue regeneration (GO:0042246)	26	0	.71	-	 < 0.01	1.00E00	1.00E00
RNA repair (GO:0042245)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
glutathione transport (GO:0034635)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
neutrophil clearance (GO:0097350)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
retinol transport (GO:0034633)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
maintenance of gastrointestinal epithelium (GO:0030277)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
regulation of microglial cell mediated cytotoxicity (GO:1904149)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of alkaline phosphatase activity (GO:0010694)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of alkaline phosphatase activity (GO:0010693)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of alkaline phosphatase activity (GO:0010692)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of microglial cell migration (GO:1904140)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular protein-containing complex localization (GO:0034629)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
mitochondrial outer membrane permeabilization (GO:0097345)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
'de novo' NAD biosynthetic process (GO:0034627)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
ripoptosome assembly (GO:0097343)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
zymogen inhibition (GO:0097341)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
inhibition of cysteine-type endopeptidase activity (GO:0097340)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
apoptotic chromosome condensation (GO:0030263)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of microglial cell migration (GO:1904139)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to laminar fluid shear stress (GO:0034616)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
response to cocaine (GO:0042220)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
lipid glycosylation (GO:0030259)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of cellular carbohydrate metabolic process (GO:0010676)	37	0	1.01	-	 < 0.01	6.26E-01	1.00E00
amino acid import across plasma membrane (GO:0089718)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
melanocyte migration (GO:0097324)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to heat (GO:0034605)	26	0	.71	-	 < 0.01	1.00E00	1.00E00
terpene metabolic process (GO:0042214)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
plasma membrane tubulation (GO:0097320)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
autophagy of peroxisome (GO:0030242)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
skeletal muscle myosin thick filament assembly (GO:0030241)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
skeletal muscle thin filament assembly (GO:0030240)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
epithelial structure maintenance (GO:0010669)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
ectodermal cell differentiation (GO:0010668)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
cellular response to vasopressin (GO:1904117)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of cardiac muscle cell apoptotic process (GO:0010666)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
response to vasopressin (GO:1904116)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
maternal determination of anterior/posterior axis, embryo (GO:0008358)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
L-histidine transmembrane transport (GO:0089709)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
asymmetric cell division (GO:0008356)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
germ cell migration (GO:0008354)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cap2 mRNA methylation (GO:0097310)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein kinase D signaling (GO:0089700)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
male sex determination (GO:0030238)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
positive regulation of cholesterol import (GO:1904109)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cardiac muscle cell apoptotic process (GO:0010659)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
striated muscle cell apoptotic process (GO:0010658)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
protein localization to ciliary inversin compartment (GO:1904108)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
muscle cell apoptotic process (GO:0010657)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
protein localization to microvillus (GO:1904106)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cap1 mRNA methylation (GO:0097309)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of antimicrobial humoral response (GO:0008348)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
glial cell migration (GO:0008347)	19	0	.52	-	 < 0.01	1.00E00	1.00E00
positive regulation of cell communication by electrical coupling (GO:0010650)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
adult feeding behavior (GO:0008343)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
determination of adult lifespan (GO:0008340)	19	0	.52	-	 < 0.01	1.00E00	1.00E00
programmed necrotic cell death (GO:0097300)	19	0	.52	-	 < 0.01	1.00E00	1.00E00
extracellular matrix disassembly (GO:0022617)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
macrophage differentiation (GO:0030225)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
DNA strand elongation (GO:0022616)	18	0	.49	-	 < 0.01	1.00E00	1.00E00
monocyte differentiation (GO:0030224)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
protein to membrane docking (GO:0022615)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
neutrophil differentiation (GO:0030223)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
membrane to membrane docking (GO:0022614)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
eosinophil differentiation (GO:0030222)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of cell communication by electrical coupling (GO:0010649)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
positive regulation of platelet-derived growth factor receptor signaling pathway (GO:0010641)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640)	18	0	.49	-	 < 0.01	1.00E00	1.00E00
megakaryocyte differentiation (GO:0030219)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
keratinocyte differentiation (GO:0030216)	48	0	1.32	-	 < 0.01	6.40E-01	1.00E00
hyaluronan catabolic process (GO:0030214)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
hyaluronan biosynthetic process (GO:0030213)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
hyaluronan metabolic process (GO:0030212)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
heparin biosynthetic process (GO:0030210)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
menstrual cycle phase (GO:0022601)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
digestive system process (GO:0022600)	21	0	.58	-	 < 0.01	1.00E00	1.00E00
negative regulation of mitochondrial fusion (GO:0010637)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of mitochondrial fusion (GO:0010636)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of mitochondrial fusion (GO:0010635)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
closure of optic fissure (GO:0061386)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
heart trabecula morphogenesis (GO:0061384)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
trabecula morphogenesis (GO:0061383)	25	0	.69	-	 < 0.01	1.00E00	1.00E00
cell migration in diencephalon (GO:0061381)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
dermatan sulfate biosynthetic process (GO:0030208)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
chondroitin sulfate catabolic process (GO:0030207)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
chondroitin sulfate biosynthetic process (GO:0030206)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
dermatan sulfate metabolic process (GO:0030205)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
chondroitin sulfate metabolic process (GO:0030204)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
glycosaminoglycan metabolic process (GO:0030203)	36	0	.99	-	 < 0.01	1.00E00	1.00E00
heparin metabolic process (GO:0030202)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
heparan sulfate proteoglycan metabolic process (GO:0030201)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
heparan sulfate proteoglycan catabolic process (GO:0030200)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of Schwann cell proliferation (GO:0010626)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of Schwann cell proliferation (GO:0010625)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of Schwann cell proliferation (GO:0010624)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
programmed cell death involved in cell development (GO:0010623)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
inferior colliculus development (GO:0061379)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
corpora quadrigemina development (GO:0061378)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
mammary gland lobule development (GO:0061377)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
G2/MI transition of meiotic cell cycle (GO:0008315)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
mammillothalamic axonal tract development (GO:0061374)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mammillary axonal complex development (GO:0061373)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
determination of heart left/right asymmetry (GO:0061371)	42	0	1.15	-	 < 0.01	6.30E-01	1.00E00
testosterone biosynthetic process (GO:0061370)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of cardiac muscle adaptation (GO:0010615)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of cardiac muscle hypertrophy (GO:0010613)	26	0	.71	-	 < 0.01	1.00E00	1.00E00
behavioral response to formalin induced pain (GO:0061368)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
tarsal gland development (GO:1903699)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of mRNA stability involved in response to stress (GO:0010610)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
behavioral response to chemical pain (GO:0061366)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
associative learning (GO:0008306)	50	0	1.37	-	 < 0.01	6.45E-01	1.00E00
negative regulation of microvillus assembly (GO:1903697)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of triglyceride lipase activity (GO:0061365)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
isoprenoid catabolic process (GO:0008300)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of wound healing, spreading of epidermal cells (GO:1903691)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
optic chiasma development (GO:0061360)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of wound healing, spreading of epidermal cells (GO:1903690)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
mRNA localization resulting in posttranscriptional regulation of gene expression (GO:0010609)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of cytoplasmic mRNA processing body assembly (GO:0010607)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
axonal transport of mitochondrion (GO:0019896)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
regulation of wound healing, spreading of epidermal cells (GO:1903689)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of Wnt protein secretion (GO:0061357)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of Wnt protein secretion (GO:0061356)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
neural precursor cell proliferation (GO:0061351)	51	0	1.40	-	 < 0.01	6.47E-01	1.00E00
pteridine metabolic process (GO:0019889)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
positive regulation of cap-independent translational initiation (GO:1903679)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
antigen processing and presentation of exogenous antigen (GO:0019884)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
regulation of cap-independent translational initiation (GO:1903677)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
antigen processing and presentation of endogenous antigen (GO:0019883)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
antigen processing and presentation (GO:0019882)	30	0	.82	-	 < 0.01	1.00E00	1.00E00
regulation of cell adhesion involved in heart morphogenesis (GO:0061344)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cell adhesion involved in heart morphogenesis (GO:0061343)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of sprouting angiogenesis (GO:1903672)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
negative regulation of sprouting angiogenesis (GO:1903671)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
regulation of sprouting angiogenesis (GO:1903670)	19	0	.52	-	 < 0.01	1.00E00	1.00E00
lysine biosynthetic process via aminoadipic acid (GO:0019878)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
establishment or maintenance of monopolar cell polarity (GO:0061339)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
behavioral response to nicotine (GO:0035095)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to nicotine (GO:0035094)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
cardiac conduction (GO:0061337)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
spermatogenesis, exchange of chromosomal proteins (GO:0035093)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
sperm chromatin condensation (GO:0035092)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
renal tubule morphogenesis (GO:0061333)	45	0	1.23	-	 < 0.01	6.34E-01	1.00E00
establishment of apical/basal cell polarity (GO:0035089)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
siRNA loading onto RISC involved in RNA interference (GO:0035087)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
cell proliferation involved in outflow tract morphogenesis (GO:0061325)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation (GO:0061324)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cell proliferation involved in heart morphogenesis (GO:0061323)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
uracil metabolic process (GO:0019860)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of cytoplasmic transport (GO:1903651)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
negative regulation of cytoplasmic transport (GO:1903650)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
thymine metabolic process (GO:0019859)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cytosine metabolic process (GO:0019858)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
5-methylcytosine metabolic process (GO:0019857)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
renal filtration cell differentiation (GO:0061318)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
pyrimidine nucleobase biosynthetic process (GO:0019856)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of cytoplasmic transport (GO:1903649)	24	0	.66	-	 < 0.01	1.00E00	1.00E00
canonical Wnt signaling pathway involved in heart development (GO:0061316)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of chaperone-mediated protein folding (GO:1903646)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
Notch signaling involved in heart development (GO:0061314)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of chaperone-mediated protein folding (GO:1903645)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of chaperone-mediated protein folding (GO:1903644)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
BMP signaling pathway involved in heart development (GO:0061312)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cell surface receptor signaling pathway involved in heart development (GO:0061311)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
negative regulation of gastrin-induced gastric acid secretion (GO:1903640)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of histone acetylation (GO:0035067)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
cardiac neural crest cell development involved in outflow tract morphogenesis (GO:0061309)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
cardiac neural crest cell development involved in heart development (GO:0061308)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of gastrin-induced gastric acid secretion (GO:1903639)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cardiac neural crest cell differentiation involved in heart development (GO:0061307)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
nuclear speck organization (GO:0035063)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
retinal blood vessel morphogenesis (GO:0061304)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cornea development in camera-type eye (GO:0061303)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of leucine-tRNA ligase activity (GO:1903634)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
smooth muscle cell-matrix adhesion (GO:0061302)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of leucine-tRNA ligase activity (GO:1903633)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of aminoacyl-tRNA ligase activity (GO:1903632)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of aminoacyl-tRNA ligase activity (GO:1903631)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of aminoacyl-tRNA ligase activity (GO:1903630)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
embryonic heart tube anterior/posterior pattern specification (GO:0035054)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of dUTP diphosphatase activity (GO:1903629)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cytolysis (GO:0019835)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
regulation of dUTP diphosphatase activity (GO:1903627)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
embryonic heart tube development (GO:0035050)	49	0	1.34	-	 < 0.01	6.42E-01	1.00E00
negative regulation of DNA catabolic process (GO:1903625)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
protein localization to photoreceptor connecting cilium (GO:1903621)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of transdifferentiation (GO:1903620)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of transdifferentiation (GO:1903618)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of calcium-dependent ATPase activity (GO:1903611)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
male pronucleus assembly (GO:0035039)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
female pronucleus assembly (GO:0035038)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
sperm entry (GO:0035037)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
sperm-egg recognition (GO:0035036)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
negative regulation of inward rectifier potassium channel activity (GO:1903609)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein localization to cytoplasmic stress granule (GO:1903608)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
leading edge cell differentiation (GO:0035026)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of Rho protein signal transduction (GO:0035025)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
negative regulation of Rho protein signal transduction (GO:0035024)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
regulation of Rho protein signal transduction (GO:0035023)	84	0	2.30	-	 < 0.01	1.76E-01	1.00E00
quinolinate biosynthetic process (GO:0019805)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of Rac protein signal transduction (GO:0035022)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of Rac protein signal transduction (GO:0035021)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of Rac protein signal transduction (GO:0035020)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
adaptation of signaling pathway (GO:0023058)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
neural plate regionalization (GO:0060897)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
neural plate pattern specification (GO:0060896)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
somatic stem cell population maintenance (GO:0035019)	29	0	.80	-	 < 0.01	1.00E00	1.00E00
limb epidermis development (GO:0060887)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
neuronal signal transduction (GO:0023041)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
CD40 signaling pathway (GO:0023035)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
semicircular canal formation (GO:0060876)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
lateral semicircular canal development (GO:0060875)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
anterior semicircular canal development (GO:0060873)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
semicircular canal development (GO:0060872)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
regulation of centriole replication (GO:0046599)	18	0	.49	-	 < 0.01	1.00E00	1.00E00
termination of signal transduction (GO:0023021)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of Ras protein signal transduction (GO:0046580)	39	0	1.07	-	 < 0.01	6.27E-01	1.00E00
signal transduction involved in regulation of gene expression (GO:0023019)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
establishment of glial blood-brain barrier (GO:0060857)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
establishment of blood-brain barrier (GO:0060856)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
branching involved in lymph vessel morphogenesis (GO:0060854)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
Notch signaling pathway involved in arterial endothelial cell fate commitment (GO:0060853)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
chondrocyte development involved in endochondral bone morphogenesis (GO:0003433)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
growth plate cartilage chondrocyte development (GO:0003431)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
growth plate cartilage chondrocyte growth (GO:0003430)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
endothelial cell fate specification (GO:0060847)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
blood vessel endothelial cell fate commitment (GO:0060846)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
arterial endothelial cell fate commitment (GO:0060844)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
venous endothelial cell differentiation (GO:0060843)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
arterial endothelial cell differentiation (GO:0060842)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
venous blood vessel development (GO:0060841)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
artery development (GO:0060840)	49	0	1.34	-	 < 0.01	6.42E-01	1.00E00
growth plate cartilage morphogenesis (GO:0003422)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
growth plate cartilage axis specification (GO:0003421)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
blood vessel endothelial cell differentiation (GO:0060837)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
smoothened signaling pathway involved in dorsal/ventral neural tube patterning (GO:0060831)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
ciliary receptor clustering involved in smoothened signaling pathway (GO:0060830)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
growth plate cartilage chondrocyte proliferation (GO:0003419)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
growth plate cartilage chondrocyte differentiation (GO:0003418)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
growth plate cartilage development (GO:0003417)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
endochondral bone growth (GO:0003416)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
chondrocyte hypertrophy (GO:0003415)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
chondrocyte differentiation involved in endochondral bone morphogenesis (GO:0003413)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
photoreceptor cell fate commitment (GO:0046552)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
piRNA metabolic process (GO:0034587)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation (GO:0060829)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation (GO:0060827)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
inactivation of X chromosome by DNA methylation (GO:0060821)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
inactivation of X chromosome by heterochromatin assembly (GO:0060820)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
optic cup formation involved in camera-type eye development (GO:0003408)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
retinal pigment epithelium development (GO:0003406)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
retinal cone cell development (GO:0046549)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
axis elongation (GO:0003401)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
retinal rod cell development (GO:0046548)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
regulation of COPII vesicle coating (GO:0003400)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
development of primary male sexual characteristics (GO:0046546)	60	0	1.65	-	 < 0.01	4.12E-01	1.00E00
development of secondary male sexual characteristics (GO:0046544)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
development of secondary female sexual characteristics (GO:0046543)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of autophagic cell death (GO:1904092)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:0097296)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
inactivation of X chromosome by genetic imprinting (GO:0060819)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
renal phosphate ion absorption (GO:0097291)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
ketone catabolic process (GO:0042182)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
inactivation of paternal X chromosome (GO:0060817)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
ketone biosynthetic process (GO:0042181)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
random inactivation of X chromosome (GO:0060816)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular ketone metabolic process (GO:0042180)	41	0	1.12	-	 < 0.01	6.28E-01	1.00E00
negative regulation of photoreceptor cell differentiation (GO:0046533)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of photoreceptor cell differentiation (GO:0046532)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
xenobiotic catabolic process (GO:0042178)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein catabolic process (GO:0042177)	74	0	2.03	-	 < 0.01	2.69E-01	1.00E00
hepatocyte apoptotic process (GO:0097284)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
mesodermal to mesenchymal transition involved in gastrulation (GO:0060809)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell differentiation involved in embryonic placenta development (GO:0060806)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
epiblast cell-extraembryonic ectoderm cell signaling involved in anterior/posterior axis specification (GO:0060802)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of cell differentiation involved in embryonic placenta development (GO:0060800)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of trophectodermal cell proliferation (GO:1904075)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of trophectodermal cell proliferation (GO:1904073)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
presynaptic active zone assembly (GO:1904071)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
complement-dependent cytotoxicity (GO:0097278)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
sphingoid biosynthetic process (GO:0046520)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
heme metabolic process (GO:0042168)	18	0	.49	-	 < 0.01	1.00E00	1.00E00
heme catabolic process (GO:0042167)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
creatinine homeostasis (GO:0097273)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
ammonium homeostasis (GO:0097272)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mitochondrial respiratory chain complex II assembly (GO:0034553)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
respiratory chain complex II assembly (GO:0034552)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
mitochondrial respiratory chain complex III assembly (GO:0034551)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
collagen fibril organization (GO:0030199)	32	0	.88	-	 < 0.01	1.00E00	1.00E00
positive regulation of blood coagulation (GO:0030194)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
sphingoid metabolic process (GO:0046519)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
positive regulation of cation transmembrane transport (GO:1904064)	61	0	1.67	-	 < 0.01	4.13E-01	1.00E00
ceramide catabolic process (GO:0046514)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
negative regulation of cation transmembrane transport (GO:1904063)	42	0	1.15	-	 < 0.01	6.30E-01	1.00E00
ceramide biosynthetic process (GO:0046513)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
sphingosine biosynthetic process (GO:0046512)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
sphinganine biosynthetic process (GO:0046511)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
lipoprotein catabolic process (GO:0042159)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
melatonin biosynthetic process (GO:0030187)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
melatonin metabolic process (GO:0030186)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
nitric oxide transport (GO:0030185)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of sensory perception of pain (GO:1904058)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of sensory perception of pain (GO:1904057)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of cholangiocyte proliferation (GO:1904056)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of cholangiocyte proliferation (GO:1904054)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
glycerol ether biosynthetic process (GO:0046504)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
intracellular mRNA localization (GO:0008298)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
uroporphyrinogen III metabolic process (GO:0046502)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
protoporphyrinogen IX metabolic process (GO:0046501)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
cellular response to glucose starvation (GO:0042149)	38	0	1.04	-	 < 0.01	6.27E-01	1.00E00
spermidine biosynthetic process (GO:0008295)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
retrograde transport, endosome to Golgi (GO:0042147)	60	0	1.65	-	 < 0.01	4.12E-01	1.00E00
acetylcholine biosynthetic process (GO:0008292)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
acetylcholine metabolic process (GO:0008291)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
oligodendrocyte apoptotic process (GO:0097252)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
late meiotic recombination nodule assembly (GO:0042140)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of Wnt signaling pathway (GO:0030177)	83	0	2.28	-	 < 0.01	1.76E-01	1.00E00
regulation of DNA-dependent DNA replication initiation (GO:0030174)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of vascular endothelial growth factor production (GO:1904046)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular response to aldosterone (GO:1904045)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to aldosterone (GO:1904044)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of lamellipodium assembly (GO:0010593)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of lamellipodium assembly (GO:0010592)	20	0	.55	-	 < 0.01	1.00E00	1.00E00
negative regulation of cystathionine beta-synthase activity (GO:1904042)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of lamellipodium assembly (GO:0010591)	25	0	.69	-	 < 0.01	1.00E00	1.00E00
regulation of cystathionine beta-synthase activity (GO:1904041)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
insulin receptor signaling pathway (GO:0008286)	36	0	.99	-	 < 0.01	1.00E00	1.00E00
meiotic DNA double-strand break formation (GO:0042138)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
neurotransmitter biosynthetic process (GO:0042136)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
neurotransmitter catabolic process (GO:0042135)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
amyloid-beta clearance (GO:0097242)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
neurotransmitter metabolic process (GO:0042133)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
hematopoietic stem cell migration to bone marrow (GO:0097241)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
platelet activation (GO:0030168)	19	0	.52	-	 < 0.01	1.00E00	1.00E00
proteoglycan catabolic process (GO:0030167)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
proteoglycan biosynthetic process (GO:0030166)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
miRNA catabolic process (GO:0010587)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
positive regulation of epithelial cell apoptotic process (GO:1904037)	21	0	.58	-	 < 0.01	1.00E00	1.00E00
miRNA metabolic process (GO:0010586)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
cellular response to methylglyoxal (GO:0097238)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular response to toxic substance (GO:0097237)	18	0	.49	-	 < 0.01	1.00E00	1.00E00
nitrate assimilation (GO:0042128)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
nitrate metabolic process (GO:0042126)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
sulfate transport (GO:0008272)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
response to vitamin B6 (GO:0034516)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mitochondrial unfolded protein response (GO:0034514)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
pancreatic juice secretion (GO:0030157)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
protein import into mitochondrial matrix (GO:0030150)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
positive regulation of collagen fibril organization (GO:1904028)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of collagen fibril organization (GO:1904027)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of collagen fibril organization (GO:1904026)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of glucose catabolic process to lactate via pyruvate (GO:1904025)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of glucose catabolic process to lactate via pyruvate (GO:1904024)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of glucose catabolic process to lactate via pyruvate (GO:1904023)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of platelet activation (GO:0010572)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of nuclear cell cycle DNA replication (GO:0010571)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of G protein-coupled receptor internalization (GO:1904021)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of G protein-coupled receptor internalization (GO:1904020)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
neutrophil activation (GO:0042119)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
endothelial cell activation (GO:0042118)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
monocyte activation (GO:0042117)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
tooth mineralization (GO:0034505)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
sphingolipid catabolic process (GO:0030149)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
sphingolipid biosynthetic process (GO:0030148)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
epithelial cell apoptotic process (GO:1904019)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
cellular response to Thyroglobulin triiodothyronine (GO:1904017)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
response to Thyroglobulin triiodothyronine (GO:1904016)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of glycoprotein biosynthetic process (GO:0010561)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of lysosomal membrane permeability (GO:0097214)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of lysosomal membrane permeability (GO:0097213)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
lysosomal membrane organization (GO:0097212)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to gonadotropin-releasing hormone (GO:0097211)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to gonadotropin-releasing hormone (GO:0097210)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
B cell proliferation (GO:0042100)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
regulation of lung blood pressure (GO:0014916)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of smooth muscle cell migration (GO:0014912)	18	0	.49	-	 < 0.01	1.00E00	1.00E00
cellular response to monosodium glutamate (GO:1904009)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to monosodium glutamate (GO:1904008)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
tRNA dihydrouridine synthesis (GO:0002943)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of eating behavior (GO:1904000)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
tRNA N2-guanine methylation (GO:0002940)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
renal filtration (GO:0097205)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
smooth muscle cell migration (GO:0014909)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
myotube differentiation involved in skeletal muscle regeneration (GO:0014908)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
myotube cell development (GO:0014904)	17	0	.47	-	 < 0.01	1.00E00	1.00E00
myotube differentiation (GO:0014902)	31	0	.85	-	 < 0.01	1.00E00	1.00E00
satellite cell activation involved in skeletal muscle regeneration (GO:0014901)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
muscle hyperplasia (GO:0014900)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
tRNA N1-guanine methylation (GO:0002939)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
desmosome organization (GO:0002934)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
retina vasculature morphogenesis in camera-type eye (GO:0061299)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
trabecular meshwork development (GO:0002930)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis (GO:0061296)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis (GO:0061295)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
canonical Wnt signaling pathway involved in metanephric kidney development (GO:0061290)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of activation of Janus kinase activity (GO:0010536)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
tRNA wobble base 5-methoxycarbonylmethyl-2-thiouridinylation (GO:0002926)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002925)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of activation of Janus kinase activity (GO:0010533)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002924)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
Wnt signaling pathway involved in kidney development (GO:0061289)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of humoral immune response (GO:0002922)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of humoral immune response (GO:0002921)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of humoral immune response (GO:0002920)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
vasopressin secretion (GO:0030103)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
natural killer cell activation (GO:0030101)	17	0	.47	-	 < 0.01	1.00E00	1.00E00
negative regulation of transposition (GO:0010529)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
regulation of transposition (GO:0010528)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
negative regulation of transposition, RNA-mediated (GO:0010526)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of transposition, RNA-mediated (GO:0010525)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of calcium ion transport into cytosol (GO:0010524)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
negative regulation of calcium ion transport into cytosol (GO:0010523)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of calcium ion transport into cytosol (GO:0010522)	35	0	.96	-	 < 0.01	1.00E00	1.00E00
positive regulation of lymphocyte anergy (GO:0002913)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of reciprocal meiotic recombination (GO:0010520)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of lymphocyte anergy (GO:0002911)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
spermidine metabolic process (GO:0008216)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
spermine metabolic process (GO:0008215)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
protein dealkylation (GO:0008214)	26	0	.71	-	 < 0.01	1.00E00	1.00E00
mineralocorticoid metabolic process (GO:0008212)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
glucocorticoid metabolic process (GO:0008211)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
negative regulation of phospholipase activity (GO:0010519)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
positive regulation of phospholipase activity (GO:0010518)	21	0	.58	-	 < 0.01	1.00E00	1.00E00
regulation of phospholipase activity (GO:0010517)	29	0	.80	-	 < 0.01	1.00E00	1.00E00
negative regulation of mature B cell apoptotic process (GO:0002906)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of mature B cell apoptotic process (GO:0002905)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of B cell apoptotic process (GO:0002903)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
positive regulation of autophagy of mitochondrion (GO:1903599)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
C21-steroid hormone metabolic process (GO:0008207)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
positive regulation of gap junction assembly (GO:1903598)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
bile acid metabolic process (GO:0008206)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
negative regulation of gap junction assembly (GO:1903597)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of gap junction assembly (GO:1903596)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
ergosterol metabolic process (GO:0008204)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of histamine secretion by mast cell (GO:1903595)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of histamine secretion by mast cell (GO:1903593)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
RNA secondary structure unwinding (GO:0010501)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903589)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903588)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of histone deubiquitination (GO:1903586)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of histone deubiquitination (GO:1903584)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of ATP metabolic process (GO:1903579)	24	0	.66	-	 < 0.01	1.00E00	1.00E00
cellular response to L-arginine (GO:1903577)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to L-arginine (GO:1903576)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cornified envelope assembly (GO:1903575)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of response to endoplasmic reticulum stress (GO:1903573)	21	0	.58	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein localization to ciliary membrane (GO:1903569)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of protein localization to ciliary membrane (GO:1903567)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein localization to cilium (GO:1903566)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein localization to cilium (GO:1903565)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of protein localization to cilium (GO:1903564)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
pattern specification involved in mesonephros development (GO:0061227)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of extracellular exosome assembly (GO:1903553)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of extracellular exosome assembly (GO:1903551)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of mesonephros development (GO:0061218)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of mesonephros development (GO:0061217)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
one-carbon compound transport (GO:0019755)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
protein localization to photoreceptor outer segment (GO:1903546)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
polyol metabolic process (GO:0019751)	57	0	1.56	-	 < 0.01	4.07E-01	1.00E00
positive regulation of exosomal secretion (GO:1903543)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
negative regulation of exosomal secretion (GO:1903542)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of exosomal secretion (GO:1903541)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
establishment of protein localization to postsynaptic membrane (GO:1903540)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
secondary metabolic process (GO:0019748)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
cell proliferation involved in mesonephros development (GO:0061209)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
protein localization to postsynaptic membrane (GO:1903539)	22	0	.60	-	 < 0.01	1.00E00	1.00E00
regulation of meiotic cell cycle process involved in oocyte maturation (GO:1903538)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
paramesonephric duct development (GO:0061205)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
nitrogen utilization (GO:0019740)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of membrane tubulation (GO:1903527)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of membrane tubulation (GO:1903526)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
antifungal humoral response (GO:0019732)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of membrane tubulation (GO:1903525)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
antibacterial humoral response (GO:0019731)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
positive regulation of blood circulation (GO:1903524)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
negative regulation of blood circulation (GO:1903523)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
positive regulation of single strand break repair (GO:1903518)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of single strand break repair (GO:1903516)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
calcium-mediated signaling (GO:0019722)	38	0	1.04	-	 < 0.01	6.27E-01	1.00E00
release of sequestered calcium ion into cytosol by endoplasmic reticulum (GO:1903514)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
endoplasmic reticulum to cytosol transport (GO:1903513)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
phytanic acid metabolic process (GO:1903512)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mucopolysaccharide metabolic process (GO:1903510)	28	0	.77	-	 < 0.01	1.00E00	1.00E00
liposaccharide metabolic process (GO:1903509)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
apical constriction (GO:0003383)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
epithelial cell morphogenesis (GO:0003382)	25	0	.69	-	 < 0.01	1.00E00	1.00E00
cell fate commitment involved in formation of primary germ layer (GO:0060795)	19	0	.52	-	 < 0.01	1.00E00	1.00E00
sphingosine-1-phosphate receptor signaling pathway (GO:0003376)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
dynamin family protein polymerization involved in mitochondrial fission (GO:0003374)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
dynamin family protein polymerization involved in membrane fission (GO:0003373)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cellular response to benomyl (GO:0072755)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to rapamycin (GO:0072752)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cellular response to leptomycin B (GO:0072750)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
hair follicle placode formation (GO:0060789)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
ectodermal placode formation (GO:0060788)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
regulation of apoptosis involved in tissue homeostasis (GO:0060785)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of cell proliferation involved in tissue homeostasis (GO:0060784)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
establishment of cell polarity involved in ameboidal cell migration (GO:0003365)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
lamellipodium assembly involved in ameboidal cell migration (GO:0003363)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
brainstem development (GO:0003360)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to anisomycin (GO:0072740)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of epithelial cell proliferation involved in prostate gland development (GO:0060770)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
noradrenergic neuron development (GO:0003358)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
noradrenergic neuron differentiation (GO:0003357)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of cilium beat frequency (GO:0003356)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
negative regulation of cilium movement (GO:0003354)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of cilium movement (GO:0003353)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of cilium movement (GO:0003352)	26	0	.71	-	 < 0.01	1.00E00	1.00E00
epithelial cilium movement involved in extracellular fluid movement (GO:0003351)	29	0	.80	-	 < 0.01	1.00E00	1.00E00
pulmonary myocardium development (GO:0003350)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
nicotinate nucleotide metabolic process (GO:0046497)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
nicotinamide nucleotide metabolic process (GO:0046496)	22	0	.60	-	 < 0.01	1.00E00	1.00E00
response to anisomycin (GO:0072739)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular response to diamide (GO:0072738)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
response to diamide (GO:0072737)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
L-methylmalonyl-CoA metabolic process (GO:0046491)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to staurosporine (GO:0072734)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
isopentenyl diphosphate metabolic process (GO:0046490)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
response to staurosporine (GO:0072733)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of epithelial cell proliferation involved in prostate gland development (GO:0060769)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of epithelial cell proliferation involved in prostate gland development (GO:0060768)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
epithelial cell proliferation involved in prostate gland development (GO:0060767)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of androgen receptor signaling pathway (GO:0060766)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
mammary duct terminal end bud growth (GO:0060763)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of branching involved in mammary gland duct morphogenesis (GO:0060762)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
epicardium-derived cardiac endothelial cell differentiation (GO:0003349)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cardiac endothelial cell differentiation (GO:0003348)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
pericardium morphogenesis (GO:0003344)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
septum transversum development (GO:0003343)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
proepicardium development (GO:0003342)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cilium movement (GO:0003341)	98	0	2.69	-	 < 0.01	1.17E-01	1.00E00
negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003340)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
ether lipid metabolic process (GO:0046485)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
response to dithiothreitol (GO:0072720)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of mast cell chemotaxis (GO:0060754)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of mast cell chemotaxis (GO:0060753)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
branch elongation involved in mammary gland duct branching (GO:0060751)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
epithelial cell proliferation involved in mammary gland duct elongation (GO:0060750)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
corneocyte development (GO:0003335)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
keratinocyte development (GO:0003334)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
negative regulation of extracellular matrix constituent secretion (GO:0003332)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
glycosphingolipid catabolic process (GO:0046479)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
positive regulation of extracellular matrix constituent secretion (GO:0003331)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of extracellular matrix constituent secretion (GO:0003330)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
glycosylceramide catabolic process (GO:0046477)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
cellular response to cisplatin (GO:0072719)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to cisplatin (GO:0072718)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular response to actinomycin D (GO:0072717)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
response to actinomycin D (GO:0072716)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
phosphatidylglycerol metabolic process (GO:0046471)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
mammary gland alveolus development (GO:0060749)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
tertiary branching involved in mammary gland duct morphogenesis (GO:0060748)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
parental behavior (GO:0060746)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
mammary gland branching involved in pregnancy (GO:0060745)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
mammary gland branching involved in thelarche (GO:0060744)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
epithelial cell maturation involved in prostate gland development (GO:0060743)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
epithelial cell differentiation involved in prostate gland development (GO:0060742)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
prostate gland stromal morphogenesis (GO:0060741)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
prostate gland epithelium morphogenesis (GO:0060740)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
pancreatic PP cell fate commitment (GO:0003329)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
type B pancreatic cell fate commitment (GO:0003327)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
pancreatic A cell fate commitment (GO:0003326)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
type B pancreatic cell development (GO:0003323)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
platelet activating factor metabolic process (GO:0046469)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
membrane lipid biosynthetic process (GO:0046467)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
membrane lipid catabolic process (GO:0046466)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
cellular response to sorbitol (GO:0072709)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to sorbitol (GO:0072708)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
acylglycerol biosynthetic process (GO:0046463)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
cellular response to mercaptoethanol (GO:0072705)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to mercaptoethanol (GO:0072704)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
neutral lipid biosynthetic process (GO:0046460)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
late endosome to Golgi transport (GO:0034499)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
early endosome to Golgi transport (GO:0034498)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
protein localization to phagophore assembly site (GO:0034497)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
prostate gland morphogenetic growth (GO:0060737)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
prostate gland growth (GO:0060736)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
regulation of eIF2 alpha phosphorylation by dsRNA (GO:0060735)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of inositol phosphate biosynthetic process (GO:0060732)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of intestinal epithelial structure maintenance (GO:0060730)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
pancreatic PP cell differentiation (GO:0003312)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
short-chain fatty acid metabolic process (GO:0046459)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
pancreatic D cell differentiation (GO:0003311)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
pancreatic A cell differentiation (GO:0003310)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
prostanoid biosynthetic process (GO:0046457)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
icosanoid biosynthetic process (GO:0046456)	18	0	.49	-	 < 0.01	1.00E00	1.00E00
dihydrofolate metabolic process (GO:0046452)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
intestinal epithelial structure maintenance (GO:0060729)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of cell proliferation involved in embryonic placenta development (GO:0060723)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of spongiotrophoblast cell proliferation (GO:0060721)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
type B pancreatic cell differentiation (GO:0003309)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
negative regulation of Wnt signaling pathway involved in heart development (GO:0003308)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of Wnt signaling pathway involved in heart development (GO:0003307)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
Wnt signaling pathway involved in heart development (GO:0003306)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
physiological cardiac muscle hypertrophy (GO:0003301)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
cardiac muscle hypertrophy (GO:0003300)	19	0	.52	-	 < 0.01	1.00E00	1.00E00
FMN metabolic process (GO:0046444)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
FAD metabolic process (GO:0046443)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
histone H3-K36 trimethylation (GO:0097198)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
L-lysine metabolic process (GO:0046440)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
phosphatidylglycerol catabolic process (GO:0034478)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
pilomotor reflex (GO:0097195)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
U6 snRNA 3'-end processing (GO:0034477)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
U5 snRNA 3'-end processing (GO:0034476)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
U2 snRNA 3'-end processing (GO:0034474)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
U1 snRNA 3'-end processing (GO:0034473)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
labyrinthine layer blood vessel development (GO:0060716)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
syncytiotrophoblast cell differentiation involved in labyrinthine layer development (GO:0060715)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
labyrinthine layer morphogenesis (GO:0060713)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
spongiotrophoblast layer development (GO:0060712)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
labyrinthine layer development (GO:0060711)	33	0	.90	-	 < 0.01	1.00E00	1.00E00
cardiac muscle hypertrophy in response to stress (GO:0014898)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
chorio-allantoic fusion (GO:0060710)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
striated muscle hypertrophy (GO:0014897)	21	0	.58	-	 < 0.01	1.00E00	1.00E00
muscle hypertrophy (GO:0014896)	22	0	.60	-	 < 0.01	1.00E00	1.00E00
response to denervation involved in regulation of muscle adaptation (GO:0014894)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
striated muscle atrophy (GO:0014891)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
D-amino acid biosynthetic process (GO:0046437)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
D-alanine metabolic process (GO:0046436)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
dentinogenesis (GO:0097187)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
amelogenesis (GO:0097186)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
germ-line stem cell division (GO:0042078)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
cellular response to azide (GO:0097185)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to azide (GO:0097184)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cell migration involved in gastrulation (GO:0042074)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
glycogen cell differentiation involved in embryonic placenta development (GO:0060709)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
spongiotrophoblast differentiation (GO:0060708)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
intraciliary transport (GO:0042073)	39	0	1.07	-	 < 0.01	6.27E-01	1.00E00
small-subunit processome assembly (GO:0034462)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of endoribonuclease activity (GO:0060702)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
striated muscle adaptation (GO:0014888)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
negative regulation of ribonuclease activity (GO:0060701)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of ribonuclease activity (GO:0060700)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
cardiac muscle adaptation (GO:0014887)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
transition between fast and slow fiber (GO:0014883)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
ruffle assembly (GO:0097178)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
regulation of catecholamine metabolic process (GO:0042069)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
epoxide metabolic process (GO:0097176)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
response to electrical stimulus involved in regulation of muscle adaptation (GO:0014878)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
response to muscle inactivity involved in regulation of muscle adaptation (GO:0014877)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
response to injury involved in regulation of muscle adaptation (GO:0014876)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
response to stimulus involved in regulation of muscle adaptation (GO:0014874)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
response to muscle activity involved in regulation of muscle adaptation (GO:0014873)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
response to muscle inactivity (GO:0014870)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
D-amino acid metabolic process (GO:0046416)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
urate metabolic process (GO:0046415)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
mesenchymal stem cell proliferation (GO:0097168)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
circadian regulation of translation (GO:0097167)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of epidermal growth factor receptor signaling pathway (GO:0042058)	34	0	.93	-	 < 0.01	1.00E00	1.00E00
ammonium ion metabolic process (GO:0097164)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
very-low-density lipoprotein particle clearance (GO:0034447)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
substrate adhesion-dependent cell spreading (GO:0034446)	28	0	.77	-	 < 0.01	1.00E00	1.00E00
negative regulation of plasma lipoprotein oxidation (GO:0034445)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of dopamine metabolic process (GO:0042053)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
regulation of plasma lipoprotein oxidation (GO:0034444)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of lipoprotein oxidation (GO:0034443)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of lipoprotein oxidation (GO:0034442)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
plasma lipoprotein particle oxidation (GO:0034441)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
skeletal myofibril assembly (GO:0014866)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of skeletal muscle contraction by chemo-mechanical energy conversion (GO:0014862)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of central B cell tolerance induction (GO:0002897)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of central B cell tolerance induction (GO:0002895)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of immunoglobulin mediated immune response (GO:0002890)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
olfactory behavior (GO:0042048)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
GABAergic neuron differentiation (GO:0097154)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
epithelial fluid transport (GO:0042045)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
glycoprotein transport (GO:0034436)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
fluid transport (GO:0042044)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
cholesterol esterification (GO:0034435)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
mesenchymal cell apoptotic process (GO:0097152)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of inhibitory postsynaptic potential (GO:0097151)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
sterol esterification (GO:0034434)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
neuronal stem cell population maintenance (GO:0097150)	18	0	.49	-	 < 0.01	1.00E00	1.00E00
steroid esterification (GO:0034433)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of skeletal muscle cell proliferation (GO:0014859)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of skeletal muscle cell proliferation (GO:0014858)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of skeletal muscle cell proliferation (GO:0014857)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
skeletal muscle cell proliferation (GO:0014856)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
insulin secretion (GO:0030073)	24	0	.66	-	 < 0.01	1.00E00	1.00E00
striated muscle cell proliferation (GO:0014855)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
response to inactivity (GO:0014854)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of excitatory postsynaptic membrane potential involved in skeletal muscle contraction (GO:0014853)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
insulin processing (GO:0030070)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of skeletal muscle contraction by neural stimulation via neuromuscular junction (GO:0014852)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to muscle activity (GO:0014850)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
proteasomal ubiquitin-independent protein catabolic process (GO:0010499)	17	0	.47	-	 < 0.01	1.00E00	1.00E00
positive regulation of myeloid leukocyte mediated immunity (GO:0002888)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of myeloid leukocyte mediated immunity (GO:0002887)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of hypersensitivity (GO:0002885)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of hypersensitivity (GO:0002883)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
peptidyl-histidine methylation, to form tele-methylhistidine (GO:0042038)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
post-translational protein acetylation (GO:0034421)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
ureter smooth muscle contraction (GO:0014849)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
urinary tract smooth muscle contraction (GO:0014848)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
growth factor dependent regulation of skeletal muscle satellite cell proliferation (GO:0014843)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of skeletal muscle satellite cell proliferation (GO:0014842)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
skeletal muscle satellite cell proliferation (GO:0014841)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of acute inflammatory response to non-antigenic stimulus (GO:0002878)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of acute inflammatory response to non-antigenic stimulus (GO:0002877)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of epidermal cell division (GO:0010482)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
epidermal cell division (GO:0010481)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
urate biosynthetic process (GO:0034418)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein refolding (GO:0042026)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
DNA endoreduplication (GO:0042023)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
tRNA 3'-trailer cleavage, endonucleolytic (GO:0034414)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
myoblast migration involved in skeletal muscle regeneration (GO:0014839)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
myoblast differentiation involved in skeletal muscle regeneration (GO:0014835)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration (GO:0014834)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
vesicle transport along actin filament (GO:0030050)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
urinary bladder smooth muscle contraction (GO:0014832)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of acute inflammatory response to antigenic stimulus (GO:0002866)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of acute inflammatory response to antigenic stimulus (GO:0002865)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of acute inflammatory response to antigenic stimulus (GO:0002864)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of gastrulation (GO:0010470)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
response to fluid shear stress (GO:0034405)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
receptor localization to synapse (GO:0097120)	29	0	.80	-	 < 0.01	1.00E00	1.00E00
recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex (GO:0034402)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
muscle filament sliding (GO:0030049)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
actin filament-based movement (GO:0030048)	45	0	1.23	-	 < 0.01	6.34E-01	1.00E00
vascular associated smooth muscle contraction (GO:0014829)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
parallel actin filament bundle assembly (GO:0030046)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
vein smooth muscle contraction (GO:0014826)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
actin filament fragmentation (GO:0030043)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
actin filament depolymerization (GO:0030042)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
artery smooth muscle contraction (GO:0014824)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
phasic smooth muscle contraction (GO:0014821)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
tonic smooth muscle contraction (GO:0014820)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
positive regulation of heart rate (GO:0010460)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
positive regulation of peripheral T cell tolerance induction (GO:0002851)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
neuroligin clustering involved in postsynaptic membrane assembly (GO:0097118)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of DNA replication (GO:0008156)	27	0	.74	-	 < 0.01	1.00E00	1.00E00
guanylate kinase-associated protein clustering (GO:0097117)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of embryonic development (GO:0045995)	41	0	1.12	-	 < 0.01	6.28E-01	1.00E00
NMDA glutamate receptor clustering (GO:0097114)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
AMPA glutamate receptor clustering (GO:0097113)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of translational initiation by iron (GO:0045994)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
endoplasmic reticulum-Golgi intermediate compartment organization (GO:0097111)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of embryonic development (GO:0045992)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
carbon catabolite activation of transcription (GO:0045991)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
carbon catabolite regulation of transcription (GO:0045990)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
translocation of peptides or proteins into host (GO:0042000)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
contractile actin filament bundle assembly (GO:0030038)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
regulation of skeletal muscle contraction (GO:0014819)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
microspike assembly (GO:0030035)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
skeletal muscle satellite cell differentiation (GO:0014816)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
microvillus assembly (GO:0030033)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
lamellipodium assembly (GO:0030032)	25	0	.69	-	 < 0.01	1.00E00	1.00E00
skeletal muscle satellite cell commitment (GO:0014813)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
muscle cell migration (GO:0014812)	18	0	.49	-	 < 0.01	1.00E00	1.00E00
negative regulation of heart rate (GO:0010459)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
exit from mitosis (GO:0010458)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
regulation of peripheral T cell tolerance induction (GO:0002849)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
centriole-centriole cohesion (GO:0010457)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
positive regulation of cell fate commitment (GO:0010455)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell fate commitment (GO:0010454)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
histone H3-K36 methylation (GO:0010452)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of striated muscle contraction (GO:0045989)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
postsynaptic density assembly (GO:0097107)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of striated muscle contraction (GO:0045988)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
postsynaptic density organization (GO:0097106)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of smooth muscle contraction (GO:0045987)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
presynaptic membrane assembly (GO:0097105)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
postsynaptic membrane assembly (GO:0097104)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
blood vessel endothelial cell fate specification (GO:0097101)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of nucleotide metabolic process (GO:0045980)	18	0	.49	-	 < 0.01	1.00E00	1.00E00
regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion (GO:0014809)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
protein maturation by protein folding (GO:0022417)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0014808)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of somitogenesis (GO:0014807)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
smooth muscle hyperplasia (GO:0014806)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
smooth muscle adaptation (GO:0014805)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to acidic pH (GO:0010447)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
fungiform papilla formation (GO:0061198)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
fungiform papilla morphogenesis (GO:0061197)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
fungiform papilla development (GO:0061196)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of mitotic cell cycle, embryonic (GO:0045976)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of translation, ncRNA-mediated (GO:0045975)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of translation, ncRNA-mediated (GO:0045974)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
cell cycle phase (GO:0022403)	17	0	.47	-	 < 0.01	1.00E00	1.00E00
negative adaptation of signaling pathway (GO:0022401)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
regulation of rhodopsin mediated signaling pathway (GO:0022400)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of type 2 immune response (GO:0002829)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
negative regulation of ribosomal DNA heterochromatin assembly (GO:0061188)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of ribosomal DNA heterochromatin assembly (GO:0061187)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
fatty acid omega-oxidation (GO:0010430)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of growth rate (GO:0045967)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of dermatome development (GO:0061185)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of dermatome development (GO:0061184)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of dermatome development (GO:0061183)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of dopamine metabolic process (GO:0045964)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of chondrocyte development (GO:0061182)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of dopamine metabolic process (GO:0045963)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of chondrocyte development (GO:0061181)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
mammary gland epithelium development (GO:0061180)	28	0	.77	-	 < 0.01	1.00E00	1.00E00
cellular anion homeostasis (GO:0030002)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria (GO:0002816)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
DNA methylation on cytosine within a CG sequence (GO:0010424)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061179)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178)	41	0	1.12	-	 < 0.01	6.28E-01	1.00E00
biosynthetic process of antibacterial peptides active against Gram-negative bacteria (GO:0002812)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
hydrogen peroxide-mediated programmed cell death (GO:0010421)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of calcium ion-dependent exocytosis (GO:0045956)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of calcium ion-dependent exocytosis (GO:0045955)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of natural killer cell mediated cytotoxicity (GO:0045953)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of mitotic recombination (GO:0045951)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of mitotic recombination (GO:0045950)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of antibacterial peptide biosynthetic process (GO:0002808)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of antimicrobial peptide biosynthetic process (GO:0002807)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of antimicrobial peptide biosynthetic process (GO:0002805)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of antibacterial peptide production (GO:0002803)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of translational initiation (GO:0045948)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
negative regulation of translational initiation (GO:0045947)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
endoplasmic reticulum polarization (GO:0061163)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
establishment of monopolar cell polarity (GO:0061162)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
positive regulation of transcription by RNA polymerase I (GO:0045943)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
positive regulation of mitotic cytokinesis (GO:1903490)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of steroid metabolic process (GO:0045940)	21	0	.58	-	 < 0.01	1.00E00	1.00E00
box H/ACA RNA metabolic process (GO:0033979)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
3'-UTR-mediated mRNA destabilization (GO:0061158)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
choline metabolic process (GO:0019695)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
pulmonary artery morphogenesis (GO:0061156)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
pulmonary artery endothelial tube morphogenesis (GO:0061155)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
endothelial tube morphogenesis (GO:0061154)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
trachea gland development (GO:0061153)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
trachea submucosa development (GO:0061152)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of muscle contraction (GO:0045933)	19	0	.52	-	 < 0.01	1.00E00	1.00E00
BMP signaling pathway involved in renal system segmentation (GO:0061151)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
renal system segmentation (GO:0061150)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
box C/D RNA metabolic process (GO:0033967)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
P-body assembly (GO:0033962)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
neural plate anterior/posterior regionalization (GO:0021999)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
neural plate axis specification (GO:0021997)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
neuropore closure (GO:0021995)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
initiation of neural tube closure (GO:0021993)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
neural plate formation (GO:0021990)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
BMP signaling pathway involved in ureter morphogenesis (GO:0061149)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
Peyer's patch morphogenesis (GO:0061146)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
lung smooth muscle development (GO:0061145)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
glyceraldehyde-3-phosphate metabolic process (GO:0019682)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
alveolar secondary septum development (GO:0061144)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of female receptivity (GO:0045925)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of female receptivity (GO:0045924)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
positive regulation of fatty acid metabolic process (GO:0045923)	30	0	.82	-	 < 0.01	1.00E00	1.00E00
lung ciliated cell differentiation (GO:0061141)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
lung secretory cell differentiation (GO:0061140)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of fatty acid metabolic process (GO:0045922)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
negative regulation of exocytosis (GO:0045920)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
olfactory lobe development (GO:0021988)	20	0	.55	-	 < 0.01	1.00E00	1.00E00
cerebral cortex development (GO:0021987)	65	0	1.78	-	 < 0.01	4.22E-01	1.00E00
habenula development (GO:0021986)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
neurohypophysis development (GO:0021985)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
NAD catabolic process (GO:0019677)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
ammonia assimilation cycle (GO:0019676)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of cytolysis (GO:0045919)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of cytolysis (GO:0045918)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of complement activation (GO:0045917)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of complement activation (GO:0045916)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of catecholamine metabolic process (GO:0045915)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of mitotic cell cycle DNA replication (GO:1903464)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of catecholamine metabolic process (GO:0045914)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of mitotic cell cycle DNA replication (GO:1903463)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
Okazaki fragment processing involved in mitotic DNA replication (GO:1903461)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of DNA recombination (GO:0045910)	31	0	.85	-	 < 0.01	1.00E00	1.00E00
hypothalamus cell differentiation (GO:0021979)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
telencephalon regionalization (GO:0021978)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
corticospinal neuron axon guidance through spinal cord (GO:0021972)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
lactate catabolic process (GO:1903457)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of vasoconstriction (GO:0045906)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
positive regulation of translational termination (GO:0045905)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of translational fidelity (GO:0045903)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of G1 to G0 transition (GO:1903452)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of translational elongation (GO:0045901)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of G1 to G0 transition (GO:1903450)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of translational elongation (GO:0045900)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
corticospinal neuron axon guidance (GO:0021966)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
spinal cord ventral commissure morphogenesis (GO:0021965)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
anterior commissure morphogenesis (GO:0021960)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of heart growth (GO:0061117)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
branching involved in pancreas morphogenesis (GO:0061114)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
pancreas morphogenesis (GO:0061113)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of brown fat cell differentiation (GO:1903444)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
dense core granule biogenesis (GO:0061110)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
corticospinal tract morphogenesis (GO:0021957)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
central nervous system interneuron axonogenesis (GO:0021956)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
central nervous system neuron axonogenesis (GO:0021955)	24	0	.66	-	 < 0.01	1.00E00	1.00E00
central nervous system neuron development (GO:0021954)	50	0	1.37	-	 < 0.01	6.45E-01	1.00E00
central nervous system projection neuron axonogenesis (GO:0021952)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
aerobic electron transport chain (GO:0019646)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
seminal vesicle epithelium development (GO:0061108)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of mitotic cytokinetic process (GO:1903438)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
seminal vesicle development (GO:0061107)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of stomach neuroendocrine cell differentiation (GO:0061106)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of mitotic cytokinetic process (GO:1903436)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of stomach neuroendocrine cell differentiation (GO:0061105)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of constitutive secretory pathway (GO:1903435)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of constitutive secretory pathway (GO:1903434)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of constitutive secretory pathway (GO:1903433)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of TORC1 signaling (GO:1903432)	30	0	.82	-	 < 0.01	1.00E00	1.00E00
neuroendocrine cell differentiation (GO:0061101)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of cell maturation (GO:1903431)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell maturation (GO:1903430)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
formation of radial glial scaffolds (GO:0021943)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
radial glia guided migration of Purkinje cell (GO:0021942)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
protein localization to microtubule cytoskeleton (GO:0072698)	36	0	.99	-	 < 0.01	1.00E00	1.00E00
positive regulation of cerebellar granule cell precursor proliferation (GO:0021940)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
protein localization to cell cortex (GO:0072697)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of cell maturation (GO:1903429)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
regulation of DNA recombination at telomere (GO:0072695)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of synaptic vesicle recycling (GO:1903423)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
negative regulation of synaptic vesicle recycling (GO:1903422)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of synaptic vesicle recycling (GO:1903421)	18	0	.49	-	 < 0.01	1.00E00	1.00E00
protein localization to endoplasmic reticulum tubular network (GO:1903420)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation (GO:0021938)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation (GO:0021937)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of cerebellar granule cell precursor proliferation (GO:0021936)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
cerebellar granule cell precursor tangential migration (GO:0021935)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
hindbrain tangential cell migration (GO:0021934)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
radial glia guided migration of cerebellar granule cell (GO:0021933)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
hindbrain radial glia guided cell migration (GO:0021932)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
urate catabolic process (GO:0019628)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cerebellar granule cell precursor proliferation (GO:0021930)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
urea metabolic process (GO:0019627)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
short-chain fatty acid catabolic process (GO:0019626)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
mitochondrial tRNA 3'-trailer cleavage, endonucleolytic (GO:0072684)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
T cell extravasation (GO:0072683)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
response to glycoside (GO:1903416)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to bile acid (GO:1903413)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to bile acid (GO:1903412)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
muscle hypertrophy in response to stress (GO:0003299)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
physiological muscle hypertrophy (GO:0003298)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
cardiac septum cell differentiation (GO:0003292)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
atrial septum secundum morphogenesis (GO:0003290)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cell proliferation in external granule layer (GO:0021924)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
T cell migration (GO:0072678)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
eosinophil migration (GO:0072677)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
lymphocyte migration (GO:0072676)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
osteoclast fusion (GO:0072675)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of sodium:potassium-exchanging ATPase activity (GO:1903408)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
multinuclear osteoclast differentiation (GO:0072674)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
catechol-containing compound catabolic process (GO:0019614)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
lamellipodium morphogenesis (GO:0072673)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of sodium:potassium-exchanging ATPase activity (GO:1903406)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
neutrophil extravasation (GO:0072672)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein localization to nuclear body (GO:1903405)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of renal phosphate excretion (GO:1903403)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of renal phosphate excretion (GO:1903402)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
L-lysine transmembrane transport (GO:1903401)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
L-arginine transmembrane transport (GO:1903400)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
atrial septum primum morphogenesis (GO:0003289)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
septum secundum development (GO:0003285)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
BMP signaling pathway involved in spinal cord dorsal/ventral patterning (GO:0021919)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
septum primum development (GO:0003284)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
atrial septum development (GO:0003283)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning (GO:0021914)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
smoothened signaling pathway involved in ventral spinal cord patterning (GO:0021910)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
2-oxobutyrate catabolic process (GO:0019606)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
butyrate metabolic process (GO:0019605)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
establishment of protein localization to peroxisome (GO:0072663)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
protein localization to peroxisome (GO:0072662)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
maintenance of protein location in plasma membrane (GO:0072660)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of endoribonuclease activity (GO:0060699)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
mechanosensory behavior (GO:0007638)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
positive regulation of phospholipid catabolic process (GO:0060697)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of phospholipid catabolic process (GO:0060696)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
chemosensory behavior (GO:0007635)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
negative regulation of cholesterol transporter activity (GO:0060695)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
optokinetic behavior (GO:0007634)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of cholesterol transporter activity (GO:0060694)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
visual behavior (GO:0007632)	37	0	1.01	-	 < 0.01	6.26E-01	1.00E00
epithelial cell differentiation involved in salivary gland development (GO:0060690)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
apoptotic process involved in heart morphogenesis (GO:0003278)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
endocardial cushion fusion (GO:0003274)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cell migration involved in endocardial cushion formation (GO:0003273)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
endocardial cushion formation (GO:0003272)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
smoothened signaling pathway involved in regulation of secondary heart field cardioblast proliferation (GO:0003271)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation (GO:0003270)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
dorsal/ventral neural tube patterning (GO:0021904)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
rostrocaudal neural tube patterning (GO:0021903)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
commitment of neuronal cell to specific neuron type in forebrain (GO:0021902)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
maintenance of protein location in membrane (GO:0072658)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
maintenance of protein location in mitochondrion (GO:0072656)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
establishment of protein localization to mitochondrion (GO:0072655)	34	0	.93	-	 < 0.01	1.00E00	1.00E00
cell differentiation involved in salivary gland development (GO:0060689)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
adult walking behavior (GO:0007628)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
regulation of branching involved in prostate gland morphogenesis (GO:0060687)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of prostatic bud formation (GO:0060686)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of prostatic bud formation (GO:0060685)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
grooming behavior (GO:0007625)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
epithelial-mesenchymal cell signaling (GO:0060684)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
ultradian rhythm (GO:0007624)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling (GO:0060683)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
primary ureteric bud growth (GO:0060682)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of female receptivity (GO:0007621)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
branch elongation involved in ureteric bud branching (GO:0060681)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
copulation (GO:0007620)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of secondary heart field cardioblast proliferation (GO:0003266)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
regulation of cardioblast proliferation (GO:0003264)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
courtship behavior (GO:0007619)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
mating (GO:0007618)	17	0	.47	-	 < 0.01	1.00E00	1.00E00
ureteric bud elongation (GO:0060677)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
mating behavior (GO:0007617)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
ureteric bud formation (GO:0060676)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
ureteric bud morphogenesis (GO:0060675)	36	0	.99	-	 < 0.01	1.00E00	1.00E00
branching involved in labyrinthine layer morphogenesis (GO:0060670)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation (GO:0003257)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation (GO:0003256)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
cardiac neural crest cell migration involved in outflow tract morphogenesis (GO:0003253)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell proliferation involved in heart valve morphogenesis (GO:0003252)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of cell proliferation involved in heart valve morphogenesis (GO:0003251)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of cell proliferation involved in heart valve morphogenesis (GO:0003250)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
UDP-glucuronate metabolic process (GO:0046398)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
5-phosphoribose 1-diphosphate metabolic process (GO:0046391)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
embryonic placenta morphogenesis (GO:0060669)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
sensory perception of smell (GO:0007608)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
negative regulation of phospholipid efflux (GO:1902999)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of branching involved in salivary gland morphogenesis by extracellular matrix-epithelial cell signaling (GO:0060668)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of neurofibrillary tangle assembly (GO:1902998)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
sensory perception of chemical stimulus (GO:0007606)	23	0	.63	-	 < 0.01	1.00E00	1.00E00
dichotomous subdivision of terminal units involved in salivary gland branching (GO:0060666)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of neurofibrillary tangle assembly (GO:1902996)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of phospholipid efflux (GO:1902995)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
phototransduction, visible light (GO:0007603)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of phospholipid efflux (GO:1902994)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of amyloid precursor protein catabolic process (GO:1902993)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
phototransduction (GO:0007602)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
salivary gland cavitation (GO:0060662)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
mitotic telomere maintenance via semi-conservative replication (GO:1902990)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
post-embryonic cardiac muscle cell growth involved in heart morphogenesis (GO:0003247)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cardiac muscle tissue growth involved in heart morphogenesis (GO:0003245)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
circumferential growth involved in left ventricle morphogenesis (GO:0003243)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
growth involved in heart morphogenesis (GO:0003241)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
deoxyribose phosphate biosynthetic process (GO:0046385)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
N-acetylneuraminate biosynthetic process (GO:0046380)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
nipple sheath formation (GO:0060659)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
nipple morphogenesis (GO:0060658)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
DNA strand elongation involved in mitotic DNA replication (GO:1902983)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cardiac atrium development (GO:0003230)	21	0	.58	-	 < 0.01	1.00E00	1.00E00
L-arabinose metabolic process (GO:0046373)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
fructose biosynthetic process (GO:0046370)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
mammary gland bud elongation (GO:0060649)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mammary gland bud morphogenesis (GO:0060648)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mitotic DNA replication preinitiation complex assembly (GO:1902977)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mitotic DNA replication initiation (GO:1902975)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
mammary gland epithelial cell differentiation (GO:0060644)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
atrial cardiac muscle tissue development (GO:0003228)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
ventricular compact myocardium morphogenesis (GO:0003223)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
ventricular trabecula myocardium morphogenesis (GO:0003222)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
right ventricular cardiac muscle tissue morphogenesis (GO:0003221)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
left ventricular cardiac muscle tissue morphogenesis (GO:0003220)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
2-oxobutyrate metabolic process (GO:0046361)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
2-oxobutyrate biosynthetic process (GO:0046360)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of transcription from RNA polymerase II promoter in response to iron (GO:0034395)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of smooth muscle cell apoptotic process (GO:0034393)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
negative regulation of smooth muscle cell apoptotic process (GO:0034392)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
regulation of smooth muscle cell apoptotic process (GO:0034391)	20	0	.55	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein localization to early endosome (GO:1902966)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of protein localization to early endosome (GO:1902965)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of transcription initiation from RNA polymerase II promoter (GO:0060633)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902963)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of microtubule-based movement (GO:0060632)	36	0	.99	-	 < 0.01	1.00E00	1.00E00
regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902962)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of meiosis I (GO:0060631)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902961)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
cardiac right ventricle formation (GO:0003219)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902960)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cardiac left ventricle formation (GO:0003218)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cardiac right ventricle morphogenesis (GO:0003215)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
cardiac left ventricle morphogenesis (GO:0003214)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
cardiac right atrium morphogenesis (GO:0003213)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
butyrate catabolic process (GO:0046359)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cardiac ventricle formation (GO:0003211)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
acetyl-CoA catabolic process (GO:0046356)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
disaccharide catabolic process (GO:0046352)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
disaccharide biosynthetic process (GO:0046351)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
lipid droplet organization (GO:0034389)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
regulation of homologous chromosome segregation (GO:0060629)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902959)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of ER to Golgi vesicle-mediated transport (GO:0060628)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
high-density lipoprotein particle clearance (GO:0034384)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
low-density lipoprotein particle clearance (GO:0034383)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of mitochondrial electron transport, NADH to ubiquinone (GO:1902958)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of mitochondrial electron transport, NADH to ubiquinone (GO:1902957)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
chylomicron remnant clearance (GO:0034382)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
plasma lipoprotein particle clearance (GO:0034381)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
regulation of mitochondrial electron transport, NADH to ubiquinone (GO:1902956)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
high-density lipoprotein particle assembly (GO:0034380)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of early endosome to recycling endosome transport (GO:1902954)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of chromosome condensation (GO:0060623)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of dendritic spine maintenance (GO:1902952)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of cholesterol import (GO:0060621)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of cholesterol import (GO:0060620)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
cardiac atrium morphogenesis (GO:0003209)	17	0	.47	-	 < 0.01	1.00E00	1.00E00
negative regulation of dendritic spine maintenance (GO:1902951)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of dendritic spine maintenance (GO:1902950)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
cardiac chamber formation (GO:0003207)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
endocardial cushion morphogenesis (GO:0003203)	21	0	.58	-	 < 0.01	1.00E00	1.00E00
amino sugar biosynthetic process (GO:0046349)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
diacylglycerol catabolic process (GO:0046340)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
very-low-density lipoprotein particle assembly (GO:0034379)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
chylomicron assembly (GO:0034378)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
craniofacial suture morphogenesis (GO:0097094)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
plasma lipoprotein particle assembly (GO:0034377)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
high-density lipoprotein particle remodeling (GO:0034375)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
synaptic vesicle clustering (GO:0097091)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of tau-protein kinase activity (GO:1902949)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
low-density lipoprotein particle remodeling (GO:0034374)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
nipple development (GO:0060618)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
presynaptic membrane organization (GO:0097090)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of tau-protein kinase activity (GO:1902948)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
very-low-density lipoprotein particle remodeling (GO:0034372)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of tau-protein kinase activity (GO:1902947)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
chylomicron remodeling (GO:0034371)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
triglyceride-rich lipoprotein particle remodeling (GO:0034370)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
fat pad development (GO:0060613)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
adipose tissue development (GO:0060612)	24	0	.66	-	 < 0.01	1.00E00	1.00E00
phosphatidylethanolamine catabolic process (GO:0046338)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
phosphatidylethanolamine metabolic process (GO:0046337)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
octopamine metabolic process (GO:0046333)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
methyl-branched fatty acid metabolic process (GO:0097089)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
lateral inhibition (GO:0046331)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
plasma lipoprotein particle remodeling (GO:0034369)	17	0	.47	-	 < 0.01	1.00E00	1.00E00
protein-lipid complex remodeling (GO:0034368)	17	0	.47	-	 < 0.01	1.00E00	1.00E00
vascular associated smooth muscle cell development (GO:0097084)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
protein-containing complex remodeling (GO:0034367)	19	0	.52	-	 < 0.01	1.00E00	1.00E00
tube lumen cavitation (GO:0060605)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
mammary gland duct morphogenesis (GO:0060603)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
branch elongation of an epithelium (GO:0060602)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
positive regulation of alcohol biosynthetic process (GO:1902932)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
lateral sprouting from an epithelium (GO:0060601)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
dichotomous subdivision of an epithelial terminal unit (GO:0060600)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of JNK cascade (GO:0046329)	27	0	.74	-	 < 0.01	1.00E00	1.00E00
glycerol biosynthetic process from pyruvate (GO:0046327)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of glucose import (GO:0046326)	28	0	.77	-	 < 0.01	1.00E00	1.00E00
negative regulation of glucose import (GO:0046325)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
regulation of glucose import (GO:0046324)	45	0	1.23	-	 < 0.01	6.34E-01	1.00E00
glucose import (GO:0046323)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of fatty acid oxidation (GO:0046322)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
positive regulation of fatty acid oxidation (GO:0046321)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
regulation of fatty acid oxidation (GO:0046320)	24	0	.66	-	 < 0.01	1.00E00	1.00E00
NAD salvage (GO:0034355)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
'de novo' NAD biosynthetic process from tryptophan (GO:0034354)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
ductus arteriosus closure (GO:0097070)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of glial cell apoptotic process (GO:0034352)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of glial cell apoptotic process (GO:0034351)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
regulation of glial cell apoptotic process (GO:0034350)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
phosphocreatine biosynthetic process (GO:0046314)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cellular response to thyroid hormone stimulus (GO:0097067)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
response to thyroid hormone (GO:0097066)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
glial cell apoptotic process (GO:0034349)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
anterior head development (GO:0097065)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
ncRNA export from nucleus (GO:0097064)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
dendritic spine maintenance (GO:0097062)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
response to type III interferon (GO:0034342)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein polyubiquitination (GO:1902916)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein polyubiquitination (GO:1902915)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
regulation of protein polyubiquitination (GO:1902914)	20	0	.55	-	 < 0.01	1.00E00	1.00E00
positive regulation of neuroepithelial cell differentiation (GO:1902913)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
alkanesulfonate biosynthetic process (GO:0046305)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
selenocysteinyl-tRNA(Sec) biosynthetic process (GO:0097056)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
RNA folding (GO:0034337)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
L-kynurenine metabolic process (GO:0097052)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
establishment of protein localization to endoplasmic reticulum membrane (GO:0097051)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
adherens junction maintenance (GO:0034334)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
retrograde axonal transport (GO:0008090)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
type B pancreatic cell apoptotic process (GO:0097050)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
adherens junction assembly (GO:0034333)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
adherens junction organization (GO:0034332)	20	0	.55	-	 < 0.01	1.00E00	1.00E00
cell junction maintenance (GO:0034331)	18	0	.49	-	 < 0.01	1.00E00	1.00E00
positive regulation of supramolecular fiber organization (GO:1902905)	135	0	3.70	-	 < 0.01	5.33E-02	1.00E00
negative regulation of autophagosome assembly (GO:1902902)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
negative regulation of antibacterial peptide production (GO:0002787)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of antibacterial peptide production (GO:0002786)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of antimicrobial peptide production (GO:0002785)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of antimicrobial peptide production (GO:0002784)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
anterograde axonal transport (GO:0008089)	34	0	.93	-	 < 0.01	1.00E00	1.00E00
motor neuron apoptotic process (GO:0097049)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
histone monoubiquitination (GO:0010390)	24	0	.66	-	 < 0.01	1.00E00	1.00E00
antibacterial peptide biosynthetic process (GO:0002780)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of muscle adaptation (GO:0014744)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of muscle hypertrophy (GO:0014742)	26	0	.71	-	 < 0.01	1.00E00	1.00E00
regulation of G2/M transition of mitotic cell cycle (GO:0010389)	60	0	1.65	-	 < 0.01	4.12E-01	1.00E00
negative regulation of muscle hyperplasia (GO:0014740)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
antibacterial peptide secretion (GO:0002779)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
antibacterial peptide production (GO:0002778)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
antimicrobial peptide biosynthetic process (GO:0002777)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
antimicrobial peptide secretion (GO:0002776)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
antimicrobial peptide production (GO:0002775)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
Fc receptor mediated inhibitory signaling pathway (GO:0002774)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mesodermal cell migration (GO:0008078)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
protein linear polyubiquitination (GO:0097039)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
heme export (GO:0097037)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of Arp2/3 complex-mediated actin nucleation (GO:0034316)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315)	18	0	.49	-	 < 0.01	1.00E00	1.00E00
Arp2/3 complex-mediated actin nucleation (GO:0034314)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
diol biosynthetic process (GO:0034312)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
diol metabolic process (GO:0034311)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
primary alcohol catabolic process (GO:0034310)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of muscle hyperplasia (GO:0014738)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of muscle atrophy (GO:0014737)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of muscle atrophy (GO:0014736)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of muscle atrophy (GO:0014735)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
skeletal muscle hypertrophy (GO:0014734)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of skeletal muscle adaptation (GO:0014733)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
skeletal muscle atrophy (GO:0014732)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
immune response-inhibiting cell surface receptor signaling pathway (GO:0002767)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
immune response-inhibiting signal transduction (GO:0002765)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of myeloid leukocyte differentiation (GO:0002763)	29	0	.80	-	 < 0.01	1.00E00	1.00E00
mature conventional dendritic cell differentiation (GO:0097029)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of antimicrobial humoral response (GO:0002760)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
establishment of blood-nerve barrier (GO:0008065)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
primary alcohol biosynthetic process (GO:0034309)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
dendritic cell dendrite assembly (GO:0097026)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
Toll signaling pathway (GO:0008063)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
lymphocyte migration into lymph node (GO:0097022)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
lymphocyte migration into lymphoid organs (GO:0097021)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of the force of skeletal muscle contraction (GO:0014728)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of twitch skeletal muscle contraction (GO:0014724)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of skeletal muscle contraction by calcium ion signaling (GO:0014722)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
twitch skeletal muscle contraction (GO:0014721)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of antimicrobial humoral response (GO:0002759)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
MyD88-independent toll-like receptor signaling pathway (GO:0002756)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
MyD88-dependent toll-like receptor signaling pathway (GO:0002755)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045899)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
negative regulation of anion channel activity (GO:0010360)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
renal protein absorption (GO:0097017)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mitochondrial fusion (GO:0008053)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
response to granulocyte macrophage colony-stimulating factor (GO:0097012)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
cellular response to granulocyte macrophage colony-stimulating factor stimulus (GO:0097011)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
female courtship behavior (GO:0008050)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
eukaryotic translation initiation factor 4F complex assembly (GO:0097010)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
skeletal muscle satellite cell activation (GO:0014719)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of satellite cell activation involved in skeletal muscle regeneration (GO:0014718)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of satellite cell activation involved in skeletal muscle regeneration (GO:0014717)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of anion channel activity (GO:0010359)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
male courtship behavior (GO:0008049)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
energy homeostasis (GO:0097009)	23	0	.63	-	 < 0.01	1.00E00	1.00E00
regulation of plasma lipoprotein particle levels (GO:0097006)	27	0	.74	-	 < 0.01	1.00E00	1.00E00
motor neuron axon guidance (GO:0008045)	18	0	.49	-	 < 0.01	1.00E00	1.00E00
positive regulation of synaptic growth at neuromuscular junction (GO:0045887)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of synaptic growth at neuromuscular junction (GO:0045886)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of smoothened signaling pathway (GO:0045880)	28	0	.77	-	 < 0.01	1.00E00	1.00E00
branchiomeric skeletal muscle development (GO:0014707)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade (GO:0085032)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of myeloid dendritic cell cytokine production (GO:0002735)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein tyrosine kinase activity (GO:0061099)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
regulation of myeloid dendritic cell cytokine production (GO:0002733)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
neuron recognition (GO:0008038)	18	0	.49	-	 < 0.01	1.00E00	1.00E00
positive regulation of dendritic cell cytokine production (GO:0002732)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of smoothened signaling pathway (GO:0045879)	23	0	.63	-	 < 0.01	1.00E00	1.00E00
cell recognition (GO:0008037)	45	0	1.23	-	 < 0.01	6.34E-01	1.00E00
regulation of dendritic cell cytokine production (GO:0002730)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
positive regulation of sister chromatid cohesion (GO:0045876)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
negative regulation of sister chromatid cohesion (GO:0045875)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of phospholipid translocation (GO:0061091)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
extracellular matrix assembly (GO:0085029)	17	0	.47	-	 < 0.01	1.00E00	1.00E00
positive regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045870)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
protein K6-linked ubiquitination (GO:0085020)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
response to non-ionic osmotic stress (GO:0010335)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of T cell cytokine production (GO:0002725)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
response to gamma radiation (GO:0010332)	34	0	.93	-	 < 0.01	1.00E00	1.00E00
regulation of sequestering of zinc ion (GO:0061088)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of histone H3-K27 methylation (GO:0061087)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045869)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of histone H3-K27 methylation (GO:0061086)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of histone H3-K27 methylation (GO:0061085)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein refolding (GO:0061084)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of protein refolding (GO:0061083)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
myeloid leukocyte cytokine production (GO:0061082)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of cytokine production involved in immune response (GO:0002719)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
negative regulation of natural killer cell mediated immunity (GO:0002716)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
membrane invagination (GO:0010324)	24	0	.66	-	 < 0.01	1.00E00	1.00E00
negative regulation of B cell mediated immunity (GO:0002713)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of prostaglandin secretion involved in immune response (GO:0061078)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of T cell mediated immunity (GO:0002710)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
ciliary body morphogenesis (GO:0061073)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
iris morphogenesis (GO:0061072)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of lymphocyte mediated immunity (GO:0002707)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
negative regulation of leukocyte mediated immunity (GO:0002704)	17	0	.47	-	 < 0.01	1.00E00	1.00E00
regulation of hydrogen peroxide metabolic process (GO:0010310)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
positive regulation of nitrogen utilization (GO:0045848)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of striated muscle tissue development (GO:0045844)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
positive regulation of adherens junction organization (GO:1903393)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of adherens junction organization (GO:1903392)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of adherens junction organization (GO:1903391)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
myotome development (GO:0061055)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of meiotic nuclear division (GO:0045836)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
negative regulation of meiotic nuclear division (GO:0045835)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway (GO:1903384)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell growth involved in cardiac muscle cell development (GO:0061052)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway (GO:1903383)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of cell growth involved in cardiac muscle cell development (GO:0061051)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
regulation of cell growth involved in cardiac muscle cell development (GO:0061050)	18	0	.49	-	 < 0.01	1.00E00	1.00E00
nucleoside bisphosphate catabolic process (GO:0033869)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
nucleoside bisphosphate biosynthetic process (GO:0033866)	20	0	.55	-	 < 0.01	1.00E00	1.00E00
positive regulation of NAD(P)H oxidase activity (GO:0033864)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of NAD(P)H oxidase activity (GO:0033861)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of NAD(P)H oxidase activity (GO:0033860)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
forebrain astrocyte development (GO:0021897)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
forebrain astrocyte differentiation (GO:0021896)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cerebral cortex neuron differentiation (GO:0021895)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
cerebral cortex GABAergic interneuron development (GO:0021894)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cerebral cortex GABAergic interneuron fate commitment (GO:0021893)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cerebral cortex GABAergic interneuron differentiation (GO:0021892)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
olfactory bulb interneuron development (GO:0021891)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cell growth involved in cardiac muscle cell development (GO:0061049)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903378)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
glucuronate metabolic process (GO:0019585)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of isotype switching (GO:0045829)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of branching involved in lung morphogenesis (GO:0061047)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of branching involved in lung morphogenesis (GO:0061046)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903377)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903376)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
negative regulation of vascular wound healing (GO:0061044)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of vascular wound healing (GO:0061043)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of endoplasmic reticulum tubular network organization (GO:1903373)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of innate immune response (GO:0045824)	30	0	.82	-	 < 0.01	1.00E00	1.00E00
vascular wound healing (GO:0061042)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of heart contraction (GO:0045823)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
regulation of endoplasmic reticulum tubular network organization (GO:1903371)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of heart contraction (GO:0045822)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
female gonad morphogenesis (GO:0061040)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of glycolytic process (GO:0045821)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
negative regulation of glycolytic process (GO:0045820)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
olfactory bulb interneuron differentiation (GO:0021889)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
hypothalamus gonadotrophin-releasing hormone neuron development (GO:0021888)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
hypothalamus gonadotrophin-releasing hormone neuron differentiation (GO:0021886)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
forebrain cell migration (GO:0021885)	35	0	.96	-	 < 0.01	1.00E00	1.00E00
forebrain neuron development (GO:0021884)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
uterus morphogenesis (GO:0061038)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of cartilage development (GO:0061037)	21	0	.58	-	 < 0.01	1.00E00	1.00E00
positive regulation of glycogen catabolic process (GO:0045819)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of cartilage development (GO:0061036)	19	0	.52	-	 < 0.01	1.00E00	1.00E00
positive regulation of fear response (GO:1903367)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of glycogen catabolic process (GO:0045818)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of cartilage development (GO:0061035)	44	0	1.21	-	 < 0.01	6.32E-01	1.00E00
negative regulation of fear response (GO:1903366)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of fear response (GO:1903365)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
olfactory bulb mitral cell layer development (GO:0061034)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of gene expression, epigenetic (GO:0045815)	19	0	.52	-	 < 0.01	1.00E00	1.00E00
negative regulation of cellular protein catabolic process (GO:1903363)	49	0	1.34	-	 < 0.01	6.42E-01	1.00E00
visceral serous pericardium development (GO:0061032)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
endodermal digestive tract morphogenesis (GO:0061031)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
epithelial cell differentiation involved in mammary gland alveolus development (GO:0061030)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
forebrain neuron differentiation (GO:0021879)	31	0	.85	-	 < 0.01	1.00E00	1.00E00
forebrain neuron fate commitment (GO:0021877)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
forebrain neuroblast division (GO:0021873)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
forebrain generation of neurons (GO:0021872)	38	0	1.04	-	 < 0.01	6.27E-01	1.00E00
forebrain regionalization (GO:0021871)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
eyelid development in camera-type eye (GO:0061029)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
establishment of endothelial barrier (GO:0061028)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
arabinose metabolic process (GO:0019566)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of Golgi organization (GO:1903358)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
umbilical cord development (GO:0061027)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cardiac muscle tissue regeneration (GO:0061026)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
glycerol catabolic process (GO:0019563)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of endocytosis (GO:0045806)	26	0	.71	-	 < 0.01	1.00E00	1.00E00
regulation of nucleus organization (GO:1903353)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
hemostasis (GO:0007599)	61	0	1.67	-	 < 0.01	4.13E-01	1.00E00
L-ornithine transmembrane transport (GO:1903352)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to dopamine (GO:1903351)	17	0	.47	-	 < 0.01	1.00E00	1.00E00
response to dopamine (GO:1903350)	17	0	.47	-	 < 0.01	1.00E00	1.00E00
blood coagulation, intrinsic pathway (GO:0007597)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
blood coagulation (GO:0007596)	59	0	1.62	-	 < 0.01	4.10E-01	1.00E00
forebrain ventricular zone progenitor cell division (GO:0021869)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
forebrain radial glial cell differentiation (GO:0021861)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
pyramidal neuron development (GO:0021860)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
histidine catabolic process to glutamate and formamide (GO:0019556)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of bicellular tight junction assembly (GO:1903348)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
hepatoblast differentiation (GO:0061017)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of bicellular tight junction assembly (GO:1903347)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
glutamate catabolic process to 2-oxoglutarate (GO:0019551)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
glutamate catabolic process to aspartate (GO:0019550)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of meiotic DNA double-strand break formation (GO:1903343)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
hepatic duct development (GO:0061011)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
gall bladder development (GO:0061010)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of meiotic DNA double-strand break formation (GO:1903341)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
respiratory gaseous exchange by respiratory system (GO:0007585)	21	0	.58	-	 < 0.01	1.00E00	1.00E00
response to nutrient (GO:0007584)	37	0	1.01	-	 < 0.01	6.26E-01	1.00E00
pyramidal neuron differentiation (GO:0021859)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
hypothalamic tangential migration using cell-axon interactions (GO:0021856)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
hypothalamus cell migration (GO:0021855)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
hypothalamus development (GO:0021854)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
cerebral cortex GABAergic interneuron migration (GO:0021853)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
pyramidal neuron migration (GO:0021852)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
common bile duct development (GO:0061009)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
arginine catabolic process to ornithine (GO:0019547)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
arginine catabolic process to glutamate (GO:0019544)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
propionate catabolic process (GO:0019543)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of vacuolar transport (GO:1903336)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
pattern specification involved in kidney development (GO:0061004)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of vacuolar transport (GO:1903335)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
propionate biosynthetic process (GO:0019542)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein folding (GO:1903334)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of dendritic spine morphogenesis (GO:0061003)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
propionate metabolic process (GO:0019541)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein folding (GO:1903333)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of dendritic spine morphogenesis (GO:0061002)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of protein folding (GO:1903332)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
regulation of dendritic spine morphogenesis (GO:0061001)	34	0	.93	-	 < 0.01	1.00E00	1.00E00
negative regulation of dendritic spine development (GO:0061000)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
nucleolar fragmentation (GO:0007576)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
age-dependent general metabolic decline (GO:0007571)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
neuroblast division in subventricular zone (GO:0021849)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cell proliferation in forebrain (GO:0021846)	21	0	.58	-	 < 0.01	1.00E00	1.00E00
substrate-independent telencephalic tangential interneuron migration (GO:0021843)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
maintenance of protein localization in organelle (GO:0072595)	26	0	.71	-	 < 0.01	1.00E00	1.00E00
negative regulation of tRNA metabolic process (GO:1903327)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of tRNA metabolic process (GO:1903326)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
oxalate transport (GO:0019532)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cell aging (GO:0007569)	38	0	1.04	-	 < 0.01	6.27E-01	1.00E00
negative regulation of protein modification by small protein conjugation or removal (GO:1903321)	63	0	1.73	-	 < 0.01	4.17E-01	1.00E00
aging (GO:0007568)	89	0	2.44	-	 < 0.01	1.78E-01	1.00E00
embryo implantation (GO:0007566)	22	0	.60	-	 < 0.01	1.00E00	1.00E00
chemorepulsion involved in postnatal olfactory bulb interneuron migration (GO:0021836)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
embryonic olfactory bulb interneuron precursor migration (GO:0021831)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
interneuron migration from the subpallium to the cortex (GO:0021830)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
pentitol catabolic process (GO:0019527)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein maturation (GO:1903319)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein maturation (GO:1903318)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
regulation of protein maturation (GO:1903317)	38	0	1.04	-	 < 0.01	6.27E-01	1.00E00
caveolin-mediated endocytosis (GO:0072584)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
clathrin-dependent endocytosis (GO:0072583)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
regulation of nitrogen cycle metabolic process (GO:1903314)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
D-gluconate metabolic process (GO:0019521)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
aldonic acid metabolic process (GO:0019520)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of mRNA metabolic process (GO:1903312)	73	0	2.00	-	 < 0.01	2.68E-01	1.00E00
endocardial cushion to mesenchymal transition involved in heart valve formation (GO:0003199)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
endocardial cushion development (GO:0003197)	28	0	.77	-	 < 0.01	1.00E00	1.00E00
tricuspid valve formation (GO:0003195)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
pulmonary valve formation (GO:0003193)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
gonadotrophin-releasing hormone neuronal migration to the hypothalamus (GO:0021828)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mitral valve formation (GO:0003192)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
postnatal olfactory bulb interneuron migration (GO:0021827)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
substrate-independent telencephalic tangential migration (GO:0021826)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
atrioventricular valve formation (GO:0003190)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
substrate-dependent cerebral cortex tangential migration (GO:0021825)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cerebral cortex tangential migration using cell-cell interactions (GO:0021823)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
pentitol metabolic process (GO:0019519)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell motility involved in cerebral cortex radial glia guided migration (GO:0021822)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
neurotransmitter-gated ion channel clustering (GO:0072578)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
endothelial cell apoptotic process (GO:0072577)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of regulated secretory pathway (GO:1903306)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
histone H3-K4 trimethylation (GO:0080182)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
tolerance induction to lipopolysaccharide (GO:0072573)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
peptidyl-proline hydroxylation (GO:0019511)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
S-adenosylhomocysteine catabolic process (GO:0019510)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
dosage compensation (GO:0007549)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
positive regulation of hexokinase activity (GO:1903301)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of hexokinase activity (GO:1903300)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
primary sex determination, germ-line (GO:0007542)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
heart valve formation (GO:0003188)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
tricuspid valve morphogenesis (GO:0003186)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
sinoatrial valve morphogenesis (GO:0003185)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
layer formation in cerebral cortex (GO:0021819)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
pulmonary valve morphogenesis (GO:0003184)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
mitral valve morphogenesis (GO:0003183)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
coronary sinus valve morphogenesis (GO:0003182)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
atrioventricular valve morphogenesis (GO:0003181)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration (GO:0021816)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
aortic valve morphogenesis (GO:0003180)	16	0	.44	-	 < 0.01	1.00E00	1.00E00
modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration (GO:0021815)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cell motility involved in cerebral cortex radial glia guided migration (GO:0021814)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cell-cell adhesion involved in neuronal-glial interactions involved in cerebral cortex radial glia guided migration (GO:0021813)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
neuronal-glial interaction involved in cerebral cortex radial glia guided migration (GO:0021812)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
L-methionine salvage from methylthioadenosine (GO:0019509)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
type B pancreatic cell maturation (GO:0072560)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
lateral sprouting involved in mammary gland duct morphogenesis (GO:0060599)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis (GO:0060598)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
primary sex determination (GO:0007538)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
mammary gland specification (GO:0060594)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
mammary gland formation (GO:0060592)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
chondroblast differentiation (GO:0060591)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
sex determination (GO:0007530)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
heart valve morphogenesis (GO:0003179)	28	0	.77	-	 < 0.01	1.00E00	1.00E00
coronary sinus valve development (GO:0003178)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
pulmonary valve development (GO:0003177)	11	0	.30	-	 < 0.01	1.00E00	1.00E00
aortic valve development (GO:0003176)	17	0	.47	-	 < 0.01	1.00E00	1.00E00
tricuspid valve development (GO:0003175)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
mitral valve development (GO:0003174)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
sinoatrial valve development (GO:0003172)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
atrioventricular valve development (GO:0003171)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
heart valve development (GO:0003170)	34	0	.93	-	 < 0.01	1.00E00	1.00E00
cerebral cortex radial glia guided migration (GO:0021801)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
cerebral cortex tangential migration (GO:0021800)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
blood vessel lumenization (GO:0072554)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of protein serine/threonine phosphatase activity (GO:0080163)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
terminal button organization (GO:0072553)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
establishment of synaptic specificity at neuromuscular junction (GO:0007529)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
neuromuscular junction development (GO:0007528)	24	0	.66	-	 < 0.01	1.00E00	1.00E00
negative regulation of lipoprotein lipid oxidation (GO:0060588)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of lipoprotein lipid oxidation (GO:0060587)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
multicellular organismal iron ion homeostasis (GO:0060586)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
somatic muscle development (GO:0007525)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of prostaglandin-endoperoxide synthase activity (GO:0060585)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of prostaglandin-endoperoxide synthase activity (GO:0060584)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
cell fate determination involved in pattern specification (GO:0060582)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cell fate commitment involved in pattern specification (GO:0060581)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
muscle cell fate determination (GO:0007521)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
myoblast fusion (GO:0007520)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
coronary vein morphogenesis (GO:0003169)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
ventral spinal cord interneuron fate determination (GO:0060580)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
Purkinje myocyte differentiation (GO:0003168)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
bundle of His development (GO:0003166)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
Purkinje myocyte development (GO:0003165)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
His-Purkinje system development (GO:0003164)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
sinoatrial node development (GO:0003163)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
atrioventricular node development (GO:0003162)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cardiac conduction system development (GO:0003161)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
endocardium morphogenesis (GO:0003160)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of fertilization (GO:0080154)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
ventral spinal cord interneuron fate commitment (GO:0060579)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
superior vena cava morphogenesis (GO:0060578)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
pulmonary vein morphogenesis (GO:0060577)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
intestinal epithelial cell development (GO:0060576)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
intestinal epithelial cell differentiation (GO:0060575)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
intestinal epithelial cell maturation (GO:0060574)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cell fate specification involved in pattern specification (GO:0060573)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
adult heart development (GO:0007512)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
morphogenesis of an epithelial bud (GO:0060572)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
morphogenesis of an epithelial fold (GO:0060571)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
morphogenesis of an endothelium (GO:0003159)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
endocardium development (GO:0003157)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
regulation of animal organ formation (GO:0003156)	17	0	.47	-	 < 0.01	1.00E00	1.00E00
outflow tract morphogenesis (GO:0003151)	36	0	.99	-	 < 0.01	1.00E00	1.00E00
glycolate catabolic process (GO:0046296)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
glycolate biosynthetic process (GO:0046295)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
formaldehyde catabolic process (GO:0046294)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
fibroblast activation (GO:0072537)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
formaldehyde biosynthetic process (GO:0046293)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
formaldehyde metabolic process (GO:0046292)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
amino acid homeostasis (GO:0080144)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
pyrimidine-containing compound transmembrane transport (GO:0072531)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mesoderm migration involved in gastrulation (GO:0007509)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of DNA-templated transcription, termination (GO:0060567)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of postsynaptic density protein 95 clustering (GO:1902897)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of DNA-templated transcription, termination (GO:0060566)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
terminal web assembly (GO:1902896)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
neuroepithelial cell differentiation (GO:0060563)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
apoptotic process involved in morphogenesis (GO:0060561)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
mesodermal cell fate specification (GO:0007501)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
membranous septum morphogenesis (GO:0003149)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
mesodermal cell fate determination (GO:0007500)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
outflow tract septum morphogenesis (GO:0003148)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
embryonic heart tube formation (GO:0003144)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
embryonic heart tube morphogenesis (GO:0003143)	41	0	1.12	-	 < 0.01	6.28E-01	1.00E00
cardiogenic plate morphogenesis (GO:0003142)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
determination of left/right asymmetry in lateral mesoderm (GO:0003140)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
pyrimidine-containing compound biosynthetic process (GO:0072528)	20	0	.55	-	 < 0.01	1.00E00	1.00E00
pyridine-containing compound catabolic process (GO:0072526)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
pyridine-containing compound biosynthetic process (GO:0072525)	19	0	.52	-	 < 0.01	1.00E00	1.00E00
pyridine-containing compound metabolic process (GO:0072524)	28	0	.77	-	 < 0.01	1.00E00	1.00E00
seminiferous tubule development (GO:0072520)	12	0	.33	-	 < 0.01	1.00E00	1.00E00
positive regulation of calcidiol 1-monooxygenase activity (GO:0060559)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of calcidiol 1-monooxygenase activity (GO:0060558)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
protein localization to spindle microtubule (GO:1902889)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of vitamin D biosynthetic process (GO:0060556)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
positive regulation of response to oxidative stress (GO:1902884)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of response to oxidative stress (GO:1902883)	21	0	.58	-	 < 0.01	1.00E00	1.00E00
regulation of response to oxidative stress (GO:1902882)	65	0	1.78	-	 < 0.01	4.22E-01	1.00E00
secondary heart field specification (GO:0003139)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
primary heart field specification (GO:0003138)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
endodermal-mesodermal cell signaling involved in heart induction (GO:0003134)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
endodermal-mesodermal cell signaling (GO:0003133)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
BMP signaling pathway involved in heart induction (GO:0003130)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
proteasome core complex assembly (GO:0080129)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
stilbene catabolic process (GO:0046272)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
phenylpropanoid catabolic process (GO:0046271)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of secondary heart field cardioblast proliferation (GO:0072513)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of necroptotic process (GO:0060545)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of strand invasion (GO:0060542)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
diaphragm morphogenesis (GO:0060540)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of amacrine cell differentiation (GO:1902871)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
heart induction (GO:0003129)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of amacrine cell differentiation (GO:1902870)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
heart field specification (GO:0003128)	7	0	.19	-	 < 0.01	1.00E00	1.00E00
trivalent inorganic anion homeostasis (GO:0072506)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
DNA demethylation (GO:0080111)	13	0	.36	-	 < 0.01	1.00E00	1.00E00
cellular trivalent inorganic anion homeostasis (GO:0072502)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
diaphragm development (GO:0060539)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of amacrine cell differentiation (GO:1902869)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cartilage morphogenesis (GO:0060536)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
regulation of retina development in camera-type eye (GO:1902866)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
trachea cartilage morphogenesis (GO:0060535)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
trachea cartilage development (GO:0060534)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
bronchus cartilage development (GO:0060532)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
propionyl-CoA biosynthetic process (GO:1902860)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of vasoconstriction by circulating norepinephrine (GO:0003117)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of vasoconstriction by norepinephrine (GO:0003116)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
detection of monosaccharide stimulus (GO:0034287)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
squamous basal epithelial stem cell differentiation involved in prostate gland acinus development (GO:0060529)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to disaccharide (GO:0034285)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development (GO:0060528)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
response to monosaccharide (GO:0034284)	65	0	1.78	-	 < 0.01	4.22E-01	1.00E00
propionyl-CoA catabolic process (GO:1902859)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis (GO:0060527)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
propionyl-CoA metabolic process (GO:1902858)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
prostate glandular acinus morphogenesis (GO:0060526)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of non-motile cilium assembly (GO:1902856)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
prostate glandular acinus development (GO:0060525)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
activation of prostate induction by androgen receptor signaling pathway (GO:0060520)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of the force of heart contraction by chemical signal (GO:0003108)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of systemic arterial blood pressure by endothelin (GO:0003100)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
terpene catabolic process (GO:0046247)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
epithelial cell proliferation involved in prostatic bud elongation (GO:0060517)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
primary prostatic bud elongation (GO:0060516)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of mitotic spindle elongation (GO:1902846)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
prostatic bud formation (GO:0060513)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
prostate gland morphogenesis (GO:0060512)	15	0	.41	-	 < 0.01	1.00E00	1.00E00
type II pneumocyte differentiation (GO:0060510)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
type I pneumocyte differentiation (GO:0060509)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
positive regulation of autophagy in response to ER overload (GO:0034263)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of nuclear migration along microtubule (GO:1902838)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of GTPase activity (GO:0034260)	27	0	.74	-	 < 0.01	1.00E00	1.00E00
bud dilation involved in lung branching (GO:0060503)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
epithelial cell proliferation involved in lung morphogenesis (GO:0060502)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
coumarin catabolic process (GO:0046226)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
aflatoxin catabolic process (GO:0046223)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
aflatoxin metabolic process (GO:0046222)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of urea metabolic process (GO:0034255)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of late endosome to lysosome transport (GO:1902823)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of late endosome to lysosome transport (GO:1902822)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
indolalkylamine catabolic process (GO:0046218)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244)	9	0	.25	-	 < 0.01	1.00E00	1.00E00
regulation of transcription elongation from RNA polymerase II promoter (GO:0034243)	27	0	.74	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein localization to microtubule (GO:1902817)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of syncytium formation by plasma membrane fusion (GO:0034242)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of protein localization to microtubule (GO:1902816)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of skeletal muscle fiber differentiation (GO:1902811)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
nitric oxide metabolic process (GO:0046209)	8	0	.22	-	 < 0.01	1.00E00	1.00E00
spermine catabolic process (GO:0046208)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
nor-spermidine metabolic process (GO:0046204)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of cellular extravasation (GO:0002693)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
spermidine catabolic process (GO:0046203)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of cellular extravasation (GO:0002692)	5	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of cellular extravasation (GO:0002691)	14	0	.38	-	 < 0.01	1.00E00	1.00E00
regulation of skeletal muscle fiber differentiation (GO:1902809)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of cell cycle G1/S phase transition (GO:1902808)	32	0	.88	-	 < 0.01	1.00E00	1.00E00
islet amyloid polypeptide processing (GO:0034231)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
enkephalin processing (GO:0034230)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of synaptic vesicle transport (GO:1902805)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of synaptic vesicle transport (GO:1902803)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of leukocyte chemotaxis (GO:0002689)	10	0	.27	-	 < 0.01	1.00E00	1.00E00
somatic recombination of T cell receptor gene segments (GO:0002681)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
